Citrus Sinensis ID: 016789
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 382 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FID9 | 880 | Probable receptor-like pr | no | no | 0.837 | 0.363 | 0.336 | 7e-50 | |
| Q9LX66 | 830 | Receptor-like protein kin | no | no | 0.945 | 0.434 | 0.330 | 2e-47 | |
| O80623 | 815 | Probable receptor-like pr | no | no | 0.845 | 0.396 | 0.339 | 2e-47 | |
| Q9FID8 | 873 | Putative receptor-like pr | no | no | 0.767 | 0.335 | 0.346 | 5e-47 | |
| Q9LX29 | 895 | Serine/threonine-protein | no | no | 0.835 | 0.356 | 0.347 | 6e-47 | |
| Q9SA72 | 849 | Probable receptor-like pr | no | no | 0.882 | 0.396 | 0.336 | 8e-47 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.719 | 0.383 | 0.372 | 1e-46 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.719 | 0.536 | 0.375 | 4e-46 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.769 | 0.431 | 0.352 | 6e-46 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.719 | 0.387 | 0.369 | 1e-45 |
| >sp|Q9FID9|Y5389_ARATH Probable receptor-like protein kinase At5g38990 OS=Arabidopsis thaliana GN=At5g38990 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 198 bits (503), Expect = 7e-50, Method: Compositional matrix adjust.
Identities = 118/351 (33%), Positives = 189/351 (53%), Gaps = 31/351 (8%)
Query: 32 QSKNYQNKNSETGSSDPSALVEWN---RGAGPSSATGQPSFGPQGARQFSMEELEQATKQ 88
+ K N++S ++ PS W G G ++ S R+FS+ E++ AT
Sbjct: 465 KRKKKSNESSVDTTNKPSTNSSWGPLLHGTGSTNTKSASSLPSDLCRRFSIYEIKSATND 524
Query: 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQ---EFVAEVTYLSEIRHRNLVT 143
F E +IG G FG VYKG + T+VA+KR + Q EF E+ LS++RH +LV+
Sbjct: 525 FEEKLIIGVGGFGSVYKGRIDGGATLVAVKRLEITSNQGAKEFDTELEMLSKLRHVHLVS 584
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS- 202
L+GYC + +LV+EY+P+G++ +HL+ S L +K+R+ I +GAA+GL +LH+
Sbjct: 585 LIGYCDDDNEMVLVYEYMPHGTLKDHLFRRDKASDPPLSWKRRLEICIGAARGLQYLHTG 644
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV---------F 253
K ++H++ KT N+L+DENF+AKV+D G+S++ GP+ S +V +
Sbjct: 645 AKYTIIHRDIKTTNILLDENFVAKVSDFGLSRV-------GPTSASQTHVSTVVKGTFGY 697
Query: 254 RDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS---NN 310
DPE + +E SD+YSFGV LLE++ + LI+WV+S + +
Sbjct: 698 LDPEYYRRQILTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVKSNFNKRTVDQ 757
Query: 311 FVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE---RIHE 358
+D L T+ M + ++C+ G RP M V+ LE ++HE
Sbjct: 758 IIDSDLTADITSTSMEKFCEIAIRCVQDRGMERPPMNDVVWALEFALQLHE 808
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 190 bits (482), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 129/390 (33%), Positives = 209/390 (53%), Gaps = 29/390 (7%)
Query: 4 SIAAVVGGAAGALAFMAIVLGLVWLCKSQSKNYQNKNSETGSSDPSALVEWNRGAGPSSA 63
++ +VG A G+L + LG ++ + K Q+ +S+T P ++ + G+ S+
Sbjct: 403 NLGLIVGSAIGSL-LAVVFLGSCFVLYKKRKRGQDGHSKTWM--PFSINGTSMGSKYSNG 459
Query: 64 TGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP 122
T S + ++ AT F E+ IG G FG VYKG L D T VA+KR G+P
Sbjct: 460 TTLTSITTNANYRIPFAAVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKR--GNP 517
Query: 123 RQ-----EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLES 177
+ EF E+ LS+ RHR+LV+L+GYC +N +L++EY+ NG++ +HLY +GL S
Sbjct: 518 KSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPS 577
Query: 178 STKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAKVADTGISKL- 235
L +KQR+ I +GAA+GL +LH+ P++H++ K+AN+L+DENF+AKVAD G+SK
Sbjct: 578 ---LTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTG 634
Query: 236 --LENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEA------S 287
L+ + GS + DPE ++ SD+YSFGV L E++ +
Sbjct: 635 PELDQTHVSTAVKGSF--GYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPR 692
Query: 288 HIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKME 347
+V+L E ++W + + + +D L G + +R +C++ G RP M
Sbjct: 693 EMVNLA--EWAMKW-QKKGQLDQIIDQSLRGNIRPDSLRKFAETGEKCLADYGVDRPSMG 749
Query: 348 IVMTELERIHEKEMALTTFMGEGTATIALG 377
V+ LE + + A+ E +T +G
Sbjct: 750 DVLWNLEYALQLQEAVIDGEPEDNSTNMIG 779
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O80623|Y2393_ARATH Probable receptor-like protein kinase At2g39360 OS=Arabidopsis thaliana GN=At2g39360 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 189 bits (481), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 127/374 (33%), Positives = 202/374 (54%), Gaps = 51/374 (13%)
Query: 8 VVGGAAGALAFMAIVLGLV--WLC--------------KSQSKNYQNKNSETGSSDPSAL 51
++ G + AL +A+V G+V W C S+ ++Q K +ETG S L
Sbjct: 410 LIAGLSAALC-VALVFGVVVSWWCIRKRRRRNRQMQTVHSRGDDHQIKKNETGES----L 464
Query: 52 VEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD- 110
+ SS G ++ + +++AT F E+ +IG G FG VYKG+LRD
Sbjct: 465 I------FSSSKIGY---------RYPLALIKEATDDFDESLVIGVGGFGKVYKGVLRDK 509
Query: 111 TVVAIKRRVGSPRQ---EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMC 167
T VA+KR RQ EF EV L++ RHR+LV+L+GYC +N ++V+EY+ G++
Sbjct: 510 TEVAVKRGAPQSRQGLAEFKTEVEMLTQFRHRHLVSLIGYCDENSEMIIVYEYMEKGTLK 569
Query: 168 NHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAK 226
+HLY+ L+ +L ++QR+ I +GAA+GL +LH+ ++H++ K+AN+L+D+NF+AK
Sbjct: 570 DHLYD--LDDKPRLSWRQRLEICVGAARGLHYLHTGSTRAIIHRDVKSANILLDDNFMAK 627
Query: 227 VADTGISKLLENIEEAGPS---HGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTG 283
VAD G+SK ++++ S GS + DPE +E SD+YSFGV +LE+V G
Sbjct: 628 VADFGLSKTGPDLDQTHVSTAVKGSF--GYLDPEYLTRQQLTEKSDVYSFGVVMLEVVCG 685
Query: 284 QEASHIVSLGSYEALIQWVRSRLSS---NNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPG 340
+ LI+W + + +D L G E ++ +T +C+S G
Sbjct: 686 RPVIDPSLPREKVNLIEWAMKLVKKGKLEDIIDPFLVGKVKLEEVKKYCEVTEKCLSQNG 745
Query: 341 RRRPKMEIVMTELE 354
RP M ++ LE
Sbjct: 746 IERPAMGDLLWNLE 759
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FID8|Y5900_ARATH Putative receptor-like protein kinase At5g39000 OS=Arabidopsis thaliana GN=At5g39000 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 188 bits (478), Expect = 5e-47, Method: Compositional matrix adjust.
Identities = 112/323 (34%), Positives = 180/323 (55%), Gaps = 30/323 (9%)
Query: 59 GPSSATGQP--SFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD--TVVA 114
G S +P S R+FS+ E++ AT F + +IG G FG VYKG + T+VA
Sbjct: 486 GTDSTNTKPAKSLPADLCRRFSIFEIKSATNDFEDKLIIGVGGFGSVYKGQIDGGATLVA 545
Query: 115 IKRRVGSPRQ---EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLY 171
+KR + Q EF E+ LS++RH +LV+L+GYC ++ +LV+EY+P+G++ +HL+
Sbjct: 546 VKRLEITSNQGAKEFETELEMLSKLRHVHLVSLIGYCDEDNEMVLVYEYMPHGTLKDHLF 605
Query: 172 ETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAKVADT 230
S L +K+R+ I +GAA+GL +LH+ K ++H++ KT N+L+DENF+ KV+D
Sbjct: 606 RRDKTSDPPLSWKRRLEICIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVTKVSDF 665
Query: 231 GISKLLENIEEAGPSHGSIVNV---------FRDPEVEESGVFSEMSDIYSFGVFLLELV 281
G+S++ GP+ S +V + DPE V +E SD+YSFGV LLE++
Sbjct: 666 GLSRV-------GPTSASQTHVSTVVKGTFGYLDPEYYRRQVLTEKSDVYSFGVVLLEVL 718
Query: 282 TGQEASHIVSLGSYEALIQWVRS---RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSS 338
+ LI+WV+S R + + +D L+ T+ + + ++C+
Sbjct: 719 CCRPIRMQSVPPEQADLIRWVKSNYRRGTVDQIIDSDLSADITSTSLEKFCEIAVRCVQD 778
Query: 339 PGRRRPKMEIVMTELE---RIHE 358
G RP M V+ LE ++HE
Sbjct: 779 RGMERPPMNDVVWALEFALQLHE 801
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LX29|ACR4_ARATH Serine/threonine-protein kinase-like protein ACR4 OS=Arabidopsis thaliana GN=ACR4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 188 bits (477), Expect = 6e-47, Method: Compositional matrix adjust.
Identities = 122/351 (34%), Positives = 198/351 (56%), Gaps = 32/351 (9%)
Query: 34 KNYQNKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETS 93
+N + ++T SS SA + N P Q + AR F+ EELE+A F E S
Sbjct: 460 RNCRCSENDTRSSKDSAFTKDNGKIRPDLDELQKR---RRARVFTYEELEKAADGFKEES 516
Query: 94 LIGFGSFGPVYKGLLRD-TVVAIKRRVGSPRQ-----EFVAEVTYLSEIRHRNLVTLLGY 147
++G GSF VYKG+LRD T VA+KR + S + EF E+ LS + H +L++LLGY
Sbjct: 517 IVGKGSFSCVYKGVLRDGTTVAVKRAIMSSDKQKNSNEFRTELDLLSRLNHAHLLSLLGY 576
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK-PP 206
C++ G ++LV+E++ +GS+ NHL+ +L++ +RV+IA+ AA+G+ +LH PP
Sbjct: 577 CEECGERLLVYEFMAHGSLHNHLHGKNKALKEQLDWVKRVTIAVQAARGIEYLHGYACPP 636
Query: 207 LVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP----SHGSIVNVFRDPEVEESG 262
++H++ K++N+L+DE A+VAD G+S LL ++ P G++ + DPE
Sbjct: 637 VIHRDIKSSNILIDEEHNARVADFGLS-LLGPVDSGSPLAELPAGTL--GYLDPEYYRLH 693
Query: 263 VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEA--LIQWVRSRLSS---NNFVDHRLA 317
+ SD+YSFGV LLE+++G++A + YE +++W + + N +D L
Sbjct: 694 YLTTKSDVYSFGVLLLEILSGRKAIDM----HYEEGNIVEWAVPLIKAGDINALLDPVLK 749
Query: 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFMG 368
E ++ ++ + +C+ G+ RP M+ V T LER AL MG
Sbjct: 750 HPSEIEALKRIVSVACKCVRMRGKDRPSMDKVTTALER------ALAQLMG 794
|
Controls formative cell division in meristems, including root tips and lateral root initiation zones of the pericycle, in response to CLE40 signal. Acts with CLE40p peptide as a ligand-receptor pair in a signal transduction pathway, coordinating movement of the root tip and organization of cell divisions in the root meristem. Required during embryogenesis and development, probably for the differentiation of protoderm and epidermal cells. Involved in the regulation of cellular organization during the development of sepal margins and ovule integument outgrowth. Can phosphorylate ALE2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 188 bits (477), Expect = 8e-47, Method: Compositional matrix adjust.
Identities = 126/374 (33%), Positives = 198/374 (52%), Gaps = 37/374 (9%)
Query: 11 GAAGALAFMAIVLGLVWLC---KSQSKNYQNKNSETGSSDPSALVEWNRGAGPSSATGQP 67
GA A+ + LG++ +C K +SK+ ++KN+ G P L N A + G
Sbjct: 436 GAGIAIIIFFVFLGILVVCLCKKRRSKSDESKNNPPGWR-PLFLHVNNSTANAKATGGSL 494
Query: 68 SFGPQGA----RQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP 122
A R+F++ E+ ATK F + IG G FG VY+G L D T++AIKR
Sbjct: 495 RLNTLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHS 554
Query: 123 RQ---EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESST 179
+Q EF E+ LS +RHR+LV+L+G+C ++ +LV+EY+ NG++ +HL+ + L
Sbjct: 555 QQGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNL---P 611
Query: 180 KLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238
L +KQR+ +G+A+GL +LH+ + ++H++ KT N+L+DENF+AK++D G+SK
Sbjct: 612 PLSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSK---- 667
Query: 239 IEEAGPS--HGSIVNVFR------DPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIV 290
AGPS H + + DPE +E SD+YSFGV L E V + +
Sbjct: 668 ---AGPSMDHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPT 724
Query: 291 SLGSYEALIQWVRSRLSSNNF---VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKME 347
L +W S N +D L G ++ E + + +C++ G+ RP M
Sbjct: 725 LPKDQINLAEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMG 784
Query: 348 IVMTELE---RIHE 358
V+ LE +IHE
Sbjct: 785 EVLWSLEYVLQIHE 798
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 187 bits (475), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 108/290 (37%), Positives = 173/290 (59%), Gaps = 15/290 (5%)
Query: 77 FSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKR-RVGSPR--QEFVAEVTY 132
F+ EEL +AT FSE +L+G G FG V+KG+LR+ VA+K+ + GS + +EF AEV
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401
Query: 133 LSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALG 192
+S + HR+LV L+GYC + ++LV+E++PN ++ HL+ G + +E+ R+ IA+G
Sbjct: 402 ISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPT---MEWSSRLKIAVG 458
Query: 193 AAKGLCHLH-SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVN 251
+AKGL +LH + P ++H++ K +N+L+D F AKVAD G++K+ + +
Sbjct: 459 SAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTF 518
Query: 252 VFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS--- 308
+ PE SG +E SD++SFGV LLEL+TG+ + ++ + +L+ W R L+
Sbjct: 519 GYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVSE 578
Query: 309 -NNF---VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354
NF VD +L + E M ++ C+ S RRP+M+ V LE
Sbjct: 579 LGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLE 628
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 186 bits (471), Expect = 4e-46, Method: Compositional matrix adjust.
Identities = 109/290 (37%), Positives = 173/290 (59%), Gaps = 15/290 (5%)
Query: 77 FSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKR-RVGSPR--QEFVAEVTY 132
F+ EL +AT +FSE +L+G G FG VYKG+L + VA+K+ +VGS + +EF AEV
Sbjct: 171 FTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNI 230
Query: 133 LSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALG 192
+S+I HRNLV+L+GYC ++LV+E++PN ++ HL+ G + +E+ R+ IA+
Sbjct: 231 ISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGRPT---MEWSLRLKIAVS 287
Query: 193 AAKGLCHLH-SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVN 251
++KGL +LH + P ++H++ K AN+L+D F AKVAD G++K+ + +
Sbjct: 288 SSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHVSTRVMGTF 347
Query: 252 VFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVR----SRLS 307
+ PE SG +E SD+YSFGV LLEL+TG+ ++ + ++L+ W R L
Sbjct: 348 GYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQALE 407
Query: 308 SNNF---VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354
+NF D +L + E M ++ C+ RRRP+M+ V+ LE
Sbjct: 408 ESNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLE 457
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 185 bits (469), Expect = 6e-46, Method: Compositional matrix adjust.
Identities = 110/312 (35%), Positives = 177/312 (56%), Gaps = 18/312 (5%)
Query: 77 FSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKR-RVGSPR--QEFVAEVTY 132
FS +EL Q T FSE +L+G G FG VYKG+L D VA+K+ ++G + +EF AEV
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386
Query: 133 LSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALG 192
+S + HR+LVTL+GYC +++LV++Y+PN ++ HL+ G T ++ RV +A G
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMT---WETRVRVAAG 443
Query: 193 AAKGLCHLH-SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVN 251
AA+G+ +LH P ++H++ K++N+L+D +F A VAD G++K+ + ++ ++
Sbjct: 444 AARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMG 503
Query: 252 VF--RDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS- 308
F PE SG SE +D+YS+GV LLEL+TG++ E+L++W R L
Sbjct: 504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQA 563
Query: 309 ------NNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMA 362
+ VD RL F M ++ C+ +RPKM V+ L+ + E+
Sbjct: 564 IENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTL-EEATD 622
Query: 363 LTTFMGEGTATI 374
+T M G + +
Sbjct: 623 ITNGMRPGQSQV 634
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 184 bits (467), Expect = 1e-45, Method: Compositional matrix adjust.
Identities = 110/298 (36%), Positives = 179/298 (60%), Gaps = 23/298 (7%)
Query: 73 GARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKR-RVGSPR--QEFVA 128
G F+ EEL T+ FS+ +++G G FG VYKG L D +VA+K+ +VGS + +EF A
Sbjct: 337 GQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKA 396
Query: 129 EVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVS 188
EV +S + HR+LV+L+GYC + ++L++EY+PN ++ +HL+ G LE+ +RV
Sbjct: 397 EVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKG---RPVLEWARRVR 453
Query: 189 IALGAAKGLCHLH-SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHG 247
IA+G+AKGL +LH P ++H++ K+AN+L+D+ F A+VAD G++KL ++ + +H
Sbjct: 454 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQ----THV 509
Query: 248 S--IVNVFR--DPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVR 303
S ++ F PE +SG ++ SD++SFGV LLEL+TG++ E+L++W R
Sbjct: 510 STRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWAR 569
Query: 304 SRLSS-------NNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354
L + VD RL + + +I C+ G +RP+M V+ L+
Sbjct: 570 PLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALD 627
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 382 | ||||||
| 255551685 | 375 | serine/threonine protein kinase, putativ | 0.981 | 1.0 | 0.719 | 1e-156 | |
| 297736893 | 385 | unnamed protein product [Vitis vinifera] | 0.937 | 0.929 | 0.743 | 1e-154 | |
| 147834873 | 496 | hypothetical protein VITISV_043188 [Viti | 0.937 | 0.721 | 0.721 | 1e-152 | |
| 359477297 | 379 | PREDICTED: serine/threonine-protein kina | 0.921 | 0.928 | 0.729 | 1e-149 | |
| 218196661 | 378 | hypothetical protein OsI_19707 [Oryza sa | 0.882 | 0.891 | 0.629 | 1e-122 | |
| 222631354 | 378 | hypothetical protein OsJ_18302 [Oryza sa | 0.882 | 0.891 | 0.626 | 1e-122 | |
| 326518874 | 378 | predicted protein [Hordeum vulgare subsp | 0.910 | 0.920 | 0.605 | 1e-119 | |
| 125529019 | 384 | hypothetical protein OsI_05098 [Oryza sa | 0.887 | 0.882 | 0.626 | 1e-117 | |
| 125573241 | 384 | hypothetical protein OsJ_04683 [Oryza sa | 0.887 | 0.882 | 0.626 | 1e-116 | |
| 357133965 | 380 | PREDICTED: probable receptor-like protei | 0.918 | 0.923 | 0.592 | 1e-116 |
| >gi|255551685|ref|XP_002516888.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223543976|gb|EEF45502.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 555 bits (1431), Expect = e-156, Method: Compositional matrix adjust.
Identities = 275/382 (71%), Positives = 313/382 (81%), Gaps = 7/382 (1%)
Query: 1 MSKSIAAVVGGAAGALAFMAIVLGLVWLCKSQSKNYQNKNSETGSSDPSALVEWNRGAGP 60
MSK AA+VGGA G A ++ +W KS KN+ NKNSETGSSDPSAL G
Sbjct: 1 MSKPYAAIVGGAVGVALVAAFII--LWFFKSHCKNFSNKNSETGSSDPSAL-----GGRS 53
Query: 61 SSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVG 120
SSA + FG QGARQF+M+ELEQATKQFS+++LIG+GSFG VYKGLL D+VVAIKRR
Sbjct: 54 SSAPSRYIFGSQGARQFTMDELEQATKQFSDSNLIGYGSFGSVYKGLLHDSVVAIKRRPN 113
Query: 121 SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTK 180
R +FVAEV YLSEIRHRNLV+LLGYC++ G QMLVFEY+PNGSMCNHLY+ GLESSTK
Sbjct: 114 VARDDFVAEVIYLSEIRHRNLVSLLGYCKERGSQMLVFEYVPNGSMCNHLYDRGLESSTK 173
Query: 181 LEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240
LEFKQR+SIALGAAKGLCHLHSL PPLVHKNF+ ANVLVDENFI KVAD GISKLLE IE
Sbjct: 174 LEFKQRLSIALGAAKGLCHLHSLNPPLVHKNFRMANVLVDENFIVKVADAGISKLLEKIE 233
Query: 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQ 300
EAGPS S VNVF+DPE E SG F+EMSD+YSFGVFLLEL+TGQEA H+ G+ E+LIQ
Sbjct: 234 EAGPSFTSGVNVFQDPETEVSGTFTEMSDVYSFGVFLLELLTGQEAVHLGFSGTDESLIQ 293
Query: 301 WVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360
WV SRL+SN+FVD RL G+FT +G+RDLIRLTL+CMS PG RPKME+V+ ELERIH++E
Sbjct: 294 WVASRLNSNSFVDRRLMGSFTRDGIRDLIRLTLRCMSFPGTGRPKMEMVVAELERIHDRE 353
Query: 361 MALTTFMGEGTATIALGSELFT 382
M LTT MGEGTAT GSELFT
Sbjct: 354 MELTTVMGEGTATFLKGSELFT 375
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297736893|emb|CBI26094.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1420), Expect = e-154, Method: Compositional matrix adjust.
Identities = 267/359 (74%), Positives = 306/359 (85%), Gaps = 1/359 (0%)
Query: 25 LVWLCKSQSKNYQNKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQ 84
VW CK Q KN+ NKNSETGSSDPSA VEWNR GPSSA P GPQGARQF+MEELEQ
Sbjct: 25 FVWFCKLQCKNFSNKNSETGSSDPSAPVEWNRRGGPSSAAAPPLSGPQGARQFTMEELEQ 84
Query: 85 ATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVT 143
ATKQF+E++LIG+GSFG VYKG L D T+VAIKRR G PR+EFVAE T LSEI+HRNLVT
Sbjct: 85 ATKQFNESNLIGYGSFGLVYKGFLSDGTIVAIKRRPGPPRREFVAEATNLSEIQHRNLVT 144
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
LLGYCQ++G QMLVFEYLPNGSMCNHLY+TGL+++TKLEFK+R+SIALGAAKGL HLH+L
Sbjct: 145 LLGYCQESGSQMLVFEYLPNGSMCNHLYDTGLDATTKLEFKRRLSIALGAAKGLRHLHTL 204
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGV 263
KPPLVH+NFKTANVLVDENFIAKVADTGIS+LLE IE+AGPS VNVF+ PE+EES
Sbjct: 205 KPPLVHRNFKTANVLVDENFIAKVADTGISRLLEKIEDAGPSQTPSVNVFQHPEIEESRT 264
Query: 264 FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323
FSE+SD+YSFGVFLLEL+TG+EA + S GS E+L QWV +RLS N+FVDHRL G+FT E
Sbjct: 265 FSEISDVYSFGVFLLELITGREALYDESFGSDESLFQWVETRLSINDFVDHRLVGSFTME 324
Query: 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFMGEGTATIALGSELFT 382
GM+DLI+L LQCMS G+ + K+E V+ ELERIHEKEMALTT MGEGT LGS+LFT
Sbjct: 325 GMKDLIKLMLQCMSLSGKWQLKIEKVVLELERIHEKEMALTTGMGEGTTKFTLGSQLFT 383
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147834873|emb|CAN74612.1| hypothetical protein VITISV_043188 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 542 bits (1397), Expect = e-152, Method: Compositional matrix adjust.
Identities = 267/370 (72%), Positives = 306/370 (82%), Gaps = 12/370 (3%)
Query: 25 LVWLCKSQSKNYQNKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQ 84
VW CK Q KN+ NKNSETGSSDPSA VEWNR GPSSA P GPQGARQF+MEELEQ
Sbjct: 125 FVWFCKLQCKNFSNKNSETGSSDPSAPVEWNRRGGPSSAAAPPLSGPQGARQFTMEELEQ 184
Query: 85 ATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVT 143
ATKQF+E++LIG+GSFG VYKG L D T+VAIKRR G PR+EFVAE T LSEI+HRNLVT
Sbjct: 185 ATKQFNESNLIGYGSFGLVYKGFLSDGTIVAIKRRPGPPRREFVAEATNLSEIQHRNLVT 244
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLY-----------ETGLESSTKLEFKQRVSIALG 192
LLGYCQ++G QMLVFEYLPNGSMCNHLY +TGL+++TKLEFK+R+SIALG
Sbjct: 245 LLGYCQESGSQMLVFEYLPNGSMCNHLYARHVTVVHCLTDTGLDATTKLEFKRRLSIALG 304
Query: 193 AAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV 252
AAKGL HLH+LKPPLVH+NFKTANVLVDENFIAKVADTGIS+LLE IE+AGPS VNV
Sbjct: 305 AAKGLRHLHTLKPPLVHRNFKTANVLVDENFIAKVADTGISRLLEKIEDAGPSQTPSVNV 364
Query: 253 FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312
F+ PE+EES FSE+SD+YSFGVFLLEL+TG+EA + S GS E+L QWV +RLS N+FV
Sbjct: 365 FQHPEIEESRTFSEISDVYSFGVFLLELITGREALYDESFGSDESLFQWVETRLSINDFV 424
Query: 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFMGEGTA 372
DHRL G+FT EGM+DLI+L LQCMS G+ + K+E V+ ELERIHEKEMALTT MGEGT
Sbjct: 425 DHRLVGSFTMEGMKDLIKLMLQCMSLSGKWQLKIEKVVLELERIHEKEMALTTGMGEGTT 484
Query: 373 TIALGSELFT 382
LGS+LFT
Sbjct: 485 KFTLGSQLFT 494
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477297|ref|XP_002276534.2| PREDICTED: serine/threonine-protein kinase-like protein ACR4-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 533 bits (1374), Expect = e-149, Method: Compositional matrix adjust.
Identities = 262/359 (72%), Positives = 301/359 (83%), Gaps = 7/359 (1%)
Query: 25 LVWLCKSQSKNYQNKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQ 84
VW CK Q KN+ NKNSETGSSDPSA GPSSA P GPQGARQF+MEELEQ
Sbjct: 25 FVWFCKLQCKNFSNKNSETGSSDPSA------PGGPSSAAAPPLSGPQGARQFTMEELEQ 78
Query: 85 ATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVT 143
ATKQF+E++LIG+GSFG VYKG L D T+VAIKRR G PR+EFVAE T LSEI+HRNLVT
Sbjct: 79 ATKQFNESNLIGYGSFGLVYKGFLSDGTIVAIKRRPGPPRREFVAEATNLSEIQHRNLVT 138
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
LLGYCQ++G QMLVFEYLPNGSMCNHLY+TGL+++TKLEFK+R+SIALGAAKGL HLH+L
Sbjct: 139 LLGYCQESGSQMLVFEYLPNGSMCNHLYDTGLDATTKLEFKRRLSIALGAAKGLRHLHTL 198
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGV 263
KPPLVH+NFKTANVLVDENFIAKVADTGIS+LLE IE+AGPS VNVF+ PE+EES
Sbjct: 199 KPPLVHRNFKTANVLVDENFIAKVADTGISRLLEKIEDAGPSQTPSVNVFQHPEIEESRT 258
Query: 264 FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323
FSE+SD+YSFGVFLLEL+TG+EA + S GS E+L QWV +RLS N+FVDHRL G+FT E
Sbjct: 259 FSEISDVYSFGVFLLELITGREALYDESFGSDESLFQWVETRLSINDFVDHRLVGSFTME 318
Query: 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFMGEGTATIALGSELFT 382
GM+DLI+L LQCMS G+ + K+E V+ ELERIHEKEMALTT MGEGT LGS+LFT
Sbjct: 319 GMKDLIKLMLQCMSLSGKWQLKIEKVVLELERIHEKEMALTTGMGEGTTKFTLGSQLFT 377
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|218196661|gb|EEC79088.1| hypothetical protein OsI_19707 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 445 bits (1145), Expect = e-122, Method: Compositional matrix adjust.
Identities = 216/343 (62%), Positives = 265/343 (77%), Gaps = 6/343 (1%)
Query: 40 NSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGS 99
+ ETGSSDPS LVEW +G SSA QGARQFS++EL QATK FSE +L+G GS
Sbjct: 40 SDETGSSDPSTLVEWGKGGRSSSAPEH-----QGARQFSLDELAQATKSFSEANLVGLGS 94
Query: 100 FGPVYKGLLRD-TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158
FG VYKGLL D +VVAIK+R+G+PRQEF EV LSEI HRN+VTL+GYCQ+ G QMLV+
Sbjct: 95 FGLVYKGLLLDGSVVAIKKRIGAPRQEFAEEVRKLSEINHRNIVTLIGYCQEGGLQMLVY 154
Query: 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVL 218
EYLPNGS+ HLY+TG S T+LEFKQR+SIA+GAAKGL HLH+L PPL+HK+FKT+NVL
Sbjct: 155 EYLPNGSVSRHLYDTGKSSMTRLEFKQRLSIAIGAAKGLNHLHTLVPPLIHKDFKTSNVL 214
Query: 219 VDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLL 278
VDENFIAKVAD G+ +LL E+ GPSHG +V++DPEV+ FSE SD+YSFGVFLL
Sbjct: 215 VDENFIAKVADAGLVRLLRGYEDVGPSHGFSSSVYQDPEVQSVLQFSESSDVYSFGVFLL 274
Query: 279 ELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSS 338
EL+TG+EA+ ++S S E+L QW+ SSN +D RL FT+EGM++ + LT QC++
Sbjct: 275 ELITGREAACLISPDSRESLAQWIEGHFSSNELIDPRLGANFTSEGMKEFVGLTFQCLTP 334
Query: 339 PGRRRPKMEIVMTELERIHEKEMALTTFMGEGTATIALGSELF 381
RRRPKM +V TEL+RI E EM+LTT MG+GTA I LGS LF
Sbjct: 335 SSRRRPKMRLVATELDRILETEMSLTTIMGDGTAIITLGSTLF 377
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|222631354|gb|EEE63486.1| hypothetical protein OsJ_18302 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 443 bits (1140), Expect = e-122, Method: Compositional matrix adjust.
Identities = 215/343 (62%), Positives = 264/343 (76%), Gaps = 6/343 (1%)
Query: 40 NSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGS 99
+ ETGSSDPS LVEW +G SSA QGARQFS++EL QATK FSE +L+G GS
Sbjct: 40 SDETGSSDPSTLVEWGKGGRSSSAPEH-----QGARQFSLDELAQATKSFSEANLVGLGS 94
Query: 100 FGPVYKGLLRD-TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158
FG VYKGLL D +VVAIK+R+G+PRQEF EV LSEI HRN+VTL+GYCQ+ G QMLV+
Sbjct: 95 FGLVYKGLLLDGSVVAIKKRIGAPRQEFAEEVRKLSEINHRNIVTLIGYCQEGGLQMLVY 154
Query: 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVL 218
EYLPNGS+ HLY+TG S T+LEFKQR+SIA+GAAKGL HLH+L PPL+HK+FKT+NVL
Sbjct: 155 EYLPNGSVSRHLYDTGKSSMTRLEFKQRLSIAIGAAKGLNHLHTLVPPLIHKDFKTSNVL 214
Query: 219 VDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLL 278
VDENFIAKVAD G+ +LL E+ PSHG +V++DPEV+ FSE SD+YSFGVFLL
Sbjct: 215 VDENFIAKVADAGLVRLLRGYEDVSPSHGFSSSVYQDPEVQSVLQFSESSDVYSFGVFLL 274
Query: 279 ELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSS 338
EL+TG+EA+ ++S S E+L QW+ SSN +D RL FT+EGM++ + LT QC++
Sbjct: 275 ELITGREAACLISPDSRESLAQWIEGHFSSNELIDPRLGANFTSEGMKEFVGLTFQCLTP 334
Query: 339 PGRRRPKMEIVMTELERIHEKEMALTTFMGEGTATIALGSELF 381
RRRPKM +V TEL+RI E EM+LTT MG+GTA I LGS LF
Sbjct: 335 SSRRRPKMRLVATELDRILETEMSLTTIMGDGTAIITLGSTLF 377
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|326518874|dbj|BAJ92598.1| predicted protein [Hordeum vulgare subsp. vulgare] gi|326525349|dbj|BAK07944.1| predicted protein [Hordeum vulgare subsp. vulgare] | Back alignment and taxonomy information |
|---|
Score = 436 bits (1120), Expect = e-119, Method: Compositional matrix adjust.
Identities = 216/357 (60%), Positives = 270/357 (75%), Gaps = 9/357 (2%)
Query: 27 WLCKSQSKNYQNKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQAT 86
W C++ ++ +N+ SETGSSDPS LVEW +G SSA + QGARQFS+EEL QAT
Sbjct: 29 W-CRAHAR--RNRTSETGSSDPSTLVEWGKGGRSSSAPER-----QGARQFSLEELAQAT 80
Query: 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLL 145
FSE +L+G GSFG VYKGLL D +VVAIKRR+G+PR EF EV LSEI HRN+VTL+
Sbjct: 81 NNFSEANLVGAGSFGLVYKGLLFDGSVVAIKRRMGAPRLEFADEVRRLSEICHRNIVTLI 140
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
GYCQ+ G QMLVFEY PNG++C+HLY++G S T+LEFKQR++IA+GAAKGL HLHSL P
Sbjct: 141 GYCQEGGLQMLVFEYSPNGNVCSHLYDSGKGSMTRLEFKQRLAIAIGAAKGLNHLHSLMP 200
Query: 206 PLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFS 265
PL+HKNFKT+NVLVDENFIAKVAD G+ +L E+ G SHG +V++DPE FS
Sbjct: 201 PLIHKNFKTSNVLVDENFIAKVADAGLVRLFRGHEDIGSSHGFSSSVYQDPEAHSVAQFS 260
Query: 266 EMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGM 325
E SD+YSFGVFLLEL+TG+EA+++ S E+L W+ + SSN +D RL G FTTEGM
Sbjct: 261 ESSDVYSFGVFLLELITGKEAANLQPPESRESLAHWLEAHFSSNELIDPRLGGGFTTEGM 320
Query: 326 RDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFMGEGTATIALGSELFT 382
++ + L QC++ RRRPKM +V EL+RI E EM+LTT MG+GTA I LGS+LFT
Sbjct: 321 KEFVGLAFQCLNPSSRRRPKMRLVAAELDRILETEMSLTTIMGDGTAIITLGSQLFT 377
|
Source: Hordeum vulgare subsp. vulgare Species: Hordeum vulgare Genus: Hordeum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|125529019|gb|EAY77133.1| hypothetical protein OsI_05098 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1097), Expect = e-117, Method: Compositional matrix adjust.
Identities = 220/351 (62%), Positives = 268/351 (76%), Gaps = 12/351 (3%)
Query: 39 KNSETGSSD-PSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGF 97
+NS+TGSS+ P LVEW R SA P + QGARQFS+EEL ATK FS+ +L+G
Sbjct: 38 RNSDTGSSETPPTLVEWGRCGRTLSA---PEY--QGARQFSLEELAHATKNFSDANLVGA 92
Query: 98 GSFGPVYKGLLRD-TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156
GSFGPVYKGLL D TVVA+KRRV SPRQ+FV EV LSEI HRN+VTL+GYCQ+ G QML
Sbjct: 93 GSFGPVYKGLLLDGTVVAVKRRVASPRQDFVDEVKRLSEIWHRNVVTLIGYCQEGGLQML 152
Query: 157 VFEYLPNGSMCNHLY-ETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTA 215
VFEYLPNGS+C HLY +TG ES T+LEFKQR+SIA+GAAKGL HLHSL PPL+HK FKT+
Sbjct: 153 VFEYLPNGSVCGHLYADTGKESMTRLEFKQRLSIAIGAAKGLNHLHSLVPPLIHKGFKTS 212
Query: 216 NVLVDENFIAKVADTGISKLLENIEEAG---PSHGSIVNVFRDPEVEESGVFSEMSDIYS 272
NVLVDENFIAKVAD GI +LL + A S ++++DPEV SE SD+YS
Sbjct: 213 NVLVDENFIAKVADAGIDRLLRGFDGAAPSHHPSSSCSSIYQDPEVHSLAQLSESSDVYS 272
Query: 273 FGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV-DHRLAGTFTTEGMRDLIRL 331
FGVFLLEL+TG+EA+ ++S E L+ W+ S SSNN V D RL G+FT+EGM++L+ L
Sbjct: 273 FGVFLLELITGKEAASLISSEPREPLVHWMESHFSSNNEVTDPRLGGSFTSEGMKELVGL 332
Query: 332 TLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFMGEGTATIALGSELFT 382
TLQC+S+ RRRPKM ++ EL+RI EKEM+LTT MG+GTA + LGS+LFT
Sbjct: 333 TLQCVSTSARRRPKMRLIAAELDRILEKEMSLTTVMGDGTAIVTLGSQLFT 383
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|125573241|gb|EAZ14756.1| hypothetical protein OsJ_04683 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1095), Expect = e-116, Method: Compositional matrix adjust.
Identities = 220/351 (62%), Positives = 267/351 (76%), Gaps = 12/351 (3%)
Query: 39 KNSETGSSD-PSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGF 97
+NS+TGSS+ P LVEW R SA P + QGARQFS+EEL ATK FS+ +L+G
Sbjct: 38 RNSDTGSSETPPTLVEWGRCGRTLSA---PEY--QGARQFSLEELAHATKNFSDANLVGA 92
Query: 98 GSFGPVYKGLLRD-TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156
GSFGPVYKGLL D TVVA+KRRV SPRQ+FV EV LSEI HRN+VTL+GYCQ+ G QML
Sbjct: 93 GSFGPVYKGLLLDGTVVAVKRRVASPRQDFVDEVKRLSEIWHRNVVTLIGYCQEGGLQML 152
Query: 157 VFEYLPNGSMCNHLY-ETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTA 215
VFEYLPNGS+C HLY TG ES T+LEFKQR+SIA+GAAKGL HLHSL PPL+HK FKT+
Sbjct: 153 VFEYLPNGSVCGHLYANTGKESMTRLEFKQRLSIAIGAAKGLNHLHSLVPPLIHKGFKTS 212
Query: 216 NVLVDENFIAKVADTGISKLLENIEEAG---PSHGSIVNVFRDPEVEESGVFSEMSDIYS 272
NVLVDENFIAKVAD GI +LL + A S ++++DPEV SE SD+YS
Sbjct: 213 NVLVDENFIAKVADAGIDRLLRGFDGAAPSHHPSSSCSSIYQDPEVHSLAQLSESSDVYS 272
Query: 273 FGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV-DHRLAGTFTTEGMRDLIRL 331
FGVFLLEL+TG+EA+ ++S E L+ W+ S SSNN V D RL G+FT+EGM++L+ L
Sbjct: 273 FGVFLLELITGKEAASLISSEPREPLVHWMESHFSSNNEVTDPRLGGSFTSEGMKELVGL 332
Query: 332 TLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFMGEGTATIALGSELFT 382
TLQC+S+ RRRPKM ++ EL+RI EKEM+LTT MG+GTA + LGS+LFT
Sbjct: 333 TLQCVSTSARRRPKMRLIAAELDRILEKEMSLTTVMGDGTAIVTLGSQLFT 383
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357133965|ref|XP_003568591.1| PREDICTED: probable receptor-like protein kinase At2g39360-like [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 425 bits (1092), Expect = e-116, Method: Compositional matrix adjust.
Identities = 212/358 (59%), Positives = 266/358 (74%), Gaps = 7/358 (1%)
Query: 26 VWLCKSQSKNYQNKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQA 85
+W C+++ + +N+ SETGSSDPS LVEW +G SSA QGAR F +EEL QA
Sbjct: 28 LW-CRARLRARRNRTSETGSSDPSTLVEWGKGGRSSSAPEH-----QGARHFPLEELAQA 81
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTL 144
T FSE +L+G GSFG VYKGLL D +VVAIKRR+G+PR EF EV LSEI HRN+VTL
Sbjct: 82 TNNFSEANLVGAGSFGLVYKGLLLDGSVVAIKRRMGAPRHEFAEEVRRLSEISHRNIVTL 141
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
+GYCQ+ G QMLV+EY PNG++C+HLY+TG S T+LEFKQR++IA+GAAKGL HLHSL
Sbjct: 142 IGYCQEGGLQMLVYEYSPNGNVCSHLYDTGKGSMTRLEFKQRLAIAIGAAKGLNHLHSLV 201
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVF 264
PL+HKNFKT+NVLVDENFIAKVAD G+ LL ++ GPS G +V++DPE F
Sbjct: 202 HPLIHKNFKTSNVLVDENFIAKVADYGLVGLLRGYDDVGPSQGFTSSVYQDPEAHSVAQF 261
Query: 265 SEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEG 324
SE SD+YSFGVFLLEL+TG+EA+ + S E+L W+ + SSN +D RL G FT+EG
Sbjct: 262 SESSDVYSFGVFLLELITGREAARLAPPESRESLAHWLEAHFSSNELIDPRLGGGFTSEG 321
Query: 325 MRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFMGEGTATIALGSELFT 382
M++ + L QC++ RRRPKM +V EL+RI E EM+LTT MG+GTA I LGS+LFT
Sbjct: 322 MKEFVGLAFQCLNPSCRRRPKMRLVAVELDRILETEMSLTTIMGDGTAIITLGSQLFT 379
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 382 | ||||||
| TAIR|locus:2090797 | 380 | AT3G26700 [Arabidopsis thalian | 0.905 | 0.910 | 0.534 | 2.1e-91 | |
| TAIR|locus:2152312 | 880 | AT5G38990 [Arabidopsis thalian | 0.866 | 0.376 | 0.347 | 1e-47 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.869 | 0.341 | 0.357 | 8.6e-47 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.814 | 0.438 | 0.354 | 8e-46 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.803 | 0.324 | 0.365 | 1.2e-45 | |
| TAIR|locus:2195814 | 651 | LYK3 "LysM-containing receptor | 0.586 | 0.344 | 0.387 | 2.2e-45 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.798 | 0.320 | 0.363 | 3.4e-45 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.837 | 0.444 | 0.347 | 3.5e-45 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.767 | 0.430 | 0.357 | 3.8e-45 | |
| TAIR|locus:2181017 | 951 | AT5G01950 [Arabidopsis thalian | 0.722 | 0.290 | 0.404 | 4.3e-45 |
| TAIR|locus:2090797 AT3G26700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 911 (325.7 bits), Expect = 2.1e-91, P = 2.1e-91
Identities = 194/363 (53%), Positives = 249/363 (68%)
Query: 25 LVWLCKSQSKNYQNKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQ 84
L+W C + KN ++ SETGSSDPS G + A + AR+F MEEL Q
Sbjct: 25 LLWFCVFRRKNL-SRTSETGSSDPSTQ------EGRNVAI---ELSMREARRFEMEELAQ 74
Query: 85 ATKQFSETSLIGFGSFGPVYKGLLRDTV-VAIKRRVGSPRQEFVAEVTYLSEIRHRNLVT 143
ATK F+ SLIG G FG VYKGLL+D V VAIK+R G P QEFV EV YLS I HRNLVT
Sbjct: 75 ATKSFTNKSLIGIGKFGEVYKGLLQDGVLVAIKKRPGLPTQEFVNEVRYLSSIHHRNLVT 134
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLE-SSTKLEFKQRVSIALGAAKGLCHLHS 202
LLG+CQ++ Q LV+EY+PNGS+ +HLY G + +LEF+ R++I++GAAKGL HLHS
Sbjct: 135 LLGFCQESNTQFLVYEYVPNGSVSSHLYGAGGKVPGNRLEFRHRLAISIGAAKGLAHLHS 194
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVN-VFRDPEVEES 261
L P L+HK+FKTANVLVDENFIAKVAD G+ L E+ G S + + +F PEV+E
Sbjct: 195 LSPRLIHKDFKTANVLVDENFIAKVADAGVRNFLGR-EDVGTSSHIVADQIFLSPEVQEF 253
Query: 262 GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNF---VDHRLAG 318
FSE SD+Y+FGVFLLELV+G+EAS S + L+ W+++ + +D RL G
Sbjct: 254 KRFSEKSDVYAFGVFLLELVSGREASEPSPSSSTQTLVDWMQNLTDYADIPMMIDERLGG 313
Query: 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFMGEGTATIALGS 378
T+T EG+ +LI LTL+C+ +RP M V+TELERI +KE++LTT MGEGT T+ LGS
Sbjct: 314 TYTAEGVEELITLTLRCVDVSSEKRPTMSFVVTELERILDKEVSLTTVMGEGTPTVTLGS 373
Query: 379 ELF 381
+LF
Sbjct: 374 QLF 376
|
|
| TAIR|locus:2152312 AT5G38990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 506 (183.2 bits), Expect = 1.0e-47, P = 1.0e-47
Identities = 123/354 (34%), Positives = 198/354 (55%)
Query: 25 LVWLCKSQSKNYQNKNSETGSSDPSALVEWN---RGAGPSSATGQPSFGPQGARQFSMEE 81
+V L + K N++S ++ PS W G G ++ S R+FS+ E
Sbjct: 458 VVVLVVMKRKKKSNESSVDTTNKPSTNSSWGPLLHGTGSTNTKSASSLPSDLCRRFSIYE 517
Query: 82 LEQATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKR-RVGSPR--QEFVAEVTYLSEI 136
++ AT F E +IG G FG VYKG + T+VA+KR + S + +EF E+ LS++
Sbjct: 518 IKSATNDFEEKLIIGVGGFGSVYKGRIDGGATLVAVKRLEITSNQGAKEFDTELEMLSKL 577
Query: 137 RHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKG 196
RH +LV+L+GYC + +LV+EY+P+G++ +HL+ S L +K+R+ I +GAA+G
Sbjct: 578 RHVHLVSLIGYCDDDNEMVLVYEYMPHGTLKDHLFRRDKASDPPLSWKRRLEICIGAARG 637
Query: 197 LCHLHS-LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIV--NVF 253
L +LH+ K ++H++ KT N+L+DENF+AKV+D G+S++ A +H S V F
Sbjct: 638 LQYLHTGAKYTIIHRDIKTTNILLDENFVAKVSDFGLSRV--GPTSASQTHVSTVVKGTF 695
Query: 254 R--DPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEA-LIQWVRSRLSS-- 308
DPE + +E SD+YSFGV LLE++ + + S+ +A LI+WV+S +
Sbjct: 696 GYLDPEYYRRQILTEKSDVYSFGVVLLEVLCCRPI-RMQSVPPEQADLIRWVKSNFNKRT 754
Query: 309 -NNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE---RIHE 358
+ +D L T+ M + ++C+ G RP M V+ LE ++HE
Sbjct: 755 VDQIIDSDLTADITSTSMEKFCEIAIRCVQDRGMERPPMNDVVWALEFALQLHE 808
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 499 (180.7 bits), Expect = 8.6e-47, P = 8.6e-47
Identities = 129/361 (35%), Positives = 206/361 (57%)
Query: 36 YQNKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLI 95
+Q + +E V W +G S G P +GAR FS EEL++ T FS +S +
Sbjct: 589 WQKRRAEQAIGLSRPFVSW-ASSGKDSG-GAPQL--KGARWFSYEELKKITNNFSVSSEL 644
Query: 96 GFGSFGPVYKGLLRDT-VVAIKR-RVGSPRQ--EFVAEVTYLSEIRHRNLVTLLGYCQQN 151
G+G +G VYKG+L+D +VAIKR + GS + EF E+ LS + H+NLV L+G+C +
Sbjct: 645 GYGGYGKVYKGMLQDGHMVAIKRAQQGSTQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ 704
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK-PPLVHK 210
G Q+LV+EY+ NGS+ + L TG S L++K+R+ +ALG+A+GL +LH L PP++H+
Sbjct: 705 GEQILVYEYMSNGSLKDSL--TG-RSGITLDWKRRLRVALGSARGLAYLHELADPPIIHR 761
Query: 211 NFKTANVLVDENFIAKVADTGISKLLENIEEAGPS---HGSIVNVFRDPEVEESGVFSEM 267
+ K+ N+L+DEN AKVAD G+SKL+ + + S G++ + DPE + +E
Sbjct: 762 DVKSTNILLDENLTAKVADFGLSKLVSDCTKGHVSTQVKGTLG--YLDPEYYTTQKLTEK 819
Query: 268 SDIYSFGVFLLELVTGQEASHIVSLGSYEAL-IQWVRSRLSSNNF------VDHRLAGTF 320
SD+YSFGV ++EL+T ++ + G Y I+ V ++ S ++F +D L
Sbjct: 820 SDVYSFGVVMMELITAKQP---IEKGKYIVREIKLVMNK-SDDDFYGLRDKMDRSLRDVG 875
Query: 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFMGEGTATIA-LGSE 379
T + + L L+C+ RP M V+ E+E I + A ++ +++ G +
Sbjct: 876 TLPELGRYMELALKCVDETADERPTMSEVVKEIEIIIQNSGASSSSSASASSSATDFGEK 935
Query: 380 L 380
L
Sbjct: 936 L 936
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 483 (175.1 bits), Expect = 8.0e-46, P = 8.0e-46
Identities = 117/330 (35%), Positives = 193/330 (58%)
Query: 40 NSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQ--FSMEELEQATKQFSETSLIGF 97
NS+ S+ ++ G G + + P G+ Q F+ EEL T+ FS+ +++G
Sbjct: 302 NSQQQSNSGNSFGSQRGGGGYTRSGSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGE 361
Query: 98 GSFGPVYKGLLRD-TVVAIKR-RVGSPR--QEFVAEVTYLSEIRHRNLVTLLGYCQQNGY 153
G FG VYKG L D +VA+K+ +VGS + +EF AEV +S + HR+LV+L+GYC +
Sbjct: 362 GGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSE 421
Query: 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNF 212
++L++EY+PN ++ +HL+ G LE+ +RV IA+G+AKGL +LH P ++H++
Sbjct: 422 RLLIYEYVPNQTLEHHLHGKG---RPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDI 478
Query: 213 KTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYS 272
K+AN+L+D+ F A+VAD G++KL ++ + + + PE +SG ++ SD++S
Sbjct: 479 KSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFS 538
Query: 273 FGVFLLELVTGQE-ASHIVSLGSYEALIQWVRSRL----SSNNF---VDHRLAGTFTTEG 324
FGV LLEL+TG++ LG E+L++W R L + +F VD RL +
Sbjct: 539 FGVVLLELITGRKPVDQYQPLGE-ESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENE 597
Query: 325 MRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354
+ +I C+ G +RP+M V+ L+
Sbjct: 598 VFRMIETAAACVRHSGPKRPRMVQVVRALD 627
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 488 (176.8 bits), Expect = 1.2e-45, P = 1.2e-45
Identities = 122/334 (36%), Positives = 190/334 (56%)
Query: 37 QNKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIG 96
Q K ++ + + +W+ G A P G + F+ EEL + T FS+ + +G
Sbjct: 587 QKKRAQRATDQMNPFAKWDAGKNEMDA---PQL--MGTKAFTFEELSKCTNNFSDANDVG 641
Query: 97 FGSFGPVYKGLLRD-TVVAIKR-RVGSPRQ--EFVAEVTYLSEIRHRNLVTLLGYCQQNG 152
G +G VYKG L + V+AIKR + GS + EF E+ LS + H+N+V LLG+C
Sbjct: 642 GGGYGQVYKGTLPNGQVIAIKRAQQGSMQGAFEFKTEIELLSRVHHKNVVKLLGFCFDQK 701
Query: 153 YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK-PPLVHKN 211
QMLV+EY+PNGS+ + L +G ++ KL++ +R+ IALG+ KGL +LH L PP++H++
Sbjct: 702 EQMLVYEYIPNGSLRDGL--SG-KNGVKLDWTRRLKIALGSGKGLAYLHELADPPIIHRD 758
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPEVEESGVFSEMSDI 270
K+ N+L+DE+ AKVAD G+SKL+ + E+A + + + DPE + +E SD+
Sbjct: 759 VKSNNILLDEHLTAKVADFGLSKLVGDPEKAHVTTQVKGTMGYLDPEYYMTNQLTEKSDV 818
Query: 271 YSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS-SNNFVD-HRLAGTFTTE----- 323
Y FGV +LEL+TG+ + GSY +++ V+ ++ S N D L T +
Sbjct: 819 YGFGVVMLELLTGKSP---IDRGSY--VVKEVKKKMDKSRNLYDLQELLDTTIIQNSGNL 873
Query: 324 -GMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356
G + + LQC+ G RP M V+ ELE I
Sbjct: 874 KGFEKYVDVALQCVEPEGVNRPTMSEVVQELESI 907
|
|
| TAIR|locus:2195814 LYK3 "LysM-containing receptor-like kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 411 (149.7 bits), Expect = 2.2e-45, Sum P(2) = 2.2e-45
Identities = 88/227 (38%), Positives = 138/227 (60%)
Query: 63 ATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP 122
A G F + F+ EE+ AT +FS+++L+G G++G VY GLLR+ VA+KR +
Sbjct: 315 ALGDGMFEIEKPMVFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLREQEVAVKRMTATK 374
Query: 123 RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLE 182
+EF AE+ L ++ H NLV L+GY +V+EY+ G + +HL++ + +T L
Sbjct: 375 TKEFAAEMKVLCKVHHSNLVELIGYAATVDELFVVYEYVRKGMLKSHLHDPQSKGNTPLS 434
Query: 183 FKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241
+ R IAL AA+GL ++H K VH++ KT+N+L+DE F AK++D G++KL+E E
Sbjct: 435 WIMRNQIALDAARGLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGLAKLVEKTGE 494
Query: 242 AGPSHGSIVNVFR--DPEVEESGVFSEMSDIYSFGVFLLELVTGQEA 286
S +V + PE G+ + SDIY+FGV L E+++G+EA
Sbjct: 495 GEISVTKVVGTYGYLAPEYLSDGLATSKSDIYAFGVVLFEIISGREA 541
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 484 (175.4 bits), Expect = 3.4e-45, P = 3.4e-45
Identities = 122/336 (36%), Positives = 198/336 (58%)
Query: 37 QNKNSE--TGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSL 94
Q K +E TG ++P A +W+ S+ P GA+ F+ EEL++ T FSE +
Sbjct: 584 QKKRAERATGQNNPFA--KWDTS---KSSIDAPQL--MGAKAFTFEELKKCTDNFSEAND 636
Query: 95 IGFGSFGPVYKGLLRD-TVVAIKR-RVGSPRQ--EFVAEVTYLSEIRHRNLVTLLGYCQQ 150
+G G +G VY+G+L + ++AIKR + GS + EF E+ LS + H+N+V LLG+C
Sbjct: 637 VGGGGYGKVYRGILPNGQLIAIKRAQQGSLQGGLEFKTEIELLSRVHHKNVVRLLGFCFD 696
Query: 151 NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK-PPLVH 209
QMLV+EY+ NGS+ + L +G +S +L++ +R+ IALG+ KGL +LH L PP++H
Sbjct: 697 RNEQMLVYEYISNGSLKDSL--SG-KSGIRLDWTRRLKIALGSGKGLAYLHELADPPIIH 753
Query: 210 KNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPEVEESGVFSEMS 268
++ K+ N+L+DEN AKVAD G+SKL+ + E+ + + + DPE + +E S
Sbjct: 754 RDIKSNNILLDENLTAKVADFGLSKLVGDPEKTHVTTQVKGTMGYLDPEYYMTNQLTEKS 813
Query: 269 DIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS-SNNFVDHR-------LAGTF 320
D+Y FGV LLEL+TG+ + G Y +++ V+++++ S + D + +A +
Sbjct: 814 DVYGFGVVLLELLTGRSP---IERGKY--VVREVKTKMNKSRSLYDLQELLDTTIIASSG 868
Query: 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356
+G + L L+C+ G RP M V+ E+E I
Sbjct: 869 NLKGFEKYVDLALRCVEEEGVNRPSMGEVVKEIENI 904
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 478 (173.3 bits), Expect = 3.5e-45, P = 3.5e-45
Identities = 117/337 (34%), Positives = 191/337 (56%)
Query: 31 SQSKNYQNKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFS 90
S N Q + S G+S +A + SS T + G FS EEL + T+ F+
Sbjct: 313 SMYNNSQQQQSSMGNSYGTAGGGYPHHQMQSSGTPDSAILGSGQTHFSYEELAEITQGFA 372
Query: 91 ETSLIGFGSFGPVYKGLLRD-TVVAIKR-RVGSPR--QEFVAEVTYLSEIRHRNLVTLLG 146
+++G G FG VYKG L+D VVA+K+ + GS + +EF AEV +S + HR+LV+L+G
Sbjct: 373 RKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRVHHRHLVSLVG 432
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKP 205
YC + +++L++EY+ N ++ +HL+ GL LE+ +RV IA+G+AKGL +LH P
Sbjct: 433 YCISDQHRLLIYEYVSNQTLEHHLHGKGLPV---LEWSKRVRIAIGSAKGLAYLHEDCHP 489
Query: 206 PLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFS 265
++H++ K+AN+L+D+ + A+VAD G+++L + + + + PE SG +
Sbjct: 490 KIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGYLAPEYASSGKLT 549
Query: 266 EMSDIYSFGVFLLELVTGQE-ASHIVSLGSYEALIQWVRSRLSS-------NNFVDHRLA 317
+ SD++SFGV LLELVTG++ LG E+L++W R L + +D RL
Sbjct: 550 DRSDVFSFGVVLLELVTGRKPVDQTQPLGE-ESLVEWARPLLLKAIETGDLSELIDTRLE 608
Query: 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354
+ + +I C+ G +RP+M V+ L+
Sbjct: 609 KRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALD 645
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 475 (172.3 bits), Expect = 3.8e-45, P = 3.8e-45
Identities = 112/313 (35%), Positives = 179/313 (57%)
Query: 77 FSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKR-RVGSPR--QEFVAEVTY 132
FS +EL Q T FSE +L+G G FG VYKG+L D VA+K+ ++G + +EF AEV
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386
Query: 133 LSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALG 192
+S + HR+LVTL+GYC +++LV++Y+PN ++ HL+ G T ++ RV +A G
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMT---WETRVRVAAG 443
Query: 193 AAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVN 251
AA+G+ +LH P ++H++ K++N+L+D +F A VAD G++K+ + ++ ++
Sbjct: 444 AARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMG 503
Query: 252 VF--RDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVS-LGSYEALIQWVRSRLSS 308
F PE SG SE +D+YS+GV LLEL+TG++ LG E+L++W R L
Sbjct: 504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGD-ESLVEWARPLLGQ 562
Query: 309 -------NNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEM 361
+ VD RL F M ++ C+ +RPKM V+ L+ + E+
Sbjct: 563 AIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTL-EEAT 621
Query: 362 ALTTFMGEGTATI 374
+T M G + +
Sbjct: 622 DITNGMRPGQSQV 634
|
|
| TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 483 (175.1 bits), Expect = 4.3e-45, P = 4.3e-45
Identities = 120/297 (40%), Positives = 175/297 (58%)
Query: 73 GARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRR-VGSPR--QEFVA 128
G R FS +EL +AT FS ++L+G G +G VY+G+L D TV AIKR GS + +EF+
Sbjct: 610 GIRGFSFKELAEATDDFSSSTLVGRGGYGKVYRGVLSDNTVAAIKRADEGSLQGEKEFLN 669
Query: 129 EVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVS 188
E+ LS + HRNLV+L+GYC + QMLV+E++ NG++ + L G ES L F R+
Sbjct: 670 EIELLSRLHHRNLVSLIGYCDEESEQMLVYEFMSNGTLRDWLSAKGKES---LSFGMRIR 726
Query: 189 IALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAKVADTGISKL---LENIEEAGP 244
+ALGAAKG+ +LH+ PP+ H++ K +N+L+D NF AKVAD G+S+L LE+ EE P
Sbjct: 727 VALGAAKGILYLHTEANPPVFHRDIKASNILLDPNFNAKVADFGLSRLAPVLED-EEDVP 785
Query: 245 SHGSIV----NVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLG-SYEALI 299
H S V + DPE + ++ SD+YS GV LEL+TG H +S G + +
Sbjct: 786 KHVSTVVRGTPGYLDPEYFLTHKLTDKSDVYSIGVVFLELLTGM---HAISHGKNIVREV 842
Query: 300 QWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356
+ R + +D R+ ++ E + L L+C RP M V+ ELE +
Sbjct: 843 KTAEQRDMMVSLIDKRME-PWSMESVEKFAALALRCSHDSPEMRPGMAEVVKELESL 898
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00019801001 | SubName- Full=Chromosome chr5 scaffold_2, whole genome shotgun sequence; (385 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 382 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-36 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-36 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-32 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-25 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-17 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-16 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-13 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-11 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-11 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-11 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-09 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-04 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| pfam12726 | 724 | pfam12726, SEN1_N, SEN1 N terminal | 0.001 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.002 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 0.002 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.003 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.003 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.003 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.004 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.004 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.004 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 1e-40
Identities = 68/200 (34%), Positives = 107/200 (53%), Gaps = 17/200 (8%)
Query: 95 IGFGSFGPVYKGLLR------DTVVAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVTL 144
+G G+FG VYKG L+ +T VA+K + G+ R+EF+ E + + ++ H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
LG C Q +V EY+P G + + L + G KL K + +AL AKG+ +L S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHG----EKLTLKDLLQMALQIAKGMEYLESKN 122
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF-RDPEVEESGV 263
VH++ N LV EN + K++D G+S+ + + G + + PE + G
Sbjct: 123 --FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 264 FSEMSDIYSFGVFLLELVTG 283
F+ SD++SFGV L E+ T
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 8e-39
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 30/209 (14%)
Query: 95 IGFGSFGPVYKGLLRDTV------VAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVTL 144
+G G+FG VYKG L+ VA+K + + +EF+ E + ++ H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
LG C + M+V EY+P G + ++L + +L +S AL A+G+ +L S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLESKN 123
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHG-------SIVNVFRDPE 257
+H++ N LV EN + K++D G+S+ L + + G + PE
Sbjct: 124 --FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMA-------PE 174
Query: 258 VEESGVFSEMSDIYSFGVFLLELVT-GQE 285
+ G F+ SD++SFGV L E+ T G+E
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEE 203
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 9e-39
Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 21/204 (10%)
Query: 95 IGFGSFGPVYKGLLRDTV------VAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVTL 144
+G G+FG VYKG L+ VA+K + + +EF+ E + ++ H N+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
LG C + +V EY+ G + ++L ++ KL +S AL A+G+ +L S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--DPEVEESG 262
+H++ N LV EN + K++D G+S+ L + + G + R PE + G
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEG 178
Query: 263 VFSEMSDIYSFGVFLLELVT-GQE 285
F+ SD++SFGV L E+ T G++
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQ 202
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 79/279 (28%), Positives = 132/279 (47%), Gaps = 47/279 (16%)
Query: 95 IGFGSFGPVYKGLLRD-----TVVAIK--RRVGSP--RQEFVAEVTYLSEIRHRNLVTLL 145
+G G+FG VYKG L+ T VA+K + S R++F+ E + ++ H N+V LL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHL----YETGLESSTKLEFKQRVSIALGAAKGLCHLH 201
G C + LV EY+ G + ++L + L K +S A+ AKG+ +L
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--DPEVE 259
S K VH++ N LV E+ + K++D G+S+ + + + G + + R PE
Sbjct: 123 SKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI-RWMAPESL 179
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLG-------SYEALIQWVRSRLSSNNFV 312
+ G+F+ SD++SFGV L E I +LG S E +++++R
Sbjct: 180 KDGIFTSKSDVWSFGVLLWE---------IFTLGATPYPGLSNEEVLEYLRK-------- 222
Query: 313 DHRLA-GTFTTEGMRDLIRLTLQCMSSPGRRRPKM-EIV 349
+RL + + + +L+ L C RP E+V
Sbjct: 223 GYRLPKPEYCPDELYELM---LSCWQLDPEDRPTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 4e-36
Identities = 67/195 (34%), Positives = 98/195 (50%), Gaps = 17/195 (8%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR----RVGSPRQEFVAEVTYLSEIRHRNLVTLLGYC 148
+G G FG VY + T VAIK S +E + E+ L ++ H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 149 QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLV 208
+ + LV EY GS+ + L E+ KL + + I L +GL +LHS ++
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK----ENEGKLSEDEILRILLQILEGLEYLHSNG--II 114
Query: 209 HKNFKTANVLVDE-NFIAKVADTGISKLLENIE-EAGPSHGSIVNVFRDPEV-EESGVFS 265
H++ K N+L+D N K+AD G+SKLL + + G+ + PEV G +S
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP--AYMAPEVLLGKGYYS 172
Query: 266 EMSDIYSFGVFLLEL 280
E SDI+S GV L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 7e-36
Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGY 147
+G GSFG VY + T +VAIK +++ R+ + E+ L +++H N+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPL 207
+ LV EY G + + L + G +L + L +LHS +
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRG-----RLSEDEARFYLRQILSALEYLHSKG--I 118
Query: 208 VHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEM 267
VH++ K N+L+DE+ K+AD G+++ L+ E+ G+ + PEV + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTP--EYMAPEVLLGKGYGKA 176
Query: 268 SDIYSFGVFLLELVTGQ 284
DI+S GV L EL+TG+
Sbjct: 177 VDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 62/190 (32%), Positives = 95/190 (50%), Gaps = 11/190 (5%)
Query: 93 SLIGFGSFGPVYKGLLRDTVVAIK--RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQ 150
+ IG G FG V G R VA+K + + Q F+AE + ++ +RH NLV LLG Q
Sbjct: 12 ATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 151 NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHK 210
+V EY+ GS+ ++L G + Q++ AL +G+ +L VH+
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRG---RAVITLAQQLGFALDVCEGMEYLEEKN--FVHR 126
Query: 211 NFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDI 270
+ NVLV E+ +AKV+D G++K G G + + PE FS SD+
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 271 YSFGVFLLEL 280
+SFG+ L E+
Sbjct: 183 WSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIK-----RRVGSPRQEFVAEVTYLSEIRHRNL 141
+ +G GSFG VYK + T +VA+K Q E+ L + H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH 201
V L+ + + LV EY G + ++ L L + IAL +GL +LH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDY-----LSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIV--NVFRDPEV- 258
S ++H++ K N+L+DEN + K+AD G++K L ++ S + V + PEV
Sbjct: 116 SNG--IIHRDLKPENILLDENGVVKIADFGLAKKL---LKSSSSLTTFVGTPWYMAPEVL 170
Query: 259 EESGVFSEMSDIYSFGVFLLELVTGQ 284
+ D++S GV L EL+TG+
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-25
Identities = 62/192 (32%), Positives = 100/192 (52%), Gaps = 10/192 (5%)
Query: 95 IGFGSFGPVYKGLLRDTV-VAIKR-RVGSPRQE-FVAEVTYLSEIRHRNLVTLLGYCQQN 151
+G G FG V+ G T VA+K + G+ E F+ E + ++RH LV L C +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKN 211
+V EY+ GS+ + L KL Q V +A A+G+ +L S +H++
Sbjct: 74 EPIYIVTEYMSKGSLLDFLKS---GEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRD 128
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPEVEESGVFSEMSDI 270
N+LV EN + K+AD G+++L+E+ +E G+ + + PE G F+ SD+
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIED-DEYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187
Query: 271 YSFGVFLLELVT 282
+SFG+ L E+VT
Sbjct: 188 WSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-25
Identities = 80/271 (29%), Positives = 127/271 (46%), Gaps = 32/271 (11%)
Query: 94 LIGFGSFGPVYKGLLRD-TVVAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYC 148
IG G+FG VYKG+L+ T VA+K R P +++F+ E L + H N+V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 149 QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLV 208
Q +V E +P GS+ L + +L K+ + ++L AA G+ +L S +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLR----KKKNRLTVKKLLQMSLDAAAGMEYLESKN--CI 115
Query: 209 HKNFKTANVLVDENFIAKVADTGISKLLEN-IEEAGPSHGSIVNVFRDPEVEESGVFSEM 267
H++ N LV EN + K++D G+S+ E I I + PE G ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 268 SDIYSFGVFLLELVTGQEASHIVSLGS--YEALI-QWVRSRLSSNNFVDHRLAGTFTTEG 324
SD++S+G+ L E SLG Y + Q R R+ S +R+ +
Sbjct: 176 SDVWSYGILLWE---------TFSLGDTPYPGMSNQQTRERIESG----YRMP---APQL 219
Query: 325 M-RDLIRLTLQCMSSPGRRRPKMEIVMTELE 354
++ RL LQC + RP + EL+
Sbjct: 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-25
Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 25/205 (12%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEFVA----EVTYLSEIRHRNLVTLLG 146
L+G GSFG VY L +DT ++A+K + +E + E+ LS ++H N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 147 YCQQNGYQML-VF-EYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHS 202
+ L +F EY+ GS+ + L + G E + +Q + GL +LHS
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE-------GLAYLHS 119
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH---GSIVNVFRDPEVE 259
+VH++ K AN+LVD + + K+AD G +K L +IE + G+ + PEV
Sbjct: 120 NG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP--YWMAPEVI 175
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQ 284
+ +DI+S G ++E+ TG+
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-22
Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 17/197 (8%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR---RVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQ 149
IG G FG VYK + T VAIK +++ + E+ L + +H N+V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 150 QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVH 209
+ +V E+ GS L + ++ L Q + KGL +LHS ++H
Sbjct: 68 KKDELWIVMEFCSGGS----LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIH 121
Query: 210 KNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPEVEESGVFSEM 267
++ K AN+L+ + K+ D G+S L + + ++V + PEV +
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSD----TKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 268 SDIYSFGVFLLELVTGQ 284
+DI+S G+ +EL G+
Sbjct: 178 ADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-22
Identities = 62/193 (32%), Positives = 103/193 (53%), Gaps = 12/193 (6%)
Query: 95 IGFGSFGPVYKGLLRDTV-VAIKR-RVGSPR-QEFVAEVTYLSEIRHRNLVTLLGYCQQN 151
+G G FG V++GL +T VA+K + G+ ++F+AE + ++RH L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKN 211
+V E + GS+ +L + L+ Q + +A A G+ +L + +H++
Sbjct: 74 EPIYIVTELMKYGSLLEYLQG---GAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRD 128
Query: 212 FKTANVLVDENFIAKVADTGISKLL-ENIEEAGPSHGSIVNV-FRDPEVEESGVFSEMSD 269
NVLV EN I KVAD G+++++ E+I EA G+ + + PE FS SD
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEA--REGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 270 IYSFGVFLLELVT 282
++SFG+ L E+VT
Sbjct: 187 VWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-21
Identities = 61/200 (30%), Positives = 107/200 (53%), Gaps = 17/200 (8%)
Query: 94 LIGFGSFGPVYKGLLR-----DTVVAIKR-RVG---SPRQEFVAEVTYLSEIRHRNLVTL 144
+IG G FG V++G+L+ + VAIK + G RQ+F++E + + + H N++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
G + M++ EY+ NG++ +L + E S+ Q V + G A G+ +L +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY----QLVGMLRGIAAGMKYLSDMN 127
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA--GPSHGSIVNVFRDPEVEESG 262
VH++ N+LV+ N KV+D G+S++LE+ E S G I + PE
Sbjct: 128 --YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 263 VFSEMSDIYSFGVFLLELVT 282
F+ SD++SFG+ + E+++
Sbjct: 186 KFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-21
Identities = 60/198 (30%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 95 IGFGSFGPVYKGLLR-----DTVVAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVTLL 145
IG G FG V +G L+ + VAIK + GS R +F+ E + + + H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
G ++ M++ EY+ NGS+ L E K Q V + G A G+ +L +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 206 PLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPEVEESGVF 264
VH++ N+LV+ N + KV+D G+S+ LE+ E + G + + + PE F
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 265 SEMSDIYSFGVFLLELVT 282
+ SD++SFG+ + E+++
Sbjct: 186 TSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 5e-21
Identities = 59/187 (31%), Positives = 96/187 (51%), Gaps = 11/187 (5%)
Query: 95 IGFGSFGPVYKGLLRDTVVAIKR-RVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGY 153
IG G FG V +G VA+K + Q F+ E ++++ H+NLV LLG NG
Sbjct: 14 IGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGL 73
Query: 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFK 213
+V E + G++ N L G + Q + +L A+G+ +L S K LVH++
Sbjct: 74 Y-IVMELMSKGNLVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLA 127
Query: 214 TANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSF 273
N+LV E+ +AKV+D G+++ + G + + + PE + FS SD++S+
Sbjct: 128 ARNILVSEDGVAKVSDFGLAR----VGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSY 183
Query: 274 GVFLLEL 280
GV L E+
Sbjct: 184 GVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 6e-21
Identities = 59/188 (31%), Positives = 98/188 (52%), Gaps = 11/188 (5%)
Query: 95 IGFGSFGPVYKGLLRDTVVAIK-RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGY-CQQNG 152
IG G FG V G R VA+K + + Q F+AE + ++++RH NLV LLG ++ G
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73
Query: 153 YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNF 212
+V EY+ GS+ ++L G + L + +L + + +L + VH++
Sbjct: 74 GLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDL 128
Query: 213 KTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYS 272
NVLV E+ +AKV+D G++K + ++ G + + PE FS SD++S
Sbjct: 129 AARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFSTKSDVWS 184
Query: 273 FGVFLLEL 280
FG+ L E+
Sbjct: 185 FGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 6e-21
Identities = 64/191 (33%), Positives = 98/191 (51%), Gaps = 11/191 (5%)
Query: 94 LIGFGSFGPVYKGLLRD-TVVAIKRRVGSPRQE----FVAEVTYLSEIRHRNLVTLLGYC 148
L+G G+FG V+KG L+D T VA+K QE F++E L + H N+V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 149 QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLV 208
Q +V E +P G + L + E L+ KQ V AL AA G+ +L S +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDE----LKTKQLVKFALDAAAGMAYLESKN--CI 115
Query: 209 HKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMS 268
H++ N LV EN + K++D G+S+ ++ + I + PE G +S S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 269 DIYSFGVFLLE 279
D++S+G+ L E
Sbjct: 176 DVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 6e-21
Identities = 68/223 (30%), Positives = 106/223 (47%), Gaps = 27/223 (12%)
Query: 81 ELEQATKQFSETSLIGFGSFGPVYKGLL-------RDTVVAIK--RRVGSP--RQEFVAE 129
E+ + +F E +G G+FG VYKG L T VAIK + P +QEF E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 130 VTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLY-----------ETGLESS 178
+S+++H N+V LLG C + ++FEYL +G + L
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 179 TKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238
+ L+ + IA+ A G+ +L S VH++ N LV E K++D G+S+ + +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176
Query: 239 IEEAGPSHGSIVNV-FRDPEVEESGVFSEMSDIYSFGVFLLEL 280
+ S++ V + PE G F+ SDI+SFGV L E+
Sbjct: 177 ADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 7e-21
Identities = 58/191 (30%), Positives = 98/191 (51%), Gaps = 13/191 (6%)
Query: 95 IGFGSFGPVYKGL-LRDTVVAIK--RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQN 151
IG G FG V+ G L VAIK R ++F+ E + ++ H LV L G C +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 152 GYQMLVFEYLPNGSMCNHL-YETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHK 210
LVFE++ +G + ++L + G S L + + L +G+ +L S ++H+
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLES--SNVIHR 124
Query: 211 NFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPEVEESGVFSEMSD 269
+ N LV EN + KV+D G+++ + + ++ S G+ V + PEV +S SD
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 270 IYSFGVFLLEL 280
++SFGV + E+
Sbjct: 184 VWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 9e-21
Identities = 54/192 (28%), Positives = 94/192 (48%), Gaps = 9/192 (4%)
Query: 95 IGFGSFGPVYKGLLR--DTVVAIK--RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQ 150
+G G +G VY+G+ + VA+K + +EF+ E + EI+H NLV LLG C +
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 151 NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHK 210
++ E++ G++ ++L E + + + +A + + +L K +H+
Sbjct: 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE--KKNFIHR 128
Query: 211 NFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDI 270
+ N LV EN + KVAD G+S+L+ + + PE FS SD+
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 188
Query: 271 YSFGVFLLELVT 282
++FGV L E+ T
Sbjct: 189 WAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-20
Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 18/208 (8%)
Query: 83 EQATKQFSETSLIGFGSFGPVYKGLLRDTV-VAIK---RRVGSPRQEFVAEVTYLSEIRH 138
E+ ++F+ +G G FG V++GL ++ V VAIK +Q+F EV L +RH
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 139 RNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLY---ETGLESSTKLEFKQRVSIALGAAK 195
++L++L C ++ E + GS+ L L ++ ++ +V A+
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQV------AE 115
Query: 196 GLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FR 254
G+ +L +H++ N+LV E+ + KVAD G+++L++ E+ S + +
Sbjct: 116 GMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIK--EDVYLSSDKKIPYKWT 171
Query: 255 DPEVEESGVFSEMSDIYSFGVFLLELVT 282
PE G FS SD++SFG+ L E+ T
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 91.0 bits (224), Expect = 3e-20
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 93 SLIGFGSFGPVYKGLLRDTVV--AIKRRVGSPRQE---FVAEVTYLSEIRH-RNLVTLLG 146
+G GSFG VY R V + +++ S +E F+ E+ L+ + H N+V L
Sbjct: 6 RKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPP 206
+ Q G LV EY+ GS+ + L + G + + + L +LHS
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI--LSALEYLHSKG-- 121
Query: 207 LVHKNFKTANVLVDEN-FIAKVADTGISKLLENIEEAGPSHGSIVNV-----FRDPEV-- 258
++H++ K N+L+D + + K+ D G++KLL + + PEV
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 259 -EESGVFSEMSDIYSFGVFLLELVTGQ 284
S SDI+S G+ L EL+TG
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 5e-20
Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 95 IGFGSFGPVYKGLLRD-------TVVAIK--RRVGSP--RQEFVAEVTYLSEIRHRNLVT 143
+G G+FG V+ G +VA+K + S R++F E L+ +H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESS---------TKLEFKQRVSIALGAA 194
G C + ++VFEY+ +G + L G +++ +L Q + IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 195 KGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE--EAGPSHGSIVNV 252
G+ +L S VH++ T N LV + + K+ D G+S+ + + G G +
Sbjct: 133 SGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVG---GHTMLP 187
Query: 253 FR--DPEVEESGVFSEMSDIYSFGVFLLELVT 282
R PE F+ SD++SFGV L E+ T
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-20
Identities = 62/191 (32%), Positives = 95/191 (49%), Gaps = 9/191 (4%)
Query: 95 IGFGSFGPVYKGLLRDTV-VAIKR-RVGSPRQE-FVAEVTYLSEIRHRNLVTLLGYCQQN 151
+G G FG V+ G T VAIK + G+ E F+ E + ++RH LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKN 211
+V EY+ GS+ + L E L Q V +A A G+ ++ + VH++
Sbjct: 74 PI-YIVTEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRD 127
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIY 271
+ AN+LV EN + KVAD G+++L+E+ E + PE G F+ SD++
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 272 SFGVFLLELVT 282
SFG+ L EL T
Sbjct: 188 SFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 95 IGFGSFGPVYKGLLR-------DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVT 143
+G GSFG VY+GL + +T VAIK + R EF+ E + + E ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYET--------GLESSTKLEFKQRVSIALGAAK 195
LLG ++V E + G + ++L GL T +F Q +A A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ---MAAEIAD 130
Query: 196 GLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FR 254
G+ +L + K VH++ N +V E+ K+ D G+++ + + ++ V +
Sbjct: 131 GMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 255 DPEVEESGVFSEMSDIYSFGVFLLELVT 282
PE + GVF+ SD++SFGV L E+ T
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 23/202 (11%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKR--RVGSPRQ---EFVAEVTYLSEIRHRNLVTLLG 146
LIG G+FG VYKGL +T VAIK+ + + E+ L ++H N+V +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
+ + ++ EY NGS+ + + G ES + Q + +GL +LH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL-------QGLAYLHEQG 119
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF-RDPEV-EESG 262
++H++ K AN+L ++ + K+AD G++ L + + + + PEV E SG
Sbjct: 120 --VIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 263 VFSEMSDIYSFGVFLLELVTGQ 284
S SDI+S G ++EL+TG
Sbjct: 176 A-STASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-19
Identities = 75/276 (27%), Positives = 127/276 (46%), Gaps = 33/276 (11%)
Query: 94 LIGFGSFGPVYKGLL-----RDTVVAIKR-RVG---SPRQEFVAEVTYLSEIRHRNLVTL 144
+IG G FG V G L R+ VAIK + G R++F++E + + + H N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
G ++ M+V EY+ NGS+ L + + Q V + G A G+ +L +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIASGMKYLSDMG 126
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG--PSHGSIVNVFRDPEVEESG 262
VH++ N+LV+ N + KV+D G+S++LE+ EA G I + PE
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 263 VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVD--HRLAGTF 320
F+ SD++S+G+ + E++ SY W S ++ +RL
Sbjct: 185 KFTSASDVWSYGIVMWEVM------------SYGERPYWEMSNQDVIKAIEEGYRLPAPM 232
Query: 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356
L +L L C RPK E +++ L+++
Sbjct: 233 DCPAA--LHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 4e-19
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 95 IGFGSFGPVYKG---LLRDT---VVAIKR----RVGSPRQEFVAEVTYLSEIRHRNLVTL 144
+G G FG V L D VA+K R +F E+ L + H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 145 LGYCQQNGYQ--MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
G C++ G + L+ EYLP+GS+ ++L ++ K+ + + KG+ +L S
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGS 127
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE--AGPSHGSIVNVFRDPEVEE 260
+ +H++ N+LV+ + K++D G++K+L ++ G + PE
Sbjct: 128 QR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 261 SGVFSEMSDIYSFGVFLLELVT 282
+ FS SD++SFGV L EL T
Sbjct: 186 TSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-19
Identities = 58/193 (30%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 95 IGFGSFGPVYKGLLRDTV-VAIKR-RVGSPRQE-FVAEVTYLSEIRHRNLVTLLGYCQQN 151
+G G FG V+ G R + VAIK R G+ ++ F+ E + ++ H NLV L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKN 211
+V EY+ NG + N+L E KL + + + + + +L S +H++
Sbjct: 72 RPIFIVTEYMANGCLLNYLR----ERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRD 125
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPEVEESGVFSEMSDI 270
N LV E+ + KV+D G+++ + + ++ S G+ V + PEV + FS SD+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLD-DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 271 YSFGVFLLELVTG 283
+SFGV + E+ +
Sbjct: 185 WSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 8e-19
Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 93 SLIGFGSFGPVYKGL--LRDTVVAIKR------------RVGSPRQEFVAEVTYLSEIRH 138
+LIG GSFG VY G+ ++A+K+ R S E+ L E++H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 139 RNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETG-LESSTKLEFKQRVSIALGAAKGL 197
N+V LG + + EY+P GS+ L G E + F +++ KGL
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI------LKGL 119
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE-NIEEAG-----PS-HGSIV 250
+LH+ ++H++ K AN+LVD K++D GISK LE N PS GS+
Sbjct: 120 NYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV- 176
Query: 251 NVFRDPEVEESGVFSEMSDIYSFGVFLLELVTG 283
+ PEV + ++ +DI+S G ++E++TG
Sbjct: 177 -FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 75/288 (26%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 94 LIGFGSFGPVYK------GLLRDTVVAIKRRVGSP--RQEFVAEVTYLSEI-RHRNLVTL 144
+IG G+FG V K GL D + + S ++F E+ L ++ H N++ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGL-----------ESSTKLEFKQRVSIALGA 193
LG C+ GY L EY P+G++ + L ++ + +++ L +Q + A
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 194 AKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF 253
A+G+ +L + +H++ N+LV EN++AK+AD G+S+ E + + G + +
Sbjct: 134 ARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRW 189
Query: 254 RDPEVEESGVFSEMSDIYSFGVFLLELVT--GQEASHIVSLGSYEALIQWVRSRLSSNNF 311
E V++ SD++S+GV L E+V+ G + YE L Q R N
Sbjct: 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN-- 247
Query: 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359
+ + DL+R QC RP ++ L R+ E+
Sbjct: 248 ---------CDDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLEE 283
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEFVAEVTYLSEIRHRNLVT 143
+ F +G GS+G VYK + ++T VVAIK V QE + E++ L + +V
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
G +N +V EY GS+ + + T T E ++ +I KGL +LHS
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITN---KTLTE-EEIAAILYQTLKGLEYLHSN 118
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVN--VFRDPEV-EE 260
K +H++ K N+L++E AK+AD G+S L + +++ + PEV +E
Sbjct: 119 K--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD---TMAKRNTVIGTPFWMAPEVIQE 173
Query: 261 SGVFSEMSDIYSFGVFLLELVTG 283
G ++ +DI+S G+ +E+ G
Sbjct: 174 IG-YNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 2e-18
Identities = 59/191 (30%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 95 IGFGSFGPVYKGLLRDTV-VAIKR-RVGSPRQE-FVAEVTYLSEIRHRNLVTLLGYCQQN 151
+G G FG V+ G T VAIK + G+ E F+ E + ++RH LV L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKN 211
+V E++ GS+ + L E L+ Q V +A A G+ ++ + +H++
Sbjct: 74 PI-YIVTEFMGKGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRD 127
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIY 271
+ AN+LV +N + K+AD G+++L+E+ E + PE G F+ SD++
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 272 SFGVFLLELVT 282
SFG+ L ELVT
Sbjct: 188 SFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 67/204 (32%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKR----RVGSPRQEFVA----EVTYLSEIRHRNLVT 143
L+G GSFG VY+GL D A+K G QE V E+ LS+++H N+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLH 201
LG ++ + E +P GS+ L + G E +L +Q + GL +LH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-------LGLEYLH 119
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV-EE 260
VH++ K AN+LVD N + K+AD G++K + A GS + PEV +
Sbjct: 120 DRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGS--PYWMAPEVIAQ 175
Query: 261 SGVFSEMSDIYSFGVFLLELVTGQ 284
G + +DI+S G +LE+ TG+
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-18
Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 9/191 (4%)
Query: 95 IGFGSFGPVYKGLLRD-TVVAIKR-RVGSPRQE-FVAEVTYLSEIRHRNLVTLLGYCQQN 151
+G G FG V+ G T VAIK + GS E F+AE + +++H LV L Q
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKN 211
++ EY+ NGS+ + L KL + + +A A+G+ + +H++
Sbjct: 74 PI-YIITEYMENGSLVDFLKT---PEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRD 127
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIY 271
+ AN+LV E K+AD G+++L+E+ E + PE G F+ SD++
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 272 SFGVFLLELVT 282
SFG+ L E+VT
Sbjct: 188 SFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 58/220 (26%), Positives = 106/220 (48%), Gaps = 25/220 (11%)
Query: 74 ARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLR---DTV---VAIKR-RVGSPRQ-- 124
R ELE+ ++G G+FG VYKG+ + V VAIK R + +
Sbjct: 1 LRILKETELEKI-------KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN 53
Query: 125 -EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEF 183
E + E ++ + H ++V LLG C + L+ + +P G + +++ +
Sbjct: 54 KEILDEAYVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRN----HKDNIGS 108
Query: 184 KQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243
+ ++ + AKG+ +L + LVH++ NVLV K+ D G++KLL+ E+
Sbjct: 109 QYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY 166
Query: 244 PSHGSIVNV-FRDPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ G V + + E +++ SD++S+GV + EL+T
Sbjct: 167 HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 94 LIGFGSFGPVYKGLLRDT-------VVAIKRRVGSPRQ----EFVAEVTYLSEI-RHRNL 141
+G G+FG V K VA+K + + V+E+ + I +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHL-----------YETGLESSTKLEFKQRVSIA 190
+ LLG C Q G +V EY +G++ + L + L K VS A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 191 LGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE-EAGPSHGSI 249
A+G+ L S K +H++ NVLV E+ + K+AD G+++ + +I+ ++G +
Sbjct: 139 YQVARGMEFLASKK--CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 250 VNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ PE V++ SD++SFGV L E+ T
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-18
Identities = 74/270 (27%), Positives = 117/270 (43%), Gaps = 33/270 (12%)
Query: 95 IGFGSFGPVYKGLLR--DTVVAIK--RRVGSP--RQEFVAEVTYLSEIRHRNLVTLLGYC 148
IG G+FG V+ G LR +T VA+K R P + +F+ E L + H N+V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 149 QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLV 208
Q +V E + G L G +L+ K+ + + AA G+ +L S +
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEG----PRLKVKELIQMVENAAAGMEYLES--KHCI 116
Query: 209 HKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV---FRDPEVEESGVFS 265
H++ N LV E + K++D G+S+ E + S G + + + PE G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 266 EMSDIYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGTFTTE 323
SD++SFG+ L E SLG+ Y L S + ++ +
Sbjct: 175 SESDVWSFGILLWE---------AFSLGAVPYANL-----SNQQTREAIEQGVRLPCPEL 220
Query: 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353
+ RL +C +RP V EL
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 56/203 (27%), Positives = 108/203 (53%), Gaps = 21/203 (10%)
Query: 94 LIGFGSFGPVYKGLL-----RDTVVAIKR-RVG---SPRQEFVAEVTYLSEIRHRNLVTL 144
+IG G FG V +G L R+ VAIK + G R++F++E + + + H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
G ++ M++ E++ NG++ + L + + + Q V + G A G+ +L +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH-----GSIVNVFRDPEVE 259
VH++ N+LV+ N + KV+D G+S+ LE+ + + P++ G I + PE
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLED-DTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 260 ESGVFSEMSDIYSFGVFLLELVT 282
F+ SD++S+G+ + E+++
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 95 IGFGSFGPVYKGLLR-DTVVAIKR-RVGSPRQE-FVAEVTYLSEIRHRNLVTLLGYCQQN 151
+G G FG V+ G +T VA+K + G+ E F+ E + ++RH LV L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKN 211
+V EY+ GS+ + L + L+ V +A A G+ ++ + +H++
Sbjct: 74 PI-YIVTEYMSKGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRD 127
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIY 271
++AN+LV + + K+AD G+++L+E+ E + PE G F+ SD++
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 272 SFGVFLLELVT 282
SFG+ L ELVT
Sbjct: 188 SFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 50/171 (29%), Positives = 90/171 (52%), Gaps = 15/171 (8%)
Query: 125 EFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHL-----------YE 172
+ V+E+ + I +H+N++ LLG C Q+G ++ EY G++ +L Y+
Sbjct: 66 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 173 TGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI 232
++ FK VS A+G+ +L S K +H++ NVLV EN + K+AD G+
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGL 183
Query: 233 SKLLENIE-EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT 282
++ + NI+ ++G + + PE V++ SD++SFGV + E+ T
Sbjct: 184 ARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 23/213 (10%)
Query: 94 LIGFGSFGPVYKGLLRDTV--------VAIKR-RVGSPRQE---FVAEVTYLSEIRHRNL 141
+G G+FG VY+G D + VA+K R G+ QE F+ E +S H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLES--STKLEFKQRVSIALGAAKGLCH 199
V LLG C N Q ++ E + G + ++L + +E L K+ + I L AKG +
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 200 LHSLKPPLVHKNFKTANVLVDE-----NFIAKVADTGISK-LLENIEEAGPSHGSIVNVF 253
L + +H++ N LV E + + K+ D G+++ + ++ G + +
Sbjct: 122 LEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 254 RDPEVEESGVFSEMSDIYSFGVFLLELVT-GQE 285
PE G F+ SD++SFGV + E++T GQ+
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 90 SETSLIGFGSFGPVYKGLLR-------DTVVAIK----RRVGSPRQEFVAEVTYLSEIRH 138
E + +G G FG V+ + +T+V +K + + + EF E+ ++ H
Sbjct: 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH 67
Query: 139 RNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYET----GLESSTKLEFKQRVSIALGAA 194
+N+V LLG C++ ++ EY G + L T L KQ+V++ A
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 195 KGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-F 253
G+ HL + + VH++ N LV KV+ +SK + N E +++ + +
Sbjct: 128 LGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKDVYN-SEYYKLRNALIPLRW 184
Query: 254 RDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASH 288
PE + FS SD++SFGV + E+ T E
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-17
Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 8/191 (4%)
Query: 95 IGFGSFGPVYKGLLRD-TVVAIKR-RVGSPR-QEFVAEVTYLSEIRHRNLVTLLGYCQQN 151
+G G FG V+ G + T VA+K + G+ Q F+ E + ++H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKN 211
++ EY+ GS+ + L + K+ + + + A+G+ ++ + +H++
Sbjct: 74 EPIYIITEYMAKGSLLDFLKS---DEGGKVLLPKLIDFSAQIAEGMAYIE--RKNYIHRD 128
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIY 271
+ ANVLV E+ + K+AD G+++++E+ E + PE G F+ SD++
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 272 SFGVFLLELVT 282
SFG+ L E+VT
Sbjct: 189 SFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 4e-17
Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 29/213 (13%)
Query: 93 SLIGFGSFGPV----YKGLLRDT--VVAIKRRVGSPR---QEFVAEVTYLSEIRHRNLVT 143
+G G+FG V Y L +T VVA+K+ S ++F E+ L ++H N+V
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 144 LLGYCQQNGYQ--MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH 201
G C G + LV EYLP GS+ ++L + +L+ ++ + A KG+ +L
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYL----QKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN------IEEAGPSHGSIVNVF-R 254
S + VH++ T N+LV+ K+ D G++K+L + E G S +F
Sbjct: 126 SKR--YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES-----PIFWY 178
Query: 255 DPEVEESGVFSEMSDIYSFGVFLLELVTGQEAS 287
PE FS SD++SFGV L EL T + S
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFTYSDKS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-17
Identities = 73/291 (25%), Positives = 130/291 (44%), Gaps = 40/291 (13%)
Query: 94 LIGFGSFGPVYKGLLR------DTVVAIKRRVGSP--RQEFVAEVTYLSEI-RHRNLVTL 144
+IG G+FG V + +++ + + + + S ++F E+ L ++ H N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETG-LE----------SSTKLEFKQRVSIALGA 193
LG C+ GY + EY P G++ + L ++ LE +++ L +Q + A
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 194 AKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF 253
A G+ +L + +H++ NVLV EN +K+AD G+S+ E + + G + +
Sbjct: 129 ATGMQYLSEKQ--FIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK--TMGRLPVRW 184
Query: 254 RDPEVEESGVFSEMSDIYSFGVFLLELVT--GQEASHIVSLGSYEALIQWVRSRLSSNNF 311
E V++ SD++SFGV L E+V+ G + YE L Q R N
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRN-- 242
Query: 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMA 362
+ + +L+R QC RP + +L R+ E A
Sbjct: 243 ---------CDDEVYELMR---QCWRDRPYERPPFAQISVQLSRMLEARKA 281
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 9e-17
Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 94 LIGFGSFGPVYKGLLRDT----VVAIKR-RVGSP----RQEFVAEVTYLSEIRHRNLVTL 144
IG GSFG VY L+R + +K + + R++ + EV L ++ H N++
Sbjct: 7 QIGKGSFGKVY--LVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
++ G +V EY G + + + + +Q + + L +LHS K
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKI-KKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG------PSHGSIVNVFRDPEV 258
++H++ K N+ + N + K+ D GISK+L + + P + S PE+
Sbjct: 124 --ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLS-------PEL 174
Query: 259 EESGVFSEMSDIYSFGVFLLELVTGQ 284
++ ++ SDI+S G L EL T +
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 31/212 (14%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKR---------RVGSPRQEFV----AEVTYLSEIRH 138
LIG G++G VY L T ++A+K+ R S +++ V +E+ L ++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 139 RNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETG-LESSTKLEFKQRVSIALGAAKGL 197
N+V LG+ Y + EY+P GS+ + L G E F ++V +GL
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV------LEGL 121
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI---EEAGPSHGSIVNVFR 254
+LHS ++H++ K N+LVD + I K++D GISK ++I ++ GS+ +
Sbjct: 122 AYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV--FWM 177
Query: 255 DPEV--EESGVFSEMSDIYSFGVFLLELVTGQ 284
PEV S +S DI+S G +LE+ G+
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 33/219 (15%)
Query: 95 IGFGSFGPVYK-------GLLRDTVVAIKR-RVGSPRQEF---VAEVTYLSEIRHRNLVT 143
+G G FG V K G T VA+K + + E ++E L ++ H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 144 LLGYCQQNGYQMLVFEYLPNGSM-----------CNHLYETGLESSTKLE--------FK 184
L G C Q+G +L+ EY GS+ ++L G +S+ L+
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 185 QRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK-LLENIEEAG 243
+S A ++G+ +L +K LVH++ NVLV E K++D G+S+ + E
Sbjct: 128 DLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT 282
S G I + E +++ SD++SFGV L E+VT
Sbjct: 186 RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 63/194 (32%), Positives = 97/194 (50%), Gaps = 15/194 (7%)
Query: 95 IGFGSFGPVYKGLLRDTV-VAIKR-RVGS-PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN 151
+G G FG V G R VAIK + GS EF+ E + ++ H LV L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 152 GYQMLVFEYLPNGSMCNHLYET--GLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVH 209
+V EY+ NG + N+L E + S LE + V +G+ +L S + +H
Sbjct: 72 RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVC------EGMAYLESKQ--FIH 123
Query: 210 KNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPEVEESGVFSEMS 268
++ N LVD+ KV+D G+S+ + + +E S GS V + PEV FS S
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 269 DIYSFGVFLLELVT 282
D+++FGV + E+ +
Sbjct: 183 DVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 52/171 (30%), Positives = 92/171 (53%), Gaps = 15/171 (8%)
Query: 125 EFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHL-----------YE 172
+ V+E+ + I +H+N++ LLG C Q+G ++ EY G++ +L ++
Sbjct: 63 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFD 122
Query: 173 TGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI 232
T +L FK VS A A+G+ +L S K +H++ NVLV E+ + K+AD G+
Sbjct: 123 TCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDNVMKIADFGL 180
Query: 233 SKLLENIE-EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT 282
++ + NI+ ++G + + PE V++ SD++SFGV L E+ T
Sbjct: 181 ARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 93 SLIGFGSFGPVYKGLLRDT--VVAIKR----RVGSPRQEFVAEVTYLSEIRHRNLVTLLG 146
++G GS G VYK + T + A+K+ R++ + E+ L +V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPP 206
+ G +V EY+ GS+ + L + G L + IA KGL +LH+ +
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQILKGLDYLHTKRH- 120
Query: 207 LVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH-GSIVNVFRDPEVEESGVFS 265
++H++ K +N+L++ K+AD GISK+LEN + + G++ + PE + +S
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTV--TYMSPERIQGESYS 178
Query: 266 EMSDIYSFGVFLLELVTGQ 284
+DI+S G+ LLE G+
Sbjct: 179 YAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 19/220 (8%)
Query: 83 EQATKQFSETSLIGFGSFGPVYKGLLR-------DTVVAIK--RRVGSPRQ--EFVAEVT 131
E A ++ + + +G GSFG VY+G+ + +T VAIK S R+ EF+ E +
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 132 YLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLY-----ETGLESSTKLEFKQR 186
+ E ++V LLG Q +++ E + G + ++L K+
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 187 VSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH 246
+ +A A G+ +L++ K VH++ N +V E+F K+ D G+++ + +
Sbjct: 122 IQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 247 GSIVNV-FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQE 285
++ V + PE + GVF+ SD++SFGV L E+ T E
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 219
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 73/287 (25%), Positives = 130/287 (45%), Gaps = 40/287 (13%)
Query: 94 LIGFGSFGPVYKGLLR------DTVVAIKRRVGSP--RQEFVAEVTYLSEI-RHRNLVTL 144
+IG G+FG V K ++ D + + S ++F E+ L ++ H N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGL-----------ESSTKLEFKQRVSIALGA 193
LG C+ GY L EY P+G++ + L ++ + +++ L +Q + A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 194 AKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF 253
A+G+ +L + +H++ N+LV EN++AK+AD G+S+ E + + G + +
Sbjct: 122 ARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRW 177
Query: 254 RDPEVEESGVFSEMSDIYSFGVFLLELVT--GQEASHIVSLGSYEALIQWVRSRLSSNNF 311
E V++ SD++S+GV L E+V+ G + YE L Q R N
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN-- 235
Query: 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358
+ + DL+R QC RP ++ L R+ E
Sbjct: 236 ---------CDDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 5e-16
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 31/206 (15%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEFVAEVTYLSEI------RHRNLVTLL 145
IG G++G VYK + T +VA+K+ R+ + ++ F +T + EI RH N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFP--ITAIREIKLLQKLRHPNIVRLK 64
Query: 146 GY---CQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEF--KQRVSIALGAAKGLCHL 200
+ M VFEY+ + L TGL S +++F Q +GL +L
Sbjct: 65 EIVTSKGKGSIYM-VFEYMDH-----DL--TGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV-- 258
HS ++H++ K +N+L++ + + K+AD G+++ A ++ I +R PE+
Sbjct: 117 HSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174
Query: 259 -EESGVFSEMSDIYSFGVFLLELVTG 283
+ D++S G L EL G
Sbjct: 175 GATR--YGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 7e-16
Identities = 67/277 (24%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 88 QFSETSLIGFGSFGPVYKGLLRD----TVVAIKR----RVGSPRQEFVA-----EVTYLS 134
++ + +G G+F Y+ RD T++A+K+ R S QE V E+ ++
Sbjct: 1 EWLKGQQLGTGAFSSCYQA--RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMA 58
Query: 135 EIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIA--LG 192
+ H +++ +LG ++ + L E++ GS+ + L + G FK+ V I
Sbjct: 59 RLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-------AFKEAVIINYTEQ 111
Query: 193 AAKGLCHLHSLKPPLVHKNFKTANVLVDEN-FIAKVADTGIS-KLLENIEEAGPSHGSIV 250
+GL +LH + ++H++ K AN+L+D ++AD G + +L AG G ++
Sbjct: 112 LLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL 169
Query: 251 NV--FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS 308
F PEV + D++S G ++E+ T + + ++ ALI + S ++
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA 229
Query: 309 NNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPK 345
+ +H + G+RD +TL+C+ RP
Sbjct: 230 PSIPEH------LSPGLRD---VTLRCLELQPEDRPP 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 94 LIGFGSFGPVYKGLLRDTV-----VAIK--RRVGSPRQ--EFVAEVTYLSEIRHRNLVTL 144
+IG G FG VY G L D+ A+K R+ + +F+ E + + H N+++L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 145 LGYC-QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
LG C G ++V Y+ +G + N + + K + L AKG+ +L S
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRS----ETHNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP---SHGSIVNVFRDPEVEE 260
K VH++ N ++DE+F KVAD G+++ + + E + + + E +
Sbjct: 118 K--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 261 SGVFSEMSDIYSFGVFLLELVT 282
+ F+ SD++SFGV L EL+T
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 28/214 (13%)
Query: 95 IGFGSFGPVYK----GLLRD-----TVVAIKRRVGSPRQ----EFVAEVTYLSEI-RHRN 140
+G G FG V GL ++ T VA+K + + ++E+ + I +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHL-----------YETGLESSTKLEFKQRVSI 189
++ LLG C Q+G ++ EY G++ +L Y +L FK VS
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 190 ALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE-EAGPSHGS 248
A A+G+ +L S K +H++ NVLV E+ + K+AD G+++ + +I+ ++G
Sbjct: 146 AYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 203
Query: 249 IVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ + PE +++ SD++SFGV L E+ T
Sbjct: 204 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 55/205 (26%), Positives = 102/205 (49%), Gaps = 28/205 (13%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVA-----EVTYLSEIRHRNLVTLLG 146
L+G GS+G V K ++T +VAIK+ + S + V E+ L ++RH NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHL--YETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
++ LVFE++ + ++ + L Y GL+ S ++ ++ + CH H+
Sbjct: 68 VFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGI----EFCHSHN-- 120
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV----FRDPEVEE 260
++H++ K N+LV ++ + K+ D G ++ L A P V +R PE+
Sbjct: 121 --IIHRDIKPENILVSQSGVVKLCDFGFARTL-----AAPGEVYTDYVATRWYRAPELLV 173
Query: 261 SGV-FSEMSDIYSFGVFLLELVTGQ 284
+ DI++ G + E++TG+
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 32/207 (15%)
Query: 95 IGFGSFGPV----YKGLLRDT-----VVAIKRRVGSPRQE-FVAEVTYLSEIRHRNLVTL 144
+G G FG V Y T V +KR G + E+ L + H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 145 LGYCQQNGYQ--MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
G C + G + L+ EY+P GS+ ++L + L + L F Q++ +G+ +LHS
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQI------CEGMAYLHS 125
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISK------LLENIEEAGPSHGSIVNVF-RD 255
+H++ NVL+D + + K+ D G++K + E G S VF
Sbjct: 126 QH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS-----PVFWYA 178
Query: 256 PEVEESGVFSEMSDIYSFGVFLLELVT 282
E + FS SD++SFGV L EL+T
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 55/189 (29%), Positives = 91/189 (48%), Gaps = 25/189 (13%)
Query: 111 TVVAIKR-RVG---SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSM 166
+VA+K R + R++F+ EV LS + N+ LLG C + ++ EY+ NG +
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 167 CNHLYETGLESSTKLEFKQRVS------IALGAAKGLCHLHSLKPPLVHKNFKTANVLVD 220
L + E+S + +S +A A G+ +L SL VH++ T N LV
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVG 164
Query: 221 ENFIAKVADTGISK-LLEN----IEEAGPSHGSIVNVFRDPEVEE--SGVFSEMSDIYSF 273
+N+ K+AD G+S+ L + ++ G R E G F+ SD+++F
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQ------GRAPLPIRWMAWESVLLGKFTTKSDVWAF 218
Query: 274 GVFLLELVT 282
GV L E++T
Sbjct: 219 GVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 18/206 (8%)
Query: 88 QFSETSLIGFGSFGPVYKGLL---RDTV---VAIK--RRVGSPRQ--EFVAEVTYLSEIR 137
+ ++G G+FG VYKG+ +TV VAIK P+ EF+ E ++ +
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 138 HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGL 197
H +LV LLG C Q LV + +P+G + ++++E ++L V IA KG+
Sbjct: 68 HPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIA----KGM 122
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDP 256
+L + LVH++ NVLV K+ D G+++LLE E+ + G + + +
Sbjct: 123 MYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVT 282
E F+ SD++S+GV + EL+T
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 27/225 (12%)
Query: 81 ELEQATKQFSETSLIGFGSFGPVYKGLL------RDTVVAIK--RRVGSPRQ--EFVAEV 130
EL + +F E +G +FG +YKG L +VAIK + + +P+Q EF E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 131 TYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLY------ETGLES------S 178
+ ++E+ H N+V LLG Q ++FEYL G + L + G S
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 179 TKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238
+ L+ + IA+ A G+ +L S VHK+ N+L+ E K++D G+S+ + +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 239 IEEAGPSHGSIVNV-FRDPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ S++ + + PE G FS SDI+SFGV L E+ +
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVAEVTYLSEIRHRN 140
+ F+ IG GSFG VYK + + T VVAIK ++ E+ +LS+ R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 141 LVTLLGYCQQNGYQM-LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCH 199
+ G G ++ ++ EY GS C L + G KL+ I GL +
Sbjct: 61 ITKYYG-SFLKGSKLWIIMEYCGGGS-CLDLLKPG-----KLDETYIAFILREVLLGLEY 113
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF------ 253
LH +H++ K AN+L+ E K+AD G+S L + S N F
Sbjct: 114 LHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-------SKRNTFVGTPFW 164
Query: 254 RDPEVEESGVFSEMSDIYSFGVFLLELVTG 283
PEV + + E +DI+S G+ +EL G
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 95 IGFGSFGPVY----KGLLRDT------VVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTL 144
+G G+FG V+ LL + V A+K S RQ+F E L+ ++H+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETG-----LESST-----KLEFKQRVSIALGAA 194
G C + ++VFEY+ +G + L G L +L Q ++IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 195 KGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-F 253
G+ +L SL VH++ T N LV + + K+ D G+S+ + + + +++ + +
Sbjct: 133 SGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190
Query: 254 RDPEVEESGVFSEMSDIYSFGVFLLELVT 282
PE F+ SDI+SFGV L E+ T
Sbjct: 191 MPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-15
Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 25/230 (10%)
Query: 81 ELEQATKQFSETSLIGFGSFGPVYKGLLRDTVV--AIKR---RVGSPRQEFVAEVTYLSE 135
E E + E ++G G++G VY T V AIK R Q E+ S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 136 IRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYE-----TGLESSTKLEFKQRVSIA 190
++HRN+V LG +NG+ + E +P GS+ L E + KQ +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL--- 118
Query: 191 LGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-NFIAKVADTGISKLLENIEEAGPSHGSI 249
+GL +LH + +VH++ K NVLV+ + + K++D G SK L I +
Sbjct: 119 ----EGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGT 172
Query: 250 VNVFRDPEVEESGV--FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEA 297
+ + PEV + G + +DI+S G ++E+ TG+ LG +A
Sbjct: 173 LQ-YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI--ELGEPQA 219
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 7e-15
Identities = 45/158 (28%), Positives = 82/158 (51%), Gaps = 14/158 (8%)
Query: 137 RHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHL-----------YETGLESSTKLEFKQ 185
+H+N++ LLG C Q G ++ EY G++ L ++ +L FK
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 186 RVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE-EAGP 244
VS A A+G+ +L S + +H++ NVLV E+ + K+AD G+++ + +I+
Sbjct: 136 LVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 245 SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT 282
S+G + + PE V++ SD++SFG+ + E+ T
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 9e-15
Identities = 66/269 (24%), Positives = 116/269 (43%), Gaps = 50/269 (18%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR-----RVGSPRQEFVAEVTYLSEIRHRNLVTLLGY 147
IG GSFG V+K + + V A+K+ R+E + E L+++ ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVS------IALGAAKGLCHLH 201
G +V EY NG L K++ + + + GL HLH
Sbjct: 68 FLDKGKLNIVMEYAENGD---------LHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH---GSIVNV--FRDP 256
S K ++H++ K+ N+ +D K+ D G++KLL + +IV + P
Sbjct: 119 SKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL------SDNTNFANTIVGTPYYLSP 170
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALI-QWVRSRLSSNNFVDHR 315
E+ E ++E SD+++ GV L E TG+ H + ALI + +R
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGK---HPFDANNQGALILKIIRGVFPP------- 220
Query: 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRP 344
++ ++ + L +L QC++ R+RP
Sbjct: 221 VSQMYS----QQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 69/227 (30%), Positives = 109/227 (48%), Gaps = 38/227 (16%)
Query: 71 PQGARQFSMEELEQATKQFSETSLIGFGSFGPVY--KGLLRDTVVAIKRRVGSPRQ---- 124
P+ A FS ++ E K F++ IG GSFG VY + + + VVAIK+ S +Q
Sbjct: 2 PEIAELFSKDDPE---KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEK 58
Query: 125 --EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY-LPNGSMCNHLYETGLESSTKL 181
+ + EV +L ++RH N + G + LV EY L + S +++ L
Sbjct: 59 WQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPL------ 112
Query: 182 EFKQRVSIA---LGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238
Q V IA GA +GL +LHS + +H++ K N+L+ E K+AD G + L
Sbjct: 113 ---QEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASL--- 164
Query: 239 IEEAGPSHGSIVNV--FRDPEV---EESGVFSEMSDIYSFGVFLLEL 280
P++ S V + PEV + G + D++S G+ +EL
Sbjct: 165 ---VSPAN-SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 70/296 (23%), Positives = 130/296 (43%), Gaps = 31/296 (10%)
Query: 69 FGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT----VVAIKRRVGSPRQ 124
F + ++ ++ ++ + K E ++I G G YKG VV V S
Sbjct: 675 FDSKVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS 731
Query: 125 EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFK 184
+A+ + +++H N+V L+G C+ L+ EY+ ++ L L ++
Sbjct: 732 SEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL--------RNLSWE 780
Query: 185 QRVSIALGAAKGLCHLH-SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243
+R IA+G AK L LH P +V N +++D + + LL
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL-----CT 834
Query: 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVR 303
+ I + + PE E+ +E SDIY FG+ L+EL+TG+ + G + ++++W R
Sbjct: 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWAR 893
Query: 304 SRLSS---NNFVDHRLAGTFTTEG--MRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354
S + ++D + G + + +++ L L C ++ RP V+ LE
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 28/204 (13%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVAEVTYLSEIR------HRNLVTLLG 146
IG G++G VYK + T +VAIK+ + + T L EI+ H N++ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKK-IKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPP 206
+ G LVFE+ M LY+ + L S +GL HS
Sbjct: 66 VFRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG-- 118
Query: 207 LVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-----FRDPEV-EE 260
++H++ K N+L++ + K+AD G+++ G + +R PE+
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLAR------SFGSPVRPYTHYVVTRWYRAPELLLG 172
Query: 261 SGVFSEMSDIYSFGVFLLELVTGQ 284
+S DI+S G EL++ +
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 95 IGFGSFGPVY----------KGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTL 144
+G G+FG V+ K + V A+K + R++F E L+ ++H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETG-----------LESSTKLEFKQRVSIALGA 193
G C ++VFEY+ +G + L G ++ +L Q + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 194 AKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE--EAGPSHGSIVN 251
A G+ +L S VH++ T N LV N + K+ D G+S+ + + + G H +
Sbjct: 133 ASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG-GHTMLPI 189
Query: 252 VFRDPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ PE F+ SD++SFGV L E+ T
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 68/258 (26%), Positives = 111/258 (43%), Gaps = 54/258 (20%)
Query: 88 QFSETSLIGFGSFGPVYKG--LLRDTVVAIKR-RVGS----PRQEFVAEVTYLSEIRHRN 140
F +G GS+G VYK L + A+K +GS R++ V E+ L+ + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 141 LVT-----LLG--YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRV--SIAL 191
+++ L G C +V EY P G + + + + ++ I +
Sbjct: 61 IISYKEAFLDGNKLC-------IVMEYAPFGDLSKAISK---RKKKRKLIPEQEIWRIFI 110
Query: 192 GAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI---EEAGPSHGS 248
+GL LH K ++H++ K+AN+L+ N + K+ D GISK+L+ + G H
Sbjct: 111 QLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH-- 166
Query: 249 IVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTG---------QEASHIVSLGSYEA-- 297
+ PEV + +S SDI+S G L E+ T Q+ + V G Y
Sbjct: 167 ----YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP 222
Query: 298 ------LIQWVRSRLSSN 309
L ++RS L
Sbjct: 223 PIYSQDLQNFIRSMLQVK 240
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-14
Identities = 55/191 (28%), Positives = 92/191 (48%), Gaps = 9/191 (4%)
Query: 95 IGFGSFGPVYKGLLRDTV-VAIKR-RVGSPRQE-FVAEVTYLSEIRHRNLVTLLGYCQQN 151
+G G FG V+ G R + VAIK G+ +E F+ E + ++ H LV L G C Q
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKN 211
+V E++ NG + N+L + KL +S+ +G+ +L + +H++
Sbjct: 72 KPLYIVTEFMENGCLLNYLR----QRQGKLSKDMLLSMCQDVCEGMEYLE--RNSFIHRD 125
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIY 271
N LV + KV+D G+++ + + E S + PEV +S SD++
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185
Query: 272 SFGVFLLELVT 282
SFGV + E+ T
Sbjct: 186 SFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-14
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 37/218 (16%)
Query: 95 IGFGSFGPVYK----GLL---RDTVVAIKR-RVGSPRQ---EFVAEVTYLSEIRHRNLVT 143
IG G+FG V++ GLL T+VA+K + + +F E ++E H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYE---TGLESSTKLEFKQR-------------- 186
LLG C L+FEY+ G + L S + R
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 187 VSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA---- 242
+ IA A G+ +L K VH++ T N LV EN + K+AD G+S+ NI A
Sbjct: 133 LCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSR---NIYSADYYK 187
Query: 243 GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLEL 280
+ +I + PE ++ SD++++GV L E+
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 5e-14
Identities = 51/223 (22%), Positives = 92/223 (41%), Gaps = 43/223 (19%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVAEV-------TYLSEIRHRN 140
+IG GSF V ++T AIK R++ +++ V V T L+ H
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQL--IKEKKVKYVKIEKEVLTRLN--GHPG 63
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL 200
++ L Q V EY PNG + ++ + G L+ K A L +L
Sbjct: 64 IIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYL 118
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR------ 254
HS ++H++ K N+L+D++ K+ D G +K+L+ + G N+
Sbjct: 119 HSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 255 -------------DPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
PE+ + SD+++ G + +++TG+
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 5e-14
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 21/200 (10%)
Query: 95 IGFGSFGPVYKGLLR-----DTVVAIK----RRVGSPRQEFVAEVTYLSEIRHRNLVTLL 145
+G G+FG V KG+ + VA+K + + ++EF+ E + ++++ H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
G C+ MLV E P G + +L + + L +A A G+ +L S
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLESKH- 115
Query: 206 PLVHKNFKTANVL-VDENFIAKVADTGISKLL--ENIEEAGPSHGSIVNVFRDPEVEESG 262
VH++ NVL V+ + AK++D G+S+ L + + G + PE G
Sbjct: 116 -FVHRDLAARNVLLVNRHQ-AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 263 VFSEMSDIYSFGVFLLELVT 282
FS SD++S+GV L E +
Sbjct: 174 KFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 59/214 (27%), Positives = 89/214 (41%), Gaps = 31/214 (14%)
Query: 87 KQFSETSLIGFGSFGPVYKG--LLRDTVVAIKRRVGSPRQEF---VAEVTYLSEIRHRNL 141
+ + IG G++G VYK + +VAIK P +F E++ L E RH N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH 201
V G + +V EY GS+ + T L Q + KGL +LH
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLH 118
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIV--NVF------ 253
+H++ K AN+L+ E+ K+AD G+S L +I F
Sbjct: 119 ETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTA---------TIAKRKSFIGTPYW 167
Query: 254 RDPEV---EESGVFSEMSDIYSFGVFLLELVTGQ 284
PEV E G + DI++ G+ +EL Q
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 6e-14
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 28/216 (12%)
Query: 95 IGFGSFGPVYKGLLR----DTV---VAIKRRVGSPRQE----FVAEVTYLSEIRHRNLVT 143
+G G+FG VY+GL R D V VA+K S ++ F+ E +S+ H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYET--GLESSTKLEFKQRVSIALGAAKGLCHLH 201
L+G + + ++ E + G + + L E E + L K + A AKG +L
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 202 SLKPPLVHKNFKTANVLVD---ENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPE 257
+H++ N L+ +AK+AD G+++ + +++ + + PE
Sbjct: 134 ENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPE 191
Query: 258 VEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLG 293
G+F+ +D++SFGV L E I SLG
Sbjct: 192 AFLDGIFTSKTDVWSFGVLLWE---------IFSLG 218
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEF----VAEVTYLSEIRHRNL 141
+++ IG G++G VYKG + T +VA+K+ R+ S + + E++ L E++H N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH 201
V L Q L+FE+L SM Y L ++ + S +G+ H
Sbjct: 62 VCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV-EE 260
S + ++H++ K N+L+D + K+AD G+++ I +H + +R PEV
Sbjct: 119 SRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVVTLWYRAPEVLLG 175
Query: 261 SGVFSEMSDIYSFGVFLLELVT 282
S +S DI+S G E+ T
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 50/205 (24%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQE-FVAEVTYLSEIRHRNL 141
+ + IG G+ G VYK R T VAIK+ R+ +E + E+ + + +H N+
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH 201
V +V EY+ GS+ + + + ++ Q + +GL +LH
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQN----FVRMNEPQIAYVCREVLQGLEYLH 133
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPEVE 259
S ++H++ K+ N+L+ ++ K+AD G + L + S+V + PEV
Sbjct: 134 SQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLT---KEKSKRNSVVGTPYWMAPEVI 188
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQ 284
+ + DI+S G+ +E+ G+
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 93 SLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVA-----EVTYLSEIRHRNLVTLL 145
++G G++G V K + T +VAIK+ S E V EV L ++RH N+V L
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHL--YETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
++ G LVFEY+ ++ L GL + + L + + + HS
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPP----DAVRSYIWQL--LQAIAYCHSH 119
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPEVEES 261
++H++ K N+LV E+ + K+ D G ++ L V +R PE+
Sbjct: 120 N--IIHRDIKPENILVSESGVLKLCDFGFARALR--ARPASPLTDYVATRWYRAPELLVG 175
Query: 262 GV-FSEMSDIYSFGVFLLELVTGQ 284
+ + D+++ G + EL+ G+
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 51/195 (26%), Positives = 81/195 (41%), Gaps = 26/195 (13%)
Query: 103 VYKGLLRDTVVAIKR----RVGSPR--QEFVAEVTYLSEIRHRNLVTLLGY----CQQNG 152
+YKG+ + V I+ G E+ L I N++ + G+
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 153 YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH-SLKPPLVHKN 211
L+ EY G + L + L FK ++ +A+ KGL +L+ P +KN
Sbjct: 96 RLSLILEYCTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKN 148
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEM---S 268
+ + LV EN+ K+ I LE I + P V+ ++ + +FSE
Sbjct: 149 LTSVSFLVTENYKLKI----ICHGLEKILSSPPFKNVNFMVYFSYKML-NDIFSEYTIKD 203
Query: 269 DIYSFGVFLLELVTG 283
DIYS GV L E+ TG
Sbjct: 204 DIYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 67/225 (29%), Positives = 113/225 (50%), Gaps = 39/225 (17%)
Query: 83 EQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEF----VAEVTYLSE 135
++ +F IG G++G VYK +DT +VA+K+ R+ + ++ F + E+ L +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 136 IRHRNLVTL----------LGYCQQNGYQMLVFEYLPNGSMCNHLYETGL----ESSTKL 181
+ HRN+V L L + + G LVFEY+ + M L E+GL E K
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLM--GLLESGLVHFSEDHIKS 120
Query: 182 EFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241
KQ + +GL + H K +H++ K +N+L++ K+AD G+++L N EE
Sbjct: 121 FMKQLL-------EGLNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLARLY-NSEE 170
Query: 242 AGPSHGSIVNV-FRDPEV---EESGVFSEMSDIYSFGVFLLELVT 282
+ P ++ + +R PE+ EE + D++S G L EL T
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEER--YGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 64/223 (28%), Positives = 109/223 (48%), Gaps = 25/223 (11%)
Query: 88 QFSETSLIGFGSFGPVYKGLLR------DTVVAIK--RRVGSPR--QEFVAEVTYLSEIR 137
+F + ++G G+FG VYKGL VAIK R SP+ +E + E ++ +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 138 HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGL 197
+ ++ LLG C + Q L+ + +P G + +++ E ++ V IA KG+
Sbjct: 68 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA----KGM 122
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDP 256
+L + LVH++ NVLV K+ D G++KLL E+ + G V + +
Sbjct: 123 NYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVT-------GQEASHIVSL 292
E +++ SD++S+GV + EL+T G AS I S+
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 223
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 88 QFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQE------FVAEVTYLSEIRHR 139
++ IG G+ G V+K R+T VA+K+ V R E + E+ L +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKK-VALRRLEGGIPNQALREIKALQACQHP 59
Query: 140 NLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCH 199
+V LL +LV EY+P+ L E + L Q S KG+ +
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV- 258
+H+ ++H++ K AN+L+ + + K+AD G+++L E SH +R PE+
Sbjct: 115 MHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172
Query: 259 EESGVFSEMSDIYSFGVFLLELVTGQ 284
+ + D+++ G EL+ G
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 19/200 (9%)
Query: 94 LIGFGSFGPVYKGLL-----RDTVVAIKR-RVG---SPRQEFVAEVTYLSEIRHRNLVTL 144
++G G FG + +G L R+ VAI R G R+ F+AE L + H N+V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
G + M+V EY+ NG++ + L + +L Q + + G A G+ +L +
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLR----KHEGQLVAGQLMGMLPGLASGMKYLSEMG 127
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPS--HGSIVNVFRDPEVEESG 262
VHK VLV+ + + K+ +G +L E+ EA + G ++ PE +
Sbjct: 128 --YVHKGLAAHKVLVNSDLVCKI--SGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 263 VFSEMSDIYSFGVFLLELVT 282
FS SD++SFG+ + E+++
Sbjct: 184 HFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 95 IGFGSFGPVY--KGLLRDTVVAIKR--RVGSPRQEFVA---EVTYLSEIRHRNLVTLLGY 147
IG GSFG +Y K IK P +E A EV L++++H N+VT
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 148 CQQNGYQMLVFEYLPNGSMCNHL-YETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPP 206
Q+NG +V EY G + + + G+ S V I+L GL H+H K
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL----GLKHIHDRK-- 121
Query: 207 LVHKNFKTANVLVDEN-FIAKVADTGISKLLEN-IEEAGPSHGSIVNVFRDPEVEESGVF 264
++H++ K+ N+ + +N +AK+ D GI++ L + +E A G+ + PE+ ++ +
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGT--PYYLSPEICQNRPY 179
Query: 265 SEMSDIYSFGVFLLELVT 282
+ +DI+S G L EL T
Sbjct: 180 NNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 95 IGFGSFGPVY----------KGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTL 144
+G G+FG V+ + + V +K + R++F E L+ ++H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLES--------STKLEFKQRVSIALGAAKG 196
G C + ++VFEY+ +G + L G ++ +L Q + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 197 LCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRD 255
+ +L S VH++ T N LV EN + K+ D G+S+ + + + +++ + +
Sbjct: 133 MVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 190
Query: 256 PEVEESGVFSEMSDIYSFGVFLLELVT 282
PE F+ SD++S GV L E+ T
Sbjct: 191 PESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 43/213 (20%)
Query: 98 GSFGPVYKGLLRDTVVAIKRRV--------GSPRQ--EFVAEVTYLSEIRHRNLVTLLGY 147
G+FG ++ G+L D + V S Q + E L + H+N++ +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 148 CQQNGYQMLVFEYLPN-GSM------CNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL 200
C ++G V N G++ C L +Q V +A+ A G+ +L
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANN---PQALSTQQLVHMAIQIACGMSYL 133
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL-----------ENIEEAGPSHGSI 249
H ++HK+ N ++DE K+ D +S+ L EN + S+
Sbjct: 134 HKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191
Query: 250 VNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT 282
VN +S SD++SFGV L EL+T
Sbjct: 192 VNKE----------YSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-13
Identities = 68/279 (24%), Positives = 129/279 (46%), Gaps = 40/279 (14%)
Query: 88 QFSETSLIGFGSFGPVY--KGLLRDTVVAIK-----RRVGSPRQEFVAEVTYLSEIRHRN 140
++ + ++G G+FG V+ + +V IK + R E L + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETG---LESSTKLEFKQRVSIALGAAKGL 197
++ ++ M+V EY P G++ ++ + L+ T L F ++ +AL
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH----- 115
Query: 198 CHLHSLKPPLVHKNFKTANVLVDEN-FIAKVADTGISKLLENIEEAGPSHGSIVNVFRDP 256
H+H+ ++H++ KT N+L+D++ + K+ D GISK+L + +A G+ + P
Sbjct: 116 -HVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGT--PCYISP 170
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316
E+ E +++ SDI++ G L EL + + A +L AL+ + S
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIMS------------ 215
Query: 317 AGTFTTEGMR---DLIRLTLQCMSSPGRRRPKMEIVMTE 352
GTF R DL +L L ++ +RP++ +M +
Sbjct: 216 -GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 73/287 (25%), Positives = 122/287 (42%), Gaps = 50/287 (17%)
Query: 94 LIGFGSFGPVYKGLLRDTV-----VAIKR----RVGSPRQEFVAEVTYLSEIRHRNLVTL 144
IG G FG VY+G+ VA+K S R++F+ E + + H ++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHL--YETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
+G +N +V E P G + ++L + L+ ++ + + ++S AL +L S
Sbjct: 73 IGVITENPV-WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA------YLES 125
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESG 262
+ VH++ NVLV K+ D G+S+ LE+ S G + + PE
Sbjct: 126 KR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 263 VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322
F+ SD++ FGV + E I+ LG Q V+ NN V R+
Sbjct: 184 RFTSASDVWMFGVCMWE---------ILMLGVKP--FQGVK-----NNDVIGRI-----E 222
Query: 323 EGMR---------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360
G R L L +C + +RP+ + +L I ++E
Sbjct: 223 NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 95 IGFGSFGPVY------KGLLRDTVVAIKRRVGSPRQEFVA----EVTYLSEIRHRNLVTL 144
+G G FG V +G VA+K +A E+ L + H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 145 LGYCQQNGYQ--MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
G C ++G L+ E+LP+GS+ +L + K+ KQ++ A+ KG+ +L S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL----PRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVN-VF-RDPEVEE 260
+ VH++ NVLV+ K+ D G++K +E +E + + VF PE
Sbjct: 128 RQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 261 SGVFSEMSDIYSFGVFLLELVT 282
F SD++SFGV L EL+T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 76/312 (24%), Positives = 138/312 (44%), Gaps = 48/312 (15%)
Query: 71 PQGARQFSMEELEQATKQFSETSLIGFGSFGPVY--KGLLRDTVVAIKRRVGSPRQ---- 124
P A F ++ E K FS+ IG GSFG VY + + VVAIK+ S +Q
Sbjct: 2 PDVAELFFKDDPE---KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 58
Query: 125 --EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLE 182
+ + EV +L ++RH N + G + LV EY + + L E + ++E
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVE 116
Query: 183 FKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242
++ GA +GL +LHS ++H++ K N+L+ E + K+ D G + ++
Sbjct: 117 I---AAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIM------ 165
Query: 243 GPSHGSI-VNVFRDPEV---EESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEAL 298
P++ + + PEV + G + D++S G+ +EL + + ++ + AL
Sbjct: 166 APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSAL 223
Query: 299 IQWVRSR---LSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELER 355
++ L S ++ +E R+ + LQ + + RP E+++ R
Sbjct: 224 YHIAQNESPALQSGHW----------SEYFRNFVDSCLQKIP---QDRPTSEVLLK--HR 268
Query: 356 IHEKEMALTTFM 367
+E T M
Sbjct: 269 FVLRERPPTVIM 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 94 LIGFGSFGPVYKG----LLRDTV-VAIK----RRVGSPRQEFVAEVTYLSEIRHRNLVTL 144
+G GSFG V +G + VA+K ++ +F+ E + + H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLES---STKLEFKQRVSIALGAAKGLCHLH 201
G + M+V E P GS+ + L + L ST ++ A+ A G+ +L
Sbjct: 62 YGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDY------AVQIANGMRYLE 114
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPS--HGSIVNVFRDPEVE 259
S + +H++ N+L+ + K+ D G+ + L E+ H + + PE
Sbjct: 115 SKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172
Query: 260 ESGVFSEMSDIYSFGVFLLELVT-GQE 285
+ FS SD++ FGV L E+ T G+E
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEE 199
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 7e-13
Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 35/245 (14%)
Query: 94 LIGFGSFGPVYKGLL-RDTVVAIKRRVGSPRQEFVAEVTY---------LSEIRHRNLVT 143
++G G++G VY GL + ++A+K+ AE Y L ++H N+V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
LG C + + E++P GS+ + L G + F + L G+ +LH+
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQIL---DGVAYLHN- 120
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD------PE 257
+VH++ K NV++ N I K+ D G ++ L + G +H +++ PE
Sbjct: 121 -NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG-THSNMLKSMHGTPYWMAPE 178
Query: 258 V-EESGVFSEMSDIYSFGVFLLELVTGQ-------EASHIVSLGSYEALIQWVRSRLSSN 309
V ESG + SDI+S G + E+ TG+ + + +G++ L+ + S+
Sbjct: 179 VINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237
Query: 310 --NFV 312
+FV
Sbjct: 238 AIDFV 242
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 8e-13
Identities = 50/191 (26%), Positives = 96/191 (50%), Gaps = 9/191 (4%)
Query: 95 IGFGSFGPVYKGLL-RDTVVAIKR-RVGSPRQE-FVAEVTYLSEIRHRNLVTLLGYCQQN 151
+G G FG V+ + T VA+K + GS E F+AE + ++H LV L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKN 211
++ E++ GS+ + L + +K + + + A+G+ + + +H++
Sbjct: 74 PIYIIT-EFMAKGSLLDFLKS---DEGSKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRD 127
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIY 271
+ AN+LV + + K+AD G+++++E+ E + PE G F+ SD++
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 272 SFGVFLLELVT 282
SFG+ L+E+VT
Sbjct: 188 SFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (166), Expect = 9e-13
Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 40/216 (18%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEF----VAEVTYLSEIRHRNL 141
+ + +G G++G VYK + T +VA+K+ R+ + + + E++ L E++H N+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 142 VTLLGYCQQNGYQMLVFEYLPN---GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLC 198
V LL LVFEY + L SI +GL
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDMDLKKYLDKR--------PGPLSPNLIKSIMYQLLRGLA 112
Query: 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV----FR 254
+ HS + ++H++ K N+L++ + + K+AD G+++ P V +R
Sbjct: 113 YCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGI-----PLRTYTHEVVTLWYR 165
Query: 255 DPEV------EESGVFSEMSDIYSFGVFLLELVTGQ 284
PE+ + V DI+S G E++TG+
Sbjct: 166 APEILLGSKHYSTAV-----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 68/270 (25%), Positives = 116/270 (42%), Gaps = 22/270 (8%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSP----RQEFVAEVTYLSEIRHRN 140
++ E S +G G+ G V K L++T + A+K P +++ + E+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 141 LVTLLGYCQQNGYQML--VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLC 198
+V G + EY GS+ + +Y+ + ++ K IA KGL
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV 258
+LHS K ++H++ K +N+L+ K+ D G+S L N AG G+ + + PE
Sbjct: 120 YLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN-SLAGTFTGT--SFYMAPER 174
Query: 259 EESGVFSEMSDIYSFGVFLLELVTGQ---EASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315
+ +S SD++S G+ LLE+ + LG E L V + D
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM--PNPELKDEP 232
Query: 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPK 345
G +E +D I+ QC+ RRP
Sbjct: 233 GNGIKWSEEFKDFIK---QCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVAEVTYLSEIRHRNLV 142
F++ IG GSFG V+KG+ T VVAIK ++ E+T LS+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 143 TLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
G ++ ++ EYL GS + L E G L+ Q +I KGL +LHS
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG-----PLDETQIATILREILKGLDYLHS 119
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPEVEE 260
K +H++ K ANVL+ E+ K+AD G++ L + + + V + PEV +
Sbjct: 120 EKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---IKRNTFVGTPFWMAPEVIK 174
Query: 261 SGVFSEMSDIYSFGVFLLELVTGQ 284
+ +DI+S G+ +EL G+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 95 IGFGSFGPVYKGLLRDTV-------VAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVT 143
+G GSFG VY+G RD + VA+K S R EF+ E + + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKL-----EFKQRVSIALGAAKGLC 198
LLG + ++V E + +G + ++L E+ ++ + +A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPE 257
+L++ K VH++ N +V +F K+ D G+++ + + ++ V + PE
Sbjct: 134 YLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191
Query: 258 VEESGVFSEMSDIYSFGVFLLELVTGQE 285
+ GVF+ SD++SFGV L E+ + E
Sbjct: 192 SLKDGVFTTSSDMWSFGVVLWEITSLAE 219
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 60/202 (29%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 95 IGFGSFGPVYKG--LLRDTVVAIKRRVGSPRQEFV----AEVTYLSEIRHRNLVTLLGYC 148
IG G+ VY L + VAIKR Q V EV +S+ H N+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 149 QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIAL---GAAKGLCHLHSLKP 205
LV YL GS + ++SS IA KGL +LHS
Sbjct: 69 VVGDELWLVMPYLSGGS-LLDI----MKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG- 122
Query: 206 PLVHKNFKTANVLVDENFIAKVADTGISK-LLENIEEAGPSHGSIVNV--FRDPEV-EES 261
+H++ K N+L+ E+ K+AD G+S L + + + V + PEV E+
Sbjct: 123 -QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 262 GVFSEMSDIYSFGVFLLELVTG 283
+ +DI+SFG+ +EL TG
Sbjct: 182 HGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 25/204 (12%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKRRVGSP-----RQEFVA---EVTYLSEIRHRNLVT 143
L+G G+FG VY DT +A+K+ P ++E A E+ L ++H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 144 LLGYCQQNGYQMLVF-EYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHL 200
G C ++ + +F EY+P GS+ + L G E+ T+ +Q + +G+ +L
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL-------EGVEYL 120
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPEV 258
HS +VH++ K AN+L D K+ D G SK L+ I +G S+ + PEV
Sbjct: 121 HSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178
Query: 259 EESGVFSEMSDIYSFGVFLLELVT 282
+ +D++S G ++E++T
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 74 ARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLL---RDTV---VAIKR-RVGSPRQEF 126
AR EL + L+G G FG V+KG+ D++ VAIK + S RQ F
Sbjct: 1 ARILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 127 VAEVTYL---SEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEF 183
++ + H +V LLG C Q LV + P GS+ +H+ + +
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLL 112
Query: 184 KQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243
V IA KG+ +L + +VH+N N+L+ + I ++AD G++ LL
Sbjct: 113 NWCVQIA----KGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLY------ 160
Query: 244 PSHGSIV-NVFRDP------EVEESGVFSEMSDIYSFGVFLLELVT 282
P + + P E G ++ SD++S+GV + E+++
Sbjct: 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 95 IGFGSFGPVY----KGLL------------RDTVVAIKR----RVGSPRQEFVAEVTYLS 134
+G G FG V+ +GL + +VA+K + R +F+ E+ +S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 135 EIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESS-------TKLEFKQRV 187
+++ N++ LLG C + ++ EY+ NG + L + +ES+ + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 188 SIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHG 247
+A+ A G+ +L SL VH++ T N LV ++ K+AD G+S+ L + + G
Sbjct: 133 YMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRNLYS-GDYYRIQG 189
Query: 248 SIVNVFRDPEVEES--GVFSEMSDIYSFGVFLLELVT 282
V R E G F+ SD+++FGV L E+ T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 69/254 (27%), Positives = 105/254 (41%), Gaps = 55/254 (21%)
Query: 123 RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTK-- 180
R +F+ EV LS ++ N++ LLG C ++ EY+ NG + L L+ +
Sbjct: 63 RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENG 122
Query: 181 ------------LEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVA 228
+ + + +AL A G+ +L SL VH++ T N LV EN K+A
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIA 180
Query: 229 DTGISKLLENIEEAGPSH---GSIVNVFR--DPEVEESGVFSEMSDIYSFGVFLLE-LVT 282
D G+S+ L AG + G V R E G F+ SD+++FGV L E L+
Sbjct: 181 DFGMSRNL----YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236
Query: 283 GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRD------------LIR 330
+E + L+ +++ AG F + R L
Sbjct: 237 CKEQPY---------------GELTDEQVIEN--AGEFFRDQGRQVYLFRPPPCPQGLYE 279
Query: 331 LTLQCMSSPGRRRP 344
L LQC S R RP
Sbjct: 280 LMLQCWSRDCRERP 293
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 47/168 (27%), Positives = 83/168 (49%), Gaps = 11/168 (6%)
Query: 123 RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSM----CNHLYETGLESS 178
R +F+ E+ +S ++ N++ LL C + ++ EY+ NG + H + E +
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 179 TK--LEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236
+ + + +A A G+ +L SL VH++ T N LV +N+ K+AD G+S+ L
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 237 ENIEEAGPSHGSIVNVFRDPEVEES--GVFSEMSDIYSFGVFLLELVT 282
+ + G V R E G F+ SD+++FGV L E++T
Sbjct: 181 YS-GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 4e-12
Identities = 66/233 (28%), Positives = 110/233 (47%), Gaps = 28/233 (12%)
Query: 60 PSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVY--KGLLRDTVVAIKR 117
PS++ P+ A F E+ E K F++ IG GSFG VY + + + VVAIK+
Sbjct: 1 PSTSRAGSLKDPEIAELFFKEDPE---KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKK 57
Query: 118 RVGSPR------QEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLY 171
S + Q+ + EV +L I+H N + G + LV EY + + L
Sbjct: 58 MSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSA--SDLL 115
Query: 172 ETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231
E + ++E +I GA +GL +LHS ++H++ K N+L+ E K+AD G
Sbjct: 116 EVHKKPLQEVEI---AAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFG 170
Query: 232 ISKLLENIEEAGPSHGSI-VNVFRDPEV---EESGVFSEMSDIYSFGVFLLEL 280
+ + A P++ + + PEV + G + D++S G+ +EL
Sbjct: 171 SASI------ASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVAEVTYLSEIRHRNLV 142
F++ IG GSFG VYKG+ T VVAIK ++ E+T LS+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 143 TLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
G + ++ EYL GS + L LE + + + KGL +LHS
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREI------LKGLDYLHS 119
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPEVEE 260
+ +H++ K ANVL+ E K+AD G++ L + + + V + PEV +
Sbjct: 120 ERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---IKRNTFVGTPFWMAPEVIK 174
Query: 261 SGVFSEMSDIYSFGVFLLELVTGQ 284
+ +DI+S G+ +EL G+
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 61/239 (25%), Positives = 112/239 (46%), Gaps = 32/239 (13%)
Query: 58 AGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAI 115
+ SS++ + G + S+ ELE+ + IG G+ G VYK + R T + A+
Sbjct: 52 SSSSSSSSSSASGSAPSAAKSLSELERVNR-------IGSGAGGTVYKVIHRPTGRLYAL 104
Query: 116 KRRVG----SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLY 171
K G + R++ E+ L ++ H N+V NG ++ E++ GS
Sbjct: 105 KVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS------ 158
Query: 172 ETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231
LE + + + +A G+ +LH +VH++ K +N+L++ K+AD G
Sbjct: 159 ---LEGTHIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFG 213
Query: 232 ISKLL-ENIEEAGPSHGSIVNVFRDPEVEES----GVFSEMS-DIYSFGVFLLELVTGQ 284
+S++L + ++ S G+I + PE + G + + DI+S GV +LE G+
Sbjct: 214 VSRILAQTMDPCNSSVGTI--AYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-12
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVAEVTYLSEIRHRNLV 142
F++ IG GSFG V+KG+ T VVAIK ++ E+T LS+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 143 TLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
G + ++ EYL GS + L + EF Q ++ KGL +LHS
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFD-----EF-QIATMLKEILKGLDYLHS 119
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPEVEE 260
K +H++ K ANVL+ E K+AD G++ L + + + V + PEV +
Sbjct: 120 EKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---IKRNTFVGTPFWMAPEVIQ 174
Query: 261 SGVFSEMSDIYSFGVFLLELVTGQ 284
+ +DI+S G+ +EL G+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 7e-12
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 95 IGFGSFGPVYKG----LLRDTVVAIK--RRVGSPRQE--FVAEVTYLSEIRHRNLVTLLG 146
IG G FG V G + V +K R +P ++ F+ EV E+ H N++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHLY-ETGLES-STKLEFKQRVSIALGAAKGLCHLHSLK 204
C ++ +LV E+ P G + N+L G+ + + + QR +A A GL LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR--MACEVASGLLWLHQAD 120
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGI--SKLLENIEEAGPSHGSIVNVFRDPEVEES- 261
+H + N + + K+ D G+ + E+ H + + PE+ E
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR-WLAPELVEIR 177
Query: 262 ------GVFSEMSDIYSFGVFLLELVT 282
++ S+I+S GV + EL T
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 8e-12
Identities = 66/225 (29%), Positives = 99/225 (44%), Gaps = 27/225 (12%)
Query: 81 ELEQATKQFSETSLIGFGSFGPVYKGLLRDTV-------VAIK----RRVGSPRQEFVAE 129
E+ +T +F E +G FG VYKG L T VAIK + G R+EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 130 VTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLES-----------S 178
S ++H N+V LLG + ++F Y + + L S
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 179 TKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238
+ LE V I A G+ L S +VHK+ T NVLV + K++D G+ + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 239 IEEAGPSHGSIVNV-FRDPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ S++ + + PE G FS SDI+S+GV L E+ +
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 8e-12
Identities = 48/172 (27%), Positives = 87/172 (50%), Gaps = 40/172 (23%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEF----VAEVTYLSEIRHR 139
++ + + IG G+FG V+K + T +VA+K+ + + ++ F + E+ L ++H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 140 NLVTLLGYC-----QQNGYQ---MLVFEYLPNGSMCNH-LYETGLESSTKLEFKQRVSIA 190
N+V L+ C N Y+ LVFE+ C H L GL S+ ++F
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEF------CEHDL--AGLLSNKNVKFT------ 117
Query: 191 LGAAK--------GLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234
L K GL ++H K ++H++ K AN+L+ ++ I K+AD G+++
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 8e-12
Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 37/162 (22%)
Query: 93 SLIGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQE-----FVA--EVTYLSEIRHRNLV 142
+G G++ VYK ++T +VAIK+ ++G ++ F A E+ L E++H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 143 TLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAA-------- 194
LL LVFE++ ET LE K SI L A
Sbjct: 66 GLLDVFGHKSNINLVFEFM----------ETDLEKVIK-----DKSIVLTPADIKSYMLM 110
Query: 195 --KGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234
+GL +LHS ++H++ K N+L+ + + K+AD G+++
Sbjct: 111 TLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 88 QFSETSLIGFGSFGPVYK----GLLRDTV---VAIK----RRVGSPRQEFVAEVTYLSEI 136
F +T +G G+FG V + GL + VA+K S R+ ++E+ +S +
Sbjct: 38 SFGKT--LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95
Query: 137 -RHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAK 195
H N+V LLG C G +++ EY G + N L + + L + +S + AK
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR---KRESFLTLEDLLSFSYQVAK 152
Query: 196 GLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FR 254
G+ L S +H++ NVL+ I K+ D G+++ + N + + V +
Sbjct: 153 GMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210
Query: 255 DPEVEESGVFSEMSDIYSFGVFLLELVT 282
PE + V++ SD++S+G+ L E+ +
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 1e-11
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 32/206 (15%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAI----KRRVGSPRQE--FVAEVTYLSEIRHRNLVTLLG 146
+G GSFG V +DT + A+ K+++ ++ + E LS I H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
Q LV EY P G + +HL + G E + + V AL +LHSL
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVL-ALE------YLHSLG 113
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF---RD---PEV 258
+++++ K N+L+D + K+ D G++K S GS N F + PEV
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAK-------ELSSEGSRTNTFCGTPEYLAPEV 164
Query: 259 EESGVFSEMSDIYSFGVFLLELVTGQ 284
+ + D +S GV L E++TG+
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR-RVGSPR----QEFVAEVTYLSEIRHRNLVTLLGY 147
IG G+FG VY + DT ++A+K R+ +E E+ L ++H NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG- 66
Query: 148 CQQNGYQMLVF-EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPP 206
+ + ++ +F EY G++ L + + + ++ L +GL +LHS
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI---RVYTLQL--LEGLAYLHSHG-- 119
Query: 207 LVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVN------VFRDPEV-- 258
+VH++ K AN+ +D N + K+ D G + L+N + G V + PEV
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN---NTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 259 --EESGVFSEMSDIYSFGVFLLELVTG 283
+ G DI+S G +LE+ TG
Sbjct: 177 GGKGKGHGRAA-DIWSLGCVVLEMATG 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT----VVAIKR------RVGSPRQEFVAEVTYLSEI 136
+F + + IG G++G VY+ RDT +VA+K+ R G P + E+T L +
Sbjct: 7 TEFEKLNRIGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGIPISS-LREITLLLNL 63
Query: 137 RHRNLVTLLGYCQQNGYQ--MLVFEYLPNGSMCNHLYETGLES-STKLEFKQRVSIALGA 193
RH N+V L LV EY C + L++ T Q + L
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEY------CEQDLASLLDNMPTPFSESQVKCLMLQL 117
Query: 194 AKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV- 252
+GL +LH ++H++ K +N+L+ + K+AD G+++ A P +V +
Sbjct: 118 LRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP--AKPMTPKVVTLW 173
Query: 253 FRDPEVE-ESGVFSEMSDIYSFGVFLLELVTGQ 284
+R PE+ ++ D+++ G L EL+ +
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 70/277 (25%), Positives = 113/277 (40%), Gaps = 49/277 (17%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEF---VAEVTYLSEIRHRNLVTLLGYC 148
+G G+ G V K L R T ++A+K R+ + E+ L + +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 149 QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRV--SIALGAAKGLCHLHSLKPP 206
NG + EY+ GS+ L + +R+ IA+ KGL +LH K
Sbjct: 69 YNNGDISICMEYMDGGSLDKIL------KEVQGRIPERILGKIAVAVLKGLTYLHE-KHK 121
Query: 207 LVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF------RDPEVEE 260
++H++ K +N+LV+ K+ D G+S L N S+ F PE +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN---------SLAKTFVGTSSYMAPERIQ 172
Query: 261 SGVFSEMSDIYSFGVFLLELVTGQ---EASHIVSLGSYEALIQWVRS---RLSSNNFVDH 314
+S SDI+S G+ L+EL TG+ + G +E L V RL S F
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKF--- 229
Query: 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351
+ +D + C+ R RP + ++
Sbjct: 230 -------SPDFQDFVN---LCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 43/218 (19%)
Query: 88 QFSETSLIGFGSFGPVYKGLLRDT--VVAIKR-----RVGSPRQEFVAEVTYLSEIRHRN 140
F + +G G++ VYKG R T +VA+K G+P + E++ + E++H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA-IREISLMKELKHEN 59
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNG---SMCNHLYETGLESSTKLEFKQRVSIALGAAKGL 197
+V L MLVFEY+ M H L+ +T F ++ KG+
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL------LKGI 113
Query: 198 --CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF-- 253
CH + ++H++ K N+L+++ K+AD G+++ + G VN F
Sbjct: 114 AFCHENR----VLHRDLKPQNLLINKRGELKLADFGLAR----------AFGIPVNTFSN 159
Query: 254 -------RDPEV-EESGVFSEMSDIYSFGVFLLELVTG 283
R P+V S +S DI+S G + E++TG
Sbjct: 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 48/214 (22%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEF--VAEVTYLSEIR-------HRNLVT 143
+G G+FG VY ++T +VAIK+ +++F E L E++ H N+V
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM----KKKFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGA---------- 193
L ++N VFEY M +LY+ K R
Sbjct: 63 LKEVFRENDELYFVFEY-----MEGNLYQL---------MKDRKGKPFSESVIRSIIYQI 108
Query: 194 AKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV- 252
+GL H+H K H++ K N+LV + K+AD G+++ + + P + V+
Sbjct: 109 LQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS----RPPYTDYVSTR 162
Query: 253 -FRDPEV-EESGVFSEMSDIYSFGVFLLELVTGQ 284
+R PE+ S +S DI++ G + EL T +
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 88 QFSETSLIGFGSFGPVYKGLLR------DTVVAIK--RRVGSPR--QEFVAEVTYLSEIR 137
+ + ++G G+FG VYKG+ VAIK R SP+ +E + E ++ +
Sbjct: 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67
Query: 138 HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGL 197
+ LLG C + Q LV + +P G + +++ E + ++ + ++ + AKG+
Sbjct: 68 SPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGM 122
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDP 256
+L ++ LVH++ NVLV K+ D G+++LL+ E + G V + +
Sbjct: 123 SYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVT 282
E F+ SD++S+GV + EL+T
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 3e-11
Identities = 67/279 (24%), Positives = 119/279 (42%), Gaps = 48/279 (17%)
Query: 94 LIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEF--------------VAEVTYLSEIRHR 139
L+G G+FG VY DT R + + + +F E+ L ++H
Sbjct: 9 LLGQGAFGRVYLCYDVDT----GRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 140 NLVTLLGYCQQNGYQMLV--FEYLPNGSMCNHLYETG-LESSTKLEFKQRVSIALGAAKG 196
+V G + + L EY+P GS+ + L G L S ++ +++ +G
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEG 118
Query: 197 LCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FR 254
+ +LHS +VH++ K AN+L D K+ D G SK L+ I +G S+ +
Sbjct: 119 MSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 255 DPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEAL--IQWVRSRLSSNNFV 312
PEV + +D++S G ++E++T + YEA+ I + ++ ++
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKP-----PWAEYEAMAAIFKIATQPTNPQLP 231
Query: 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351
H +E RD + C+ R RP E ++
Sbjct: 232 SH------ISEHARDFLG----CIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 50/210 (23%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 94 LIGFGSFGPVYKGLLR--DTV---VAIK--RRVGSPR---QEFVAEVTYLSEIRHRNLVT 143
++G G FG V +G L D VA+K + +EF++E + + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 144 LLGYC------QQNGYQMLVFEYLPNGSMCNHLYETGLES-STKLEFKQRVSIALGAAKG 196
L+G C Q+ M++ ++ +G + + L + L KL + + + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 197 LCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRD 255
+ +L + +H++ N ++ E+ VAD G+SK + + + + + V +
Sbjct: 126 MEYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 256 PEVEESGVFSEMSDIYSFGVFLLELVT-GQ 284
E V++ SD+++FGV + E+ T GQ
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 7e-11
Identities = 53/214 (24%), Positives = 83/214 (38%), Gaps = 38/214 (17%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK----RRVGS-PRQEFVAEVTYLSEIRHRNLVTLLGY 147
IG GSFG V K + ++ K + +Q+ V+EV L E++H N+V Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64
Query: 148 CQ-----QNGYQMLVFEYLPNG---SMCNHLYETG--LESSTKLEFKQRVSIALGAAKGL 197
N +V EY G + + +E ++ +AL
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE---- 120
Query: 198 CHLHSLKPPLV-HKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF--- 253
CH S V H++ K AN+ +D N K+ D G++K+L + S +
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-------DSSFAKTYVGT 173
Query: 254 ---RDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
PE + E SDI+S G + EL
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-11
Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 88 QFSETSLIGFGSFGPVYKGLLRDTV---------VAIKRRVGSPRQEFVAEVTYLSEIRH 138
++ + IG GSFG L++ + I + R+E EV LS ++H
Sbjct: 1 KYVKVKKIGEGSFGKAI--LVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 139 RNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQR------VSIALG 192
N+V ++NG +V +Y G LY+ + + + F + V I L
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGD----LYKK-INAQRGVLFPEDQILDWFVQICL- 112
Query: 193 AAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN-IEEAGPSHGSIVN 251
L H+H K ++H++ K+ N+ + ++ K+ D GI+++L + +E A G+
Sbjct: 113 ---ALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGT--P 165
Query: 252 VFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEA 286
+ PE+ E+ ++ SDI++ G L E+ T + A
Sbjct: 166 YYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 32/206 (15%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKRRVGS---PRQEFVA--EVTYLSEIRHRNLVTLLGY 147
IG GS+G V+K R+T +VAIK+ V S P + +A E+ L +++H NLV L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETGLESSTK-LEFKQRVSIALGAAKGL--CHLHSLK 204
++ LVFEY C+H LE + + + I + + CH H+
Sbjct: 69 FRRKRKLHLVFEY------CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC- 121
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV----FRDPE--V 258
+H++ K N+L+ + K+ D G +++L GP V +R PE V
Sbjct: 122 ---IHRDVKPENILITKQGQIKLCDFGFARIL-----TGPGDDYTDYVATRWYRAPELLV 173
Query: 259 EESGVFSEMSDIYSFGVFLLELVTGQ 284
++ + D+++ G EL+TGQ
Sbjct: 174 GDT-QYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVA---EVTYLSEIRHRNL 141
+ F IG G++G VYK +T + AIK P ++F E+ + + +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH 201
V G + + E+ GS+ + + TG S +++ + R ++ +GL +LH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPE-- 257
S +H++ K AN+L+ +N K+AD G+S I S + + PE
Sbjct: 124 SKGK--MHRDIKGANILLTDNGHVKLADFGVSA---QITATIAKRKSFIGTPYWMAPEVA 178
Query: 258 -VEESGVFSEMSDIYSFGVFLLEL 280
VE G ++++ DI++ G+ +EL
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQ--EFVAEVTYLSEIRHRNLVTLL-GYC 148
+G G+FG VYK ++T A K ++ S + +F+ E+ LSE +H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 149 QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLV 208
+N +L+ E+ G++ + + E L Q + + L LHS K ++
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHK--VI 125
Query: 209 HKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPEVEESGVFSE 266
H++ K N+L+ + K+AD G+S ++ + + + + PEV F +
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ---KRDTFIGTPYWMAPEVVACETFKD 182
Query: 267 -----MSDIYSFGVFLLELVTGQEASHIVS 291
+DI+S G+ L+EL + H ++
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPPHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 71 PQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQ---- 124
P+ A F ++ E+ F IG GSFG VY T VVA+K+ S +Q
Sbjct: 8 PEIADLFYKDDPEEI---FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEK 64
Query: 125 --EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTK-L 181
+ + EV +L +++H N + G + LV EY C LE K L
Sbjct: 65 WQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY------CLGSASDLLEVHKKPL 118
Query: 182 EFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241
+ + +I GA +GL +LHS ++H++ K N+L+ E K+AD G +
Sbjct: 119 QEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASK------ 170
Query: 242 AGPSHGSI-VNVFRDPEV---EESGVFSEMSDIYSFGVFLLEL 280
+ P++ + + PEV + G + D++S G+ +EL
Sbjct: 171 SSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 69/290 (23%), Positives = 121/290 (41%), Gaps = 46/290 (15%)
Query: 88 QFSETSLIGFGSFGPVYKGLLRDT--VVAIK-RRVGSPRQEFVA----EVTYLSEIRH-- 138
+ LIG G++G VY+G T VVA+K + +P + V+ EV LS++R
Sbjct: 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQ 60
Query: 139 -RNLVTLLGYCQQNGYQM-LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKG 196
N+ G G ++ ++ EY GS+ L + + K I
Sbjct: 61 PPNITKYYG-SYLKGPRLWIIMEYAEGGSV------RTLMKAGPIAEKYISVIIREVLVA 113
Query: 197 LCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDP 256
L ++H K ++H++ K AN+LV K+ D G++ LL N + S + P
Sbjct: 114 LKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL-NQNSSKRSTFVGTPYWMAP 170
Query: 257 EVEESGV-FSEMSDIYSFGVFLLELVTG------QEASHIVSLGSYEALIQWVRSRLSSN 309
EV G + +DI+S G+ + E+ TG +A + L + + RL N
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-----IPKSKPPRLEDN 225
Query: 310 NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359
+ ++ +R+ + L P R E++ ++ + H K
Sbjct: 226 GY----------SKLLREFVAACLD--EEPKERLSAEELLKSKWIKAHSK 263
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 88 QFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVAEVT-----YLSEIRHRN 140
+F ++G G++G V K ++T +VAIK+ S E V E T L ++ N
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL 200
+V L ++ G LVFEY+ +M L E + + E + L A CH
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEK-NMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCH- 117
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEE 260
K +VH++ K N+L+ N + K+ D G ++ L A + +R PE+
Sbjct: 118 ---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174
Query: 261 SGVFSEMSDIYSFGVFLLELVTGQ 284
+ + D++S G L EL GQ
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 95 IGFGSFGPVYKGLLR--DTV--VAIKRR-----VGSPRQEFVAEVTYLSEIRHRNLVTLL 145
+G G FG V +G L D++ VA+K S ++F++E + E H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 146 GYCQQN----GYQ--MLVFEYLPNGSMCNHLYETGL-ESSTKLEFKQRVSIALGAAKGLC 198
G C Q GY +++ ++ +G + + L + L + L + V A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV---FRD 255
+L S +H++ N +++EN VAD G+SK + N + G I + +
Sbjct: 127 YLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY--RQGRIAKMPVKWIA 182
Query: 256 PEVEESGVFSEMSDIYSFGVFLLELVT-GQ 284
E V++ SD++SFGV + E+ T GQ
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQ 212
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 52/224 (23%), Positives = 91/224 (40%), Gaps = 43/224 (19%)
Query: 95 IGFGSFGPVYKGL--LRDTVVAIKR--------RVGSPRQ-------EFVA--EVTYLSE 135
+G G++G V K L +VAIK+ V RQ F E+ ++E
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 136 IRHRNLVTLLG-YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAA 194
I+H N++ L+ Y + + LV + M + L + ++ +L Q I L
Sbjct: 77 IKHENIMGLVDVYVEG-DFINLVMDI-----MASDLKKV-VDRKIRLTESQVKCILLQIL 129
Query: 195 KGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-- 252
GL LH K +H++ AN+ ++ I K+AD G+++ +
Sbjct: 130 NGLNVLH--KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 253 -----------FRDPE-VEESGVFSEMSDIYSFGVFLLELVTGQ 284
+R PE + + + D++S G EL+TG+
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 8e-10
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIKR-RV-----GSPRQEFVAEVTYLSEIRHRN 140
F + IG G++G VYK + T VVA+K+ R+ G P + E++ L E+ H N
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNHPN 60
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL 200
+V LL LVFE+L + + + + L S L + L CH
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV-E 259
H ++H++ K N+L++ K+AD G+++ + +H + +R PE+
Sbjct: 119 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILL 173
Query: 260 ESGVFSEMSDIYSFGVFLLELVT 282
+S DI+S G E+VT
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 95 IGFGSFGPVYKG--LLRDTVVAIKR------RVGSPRQEFVAEVTYLSEIRHRNLVTLLG 146
IG G F VYK LL VVA+K+ RQ+ + E+ L ++ H N++ L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 147 YCQQNGYQMLVFEYLPNGS---MCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
+N +V E G M H + + +K V + L H+HS
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHMHSK 125
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPE-VEE 260
+ ++H++ K ANV + + K+ D G+ + + +H S+V + PE + E
Sbjct: 126 R--IMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAH-SLVGTPYYMSPERIHE 180
Query: 261 SGVFSEMSDIYSFGVFLLEL 280
+G ++ SDI+S G L E+
Sbjct: 181 NG-YNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 1e-09
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIKRR--VGSPRQEFVAEVTYLSEI-RHRNLVT 143
F L+G G++G VYKG T + AIK G +E E+ L + HRN+ T
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 144 LLG-YCQQNGYQM-----LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGL 197
G + ++N M LV E+ GS+ + + T L+ + I +GL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGL 124
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSI-VNVFRDP 256
HLH K ++H++ K NVL+ EN K+ D G+S L+ G + I + P
Sbjct: 125 SHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGTPYWMAP 180
Query: 257 EV-----EESGVFSEMSDIYSFGVFLLELVTG 283
EV + SD++S G+ +E+ G
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 65/293 (22%), Positives = 124/293 (42%), Gaps = 46/293 (15%)
Query: 89 FSETSLIGFGSFGPVYKGLLR---DTVVAIKRRV-------GSPRQEFVAEVTYLSEIRH 138
F+ ++G G FG V + L+ + + ++ S +EF+ E + E H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 139 RNLVTLLGYCQQNGYQ------MLVFEYLPNGSMCNHLYETGL-ESSTKLEFKQRVSIAL 191
N++ L+G ++ + M++ ++ +G + L + + E L + V +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 192 GAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVN 251
A G+ +L S +H++ N +++EN VAD G+SK + + + S +
Sbjct: 121 DIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178
Query: 252 V-FRDPEVEESGVFSEMSDIYSFGVFLLELVT-------GQEASHIVSLGSYEALIQWVR 303
V + E V++ SD+++FGV + E++T G E S I Y LI+ R
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI-----YNYLIKGNR 233
Query: 304 SRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356
+ + + D+ L QC S + RP + + +LE I
Sbjct: 234 LKQP--------------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 68/269 (25%), Positives = 125/269 (46%), Gaps = 29/269 (10%)
Query: 95 IGFGSFGPVYKGLLRDT-----VVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQ 149
+G G++G VYK T V IK G E+ + E +H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 150 QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVH 209
+ EY GS+ + + TG S ++ + R ++ +GL +LHS +H
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK--MH 129
Query: 210 KNFKTANVLVDENFIAKVADTGI-SKLLENIEEAGPSHGSIVNVFRDPE---VEESGVFS 265
++ K AN+L+ +N K+AD G+ +K+ I + G+ + PE VE++G ++
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGT--PYWMAPEVAAVEKNGGYN 187
Query: 266 EMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA-GTFTTEG 324
++ DI++ G+ +EL + + L AL +S +NF +L T +
Sbjct: 188 QLCDIWAVGITAIEL--AELQPPMFDLHPMRALFL-----MSKSNFQPPKLKDKTKWSST 240
Query: 325 MRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353
+ ++++L +P ++RP E ++T L
Sbjct: 241 FHNFVKISL--TKNP-KKRPTAERLLTHL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVA-----EVTYLSEIRHRN-LVTLLG 146
IG G++G VYK ++T +VA+K+ +E + E++ L + +V LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 147 YC---QQNGYQM--LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH 201
++NG LVFEYL + + + G L K S KG+ H H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127
Query: 202 SLKPPLVHKNFKTANVLVD-ENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV-E 259
++H++ K N+LVD + + K+AD G+ + +I +H + +R PEV
Sbjct: 128 KHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIVTLWYRAPEVLL 184
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQ 284
S +S DI+S G E+ Q
Sbjct: 185 GSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 88 QFSETSLIGFGSFGPVYKGLLRDT--VVAIKR-RV-----GSPRQEFVAEVTYLSEIRHR 139
Q+ + IG G++G VYK R T +A+K+ R+ G P + E++ L E++H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA-IREISLLKEMQHG 61
Query: 140 NLVTL--LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRV--SIALGAAK 195
N+V L + + ++ Y LVFEYL + + H ++SS R+ + +
Sbjct: 62 NIVRLQDVVHSEKRLY--LVFEYL-DLDLKKH-----MDSSPDFAKNPRLIKTYLYQILR 113
Query: 196 GLCHLHSLKPPLVHKNFKTANVLVDE-NFIAKVADTGISKLLENIEEAGPSHGSIVNVFR 254
G+ + HS + ++H++ K N+L+D K+AD G+++ I +H + +R
Sbjct: 114 GIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVVTLWYR 170
Query: 255 DPEV-EESGVFSEMSDIYSFGVFLLELVT 282
PE+ S +S DI+S G E+V
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 48/200 (24%), Positives = 97/200 (48%), Gaps = 23/200 (11%)
Query: 95 IGFGSFGP--VYKGLLRDTVVAIKRRVG----SPRQEFVA--EVTYLSEIRHRNLVTLLG 146
+G G+FG +Y+ D++V K V S ++ A E+ LS ++H N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKE-VNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIAL--GAAKGLCHLHSLK 204
+ + ++ EY G+ LY+ + +L F++ + + + ++H K
Sbjct: 67 HFMDDNTLLIEMEYANGGT----LYDKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIH--K 119
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPEVEESG 262
++H++ KT N+ + + + K+ D GISK+L E + ++V + PE+ +
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAE--TVVGTPYYMSPELCQGV 176
Query: 263 VFSEMSDIYSFGVFLLELVT 282
++ SDI++ G L EL+T
Sbjct: 177 KYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 19/205 (9%)
Query: 95 IGFGSFGPVYKGLLRDTVVAIKRRVGSPRQE-----FVAEVTYLSEIRHRNLVTLLGYCQ 149
+G G+FG VYK ++T +V + E ++ E+ L+ H +V LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 150 QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVH 209
+G ++ E+ P G+ + LE L Q I + L +LHS+K ++H
Sbjct: 80 WDGKLWIMIEFCPGGA----VDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIH 133
Query: 210 KNFKTANVLVDENFIAKVADTGIS-KLLENIEEAGPSHGSIVNVFRDPEV-----EESGV 263
++ K NVL+ + K+AD G+S K ++ ++ G+ + PEV +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGT--PYWMAPEVVMCETMKDTP 191
Query: 264 FSEMSDIYSFGVFLLELVTGQEASH 288
+ +DI+S G+ L+E+ + H
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPPHH 216
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 43/217 (19%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR----RVGSPRQE--FVAEVTYLSEIRH 138
F +G GSFG V + + A+K ++ +Q + E L IRH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 139 RNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEF-KQRVSIALGAAKGL 197
LV L G Q + LV EY+P G + +HL ++G F +V +AL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE----- 115
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD-- 255
+LHSL +V+++ K N+L+D + K+ D G +K ++ R
Sbjct: 116 -YLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG---------------RTYT 157
Query: 256 ---------PEVEESGVFSEMSDIYSFGVFLLELVTG 283
PE+ S + + D ++ G+ + E++ G
Sbjct: 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 62/256 (24%), Positives = 93/256 (36%), Gaps = 41/256 (16%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK----------RRVGSPRQEFVAEVTYLSEIRHRNLV 142
IG G+FG V RDT + A+K V + E L E+ H LV
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNE----RRILQELNHPFLV 63
Query: 143 TLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHL 200
L Q LV + L G + HL + E K I L L +L
Sbjct: 64 NLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWI---CEIVLA----LEYL 116
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEE 260
HS ++H++ K N+L+DE + D I+ + + G+ + PEV
Sbjct: 117 HSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTP--GYMAPEVLC 172
Query: 261 SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALI--QWVRSRLSSNNFVDHRLAG 318
+S D +S GV E + G+ S + + Q L
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPA--------- 223
Query: 319 TFTTEGMRDLIRLTLQ 334
T++TE + D I L+
Sbjct: 224 TWSTEAI-DAINKLLE 238
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 18/149 (12%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR-RV-----GSPRQEFVAEVTYLSEIRHRNLVTLLG 146
IG G++G V+K R+T +VA+KR R+ G P E+ L E++H+N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-REICLLKELKHKNIVRLYD 66
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHLYETGLES-STKLEFKQRVSIALGAAKGLCHLHSLKP 205
+ LVFEY C+ + +S + ++ + S KGL HS
Sbjct: 67 VLHSDKKLTLVFEY------CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN- 119
Query: 206 PLVHKNFKTANVLVDENFIAKVADTGISK 234
++H++ K N+L+++N K+AD G+++
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 23/201 (11%)
Query: 95 IGFGSFGPVYKGL--LRDTVVAIKR-----RVGSPRQEFVAEVTYLSEIRHRNLVTLLGY 147
+G G++ VYKG L D +VA+K G+P + EV+ L +++H N+VTL
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHDI 72
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETGLE---SSTKLEFKQRVSIALGAAKGLCHLHSLK 204
LVFEYL + + +L + G + KL Q + +GL + H K
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLL-------RGLNYCHRRK 124
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV-EESGV 263
++H++ K N+L++E K+AD G+++ ++I S+ + +R P++ S
Sbjct: 125 --VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTD 181
Query: 264 FSEMSDIYSFGVFLLELVTGQ 284
+S D++ G E+ TG+
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-09
Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 23/198 (11%)
Query: 95 IGFGSFGPVYKGLLR----DTVVAIK-----RRVGSPRQEFVAEVTYLSEIRHRNLVTLL 145
+G G+FG V KG+ + + VA+K + + E + E + ++ + +V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYET-GLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
G C+ + MLV E G + L + + E +VS+ G+ +L
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLEETN 115
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLL---ENIEEAGPSHGSIVNVFRDPEVEES 261
VH++ NVL+ AK++D G+SK L EN +A +HG + PE
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA-KTHGKWPVKWYAPECMNY 172
Query: 262 GVFSEMSDIYSFGVFLLE 279
FS SD++SFGV + E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 65/280 (23%), Positives = 119/280 (42%), Gaps = 40/280 (14%)
Query: 95 IGFGSFGPVYKG--LLRDTVVAIKR------RVGSPRQEFVAEVTYLSEIRHRNLVTLLG 146
IG G F VY+ LL VA+K+ R + + E+ L ++ H N++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 147 YCQQNGYQMLVFEYLPNGS---MCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
++ +V E G M H + K +K V + L H+HS
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMHSR 125
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPE-VEE 260
+ ++H++ K ANV + + K+ D G+ + + A +H S+V + PE + E
Sbjct: 126 R--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AH-SLVGTPYYMSPERIHE 180
Query: 261 SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSY---EALIQWVRSRLSSNNFVDHRLA 317
+G ++ SDI+S G L E+ Q + + Y + + Q L S+++
Sbjct: 181 NG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY------ 233
Query: 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357
+E +R L+ + C++ +RP + V +R+H
Sbjct: 234 ----SEELRQLVNM---CINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 23/168 (13%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR------RVGSPRQEFVAEVTYLSEIRHRNLVTLLG 146
+G G+FG VYK T VVA+K+ + G P E+ L +++H N+V L+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-REIKILKKLKHPNVVPLID 74
Query: 147 ----YCQQNGYQMLVFEYLPNGSMCNHLYETGLES--STKLEFKQRVSIALGAAKGLCHL 200
++ + Y+ M + L +GL S KL Q L +G+ +L
Sbjct: 75 MAVERPDKSKRKRGSV-YMVTPYMDHDL--SGLLENPSVKLTESQIKCYMLQLLEGINYL 131
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGS 248
H ++H++ K AN+L+D I K+AD G L + P+
Sbjct: 132 HENH--ILHRDIKAANILIDNQGILKIADFG---LARPYDGPPPNPKG 174
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 82 LEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVAEVTYLSEIR-- 137
L T F +IG G++G VYK + T +VAIK + ++ E+ E
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEI--KEEYNIL 56
Query: 138 -----HRNLVTLLG-YCQQN----GYQM-LVFEYLPNGSMCNHLYETGLESSTKLEFKQR 186
H N+ T G + ++N Q+ LV E GS+ + L + + +L+ +
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWI 115
Query: 187 VSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH 246
I +GL +LH K ++H++ K N+L+ +N K+ D G+S L++ G +
Sbjct: 116 AYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS--TLGRRN 171
Query: 247 GSIVNVF-RDPEV---EES--GVFSEMSDIYSFGVFLLELVTGQ 284
I + PEV +E + SD++S G+ +EL G+
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 53/199 (26%), Positives = 99/199 (49%), Gaps = 19/199 (9%)
Query: 95 IGFGSFGPVYKGL--LRDTVVAIKR-----RVGSPRQEFVAEVTYLSEIRHRNLVTLLGY 147
+G G++ V+KG L + +VA+K G+P + EV+ L +++H N+VTL
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA-IREVSLLKDLKHANIVTLHDI 72
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIAL-GAAKGLCHLHSLKPP 206
+ LVFEYL + + ++ + G S V I L +GL + H K
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSM-----HNVKIFLYQILRGLAYCHRRK-- 124
Query: 207 LVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV-EESGVFS 265
++H++ K N+L++E K+AD G+++ +++ S+ + +R P+V S +S
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 266 EMSDIYSFGVFLLELVTGQ 284
D++ G E+ +G+
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKRRVGSP-RQEFVAEVT-------YLSEIRHRNLVT 143
L+G G+FG VY DT +A+K+ P QE EV L +RH +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 144 LLGYCQQNGYQ--MLVF-EYLPNGSMCNHLYETG--LESSTKLEFKQRVSIALGAAKGLC 198
G C ++ + + +F EY+P GS+ + L G E+ T+ +Q + +G+
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL-------QGVS 120
Query: 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDP 256
+LHS +VH++ K AN+L D K+ D G SK ++ I +G S+ + P
Sbjct: 121 YLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVT 282
EV + +D++S ++E++T
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKRRVGSPR-----QEFVA---EVTYLSEIRHRNLVT 143
L+G G+FG VY DT +A+K+ P +E A E+ L + H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 144 LLGYCQQNGYQML--VFEYLPNGSMCNHLYETG--LESSTKLEFKQRVSIALGAAKGLCH 199
G + + L E++P GS+ + L G E+ T+ +Q + +G+ +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL-------EGVSY 121
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPE 257
LHS +VH++ K AN+L D K+ D G SK L+ I +G S+ + PE
Sbjct: 122 LHS--NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 258 VEESGVFSEMSDIYSFGVFLLELVT 282
V + +DI+S G ++E++T
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 29/205 (14%)
Query: 95 IGFGSFGPVYKG--LLRDTVVAIKR-RV-----GSPRQEFVAEVTYLSEIRHRNLVTLLG 146
IG G++G VYK L +VA+K+ R+ G P + E++ L E+ H N+V LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA-IREISLLKELNHPNIVRLLD 65
Query: 147 --YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRV----SIALGAAKGLCHL 200
+ + Y LVFE+L + + ++SS + L CH
Sbjct: 66 VVHSENKLY--LVFEFL------DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV-E 259
H ++H++ K N+L+D K+AD G+++ + +H + +R PE+
Sbjct: 118 HR----VLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILL 172
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQ 284
S +S DI+S G E+V +
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 44/162 (27%), Positives = 75/162 (46%), Gaps = 18/162 (11%)
Query: 128 AEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETG--LESSTKLEFKQ 185
AE L ++H +V L+ Q G L+ EYL G + HL G +E + +
Sbjct: 49 AERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF-YLS 107
Query: 186 RVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPS 245
+S+AL HLH +++++ K N+L+D K+ D G+ K E+I E +
Sbjct: 108 EISLALE------HLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVT 157
Query: 246 H---GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
H G+I + PE+ + D +S G + +++TG
Sbjct: 158 HTFCGTI--EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 45/218 (20%)
Query: 89 FSETSLIGFGSFGPVYKG--LLRDTVVAIKR-RV-----GSPRQEFVAEVTYLSEIR--- 137
+ E + IG G++G VYK L VA+K+ RV G P + E+ L ++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP-LSTLREIALLKQLESFE 59
Query: 138 HRNLVTLLGYCQQNGYQM-------LVFEYLPN--GSMCNHLYETGLESST-KLEFKQRV 187
H N+V LL C G + LVFE++ + + + GL T K +Q +
Sbjct: 60 HPNIVRLLDVCH--GPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 188 SIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHG 247
G+ LHS + +VH++ K N+LV + K+AD G++++
Sbjct: 118 R-------GVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYSF-------EM 161
Query: 248 SIVNV-----FRDPEVEESGVFSEMSDIYSFGVFLLEL 280
++ +V +R PEV ++ D++S G EL
Sbjct: 162 ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 19/199 (9%)
Query: 95 IGFGSFGPVYKGL--LRDTVVAIKR-----RVGSPRQEFVAEVTYLSEIRHRNLVTLLGY 147
+G G++ V+KG L + +VA+K G+P + EV+ L ++H N+VTL
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA-IREVSLLKNLKHANIVTLHDI 71
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIAL-GAAKGLCHLHSLKPP 206
LVFEYL + + L++ L V I + +GL + H K
Sbjct: 72 IHTERCLTLVFEYLDSD------LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK-- 123
Query: 207 LVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV-EESGVFS 265
++H++ K N+L++E K+AD G+++ +++ S+ + +R P+V S +S
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 266 EMSDIYSFGVFLLELVTGQ 284
D++ G L E+ TG+
Sbjct: 183 TPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDTVVAIKRRV------GSPRQEFVAEVTYLSEIRHRNLV 142
F + S +G G+ G V+K + + + + R++ + R + + E+ L E +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 143 TLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
G +G + E++ GS+ L + G L +VSIA+ KGL +L
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL---GKVSIAV--IKGLTYLRE 121
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGIS-KLLENIEEAGPSHGSIVNVFRDPEVEES 261
K ++H++ K +N+LV+ K+ D G+S +L++++ + S + PE +
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS----YMSPERLQG 176
Query: 262 GVFSEMSDIYSFGVFLLELVTGQ 284
+S SDI+S G+ L+E+ G+
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 61/240 (25%), Positives = 102/240 (42%), Gaps = 33/240 (13%)
Query: 79 MEELEQATKQFSETSLIGFGSFG-----------PVYKGLLRDTVVAIKRRVGSPRQEFV 127
+ +L+ + + +IG G+FG VY L IKR S F
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR---SDSAFFW 91
Query: 128 AEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRV 187
E ++ +V L Q + Y +V EY+P G + N + + + V
Sbjct: 92 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEV 151
Query: 188 SIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH- 246
+AL A +HS+ L+H++ K N+L+D++ K+AD G ++E G
Sbjct: 152 VLALDA------IHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCM---KMDETGMVRC 200
Query: 247 GSIVNV--FRDPEVEES----GVFSEMSDIYSFGVFLLELVTGQEASHIVSL-GSYEALI 299
+ V + PEV +S G + D +S GVFL E++ G + SL G+Y ++
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIK--RRVGSPRQEFVAEVTYLSEI-RHRNLVT 143
F ++G G++G VYKG T + AIK +E E+ L + HRN+ T
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 144 LLGY------CQQNGYQMLVFEYLPNGSMCNHLYETGLESSTK---LEFKQRVSIALGAA 194
G + LV E+ GS+ T L +TK L+ I
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSV------TDLVKNTKGNALKEDWIAYICREIL 131
Query: 195 KGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSI-VNVF 253
+GL HLH+ K ++H++ K NVL+ EN K+ D G+S L+ G + I +
Sbjct: 132 RGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGTPYW 187
Query: 254 RDPEV---EES--GVFSEMSDIYSFGVFLLELVTG 283
PEV +E+ + SDI+S G+ +E+ G
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 53/223 (23%), Positives = 101/223 (45%), Gaps = 25/223 (11%)
Query: 88 QFSETSLIGFGSFGP--VYKGLLRDTVVAIKR----RVGSPRQEFVAEVTYLSEIRHRNL 141
Q++ ++G GSFG + + + D A+K + S ++ E L++++H N+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHL-YETGLESSTKLEFKQRVSIALGAAKGLCHL 200
V + +G+ +V EY G + + + G + V + LG H+
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ----HI 116
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV----FRDP 256
H + ++H++ K+ N+ + +N K+ D G ++LL + P + V + P
Sbjct: 117 H--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS-----PGAYACTYVGTPYYVPP 169
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALI 299
E+ E+ ++ SDI+S G L EL T H S++ LI
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCT---LKHPFQANSWKNLI 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 75/289 (25%), Positives = 117/289 (40%), Gaps = 64/289 (22%)
Query: 95 IGFGSFGPVYKGLLRD---------TVVAIKRRVGSPR---QEFVAEVTYLSEIRHRNLV 142
+G G+F ++KG+ R+ T V +K S R + F + +S++ H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 143 TLLGYCQQNGYQMLVFEYLPNGSMCNHLYETG--LESSTKLEFKQRVSIALGAAKGLCHL 200
G C ++V EY+ GS+ +L + + S KLE ++++ AL L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALH------FL 116
Query: 201 HSLKPPLVHKNFKTANVLVDEN---------FIAKVADTGISK-------LLENIEEAGP 244
L H N NVL+ FI K++D GIS LLE I P
Sbjct: 117 EDKG--LTHGNVCAKNVLLIREEDRKTGNPPFI-KLSDPGISITVLPKEILLERIPWVPP 173
Query: 245 SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS 304
+E S +D +SFG L E+ +G + + +L S + L Q+
Sbjct: 174 EC-----------IENPQNLSLAADKWSFGTTLWEIFSGGDKP-LSALDSQKKL-QFYED 220
Query: 305 RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353
R H+L TE L L QCM RP ++ +L
Sbjct: 221 R--------HQLPAPKWTE----LANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 40/213 (18%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKRRVGSPR-----QEFVAEVTYLSEIR-HRNLVTLLG 146
+G G++G V+K + R T VVA+K+ + R Q E+ +L E+ H N+V LL
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74
Query: 147 -YCQQNG---YQMLVFEYLPNGSMCNHLYETGLESSTK---LEFKQRVSIALGAAKGLCH 199
+N Y LVFEY+ ET L + + LE + I K L +
Sbjct: 75 VIKAENDKDIY--LVFEYM----------ETDLHAVIRANILEDVHKRYIMYQLLKALKY 122
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV------- 252
+HS ++H++ K +N+L++ + K+AD G+++ L +EE + + V
Sbjct: 123 IHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE---NPENPVLTDYVATRW 177
Query: 253 FRDPEV-EESGVFSEMSDIYSFGVFLLELVTGQ 284
+R PE+ S +++ D++S G L E++ G+
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 46/197 (23%), Positives = 93/197 (47%), Gaps = 18/197 (9%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR---RVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQ 149
IG GS G V ++ + +VA+K+ R R+ EV + + +H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 150 QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVH 209
+V E+L G++ T + + T++ +Q ++ L K L LH+ ++H
Sbjct: 88 VGDELWVVMEFLEGGAL------TDIVTHTRMNEEQIAAVCLAVLKALSVLHA--QGVIH 139
Query: 210 KNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPEVEESGVFSEM 267
++ K+ ++L+ + K++D G + + P S+V + PE+ +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 268 SDIYSFGVFLLELVTGQ 284
DI+S G+ ++E+V G+
Sbjct: 197 VDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 43/149 (28%), Positives = 66/149 (44%), Gaps = 17/149 (11%)
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQ-RVSIALGA-AKGLC 198
LVTL Q + L+ +Y+ G + HLY+ F + V + + L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE-------HFTESEVRVYIAEIVLALD 119
Query: 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL--ENIEEAGPSHGSIVNVFRDP 256
HLH L +++++ K N+L+D + D G+SK E E A G+I + P
Sbjct: 120 HLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTI--EYMAP 175
Query: 257 EVEESGV--FSEMSDIYSFGVFLLELVTG 283
EV G + D +S GV EL+TG
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRR--VGSPRQEFVA-EVTYLSEIRHRNL 141
K+++ IG G+ G VY + T VAIK+ P++E + E+ + E ++ N+
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH 201
V L +V EYL GS+ + + ET ++ Q ++ + L LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALDFLH 132
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEES 261
S + ++H++ K+ N+L+ + K+ D G + E++ S + PEV
Sbjct: 133 SNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 262 GVFSEMSDIYSFGVFLLELVTGQ 284
+ DI+S G+ +E+V G+
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 27/202 (13%)
Query: 95 IGFGSFGPVYKGLLRDTVVAIKRRV------GSPRQEFVAEVTYLSEIRHRNLVTLLGYC 148
+G G+ G V K T + ++V S R++ + E+ + E R +V+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 149 QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLV 208
+ E++ GS+ + +Y+ G ++ K IA+ +GL +L++ ++
Sbjct: 73 LNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGK----IAVAVVEGLTYLYN-VHRIM 126
Query: 209 HKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF------RDPEVEESG 262
H++ K +N+LV+ K+ D G+S L N SI + F PE + G
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELIN---------SIADTFVGTSTYMSPERIQGG 177
Query: 263 VFSEMSDIYSFGVFLLELVTGQ 284
++ SD++S G+ ++EL G+
Sbjct: 178 KYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 24/204 (11%)
Query: 95 IGFGSFGPVYKG--LLRDTVVAIKR------RVGSPRQEFVAEVTYLSEIRHRNLVTLLG 146
IG G F VY+ LL VA+K+ RQ+ V E+ L ++ H N++ L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 147 YCQQNGYQMLVFEYLPNG---SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
++ +V E G M + + + +K V + + H+HS
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEHMHSR 125
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPE-VEE 260
+ ++H++ K ANV + + K+ D G+ + + + +H S+V + PE + E
Sbjct: 126 R--VMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAH-SLVGTPYYMSPERIHE 180
Query: 261 SGVFSEMSDIYSFGVFLLELVTGQ 284
+G ++ SDI+S G L E+ Q
Sbjct: 181 NG-YNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 31/207 (14%)
Query: 95 IGFGSFGPVYKG-------LLRDTVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGY 147
+G GS+ VYKG L+ V+ ++ G+P + E + L ++H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHANIVLLHDI 71
Query: 148 CQQNGYQMLVFEYLPNGSMCNHL--YETGLE-SSTKLEFKQRVSIALGAAKGLCHLHSLK 204
LVFEY+ + +C ++ + GL + KL Q + +GL ++H +
Sbjct: 72 IHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLL-------RGLSYIH--Q 121
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH---GSIVNV-FRDPEV-E 259
++H++ K N+L+ + K+AD G+++ ++ PSH +V + +R P+V
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLAR-----AKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQEA 286
S +S D++ G +E++ G A
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFV-----AEVTYLSE------IRHRN 140
++G GSFG V L+ T AIK + +++ V E T + H
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIK----ALKKDVVLEDDDVECTMVERRVLALAWEHPF 57
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL 200
L L Q + V EYL G + H+ +G + F AA+ +C L
Sbjct: 58 LTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFY--------AAEIICGL 109
Query: 201 HSL-KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVE 259
L K +++++ K NVL+D++ K+AD G+ K N E + + + PE+
Sbjct: 110 QFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPD-YIAPEIL 168
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQEASH 288
+ ++E D +SFGV L E++ GQ H
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 86 TKQFSETSLIGFGSFGPV--YKGLLRDTVVAIKRRVGSPRQEFVAEVTY-----LSEIRH 138
T ++ + +G G+FG V + L VAIK+ + +A+ TY L +RH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 139 RNLVTLLG-YCQQNGYQMLVFEYLPNGSMCNHLYETG-LESSTKLEFKQRVSIALGAAKG 196
N+++L + V E L G+ + L + LE +F Q +G
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEK----QFIQ--YFLYQILRG 120
Query: 197 LCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FR 254
L ++HS +VH++ K +N+L++EN K+ D G++++ + P V+ +R
Sbjct: 121 LKYVHS--AGVVHRDLKPSNILINENCDLKICDFGLARIQD------PQMTGYVSTRYYR 172
Query: 255 DPEVEES-GVFSEMSDIYSFGVFLLELVTGQ 284
PE+ + + DI+S G E++ G+
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 3e-07
Identities = 48/207 (23%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVG--------SPRQEFVA-EVTYLSEIR 137
K+++ IG G+ G V+ VA + V P++E + E+ + E++
Sbjct: 19 KKYTRYEKIGQGASGTVFTA----IDVATGQEVAIKQINLQKQPKKELIINEILVMKELK 74
Query: 138 HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGL 197
+ N+V L +V EYL GS+ + + ET ++ + Q ++ + L
Sbjct: 75 NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEA------QIAAVCRECLQAL 128
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPE 257
LH+ + ++H++ K+ NVL+ + K+ D G + E++ S + PE
Sbjct: 129 EFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPE 185
Query: 258 VEESGVFSEMSDIYSFGVFLLELVTGQ 284
V + DI+S G+ +E+V G+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 51/209 (24%), Positives = 84/209 (40%), Gaps = 32/209 (15%)
Query: 95 IGFGSFGPVY---KGLLRDTVVAIK---RRVGSPR---QEFVAEVTYLSEIRHRNLVTLL 145
I G++G V+ K D + AIK + + + + E LS+ + +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGD-IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 146 GYCQQNGYQM-LVFEYLPNGSMCNHL---YETGLESSTKLEFKQRVSIALGAAKGLCHLH 201
Y Q + LV EYLP G L + E ++ + V L +LH
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGD-LASLLENVGSLDEDVARIYIAEIV-------LALEYLH 110
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-------FR 254
S ++H++ K N+L+D N K+ D G+SK+ + + + +
Sbjct: 111 SNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 255 DPEVEESGVFSEMSDIYSFGVFLLELVTG 283
PEV S+ D +S G L E + G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 94 LIGFGSFGPVY---------------KGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEIRH 138
++G GSFG V+ +L+ + ++ RV + E L+E+ H
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-----ERDILAEVNH 57
Query: 139 RNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLC 198
+V L Q G L+ ++L G + L + + + ++F +AL L
Sbjct: 58 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALA----LD 112
Query: 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV 258
HLHSL +++++ K N+L+DE K+ D G+SK + E+ S V + PEV
Sbjct: 113 HLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE-YMAPEV 169
Query: 259 EESGVFSEMSDIYSFGVFLLELVTG 283
++ +D +SFGV + E++TG
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 21/197 (10%)
Query: 95 IGFGSFGPVYKGLLR----DTVVAIK----RRVGSPRQEFVAEVTYLSEIRHRNLVTLLG 146
+G G+FG V KG+ + VAIK S R E + E + ++ + +V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHL--YETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
C+ MLV E G + L + + S +E +VS+ + +G
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG-------- 113
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLL--ENIEEAGPSHGSIVNVFRDPEVEESG 262
VH++ NVL+ AK++D G+SK L ++ S G + PE
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 263 VFSEMSDIYSFGVFLLE 279
FS SD++S+G+ + E
Sbjct: 174 KFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 42/149 (28%), Positives = 61/149 (40%), Gaps = 10/149 (6%)
Query: 95 IGFGSFGPVY-----KGLLRDTVVAIKRRVGSPRQE---FVAEVTYLSEIRHRNLVTLLG 146
IG G FG V G VV + RV + QE F+ E ++H NL+ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPP 206
C + +LV E+ P G + +L + +A A GL HLH K
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--KNN 120
Query: 207 LVHKNFKTANVLVDENFIAKVADTGISKL 235
+H + N L+ + K+ D G+S
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 21/160 (13%)
Query: 88 QFSETSLIGFGSFGPVYKGLLRDTVV----AIK----RRVGSPRQE--FVAEVTYLSEIR 137
+G G+FG V+ L+RD + A+K V +QE E L E+
Sbjct: 2 DLERIKTVGTGTFGRVH--LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 138 HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETG-LESSTKLEFKQRVSIALGAAKG 196
H ++ L + ++ EY+P G + ++L +G +ST L + + AL
Sbjct: 60 HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALE---- 115
Query: 197 LCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236
+LHS + +V+++ K N+L+D+ K+ D G +K L
Sbjct: 116 --YLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKL 151
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 43/177 (24%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 113 VAIKR---RVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNH 169
VA+K R R+ EV + + +H+N+V + ++ E+L G++
Sbjct: 49 VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL--- 105
Query: 170 LYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVAD 229
T + S T+L +Q ++ + LC+LHS ++H++ K+ ++L+ + K++D
Sbjct: 106 ---TDIVSQTRLNEEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSD 160
Query: 230 TGISKLLENIEEAGPSHGSIVNV--FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
G I + P S+V + PEV + DI+S G+ ++E+V G+
Sbjct: 161 FG---FCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 19/105 (18%)
Query: 189 IALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN----IEEAG- 243
IA+ K L +LHS K ++H++ K +NVL++ N K+ D GIS L + +AG
Sbjct: 108 IAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGC 166
Query: 244 -----PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTG 283
P +PE+ + G + SD++S G+ ++EL TG
Sbjct: 167 KPYMAPER-------INPELNQKG-YDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 83 EQATKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRV------GSPRQEFVAEVTYLSEI 136
E F S +G G+ G V K + + + + R++ + R + + E+ L E
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 137 RHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKG 196
+V G +G + E++ GS+ L E E +VSIA+ +G
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAV--LRG 115
Query: 197 LCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS-KLLENIEEAGPSHGSIVNVFRD 255
L +L K ++H++ K +N+LV+ K+ D G+S +L++++ + S +
Sbjct: 116 LAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS----YMS 170
Query: 256 PEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
PE + +S SDI+S G+ L+EL G+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 8e-07
Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRR--VGSPRQEFVA-EVTYLSEIRHRNL 141
K+++ IG G+ G VY + T VAI++ P++E + E+ + E ++ N+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH 201
V L +V EYL GS+ + + ET ++ Q ++ + L LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLH 133
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEES 261
S + ++H++ K+ N+L+ + K+ D G + E++ S + PEV
Sbjct: 134 SNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 262 GVFSEMSDIYSFGVFLLELVTGQ 284
+ DI+S G+ +E++ G+
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-07
Identities = 47/202 (23%), Positives = 89/202 (44%), Gaps = 23/202 (11%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVA--EVTYLSEIRHRNLVTLLG 146
+G G FG V ++ T + A K +R+ + E +A E L ++ R +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHLY---ETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
+ LV + G + H+Y E G + + + ++ GL HLH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQI------ICGLEHLHQR 114
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSI-VNVFRDPEVEESG 262
+ +V+++ K NVL+D++ +++D G L ++ G + PEV +
Sbjct: 115 R--IVYRDLKPENVLLDDHGNVRISDLG---LAVELKGGKKIKGRAGTPGYMAPEVLQGE 169
Query: 263 VFSEMSDIYSFGVFLLELVTGQ 284
V+ D ++ G L E++ G+
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 94 LIGFGSFGPVYKGLLRDT-----VVAIKRRVGSPRQEF---VAEVTYLSEIRHRNLVTLL 145
++G GSFG V+ L+ T + A+K+ V + + E LS +T L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 146 GYC--QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
YC Q V EYL G + H+ +S K + + A GL LHS
Sbjct: 62 -YCTFQTKENLFFVMEYLNGGDLMFHI-----QSCHKFDLPRATFYAAEIICGLQFLHS- 114
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN-IEEAGPSHGSIVNVFRDPEVEESG 262
+V+++ K N+L+D + K+AD G+ K EN + +A + PE+
Sbjct: 115 -KGIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQ 171
Query: 263 VFSEMSDIYSFGVFLLELVTGQEASH 288
++ D +SFGV L E++ GQ H
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 66/267 (24%), Positives = 110/267 (41%), Gaps = 50/267 (18%)
Query: 78 SMEELEQATKQFSETSLIGFGSFGPVYKGLLR----DTVVAIKRRVGSPRQEFV--AEVT 131
+ +L + F +IG G+FG V L+R V A+K + E + ++
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQ--LVRHKSSKQVYAMKLL---SKFEMIKRSDSA 88
Query: 132 YLSEIR----HRN---LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFK 184
+ E R H N +V L Q + Y +V EY+P G + N + + +
Sbjct: 89 FFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYT 148
Query: 185 QRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP 244
V +AL A +HS+ +H++ K N+L+D++ K+AD G ++ G
Sbjct: 149 AEVVLALDA------IHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGM 197
Query: 245 SHGSIVNVFRD---PEVEES----GVFSEMSDIYSFGVFLLELVTGQEASHIVSL-GSYE 296
D PEV +S G + D +S GVFL E++ G + SL G+Y
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 257
Query: 297 ALIQWVRSRLSSNNFVDHRLAGTFTTE 323
+DH+ + TF +
Sbjct: 258 -------------KIMDHKNSLTFPDD 271
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 46/197 (23%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR---RVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQ 149
IG GS G V + T VA+K+ R R+ EV + + H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 150 QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVH 209
+V E+L G++ T + + T++ +Q ++ L + L +LH+ ++H
Sbjct: 90 VGDELWVVMEFLEGGAL------TDIVTHTRMNEEQIATVCLSVLRALSYLHN--QGVIH 141
Query: 210 KNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPEVEESGVFSEM 267
++ K+ ++L+ + K++D G + + P S+V + PEV +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 268 SDIYSFGVFLLELVTGQ 284
DI+S G+ ++E++ G+
Sbjct: 199 VDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 95 IGFGSFGPV----YKGLLRDTVVA-IKRRVGSPRQEFVAE--VTYLSEIRHRNLVTLLGY 147
+G GS+G V ++ + V+ + R S R+ AE LS+++H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 148 CQ-QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPP 206
+ ++G +V + G + + L E + L Q V + A L +LH +
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKE---QKGKLLPENQVVEWFVQIAMALQYLH--EKH 122
Query: 207 LVHKNFKTANVLVDENFIAKVADTGISKLLEN-IEEAGPSHGSIVNVFRDPEVEESGVFS 265
++H++ KT NV + I KV D GI+++LEN + A G+ + PE+ + ++
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGT--PYYMSPELFSNKPYN 180
Query: 266 EMSDIYSFGVFLLELVTGQEA 286
SD+++ G + E+ T + A
Sbjct: 181 YKSDVWALGCCVYEMATLKHA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 48/197 (24%), Positives = 91/197 (46%), Gaps = 18/197 (9%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR---RVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQ 149
IG GS G V + T VA+K+ R R+ EV + + +H N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 150 QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVH 209
+V E+L G++ T + + T++ +Q ++ L K L LH+ ++H
Sbjct: 87 VGDELWVVMEFLEGGAL------TDIVTHTRMNEEQIATVCLAVLKALSFLHAQG--VIH 138
Query: 210 KNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPEVEESGVFSEM 267
++ K+ ++L+ + K++D G + + P S+V + PEV +
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCA---QVSKEVPRRKSLVGTPYWMAPEVISRLPYGTE 195
Query: 268 SDIYSFGVFLLELVTGQ 284
DI+S G+ ++E+V G+
Sbjct: 196 VDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 31/239 (12%)
Query: 79 MEELEQATKQFSETSLIGFGSFG-----------PVYKGLLRDTVVAIKRRVGSPRQEFV 127
+ +L + + +IG G+FG VY L IKR S F
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR---SDSAFFW 91
Query: 128 AEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRV 187
E ++ +V L Q + Y +V EY+P G + N + + + V
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV 151
Query: 188 SIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL--ENIEEAGPS 245
+AL A +HS+ +H++ K N+L+D++ K+AD G + E + +
Sbjct: 152 VLALDA------IHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 203
Query: 246 HGSIVNVFRDPEVEES----GVFSEMSDIYSFGVFLLELVTGQEASHIVSL-GSYEALI 299
G+ + PEV +S G + D +S GVFL E++ G + SL G+Y ++
Sbjct: 204 VGT--PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRR--VGSPRQEFVA-EVTYLSEIRHRNL 141
K+++ IG G+ G VY + T VAIK+ P++E + E+ + E +H N+
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH 201
V L +V EYL GS+ + + ET ++ Q ++ + L LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEFLH 132
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEES 261
S + ++H++ K+ N+L+ + K+ D G + E++ S + PEV
Sbjct: 133 SNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 262 GVFSEMSDIYSFGVFLLELVTGQ 284
+ DI+S G+ +E+V G+
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 53/206 (25%), Positives = 82/206 (39%), Gaps = 37/206 (17%)
Query: 95 IGFGSFGPVY-------------KGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEIRHRNL 141
I G+FG VY K L + ++A + AE +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTN-----VKAERAIMMIQGESPY 58
Query: 142 VTLLGYCQQNG-YQMLVFEYLPNGSMCNHLYET--GLESSTKLEFKQRVSIALGAAKGLC 198
V L Y Q+ Y LV EYL NG C L +T GL ++ V + +
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYL-NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVE------ 111
Query: 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL-LENIEEAGPSHGSIVNVFRDPE 257
LH + ++H++ K N+L+D+ K+ D G+S+ LEN + G + PE
Sbjct: 112 DLH--QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD------YLAPE 163
Query: 258 VEESGVFSEMSDIYSFGVFLLELVTG 283
+MSD +S G + E + G
Sbjct: 164 TILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 26/170 (15%)
Query: 189 IALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGS 248
IA+ KGL +L SLK ++H++ K +N+LV+ K+ D G+S L N A G+
Sbjct: 100 IAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-SIAKTYVGT 156
Query: 249 IVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ------EASH--IVSLGSYEALIQ 300
N + PE + SD++S G+ +EL G+ + + ++ L + ++
Sbjct: 157 --NAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD 214
Query: 301 WVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVM 350
L F + + QCM + RP E +M
Sbjct: 215 EDPPVLPVGQFSE-------------KFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 58/267 (21%), Positives = 107/267 (40%), Gaps = 46/267 (17%)
Query: 30 KSQSKNYQNKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQF 89
K + + N+ D +++ + P+ K +
Sbjct: 34 KLDEEERSHNNNAGEDEDEEKMIDNDINRSPN-------------------------KSY 68
Query: 90 SETSLIGFGSFGPVYKGLLRDTV--VAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGY 147
++IG GSFG VY+ + DT VAIK+ + P Q E+ + + H N++ L Y
Sbjct: 69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNLNHINIIFLKDY 127
Query: 148 C--------QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCH 199
++N + +V E++P + + L + S L + L +
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAY 185
Query: 200 LHSLKPPLVHKNFKTANVLVDEN-FIAKVADTGISKLLENIEEAGPSHGSIVNVF-RDPE 257
+HS + H++ K N+L+D N K+ D G +K N+ S I + F R PE
Sbjct: 186 IHS--KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK---NLLAGQRSVSYICSRFYRAPE 240
Query: 258 VEESGV-FSEMSDIYSFGVFLLELVTG 283
+ ++ D++S G + E++ G
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDTVVAIKRRV------GSPRQEFVAEVTYLSEIRHRNLV 142
F + +G G+ G V K L R + + + R++ + R + + E+ L E +V
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62
Query: 143 TLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
G +G + E++ GS+ L + G ++SIA+ +GL +L
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPENILGKISIAV--LRGLTYLRE 117
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF------RDP 256
K ++H++ K +N+LV+ K+ D G+S L S+ N F P
Sbjct: 118 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---------IDSMANSFVGTRSYMSP 167
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVTG 283
E + ++ SDI+S G+ L+E+ G
Sbjct: 168 ERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 94 LIGFGSFGPVYKGLLRDT-----VVAIKRRV---GSPRQEFVAEVTYLSEIRHRNLVTLL 145
++G GSFG V L+ V A+K+ V + + E L+ +T L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 146 GYC--QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
YC Q + V E+L G + H+ + G + + + A GL LHS
Sbjct: 62 -YCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHS- 114
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD---PEVEE 260
+++++ K NV++D + K+AD G+ K EN+ G + S D PE+ +
Sbjct: 115 -KGIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENV--FGDNRASTFCGTPDYIAPEILQ 169
Query: 261 SGVFSEMSDIYSFGVFLLELVTGQEASH 288
++ D +SFGV L E++ GQ H
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 7e-06
Identities = 45/201 (22%), Positives = 79/201 (39%), Gaps = 25/201 (12%)
Query: 95 IGFGSFGPVYKGLLRDTVVA------IKRRVGSPRQE--FVAEVTYLSEIRHRNLVTLLG 146
+G G FG V ++ KR + Q+ +E L E H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPP 206
+ Y ++ EY G + L + GL F +LH+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF-----YIACVVLAFEYLHNRG-- 113
Query: 207 LVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA----GPSHGSIVNVFRDPEVEESG 262
+++++ K N+L+D N K+ D G +K L++ ++ G + PE+ +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE------YVAPEIILNK 167
Query: 263 VFSEMSDIYSFGVFLLELVTG 283
+ D +S G+ L EL+TG
Sbjct: 168 GYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 38/218 (17%)
Query: 89 FSETSLIGFGSFGPVY----------------KGLLRDTVVAIKRRVGSPRQEFVAEVTY 132
F ++G G++G V+ K L + T+V + R E
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTR----TERQV 57
Query: 133 LSEIRHRNLVTLLGYCQQNGYQM-LVFEYLPNGSMCNHLYETGLESSTKLEFK-QRVSIA 190
L IR + L Y Q ++ L+ +Y+ G + HL S + FK Q V I
Sbjct: 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-------SQRERFKEQEVQIY 110
Query: 191 LGA-AKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK--LLENIEEAGPSHG 247
G L HLH L +++++ K N+L+D N + D G+SK + +E A G
Sbjct: 111 SGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG 168
Query: 248 SIVNVFRDPEVEESGV--FSEMSDIYSFGVFLLELVTG 283
+I + P++ G + D +S GV + EL+TG
Sbjct: 169 TI--EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 24/201 (11%)
Query: 95 IGFGSFGPVYKGLLRDT-----VVAIKRRVGSPRQEF---VAEVTYLSEIRHRNLVTLLG 146
IG GSFG V + RDT + I++ R E +AE T L+++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLC---HLHSL 203
Q LV ++ G + +HL G ++ F A+ LC +LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFY--------TAELLCALENLHKF 112
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKL-LENIEEAGPSHGSIVNVFRDPEVEESG 262
+++++ K N+L+D + D G+ KL +++ ++ G+ + PE+
Sbjct: 113 N--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGT--PEYLAPELLLGH 168
Query: 263 VFSEMSDIYSFGVFLLELVTG 283
+++ D ++ GV L E++TG
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 58/274 (21%), Positives = 101/274 (36%), Gaps = 104/274 (37%)
Query: 95 IGFGSFGPVYKGLLRDT-------VVAIKR-RVGSPRQEFVAEVTYLSEI----RHRNLV 142
+G G+FG V + VA+K + G+ E+ A +T L + H N+V
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 143 TLLGYC-QQNGYQMLVFEYLPNGSMCNHL------YETGLESSTKLEF-------KQR-- 186
LLG C + G M++ EY G++ N+L + ST+ KQR
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 187 -----------------------------------------VSIALGAAKGLCHLHSLKP 205
+S + A+G+ L S K
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK- 193
Query: 206 PLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESG--- 262
+H++ N+L+ EN + K+ D G+++ ++++DP+ G
Sbjct: 194 -CIHRDLAARNILLSENNVVKICDFGLAR----------------DIYKDPDYVRKGDAR 236
Query: 263 --------------VFSEMSDIYSFGVFLLELVT 282
V++ SD++SFGV L E+ +
Sbjct: 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 32/214 (14%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKR-RV-----GSPRQEF--VAEVTYL 133
+Q+ + IG G++G V+K RD VA+KR RV G P VA + +L
Sbjct: 1 QQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58
Query: 134 SEIRHRNLVTLLGYC-----QQNGYQMLVFEYLPNG--SMCNHLYETGLESSTKLEFKQR 186
H N+V L C + LVFE++ + + + E G+ + T +
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD---- 114
Query: 187 VSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH 246
+ +GL LHS + +VH++ K N+LV + K+AD G++++ + +
Sbjct: 115 --MMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTS 168
Query: 247 GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLEL 280
+ +R PEV ++ D++S G E+
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 23/166 (13%)
Query: 88 QFSETSLIGFGSFGPVYKGLLRD----TVVAIKRRVGSPR------QEFVAEVTYLSEIR 137
++ IG G++G VYK ++ AIK+ G Q E+ L E++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 138 HRNLVTLLGYCQQNGYQM--LVFEYLPN--GSMCNHLYETGLESSTKLEFKQRVSIALGA 193
H N+V+L+ ++ + L+F+Y + + + S K S+
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK---SLLWQI 117
Query: 194 AKGLCHLHSLKPPLVHKNFKTANVLV----DENFIAKVADTGISKL 235
G+ +LHS ++H++ K AN+LV E + K+ D G+++L
Sbjct: 118 LNGVHYLHS--NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 54/206 (26%), Positives = 84/206 (40%), Gaps = 21/206 (10%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGS------PRQEFVAEVTYLSEIRH 138
K F + +G G +G V+ +DT +VA+KR S + + E L+ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 139 RNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLC 198
LV LL Q + Y L EY+P G L G+ S F A+
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFY--------MAEMFE 112
Query: 199 HLHSL-KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPE 257
+ +L + +H++ K N L+D + K+ D G+SK + A GS + PE
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTYANSVVGS--PDYMAPE 168
Query: 258 VEESGVFSEMSDIYSFGVFLLELVTG 283
V + D +S G L E + G
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 54/222 (24%), Positives = 98/222 (44%), Gaps = 33/222 (14%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIK---RRVGSPRQEFV------AEVTYLSEIR 137
K++ + IG G+ G V DTV+ I +++ P Q E+ L +
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAF--DTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN 78
Query: 138 HRNLVTLLG-YCQQNGYQ-----MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIAL 191
H+N+++LL + Q + LV E L + ++C ++ +L+ ++ +
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIH-------MELDHERMSYLLY 130
Query: 192 GAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVN 251
G+ HLHS ++H++ K +N++V + K+ D G+++ P +
Sbjct: 131 QMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY--VVTR 186
Query: 252 VFRDPEVEESGVFSEMSDIYSFGVFLLELVTG----QEASHI 289
+R PEV + E DI+S G + ELV G Q HI
Sbjct: 187 YYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 52/204 (25%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVA--EVTYLSEIRHRN--LVT 143
+IG G FG VY DT + A+K +R+ + E +A E LS + + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 144 LLGYCQQNGYQM-LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
+ Y ++ + + + G + HL + G+ S ++ F I GL H+H+
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL-----GLEHMHN 115
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSI-VNVFRDPEVEES 261
+V+++ K AN+L+DE+ +++D G++ + + P H S+ + + PEV +
Sbjct: 116 RF--VVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKP-HASVGTHGYMAPEVLQK 169
Query: 262 GV-FSEMSDIYSFGVFLLELVTGQ 284
GV + +D +S G L +L+ G
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 50/205 (24%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIKR----RVGSPRQEFVA--EVTYLSEIRHRN 140
F + ++G G FG V +R T + A K+ R+ + E +A E L ++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL 200
+V+L + LV + G + H+Y G E + V A GL L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDL 118
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPEVE 259
H + +V+++ K N+L+D++ +++D G++ ++ E G + V + PEV
Sbjct: 119 HQER--IVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVV 173
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQ 284
++ ++ D ++ G L E++ GQ
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 32/129 (24%), Positives = 65/129 (50%), Gaps = 7/129 (5%)
Query: 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTA 215
LV + G + H+Y G LE ++ + + G+ HLHS+ +V+++ K
Sbjct: 70 LVMSLMNGGDLKYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPE 124
Query: 216 NVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGV 275
NVL+D+ +++D G++ L++ + G+ N + PE+ + +S D ++ G
Sbjct: 125 NVLLDDQGNCRLSDLGLAVELKDGKTITQRAGT--NGYMAPEILKEEPYSYPVDWFAMGC 182
Query: 276 FLLELVTGQ 284
+ E+V G+
Sbjct: 183 SIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 57/238 (23%), Positives = 89/238 (37%), Gaps = 51/238 (21%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT----VVAIKRRVGSP--RQEFVA----EVTYLSEI 136
F +IG G+FG V+ L+RD V A+K S ++ +A E L++
Sbjct: 1 DDFEVIKVIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA 58
Query: 137 RHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHL--YETGLESSTKLEFKQRVSIALGAA 194
+V L Q + LV EY+P G + N L + E + + + V A
Sbjct: 59 DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV-----LA 113
Query: 195 KGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK--------LLENIEEAGPSH 246
L +H L +H++ K N+L+D + K+AD G+ K +
Sbjct: 114 --LDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 247 GSIVNVFRD--------------------PEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
V V R PEV + D +S GV L E++ G
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 7/87 (8%)
Query: 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI--EEAGPSH-GSIVNVFRD 255
H+HS ++H++ K+AN+L+ N + K+ D G SK+ ++ G + G+ V
Sbjct: 158 HVHSKH--MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV--A 213
Query: 256 PEVEESGVFSEMSDIYSFGVFLLELVT 282
PE+ +S+ +D++S GV L EL+T
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 68/273 (24%), Positives = 113/273 (41%), Gaps = 61/273 (22%)
Query: 95 IGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLV--TLLGYC---- 148
IG G+FG VY+ +DT +V S ++E VA+ I RN++ TLL
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS-KKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 149 ------QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFK-QRVSIALGAAKGLCHLH 201
Q + LV +Y+ G + HL + G S + +F + +AL HLH
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALE------HLH 113
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF------RD 255
K +V+++ K N+L+D + D G+SK A + N F
Sbjct: 114 --KYDIVYRDLKPENILLDATGHIALCDFGLSK-------ANLTDNKTTNTFCGTTEYLA 164
Query: 256 PEV--EESGVFSEMSDIYSFGVFLLELVTG---------QEASHIVSLGSYEALIQWVRS 304
PEV +E G +++ D +S GV + E+ G Q+ ++ G +++ ++
Sbjct: 165 PEVLLDEKG-YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK----VRFPKN 219
Query: 305 RLSSN--NFV--------DHRLAGTFTTEGMRD 327
LS FV HRL +++
Sbjct: 220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 88 QFSETSLIGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEF----VAEVTYLSEIR--- 137
Q+ + IG G++G VYK + VA+K RV + V EV L +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 138 HRNLVTLLGYC-----QQNGYQMLVFEYLPNG--SMCNHLYETGLESSTKLEFKQRVSIA 190
H N+V L+ C + LVFE++ + + + GL + T + ++
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQF--- 117
Query: 191 LGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIV 250
+GL LH+ +VH++ K N+LV K+AD G++++ P +V
Sbjct: 118 ---LRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP---VVV 169
Query: 251 NV-FRDPEVEESGVFSEMSDIYSFGVFLLEL 280
+ +R PEV ++ D++S G E+
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 27/209 (12%)
Query: 95 IGFGSFGPVYKGLLRDTVVAIKRRVGSPRQE-----FVAEVTYLSEIRHRNLVTLL-GYC 148
+G G+FG VYK ++T V +V + E ++ E+ L+ H N+V LL +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 149 QQNGYQMLVFEYLPNGSMCNHLYETG---LESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
+N +L+ E+ G++ + E E ++ KQ + + L +LH K
Sbjct: 73 YENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-------EALNYLHENK- 123
Query: 206 PLVHKNFKTANVLVDENFIAKVADTGIS-KLLENIEEAGPSHGSIVNVFRDPEV-----E 259
++H++ K N+L + K+AD G+S K I+ G+ + PEV
Sbjct: 124 -IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT--PYWMAPEVVMCETS 180
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQEASH 288
+ + +D++S G+ L+E+ + H
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHH 209
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 57/233 (24%), Positives = 91/233 (39%), Gaps = 29/233 (12%)
Query: 71 PQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD----TVVAIKRRVGSPRQEF 126
P + +E L T + IG G++G VYK + V I + +E
Sbjct: 6 PYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEI 65
Query: 127 VAEVTYLSEI-RHRNLVTLLGYC----QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKL 181
AE L + H N+V G + G Q+ + L NG L + L +L
Sbjct: 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL 125
Query: 182 EFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS------KL 235
+ I GA GL HLH+ + ++H++ K N+L+ K+ D G+S +L
Sbjct: 126 DEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183
Query: 236 LENIEEAGPSHGSIVNVFRDPEV-----EESGVFSEMSDIYSFGVFLLELVTG 283
N P + PEV + + D++S G+ +EL G
Sbjct: 184 RRNTSVGTP-------FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 52/191 (27%), Positives = 78/191 (40%), Gaps = 25/191 (13%)
Query: 113 VAIK-RRVGSPRQE-----FVAEVTYLSEIRHRNLVTLL--GYCQQNGYQMLVFEYLPNG 164
VAIK R +P +E F E + + H N+V LL G G VFEY+P
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAP-PGLLFAVFEYVPGR 64
Query: 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV---DE 221
++ L G L + + L L H +VH++ K N++V
Sbjct: 65 TLREVLAADGA-----LPAGETGRLMLQVLDALACAH--NQGIVHRDLKPQNIMVSQTGV 117
Query: 222 NFIAKVADTGISKLLENIEEAGPSHGSIVN------VFRDPEVEESGVFSEMSDIYSFGV 275
AKV D GI LL + +A + + + PE + SD+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 276 FLLELVTGQEA 286
LE +TGQ
Sbjct: 178 IFLECLTGQRV 188
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 45/212 (21%)
Query: 95 IGFGSFGPVYKGL--LRDTVVAIKR-RV----GSPRQEFVA--EVTYLSEIRHRNLVTLL 145
+G GS+ VYKG L +VA+K R+ G+P F A E + L +++H N+VTL
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP---FTAIREASLLKDLKHANIVTLH 69
Query: 146 GYCQQNGYQMLVFEYL-----------PNG-SMCNHLYETGLESSTKLEFKQRVSIALGA 193
LVFEYL G SM N +L Q +
Sbjct: 70 DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHN----------VRLFLFQLL------ 113
Query: 194 AKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF 253
+GL + H + ++H++ K N+L+ E K+AD G+++ +++ S+ + +
Sbjct: 114 -RGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWY 169
Query: 254 RDPEV-EESGVFSEMSDIYSFGVFLLELVTGQ 284
R P+V S +S D++ G E+ TG+
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 3e-05
Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 37/214 (17%)
Query: 92 TSLIGFGSFGPVYKGL--LRDTVVAIKRRVGSPRQEFVA------EVTYLSEIRHRNLVT 143
IG G++G V + VAIK+ + + + + E+ L +RH N++
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKK-ISNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 144 LL-------GYCQQNGYQMLVFEYLPNGSMCNHLYETGL----ESSTKLEFKQRVSIALG 192
LL + Y +V E L ET L +S L
Sbjct: 64 LLDILRPPSPEDFNDVY--IVTE----------LMETDLHKVIKSPQPLTDDHIQYFLYQ 111
Query: 193 AAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP--SHGSIV 250
+GL +LHS ++H++ K +N+LV+ N K+ D G+++ ++ E+ + +
Sbjct: 112 ILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT 169
Query: 251 NVFRDPEV-EESGVFSEMSDIYSFGVFLLELVTG 283
+R PE+ S +++ DI+S G EL+T
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEF---VAEVTYLSEIRHRNLVTLLGYC 148
+G G++G VYK L R T +A+K R+ +F + E+ L + +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 149 QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLV 208
G + EY+ GS+ + LY G+ + E I KGL L + ++
Sbjct: 69 FIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPE-DVLRRITYAVVKGLKFLKE-EHNII 125
Query: 209 HKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSI-VNVFRDPEVEESG----- 262
H++ K NVLV+ N K+ D G+S L A + +I + PE +SG
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNL----VASLAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 263 -VFSEMSDIYSFGVFLLELVTG 283
++ SD++S G+ +LE+ G
Sbjct: 182 PTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVA--EVTYLSEIRHRN--LVT 143
+IG G FG VY DT + A+K +R+ + E +A E LS + + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 144 LLGYCQQNGYQM-LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
+ Y ++ + + + G + HL + G+ S ++ F A GL H+H+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIILGLEHMHN 115
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSI-VNVFRDPEVEES 261
+V+++ K AN+L+DE+ +++D G++ + + P H S+ + + PEV +
Sbjct: 116 RF--VVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKP-HASVGTHGYMAPEVLQK 169
Query: 262 GV-FSEMSDIYSFGVFLLELVTGQ 284
G + +D +S G L +L+ G
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 17/205 (8%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIKR----RVGSPRQEFVA--EVTYLSEIRHRN 140
F + ++G G FG V +R T + A KR R+ + E +A E L ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL 200
+V L + LV + G + H+Y G + E ++ + A GL L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDL 118
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPEVE 259
H + V+++ K N+L+D+ +++D G++ I E G + V + PEV
Sbjct: 119 H--RENTVYRDLKPENILLDDYGHIRISDLGLAV---KIPEGESIRGRVGTVGYMAPEVL 173
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQ 284
+ ++ D + G + E++ GQ
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 41/158 (25%), Positives = 69/158 (43%), Gaps = 11/158 (6%)
Query: 129 EVTYLSEIRHRNLVTLLGYCQQNGYQM-LVFEYLPNGSMCNHLYETGLESSTKLEF-KQR 186
E L +R + L Y Q ++ L+ +Y+ G M HLY+ S ++ F
Sbjct: 54 ERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE 113
Query: 187 VSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK-LLENIEEAGPS 245
+ +AL HLH L +V+++ K N+L+D + D G+SK L +E S
Sbjct: 114 IILALE------HLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS 165
Query: 246 HGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTG 283
+ + G + D +S G+ + EL+TG
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 27/222 (12%)
Query: 76 QFSMEELEQAT----KQFSETSLIGFGSFGPV---YKGLLRDTVVAIKRRVGSPRQEFV- 127
QF E+ +T K++ IG G+ G V Y +L D VAIK+ + P Q
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKK-LSRPFQNQTH 59
Query: 128 -----AEVTYLSEIRHRNLVTLLG-YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKL 181
E+ + + H+N+++LL + Q E + + L + L ++
Sbjct: 60 AKRAYRELVLMKCVNHKNIISLLNVFTPQK-----SLEEFQDVYLVMELMDANLCQVIQM 114
Query: 182 EFK-QRVSIALGAAK-GLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239
E +R+S L G+ HLHS ++H++ K +N++V + K+ D G+++
Sbjct: 115 ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
Query: 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELV 281
P + +R PEV + E DI+S G + E+V
Sbjct: 173 FMMTPY--VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 95 IGFGSFGPVYKGLLRDT-------VVAIKRRVGSPRQEFVA--EVTYLSEIRHRNLVTLL 145
+G GS+ VYKG+ R V+++K G P F A E + L ++H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVP---FTAIREASLLKGLKHANIVLLH 69
Query: 146 GYCQQNGYQMLVFEYLPNG---SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
VFEY+ M H GL F ++ +GL ++H
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQH--PGGLHPYNVRLFMFQL------LRGLAYIHG 121
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESG 262
++H++ K N+L+ K+AD G+++ ++I S + +R P+V
Sbjct: 122 QH--ILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGA 178
Query: 263 V-FSEMSDIYSFGVFLLELVTGQEA 286
+S DI+ G +E++ GQ A
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 26/204 (12%)
Query: 94 LIGFGSFGPVYKGLLRDTVVA-------IKRRVGSPRQEF---VAEVTYLSEIRHRNLVT 143
L+G G+FG V L+R+ +K+ V + E + E L RH L +
Sbjct: 2 LLGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGA--AKGLCHLH 201
L Q V EY+ G + HL + S + F GA L +LH
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-------YGAEIVSALDYLH 112
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSI-VNVFRDPEVEE 260
S K +V+++ K N+++D++ K+ D G+ K E I +A + PEV E
Sbjct: 113 SGK--IVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLE 168
Query: 261 SGVFSEMSDIYSFGVFLLELVTGQ 284
+ D + GV + E++ G+
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 52/223 (23%), Positives = 103/223 (46%), Gaps = 26/223 (11%)
Query: 77 FSMEELEQAT----KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVA-- 128
F EE+ + ++++ +G G++G V + + T VAIK+ + E A
Sbjct: 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKR 60
Query: 129 ---EVTYLSEIRHRNLVTLLG-YCQQNGYQMLVFEYLPNGSMCNHLYET-GLE-SSTKLE 182
E+T L ++H N++ LL + YL M L + G S K++
Sbjct: 61 AYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQ 120
Query: 183 FKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242
+ + GL ++HS ++H++ K N+ V+E+ K+ D G+++ +A
Sbjct: 121 Y-----LVYQMLCGLKYIHS--AGIIHRDLKPGNLAVNEDCELKILDFGLARH----ADA 169
Query: 243 GPSHGSIVNVFRDPEVEESGV-FSEMSDIYSFGVFLLELVTGQ 284
+ + +R PEV + + +++ DI+S G + E++TG+
Sbjct: 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 19/207 (9%)
Query: 92 TSLIGFGSFGPVYKGLLR----DTVVAIKRRVGSPRQEFVAEVTYLSEIR-HRNLVTLLG 146
IG G++G V+K L + V I + +E AE L + H N+V G
Sbjct: 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 147 YC----QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
+NG Q+ + L NG L + L+ ++E I A GL HLH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE-EAGPSHGSIVNVFRDPEV--- 258
K +H++ K N+L+ K+ D G+S L + S G+ + PEV
Sbjct: 143 NKT--IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGT--PFWMAPEVIAC 198
Query: 259 --EESGVFSEMSDIYSFGVFLLELVTG 283
+ + D++S G+ +EL G
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 38/157 (24%)
Query: 98 GSFGPVYKGLLRDT--VVAIKR------RVGSPRQEFVAEVTYLSEI------RHRNLVT 143
G++G VY+ + T +VA+K+ + G P +T L EI +H N+VT
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFP-------ITSLREINILLKLQHPNIVT 68
Query: 144 L----LGYCQQNGYQMLVFEYLPNG--SMCNHLYETGLESSTKLEFKQRVSIALGAAKGL 197
+ +G Y +V EY+ + S+ + + L+S K Q +S G+
Sbjct: 69 VKEVVVGSNLDKIY--MVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLS-------GV 119
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234
HLH ++H++ KT+N+L++ I K+ D G+++
Sbjct: 120 AHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 50/226 (22%), Positives = 105/226 (46%), Gaps = 31/226 (13%)
Query: 75 RQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDTVVAIK---RRVGSPRQEFV-AEV 130
RQ + + + +++ S +G G++G V DT ++ +++ P Q + A+
Sbjct: 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKR 62
Query: 131 TY-----LSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQ 185
TY L ++H N++ LL E + + HL L + K Q
Sbjct: 63 TYRELRLLKHMKHENVIGLLDVFTP----ARSLEEFNDVYLVTHLMGADLNNIVKC---Q 115
Query: 186 RVS------IALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239
+++ + +GL ++HS ++H++ K +N+ V+E+ K+ D G+++ ++
Sbjct: 116 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 172
Query: 240 EEAGPSHGSIVNVFRDPEVEESGV-FSEMSDIYSFGVFLLELVTGQ 284
E G +R PE+ + + +++ DI+S G + EL+TG+
Sbjct: 173 EMTGY---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 34/208 (16%)
Query: 94 LIGFGSFGPVYKGLLRDTVVA-------IKRRVGSPRQEFVAEVT---YLSEIRHRNLVT 143
L+G G+FG V L+R+ +K+ V + E +T L RH L
Sbjct: 2 LLGKGTFGKVI--LVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEF-KQRVSIALGAAKGLCHLHS 202
L Q + V EY G + HL + S + F + ALG +LHS
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------YLHS 113
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF------RDP 256
+V+++ K N+++D++ K+ D G+ K E I S G+ + F P
Sbjct: 114 CD--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGI-----SDGATMKTFCGTPEYLAP 164
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVTGQ 284
EV E + D + GV + E++ G+
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 50/211 (23%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 94 LIGFGSFGPVYKGLLRD---TVVAIK-------------RRVGSPRQEFVAEVTYLSE-I 136
+G G+FG VYK ++ ++A+K R + V+EVT + E +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 137 RHRNLVTLLGYCQQNGYQMLVFEYL---PNGSMCNHLYETGLESSTKLEFKQRVSIALGA 193
RH N+V +N +V + + P G N L E + + + V + L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 194 AKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF 253
L +LH K +VH++ N+++ E+ + D G++K + + G+I+ +
Sbjct: 126 ---LRYLHKEKR-IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTIL--Y 179
Query: 254 RDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
PE+ ++ + E +D+++FG L ++ T Q
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQ 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 46/171 (26%), Positives = 72/171 (42%), Gaps = 34/171 (19%)
Query: 95 IGFGSFGPVYKGLLR------------DTVVAIK--RRVGSPRQEFVAEVTYLSEIRHRN 140
+G G+F +YKG+LR + V +K F + +S++ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCN--HLYETGLESSTKLEFKQRVSIALGAAKGLC 198
LV L G C ++ M V EY+ G + H + + KL+ +A A L
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPLDVFLHREKNNVSLHWKLD------VAKQLASALH 115
Query: 199 HLHSLKPPLVHKNFKTANVLVDEN--------FIAKVADTGISKLLENIEE 241
+L K LVH N N+LV FI K++D GI + + EE
Sbjct: 116 YLEDKK--LVHGNVCGKNILVARYGLNEGYVPFI-KLSDPGIPITVLSREE 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 55/237 (23%), Positives = 98/237 (41%), Gaps = 35/237 (14%)
Query: 126 FVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQ 185
F + + ++ H+++V L G C ++ ++V E++ G + ++ +T +FK
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK- 109
Query: 186 RVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN--------FIAKVADTGISKLLE 237
+A A L +L LVH N T N+L+ FI K++D GI +
Sbjct: 110 ---VAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFI-KLSDPGIPITVL 163
Query: 238 NIEEAGPSHGSIVNVFRDPE-VEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYE 296
+ +E I PE VE+S S +D +SFG L E+ E + L +
Sbjct: 164 SRQECVERIPWIA-----PECVEDSKNLSIAADKWSFGTTLWEICYNGE----IPLKD-K 213
Query: 297 ALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353
L + + R + T ++L L CM+ +RP +M ++
Sbjct: 214 TLAE--KERFYEGQCM-------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 17/149 (11%)
Query: 141 LVTLLGYCQQNGYQM-LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGA--AKGL 197
+T L C Q ++ V EY+ G + + + G FK+ ++ A A GL
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG-------RFKEPHAVFYAAEIAIGL 114
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRD 255
LHS +++++ K NV++D K+AD G+ K EN+ + G + + +
Sbjct: 115 FFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWD-GVTTKTFCGTPDYIA 169
Query: 256 PEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
PE+ + + D ++FGV L E++ GQ
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 34/131 (25%), Positives = 64/131 (48%), Gaps = 12/131 (9%)
Query: 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTA 215
V EY+ G + H+ + G K + Q V A + GL LH + +++++ K
Sbjct: 78 FVMEYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLH--RRGIIYRDLKLD 130
Query: 216 NVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPEVEESGVFSEMSDIYSF 273
NV++D K+AD G+ K E++ + G + + + PE+ + + D +++
Sbjct: 131 NVMLDSEGHIKIADFGMCK--EHMVD-GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAY 187
Query: 274 GVFLLELVTGQ 284
GV L E++ GQ
Sbjct: 188 GVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 40/150 (26%), Positives = 61/150 (40%), Gaps = 19/150 (12%)
Query: 95 IGFGSFGPVY-------KGLLRDTVVAIKRRVGSPRQ-EFVAEVTYLSEIRHRNLVTLLG 146
IG G FG V G+ R V +K S Q EF+ + ++H N++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 147 YCQQNGYQMLVFEYLPNGSM----CNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
C + +LVFEY G + + L QR++ + A G+ H+H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL---QRMACEIAA--GVTHMH- 116
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGI 232
K +H + N + + KV D GI
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 53/211 (25%), Positives = 82/211 (38%), Gaps = 40/211 (18%)
Query: 94 LIGFGSFGPVY------------KGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEIRHRNL 141
L+G G+FG V +LR V+ K V V E L RH L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT----VTESRVLQNTRHPFL 57
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGA--AKGLCH 199
L Q + V EY G + HL + + + F GA L +
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-------YGAEIVSALEY 110
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF------ 253
LHS +V+++ K N+++D++ K+ D G+ K G S G+ + F
Sbjct: 111 LHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCGTPEY 161
Query: 254 RDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
PEV E + D + GV + E++ G+
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 39/136 (28%), Positives = 63/136 (46%), Gaps = 24/136 (17%)
Query: 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGA--AKGLCHLHSLKPPLVHKNFKT 214
V EY+ G + H+ + G +FK+ ++ A A GL LHS +++++ K
Sbjct: 79 VMEYVNGGDLMYHIQQVG-------KFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKL 129
Query: 215 ANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD------PEVEESGVFSEMS 268
NV++D K+AD G+ K ENI G F PE+ + +
Sbjct: 130 DNVMLDAEGHIKIADFGMCK--ENIFG-----GKTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 269 DIYSFGVFLLELVTGQ 284
D ++FGV L E++ GQ
Sbjct: 183 DWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 26/91 (28%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 195 KGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR 254
+GL +LHS ++H++ K N+LV+ N + K+ D G++++ E E + + +R
Sbjct: 114 RGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYR 171
Query: 255 DPEV-EESGVFSEMSDIYSFGVFLLELVTGQ 284
PE+ S ++ DI+S G EL+ +
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 55/226 (24%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFV-AEVTY-----LSEIRH 138
++ S +G G++G V T VAIK+ + P Q + A+ TY L + H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKK-LSRPFQSAIHAKRTYRELRLLKHMDH 73
Query: 139 RNLVTLLGYCQQNGYQMLVFEYLPNGS--------MCNHLYETGLESSTKLEFKQRVS-- 188
N++ LL VF P S + HL L + K Q++S
Sbjct: 74 ENVIGLLD----------VFT--PASSLEDFQDVYLVTHLMGADLNNIVKC---QKLSDD 118
Query: 189 ----IALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP 244
+ +GL ++HS ++H++ K +N+ V+E+ K+ D G+++ + +E
Sbjct: 119 HIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTD--DEMT- 173
Query: 245 SHGSIVNV-FRDPEVEESGVFSEMS-----DIYSFGVFLLELVTGQ 284
G + +R PE+ + + M DI+S G + EL+TG+
Sbjct: 174 --GYVATRWYRAPEI----MLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 30/211 (14%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRD---TVVAIKRRVGSP--RQEFV----AEVTYLSEIR 137
+ F+ +G GSFG V ++ VAIKR S +Q+ V +E L+ I
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 138 HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGL 197
H V L G + Y LV E++ G L F V A L
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK-------RFPNDVGCFYAAQIVL 142
Query: 198 C--HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE---AGPSHGSIVNV 252
+L SL +V+++ K N+L+D++ K+ D G +K+++ P + +
Sbjct: 143 IFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIA---- 196
Query: 253 FRDPEVEESGVFSEMSDIYSFGVFLLELVTG 283
PE+ + + +D ++ G+F+ E++ G
Sbjct: 197 ---PEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 52/219 (23%)
Query: 94 LIGFGSFGPVYKGLLRD--TVVAIKR----RVGSPRQEFVAEVTYLSEIRHRNLVTLLGY 147
IG G+FG V K L + T++A+KR ++ + ++ + +R + ++ +
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MRSSDCPYIVKF 68
Query: 148 CQQNGYQMLVFEYLPNGS--MCNHLYETGLE-------SSTKLEFKQRV--SIALGAAKG 196
Y L E G +C L + L+ K + + IA+ K
Sbjct: 69 -----YGALFRE----GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119
Query: 197 LCHL-HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN----IEEAG------PS 245
L +L LK ++H++ K +N+L+D N K+ D GIS L + +AG P
Sbjct: 120 LNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 177
Query: 246 HGSIVNVFR-DPEVEESGVFSEMSDIYSFGVFLLELVTG 283
R DP + + SD++S G+ L E+ TG
Sbjct: 178 --------RIDPSARDG--YDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 26/91 (28%), Positives = 48/91 (52%), Gaps = 8/91 (8%)
Query: 200 LHSLKPP--LVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPE 257
LH LK ++H++ K +N+L+D + K+ D GIS L ++ + + + PE
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRSAGCAAYMAPE 184
Query: 258 -VEESGVFSEM---SDIYSFGVFLLELVTGQ 284
++ + +D++S G+ L+EL TGQ
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 27/224 (12%)
Query: 77 FSMEELEQAT----KQFSETSLIGFGSFGPV---YKGLLRDTVVAIKRRVGSPRQEFV-- 127
F E+ +T K++ IG G+ G V Y +L V AIK+ + P Q
Sbjct: 10 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNV-AIKK-LSRPFQNQTHA 67
Query: 128 ----AEVTYLSEIRHRNLVTLLG-YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLE 182
E+ + + H+N++ LL + Q E + + L + L ++E
Sbjct: 68 KRAYRELVLMKCVNHKNIIGLLNVFTPQKS-----LEEFQDVYIVMELMDANLCQVIQME 122
Query: 183 FK-QRVSIALGAAK-GLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240
+R+S L G+ HLHS ++H++ K +N++V + K+ D G+++
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180
Query: 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
P + +R PEV + E DI+S G + E++ G
Sbjct: 181 MMTPY--VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 55/212 (25%), Positives = 83/212 (39%), Gaps = 41/212 (19%)
Query: 94 LIGFGSFGPV----YKG--------LLRDTVVAIKRRVGSPRQEFVAEVTYLSEIRHRNL 141
++G GSFG V KG +L+ V+ V E V L+ +H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTE--KRVLALAG-KHPFL 58
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGA--AKGLCH 199
L Q V EY+ G + H+ +G F + + A GL
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-------RFDEPRARFYAAEIVLGLQF 111
Query: 200 LHSLKPPLVHKNFKTANVLVD-ENFIAKVADTGISKLLENIEEAGPSHGSIVNVF----- 253
LH +++++ K NVL+D E I K+AD G+ K E I G + F
Sbjct: 112 LHERG--IIYRDLKLDNVLLDSEGHI-KIADFGMCK--EGILG-----GVTTSTFCGTPD 161
Query: 254 -RDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
PE+ + D ++ GV L E++ GQ
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 8e-04
Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIKR----RVGSPRQEFVA--EVTYLSEIRHRN 140
F ++G G FG V +R T + A K+ R+ + E +A E L ++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL 200
+V+L + LV + G + H+Y G + + ++ V A GL L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDL 118
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPEVE 259
H + +V+++ K N+L+D+ +++D G L I E G + V + PEV
Sbjct: 119 HRER--IVYRDLKPENILLDDYGHIRISDLG---LAVEIPEGETIRGRVGTVGYMAPEVV 173
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQ 284
++ ++ D + G + E++ G+
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 8e-04
Identities = 50/199 (25%), Positives = 83/199 (41%), Gaps = 23/199 (11%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQ--EFVAEVTYLSEIRHRNLVTLLG 146
+G GSFG V + T AIK R + +Q E + L E+ H +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLC--HLHSLK 204
Q + E++ G + HL + G F V+ A L +LHS
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAG-------RFPNDVAKFYHAELVLAFEYLHSKD 138
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVF 264
+++++ K N+L+D KV D G +K + + G+ + PEV +S
Sbjct: 139 --IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFTLCGT--PEYLAPEVIQSKGH 192
Query: 265 SEMSDIYSFGVFLLELVTG 283
+ D ++ GV L E + G
Sbjct: 193 GKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIKR----RVGSPRQEFVA--EVTYLSEIRHRN 140
F ++G G FG V +R T + A K+ R+ + E +A E L ++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL 200
+V+L + LV + G + H+Y G F ++ +I AA+ C L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-----FDEQRAI-FYAAELCCGL 115
Query: 201 HSL-KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPEV 258
L + +V+++ K N+L+D+ +++D G L I E G + V + PEV
Sbjct: 116 EDLQRERIVYRDLKPENILLDDRGHIRISDLG---LAVQIPEGETVRGRVGTVGYMAPEV 172
Query: 259 EESGVFSEMSDIYSFGVFLLELVTGQ 284
+ ++ D + G + E++ GQ
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 43/190 (22%), Positives = 85/190 (44%), Gaps = 21/190 (11%)
Query: 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANV 217
++ + + N L + G E T L+ +S A+G+ L S VH++ NV
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDL---LSFTYQVARGMEFLASKN--CVHRDLAARNV 268
Query: 218 LVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPEVEESGVFSEMSDIYSFGVF 276
L+ + I K+ D G+++ + + + + V + PE +++ +SD++S+G+
Sbjct: 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGIL 328
Query: 277 LLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQ 334
L E I SLG Y +I V S + +R+A +++ + ++
Sbjct: 329 LWE---------IFSLGGTPYPGMI--VDSTFYNKIKSGYRMAK--PDHATQEVYDIMVK 375
Query: 335 CMSSPGRRRP 344
C +S +RP
Sbjct: 376 CWNSEPEKRP 385
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|221737 pfam12726, SEN1_N, SEN1 N terminal | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 32/132 (24%), Positives = 53/132 (40%), Gaps = 15/132 (11%)
Query: 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTAN 216
V + LP + L + L S+ L L + L L K P K+ TA
Sbjct: 433 VSDILPP--LWKSLLDALLPSNLSL-----AKSLLSSLLPLNGLE--KFPPKGKDELTAE 483
Query: 217 VLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEE---SGVFSEMSDIYSF 273
+ ++ + IS++LE + + PS + ++ DP+ S +FS DIY
Sbjct: 484 KTQFNKIVQQLTEL-ISQILERLSDFDPSE--LSSLLSDPDAARAIWSCLFSPDQDIYQA 540
Query: 274 GVFLLELVTGQE 285
LL+ V +
Sbjct: 541 ATNLLKEVFDVD 552
|
This domain is found at the N terminal of the helicase SEN1. SEN1 is a Pol II termination factor for noncoding RNA genes. The N terminal of SEN1, unlike the C terminal, is not required for growth. Length = 724 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 48/197 (24%), Positives = 85/197 (43%), Gaps = 36/197 (18%)
Query: 111 TVVAIKRRVGSPRQEFVAEVTYLSEIRH----RNLVTLLGYCQQNGY------------Q 154
T + R P+++ VA+ L++ R R+ + L C G
Sbjct: 81 TAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL 140
Query: 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQR------VSIALGAAKGLCHLHSLKPPLV 208
+L+ EY G + + + E L F++ I L L +HS K ++
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKE---HLPFQEYEVGLLFYQIVLA----LDEVHSRK--MM 191
Query: 209 HKNFKTANVLVDENFIAKVADTGISKLLEN---IEEAGPSHGSIVNVFRDPEVEESGVFS 265
H++ K+AN+ + I K+ D G SK + ++ A G+ + PE+ E +S
Sbjct: 192 HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT--PYYLAPELWERKRYS 249
Query: 266 EMSDIYSFGVFLLELVT 282
+ +D++S GV L EL+T
Sbjct: 250 KKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 52/213 (24%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVAEVTY-----LSEIRHRNL 141
+ + +G G++G V L R T VAIK+ + E A+ Y L ++H N+
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLY------ETGLESSTKLE--FKQRVS-IALG 192
+ LL VF + + Y T L K E + R+ +
Sbjct: 77 IGLLD----------VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQ 126
Query: 193 AAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV 252
KGL ++H+ ++H++ K N+ V+E+ K+ D G+++ ++ E G +
Sbjct: 127 MLKGLKYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS-EMTGY---VVTRW 180
Query: 253 FRDPEVEESGV-FSEMSDIYSFGVFLLELVTGQ 284
+R PEV + + +++ DI+S G + E++TG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 23/161 (14%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSP--RQEFVAEV----TYLSEIRHRN 140
F +IG G+FG V +DT + A+K+ S +E VA V L+E +
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 141 LVTLLGYC--QQNGYQMLVFEYLPNGSMCNHL--YETGLESSTKLEFKQRVSIALGAAKG 196
+V L Y Q Y L+ EYLP G M L +T E T+ + + +A+ +
Sbjct: 63 VVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI-LAIDS--- 116
Query: 197 LCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237
+H L +H++ K N+L+D K++D G+ L+
Sbjct: 117 ---IHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 14/95 (14%)
Query: 88 QFSETSLIGFGSFGPVYK----GL------LRDTVVAIKRRVGSPRQE-FVAEVTYLSEI 136
QF +T +G G+FG V + GL LR V +K + +E ++E+ LS +
Sbjct: 41 QFGKT--LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHL 98
Query: 137 -RHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHL 170
+H+N+V LLG C G +++ EY G + N L
Sbjct: 99 GQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 53/228 (23%), Positives = 94/228 (41%), Gaps = 38/228 (16%)
Query: 95 IGFGSFGPVYKGLLRDTV-----VAIKRRVGSPRQ--EFVAEVTYLSEIRHRNLVTLLGY 147
IG G FG V+ + T AI R R+ + V EV + E++H+N+V +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 148 CQQNGYQML--VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK- 204
Q L + E+ G + ++ + + K+E V I L + H+LK
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNI-QKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139
Query: 205 ----PPLVHKNFKTANVLVDENF-----------------IAKVADTGISKLLENIEEAG 243
++H++ K N+ + IAK+ D G+SK NI
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK---NIGIES 196
Query: 244 PSHGSI-VNVFRDPE--VEESGVFSEMSDIYSFGVFLLELVTGQEASH 288
+H + + PE + E+ + + SD+++ G + EL +G+ H
Sbjct: 197 MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244
|
Length = 1021 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 26/121 (21%), Positives = 53/121 (43%), Gaps = 35/121 (28%)
Query: 179 TKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238
+ L + + + A+G+ L S K +H++ N+L+ EN + K+ D G+++
Sbjct: 169 SPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLAR---- 222
Query: 239 IEEAGPSHGSIVNVFRDPEVEESG-----------------VFSEMSDIYSFGVFLLELV 281
++++DP+ G V++ SD++SFGV L E+
Sbjct: 223 ------------DIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF 270
Query: 282 T 282
+
Sbjct: 271 S 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 56/241 (23%), Positives = 97/241 (40%), Gaps = 53/241 (21%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIK--RRVGSPRQEFV----AEVTYLSEIRH 138
+ F +IG G+FG V +DT V A+K R+ +E V AE L E
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 139 RNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLY--ETGLESSTKLEFKQRVSIALGAAKG 196
+V + Q L+ E+LP G M L +T E T+ + V +A+ +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV-LAIDS--- 116
Query: 197 LCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI---------SKLLENIEEAGPSHG 247
+H L +H++ K N+L+D K++D G+ ++ N+ + PS
Sbjct: 117 ---IHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 248 SIVNV-------------------------FRDPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ N+ + PEV ++++ D +S GV + E++
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 283 G 283
G
Sbjct: 232 G 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 56/239 (23%), Positives = 94/239 (39%), Gaps = 53/239 (22%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT----VVAIKRRVGSPRQEFVA----EVTYLSEIRHRN 140
F +IG G+FG V +DT + I R+ +E VA E L E
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLY--ETGLESSTKLEFKQRVSIALGAAKGLC 198
+V + Q L+ E+LP G M L +T E +T+ + V +A+ A
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV-LAIDA----- 116
Query: 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI---------SKLLENIEEAGPSHGSI 249
+H L +H++ K N+L+D K++D G+ ++ N+ PS S
Sbjct: 117 -IHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 250 VNV-------------------------FRDPEVEESGVFSEMSDIYSFGVFLLELVTG 283
N+ + PEV ++++ D +S GV + E++ G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 27/205 (13%)
Query: 94 LIGFGSFGPVYKGLLRDTVVA-------IKRRVGSPRQEFVAEVT---YLSEIRHRNLVT 143
L+G G+FG V L+++ +K+ V + E +T L RH L
Sbjct: 2 LLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGA--AKGLCHLH 201
L Q + V EY G + HL + S + F GA L +LH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSALDYLH 112
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPEVE 259
S K +V+++ K N+++D++ K+ D G+ K E I++ G + + + PEV
Sbjct: 113 SEKN-VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKD-GATMKTFCGTPEYLAPEVL 168
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQ 284
E + D + GV + E++ G+
Sbjct: 169 EDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 27/119 (22%), Positives = 52/119 (43%), Gaps = 35/119 (29%)
Query: 181 LEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240
L + + + AKG+ L S K +H++ N+L+ EN + K+ D G+++
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLAR------ 227
Query: 241 EAGPSHGSIVNVFRDPEVEESG-----------------VFSEMSDIYSFGVFLLELVT 282
++++DP+ G V++ SD++SFGV L E+ +
Sbjct: 228 ----------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 382 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.1 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.9 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.87 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.86 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.82 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.72 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.58 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.51 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.49 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.4 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.37 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.28 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.23 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.18 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.16 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.1 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.08 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.08 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.05 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.99 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.94 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.91 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.88 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.88 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.77 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.7 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.66 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.66 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.53 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.3 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 97.26 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.17 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.03 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.96 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.95 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.94 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.67 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.65 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.47 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.19 | |
| PLN02236 | 344 | choline kinase | 96.11 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.05 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.91 | |
| PF02439 | 38 | Adeno_E3_CR2: Adenovirus E3 region protein CR2; In | 95.12 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.1 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.86 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.61 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.42 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.15 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 93.97 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.81 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 93.55 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-58 Score=431.51 Aligned_cols=282 Identities=43% Similarity=0.721 Sum_probs=244.3
Q ss_pred CCcccCHHHHHHHHhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEE
Q 016789 73 GARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYC 148 (382)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~ 148 (382)
..+.|+++++..+|++|...+.||+|+||.||+|...+ ..||||+..... ..+|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999988 899999877543 46799999999999999999999999
Q ss_pred EeCC-eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCCeeecCCCcEE
Q 016789 149 QQNG-YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL-KPPLVHKNFKTANVLVDENFIAK 226 (382)
Q Consensus 149 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~ivHrDlk~~Nill~~~~~~k 226 (382)
.+.+ +.+||||||++|+|.++|+..... .++|..|++||.++|+||+|||.. .++||||||||+|||||+++++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9998 599999999999999999875422 789999999999999999999984 56899999999999999999999
Q ss_pred EeecCCccccccccccCCCcc-cccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh-
Q 016789 227 VADTGISKLLENIEEAGPSHG-SIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS- 304 (382)
Q Consensus 227 l~DfGla~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~- 304 (382)
|+|||+|+..... ....... .+|.+|+|||+...+..+.++|||||||+|+||+||+++.+.........+..|...
T Consensus 218 lsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999755431 1111122 678889999999999999999999999999999999998876554444557777654
Q ss_pred --hcCCCcccccccC-CCCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 016789 305 --RLSSNNFVDHRLA-GTFTT-EGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358 (382)
Q Consensus 305 --~~~~~~~~d~~~~-~~~~~-~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~ 358 (382)
.....+++|+.+. +.++. ++...+.+++.+|++.+|.+||+|.+|++.|+.+..
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 3356789999988 66665 688999999999999999999999999999966653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-53 Score=394.18 Aligned_cols=255 Identities=33% Similarity=0.448 Sum_probs=213.4
Q ss_pred CCCeeeccCcccEEEEEECCee-EEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCC-eeEEEEeecCC
Q 016789 91 ETSLIGFGSFGPVYKGLLRDTV-VAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNG-YQMLVFEYLPN 163 (382)
Q Consensus 91 ~~~~lg~G~~g~V~~~~~~~~~-vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~ 163 (382)
..+.+|+|+||+||+|.+.++. ||+|++.... ..+|.+|+.+|.+++|||||+++|+|.+.. ...+|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 3455999999999999999977 9999987543 458999999999999999999999999987 79999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC-cEEEeecCCcccccccccc
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF-IAKVADTGISKLLENIEEA 242 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~~~~~~~~~ 242 (382)
|+|.++|+.. ....+++..++.++.|||+||.|||++++ ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 9999999874 23479999999999999999999999776 99999999999999997 99999999998665432 2
Q ss_pred CCCcccccccccCccccc--cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 243 GPSHGSIVNVFRDPEVEE--SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~--~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
..+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... ......+.... .....
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~~---------~Rp~~ 267 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVGG---------LRPPI 267 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcC---------CCCCC
Confidence 333467889999999999 56899999999999999999999999986543 22222222111 11123
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhh
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMA 362 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~ 362 (382)
+..++..+..++.+||+.||..||++.+++..|+.+......
T Consensus 268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 344678899999999999999999999999999999875443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=416.24 Aligned_cols=260 Identities=27% Similarity=0.432 Sum_probs=220.5
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGY 153 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 153 (382)
.+.+....+.||+|+||+||+|...+ ..||||.++... ..+|.+|+++|..++|||||+|+|+|.++++
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 44556667889999999999998643 579999887643 3589999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCCC---------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLES---------STKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI 224 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~ 224 (382)
.+||+|||..|||.++|+.+.... ..+++..+.+.||.|||.||.||.+++ +|||||..+||||.++..
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGENLV 641 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccceE
Confidence 999999999999999998654322 223889999999999999999999988 999999999999999999
Q ss_pred EEEeecCCccccccccccCCC-cccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHH
Q 016789 225 AKVADTGISKLLENIEEAGPS-HGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWV 302 (382)
Q Consensus 225 ~kl~DfGla~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~ 302 (382)
|||+|||+++..-+.+..... ..-.+.+||+||.+..++||.+||||||||+|||++| |+.|+..... ++.++.+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~EVIe~i 718 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---QEVIECI 718 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---HHHHHHH
Confidence 999999999987665555443 4456778999999999999999999999999999999 7888875433 3444444
Q ss_pred HhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 303 RSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 303 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
+.+ ++ ...+..+|..+.+|+..||+.+|.+||+++||-..|+.....
T Consensus 719 ~~g---------~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 719 RAG---------QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HcC---------Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 432 12 356778899999999999999999999999999999988654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-54 Score=399.79 Aligned_cols=255 Identities=27% Similarity=0.450 Sum_probs=219.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECCe-eEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDT-VVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~-~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.+...+.||+|.||.||.|.+++. .||+|.+... ..++|.+|+++|++|+|+|||+++|+|..++.++||||||+.
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 3444567799999999999999985 8999987763 347899999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.++|... ....+.....+.++.|||+||+||++++ +|||||.++||||+++..+||+|||+|+...+.....
T Consensus 286 GsLl~yLr~~---~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 286 GSLLDYLRTR---EGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred CcHHHHhhhc---CCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999999872 3457889999999999999999999988 9999999999999999999999999999776666666
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
......+..|.|||.+..+.|+.|||||||||+||||+| |+.|+.... ..++++.+.. ..+.+.|.
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms---n~ev~~~le~----------GyRlp~P~ 427 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS---NEEVLELLER----------GYRLPRPE 427 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC---HHHHHHHHhc----------cCcCCCCC
Confidence 666677788999999999999999999999999999999 677765332 2333433333 33335567
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.++..+.+++..||+.+|++|||++.+...|+++...
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 7889999999999999999999999999999988754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-51 Score=365.49 Aligned_cols=244 Identities=23% Similarity=0.308 Sum_probs=205.3
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCC-eeEEEEeec
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG-YQMLVFEYL 161 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~ 161 (382)
++..+.||+|..|+||+++++. ..+|+|.+... ...++.+|++++++.+||+||.+||.|.... ...++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 3456789999999999999985 78999988433 3457899999999999999999999999998 599999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++|||.+.+...+ .+++.....|+.+|.+||.|||+ .+ ||||||||+|+|++..|++||||||.+..+.+.
T Consensus 161 DgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred CCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999997653 68999999999999999999995 66 999999999999999999999999999987664
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccC--CCChhHHHHHHHhhcCCCcccccccCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVS--LGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
......||..|||||.+.+..|+.++||||||++++|+.+|+.|+.... ....-++..++..... |
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp------P---- 300 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP------P---- 300 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC------C----
Confidence 2344567888999999999999999999999999999999999986531 2233445554443211 1
Q ss_pred CCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 319 TFTT-EGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 319 ~~~~-~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..+. .++.++..++..||++||.+||++.|+++.
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1222 356788999999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=396.11 Aligned_cols=266 Identities=27% Similarity=0.451 Sum_probs=228.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-----eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
+...+.++||.|.||.|++|+++. ..||||.++.. .+.+|+.|+.||.++.||||++|.|+.+.....++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 345567899999999999999863 58999998753 345899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
+|||++|+|..+|+.+. .++.+.++..++++||.||.||.+.+ +|||||.++|||++.+..+|++|||+++.++
T Consensus 709 TEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999998753 36999999999999999999999988 9999999999999999999999999999887
Q ss_pred cccccC--CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 238 NIEEAG--PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 238 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
++.... ...+.++.+|.|||.+...++|.+|||||||+++||.++ |.+|+-+... .+.+..+...
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---QdVIkaIe~g--------- 850 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVIKAIEQG--------- 850 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---HHHHHHHHhc---------
Confidence 655333 234566788999999999999999999999999999887 8899865442 2333333333
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhhhhhccCCc
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFMGEGT 371 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~~~~~~~~~~ 371 (382)
...+.+.+++..|.+|++.||++|-.+||.+.+++..|+++.....+++.....++
T Consensus 851 -yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~ 906 (996)
T KOG0196|consen 851 -YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESP 906 (996)
T ss_pred -cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCC
Confidence 22345778999999999999999999999999999999999999888877655443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=350.27 Aligned_cols=206 Identities=26% Similarity=0.422 Sum_probs=178.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
.+|...+.||+|+||+||+|+++. ..||||.+... ..+-...|+.+|+.++|||||++++++..++..|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 457777889999999999999876 68999987654 23457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC------CcEEEeecCCc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN------FIAKVADTGIS 233 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~------~~~kl~DfGla 233 (382)
||.+|+|.++++..+ .+++.....++.|+|.||++||+++ ||||||||.||||+.. -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999875 6899999999999999999999988 9999999999999764 56899999999
Q ss_pred cccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS 304 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 304 (382)
+.+.+.... .+..|++.|||||++..+.|+.|+|+||+|+++|++++|+.||+.. ...++..+.+.
T Consensus 163 R~L~~~~~a--~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~---t~~eL~~~~~k 228 (429)
T KOG0595|consen 163 RFLQPGSMA--ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE---TPKELLLYIKK 228 (429)
T ss_pred hhCCchhHH--HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc---CHHHHHHHHhc
Confidence 988754332 3446788999999999999999999999999999999999999754 33444444443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=365.05 Aligned_cols=244 Identities=21% Similarity=0.326 Sum_probs=205.4
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
..|...+.||+|||+.||.++.. +..+|+|.+.. ..++...+|+++.++|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 46889999999999999999884 47999998654 34567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
|+|.+|+|.+++..++ .+++.....+..||+.||.|||+.+ |+|||||..|+|++++.++||+|||||..++.
T Consensus 98 ELC~~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999987543 7999999999999999999999988 99999999999999999999999999998875
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
+.. ...+..|||.|.|||++....++..+||||+||++|.|+.|++||.... ..+....+. ..+.
T Consensus 171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~---vkety~~Ik----~~~Y------- 235 (592)
T KOG0575|consen 171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT---VKETYNKIK----LNEY------- 235 (592)
T ss_pred ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch---HHHHHHHHH----hcCc-------
Confidence 433 2334568899999999999999999999999999999999999997432 111111111 1111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..|...+....+||.++|+.||.+|||+.+|+.-
T Consensus 236 ~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1223445667788999999999999999999863
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=339.74 Aligned_cols=254 Identities=21% Similarity=0.289 Sum_probs=205.6
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccC-----CchHHHHHHHHHHhcCCCCCccceee-EEEeCCe-eEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVG-----SPRQEFVAEVTYLSEIRHRNLVTLLG-YCQQNGY-QMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~lv 157 (382)
.+|++.++||+|.||+||++... +..+|.|.+.- ..+++...|+.+|++|+|||||++++ .+.+++. +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 34666788999999999999754 47889987652 34567899999999999999999999 4444444 8999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc--CCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS--LKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~--~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
||||..|+|...+...+ .....+++..+++++.|++.||.++|+ ....|+||||||.||+++.+|.+||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K-~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFK-KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHH-hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999887654 344578999999999999999999998 334499999999999999999999999999998
Q ss_pred cccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
+.+..... ....|||.||+||.+...+|+.+|||||+||++|||+.-++||... ...++.+.+... ..
T Consensus 178 l~s~~tfA-~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~qg-d~------- 245 (375)
T KOG0591|consen 178 LSSKTTFA-HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIEQG-DY------- 245 (375)
T ss_pred hcchhHHH-HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHHcC-CC-------
Confidence 87654433 3457899999999999999999999999999999999999999753 344444443332 10
Q ss_pred cCCCCC-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 016789 316 LAGTFT-TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELER 355 (382)
Q Consensus 316 ~~~~~~-~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~ 355 (382)
.+.+ .-.+..+.+++..|+..||+.||+...+++.+..
T Consensus 246 --~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 --PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1123 4457889999999999999999996555555443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=350.18 Aligned_cols=249 Identities=18% Similarity=0.240 Sum_probs=200.2
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----------chHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG 152 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 152 (382)
..+.|...+.||+|+||.|-+|..+. +.||+|++... ......+|+++|++|+|||||++.+++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34567788999999999999998765 79999986532 1124579999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC---CcEEEee
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN---FIAKVAD 229 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~---~~~kl~D 229 (382)
..||||||++||+|.+++...+ .+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999998765 4566666789999999999999988 9999999999999765 7899999
Q ss_pred cCCccccccccccCCCcccccccccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh-h
Q 016789 230 TGISKLLENIEEAGPSHGSIVNVFRDPEVEESGV---FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS-R 305 (382)
Q Consensus 230 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-~ 305 (382)
||+|+.... ...+.+..||+.|.|||++.+.. +..++|+||+||+||-+++|.+||....... .+.+.+.. .
T Consensus 323 FGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~~G~ 398 (475)
T KOG0615|consen 323 FGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQILKGR 398 (475)
T ss_pred cchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHhcCc
Confidence 999998763 33455667899999999997765 3457899999999999999999997543221 12222211 1
Q ss_pred cCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 306 LSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 306 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
... ......+..++..++|.++|..||++||++.|+++-
T Consensus 399 y~f--------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 399 YAF--------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ccc--------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 111 112234556788899999999999999999998863
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=355.86 Aligned_cols=263 Identities=26% Similarity=0.426 Sum_probs=211.7
Q ss_pred CHHHHHHHHhCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 016789 78 SMEELEQATKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNG 152 (382)
Q Consensus 78 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 152 (382)
+.++++...+.+.....||+|.||+||+|.|.+ .||||.+.... .+.|.+|+..+++-+|.||+-++|+|.+..
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 447777777888889999999999999999976 57888866432 357999999999999999999999999988
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCC
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI 232 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGl 232 (382)
. .+|+.+|+|-+|+.+||... .+++....+.||.|||+|+.|||..+ |||||||+.||++.+++.|||+|||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred e-eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccc
Confidence 7 89999999999999998653 57999999999999999999999988 99999999999999999999999999
Q ss_pred cccccccc-ccCCCcccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh-hcC
Q 016789 233 SKLLENIE-EAGPSHGSIVNVFRDPEVEE---SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS-RLS 307 (382)
Q Consensus 233 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~ 307 (382)
+..-.... ........+...|||||++. ..+|++++||||||+|+|||++|..|+... ..++++ |... ...
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~---~~dqIi-fmVGrG~l 610 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ---NRDQII-FMVGRGYL 610 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC---ChhheE-EEeccccc
Confidence 86433221 11122334556799999985 456999999999999999999999999722 222221 1111 111
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 016789 308 SNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358 (382)
Q Consensus 308 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~ 358 (382)
..+.. .....+++++.+|+..||..++++||.+.+|+..|+.+..
T Consensus 611 ~pd~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 611 MPDLS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred Cccch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11111 1234567889999999999999999999999999988876
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=347.73 Aligned_cols=262 Identities=27% Similarity=0.368 Sum_probs=211.8
Q ss_pred HHHhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 84 QATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 84 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
-+++...+.+.||+|-||.|.++...+ ..||||.+.... +.+|.+|+++|.+++||||++++|+|..++.+++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 344567778899999999999999888 899999987643 468999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
|||++|+|.+++..+..+. .......+|+.|||.||+||.+.+ +|||||.++|||+|.++++||+|||+++-+-.
T Consensus 615 EYmEnGDLnqFl~aheapt---~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT---AETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHhcCcHHHHHHhccCcc---cccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999998764322 455667789999999999999998 99999999999999999999999999996655
Q ss_pred ccccCC-CcccccccccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 239 IEEAGP-SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT--GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 239 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
.+.... .....+.+|||||.+..+++|.+||||+||+++||+++ ...|+..... ++.++....-.... ...
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~---~~~ 763 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQ---GRQ 763 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCC---Ccc
Confidence 444332 33455678999999999999999999999999999887 4567654322 22222221111100 011
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
.....+.-++..+.+++.+||..|.++||+++++...|++.
T Consensus 764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 12234567788999999999999999999999999988765
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=379.07 Aligned_cols=260 Identities=27% Similarity=0.460 Sum_probs=215.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 155 (382)
.+....+.||+|+||.||.|.+.+ ..||+|.+... ...+|++|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344567789999999999998765 24889887654 2457999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCC--CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 156 LVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
+++|||++|+|..+|++.+. .....+....++.++.|||+|+.||++++ +|||||.++||||++...+||+|||+|
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999998643 22457899999999999999999999988 999999999999999999999999999
Q ss_pred cccccccccCCCc-ccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcc
Q 016789 234 KLLENIEEAGPSH-GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 234 ~~~~~~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (382)
+.+...+...... ...+..|||||.+..+.||.|+|||||||+|||++| |..|+...+ +.+.+..+....
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~--n~~v~~~~~~gg------ 921 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS--NFEVLLDVLEGG------ 921 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc--hHHHHHHHHhCC------
Confidence 9655444433322 345567999999999999999999999999999999 677776432 222222233221
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEM 361 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~ 361 (382)
+.+.+..++..+.+|+.+||+.+|++||++..+++.+..+.....
T Consensus 922 -----RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 922 -----RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred -----ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 124567788899999999999999999999999999998876543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=336.63 Aligned_cols=238 Identities=22% Similarity=0.262 Sum_probs=194.4
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..++||+|+||+||.++.++ +.+|+|.+.+. ......+|..+|.+++||+||+++-.|++.+.+|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 578899999999999999998776 68899876542 2345788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+.||.|..+|.+.+ .+++....-.+++|+.||.|||+.+ ||||||||+|||+|++|+++|+|||+++....
T Consensus 105 d~~~GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred eccCCccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999998654 6788878888999999999999988 99999999999999999999999999985433
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
... ......||+.|||||++....|+.++|+||+|+++|||++|.+||...+. ....+.+.... + .
T Consensus 178 ~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~---~~~~~~I~~~k----~---~--- 243 (357)
T KOG0598|consen 178 DGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV---KKMYDKILKGK----L---P--- 243 (357)
T ss_pred CCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH---HHHHHHHhcCc----C---C---
Confidence 222 23345788999999999999999999999999999999999999975432 22222222111 0 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCC
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPK 345 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs 345 (382)
..+.-......+++...++.||++|..
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 011112355677888999999999974
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=327.28 Aligned_cols=256 Identities=23% Similarity=0.287 Sum_probs=199.4
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCchH-----HHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQ-----EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~-----~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
.|+...++|+|+||.||++++++ +.||||++.+++.+ -.++|+++|++++|||+|.++.+|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 46677789999999999999886 69999999876543 357899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
|+. ++.+-|.... ..++......++.|++.|+.|+|+++ +|||||||+||||+.++.+||||||+|+.+.. .
T Consensus 83 ~dh-TvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p 154 (396)
T KOG0593|consen 83 CDH-TVLHELERYP----NGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSA-P 154 (396)
T ss_pred cch-HHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence 976 4555554432 25788899999999999999999988 99999999999999999999999999998864 2
Q ss_pred ccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC--------Ccc
Q 016789 241 EAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS--------NNF 311 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~ 311 (382)
....+....|.+|+|||.+.+ .+|+..+||||+||++.||++|.+.|...++-+.-.++......+.+ +++
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 233455667888999999877 67999999999999999999999988754432222222211111111 111
Q ss_pred c----ccccCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 312 V----DHRLAGTFT-----TEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 312 ~----d~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+ -|......+ +.....++++++.|++.||.+|++-++++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1 111111111 223557899999999999999999999874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=356.68 Aligned_cols=261 Identities=26% Similarity=0.378 Sum_probs=210.4
Q ss_pred HHHHHhCCCCCCeeeccCcccEEEEEECC-----ee-EEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEE
Q 016789 82 LEQATKQFSETSLIGFGSFGPVYKGLLRD-----TV-VAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQ 149 (382)
Q Consensus 82 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~-vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~ 149 (382)
|+...++....+.||+|+||.||+|.+.. .. ||+|....+ ...+|++|+++|++++|||||++||++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 33334455566899999999999998753 23 899987642 2357999999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEee
Q 016789 150 QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVAD 229 (382)
Q Consensus 150 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~D 229 (382)
...++++|||+|+||+|.++|.+.+ ..++...+..++.+.|.||+|||+.+ ++||||.++|||++.++.+||+|
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999998764 26899999999999999999999988 99999999999999999999999
Q ss_pred cCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCC
Q 016789 230 TGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSS 308 (382)
Q Consensus 230 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 308 (382)
||+++.-.. ..........+..|+|||.+....|+.++|||||||++||+++ |..|+.... ..++..++....
T Consensus 306 FGLs~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~---~~~v~~kI~~~~-- 379 (474)
T KOG0194|consen 306 FGLSRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK---NYEVKAKIVKNG-- 379 (474)
T ss_pred cccccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC---HHHHHHHHHhcC--
Confidence 999885431 1111212345678999999999999999999999999999999 788886432 233344432211
Q ss_pred CcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 016789 309 NNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEM 361 (382)
Q Consensus 309 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~ 361 (382)
.....+...+..+..++.+||..||++||+|.++.+.|+.+.....
T Consensus 380 -------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 380 -------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred -------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1112233456677888889999999999999999999999986644
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=336.34 Aligned_cols=250 Identities=27% Similarity=0.357 Sum_probs=199.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCC--eeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNG--YQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 159 (382)
.++...+.||+|+||.||++.+.+ ...|||...... .+.+.+|+.+|++++|||||+++|...... ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 346677899999999999999876 789999866543 345889999999999999999999855444 6899999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC-CCcEEEeecCCcccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-NFIAKVADTGISKLLEN 238 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-~~~~kl~DfGla~~~~~ 238 (382)
|+++|+|.+++.+.+ + .+++..+.....||++||+|||+++ ||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g---~-~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG---G-KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcC---C-CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999998764 2 5999999999999999999999877 999999999999999 79999999999987763
Q ss_pred --ccccCCCcccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 239 --IEEAGPSHGSIVNVFRDPEVEESGV-FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 239 --~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
..........+|+.|||||++.++. ...++||||+||++.||+||++||... ......+....... . .|
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~-~-----~P- 242 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGRED-S-----LP- 242 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccC-C-----CC-
Confidence 2222334567889999999998643 335999999999999999999999743 11111111111111 1 11
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L 353 (382)
..+...+....+++..|++.||++|||+.++++.-
T Consensus 243 ---~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 243 ---EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ---CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 23344556778888899999999999999998864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=341.76 Aligned_cols=249 Identities=20% Similarity=0.267 Sum_probs=206.2
Q ss_pred HHHHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCe
Q 016789 83 EQATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGY 153 (382)
Q Consensus 83 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 153 (382)
....++|.+++.||+|+|++|++|+... +.+|+|++.+. ...-+..|-++|.+| .||.|++|+-.|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 4455789999999999999999998876 68999986542 223466788999999 79999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
+|+|+||+++|+|.++|.+.+ .+++......+.+|+.||+|||++| ||||||||+|||+|+++++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeecccc
Confidence 999999999999999999876 6888888999999999999999988 999999999999999999999999999
Q ss_pred ccccccccc----------CC--CcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHH
Q 016789 234 KLLENIEEA----------GP--SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQW 301 (382)
Q Consensus 234 ~~~~~~~~~----------~~--~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~ 301 (382)
+.+...... .. ....||..|.+||++.++..+..+|+|+|||+||.|+.|++||.... + ....+.
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--e-yliFqk 298 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN--E-YLIFQK 298 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc--H-HHHHHH
Confidence 987543222 11 23467888999999999999999999999999999999999997532 1 111121
Q ss_pred HHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 302 VRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 302 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
+.. ++. .+++..++...+|+.+.|..||.+|++..++-+-
T Consensus 299 I~~-------l~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 IQA-------LDY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHH-------hcc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 111 111 2344445778899999999999999999887664
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=343.04 Aligned_cols=260 Identities=23% Similarity=0.389 Sum_probs=202.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC-------CeeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCccceeeEEEeC-C
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR-------DTVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVTLLGYCQQN-G 152 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 152 (382)
.++|+..+.||+|+||.||+|.+. ...||+|.+.... ...+.+|+.++..+ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 456888999999999999999752 1479999876432 34688999999999 899999999988764 4
Q ss_pred eeEEEEeecCCCChhhhhhhcCCC--------------------------------------------------------
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGLE-------------------------------------------------------- 176 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 176 (382)
..+++|||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 688999999999999998753210
Q ss_pred -CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc-CCCccccccccc
Q 016789 177 -SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA-GPSHGSIVNVFR 254 (382)
Q Consensus 177 -~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~ 254 (382)
....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........ ......++..|+
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 0134778889999999999999999977 999999999999999999999999999865332211 112233456799
Q ss_pred CccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHh
Q 016789 255 DPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTL 333 (382)
Q Consensus 255 aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~ 333 (382)
|||.+.+..++.++|||||||++|||++ |..||..... ............. . ..+...+..+.+++.
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~--~~~~~~~~~~~~~------~----~~~~~~~~~l~~li~ 311 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI--NEEFCQRLKDGTR------M----RAPENATPEIYRIML 311 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHHHhcCCC------C----CCCCCCCHHHHHHHH
Confidence 9999999999999999999999999997 9999864332 1122222211110 0 112233467889999
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 334 QCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 334 ~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
+||+.||.+||++.++++.|+++..+
T Consensus 312 ~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 312 ACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=346.73 Aligned_cols=248 Identities=26% Similarity=0.399 Sum_probs=207.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCCh
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 166 (382)
+....++-||+|+.|.||+|++.+..||||++..- -..+|.-|++|+||||+.|.|+|....-.++|||||+.|.|
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el----kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL----KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred HHhhhhhhhccCcccceeeeeccCceehhHHHhhh----hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 33445667999999999999999999999987432 23568889999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCc
Q 016789 167 CNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH 246 (382)
Q Consensus 167 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 246 (382)
++.|+.. ..+.....+.+..+||.||.|||.++ |||||||+-||||+.+..|||+|||-++...... . .-.
T Consensus 200 ~~VLka~-----~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-T-kMS 270 (904)
T KOG4721|consen 200 YEVLKAG-----RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-T-KMS 270 (904)
T ss_pred HHHHhcc-----CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhhh-h-hhh
Confidence 9999764 36788888999999999999999988 9999999999999999999999999998765431 1 122
Q ss_pred ccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHH
Q 016789 247 GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMR 326 (382)
Q Consensus 247 ~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 326 (382)
..||..|||||++.+.+.++|+||||||||||||+||.-|+.+.+.. .+-| .+=...+....+..+++
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIw--------GVGsNsL~LpvPstcP~ 338 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIW--------GVGSNSLHLPVPSTCPD 338 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEE--------eccCCcccccCcccCch
Confidence 35678899999999999999999999999999999999998754321 0111 11122344456778889
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 327 DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 327 ~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
-+.-|+++||+..|.+||++++++.-|+-...+
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 999999999999999999999999998766544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=337.73 Aligned_cols=257 Identities=22% Similarity=0.300 Sum_probs=203.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCch-----HHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPR-----QEFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQML 156 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~-----~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 156 (382)
...|+..+.||+|+||.||+|+... ..||+|++.-... .-..+||.+|++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3567778899999999999998765 6899998764432 2357899999999999999999998877 68999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
|+|||++ +|.-++... .-.++..++..++.|++.||+|||+++ |+|||||.+|||||.+|.+||+|||||++.
T Consensus 196 VFeYMdh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccceeec
Confidence 9999976 777777543 347899999999999999999999988 999999999999999999999999999988
Q ss_pred ccccccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC------
Q 016789 237 ENIEEAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN------ 309 (382)
Q Consensus 237 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 309 (382)
........+....|.+|+|||.+.+. .|+.+.|+||.||||.||+.|++.+.... +.+++......-.+..
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t--EveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT--EVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc--HHHHHHHHHHHhCCCChhcccc
Confidence 77776667778889999999998765 59999999999999999999999987433 3333322222211111
Q ss_pred -ccc---ccccCCCCCH-------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 -NFV---DHRLAGTFTT-------EGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 -~~~---d~~~~~~~~~-------~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+. .......+.. ..+...++|+..+|..||.+|.|+.++++
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 110 0011111111 12456788999999999999999998875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=329.45 Aligned_cols=258 Identities=22% Similarity=0.243 Sum_probs=204.9
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
.++|+..++||.|..++||+|+... ..||||++.-+ ..+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3578889999999999999998754 79999997532 24678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
||.+||+.+.+...-.. .+++..+..|.+++.+||.|||++| .||||||+.||||+.+|.|||+|||.+-.+...
T Consensus 105 fMa~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999875422 3889999999999999999999988 999999999999999999999999987655432
Q ss_pred cccC--C-CcccccccccCccccc--cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 240 EEAG--P-SHGSIVNVFRDPEVEE--SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 240 ~~~~--~-~~~~~~~~y~aPE~~~--~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
.... . ....++++|||||++. ...|+.|+||||||++..||.+|..||....+ ...+...++.... ...-.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--mkvLl~tLqn~pp--~~~t~ 255 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--MKVLLLTLQNDPP--TLLTS 255 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--HHHHHHHhcCCCC--Ccccc
Confidence 2111 1 3446889999999953 34599999999999999999999999975432 2233332322111 11111
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.+..+........+.+++..||++||.+|||++++++-
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11112223345688999999999999999999998863
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=328.60 Aligned_cols=243 Identities=21% Similarity=0.325 Sum_probs=197.7
Q ss_pred CCeeeccCcccEEEEEECCeeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEEeec
Q 016789 92 TSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQ----NGYQMLVFEYL 161 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 161 (382)
...+|+|++|.||+|.+.+..||+|...... .+.|.+|+.+|++++||||++++|++.+ ....++||||+
T Consensus 25 ~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred CeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 3679999999999999999999999876432 2457799999999999999999999877 34678999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL-KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++|+|.+++... ..+++.....++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 105 TRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999999754 2588899999999999999999974 5 8899999999999999999999999998654321
Q ss_pred ccCCCcccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEES--GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ...+.......... .
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~---~~~~~~~i~~~~~~---------~ 241 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT---TKEIYDLIINKNNS---------L 241 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhcCCC---------C
Confidence 22345677999999976 679999999999999999999999997432 22222222111110 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
..+...+..+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 112234567889999999999999999999999999875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=343.28 Aligned_cols=262 Identities=23% Similarity=0.367 Sum_probs=223.9
Q ss_pred HHHHHHHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc--hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 016789 80 EELEQATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP--RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 80 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 155 (382)
++|+-.+.+....++||-|.||.||.|.|+. ..||||.++++. .++|+.|..+|+.++|||+|+|+|+|+.....|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 5666667777788899999999999999987 689999988764 468999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+|+|||.+|+|.++|+.+.. ..++.-.++.+|.||+.||+||...+ +|||||.++|||+.++..+||+|||++++
T Consensus 340 IiTEfM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEecccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999998753 35777788999999999999999877 99999999999999999999999999999
Q ss_pred cccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
+..+....-.....+.-|.|||.+....++.|+|||+|||+|||+.| |..|+...+ ..++...+ ..
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid---lSqVY~LL----------Ek 481 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYGLL----------EK 481 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc---HHHHHHHH----------hc
Confidence 87665544444455667999999999999999999999999999998 777775433 22222222 23
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.+..+.+..|+..+.+|+..||+-+|.+||++.|+-+.++.+...
T Consensus 482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 334455778889999999999999999999999999999888644
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=323.25 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=202.3
Q ss_pred hCCCCCCeeeccCcccEEEEEEC-----CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR-----DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
++|+..+.||+|+||.||+|.+. ...+|+|...... ...|.+|+.++.+++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999764 2589999876532 24688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999987542 36889999999999999999999877 9999999999999999999999999876543
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
............+..|+|||.+.+..++.++|||||||++||+++ |+.||.... .....+.......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~---~~~~~~~~~~~~~--------- 226 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS---GQDVIKAVEDGFR--------- 226 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC---HHHHHHHHHCCCC---------
Confidence 222112222334567999999999999999999999999999875 999986432 2222332221111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
...+..++..+.+++.+||+.+|.+||++.++.+.|+++
T Consensus 227 -~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 -LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 112334556788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=337.11 Aligned_cols=246 Identities=20% Similarity=0.296 Sum_probs=204.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC---chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS---PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
..|.....||+|+.|.||.+.... ..||+|++... .++-..+|+.+|+..+|+|||+++..+...+.+|.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 467777889999999999997654 68999986532 3456789999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++|+|.+.+... .+++.++..|+.+++.||+|||..+ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999988654 5899999999999999999999988 99999999999999999999999999987765433
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
......||++|||||+.....|+.+.||||||++++||+-|.+||-...+- .-+..+..... +.+ ..+
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl---rAlyLIa~ng~------P~l--k~~ 492 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYLIATNGT------PKL--KNP 492 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH---HHHHHHhhcCC------CCc--CCc
Confidence 445567899999999999999999999999999999999999999743221 11111111111 111 223
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
...+..+.+++.+||+.|+++||++.|+++-
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 4456788899999999999999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=324.06 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=204.4
Q ss_pred CCCCeeeccCcccEEEEEECCeeEEEEEccCCchHHHHHHHHHHhcC--CCCCccceeeEEEeCC----eeEEEEeecCC
Q 016789 90 SETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEI--RHRNLVTLLGYCQQNG----YQMLVFEYLPN 163 (382)
Q Consensus 90 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~~----~~~lv~e~~~~ 163 (382)
...+++|+|.||.||+|.+.++.||||++.....+.|.+|-+|.+.. +|+||++++++-.... ..+||+||.+.
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred hhHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 34567999999999999999999999999999999999998887764 7999999999876655 78999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-------CCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-------LKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-------~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
|+|.++|..+ .++|....+|+..+++||+|||+ .+|+|+|||||++||||.+|+++.|+|||+|..+
T Consensus 293 GsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 293 GSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred CcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 9999999865 68999999999999999999996 3578999999999999999999999999999988
Q ss_pred ccccccCC-CcccccccccCccccccCC-CC-----ccchhHHHHHHHHHHHhCCCCCCccCC--------------CCh
Q 016789 237 ENIEEAGP-SHGSIVNVFRDPEVEESGV-FS-----EMSDIYSFGVFLLELVTGQEASHIVSL--------------GSY 295 (382)
Q Consensus 237 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~-~~-----~~sDvws~G~vl~el~tg~~p~~~~~~--------------~~~ 295 (382)
......+. ....||.+|||||++.+.. +. .+.||||+|.|||||++...-++.... ...
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 76544443 2357899999999987643 22 368999999999999997654421000 011
Q ss_pred hHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 296 EALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 296 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
+++...+......+.+.|.-.. -..+..+.+.+..||..||+.|.|+.=|.+++.++.
T Consensus 447 e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 447 EEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred HHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 2222222222222222222111 144678899999999999999999999999888775
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=321.22 Aligned_cols=267 Identities=23% Similarity=0.350 Sum_probs=211.2
Q ss_pred HHHhCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCchHHHHHHHHHHhcC--CCCCccceeeEEEeCC----eeEEE
Q 016789 84 QATKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEI--RHRNLVTLLGYCQQNG----YQMLV 157 (382)
Q Consensus 84 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~~----~~~lv 157 (382)
...++....+.||+|.||.||+|.|++..||||++...+...|.+|.++.... +|+||+.+++.-..++ .+|||
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred hhhheeEEEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 34566778889999999999999999999999999999999999999988775 9999999999876543 68999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc------CCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS------LKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~------~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
++|.+.|||.|+|... .++....++++..+|.||+|||. .+|.|.|||||+.|||+..++.+.|+|+|
T Consensus 288 TdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred eecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999764 68999999999999999999993 46889999999999999999999999999
Q ss_pred Ccccccccc---ccCCCcccccccccCccccccCC----C--CccchhHHHHHHHHHHHhC----------CCCCCccCC
Q 016789 232 ISKLLENIE---EAGPSHGSIVNVFRDPEVEESGV----F--SEMSDIYSFGVFLLELVTG----------QEASHIVSL 292 (382)
Q Consensus 232 la~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~----~--~~~sDvws~G~vl~el~tg----------~~p~~~~~~ 292 (382)
||....+.. ........||.+|||||++...- + -..+||||||.|+||+... +.||.+.-+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 997655432 22345667899999999986542 1 1358999999999999763 457665433
Q ss_pred CChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 016789 293 GSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358 (382)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~ 358 (382)
.+.. .+..++....+.+.-..-....+.+.+..+.++++.||..+|..|.|+--+-+.|.++.+
T Consensus 442 ~DPs--~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 442 SDPS--FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCC--HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 3221 111222111111111111123456788999999999999999999999999999998874
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=325.65 Aligned_cols=260 Identities=26% Similarity=0.361 Sum_probs=199.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC------------------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccce
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD------------------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTL 144 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~------------------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l 144 (382)
.+|...+.||+|+||.||++.+.+ ..+|+|...... ..+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568888999999999999997532 368999876532 3468899999999999999999
Q ss_pred eeEEEeCCeeEEEEeecCCCChhhhhhhcCCC--------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceec
Q 016789 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLE--------------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHK 210 (382)
Q Consensus 145 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHr 210 (382)
++++...+..++||||+++|+|.+++...... ....+++.....++.|++.||.|||+.+ |+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH~ 162 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHR 162 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--cccc
Confidence 99999999999999999999999998654211 1235788899999999999999999987 9999
Q ss_pred CCCCCCeeecCCCcEEEeecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhC--CCCC
Q 016789 211 NFKTANVLVDENFIAKVADTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTG--QEAS 287 (382)
Q Consensus 211 Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg--~~p~ 287 (382)
||||+|||++.++.+||+|||+++.+....... .....++..|+|||++..+.++.++||||||+++|||+++ ..|+
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 999999999999999999999998654322211 1222345679999999888999999999999999999974 5566
Q ss_pred CccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 288 HIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
..... ............... .......++.++..+.+++.+||+.||.+||++.+|.+.|+
T Consensus 243 ~~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 243 GELTD---EQVIENAGEFFRDQG---RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CcCCH---HHHHHHHHHHhhhcc---ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 53321 222222211110000 00001112234567899999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=336.71 Aligned_cols=242 Identities=25% Similarity=0.344 Sum_probs=203.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCchH-----HHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQ-----EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~-----~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
++|...+.||+|.||.||||+-+. +.||+|.+.+..+. ...+|+++++.++||||+.++++|.+..++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 356777889999999999998776 78999987654433 48899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
||.+ +|..+|...+ .+++..+..|+.++..||.|||+.+ |+|||+||.|||++.++.+|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9976 9999997654 7999999999999999999999988 99999999999999999999999999997654
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
.....+...|||.|||||...+++|+..+|.||+||++||+++|++||... ....++..+... +. .
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv~~I~~d--------~v---~ 218 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLVKSILKD--------PV---K 218 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHHHHHhcC--------CC---C
Confidence 223345567899999999999999999999999999999999999999742 122333322211 11 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+......+.+++...+.+||.+|.+..+++.
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 23355677889999999999999999998875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=309.88 Aligned_cols=231 Identities=22% Similarity=0.282 Sum_probs=195.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||.|+||.|.+++.+. ..+|+|.+.... .+...+|..+|+.+.||+++++++.+.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 457778899999999999998875 689999876542 245678999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||.+||.|..+|++.+ +++.....-+|.||+.||+|||+++ |++|||||+|||+|.+|.+||+|||.|+.+..
T Consensus 124 eyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999999875 6888888999999999999999988 99999999999999999999999999997654
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh-hcCCCcccccccC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS-RLSSNNFVDHRLA 317 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~~~ 317 (382)
...+-.|||.|+|||.+...+|+.++|+|||||++|||+.|.+||..... ..+.+.+.. ..
T Consensus 197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI~~~~v----------- 258 (355)
T KOG0616|consen 197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKILEGKV----------- 258 (355)
T ss_pred ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHHHhCcc-----------
Confidence 23455789999999999999999999999999999999999999986543 222222111 11
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCC
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRR 343 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~R 343 (382)
.+|.-....+.+|+...++.|-.+|
T Consensus 259 -~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2334444667788889999999988
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=334.15 Aligned_cols=253 Identities=24% Similarity=0.385 Sum_probs=215.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC------eeEEEEEccC----CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD------TVVAIKRRVG----SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
......+.||.|.||.||+|.+.. --||||..+. ...+.|+.|..+|++++||||++++|+|.+. +.|+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 334556789999999999998754 2688887654 3456899999999999999999999999885 5899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
|||.++-|.|.++|.... ..++.......+.|++.+|+|||+.+ +|||||.++|||+...-.+||+|||+++.+
T Consensus 468 vmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999998653 46888899999999999999999988 999999999999999999999999999999
Q ss_pred ccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 237 ENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 237 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
+.......+.+..+.-|||||.+...++|.+||||.|||.+||+++ |..||......+.- ..+...
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------------~~iEnG 608 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------------GHIENG 608 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------------EEecCC
Confidence 8877777777777788999999999999999999999999999988 88999754321110 111222
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
-+.+.++.|+..+..++.+||.+||.+||.+.++...|+.+..+
T Consensus 609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 23356788899999999999999999999999999999998875
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=335.80 Aligned_cols=257 Identities=22% Similarity=0.357 Sum_probs=201.6
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC-------CeeEEEEEccCC----chHHHHHHHHHHhcC-CCCCccceeeEEEeCCe
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR-------DTVVAIKRRVGS----PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGY 153 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 153 (382)
.++|+..+.||+|+||.||+|.+. ...||+|.+... ..+.+.+|+.++..+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 456888899999999999999742 247999987643 234688999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCC----------------------------------------------------------
Q 016789 154 QMLVFEYLPNGSMCNHLYETGL---------------------------------------------------------- 175 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 175 (382)
.++|||||++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999875321
Q ss_pred ------------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 176 ------------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 176 ------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
.....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 01124788899999999999999999977 9999999999999999999999999998654332211
Q ss_pred C-CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 244 P-SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 244 ~-~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
. ....++..|+|||.+.+..++.++|||||||++|||++ |..||.... ......+........ ..+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~--~~~~~~~~~~~~~~~----------~~~ 339 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP--VDSKFYKMIKEGYRM----------LSP 339 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC--chHHHHHHHHhCccC----------CCC
Confidence 1 12233456999999999999999999999999999998 888876432 122233333222110 011
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
...+..+.+++.+||+.||++||++.+|++.|++.
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 12245688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=330.71 Aligned_cols=249 Identities=22% Similarity=0.269 Sum_probs=202.5
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC--------chHHHHHHHHHHhcCC-CCCccceeeEEEeCCee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS--------PRQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~--------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 154 (382)
...|...+.||+|+||+|+.|.+.. ..||+|..... ..+...+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 4578889999999999999998754 78999964432 1234557999999998 99999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC-CcEEEeecCCc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN-FIAKVADTGIS 233 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~-~~~kl~DfGla 233 (382)
++||||+.+|+|.+++.+.+ .+.+.....++.|++.|++|||+++ |+||||||+|+|+|.+ +++||+|||++
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEecCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999998744 6777889999999999999999988 9999999999999999 99999999999
Q ss_pred cccccccccCCCcccccccccCccccccCC-CC-ccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcc
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEESGV-FS-EMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (382)
.... ..........|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... ...+...+.. .++
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~---~~~l~~ki~~----~~~ 240 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN---VPNLYRKIRK----GEF 240 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc---HHHHHHHHhc----CCc
Confidence 9774 2333455667889999999999877 76 78999999999999999999998522 1222221111 111
Q ss_pred cccccCCCCCHHH-HHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 312 VDHRLAGTFTTEG-MRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 312 ~d~~~~~~~~~~~-~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
.++... +..+..++.+|+..||.+|+++.+++ .-.-+.
T Consensus 241 -------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 241 -------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred -------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 111222 56788899999999999999999999 444444
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=322.18 Aligned_cols=255 Identities=30% Similarity=0.452 Sum_probs=205.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 155 (382)
++|+..+.||+|+||.||+|.... ..+++|...... ..+|.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357788899999999999998643 468999876432 246889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCC-----------CcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESS-----------TKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI 224 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~ 224 (382)
++|||+++|+|.+++........ ..+++.....++.|++.||.|||+.+ ++||||||+||++++++.
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcCCCc
Confidence 99999999999999976432211 46888999999999999999999987 999999999999999999
Q ss_pred EEEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHH
Q 016789 225 AKVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWV 302 (382)
Q Consensus 225 ~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~ 302 (382)
+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ..+...+
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~~~i 239 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVIEMI 239 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH
Confidence 999999999765332221 1222334567999999998899999999999999999998 9999874332 2333332
Q ss_pred HhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 303 RSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 303 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
.... ....+...+..+.+++.+||+.||.+||++.+|++.|+++
T Consensus 240 ~~~~----------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 240 RSRQ----------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HcCC----------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 2211 1122345567899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=367.02 Aligned_cols=257 Identities=25% Similarity=0.448 Sum_probs=205.8
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNG 164 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 164 (382)
..|...++||+|+||.||+|... +..||+|++..... ....|++.+++++||||++++|+|.+.+..++||||+++|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g 768 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK 768 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCC
Confidence 45778889999999999999874 47899998764322 2245688999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL-KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
+|.++++ .++|..+..++.|+++||+|||.. .++|+||||||+||+++.++..++. ||.+.....
T Consensus 769 ~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 769 NLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred cHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 9999985 378999999999999999999954 3559999999999999999988876 665543221
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhh---cCCCcccccccCC--
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSR---LSSNNFVDHRLAG-- 318 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~d~~~~~-- 318 (382)
.....+++.|+|||++.+..++.++|||||||++|||+||+.|++... .......+|.... ......+|+.+..
T Consensus 835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 112245678999999999999999999999999999999999985432 2233455554432 1223445555533
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
..+.++...+.+++.+||+.||++||+|.||++.|+++...
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 23456777899999999999999999999999999998754
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=335.05 Aligned_cols=258 Identities=22% Similarity=0.367 Sum_probs=201.6
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCccceeeEEEeCCe
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGY 153 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 153 (382)
.++|...+.||+|+||.||++.... ..||+|.+.... ...+.+|+.+++.+ +||||++++++|...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 3568888999999999999997532 379999876432 24578899999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCC----------------------------------------------------------
Q 016789 154 QMLVFEYLPNGSMCNHLYETGL---------------------------------------------------------- 175 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 175 (382)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999864320
Q ss_pred -------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC-CCcc
Q 016789 176 -------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG-PSHG 247 (382)
Q Consensus 176 -------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~ 247 (382)
.....+++...+.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++......... ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 01234788889999999999999999977 9999999999999999999999999997654322111 1122
Q ss_pred cccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHH
Q 016789 248 SIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMR 326 (382)
Q Consensus 248 ~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 326 (382)
.++..|+|||++.+..++.++|||||||++|||++ |+.||...... ............ . ..+...+.
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--~~~~~~~~~~~~---~-------~~~~~~~~ 342 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--SKFYKMVKRGYQ---M-------SRPDFAPP 342 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--HHHHHHHHcccC---c-------cCCCCCCH
Confidence 23456999999998899999999999999999997 99998754321 111111111110 0 01111246
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 327 DLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 327 ~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
.+.+++.+||+.||.+||++.+|++.|+++.
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 7889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=316.88 Aligned_cols=252 Identities=23% Similarity=0.377 Sum_probs=204.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc--hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP--RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
.+|...+.||+|+||.||+|...+ ..+++|...... ..++.+|+++++.++||||+++++++...+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 457777899999999999998864 689999876543 3578899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999986542 235889999999999999999999877 999999999999999999999999999876543322
Q ss_pred CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 243 GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
.......+..|+|||.+.+..++.++||||||+++|||++ |..|+.... .....+...... ....+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~---~~~~~~~~~~~~----------~~~~~ 227 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYELLEKGY----------RMERP 227 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHCCC----------CCCCC
Confidence 2222233456999999999999999999999999999998 888886432 222222222111 11122
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 23456788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=314.70 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=200.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
++|+..+.||+|+||.||++.+.. ..+++|..... ...+|.+|++++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 457778899999999999998876 57899976543 346789999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||.++.........
T Consensus 84 ~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 84 GCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999987532 25889999999999999999999877 9999999999999999999999999998654333222
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
......+..|+|||.+.+..++.++||||||+++|||++ |+.||.... ............. ... +.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~---~~~~~~~i~~~~~---~~~-------~~ 224 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS---NYEVVEMISRGFR---LYR-------PK 224 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHCCCC---CCC-------CC
Confidence 222334457999999998889999999999999999999 888986432 2223333222111 111 11
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L 353 (382)
..+..+.+++.+||+.||.+||++.++++.|
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 2235688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=320.21 Aligned_cols=244 Identities=32% Similarity=0.522 Sum_probs=191.2
Q ss_pred CCeeeccCcccEEEEEEC------CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 92 TSLIGFGSFGPVYKGLLR------DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
.+.||.|.||.||+|.+. +..|+||.+.... .++|.+|++.+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999998 3689999985432 357999999999999999999999999888899999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++|+|.++|... ....+++..+..|+.|++.||.|||+.+ ++|+||+++|||+++++.+||+|||++........
T Consensus 84 ~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccc---cccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence 999999999875 2346899999999999999999999987 99999999999999999999999999986632211
Q ss_pred c-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 242 A-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 242 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
. ..........|+|||.+.+..++.++||||||+++|||++ |+.|+... ........+...... .
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~~~~~~~~~----------~ 225 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIEKLKQGQRL----------P 225 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHHHHHTTEET----------T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccc----------e
Confidence 1 1222334567999999999889999999999999999999 67887543 233333333322111 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L 353 (382)
.+..++..+.+++.+||+.||.+||++.++++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1223356788999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=315.15 Aligned_cols=253 Identities=26% Similarity=0.409 Sum_probs=204.7
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
.++|+..+.||+|+||.||+|.+.. ..+++|..... ...++.+|+.++++++||||+++++++...+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 4568888999999999999998765 67999987643 24578999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 85 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 85 YGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred CCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 999999987542 346899999999999999999999877 999999999999999999999999999876532222
Q ss_pred CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 243 GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
.......+..|+|||.+.+..++.++||||||+++|||++ |+.||.... ............. ...+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~----------~~~~ 226 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEVLQQVDQGYR----------MPCP 226 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCC----------CCCC
Confidence 1222222356999999999899999999999999999999 888886432 2222222221110 1122
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
...+..+.+++.+||+.||.+||++.++++.|+++
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 33457789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=298.81 Aligned_cols=255 Identities=20% Similarity=0.313 Sum_probs=202.0
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|...+.+|+|.||.||+|++.. +.||+|++.... .....+|+..|+.++|+||+.++++|-..+.+.||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 57777899999999999999865 689999876432 23578999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
|+ -+|...+++. ...+...++..++.++.+|++|||+.. |+||||||.|+|++.+|.+||+|||+++...+..
T Consensus 83 m~-tdLe~vIkd~----~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 83 MP-TDLEVVIKDK----NIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred cc-ccHHHHhccc----ccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 96 4888888654 346888899999999999999999988 9999999999999999999999999999886644
Q ss_pred ccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC----------
Q 016789 241 EAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN---------- 309 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 309 (382)
.... ....|.+|+|||.+.+. .|+...|+||.||++.||+-|.+-|... .+.+++....+....+.
T Consensus 156 ~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~--sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 156 RIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD--SDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred cccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC--chHHHHHHHHHHcCCCCcccCcccccc
Confidence 4333 23667889999998765 5999999999999999999999777533 34445544444322221
Q ss_pred -cccccccC-----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 310 -NFVDHRLA-----GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 310 -~~~d~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
+..+-... ...-+.+....++++..++..||.+|+++.|+++.
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111100 01122345667999999999999999999998864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=325.17 Aligned_cols=240 Identities=21% Similarity=0.266 Sum_probs=195.4
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCch------HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPR------QEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~------~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+.+..||+|+||.||+|+-++ ..+|+|++.++.. ..+..|-.+|....+|.||+++..|++.+.+||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 578899999999999999998765 6999999876532 35788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||++||++..+|.+.+ .|++....-.+.+++.|+.-||+.| +|||||||+|+|||..|++||+||||+.-+..
T Consensus 221 EylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999999998754 6888888889999999999999988 99999999999999999999999999853311
Q ss_pred c----------------------cccC------------------------CCcccccccccCccccccCCCCccchhHH
Q 016789 239 I----------------------EEAG------------------------PSHGSIVNVFRDPEVEESGVFSEMSDIYS 272 (382)
Q Consensus 239 ~----------------------~~~~------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvws 272 (382)
. +... .....|||.|||||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0 0000 00124788999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCccCCCCh-hHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC
Q 016789 273 FGVFLLELVTGQEASHIVSLGSY-EALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPK 345 (382)
Q Consensus 273 ~G~vl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs 345 (382)
+||++|||+.|-+||....+.+. ..++.|.... .. +...+......+||.+|+. ||++|..
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-~f----------P~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL-KF----------PEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-cC----------CCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999986654332 2333433221 11 1112223677889999999 9999987
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=326.82 Aligned_cols=244 Identities=25% Similarity=0.312 Sum_probs=202.5
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
.|+..+.||+|.||.||+|.... +.||+|.+.-. ..++..+|+.+|.+++++||.++||.+..+..+|++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 46667889999999999999876 68999987633 3457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
.+|++.+.|.... .+.+..+.-|..++..||.|||..+ .+|||||+.|||+..+|.+|++|||.+-.+.+...
T Consensus 94 ~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred cCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999987543 3466666678899999999999988 99999999999999999999999999988766554
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
.. .+..||+.|||||++....|+.++||||||++.+||.+|.+|+....+.....+ +.........
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------------Ipk~~PP~L~ 232 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------------IPKSAPPRLD 232 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------------ccCCCCCccc
Confidence 44 567889999999999988999999999999999999999999875433111110 1111111222
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
......+.+++..||++||+.||++.++++.
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3556789999999999999999999998864
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=320.30 Aligned_cols=253 Identities=18% Similarity=0.246 Sum_probs=198.7
Q ss_pred CCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 89 FSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
|+..+.||+|+||.||++... +..+|+|...... ...+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999875 4789999765321 23578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++|+|.+++.... ...+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998886532 235889999999999999999999977 9999999999999999999999999998653322
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChh-HHHHHHHhhcCCCcccccccCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYE-ALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
. .....++..|+|||.+.+..++.++|||||||++|||++|+.||......... ........ ....
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-----------~~~~ 223 (285)
T cd05631 157 T--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE-----------DQEE 223 (285)
T ss_pred e--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc-----------cccc
Confidence 1 12334678899999999999999999999999999999999999754322111 11111100 0011
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH--HHHHHHh
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPK-----MEIVMTE--LERIHEK 359 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~~v~~~--L~~i~~~ 359 (382)
++...+..+.+++.+||+.||.+||+ +.++++. ++++..+
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence 22334567889999999999999997 7777763 4444333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=330.04 Aligned_cols=248 Identities=22% Similarity=0.267 Sum_probs=198.7
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+|+..+.||+|+||.||+|.+.. ..+|+|.+... ....+.+|++++..++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 57888999999999999999864 68999986532 23467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++|+|.+++...+ .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred CCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999997543 5788899999999999999999988 99999999999999999999999999986543
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+..... .+..+... .
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~--~~~~~~~~-~ 224 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---NETWENLKYWKE--TLQRPVYD-D 224 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH---HHHHHHHHhccc--cccCCCCC-c
Confidence 22234567889999999999999999999999999999999999975332 221111111000 00001100 0
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.....+..+.+++.+||+.+|.+||++.++++.
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 012334677889999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=327.58 Aligned_cols=255 Identities=20% Similarity=0.326 Sum_probs=200.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC--chHH--HHHHHHHHhcCC-CCCccceeeEEEeCC-eeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS--PRQE--FVAEVTYLSEIR-HRNLVTLLGYCQQNG-YQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~--~~~~--~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~lv~ 158 (382)
++|...+.||.|+||.||+|+... ..||+|+++.. ..++ -++|+..|++|+ ||||+++..++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 457778899999999999998765 68999987643 2333 468999999998 999999999998887 999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
|||+ .+|.+.+.++ ...+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+.+.+
T Consensus 90 E~Md-~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 90 EFMD-CNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred Hhhh-hhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEeccccccccccc
Confidence 9995 5899998765 357999999999999999999999988 99999999999999999999999999997765
Q ss_pred ccccCCCcccccccccCcccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCc-------
Q 016789 239 IEEAGPSHGSIVNVFRDPEVE-ESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNN------- 310 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 310 (382)
... .+...-|.+|+|||++ +.+.|+.+.|+||+||+++|+.+-++.|...+ +.+++.....-.+....
T Consensus 163 kpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s--E~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 163 KPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS--EIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred CCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc--HHHHHHHHHHHhCCCccccchhHH
Confidence 332 2344567889999986 56779999999999999999999998886433 22332222211111110
Q ss_pred -------ccccccCC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 311 -------FVDHRLAG----TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 311 -------~~d~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
+.-+...+ ..-+..+.+..+++.+|++.||.+|||+.+.++.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00111111 0112256788899999999999999999999875
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=315.60 Aligned_cols=252 Identities=23% Similarity=0.415 Sum_probs=203.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
++|+..+.||+|+||.||+|...+ ..+++|..... ..+.+.+|+.++++++||||+++++++...+..++++||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 568888999999999999998765 67899986643 245789999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..........
T Consensus 86 ~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 86 GSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 99999987542 335788899999999999999999877 9999999999999999999999999998765432222
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
.....++..|+|||.+....++.++||||||+++|||+| |+.||.... .............. ....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~~~~~~----------~~~~ 227 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSALQRGYRM----------PRME 227 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC---HHHHHHHHHcCCCC----------CCCC
Confidence 222334556999999998889999999999999999998 899986432 22222222221110 1112
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
..+..+.+++.+||+.+|++||++.++.+.|+++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 2345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=320.77 Aligned_cols=257 Identities=22% Similarity=0.242 Sum_probs=195.3
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|+..+.||+|+||.||++++.. ..+|+|+.... ....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 57888999999999999999864 68999986532 234678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++++.+..... . ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~-~----~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 82 VEKNMLELLEE-M----PNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred CCCCHHHHHHh-c----CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99876654432 2 135888899999999999999999877 9999999999999999999999999998764433
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc---------CCC--
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL---------SSN-- 309 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------~~~-- 309 (382)
........+++.|+|||.+.+..++.++|||||||++|||++|+.||......+............ ...
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 222233456778999999998889999999999999999999999997533211111111100000 000
Q ss_pred -cccccccCC------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 -NFVDHRLAG------TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 -~~~d~~~~~------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
....+.... ......+..+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 011123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=343.32 Aligned_cols=262 Identities=19% Similarity=0.252 Sum_probs=212.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCch---HHHHHHHHHHhcCC-CCCccceeeE-EEe------CCe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPR---QEFVAEVTYLSEIR-HRNLVTLLGY-CQQ------NGY 153 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~---~~~~~e~~~l~~l~-h~niv~l~~~-~~~------~~~ 153 (382)
.++++.++|.+|||+.||.|...+ ..+|+|++...+. +...+|+++|+.|+ |+|||.+++. ... .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 456677899999999999998865 6899999775543 46789999999997 9999999993 321 136
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.+|+||||.+|+|-+++..+. ...|.+..+++|+.|+++|+++||.+++||||||||.+||||+.+++.||||||.+
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEeehhhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 789999999999999998754 22499999999999999999999999999999999999999999999999999998
Q ss_pred ccccccc-ccC-------CCcccccccccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHH
Q 016789 234 KLLENIE-EAG-------PSHGSIVNVFRDPEVE---ESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWV 302 (382)
Q Consensus 234 ~~~~~~~-~~~-------~~~~~~~~~y~aPE~~---~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~ 302 (382)
.-.-... ... .-....|+.|++||++ .+.++++|+|||||||+||-|+....||....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----------- 262 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----------- 262 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-----------
Confidence 6332111 100 0112347789999997 46679999999999999999999999997431
Q ss_pred HhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhhhhhc
Q 016789 303 RSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFM 367 (382)
Q Consensus 303 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~~~~~~ 367 (382)
...+++..+.-+-.+..+..+.+||..||+.||++||++.+|+..+-+|....+...+..
T Consensus 263 -----~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 263 -----KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred -----ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 123334444333346788999999999999999999999999999999988877765544
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=312.90 Aligned_cols=251 Identities=28% Similarity=0.465 Sum_probs=203.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-----eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
++|+..+.||+|+||.||+|.+.. ..+++|...... ..+|.+|+.++++++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999998752 478999865432 34688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999987642 26889999999999999999999977 9999999999999999999999999998765
Q ss_pred ccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 238 NIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 238 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
..... .......+..|+|||.+.+..++.++||||||+++|||++ |..|+.... ..............
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~------- 227 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS---NQDVIKAVEDGYRL------- 227 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHHcCCCC-------
Confidence 22211 1122334567999999998899999999999999999998 998986432 22222322221110
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
..+.+.+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 ---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ---PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11223456788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=330.97 Aligned_cols=258 Identities=21% Similarity=0.356 Sum_probs=203.3
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcCC-CCCccceeeEEEeCCe
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGY 153 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 153 (382)
.+.|.+.++||+|+||.||+|.+.. ..||+|.+.... .+.+.+|+++++++. ||||++++++|...+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4678888999999999999998642 368999876432 356889999999996 9999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCC---------------------------------------------------------
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLE--------------------------------------------------------- 176 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------- 176 (382)
.++|||||++|+|.++|......
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999998753210
Q ss_pred ----------------------------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC
Q 016789 177 ----------------------------------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN 222 (382)
Q Consensus 177 ----------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~ 222 (382)
....+++..+..++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~~~ 273 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEeCC
Confidence 0124788888999999999999999977 9999999999999999
Q ss_pred CcEEEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHH
Q 016789 223 FIAKVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQ 300 (382)
Q Consensus 223 ~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~ 300 (382)
+.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ......
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~--~~~~~~ 351 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV--DSTFYN 351 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch--hHHHHH
Confidence 99999999999865432221 1122234567999999998899999999999999999997 8888864321 111111
Q ss_pred HHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 301 WVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 301 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
...... ....+...+..+.+++.+||+.||++||++.+|.+.|+++.
T Consensus 352 ~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 352 KIKSGY----------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHhcCC----------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 111111 01112344567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=322.55 Aligned_cols=240 Identities=20% Similarity=0.230 Sum_probs=195.9
Q ss_pred CCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+|+..+.||+|+||.||++... +..+|+|..... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5788899999999999999987 478999986532 23457889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++|+|.+++...+ .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 82 YVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred CCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999987643 5788889999999999999999987 999999999999999999999999999865432
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
.....+++.|+|||.+.+..++.++|||||||++|||++|+.||.... .....+...... . .
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~-------~----~ 216 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN---PFGIYEKILAGK-------L----E 216 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCC-------c----C
Confidence 122346778999999999889999999999999999999999986432 222222221110 0 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPK-----MEIVMTE 352 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~~v~~~ 352 (382)
.+......+.+++.+||+.||.+||+ +.++++.
T Consensus 217 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 12222456789999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=321.90 Aligned_cols=254 Identities=23% Similarity=0.374 Sum_probs=201.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECC------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
.+|+..+.||+|+||.||+|.+.. ..+|+|...... .+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468889999999999999998642 248999875432 35788999999999999999999999875 4679
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
++||+++|+|.+++.... ..+++...+.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 86 v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999997642 35788899999999999999999987 999999999999999999999999999876
Q ss_pred ccccccCC-CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 237 ENIEEAGP-SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 237 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
........ .....+..|+|||.+.+..++.++||||||+++|||++ |+.|+.... .....+........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~~------ 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSILEKGERL------ 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHhCCCCC------
Confidence 54322211 12233557999999999999999999999999999998 999986432 22222222221110
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
..+..++..+.+++.+||+.||.+||++.+++..|..+..+.
T Consensus 231 ----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 111223356788999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=314.17 Aligned_cols=253 Identities=26% Similarity=0.468 Sum_probs=206.4
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
...+|+..+.||.|+||.||+|...+ ..+++|...... ...+..|+.+++.++||||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568888999999999999999876 788998876543 35788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++|+|.+++.+.. ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999997642 346899999999999999999999977 9999999999999999999999999998664322
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
.. .....++..|++||.+....++.++||||||+++|+|++ |+.||.... ............. ..
T Consensus 159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~~----------~~ 224 (261)
T cd05148 159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQITAGYR----------MP 224 (261)
T ss_pred cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHHhCCc----------CC
Confidence 21 223334567999999988889999999999999999998 888886432 2222222221111 11
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
.+...+..+.+++.+||+.||.+||++.++++.|+.+
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 2234456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=316.05 Aligned_cols=257 Identities=27% Similarity=0.410 Sum_probs=203.6
Q ss_pred CCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
+|+..+.||+|+||.||+|.... ..+++|...... ...+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 36677899999999999998642 468888765432 2468899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCC-------------------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCe
Q 016789 157 VFEYLPNGSMCNHLYETGL-------------------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANV 217 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Ni 217 (382)
++||+.+|+|.+++..... .....+++...+.++.|++.||.|||+.+ ++||||||+||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~ni 158 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNV 158 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhheE
Confidence 9999999999999875321 11235789999999999999999999877 99999999999
Q ss_pred eecCCCcEEEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCCh
Q 016789 218 LVDENFIAKVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSY 295 (382)
Q Consensus 218 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~ 295 (382)
|+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.... .
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~ 235 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---P 235 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---H
Confidence 9999999999999999865332221 1122234556999999988889999999999999999999 998885432 2
Q ss_pred hHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 296 EALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 296 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
..+.+....... ...+...+..+.+++.+||+.||++||++.++++.|+++..+
T Consensus 236 ~~~~~~~~~~~~----------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 236 ERLFNLLKTGYR----------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHHHhCCCC----------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 333333322211 111223346788999999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=322.57 Aligned_cols=243 Identities=21% Similarity=0.324 Sum_probs=190.0
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
+|+..+.||+|+||.||++.+.. ..||+|.+.... ...+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 45566789999999999998863 789999875432 346889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++|+|.+.. ...+..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 155 ~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 155 DGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999985432 3456677889999999999999987 99999999999999999999999999986643221
Q ss_pred cCCCcccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 242 AGPSHGSIVNVFRDPEVEES-----GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
......++..|+|||.+.. ...+.++|||||||++|||++|+.||......+...+.........
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 293 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP--------- 293 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC---------
Confidence 1123356788999998743 2345689999999999999999999974333333332222111100
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
...+...+..+.+++.+||+.||++||++.|+++.
T Consensus 294 -~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 -PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122345678899999999999999999999874
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=321.98 Aligned_cols=254 Identities=20% Similarity=0.250 Sum_probs=198.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
++|+..+.||+|+||.||++.... ..+|+|...... ...+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 578888999999999999999874 678888765432 34688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++|+|.+++.... .+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 85 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 85 MDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 99999999987643 578899999999999999999974 239999999999999999999999999987653321
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC---C--Cc-----
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS---S--NN----- 310 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~--~~----- 310 (382)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ..+......... . ..
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA---KELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhcccccccccCCccccCcc
Confidence 2223467789999999998999999999999999999999999964322 111111110000 0 00
Q ss_pred -----------------------ccc----cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 311 -----------------------FVD----HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 311 -----------------------~~d----~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..+ ...........+..+.+++.+||+.||++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 000000011235678999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=323.96 Aligned_cols=240 Identities=20% Similarity=0.224 Sum_probs=194.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|...+.||+|+||.||+|.+.. ..+|+|..... ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 457888999999999999999864 68999986532 2346889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++...+ .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999997643 5788888899999999999999987 99999999999999999999999999986543
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.. ....+++.|+|||.+.+..++.++|||||||++|||++|+.||.... .....+.+... ..
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~----~~------- 232 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT---PFRIYEKILAG----RL------- 232 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC---HHHHHHHHhcC----Cc-------
Confidence 21 22356788999999999999999999999999999999999996432 11222111111 00
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPK-----MEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~~v~~ 351 (382)
..+......+.+++.+||+.||.+||+ +.++++
T Consensus 233 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111112356788999999999999997 566653
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=310.32 Aligned_cols=248 Identities=24% Similarity=0.376 Sum_probs=199.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
.+|+..+.||+|+||.||++.+.. ..+++|..... ....|.+|++++++++||||+++++++...+..++|+||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 357778899999999999998865 57899986543 345788999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
++|.+++.... ..+++.....++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++...+.....
T Consensus 84 ~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 84 GCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999987542 25889999999999999999999987 9999999999999999999999999988654322222
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
......+..|+|||.+.+..++.++||||||+++|||++ |+.||..... ............ ...+.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~----------~~~~~ 224 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESVSAGYR----------LYRPK 224 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHHHcCCc----------CCCCC
Confidence 222223456999999998899999999999999999999 7888864322 222222211110 01112
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L 353 (382)
..+..+.+++.+||+.+|++||++.++++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 2456788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=313.77 Aligned_cols=260 Identities=24% Similarity=0.381 Sum_probs=206.1
Q ss_pred hCCCCCCeeeccCcccEEEEEEC-------CeeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR-------DTVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
.+|...+.||+|+||+||++... ...+++|...... ...+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56788899999999999999752 2468888876543 3468899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCC--------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEe
Q 016789 157 VFEYLPNGSMCNHLYETGL--------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVA 228 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~ 228 (382)
|+||+++++|.+++...+. .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCcEEec
Confidence 9999999999999975432 12235899999999999999999999977 9999999999999999999999
Q ss_pred ecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhc
Q 016789 229 DTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 229 DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...........
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~~~i~~~~ 239 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECITQGR 239 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCC
Confidence 99999865432221 1122334567999999998899999999999999999999 8888864331 22222222111
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 016789 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEM 361 (382)
Q Consensus 307 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~ 361 (382)
. . .. +...+..+.+++.+||+.||.+||++.++.+.|+++.....
T Consensus 240 ~-~-----~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~ 284 (288)
T cd05093 240 V-L-----QR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284 (288)
T ss_pred c-C-----CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence 0 0 00 11233568999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=325.07 Aligned_cols=237 Identities=21% Similarity=0.210 Sum_probs=191.6
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNG 164 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 164 (382)
+.||+|+||.||++.... ..+|+|.+... ....+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 369999999999998754 68999986532 1245778999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCC
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP 244 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 244 (382)
+|.+++...+ .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 9999987643 5788999999999999999999988 9999999999999999999999999987532211 112
Q ss_pred CcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHH
Q 016789 245 SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEG 324 (382)
Q Consensus 245 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 324 (382)
....+++.|+|||.+.+..++.++|||||||++|||++|+.||.... ........... +. .++...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~~~~~-------~~----~~p~~~ 218 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILME-------EI----RFPRTL 218 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHHHHHcC-------CC----CCCCCC
Confidence 23356788999999999999999999999999999999999996432 22222222111 01 112233
Q ss_pred HHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 016789 325 MRDLIRLTLQCMSSPGRRRP-----KMEIVMT 351 (382)
Q Consensus 325 ~~~l~~l~~~cl~~dp~~RP-----s~~~v~~ 351 (382)
+..+.+++.+||+.||++|| ++.++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 46678899999999999999 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=298.00 Aligned_cols=261 Identities=19% Similarity=0.254 Sum_probs=206.5
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC---chHHHHHHHHHHhcCCCCCccceeeEEEeC-----CeeE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS---PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN-----GYQM 155 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 155 (382)
.++|++.+.||+|||+-||.+..- +..+|+|++.-. ..+..++|++..++++|||+++++++...+ ...|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 367899999999999999998753 478999986543 345688999999999999999999987543 3589
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
++++|...|+|.+.+..... .+..+++.+.+.|+.++++||.+||+..+++.||||||.|||+.+++.+++.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999987653 34579999999999999999999999999999999999999999999999999999875
Q ss_pred ccccc--------ccCCCcccccccccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh
Q 016789 236 LENIE--------EAGPSHGSIVNVFRDPEVEES---GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS 304 (382)
Q Consensus 236 ~~~~~--------~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 304 (382)
..-.- .........+..|+|||.+.- ...++++|||||||+||+|+.|..||+..-. .+.++
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSl------ 251 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSL------ 251 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeE------
Confidence 42110 011122345667999999854 4478999999999999999999999974321 11110
Q ss_pred hcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 305 RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 305 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
.-.+....+..+.....++.+.+++++|++.||.+||+..+++..++.+.
T Consensus 252 ---aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 ---ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 01122223333333447789999999999999999999999999998763
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=313.95 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=202.4
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 155 (382)
.+|...+.||+|+||.||+|...+ ..+++|...... .+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999997632 579999876432 357899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCC---------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEE
Q 016789 156 LVFEYLPNGSMCNHLYETGL---------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAK 226 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~k 226 (382)
+||||+++|+|.+++...+. .....+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCCeEE
Confidence 99999999999999976531 22345789999999999999999999987 99999999999999999999
Q ss_pred EeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHh
Q 016789 227 VADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRS 304 (382)
Q Consensus 227 l~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 304 (382)
|+|||+++........ .......+..|+|||++.+..++.++||||||+++|||++ |..||.... ..........
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~---~~~~~~~~~~ 239 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS---NEEVIECITQ 239 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHc
Confidence 9999999765332221 1122234567999999999999999999999999999999 999986432 2223332221
Q ss_pred hcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 305 RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 305 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
.. . ...+...+..+.+++.+||+.||.+||++.||++.|+
T Consensus 240 ~~-~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 240 GR-L---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CC-c---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11 0 0111233467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=314.85 Aligned_cols=261 Identities=24% Similarity=0.375 Sum_probs=199.7
Q ss_pred CCCCCCeeeccCcccEEEEEEC------CeeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR------DTVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQM 155 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 155 (382)
.|...+.||+|+||+||++.+. +..+|+|..... ....|.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 3477889999999999887642 357999987643 235688999999999999999999988654 4678
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
++|||+++|+|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 85 lv~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeecccccc
Confidence 999999999999998653 4899999999999999999999987 99999999999999999999999999986
Q ss_pred cccccccC--CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhh---cCCCc
Q 016789 236 LENIEEAG--PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSR---LSSNN 310 (382)
Q Consensus 236 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 310 (382)
........ ......+..|+|||.+.+..++.++||||||+++|||++|+.|+...... ........... ....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhh
Confidence 64322211 12223455699999998888999999999999999999999997643211 11111100000 00011
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 311 FVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 311 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
..+.......+...+..+.+++.+||+.||++||++.++++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111112223344578999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=310.27 Aligned_cols=249 Identities=25% Similarity=0.403 Sum_probs=199.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCCc--hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP--RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
++|...+.||+|+||.||++.+.+ ..+|+|...... .++|.+|+.++++++||||+++++++......+++|||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 457778899999999999998876 469999876432 45789999999999999999999999998899999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 84 GCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999987542 25899999999999999999999987 9999999999999999999999999988654332222
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
.....++..|++||...+..++.++||||||+++|||++ |..||..... ............. ..+.
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~----------~~~~ 224 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKVSQGLRL----------YRPH 224 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHhcCCCC----------CCCC
Confidence 222234456999999998889999999999999999999 9989864321 2222222111100 0111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
..+..+.+++.+||+.||.+||++.++++.|+
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 23467889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=314.66 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=201.0
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGY 153 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 153 (382)
.+++|+..+.||+|+||.||+|.+.+ ..+|+|...... ..++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45678999999999999999998642 469999865432 3468899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCC-----CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEe
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLE-----SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVA 228 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~ 228 (382)
.++||||+++|+|.+++...... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCEEEC
Confidence 99999999999999998764321 1234678889999999999999999977 9999999999999999999999
Q ss_pred ecCCccccccccccCC-CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhc
Q 016789 229 DTGISKLLENIEEAGP-SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 229 DfGla~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
|||+++.......... ....++..|+|||.+.+..++.++||||||+++|||++ |..||.... ............
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~---~~~~~~~~~~~~ 238 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS---NEQVLRFVMEGG 238 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHcCC
Confidence 9999876543322111 12233567999999998889999999999999999999 678876432 222222222111
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 307 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
.. ..+...+..+.+++.+||+.||++||++.++++.|+
T Consensus 239 ----~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 239 ----LL------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ----cC------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00 112233467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=326.54 Aligned_cols=254 Identities=17% Similarity=0.173 Sum_probs=194.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNG 164 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 164 (382)
..|+..+.||+|+||.||++.... ..||+|... ...+.+|++++++++||||+++++++......++|+|++. +
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~ 167 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-T 167 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-C
Confidence 569999999999999999998865 689999643 3457889999999999999999999999999999999994 7
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCC
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP 244 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 244 (382)
+|..++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..........
T Consensus 168 ~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 168 DLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240 (391)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence 8888886532 5788999999999999999999987 99999999999999999999999999975433222222
Q ss_pred CcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCC-----hhHHHHHHHhhcCCC-c--------
Q 016789 245 SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS-----YEALIQWVRSRLSSN-N-------- 310 (382)
Q Consensus 245 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~-~-------- 310 (382)
....+|+.|+|||++.+..++.++|||||||++|||++|+.|+....... ...+........... .
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 33457888999999999999999999999999999999998875322110 011111111100000 0
Q ss_pred ------------ccccccCC--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 311 ------------FVDHRLAG--TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 311 ------------~~d~~~~~--~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+.... ....+.+..+.+++.+||+.||.+|||+.|+++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 001133567889999999999999999999985
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=307.86 Aligned_cols=251 Identities=28% Similarity=0.423 Sum_probs=201.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
.+|+..+.||+|+||.||+|.+.+ ..+++|..... ....|.+|++++++++||||+++++++.. ...++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCC
Confidence 468888999999999999998866 57999987643 24578999999999999999999998754 457999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||.++.+.......
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 85 GSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CcHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 99999997532 235789999999999999999999977 9999999999999999999999999998665433222
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
.....++..|+|||...+..++.++||||||+++|||++ |..||.... ............ ....+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~---~~~~~~~~~~~~----------~~~~~~ 226 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQVERGY----------RMPCPP 226 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---hHHHHHHHhcCC----------CCCCcc
Confidence 223334567999999988889999999999999999999 777875432 112221111110 011233
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
+.+..+.+++.+||+.||++||++.++++.|+..
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 4567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=302.23 Aligned_cols=256 Identities=20% Similarity=0.239 Sum_probs=201.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCchH-----HHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQ-----EFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~-----~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 157 (382)
++|+..+.|++|+||.||+|+++. ..||+|+++.+... .-++|+.+|.+.+|||||.+-.+..-. +.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 457778899999999999999875 69999998754432 358999999999999999999887643 579999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
||||+. +|...+...+ +.+.......+..|+.+|++|||.+. |+|||||++|+|+++.|.+||+|||+|+.+.
T Consensus 156 Me~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhc
Confidence 999965 8888887654 47888999999999999999999988 9999999999999999999999999999876
Q ss_pred cccccCCCcccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGV-FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
+.. ...+....|.+|+|||.+.+.+ |+++.|+||+||++.||+++++.|.... +.+++-..+.....+.+-+-+.+
T Consensus 229 sp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s--E~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 229 SPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS--EIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred CCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc--hHHHHHHHHHHhCCCccccCCCc
Confidence 542 2334556788999999987755 9999999999999999999999887433 34444444443332222111111
Q ss_pred C-------------------CCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 317 A-------------------GTFTTE-GMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 317 ~-------------------~~~~~~-~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
. ..+... ..+.-++++...+..||.+|.|+.|.++-
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0 001111 23566788889999999999999998763
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=313.08 Aligned_cols=258 Identities=24% Similarity=0.387 Sum_probs=205.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCch---HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSPR---QEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
.+|...+.||+|+||.||++.... ..+++|....... +.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 357778899999999999997532 4688888765432 468899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcE
Q 016789 157 VFEYLPNGSMCNHLYETGL-----------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIA 225 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~ 225 (382)
||||+++++|.+++..... .....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCcE
Confidence 9999999999999976431 12235899999999999999999999987 9999999999999999999
Q ss_pred EEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHH
Q 016789 226 KVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVR 303 (382)
Q Consensus 226 kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~ 303 (382)
+|+|||++......... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||..... ....+...
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~~ 239 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEVIECIT 239 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHh
Confidence 99999999765432211 1122334567999999999999999999999999999999 9999864332 22222222
Q ss_pred hhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 304 SRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 304 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
..... ..+...+..+.+++.+||+.||++||++.+|++.|+++...
T Consensus 240 ~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 240 QGRVL----------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCCCC----------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11100 11122356788999999999999999999999999999653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=316.15 Aligned_cols=260 Identities=26% Similarity=0.446 Sum_probs=203.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC----eeEEEEEccCC----chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD----TVVAIKRRVGS----PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~----~~vavK~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 157 (382)
++|+..+.||+|+||.||+|.+.. ..+++|..... ....+.+|++++.++ +||||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 467888999999999999998754 34677765532 224688899999999 899999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEE
Q 016789 158 FEYLPNGSMCNHLYETGLE-----------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAK 226 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~k 226 (382)
+||+++|+|.+++...+.. ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCCCcEE
Confidence 9999999999999765321 1235789999999999999999999987 99999999999999999999
Q ss_pred EeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhh
Q 016789 227 VADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSR 305 (382)
Q Consensus 227 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 305 (382)
|+|||++....... .......+..|+|||.+.+..++.++|||||||++|||+| |..||..... ....+.....
T Consensus 165 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~ 239 (303)
T cd05088 165 IADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQG 239 (303)
T ss_pred eCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHHHHHHhcC
Confidence 99999986432111 1112233456999999988889999999999999999998 9999864322 2222222111
Q ss_pred cCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhh
Q 016789 306 LSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMAL 363 (382)
Q Consensus 306 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~~ 363 (382)
... ..+...+..+.+++.+||+.+|.+||++.++++.|+++.++..+.
T Consensus 240 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 240 YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred CcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 100 111223456789999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=315.51 Aligned_cols=258 Identities=27% Similarity=0.448 Sum_probs=205.3
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCccceeeEEEeCC
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVTLLGYCQQNG 152 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 152 (382)
..++|+..+.||+|+||.||++...+ ..+++|...... ..++.+|++++.++ +||||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34568888999999999999998643 578999876432 23588899999999 7999999999999999
Q ss_pred eeEEEEeecCCCChhhhhhhcCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGL-----------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE 221 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~ 221 (382)
..+++|||+++|+|.+++..... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~~ 167 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTE 167 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEcC
Confidence 99999999999999999975321 23446899999999999999999999877 999999999999999
Q ss_pred CCcEEEeecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHH
Q 016789 222 NFIAKVADTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALI 299 (382)
Q Consensus 222 ~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~ 299 (382)
++.+||+|||+++.+....... ......+..|+|||.+.+..++.++|||||||++|||++ |..|+.... .....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~ 244 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---VEELF 244 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC---HHHHH
Confidence 9999999999998765433221 122234456999999998899999999999999999998 888876432 22222
Q ss_pred HHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 300 QWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 300 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
+....... ...+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 245 ~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 KLLKEGYR----------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHcCCc----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 22221110 1122234567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=324.23 Aligned_cols=247 Identities=20% Similarity=0.280 Sum_probs=210.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC-----CchHHHHHHHHHHhcCCCCCccceeeEEEeCCe-eEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG-----SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGY-QMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 158 (382)
++|...+.+|+|+||.++..+++. ..+++|.+.. ..+....+|+.++++++|||||.+.+.+..++. +++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 467788999999999999987765 6888887543 234467899999999999999999999998887 99999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
+||+||++.+.+.+.+ +..+++..+..++.|++.|+.|||+.+ |+|||||+.|||++.+..|||+|||+|+.+.+
T Consensus 84 ~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998764 456899999999999999999999877 99999999999999999999999999999877
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
... ......||+.||+||.+.+.+|+.|+|+|||||++|||++-+++|...+ ...++..+... ...
T Consensus 159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~---m~~Li~ki~~~----------~~~ 224 (426)
T KOG0589|consen 159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN---MSELILKINRG----------LYS 224 (426)
T ss_pred chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc---hHHHHHHHhhc----------cCC
Confidence 552 3445678999999999999999999999999999999999999997543 33444333221 122
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
+.+...+..+..++..|++.+|..||++.+++..
T Consensus 225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 4456677889999999999999999999999987
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=324.48 Aligned_cols=241 Identities=21% Similarity=0.250 Sum_probs=195.4
Q ss_pred hCCCCCCeeeccCcccEEEEEECC---eeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD---TVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~---~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
++|...+.||+|+||.||+|.+.. ..+|+|.+.. .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 458888999999999999998654 4799997642 2234678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++.... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 110 ~Ey~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999997643 5888899999999999999999987 9999999999999999999999999998654
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.. .....+++.|+|||++.+..++.++|||||||++|||++|+.||.... .....+.+.... .
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~~i~~~~----~------ 245 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE---PLLIYQKILEGI----I------ 245 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC---HHHHHHHHhcCC----C------
Confidence 32 223456788999999998889999999999999999999999997432 112222111110 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRP-----KMEIVMTE 352 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~~v~~~ 352 (382)
.++...+..+.+++.+||+.||++|+ +++++++.
T Consensus 246 -~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11122234567899999999999995 78887664
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=314.07 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=193.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
++|...+.||+|+||.||+|.... ..+|+|..... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 458888999999999999998764 68999976532 234678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++ |+|.+++...+ ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 97 58988886542 25788899999999999999999987 9999999999999999999999999997543322
Q ss_pred ccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC-----------
Q 016789 241 EAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS----------- 308 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 308 (382)
. ......+++.|+|||.+.+ ..++.++||||+||++|||++|++||......+ .+..........
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE--ELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhccccc
Confidence 1 1223345778999998865 568999999999999999999999996533211 111111100000
Q ss_pred Cc---ccccccCCC----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 309 NN---FVDHRLAGT----FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 309 ~~---~~d~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.. ...+..... ..........+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 000110000 00112356789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=321.34 Aligned_cols=246 Identities=20% Similarity=0.243 Sum_probs=193.3
Q ss_pred CCCCCCeeeccCcccEEEEEEC-----CeeEEEEEccCC-------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR-----DTVVAIKRRVGS-------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 154 (382)
+|+..+.||+|+||.||++... +..+|+|..... ....+..|+.++..+ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4777889999999999998763 368999986431 123577899999999 599999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++||||+++|+|.+++.... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999987643 5788999999999999999999987 9999999999999999999999999998
Q ss_pred ccccccccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChh-HHHHHHHhhcCCCccc
Q 016789 235 LLENIEEAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYE-ALIQWVRSRLSSNNFV 312 (382)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 312 (382)
..............++..|+|||.+.+. .++.++|||||||++|||++|+.||......... ........ .
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---~---- 226 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK---C---- 226 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc---C----
Confidence 6543333233334578889999998765 4789999999999999999999999643322221 11111111 0
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRP-----KMEIVMT 351 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~~v~~ 351 (382)
++. .+...+..+.+++.+||+.||++|| ++.++++
T Consensus 227 ~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 DPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111 1223345678899999999999999 6667664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=308.49 Aligned_cols=250 Identities=26% Similarity=0.442 Sum_probs=200.4
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
++|+..+.||+|+||.||++...+ ..+++|..... ..++|.+|+.++++++|||++++++++.. ...+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCC
Confidence 467888999999999999998765 57888887643 34679999999999999999999998854 567999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
++|.+++.... ...+++..+..++.+++.||.|||+.+ ++||||||+||++++++.++|+|||++..+.......
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 85 GSLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 99999987532 235889999999999999999999977 9999999999999999999999999998654432222
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
.....++..|+|||.+.+..++.++|+||||+++|||++ |..||.... ............ ....+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~----------~~~~~~ 226 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN---NREVLEQVERGY----------RMPCPQ 226 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCC----------CCCCCC
Confidence 222233456999999988889999999999999999999 888886432 222222222111 111223
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTELER 355 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~ 355 (382)
+.+..+.+++.+||+.||.+|||+.++.+.|++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 445678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=320.18 Aligned_cols=237 Identities=22% Similarity=0.245 Sum_probs=188.7
Q ss_pred eeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCCh
Q 016789 95 IGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 95 lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 166 (382)
||+|+||.||++.... ..+|+|.+... ....+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999864 68999976532 234578899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCc
Q 016789 167 CNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH 246 (382)
Q Consensus 167 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 246 (382)
.+++...+ .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQREG-----RFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 99987543 5888999999999999999999987 9999999999999999999999999997543221 11223
Q ss_pred ccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHH
Q 016789 247 GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMR 326 (382)
Q Consensus 247 ~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 326 (382)
..+++.|+|||.+.+..++.++|||||||++|||++|+.||.... .....+..... . . ..+...+.
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~---~~~~~~~~~~~----~---~----~~~~~~~~ 218 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN---VNEMYRKILQE----P---L----RFPDGFDR 218 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC---HHHHHHHHHcC----C---C----CCCCcCCH
Confidence 456788999999999999999999999999999999999996432 12222211110 0 0 11223345
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHH
Q 016789 327 DLIRLTLQCMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 327 ~l~~l~~~cl~~dp~~RPs~~~v~~~L 353 (382)
.+.+++.+||+.||.+||+...+.+.|
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 678899999999999998754444433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.46 Aligned_cols=260 Identities=23% Similarity=0.365 Sum_probs=201.6
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCccceeeEEEeC-C
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVTLLGYCQQN-G 152 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 152 (382)
.++|++.+.||+|+||.||+|...+ +.||+|++.... .+.+.+|+.++.++ +||||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 3568889999999999999997532 579999876432 23577899999999 899999999988654 5
Q ss_pred eeEEEEeecCCCChhhhhhhcCCC--------------------------------------------------------
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGLE-------------------------------------------------------- 176 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 176 (382)
..++++||+++|+|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999988643210
Q ss_pred CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc-CCCcccccccccC
Q 016789 177 SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA-GPSHGSIVNVFRD 255 (382)
Q Consensus 177 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~a 255 (382)
....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++..+...... ......++..|+|
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 0126789999999999999999999877 999999999999999999999999999876432211 1222334566999
Q ss_pred ccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhh
Q 016789 256 PEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQ 334 (382)
Q Consensus 256 PE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~ 334 (382)
||++.+..++.++|||||||++|||++ |..||..... .+.+.......... ..+...+..+.+++.+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI--DEEFCRRLKEGTRM----------RAPEYATPEIYSIMLD 311 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc--cHHHHHHHhccCCC----------CCCccCCHHHHHHHHH
Confidence 999999999999999999999999998 9999864321 12222222211110 1112234678899999
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 335 CMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 335 cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
||+.+|++||++.++++.|+++.++
T Consensus 312 cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=312.65 Aligned_cols=256 Identities=26% Similarity=0.426 Sum_probs=201.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC----eeEEEEEccCC----chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD----TVVAIKRRVGS----PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~----~~vavK~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 157 (382)
++|+..+.||+|+||.||+|.... ..+++|..... ..+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888999999999999998754 24677776532 124688899999999 799999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEE
Q 016789 158 FEYLPNGSMCNHLYETGLE-----------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAK 226 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~k 226 (382)
+||+++|+|.+++...... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+|
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCeEE
Confidence 9999999999999764311 1135889999999999999999999977 99999999999999999999
Q ss_pred EeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhh
Q 016789 227 VADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSR 305 (382)
Q Consensus 227 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 305 (382)
|+|||++....... .......+..|+|||.+....++.++|||||||++|||++ |..||.... .....+.....
T Consensus 160 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~---~~~~~~~~~~~ 234 (297)
T cd05089 160 IADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT---CAELYEKLPQG 234 (297)
T ss_pred ECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHhcC
Confidence 99999986432211 1112223456999999998889999999999999999998 999986432 22222222111
Q ss_pred cCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 306 LSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 306 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
. ....+...+..+.+++.+||+.||.+||++.++++.|+++...
T Consensus 235 ~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 235 Y----------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred C----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 1111223446788999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=311.37 Aligned_cols=254 Identities=28% Similarity=0.404 Sum_probs=199.7
Q ss_pred hCCCCCCeeeccCcccEEEEEEC------CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR------DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
++|+..+.||+|+||.||+|.+. ...+++|...... ...+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 35777889999999999999852 2578999876432 2468889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCC------------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc
Q 016789 157 VFEYLPNGSMCNHLYETGL------------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI 224 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~ 224 (382)
+|||+++|+|.+++..... .....+++.....++.|++.||.|||+.+ ++||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcCCCc
Confidence 9999999999999864321 11235788899999999999999999977 999999999999999999
Q ss_pred EEEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHH
Q 016789 225 AKVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWV 302 (382)
Q Consensus 225 ~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~ 302 (382)
+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.... .....+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~---~~~~~~~~ 239 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---NQEVIEMV 239 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH
Confidence 999999999865432211 1122233556999999988889999999999999999999 888886432 22223322
Q ss_pred HhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 016789 303 RSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELER 355 (382)
Q Consensus 303 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~ 355 (382)
...... ..+...+..+.+++.+||+.||.+||++.++.+.|..
T Consensus 240 ~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 RKRQLL----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 221110 1122334678889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=317.58 Aligned_cols=256 Identities=20% Similarity=0.264 Sum_probs=195.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
++|+..+.||+|+||.||++.+.. ..+++|..... ....+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 578889999999999999999864 67888875543 224688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL-KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
+++|+|.+++...+ .+++.....++.+++.||.|||+. + ++||||||+|||++.++.+||+|||++..+...
T Consensus 85 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 85 MDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999997643 578888899999999999999973 5 999999999999999999999999998755322
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCc---------
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNN--------- 310 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 310 (382)
. .....++..|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus 158 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred c---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 1 1223456789999999988899999999999999999999999864332111110000000000000
Q ss_pred -------------------ccccccCC---CC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 311 -------------------FVDHRLAG---TF-TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 311 -------------------~~d~~~~~---~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
+.+..... .. .......+.+++.+||+.||++||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00000000 00 00123568899999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=309.22 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=197.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--e----eEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--T----VVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~----~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
.+|+..+.||+|+||.||+|.+.. . .+++|...... ..++..|+..++++.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 357778899999999999998743 2 47778765332 2456778888999999999999998864 45789
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
++||+++|+|.+++.... ..+++.....++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+
T Consensus 86 i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999997542 35889999999999999999999877 999999999999999999999999999865
Q ss_pred cccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 237 ENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 237 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
...... ......++..|+|||.+.++.++.++||||||+++|||++ |+.|+..... ....+....... ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~~---~~~~ 233 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HEVPDLLEKGER---LAQP 233 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCCc---CCCC
Confidence 432221 1122334567999999998899999999999999999998 9999864322 222232222111 1111
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~ 358 (382)
..++..+.+++.+||..||++||++.++++.|..+..
T Consensus 234 -------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 234 -------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1123467788999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=329.33 Aligned_cols=238 Identities=21% Similarity=0.271 Sum_probs=196.2
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 156 (382)
-++|...++||+|.||+|+++..++ ..+|||.+++. +.+....|.+++.-. +||.+++++.+|++.+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 3578999999999999999999876 68999987653 335577788888777 59999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
||||+.||++..+.+. ..+++....-+|+.|+.||.|||+++ ||+||||.+|||||.+|++||+|||+++..
T Consensus 447 vmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEeccccccccc
Confidence 9999999995554432 36899999999999999999999988 999999999999999999999999999853
Q ss_pred ccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 237 ENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 237 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
-. .....++-.||+.|||||++....|+.++|+|||||+||||+.|+.||...+ .+++.+.+... |+
T Consensus 519 m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd---Eee~FdsI~~d-------~~-- 585 (694)
T KOG0694|consen 519 MG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD---EEEVFDSIVND-------EV-- 585 (694)
T ss_pred CC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcC-------CC--
Confidence 22 2224556678999999999999999999999999999999999999997543 23333322211 11
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKM 346 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 346 (382)
.||.-.+.+..+++.+++.+||++|..+
T Consensus 586 --~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 --RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2344456677888899999999999998
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=307.31 Aligned_cols=257 Identities=21% Similarity=0.267 Sum_probs=204.4
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|+||.||+|... +..+++|..... ....+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999875 478999965421 1246889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++.... .....++......++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFK-KQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998886432 12235788899999999999999999987 99999999999999999999999999886543
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.... .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+..... ......+....... + .
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~------~---~ 227 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQKIEQCDY------P---P 227 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHHHhcCCC------C---C
Confidence 2211 1223456679999999888899999999999999999999999864322 12222222221110 0 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
......+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 112344577899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=325.49 Aligned_cols=241 Identities=21% Similarity=0.273 Sum_probs=202.1
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
|..++.||+|+.|.|-+|++.. +.+|||.+.... ...+.+|+-+|+-+.|||++++|+++.+..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 5667889999999999999865 789999876541 23578999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++|.|.+++...+ .+++....+.+.||..|+.|+|..+ |+||||||+|+|||.++.+||+|||+|.+-.++.
T Consensus 94 v~gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 94 VPGGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred cCCchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 99999999998876 6888999999999999999999988 9999999999999999999999999998654443
Q ss_pred ccCCCcccccccccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFS-EMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
... +..|.+-|.|||++.+.+|. .++||||+||+||.|+||+.||++ ++...+...+..+. -.
T Consensus 167 lLe--TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV~~G~-----------f~ 230 (786)
T KOG0588|consen 167 LLE--TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKVQRGV-----------FE 230 (786)
T ss_pred ccc--ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHHHcCc-----------cc
Confidence 333 34567889999999999875 689999999999999999999983 23344444333321 02
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.+...+.+..+|+.+|+..||++|.|++||++-
T Consensus 231 MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 231 MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 233444567788889999999999999999875
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=313.82 Aligned_cols=252 Identities=22% Similarity=0.218 Sum_probs=197.6
Q ss_pred HHHHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----------------chHHHHHHHHHHhcCCCCCccc
Q 016789 83 EQATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----------------PRQEFVAEVTYLSEIRHRNLVT 143 (382)
Q Consensus 83 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----------------~~~~~~~e~~~l~~l~h~niv~ 143 (382)
....++|++...||+|.||.|-+|.... +.+|+|++.+. ..+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3445789999999999999999998764 79999986532 1246889999999999999999
Q ss_pred eeeEEEeC--CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC
Q 016789 144 LLGYCQQN--GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE 221 (382)
Q Consensus 144 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~ 221 (382)
|+.+..+. +.+|||+|||..|.+...=. ....+.+.+...++.++..||+|||.++ ||||||||+|+||++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcC
Confidence 99998754 68999999999998754321 2223899999999999999999999988 999999999999999
Q ss_pred CCcEEEeecCCcccccccccc----CCCcccccccccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCccCCC
Q 016789 222 NFIAKVADTGISKLLENIEEA----GPSHGSIVNVFRDPEVEESGV----FSEMSDIYSFGVFLLELVTGQEASHIVSLG 293 (382)
Q Consensus 222 ~~~~kl~DfGla~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~----~~~~sDvws~G~vl~el~tg~~p~~~~~~~ 293 (382)
+|++||+|||.+......... ......|||.|+|||.+..+. .+.+.||||+||+||.|+.|+.||....
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-- 323 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-- 323 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--
Confidence 999999999999866322111 123367899999999987733 4567899999999999999999997432
Q ss_pred ChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 016789 294 SYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L 353 (382)
...+.+. +++..+.-+..++..+.+.+|++++|.+||++|.+..+|....
T Consensus 324 -~~~l~~K---------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 324 -ELELFDK---------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -HHHHHHH---------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 1111111 1122222222345677899999999999999999999987543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=320.48 Aligned_cols=237 Identities=22% Similarity=0.206 Sum_probs=190.0
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNG 164 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 164 (382)
+.||+|+||.||++.... ..+|+|.+... ....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 369999999999998754 68999986532 2245778999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCC
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP 244 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 244 (382)
+|..++.... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 9998886543 5889999999999999999999987 9999999999999999999999999987532211 112
Q ss_pred CcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHH
Q 016789 245 SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEG 324 (382)
Q Consensus 245 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 324 (382)
....+++.|+|||.+.+..++.++|||||||++|||++|+.||.... ........... . . ..+...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~~~~~----~---~----~~p~~~ 218 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILME----E---I----RFPRTL 218 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHhcC----C---C----CCCCCC
Confidence 23356788999999999999999999999999999999999996432 12222211110 0 0 112233
Q ss_pred HHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 016789 325 MRDLIRLTLQCMSSPGRRRP-----KMEIVMT 351 (382)
Q Consensus 325 ~~~l~~l~~~cl~~dp~~RP-----s~~~v~~ 351 (382)
+..+.+++.+||+.||.+|| ++.++++
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 45678899999999999998 7887765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=307.29 Aligned_cols=253 Identities=23% Similarity=0.379 Sum_probs=199.7
Q ss_pred CCCCCeeeccCcccEEEEEECC-----eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCe-----
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGY----- 153 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 153 (382)
|...+.||+|+||.||+|.... ..+|+|.+.... ...+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998743 569999866431 2468899999999999999999999876554
Q ss_pred -eEEEEeecCCCChhhhhhhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 154 -QMLVFEYLPNGSMCNHLYETGL-ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 154 -~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
.++++||+++|+|..++..... .....+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCcc
Confidence 7899999999999999865432 22346899999999999999999999977 9999999999999999999999999
Q ss_pred CccccccccccCC-CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCC
Q 016789 232 ISKLLENIEEAGP-SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSN 309 (382)
Q Consensus 232 la~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 309 (382)
+++.......... .....+..|+|||.+.+..++.++||||||+++|||++ |..||.... .....++......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~---~~~~~~~~~~~~~-- 233 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE---NHEIYDYLRHGNR-- 233 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC--
Confidence 9986643322211 11223456999999988889999999999999999999 888875432 2233333322111
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 310 NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 310 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
...+...+..+.+++.+||+.||.+||++.++++.|+++
T Consensus 234 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 --------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011233456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=305.32 Aligned_cols=241 Identities=25% Similarity=0.377 Sum_probs=192.7
Q ss_pred eeeccCcccEEEEEEC----CeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCC
Q 016789 94 LIGFGSFGPVYKGLLR----DTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNG 164 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~----~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 164 (382)
.||+|+||.||+|.+. +..+|+|...... .+++.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999763 3689999865432 3468899999999999999999998864 4678999999999
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc--
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA-- 242 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~-- 242 (382)
+|.+++.... .+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++..+......
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999986532 5888999999999999999999987 999999999999999999999999999866433221
Q ss_pred CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 243 GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
......++..|+|||.+....++.++|+||||+++|||++ |+.||.... .....+....... ...+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~i~~~~~----------~~~~ 220 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK---GNEVTQMIESGER----------MECP 220 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHCCCC----------CCCC
Confidence 1122233467999999988889999999999999999998 999986432 2233333332111 1112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELER 355 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~ 355 (382)
...+..+.+++.+||+.||++||++.+|.+.|++
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 2344678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=291.47 Aligned_cols=243 Identities=22% Similarity=0.301 Sum_probs=201.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|-||.||.|+.+. -.||+|.+..+ ...++.+|+++-+.|+||||+++|+++.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 468889999999999999999877 48899986543 3457889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||.++|++...|.... ...+++.....+..|+|.||.|+|..+ |+||||||+|+|++..+.+||+|||-+....
T Consensus 102 Eya~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EecCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999998543 335777778889999999999999877 9999999999999999999999999987543
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
......-.+|..|.+||+..+..++...|+|++|++.||++.|.+||.... ..+..+.+.+ -++.
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k----~~~~------ 240 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRK----VDLK------ 240 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHH----cccc------
Confidence 223345567888999999999999999999999999999999999997544 2222222222 1111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
++...+....+++.+|+..+|.+|.+..|+++
T Consensus 241 -~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 241 -FPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -CCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 12333456778899999999999999999875
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=323.98 Aligned_cols=259 Identities=21% Similarity=0.358 Sum_probs=202.5
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcCC-CCCccceeeEEEeCC
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEIR-HRNLVTLLGYCQQNG 152 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 152 (382)
..++|...+.||+|+||.||+|++.+ ..||+|++.... .+.+.+|+.+|.++. ||||++++++|...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 34567778899999999999998643 479999876432 236889999999997 999999999999999
Q ss_pred eeEEEEeecCCCChhhhhhhcCC---------------------------------------------------------
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGL--------------------------------------------------------- 175 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 175 (382)
..++|+||+++|+|.++++..+.
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999975421
Q ss_pred ------------------------------------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee
Q 016789 176 ------------------------------------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV 219 (382)
Q Consensus 176 ------------------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill 219 (382)
.....+++...+.++.|++.||.|||+.+ ++||||||+|||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl 272 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLI 272 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEE
Confidence 01124677888999999999999999877 9999999999999
Q ss_pred cCCCcEEEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhH
Q 016789 220 DENFIAKVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEA 297 (382)
Q Consensus 220 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~ 297 (382)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ...
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~--~~~ 350 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM--NEQ 350 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc--hHH
Confidence 99999999999999865332211 1112234567999999998889999999999999999998 8888864321 112
Q ss_pred HHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 298 LIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 298 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
........... ..+...+..+.+++.+||+.+|.+||++.++++.|+++.
T Consensus 351 ~~~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 FYNAIKRGYRM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 22222211110 112223467889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=304.19 Aligned_cols=243 Identities=28% Similarity=0.417 Sum_probs=193.0
Q ss_pred CeeeccCcccEEEEEEC--CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCCh
Q 016789 93 SLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 166 (382)
+.||+|+||.||+|... ++.+++|...... ...+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999875 4789999765332 34688999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCC-C
Q 016789 167 CNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP-S 245 (382)
Q Consensus 167 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~ 245 (382)
.+++.... ..+++...+.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99986532 35789999999999999999999877 99999999999999999999999999876543211111 1
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHH
Q 016789 246 HGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEG 324 (382)
Q Consensus 246 ~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 324 (382)
....+..|+|||.+.++.++.++||||||+++|||++ |..|+..... .......... .....+...
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~~~~~~~~~----------~~~~~~~~~ 221 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQTREAIEQG----------VRLPCPELC 221 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HHHHHHHHcC----------CCCCCcccC
Confidence 1122345999999999899999999999999999998 8888764321 1111111111 111122334
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 325 MRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 325 ~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
+..+.+++.+||+.||++||++.++.++|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=310.91 Aligned_cols=260 Identities=25% Similarity=0.379 Sum_probs=201.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC------------------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccce
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD------------------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTL 144 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~------------------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l 144 (382)
.+|+..+.||+|+||.||++.+.. ..+++|...... ..++.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 568888999999999999997653 358899876542 3468899999999999999999
Q ss_pred eeEEEeCCeeEEEEeecCCCChhhhhhhcCCC------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCee
Q 016789 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLE------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVL 218 (382)
Q Consensus 145 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nil 218 (382)
++++..++..++++||+++++|.+++...... ....+++..++.++.|++.||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Nil 162 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCL 162 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhcee
Confidence 99999999999999999999999999765422 2236899999999999999999999987 999999999999
Q ss_pred ecCCCcEEEeecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCccCCCCh
Q 016789 219 VDENFIAKVADTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT--GQEASHIVSLGSY 295 (382)
Q Consensus 219 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t--g~~p~~~~~~~~~ 295 (382)
++.++.++|+|||+++.+....... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.... .
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~---~ 239 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT---D 239 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC---h
Confidence 9999999999999987654332211 122334567999999988889999999999999999998 566765322 1
Q ss_pred hHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 296 EALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 296 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
.............. +.......+...+..+.+++.+||+.||.+||++.++++.|+
T Consensus 240 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQVIENAGHFFRDD---GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHHhccccc---cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 22222222110000 000001112233467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=312.08 Aligned_cols=254 Identities=22% Similarity=0.270 Sum_probs=189.8
Q ss_pred CCCCCCeeeccCcccEEEEEEC---CeeEEEEEccCC-----chHHHHHHHHHHhcC---CCCCccceeeEEEe-----C
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR---DTVVAIKRRVGS-----PRQEFVAEVTYLSEI---RHRNLVTLLGYCQQ-----N 151 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~-----~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~ 151 (382)
+|+..+.||+|+||.||+|... +..+|+|.+... ....+.+|+.+++.+ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6888899999999999999873 367899976532 123566777777665 69999999999852 3
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
...++|+||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 46899999996 68998886542 235889999999999999999999987 9999999999999999999999999
Q ss_pred CccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC-C-
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS-N- 309 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~- 309 (382)
+++..... .......+++.|+|||.+.+..++.++|||||||++|||++|++||..... ...+.......... .
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~--~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLPGEE 231 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChh
Confidence 99765432 122234567789999999888999999999999999999999999975332 11111111110000 0
Q ss_pred ----------cccccccCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 ----------NFVDHRLAG---TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 ----------~~~d~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
....+.... ...++.+..+.+++.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000000 001123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=314.39 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=205.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC---------eeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCccceeeEEEeCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD---------TVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVTLLGYCQQNG 152 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 152 (382)
++|...+.||+|+||.||++...+ ..+|+|...... ..++..|++++..+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 468889999999999999997632 368999876432 24678899999999 7999999999999999
Q ss_pred eeEEEEeecCCCChhhhhhhcCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGLE-----------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE 221 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~ 221 (382)
..++||||+++|+|.+++...... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~~ 175 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTE 175 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheEEcC
Confidence 999999999999999999764321 2235899999999999999999999877 999999999999999
Q ss_pred CCcEEEeecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHH
Q 016789 222 NFIAKVADTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALI 299 (382)
Q Consensus 222 ~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~ 299 (382)
++.+||+|||+++......... ......+..|+|||.+.+..++.++|||||||++|||++ |..|+... ....+.
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~---~~~~~~ 252 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---PVEELF 252 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC---CHHHHH
Confidence 9999999999997654322211 122233457999999998889999999999999999998 78887532 222333
Q ss_pred HHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 300 QWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 300 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
........ ...+...+..+.+++.+||+.+|.+||++.++++.|+++.+.
T Consensus 253 ~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 253 KLLKEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHcCCC----------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 22221110 112233456788999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=312.27 Aligned_cols=259 Identities=26% Similarity=0.428 Sum_probs=205.3
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC---------CeeEEEEEccCC----chHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR---------DTVVAIKRRVGS----PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQN 151 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 151 (382)
..+|...+.||+|+||.||++... ...+++|..... ...++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 356788899999999999999752 136899887542 234688999999999 899999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLE-----------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD 220 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~ 220 (382)
...+++|||+++|+|.+++...... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nili~ 171 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVT 171 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEEEc
Confidence 9999999999999999999864321 1245788999999999999999999987 99999999999999
Q ss_pred CCCcEEEeecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHH
Q 016789 221 ENFIAKVADTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEAL 298 (382)
Q Consensus 221 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~ 298 (382)
+++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+... ....+
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---~~~~~ 248 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI---PVEEL 248 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC---CHHHH
Confidence 99999999999998764432222 222334567999999998889999999999999999998 77777532 22233
Q ss_pred HHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 299 IQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.+........ ..+...+..+.+++.+||+.+|.+||++.++++.|+++..-
T Consensus 249 ~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 249 FKLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 3322221110 11223456788899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=304.31 Aligned_cols=248 Identities=28% Similarity=0.450 Sum_probs=204.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCc--hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP--RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNG 164 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 164 (382)
++|+..+.||.|+||.||++...++.+++|...... .+.+.+|+.++++++|+||+++++++...+..++||||++++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG 85 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCC
Confidence 467888999999999999999999999999877653 357889999999999999999999999888999999999999
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCC
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP 244 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 244 (382)
+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.++.......
T Consensus 86 ~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 86 SLVDYLRSRG---RAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred cHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 9999987542 235899999999999999999999987 99999999999999999999999999986633221
Q ss_pred CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 245 SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 245 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
....+..|+|||.+....++.++||||||+++||+++ |..||.... ...+......... ...+..
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~~----------~~~~~~ 223 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPHVEKGYR----------MEAPEG 223 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHhcCCC----------CCCccC
Confidence 2233456999999988889999999999999999998 998886432 2222222221111 111223
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
.+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 224 CPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 356788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=320.24 Aligned_cols=238 Identities=22% Similarity=0.217 Sum_probs=191.1
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNG 164 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 164 (382)
+.||+|+||.||++.... ..+|+|.+... ....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 369999999999998764 68999986532 2346788999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCC
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP 244 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 244 (382)
+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 9998886542 5889999999999999999999987 9999999999999999999999999987532211 112
Q ss_pred CcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHH
Q 016789 245 SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEG 324 (382)
Q Consensus 245 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 324 (382)
....+++.|+|||.+.+..++.++|||||||++|||++|+.||.... .....+.... . +. ..+...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~---~~~~~~~~~~----~---~~----~~p~~~ 218 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILM----E---DI----KFPRTL 218 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC---HHHHHHHhcc----C---Cc----cCCCCC
Confidence 23356788999999998899999999999999999999999996432 1222221110 0 01 112233
Q ss_pred HHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 016789 325 MRDLIRLTLQCMSSPGRRRP-----KMEIVMTE 352 (382)
Q Consensus 325 ~~~l~~l~~~cl~~dp~~RP-----s~~~v~~~ 352 (382)
+..+.+++.+||+.||.+|| ++.++++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 45678899999999999997 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=308.35 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=200.2
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 154 (382)
.++|...+.||+|+||.||+|.+.. ..+++|...... ...|..|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3568888999999999999998854 578888765332 24688999999999999999999999998899
Q ss_pred EEEEeecCCCChhhhhhhcCC--CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC---cEEEee
Q 016789 155 MLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF---IAKVAD 229 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~---~~kl~D 229 (382)
++||||+++|+|.+++...+. .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEecc
Confidence 999999999999999976542 12236899999999999999999999987 99999999999998654 699999
Q ss_pred cCCccccccccccCC-CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcC
Q 016789 230 TGISKLLENIEEAGP-SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLS 307 (382)
Q Consensus 230 fGla~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 307 (382)
||+++.+........ .....+..|+|||++.+..++.++|||||||++|||++ |+.||..... ............
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~~~~~~~~ 239 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEFVTGGGR 239 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHcCCc
Confidence 999987633221111 11122356999999998899999999999999999997 8888864322 222222221111
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 308 SNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 308 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
...+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus 240 ----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 ----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1112334567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=325.46 Aligned_cols=247 Identities=21% Similarity=0.240 Sum_probs=198.1
Q ss_pred CCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+|...+.||+|+||+||+|... +..+|+|.+... ....+..|++++..++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5788899999999999999987 478999986532 23468889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++|+|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 82 YMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred CCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999999764 26888999999999999999999977 999999999999999999999999999866443
Q ss_pred c----------------------------ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccC
Q 016789 240 E----------------------------EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVS 291 (382)
Q Consensus 240 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~ 291 (382)
. ........+++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 011223456788999999999999999999999999999999999997543
Q ss_pred CCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 016789 292 LGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPK-MEIVMTE 352 (382)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-~~~v~~~ 352 (382)
. ......+.... ....-+ .....+..+.+++.+|++ ||.+||+ +.++++.
T Consensus 235 ~---~~~~~~i~~~~--~~~~~p-----~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 L---QETYNKIINWK--ESLRFP-----PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H---HHHHHHHhccC--CcccCC-----CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 11111111100 000000 011134678889999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=307.71 Aligned_cols=259 Identities=22% Similarity=0.346 Sum_probs=205.7
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEe-CCee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQ-NGYQ 154 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 154 (382)
.++|...+.||+|+||.||+|.+.. ..+++|...... ...+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888999999999999998754 678888765432 2457889999999999999999998876 4678
Q ss_pred EEEEeecCCCChhhhhhhcCCC---CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 155 MLVFEYLPNGSMCNHLYETGLE---SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
++++||+++|+|.+++...... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEECCCC
Confidence 9999999999999998764321 1246899999999999999999999877 9999999999999999999999999
Q ss_pred CccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCC
Q 016789 232 ISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSN 309 (382)
Q Consensus 232 la~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 309 (382)
+++.+....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||.... ...+..+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~~~~~~- 238 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID---PFEMAAYLKDGYRL- 238 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC---HHHHHHHHHcCCCC-
Confidence 998654322211 112233456999999998889999999999999999999 999986432 22333333322111
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 310 NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 310 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
..+..++..+.+++.+||+.||++||++.++++.|+++.++
T Consensus 239 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 239 ---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11122346788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=309.33 Aligned_cols=263 Identities=25% Similarity=0.365 Sum_probs=199.3
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG-----YQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~ 160 (382)
.|...+++|.|+||.||+|...+ ..+|||+...+.+ .-.+|+++|+.+.|||||++.-++.... ...+||||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 46667899999999999999876 6899998765533 2346999999999999999998886542 23579999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC-CcEEEeecCCccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN-FIAKVADTGISKLLENI 239 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~-~~~kl~DfGla~~~~~~ 239 (382)
|+. +|.+.++..- .....++...+.-+..|+.+||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.+...
T Consensus 104 mP~-tL~~~~r~~~-~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYT-RANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred chH-HHHHHHHHHh-hcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 975 8998887531 22346777788889999999999999977 9999999999999976 99999999999988765
Q ss_pred cccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC----------
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS---------- 308 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 308 (382)
+.. ...-.+..|+|||.+.+. .|+.+.||||.|||+.||+-|++.|...+ ...++...+.--+..
T Consensus 180 epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s--~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 180 EPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS--SVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred CCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC--HHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 543 233456789999998664 59999999999999999999999987543 233333333321111
Q ss_pred C--cccccccCCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHHh
Q 016789 309 N--NFVDHRLAGT-----FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE--LERIHEK 359 (382)
Q Consensus 309 ~--~~~d~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~--L~~i~~~ 359 (382)
+ +.-.+.+... .....+.+..+++.++++++|.+|.++.|++.. ++.+.+.
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 1 1111222211 233446788899999999999999999998854 5555544
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=303.64 Aligned_cols=250 Identities=27% Similarity=0.423 Sum_probs=199.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
.+|.....||+|+||.||++.+.+ ..+++|..... ..+.+.+|+.++++++|||++++++++.. +..+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence 457778899999999999998866 47899976543 23578899999999999999999998754 567899999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++..........
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 85 GSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999997532 235789999999999999999999877 9999999999999999999999999998664332222
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
.....++..|+|||...+..++.++||||||+++|||++ |+.||.... ............. ...+.
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~----------~~~~~ 226 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV---NREVLEQVERGYR----------MPCPQ 226 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC----------CCCCc
Confidence 222234566999999988889999999999999999999 888886432 1222222222111 01123
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTELER 355 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~ 355 (382)
..+..+.+++.+||+.||.+||++.++++.|++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 227 GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=305.36 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=195.5
Q ss_pred CCCCeeeccCcccEEEEEECC----eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeC------Cee
Q 016789 90 SETSLIGFGSFGPVYKGLLRD----TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN------GYQ 154 (382)
Q Consensus 90 ~~~~~lg~G~~g~V~~~~~~~----~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 154 (382)
...+.||+|+||.||+|.+.. ..+|+|..... ....+..|+.+++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999998765 25889876532 234688899999999999999999987532 246
Q ss_pred EEEEeecCCCChhhhhhhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 155 MLVFEYLPNGSMCNHLYETGL-ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
++++||+++|+|.+++..... .....+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCcc
Confidence 899999999999998754332 22345889999999999999999999877 999999999999999999999999999
Q ss_pred cccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcc
Q 016789 234 KLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 234 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (382)
+.+....... ......++.|++||......++.++||||||+++|||++ |+.||.... .....+........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~~~~~~~--- 233 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE---NSEIYDYLRQGNRL--- 233 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHcCCCC---
Confidence 8764332211 122234567999999999899999999999999999999 788886422 22222222221110
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
..+...+..+.+++.+||+.||++||++.++++.|+++
T Consensus 234 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 -------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11123346688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=306.47 Aligned_cols=248 Identities=27% Similarity=0.471 Sum_probs=194.8
Q ss_pred CeeeccCcccEEEEEECC----eeEEEEEccCC----chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD----TVVAIKRRVGS----PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~----~~vavK~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||.||+|...+ ..+++|..... ..+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 358999999999998764 25688876532 234688999999999 799999999999999999999999999
Q ss_pred CChhhhhhhcCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCC
Q 016789 164 GSMCNHLYETGL-----------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI 232 (382)
Q Consensus 164 gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGl 232 (382)
|+|.+++..... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCCC
Confidence 999999976431 11235789999999999999999999977 99999999999999999999999999
Q ss_pred ccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcc
Q 016789 233 SKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (382)
+...... ........+..|+|||++....++.++||||||+++|||++ |..||.... .....+........
T Consensus 159 ~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---~~~~~~~~~~~~~~--- 230 (270)
T cd05047 159 SRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKLPQGYRL--- 230 (270)
T ss_pred ccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC---HHHHHHHHhCCCCC---
Confidence 8633211 11112233456999999988889999999999999999997 999986432 22222222111100
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
..+...+..+.+++.+||+.||.+||++.++++.|+++.
T Consensus 231 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 -------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111223456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=303.92 Aligned_cols=248 Identities=28% Similarity=0.417 Sum_probs=201.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCc-hHHHHHHHHHHhcCCCCCccceeeEEE-eCCeeEEEEeecCCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP-RQEFVAEVTYLSEIRHRNLVTLLGYCQ-QNGYQMLVFEYLPNG 164 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~~g 164 (382)
++|...+.||+|+||.||++...+..+++|...... .+.+.+|+.++++++|+|++++++++. ..+..++++||+++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 467888999999999999999999899999876543 457899999999999999999999765 456789999999999
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCC
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP 244 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 244 (382)
+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 86 ~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 86 SLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred cHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence 9999987643 235789999999999999999999987 9999999999999999999999999987543322
Q ss_pred CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 245 SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 245 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....+..|+|||.+....++.++||||||+++|||++ |+.|+... ....+......... ...+..
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~---~~~~~~~~~~~~~~----------~~~~~~ 223 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGYK----------MDAPDG 223 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhcCCC----------CCCCCC
Confidence 12223456999999998889999999999999999998 88888632 22233333222111 111223
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
.+..+.+++.+||+.||++||++.++++.|+++
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=309.92 Aligned_cols=253 Identities=28% Similarity=0.361 Sum_probs=198.8
Q ss_pred CCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
+|...+.||+|+||.||+|...+ ..+|+|...... ...+.+|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 35566789999999999998642 579999876443 2457889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcE
Q 016789 157 VFEYLPNGSMCNHLYETGL-----------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIA 225 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~ 225 (382)
++||+++++|.+++..... .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecCCCce
Confidence 9999999999999863211 11235788889999999999999999877 9999999999999999999
Q ss_pred EEeecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHH
Q 016789 226 KVADTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVR 303 (382)
Q Consensus 226 kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~ 303 (382)
||+|||+++.+....... ......++.|+|||.+.+..++.++||||||+++|||++ |..|+.... .....+...
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~i~ 240 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVIEMIR 240 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHH
Confidence 999999988654322211 122334567999999988889999999999999999998 777875432 222332222
Q ss_pred hhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 016789 304 SRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELER 355 (382)
Q Consensus 304 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~ 355 (382)
.... ...+.+.+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 241 ~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 NRQV----------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cCCc----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2110 11223445678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=305.69 Aligned_cols=251 Identities=26% Similarity=0.437 Sum_probs=201.1
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCCc--hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP--RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
.++|+..++||+|+||.||+|...+ ..+++|...... ..+|.+|+.++++++||||+++++++. .+..++++||++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 4568888999999999999998765 789999876433 467899999999999999999999875 456899999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+|+|.+++.... ...+++.....++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 84 NGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999986532 346889999999999999999999987 999999999999999999999999999766532222
Q ss_pred CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 243 GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
......++..|+|||.+....++.++||||||+++|||++ |+.||.... .............. ..+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~~~~~~----------~~~ 225 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT---NPEVIQNLERGYRM----------PRP 225 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHcCCCC----------CCC
Confidence 2222234557999999998889999999999999999999 999986432 22222222211110 111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELER 355 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~ 355 (382)
...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 2234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=303.25 Aligned_cols=242 Identities=24% Similarity=0.357 Sum_probs=192.7
Q ss_pred eeccCcccEEEEEEC----CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCCh
Q 016789 95 IGFGSFGPVYKGLLR----DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 95 lg~G~~g~V~~~~~~----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 166 (382)
||+|+||.||+|.+. +..+|+|...... .+.+.+|+.++++++||||+++++++.. ...++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 899999999999764 2468999876543 2468899999999999999999998864 467999999999999
Q ss_pred hhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC--C
Q 016789 167 CNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG--P 244 (382)
Q Consensus 167 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~--~ 244 (382)
.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......... .
T Consensus 82 ~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 82 NKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99986432 36899999999999999999999987 9999999999999999999999999998654332211 1
Q ss_pred CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 245 SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 245 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....+..|+|||.+....++.++||||||+++||+++ |+.||..... ......+..... ...+..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~----------~~~~~~ 222 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---PEVMSFIEQGKR----------LDCPAE 222 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHHCCCC----------CCCCCC
Confidence 22233467999999988889999999999999999996 9999875432 222222222111 112233
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
++..+.+++.+||+.||++||++.+|.+.|+.+
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 456788899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=310.44 Aligned_cols=260 Identities=24% Similarity=0.372 Sum_probs=197.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC----------------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD----------------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLG 146 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~----------------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~ 146 (382)
++|+..+.||+|+||.||++...+ ..+|+|...... ...|.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 568888999999999999987642 258899876432 346889999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhhhhhhcCCC-------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee
Q 016789 147 YCQQNGYQMLVFEYLPNGSMCNHLYETGLE-------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV 219 (382)
Q Consensus 147 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill 219 (382)
++...+..++||||+++++|.+++...... ....+++..++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nill 162 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLV 162 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEEE
Confidence 999999999999999999999998654211 1224788999999999999999999987 9999999999999
Q ss_pred cCCCcEEEeecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCccCCCChh
Q 016789 220 DENFIAKVADTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT--GQEASHIVSLGSYE 296 (382)
Q Consensus 220 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t--g~~p~~~~~~~~~~ 296 (382)
++++.+||+|||++.......... .....++..|+|||.+.++.++.++||||||+++|||++ |..||..... .
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~---~ 239 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD---E 239 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---H
Confidence 999999999999997653322111 112233557999999998889999999999999999998 4556653321 2
Q ss_pred HHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 297 ALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 297 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
............. ........+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus 240 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTGEFFRNQ---GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHhhhhc---cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 2221111100000 000000112223468999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=300.97 Aligned_cols=243 Identities=29% Similarity=0.444 Sum_probs=194.2
Q ss_pred CeeeccCcccEEEEEECC-eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCChh
Q 016789 93 SLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMC 167 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 167 (382)
++||+|+||.||+|...+ ..+++|...... ...+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999998765 678999865432 236889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCcc
Q 016789 168 NHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHG 247 (382)
Q Consensus 168 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 247 (382)
+++.... ..+++..+..++.+++.+|.|||+.+ ++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 9886532 25789999999999999999999877 99999999999999999999999999875433222222222
Q ss_pred cccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHH
Q 016789 248 SIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMR 326 (382)
Q Consensus 248 ~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 326 (382)
..+..|+|||++....++.++||||||+++||+++ |..||.... ............. ...+...+.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~---~~~~~~~~~~~~~----------~~~~~~~~~ 221 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT---NQQAREQVEKGYR----------MSCPQKCPD 221 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHHHcCCC----------CCCCCCCCH
Confidence 33456999999998889999999999999999999 888986432 1122222211110 011223456
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 327 DLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 327 ~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
.+.+++.+||+.+|++||++.++++.|.
T Consensus 222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 222 DVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 7889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=304.32 Aligned_cols=251 Identities=27% Similarity=0.471 Sum_probs=202.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-----eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
++|+..+.||+|+||.||+|.... ..+++|...... .+.+..|++++++++||||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467788999999999999998753 368998865432 34688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999986532 35889999999999999999999987 9999999999999999999999999998664
Q ss_pred cccccCC--CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 238 NIEEAGP--SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 238 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
....... .....+..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~---~~~~~~~i~~~~~------- 228 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS---NHEVMKAINDGFR------- 228 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC---HHHHHHHHhcCCC-------
Confidence 3322111 11223456999999998889999999999999999998 999986432 2222222221111
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
...+.+.+..+.+++.+||+.||.+||++.+|++.|+++
T Consensus 229 ---~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 ---LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111223456788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=330.48 Aligned_cols=248 Identities=19% Similarity=0.201 Sum_probs=196.8
Q ss_pred CCCCCCeeeccCcccEEEEEECC---eeEEEEEccCCch---HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD---TVVAIKRRVGSPR---QEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~---~~vavK~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
.|...+.||+|+||.||+|.... ..+++|....... ..+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 37788899999999999997643 5677786543322 35778999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++|+|.+++.... .....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 9999999886532 12335788899999999999999999977 99999999999999999999999999986643222
Q ss_pred c-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 242 A-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 242 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
. ......+++.|+|||.+.+..++.++|||||||++|||++|+.||.... ............ .. ..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~---~~~~~~~~~~~~-~~---------~~ 291 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQQVLYGK-YD---------PF 291 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCC-CC---------CC
Confidence 1 1223347888999999999999999999999999999999999986432 222222221110 00 11
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+...+..+.+++.+||+.||++||++.+++.
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 2223457889999999999999999999865
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=303.61 Aligned_cols=251 Identities=28% Similarity=0.466 Sum_probs=201.7
Q ss_pred hCCCCCCeeeccCcccEEEEEEC-----CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR-----DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
.+|...+.||+|+||.||+|.+. ...+++|...... ...|.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999863 2378998875432 34688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++.... ..+++.....++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999997542 35789999999999999999999987 9999999999999999999999999998765
Q ss_pred cccccCC--CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 238 NIEEAGP--SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 238 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
....... .....+..|++||.+.+..++.++|+||||+++||+++ |..||..... .............
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~~~~~~------ 228 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIKAIEEGYRL------ 228 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHHHHhCCCcC------
Confidence 4322111 12223456999999998889999999999999999887 9999864322 2222222221110
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
..+...+..+.+++.+||+.+|.+||+|.++++.|+++
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 ----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=308.54 Aligned_cols=260 Identities=24% Similarity=0.355 Sum_probs=198.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECC------------------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccce
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD------------------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTL 144 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~------------------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l 144 (382)
++|+..+.||+|+||.||++...+ ..+|+|...... ..+|.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 468888999999999999985431 368898876432 3568899999999999999999
Q ss_pred eeEEEeCCeeEEEEeecCCCChhhhhhhcCCC------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCee
Q 016789 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLE------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVL 218 (382)
Q Consensus 145 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nil 218 (382)
++++...+..+++|||+++|+|.+++...... ....+++.....++.|++.||+|||+.+ ++||||||+|||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Nil 162 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCL 162 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheEE
Confidence 99999999999999999999999999765321 1235788899999999999999999987 999999999999
Q ss_pred ecCCCcEEEeecCCccccccccccCC-CcccccccccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCccCCCCh
Q 016789 219 VDENFIAKVADTGISKLLENIEEAGP-SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT--GQEASHIVSLGSY 295 (382)
Q Consensus 219 l~~~~~~kl~DfGla~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t--g~~p~~~~~~~~~ 295 (382)
++.++.++|+|||+++.+........ .....+..|++||....+.++.++|||||||++|||++ |..|+.....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~--- 239 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD--- 239 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh---
Confidence 99999999999999986543221111 11223456999999888889999999999999999998 6677754322
Q ss_pred hHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 296 EALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 296 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
............... .......+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus 240 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQVIENTGEFFRDQG---RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHHhhcc---ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111111110000000 00000112234467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=306.42 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=200.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--e----eEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--T----VVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~----~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
++|+..+.||+|+||+||+|.+.. . .||+|...... ..++.+|+.++..++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 467888999999999999998643 2 47999865432 34678899999999999999999999764 4689
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
++||+++|+|.+++.... ..+++...+.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+
T Consensus 86 ~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999987532 35889999999999999999999987 999999999999999999999999999876
Q ss_pred cccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 237 ENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 237 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
...... .......+..|+|||...+..++.++|||||||++|||++ |..||.... ...+..+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~~------ 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP---AREIPDLLEKGERL------ 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHCCCcC------
Confidence 432221 1122234567999999998899999999999999999998 888886432 22333333321111
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
..+...+..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 231 ----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 231 ----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 11123346788999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=304.81 Aligned_cols=252 Identities=28% Similarity=0.460 Sum_probs=203.8
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
.++|...+.||+|+||.||++...+ ..+++|.+... ...++.+|+.++++++||||+++++++......+++|||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 4678888999999999999998766 67899987643 34679999999999999999999999999889999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+......
T Consensus 85 ~~~L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 85 KGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 999999997632 346899999999999999999999987 999999999999999999999999999876532222
Q ss_pred CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 243 GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
.......+..|+|||.+.+..++.++|+||||+++|||++ |+.||.... .....+....... ...+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~~~~~~~----------~~~~ 226 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLEQVERGYR----------MPRP 226 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC----------CCCC
Confidence 1222233456999999998889999999999999999999 898885322 2222222222111 0111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELER 355 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~ 355 (382)
.+.+..+.+++.+||+.+|.+||++.++.+.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 2235678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=330.41 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=208.9
Q ss_pred CCCCCeeeccCcccEEEEEECC------eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD------TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
....++||+|+||+||+|.|-. -+||+|.+... ...++++|+.+|.++.|||+++++|+|.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 3456789999999999998742 37899886542 3568999999999999999999999998876 78999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
+||+.|+|.++++..+ ..+.....+.+..|||+||.|||.++ +|||||.++|||+.+-..+||.|||+++.+..
T Consensus 777 q~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 9999999999998754 35777889999999999999999877 99999999999999999999999999999876
Q ss_pred ccccCC-CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 239 IEEAGP-SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 239 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
+...-. ..+..++-|||-|.+....|+.++|||||||++||++| |..|++.....+... .++.. .
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d---lle~g----------e 917 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD---LLEKG----------E 917 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH---HHhcc----------c
Confidence 654332 33445566999999999999999999999999999999 888987654332222 22221 1
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
+...++-++.++..++.+||..|+..||+++++...+.++...
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 1245667788999999999999999999999999998777543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=316.13 Aligned_cols=254 Identities=19% Similarity=0.288 Sum_probs=189.8
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeC-----CeeE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN-----GYQM 155 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 155 (382)
+|+..+.||+|+||.||+|.... ..+|+|++... ....+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 36778899999999999998764 78999986532 224588999999999999999999988643 2579
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+||||+. ++|.+++.... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 68988886532 5889999999999999999999988 99999999999999999999999999986
Q ss_pred ccccccc--CCCcccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc-CC--
Q 016789 236 LENIEEA--GPSHGSIVNVFRDPEVEES--GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL-SS-- 308 (382)
Q Consensus 236 ~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~-- 308 (382)
....... ......+++.|+|||++.+ ..++.++|||||||++|||++|++||....... ..+...... ..
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~ 229 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSP 229 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCH
Confidence 5322211 1123456788999999865 678999999999999999999999996432111 111000000 00
Q ss_pred -----------Ccccc---cccCCCCC---HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 309 -----------NNFVD---HRLAGTFT---TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 309 -----------~~~~d---~~~~~~~~---~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
....+ ........ +..+..+.+++.+||+.||++||++.++++.
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 00000000 1123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=309.48 Aligned_cols=258 Identities=24% Similarity=0.378 Sum_probs=202.4
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGY 153 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 153 (382)
.+.+|+..+.||+|+||.||+|...+ ..+|+|...... ...+.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45678899999999999999997542 478999865432 2357889999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCC-----CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEe
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLE-----SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVA 228 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~ 228 (382)
.++||||+++|+|.+++...... ......+..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999999764321 1234567788899999999999999877 9999999999999999999999
Q ss_pred ecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhc
Q 016789 229 DTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 229 DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
|||+++......... .....++..|+|||.+.++.++.++|||||||++|||++ |..||.... ............
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~---~~~~~~~~~~~~ 238 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS---NEQVLKFVMDGG 238 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCC
Confidence 999988654322211 112233556999999998899999999999999999999 677876422 222333222111
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 307 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
.. ..+...+..+.+++.+||+.||.+||++.++++.|++..
T Consensus 239 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 239 YL----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 00 112233467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=311.12 Aligned_cols=258 Identities=25% Similarity=0.434 Sum_probs=203.7
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC---------CeeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR---------DTVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVTLLGYCQQN 151 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 151 (382)
..+|...+.||+|+||.||++... ...+++|...... ..++.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356788899999999999999752 2468888866432 24678899999999 699999999999998
Q ss_pred CeeEEEEeecCCCChhhhhhhcCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGL-----------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD 220 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~ 220 (382)
+..++++||+++|+|.+++..... .....+++.....++.|++.||.|||+.+ ++||||||+|||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~ 168 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVT 168 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEEc
Confidence 999999999999999999976431 12345899999999999999999999877 99999999999999
Q ss_pred CCCcEEEeecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHH
Q 016789 221 ENFIAKVADTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEAL 298 (382)
Q Consensus 221 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~ 298 (382)
+++.+||+|||+++......... ......+..|+|||.+.+..++.++||||||+++|||++ |..||.... ....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~---~~~~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---VEEL 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC---HHHH
Confidence 99999999999998664322211 122233456999999998889999999999999999999 888875432 2233
Q ss_pred HHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 016789 299 IQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358 (382)
Q Consensus 299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~ 358 (382)
......... ...+...+..+.+++.+||+.||++||++.++++.|+++..
T Consensus 246 ~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 246 FKLLREGHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHHcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 332222110 01122334578899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=307.38 Aligned_cols=242 Identities=19% Similarity=0.246 Sum_probs=190.1
Q ss_pred eeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCCh
Q 016789 95 IGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 95 lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 166 (382)
||+|+||+||++.... ..+|+|...... .+.+..|+++++.++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999998764 689999865321 13567899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCc
Q 016789 167 CNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH 246 (382)
Q Consensus 167 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 246 (382)
.+.+.... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+...... ...
T Consensus 81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 98876432 22346899999999999999999999987 999999999999999999999999999765432221 222
Q ss_pred ccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCCh-hHHHHHHHhhcCCCcccccccCCCCCHHHH
Q 016789 247 GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSY-EALIQWVRSRLSSNNFVDHRLAGTFTTEGM 325 (382)
Q Consensus 247 ~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 325 (382)
..+++.|+|||.+.+..++.++||||||+++|||++|+.||........ ..... ... ... ...+...+
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~---~~~------~~~--~~~~~~~~ 225 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RIL------NDS--VTYPDKFS 225 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH---hhc------ccC--CCCcccCC
Confidence 3567789999999999999999999999999999999999974332111 11111 100 000 01223445
Q ss_pred HHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 016789 326 RDLIRLTLQCMSSPGRRRP-----KMEIVMT 351 (382)
Q Consensus 326 ~~l~~l~~~cl~~dp~~RP-----s~~~v~~ 351 (382)
..+.+++.+||+.||++|| +++++++
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 6788999999999999999 5566664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=307.46 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=202.7
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 154 (382)
.++|...+.||+|+||.||+|.... ..+++|...... ...+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3568888999999999999998753 579999876432 24688999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCC-----CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEee
Q 016789 155 MLVFEYLPNGSMCNHLYETGLE-----SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVAD 229 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~D 229 (382)
++||||+++|+|.+++...... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCEEECC
Confidence 9999999999999999764321 1234788999999999999999999877 99999999999999999999999
Q ss_pred cCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcC
Q 016789 230 TGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLS 307 (382)
Q Consensus 230 fGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 307 (382)
||+++.+....... .....++..|+|||.+.+..++.++||||||+++||+++ |..||.... .....+.......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---~~~~~~~~~~~~~ 239 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS---NEEVLKFVIDGGH 239 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC---HHHHHHHHhcCCC
Confidence 99998654432211 122334567999999988889999999999999999998 888886432 2333333321110
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 308 SNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 308 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
. ..+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 240 -~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 240 -L---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -C---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0 112223567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=321.42 Aligned_cols=249 Identities=22% Similarity=0.264 Sum_probs=196.1
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
.++|+..+.||+|+||.||++.... ..+|+|.+... ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 4578889999999999999998864 68999986531 223577899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++... .++......++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 122 ~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 122 MEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999988653 4677888889999999999999987 9999999999999999999999999998664
Q ss_pred cccccCCCcccccccccCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccc
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESG----VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVD 313 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (382)
...........+++.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+... ...+.
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~--~~~~~- 267 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMDH--KNSLT- 267 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH---HHHHHHHHcC--CCcCC-
Confidence 4332223344578889999998653 478999999999999999999999974332 1111111111 00010
Q ss_pred cccCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 016789 314 HRLAGTFTTEGMRDLIRLTLQCMSSPGRR--RPKMEIVMTE 352 (382)
Q Consensus 314 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~~v~~~ 352 (382)
+ ......+..+.+++.+||+.+|.+ ||++.++++.
T Consensus 268 --~--~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 --F--PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --C--CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 111123467788999999999988 9999999653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=308.22 Aligned_cols=247 Identities=19% Similarity=0.242 Sum_probs=196.1
Q ss_pred CCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+|+..+.||+|+||+||++... +..+|+|.+.... ...+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677789999999999999875 4789999875321 2346789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++|+|.+++.... ...+++.....++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999998886532 235889999999999999999999977 999999999999999999999999999865432
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChh-HHHHHHHhhcCCCcccccccCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYE-ALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.. .....++..|+|||.+.+..++.++||||+|+++|||++|+.||......... ........ ...
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~-----------~~~ 222 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE-----------DQE 222 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh-----------ccc
Confidence 21 12234567899999999888999999999999999999999999743321111 11111110 011
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRP-----KMEIVMTE 352 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~~v~~~ 352 (382)
.++...+..+.+++.+||+.||.+|| ++.++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 22334456788999999999999999 77787653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=315.56 Aligned_cols=237 Identities=19% Similarity=0.221 Sum_probs=188.5
Q ss_pred CeeeccCcccEEEEEEC-----CeeEEEEEccCC-------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 93 SLIGFGSFGPVYKGLLR-----DTVVAIKRRVGS-------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+.||+|+||.||++... +..+|+|.+... ....+.+|+++|+.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999763 368999986532 123567899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++|+|.+++...+ .+.+.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999987643 5677888889999999999999987 9999999999999999999999999987432221
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
. ......+++.|+|||.+.+..++.++|||||||++|||++|+.||.... ........... . . ..
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~---~~~~~~~~~~~---~----~----~~ 219 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN---RKKTIDKILKG---K----L----NL 219 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC---HHHHHHHHHcC---C----C----CC
Confidence 1 1222356788999999998889999999999999999999999997432 11212111111 0 0 11
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRP-----KMEIVMT 351 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RP-----s~~~v~~ 351 (382)
+...+..+.+++.+||+.||++|| ++.++++
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 222345678999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=309.81 Aligned_cols=255 Identities=19% Similarity=0.275 Sum_probs=192.4
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
++|...+.||+|+||.||+|... +..+|+|.+.... ...+.+|+.+++.++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 57888999999999999999986 3789999865322 23577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++ ++|.+++.... ..++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 85 VH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 95 68888876532 35788889999999999999999987 9999999999999999999999999987543221
Q ss_pred ccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh-hcCCC---------
Q 016789 241 EAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS-RLSSN--------- 309 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~--------- 309 (382)
.......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||..... .....+.... .....
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchhh
Confidence 11223445778999998865 4588999999999999999999999974321 1111111111 00000
Q ss_pred --cccccccCCCCCH---------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 --NFVDHRLAGTFTT---------EGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 --~~~d~~~~~~~~~---------~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...........+. ..+..+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000000 11245778999999999999999999886
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=327.63 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=204.7
Q ss_pred CCCCeeeccCcccEEEEEECC-----eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 90 SETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 90 ~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
...++||+|.||.|++|.|.. ..||||.+... ..++|++|+.+|.+|+|||+++|||+..+ ....||+|+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 345689999999999999975 47999987654 35789999999999999999999999998 678999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++.|||.+.|++.. ...+....+..++.|||.||.||.+++ +|||||.++|+|+-....|||+|||+.+-+...+
T Consensus 192 aplGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999832 346888889999999999999999988 9999999999999999999999999999876443
Q ss_pred ccC--CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 241 EAG--PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 241 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
... ......+..|.|||.+....|+.+||||+|||++|||+| |..||.... ...+++.+. ..-.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~---g~qIL~~iD----------~~er 333 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR---GIQILKNID----------AGER 333 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC---HHHHHHhcc----------cccc
Confidence 322 123344566999999999999999999999999999999 567876432 333333322 2222
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
...+..+++++.+++++||..+|.+||++..+.+.+-..
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 245677889999999999999999999999998665433
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=315.82 Aligned_cols=244 Identities=18% Similarity=0.198 Sum_probs=188.8
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||.||++.... ..+|+|.+... ....+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 369999999999998864 68999987532 123577899999988 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 99998886542 6899999999999999999999987 9999999999999999999999999987432111 11
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCC--hhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
.....+++.|+|||++.+..++.++|+|||||++|||++|+.||......+ ......+......... . ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---~----~~p 225 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ---I----RIP 225 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC---C----CCC
Confidence 223456788999999999999999999999999999999999996432211 1111111111110000 0 112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPK------MEIVMT 351 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs------~~~v~~ 351 (382)
...+..+.+++.+||+.||.+||+ +.++++
T Consensus 226 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 226 RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 223456788999999999999998 556653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=309.80 Aligned_cols=260 Identities=25% Similarity=0.374 Sum_probs=196.7
Q ss_pred hCCCCCCeeeccCcccEEEEEEC------CeeEEEEEccCCch---HHHHHHHHHHhcCCCCCccceeeEEEeC--CeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR------DTVVAIKRRVGSPR---QEFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 155 (382)
.+|+..+.||+|+||.||++... +..+++|....... ..+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778899999999999999753 35899998765433 4688999999999999999999987543 4678
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+|+||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999986542 25889999999999999999999987 99999999999999999999999999986
Q ss_pred cccccccC--CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC----
Q 016789 236 LENIEEAG--PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN---- 309 (382)
Q Consensus 236 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 309 (382)
+....... ......+..|+|||.+.+..++.++||||||+++|||++|..++...... ..+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVY 233 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchH
Confidence 64322211 11122334599999999888999999999999999999998765422110 000000000000
Q ss_pred ---cccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 310 ---NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 310 ---~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
+.+........+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000011111223456788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=305.52 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=199.0
Q ss_pred hCCCCCCeeeccCcccEEEEEEC-------CeeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR-------DTVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
++|...+.||+|+||.||++... +..+++|...... ...+.+|+++++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777889999999999999642 2478888766433 3478999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCC----------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEE
Q 016789 157 VFEYLPNGSMCNHLYETGL----------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAK 226 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~k 226 (382)
++||+++|+|.+++..... .....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCCCCEE
Confidence 9999999999999976431 11235889999999999999999999877 99999999999999999999
Q ss_pred EeecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHh
Q 016789 227 VADTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRS 304 (382)
Q Consensus 227 l~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 304 (382)
|+|||++.......... .....+++.|+|||.+.+..++.++|||||||++|||++ |.+||..... ....+....
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~ 239 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEAIECITQ 239 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HHHHHHHHc
Confidence 99999987553322111 112223567999999999999999999999999999998 8888864321 222222221
Q ss_pred hcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 305 RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 305 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
.... ..+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 240 ~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 240 GREL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1110 111223456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=304.83 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=202.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-----eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
.+|...+.||+|+||.||+|.+.+ ..+++|...... .+.+.+|+.++++++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457778899999999999998643 368888765432 3468899999999999999999998875 457899
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++.... ..+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999997542 25899999999999999999999977 9999999999999999999999999998665
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
............+..|+|||.+....++.++||||||+++||+++ |..||..... .............
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~~~~~~-------- 227 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---NDVIGRIENGERL-------- 227 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCcC--------
Confidence 433222222333456999999988889999999999999999996 9999864432 2222222211100
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
..+...+..+.+++.+||..+|.+||++.++++.|+++..++
T Consensus 228 --~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 228 --PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 112234567889999999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=302.35 Aligned_cols=244 Identities=26% Similarity=0.380 Sum_probs=195.7
Q ss_pred CeeeccCcccEEEEEECC-----eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD-----TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||.||+|.+.. ..+++|...... ..++.+|+.+++.+.||||+++++++.. +..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 369999999999997643 478999876443 3468899999999999999999998764 467999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999997643 6889999999999999999999877 9999999999999999999999999998664332221
Q ss_pred C--CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 244 P--SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 244 ~--~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ............. ...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~---~~~~~~~~~~~~~----------~~~ 219 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK---GAEVIAMLESGER----------LPR 219 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHHcCCc----------CCC
Confidence 1 12223456999999999999999999999999999998 999986432 2233333322111 011
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
+...+..+.+++.+||+.||.+||++.++++.|+++.
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 2234567889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=313.34 Aligned_cols=234 Identities=24% Similarity=0.281 Sum_probs=184.9
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||.||+|...+ ..+|+|.+... ....+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999865 57999976532 223455667777654 899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 99999886543 5888889999999999999999977 9999999999999999999999999997543222 12
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....+++.|+|||.+.+..++.++|||||||++|||++|+.||.... .......+... . + .++..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~~---~----~----~~~~~ 218 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED---EDELFDSILND---R----P----HFPRW 218 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcC---C----C----CCCCC
Confidence 223456788999999999899999999999999999999999997432 22222222111 0 1 11222
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKMEI 348 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~~ 348 (382)
.+..+.+++.+||+.||.+||++.+
T Consensus 219 ~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 219 ISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChH
Confidence 3456778999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=302.32 Aligned_cols=250 Identities=23% Similarity=0.290 Sum_probs=188.9
Q ss_pred eeeccCcccEEEEEECC----eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCC
Q 016789 94 LIGFGSFGPVYKGLLRD----TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGS 165 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~~----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 165 (382)
.||+|+||.||+|...+ ..+++|...... ...+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998643 468888765432 2368889999999999999999999999889999999999999
Q ss_pred hhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC-C
Q 016789 166 MCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG-P 244 (382)
Q Consensus 166 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~ 244 (382)
|.+++...........++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 999997654333345677888899999999999999977 9999999999999999999999999987543322111 1
Q ss_pred CcccccccccCccccccC-------CCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 245 SHGSIVNVFRDPEVEESG-------VFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 245 ~~~~~~~~y~aPE~~~~~-------~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
....++..|+|||++.+. .++.++|+||||+++|||++ |+.||..... ......... .......++.+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~~~~~~~-~~~~~~~~~~~ 235 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD---EQVLTYTVR-EQQLKLPKPRL 235 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHhh-cccCCCCCCcc
Confidence 122345679999998642 35789999999999999996 9999864332 111111111 11111222222
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
.. ..+..+.+++..|| .+|++||++.+|++.|+
T Consensus 236 ~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 236 KL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 21 12345777888999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=322.62 Aligned_cols=247 Identities=20% Similarity=0.238 Sum_probs=193.4
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|+||+||++.... +.+|+|.+... ....+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 368888999999999999999864 68999987532 1235778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++...+ .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999987643 5889999999999999999999988 99999999999999999999999999875432
Q ss_pred cccc-------------------------------------CCCcccccccccCccccccCCCCccchhHHHHHHHHHHH
Q 016789 239 IEEA-------------------------------------GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELV 281 (382)
Q Consensus 239 ~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~ 281 (382)
.... ......+|+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 001124788899999999999999999999999999999
Q ss_pred hCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 016789 282 TGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPK---MEIVMT 351 (382)
Q Consensus 282 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs---~~~v~~ 351 (382)
+|..||..... ........... ..+..+. ....+..+.+++.+|+. +|.+|++ +.++++
T Consensus 234 ~G~~Pf~~~~~---~~~~~~i~~~~--~~~~~~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNP---QETYRKIINWK--ETLQFPD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCH---HHHHHHHHcCC--CccCCCC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999974331 12211111110 0010000 11123456778888986 9999998 877766
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=301.55 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=196.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc--------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP--------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~--------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
++|...+.||+|++|.||++.... ..+++|...... ...+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 468888999999999999998754 789999764321 2357889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
|+||+++++|.+.+.... .+++.....++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999887643 5788888999999999999999988 999999999999999999999999998765
Q ss_pred ccccccCC--CcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 237 ENIEEAGP--SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 237 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
........ ....++..|+|||.+.+..++.++||||||+++|||++|+.||.... ....... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~-~~~~~-------- 223 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE--AMAAIFK-IATQP-------- 223 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc--hHHHHHH-HhccC--------
Confidence 43221111 22335567999999999889999999999999999999999986432 1111111 11110
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.....+......+.+++.+||+.+|.+||++.++++.
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 -TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0112223345678889999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=325.42 Aligned_cols=264 Identities=21% Similarity=0.316 Sum_probs=193.3
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhcCCCCCccceeeEEEeC--------CeeE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQN--------GYQM 155 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~~~~ 155 (382)
..+|...+.||+|+||.||+|.... ..||+|++... .....+|+.+|+.++||||+++++++... ..++
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 3578999999999999999998854 68999987543 23345799999999999999999876432 2467
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC-cEEEeecCCcc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF-IAKVADTGISK 234 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~ 234 (382)
+||||++ ++|.+++.... .....+++.....++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++
T Consensus 144 lvmE~~~-~~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 144 VVMEFIP-QTVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEecCC-ccHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeeccccch
Confidence 8999997 47777765432 22346889999999999999999999987 99999999999999664 79999999998
Q ss_pred ccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC-----
Q 016789 235 LLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS----- 308 (382)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----- 308 (382)
.+..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|.+||..... ...+..........
T Consensus 220 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 220 NLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS--VDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred hccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHH
Confidence 6643222 122345778999999865 4689999999999999999999999974332 12222221111000
Q ss_pred ----Ccccc--------cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHH
Q 016789 309 ----NNFVD--------HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE--LERIHE 358 (382)
Q Consensus 309 ----~~~~d--------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~--L~~i~~ 358 (382)
....+ ..+...++...+..+.+++.+||+.||.+|||+.|+++. ++.+..
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 00000 001111122234678899999999999999999999843 555544
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=318.85 Aligned_cols=238 Identities=21% Similarity=0.204 Sum_probs=189.7
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNG 164 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 164 (382)
+.||+|+||.||++.... ..+|+|.+... ....+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 369999999999998754 68999986532 2245678999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
+|.+++.... .+++.....++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 9998886542 58899999999999999999997 56 99999999999999999999999999875322111 1
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....+++.|+|||.+.+..++.++|||||||++|||++|+.||.... ........... . .. ++..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~---~~~~~~~i~~~----~---~~----~p~~ 218 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILME----E---IR----FPRT 218 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC---HHHHHHHHhcC----C---CC----CCCC
Confidence 223346788999999999999999999999999999999999996432 22222221111 0 01 1122
Q ss_pred HHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRP-----KMEIVMTE 352 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RP-----s~~~v~~~ 352 (382)
.+..+.+++.+||+.||.+|| ++.++++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 345678899999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=322.22 Aligned_cols=248 Identities=19% Similarity=0.247 Sum_probs=190.0
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
.|...+.||+|+||+||+|.... ..+|+|.+... ....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57788999999999999998865 68999987532 12457889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++|+|.+++.... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999987643 5788888889999999999999987 999999999999999999999999997643110
Q ss_pred ccc----------------------------------------------CCCcccccccccCccccccCCCCccchhHHH
Q 016789 240 EEA----------------------------------------------GPSHGSIVNVFRDPEVEESGVFSEMSDIYSF 273 (382)
Q Consensus 240 ~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~ 273 (382)
... ......+|+.|+|||.+.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 000 0012347788999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhh--ccCCCCCCCCCHHHHHH
Q 016789 274 GVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQ--CMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 274 G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~--cl~~dp~~RPs~~~v~~ 351 (382)
||++|||++|+.||...... .......... ... .. ......+..+.+++.+ |+..+|..||++.++++
T Consensus 235 G~il~elltG~~Pf~~~~~~--~~~~~i~~~~---~~~---~~--~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPT--ETQLKVINWE---NTL---HI--PPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHH--HHHHHHHccc---ccc---CC--CCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 99999999999999753321 1111111100 000 00 0011123445566666 55667777999999986
Q ss_pred H
Q 016789 352 E 352 (382)
Q Consensus 352 ~ 352 (382)
-
T Consensus 305 h 305 (381)
T cd05626 305 H 305 (381)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=306.65 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=201.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC-------CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR-------DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 154 (382)
.++|+..+.||+|+||.||++... ...+++|.+.... ..++.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356888899999999999999863 3689999876542 34688999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCC-----------------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCe
Q 016789 155 MLVFEYLPNGSMCNHLYETGL-----------------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANV 217 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Ni 217 (382)
++++||+++|+|.+++..... .....+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~ni 161 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNC 161 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhhe
Confidence 999999999999999975321 11235788899999999999999999877 99999999999
Q ss_pred eecCCCcEEEeecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCCh
Q 016789 218 LVDENFIAKVADTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSY 295 (382)
Q Consensus 218 ll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~ 295 (382)
+++.++.++|+|||++..+....... ......+..|+|||.+.+..++.++|||||||++|||++ |..||.... .
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~---~ 238 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA---H 238 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---H
Confidence 99999999999999987654332211 112223456999999998899999999999999999998 777875332 2
Q ss_pred hHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 016789 296 EALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELER 355 (382)
Q Consensus 296 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~ 355 (382)
........... .. ..+...+..+.+++.+||+.||.+||++.|+++.|++
T Consensus 239 ~~~~~~~~~~~----~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVIYYVRDGN----VL------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHhcCC----CC------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 23333222111 00 1122345678899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=315.18 Aligned_cols=240 Identities=23% Similarity=0.270 Sum_probs=187.7
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHH---hcCCCCCccceeeEEEeCCeeEEE
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYL---SEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
|+..+.||+|+||.||++.+.. ..+|+|.+... ..+.+..|+.++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 4567889999999999998864 68999987532 123456666554 567899999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|...+.. ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999888754 25899999999999999999999987 9999999999999999999999999987532
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
... .......+++.|+|||.+.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~---~~~~~~~i~~~~-------~--- 218 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD---EEEVFDSIVNDE-------V--- 218 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCC-------C---
Confidence 211 11223456788999999999999999999999999999999999986432 222222221110 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPK-----MEIVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~~v~~ 351 (382)
.++...+..+.+++.+||+.||.+||+ +.++++
T Consensus 219 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 -RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 112223466788999999999999995 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=307.39 Aligned_cols=253 Identities=21% Similarity=0.364 Sum_probs=200.3
Q ss_pred hCCCCCCeeeccCcccEEEEEEC-------CeeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCccceeeEEEeCCee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR-------DTVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 154 (382)
++|...+.||+|+||.||++... ...+|+|...... .+.+.+|+.+++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 56888899999999999999752 1478999766432 24688999999999 799999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
+++|||+++|+|.+++.... ...+++.....++.|++.||.|||+.+ ++|+||||+|||++.++.++++|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999987532 224899999999999999999999977 9999999999999999999999999998
Q ss_pred cccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 235 LLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 235 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
........ ......++..|+|||.+....++.++|||||||++|||++ |..||..... .............
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--~~~~~~~~~~~~~----- 262 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--DSKFYKLIKEGYR----- 262 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--hHHHHHHHHcCCc-----
Confidence 65432211 1112234567999999998889999999999999999998 8999864322 1122222111110
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
...+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 263 -----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 -----MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 011112245788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=302.70 Aligned_cols=256 Identities=20% Similarity=0.291 Sum_probs=202.9
Q ss_pred CCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+|+..+.||+|+||.||++... +..+++|..... ...++.+|+.+++.++||||+++++++...+..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 5777789999999999999864 478899975431 23478899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++++|.+++.... .....+++...+.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999999887532 22346899999999999999999999987 999999999999999999999999998765432
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
... .....++..|+|||.+.+..++.++|+||||+++|||++|..||..... +........... ..+..
T Consensus 160 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~------~~~~~--- 228 (267)
T cd08229 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQC------DYPPL--- 228 (267)
T ss_pred Ccc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-hHHHHhhhhhcC------CCCCC---
Confidence 211 1223456779999999988899999999999999999999999864321 111211111110 00111
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
.....+..+.+++.+||+.||.+||+|.+|++.++++.
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11234567889999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=302.41 Aligned_cols=251 Identities=22% Similarity=0.416 Sum_probs=201.3
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCCc--hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP--RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
...|...+.||+|+||.||++.+.+ ..+++|...... .+.+.+|++++++++|+||+++++++.. ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 3568888999999999999998765 678898766433 3578899999999999999999999887 67899999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.+.........
T Consensus 84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 84 KGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999997632 335788899999999999999999877 999999999999999999999999999766433222
Q ss_pred CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 243 GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
......++..|+|||++....++.++|+||||+++|++++ |+.||.... .....+........ ..+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~~~~~~----------~~~ 225 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRALERGYRM----------PRP 225 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHhCCCCC----------CCc
Confidence 2222334456999999998889999999999999999999 888886432 22233322221110 112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELER 355 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~ 355 (382)
...+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2344678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=299.66 Aligned_cols=256 Identities=21% Similarity=0.314 Sum_probs=204.9
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|+||.||+|... +..+++|.... .....+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46888899999999999999986 47889987542 12457889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++.... .....+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886542 22346889999999999999999999987 99999999999999999999999999876543
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ......+..... ...
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~----------~~~ 226 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEKC----------DYP 226 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhhhhcC----------CCC
Confidence 2211 1223456679999999988899999999999999999999999864321 111121111110 001
Q ss_pred CCC-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 319 TFT-TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 319 ~~~-~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
..+ ...+..+.+++.+||+.+|.+||++.++++.|+++.
T Consensus 227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 112 244567889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=315.30 Aligned_cols=249 Identities=20% Similarity=0.227 Sum_probs=190.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|+||+||++.... ..+|+|.+... ....+..|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 368888999999999999998764 68999987542 1245778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++...+ .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999997643 5889999999999999999999987 99999999999999999999999999875532
Q ss_pred cccc----------------------------------CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCC
Q 016789 239 IEEA----------------------------------GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284 (382)
Q Consensus 239 ~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~ 284 (382)
.... ......+|+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 001235788899999999999999999999999999999999
Q ss_pred CCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhcc--CCCCCCCCCHHHHHHH
Q 016789 285 EASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCM--SSPGRRRPKMEIVMTE 352 (382)
Q Consensus 285 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl--~~dp~~RPs~~~v~~~ 352 (382)
.||..... ......+.... .....+.. ... ...+.+++.+++ ..++..||++.|+++.
T Consensus 234 ~Pf~~~~~---~~~~~~i~~~~--~~~~~p~~-~~~----s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETP---QETYKKVMNWK--ETLIFPPE-VPI----SEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCH---HHHHHHHHcCc--CcccCCCc-CCC----CHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 99974321 22222111110 11111110 011 234455555533 2344567999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=314.08 Aligned_cols=239 Identities=18% Similarity=0.208 Sum_probs=185.3
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||.||++.... ..+|+|.+... ....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 369999999999998865 68999986532 123467888888777 799999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|..++...+ .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 99998886542 6889999999999999999999987 99999999999999999999999999875322111 1
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCCh--hHHHHHHHhhcCCCcccccccCCCCC
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSY--EALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||........ .....+.......... ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-------~~p 225 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-------RIP 225 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-------CCC
Confidence 2233567889999999999999999999999999999999999963221111 1111111111100100 122
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKM 346 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~ 346 (382)
...+..+.+++.+||+.||.+||+.
T Consensus 226 ~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 226 RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 2334567889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=320.01 Aligned_cols=248 Identities=22% Similarity=0.225 Sum_probs=195.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|...+.||+|+||+||++.... ..+|+|.+... ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 357888999999999999998764 68999986542 2245788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++.... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 81 e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999997642 25888999999999999999999987 99999999999999999999999999987654
Q ss_pred ccccCCCcccccccccCccccc------cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEE------SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
..........+++.|+|||++. ...++.++|||||||++|||++|+.||..... ......+... ....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~~~---~~~~ 228 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKTYNNIMNF---QRFL 228 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHHHHHHHcC---CCcc
Confidence 3332223345678899999986 45688999999999999999999999964321 1111111111 1111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. .......+..+.+++..|++ ||.+||++.++++
T Consensus 229 ~----~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 K----FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C----CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 00111234567788889998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=318.87 Aligned_cols=249 Identities=22% Similarity=0.261 Sum_probs=194.3
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
.++|+..+.||+|+||.||++.... ..+|+|.+.. .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 4678889999999999999999865 6899997643 1234577899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++... .+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 122 ~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 122 MEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999988643 4788888999999999999999987 9999999999999999999999999998764
Q ss_pred cccccCCCcccccccccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccc
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGV----FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVD 313 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (382)
...........+++.|+|||.+.... ++.++||||+||++|||++|+.||..... ......+..... .
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~---~~~~~~i~~~~~--~--- 265 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL---VGTYSKIMDHKN--S--- 265 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCc--c---
Confidence 33322223445788899999986543 78899999999999999999999974321 111111111100 0
Q ss_pred cccCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 016789 314 HRLAGTFTTEGMRDLIRLTLQCMSSPGRR--RPKMEIVMTE 352 (382)
Q Consensus 314 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~~v~~~ 352 (382)
+........+..+.+++..|++.++.+ ||++.++++.
T Consensus 266 --~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 --LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000111223456778888999865544 8899988775
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=312.37 Aligned_cols=236 Identities=25% Similarity=0.283 Sum_probs=187.2
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||+||+|...+ ..+|+|.+... ....+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999865 68999986532 234466777888764 899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 99999987542 5788889999999999999999987 9999999999999999999999999987432211 11
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....++..|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+...... +. ++..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~i~~~~-------~~----~~~~ 218 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD---EEELFQSIRMDN-------PC----YPRW 218 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCC-------CC----CCcc
Confidence 223346788999999999899999999999999999999999997432 223332222110 11 1112
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKME-IVM 350 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~-~v~ 350 (382)
....+.+++.+||+.||.+||++. ++.
T Consensus 219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 219 LTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 335678899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=298.81 Aligned_cols=246 Identities=26% Similarity=0.351 Sum_probs=199.2
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccC-----CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG-----SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|...+.||+|+||.||++.... ..+++|.... ....++.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 36677899999999999998854 7889987643 2345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++++|.+++.... ...+++.....++.+++.||.|||+.+ ++|+||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999997642 246889999999999999999999877 9999999999999999999999999988664432
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
... ....++..|+|||+..+..++.++|+||||+++|||++|+.||.... ............ ....
T Consensus 156 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~----------~~~~ 221 (256)
T cd08529 156 NFA-NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKIIRGV----------FPPV 221 (256)
T ss_pred chh-hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCC----------CCCC
Confidence 221 22345677999999999999999999999999999999999986433 222222221110 0111
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
+...+..+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 22345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=313.06 Aligned_cols=232 Identities=21% Similarity=0.247 Sum_probs=186.1
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||.||++.... +.+|+|.+... ....+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999864 68999986532 234567888888876 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 99999887643 5888999999999999999999987 9999999999999999999999999987532211 11
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....+++.|+|||.+.+..++.++|||||||++|||++|+.||.... .....+..... .. ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i~~~----~~-------~~~~~ 218 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILND----EV-------VYPTW 218 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcC----CC-------CCCCC
Confidence 223456788999999999999999999999999999999999997432 22222222211 00 11122
Q ss_pred HHHHHHHHHhhccCCCCCCCCCH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKM 346 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~ 346 (382)
.+..+.+++.+||+.||.+||++
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCC
Confidence 34567889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=318.38 Aligned_cols=257 Identities=20% Similarity=0.274 Sum_probs=192.4
Q ss_pred CCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG-----YQM 155 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 155 (382)
+|+..+.||+|+||.||++... +..+|+|++... ....+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4677889999999999999875 478999987542 2246789999999999999999999998776 789
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+|+||+. ++|.+.+... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 6787777543 36889999999999999999999987 99999999999999999999999999986
Q ss_pred cccccccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHH-------------
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQW------------- 301 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~------------- 301 (382)
.............++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+..
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 543332222333457789999998764 479999999999999999999999975432111110000
Q ss_pred ---HHhhcCCCcccccccC--CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 302 ---VRSRLSSNNFVDHRLA--GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 302 ---~~~~~~~~~~~d~~~~--~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
............+... .....+....+.+++.+||+.||.+|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000000 00111224567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=300.17 Aligned_cols=246 Identities=28% Similarity=0.446 Sum_probs=198.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECCeeEEEEEccCC-chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGS-PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGS 165 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 165 (382)
++|...+.||+|+||.||++...+..+++|..... ....+.+|+.++++++|||++++++++.... .+++|||+++|+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~ 84 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGN 84 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCCC
Confidence 45788899999999999999988889999987654 3457899999999999999999999987654 799999999999
Q ss_pred hhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCC
Q 016789 166 MCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPS 245 (382)
Q Consensus 166 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 245 (382)
|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...... ..
T Consensus 85 L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~~ 155 (254)
T cd05083 85 LVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VD 155 (254)
T ss_pred HHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceecccc----CC
Confidence 999997642 235789999999999999999999877 999999999999999999999999998754321 11
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHH
Q 016789 246 HGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEG 324 (382)
Q Consensus 246 ~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 324 (382)
....+..|+|||.+.+..++.++|+||||+++|||++ |+.||.... ............. ...+...
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~~~~~----------~~~~~~~ 222 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS---LKEVKECVEKGYR----------MEPPEGC 222 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC---HHHHHHHHhCCCC----------CCCCCcC
Confidence 1223456999999998889999999999999999998 888886432 2222222221111 1112234
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 016789 325 MRDLIRLTLQCMSSPGRRRPKMEIVMTELER 355 (382)
Q Consensus 325 ~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~ 355 (382)
+..+.+++.+||+.+|.+||++.++++.|++
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 5678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=302.59 Aligned_cols=251 Identities=25% Similarity=0.445 Sum_probs=200.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-----eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
.+|+..+.||+|+||.||+|.... ..+++|...... ..+|..|+.++++++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 346778899999999999998753 369999876432 34788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccc
Confidence 99999999999987532 35889999999999999999999977 9999999999999999999999999987654
Q ss_pred cccccCC----CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 238 NIEEAGP----SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 238 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
....... .....+..|+|||.+....++.++||||||+++||+++ |..||.... .....++......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~---~~~~~~~i~~~~~----- 229 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---NQDVINAIEQDYR----- 229 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC---HHHHHHHHHcCCc-----
Confidence 3222111 11112346999999999999999999999999999887 999986432 2223333321111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
...+.+.+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 230 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 -----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011233456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=318.00 Aligned_cols=255 Identities=19% Similarity=0.185 Sum_probs=193.1
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCC
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGS 165 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 165 (382)
.|...+.||+|+||.||++.+.. ..||+|... ...+.+|+++|++++||||+++++++...+..++|||++ .++
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~ 245 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSD 245 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCC
Confidence 57888899999999999999876 678998643 234678999999999999999999999999999999999 478
Q ss_pred hhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC-C
Q 016789 166 MCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG-P 244 (382)
Q Consensus 166 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~ 244 (382)
|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....... .
T Consensus 246 L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 246 LYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 888886532 26899999999999999999999987 9999999999999999999999999998654322111 1
Q ss_pred CcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCC-----ChhHHHHHHHhhcC-CCccc---c--
Q 016789 245 SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLG-----SYEALIQWVRSRLS-SNNFV---D-- 313 (382)
Q Consensus 245 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~-~~~~~---d-- 313 (382)
....++..|+|||++.+..++.++|||||||++|||++|..|+...... ....+.+.+..... ...+. .
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 2235788899999999999999999999999999999988765432211 11222222222100 00000 0
Q ss_pred --------------cccCCCCC---HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 314 --------------HRLAGTFT---TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 314 --------------~~~~~~~~---~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
+....... ......+.+++.+||+.||.+|||+.|+++.
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000 0112367789999999999999999999863
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=311.64 Aligned_cols=237 Identities=21% Similarity=0.238 Sum_probs=189.7
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||+||++.... ..+|+|.+... ....+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999998865 68999986532 234567888898888 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|..++...+ .+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 99998887543 5899999999999999999999987 99999999999999999999999999864321111 1
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....+++.|+|||.+.+..++.++|||||||++|||++|+.||.... ........... .. ..+..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~~i~~~----~~-------~~~~~ 218 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQSILED----EV-------RYPRW 218 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcC----CC-------CCCCc
Confidence 122346778999999999999999999999999999999999996432 22222222111 00 11222
Q ss_pred HHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKM-----EIVMT 351 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~-----~~v~~ 351 (382)
.+..+.+++.+||+.||.+||++ .++++
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 34678899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=313.12 Aligned_cols=237 Identities=22% Similarity=0.242 Sum_probs=188.9
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCC-CCccceeeEEEeCCeeEEEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRH-RNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 158 (382)
+|+..+.||+|+||.||+|...+ ..+|+|.+... ....+..|.+++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47778899999999999998875 58999986532 23467789999999976 46888999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++.... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999887543 5788899999999999999999987 99999999999999999999999999874321
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.. .......+++.|+|||++.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~-------~---- 218 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQSIMEHN-------V---- 218 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCC-------C----
Confidence 11 11223346788999999999999999999999999999999999996432 222222222110 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKM 346 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 346 (382)
.++...+..+.+++.+||+.||.+||+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1122234567889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=299.36 Aligned_cols=248 Identities=24% Similarity=0.442 Sum_probs=199.2
Q ss_pred hCCCCCCeeeccCcccEEEEEEC-CeeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR-DTVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
.+|+..+.||+|+||.||++.+. +..+++|..... ...+|.+|++++++++|||++++++++......++++||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 35777889999999999999876 478899987643 245799999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... ..+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||++..........
T Consensus 84 ~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 84 GCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999987532 25788999999999999999999987 9999999999999999999999999987654322221
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
......+..|+|||.+.++.++.++||||||+++|||++ |..||.... .....+...... ....+.
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~~~~---~~~~~~------- 224 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS---NSEVVETINAGF---RLYKPR------- 224 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHhCCC---CCCCCC-------
Confidence 222233457999999998889999999999999999998 899886422 222332222111 111111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L 353 (382)
..+..+.+++.+||+.+|++||++.++++.|
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1246788999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=329.46 Aligned_cols=251 Identities=19% Similarity=0.245 Sum_probs=197.9
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCC------
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG------ 152 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 152 (382)
.++|...+.||+|+||+||++... +..+|+|.+... ....+.+|+..+..++|+||+++...+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 457889999999999999999875 478999986532 1245788999999999999999988765432
Q ss_pred --eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeec
Q 016789 153 --YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADT 230 (382)
Q Consensus 153 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~Df 230 (382)
..++||||+++|+|.+++.... .....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEEEEec
Confidence 3689999999999999997643 22346889999999999999999999977 999999999999999999999999
Q ss_pred CCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC
Q 016789 231 GISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN 309 (382)
Q Consensus 231 Gla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 309 (382)
|+++........ ......+++.|+|||.+.+..++.++|||||||++|||++|+.||.... ............ .
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---~~~~~~~~~~~~-~- 262 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---MEEVMHKTLAGR-Y- 262 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHhcCC-C-
Confidence 999865432211 1223457788999999999999999999999999999999999996432 222222111110 0
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 310 NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 310 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
+ ..+...+..+.+++.+||+.||.+||++.++++.
T Consensus 263 ---~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 ---D-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ---C-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 1223345678899999999999999999998763
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=311.83 Aligned_cols=259 Identities=26% Similarity=0.427 Sum_probs=204.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC---------eeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCccceeeEEEeCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD---------TVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVTLLGYCQQNG 152 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 152 (382)
.+|...+.||+|+||.||++...+ ..+++|...... ..++.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468888999999999999997531 368999766432 34688999999999 7999999999999999
Q ss_pred eeEEEEeecCCCChhhhhhhcCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGL-----------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE 221 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~ 221 (382)
..++++||+++|+|.+++..... .....+++..++.++.|++.||.|||+.+ ++||||||+|||++.
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nill~~ 169 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTE 169 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcC
Confidence 99999999999999999976431 12346889999999999999999999977 999999999999999
Q ss_pred CCcEEEeecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHH
Q 016789 222 NFIAKVADTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALI 299 (382)
Q Consensus 222 ~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~ 299 (382)
++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.... .....
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~ 246 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---VEELF 246 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHHH
Confidence 9999999999998654322211 122233456999999999999999999999999999999 788875432 22222
Q ss_pred HHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 300 QWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 300 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
........ ...+...+..+.+++.+||+.+|.+||++.++++.|+++....
T Consensus 247 ~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 247 KLLKEGHR----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHcCCC----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 22221110 0112233467889999999999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=311.28 Aligned_cols=260 Identities=23% Similarity=0.362 Sum_probs=198.9
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC-------CeeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCccceeeEEEeC-C
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR-------DTVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVTLLGYCQQN-G 152 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 152 (382)
.++|+..+.||+|+||.||+|.+. .+.+|+|.+.... ...+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 356888999999999999999742 3689999876432 24578899999999 689999999988654 4
Q ss_pred eeEEEEeecCCCChhhhhhhcCCC--------------------------------------------------------
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGLE-------------------------------------------------------- 176 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 176 (382)
..+++|||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999998753210
Q ss_pred ------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc-cCCCcccc
Q 016789 177 ------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE-AGPSHGSI 249 (382)
Q Consensus 177 ------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~ 249 (382)
....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++........ .......+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 0124678888999999999999999987 99999999999999999999999999976532211 11122234
Q ss_pred cccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHH
Q 016789 250 VNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDL 328 (382)
Q Consensus 250 ~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l 328 (382)
+..|+|||.+.+..++.++||||||+++|||++ |..|+..... .............. ..+......+
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~~----------~~~~~~~~~~ 311 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEEFCRRLKEGTRM----------RAPDYTTPEM 311 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc--cHHHHHHHhccCCC----------CCCCCCCHHH
Confidence 556999999988889999999999999999997 8888864321 11222211111100 0011123467
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 329 IRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 329 ~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.+++.+||+.||.+||++.++++.|+.+.+.
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 8999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=310.18 Aligned_cols=238 Identities=19% Similarity=0.230 Sum_probs=188.9
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||.||+|...+ ..+|+|.+... ....+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999998865 58999986532 224567888888866 799999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|...+...+ .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 99998887543 5788899999999999999999987 99999999999999999999999999875322211 1
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....+++.|+|||.+.+..++.++|||||||++|||++|+.||.... .....+..... .. ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~~i~~~----~~-------~~p~~ 218 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFESILHD----DV-------LYPVW 218 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHHHHHHHHcC----CC-------CCCCC
Confidence 223346788999999999899999999999999999999999997432 22222222211 11 01112
Q ss_pred HHHHHHHHHhhccCCCCCCCC-------CHHHHHHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRP-------KMEIVMTE 352 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RP-------s~~~v~~~ 352 (382)
.+..+.+++.+||+.||++|| ++.++++.
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 235678899999999999999 67776643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=300.24 Aligned_cols=250 Identities=24% Similarity=0.269 Sum_probs=186.8
Q ss_pred eeeccCcccEEEEEECC----eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCC
Q 016789 94 LIGFGSFGPVYKGLLRD----TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGS 165 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~~----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 165 (382)
.||+|+||.||+|.... ..+++|...... ...|.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997533 478888765432 2367889999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC-C
Q 016789 166 MCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG-P 244 (382)
Q Consensus 166 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~ 244 (382)
|.+++...........++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 999998754333334567888899999999999999987 9999999999999999999999999987543221111 1
Q ss_pred CcccccccccCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 245 SHGSIVNVFRDPEVEES-------GVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 245 ~~~~~~~~y~aPE~~~~-------~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
....++..|+|||++.. ..++.++|||||||++|||++ |..||.... +...+...... ....+.++.+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~~~~~~~~~~--~~~~~~~~~~ 235 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS--DEQVLKQVVRE--QDIKLPKPQL 235 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC--HHHHHHHHhhc--cCccCCCCcc
Confidence 22234556999998643 357889999999999999999 677775332 11111111111 1111222222
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
+...+..+.+++..|| .||++||++++|++.|.
T Consensus 236 ----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 236 ----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2233455667788898 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=322.19 Aligned_cols=247 Identities=20% Similarity=0.225 Sum_probs=190.3
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+|+..+.||+|+||.||+++... ..+|+|.+... ....+.+|+++|++++||||+++++.+...+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 68888999999999999998765 68999987532 23457889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++|+|.+++.+.+ .++......++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999997643 5788888889999999999999987 999999999999999999999999997532100
Q ss_pred cc------------------------------------------cCCCcccccccccCccccccCCCCccchhHHHHHHH
Q 016789 240 EE------------------------------------------AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFL 277 (382)
Q Consensus 240 ~~------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl 277 (382)
.. .......+++.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00 000112467889999999999999999999999999
Q ss_pred HHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCC---CHHHHHHH
Q 016789 278 LELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRP---KMEIVMTE 352 (382)
Q Consensus 278 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP---s~~~v~~~ 352 (382)
|||++|+.||...... .......... ..... ......+..+.+++.+|+ .+|.+|+ ++.++++.
T Consensus 235 yell~G~~Pf~~~~~~---~~~~~i~~~~--~~~~~-----~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 235 YEMLVGQPPFLADTPA---ETQLKVINWE--TTLHI-----PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eehhhCCCCCCCCCHH---HHHHHHhccC--ccccC-----CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999999754321 1111111100 00000 001122345566777766 4999999 77887754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=297.22 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=190.1
Q ss_pred CeeeccCcccEEEEEECC-----eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEEEeecC
Q 016789 93 SLIGFGSFGPVYKGLLRD-----TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQ-NGYQMLVFEYLP 162 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 162 (382)
+.||+|+||.||+|.+.+ ..+|+|...... ...+.+|+.+++.++||||+++++++.. ++..++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998642 478999875422 3468889999999999999999998764 456789999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+|+|.+++.... ....+.....++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999987542 24577788899999999999999977 999999999999999999999999999755432211
Q ss_pred C---CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCC-CCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 243 G---PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ-EASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 243 ~---~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
. .....++..|+|||.+....++.++||||||+++|||++|+ +|+... .............. .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~~~~~~~~~~~~---~------- 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---DSFDITVYLLQGRR---L------- 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHhcCCC---C-------
Confidence 1 11223455799999998888999999999999999999965 455422 22222222221110 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
..+...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 011123457889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=302.89 Aligned_cols=243 Identities=19% Similarity=0.256 Sum_probs=189.2
Q ss_pred eeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCCh
Q 016789 95 IGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 95 lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 166 (382)
||+|+||.||++.... ..+|+|.+... ....+..|++++++++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999998764 78999976532 123456799999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCc
Q 016789 167 CNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH 246 (382)
Q Consensus 167 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 246 (382)
.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~ 153 (277)
T cd05607 81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQ 153 (277)
T ss_pred HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eec
Confidence 98886542 235788999999999999999999977 99999999999999999999999999876543221 122
Q ss_pred ccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHH
Q 016789 247 GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMR 326 (382)
Q Consensus 247 ~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 326 (382)
..++..|+|||++.+..++.++||||+||++|||++|+.||........ .......... ... . .. ....+.
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~-~~~-~--~~---~~~~~~ 224 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLE-DEV-K--FE---HQNFTE 224 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhc-ccc-c--cc---cccCCH
Confidence 3466789999999988899999999999999999999999864322111 1111111110 000 0 00 012345
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHH
Q 016789 327 DLIRLTLQCMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 327 ~l~~l~~~cl~~dp~~RPs~~~v~~~L 353 (382)
.+.+++.+||+.||.+||+++|+++.+
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccchhhh
Confidence 678999999999999999998876443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=305.91 Aligned_cols=263 Identities=25% Similarity=0.393 Sum_probs=204.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
.+|+..+.||+|+||.||+|.+.. ..+++|...... ..++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 457778899999999999998742 257888766432 23678899999999999999999998764 4678
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
++||+++|+|.+++.... ..+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999987542 25788899999999999999999977 999999999999999999999999999866
Q ss_pred cccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 237 ENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 237 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
...... .......+..|+|||.+.+..++.++||||||+++|||++ |+.|+.... .....++.......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~~------ 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDLLEKGERL------ 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHCCCCC------
Confidence 432221 1112233557999999998899999999999999999998 888886432 22233333221111
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhhhhhccC
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFMGE 369 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~~~~~~~~ 369 (382)
..+..++..+.+++.+||..||++||++.++++.|+.+.........+.++
T Consensus 231 ----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~~ 281 (303)
T cd05110 231 ----PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGD 281 (303)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhheeeccC
Confidence 011123456889999999999999999999999999987665554444333
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=316.02 Aligned_cols=234 Identities=22% Similarity=0.226 Sum_probs=188.1
Q ss_pred CeeeccCcccEEEEEE-----CCeeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 93 SLIGFGSFGPVYKGLL-----RDTVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
+.||+|+||.||++.. .+..+|+|.+... ....+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 2368999986542 22356789999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+|+|.+++.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 999999986542 5889999999999999999999988 99999999999999999999999999876543211
Q ss_pred CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 243 GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
......+++.|+|||.+....++.++|||||||++|||++|+.||.... ............ ...+.
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~---~~~~~~~i~~~~-----------~~~p~ 219 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD---RKETMTMILKAK-----------LGMPQ 219 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC---HHHHHHHHHcCC-----------CCCCC
Confidence 1223346778999999998889999999999999999999999996432 222222221110 01122
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHH
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEI 348 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~ 348 (382)
..+..+.+++.+||+.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 33456788999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=313.34 Aligned_cols=237 Identities=22% Similarity=0.241 Sum_probs=189.0
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 158 (382)
+|...+.||+|+||.||+|.... ..+|+|.+... ....+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47778899999999999998875 58999986532 123466777888777 5899999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999886543 5788999999999999999999987 99999999999999999999999999875322
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.. .......+++.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+.+.... .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~-----------~ 218 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIMEHN-----------V 218 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCC-----------C
Confidence 11 11223356788999999999999999999999999999999999997432 223332222110 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKM 346 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 346 (382)
.++...+..+.+++.+||+.||.+|++.
T Consensus 219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1122334567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=301.87 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=200.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 155 (382)
++|+....||+|+||.||+|.... ..+++|...... .+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 568888999999999999998642 578998775432 246899999999999999999999999988999
Q ss_pred EEEeecCCCChhhhhhhcCCCC----CCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 156 LVFEYLPNGSMCNHLYETGLES----STKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
+||||+++|+|.+++....... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++|||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEcccc
Confidence 9999999999999997643111 225899999999999999999999987 9999999999999999999999999
Q ss_pred CccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCc
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNN 310 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 310 (382)
++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~~~~~---- 235 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRLQAGK---- 235 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHHHcCC----
Confidence 987543322222223344566999999988889999999999999999999 7778753321 22222221110
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 311 FVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 311 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
.....+...+..+.+++.+||+.||.+||++.++++.|.
T Consensus 236 -----~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 -----LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -----cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 001112234467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=318.02 Aligned_cols=246 Identities=19% Similarity=0.230 Sum_probs=187.3
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
.|+..+.||+|+||+||+|.... ..+|+|.+.... ...+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 57788999999999999998865 689999875421 2467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
||++|+|.+++.+.+ .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999987643 5788888899999999999999987 999999999999999999999999997533110
Q ss_pred cc----------------------------------------------cCCCcccccccccCccccccCCCCccchhHHH
Q 016789 240 EE----------------------------------------------AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSF 273 (382)
Q Consensus 240 ~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~ 273 (382)
.. .......+|+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 00 00011246788999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHH
Q 016789 274 GVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPK---MEIVM 350 (382)
Q Consensus 274 G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs---~~~v~ 350 (382)
||++|||++|+.||..... ............ . .........+....+++.+++ .||.+|++ +.+++
T Consensus 235 Gvil~elltG~~Pf~~~~~--~~~~~~i~~~~~---~-----~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTP--LETQMKVINWQT---S-----LHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred hHHHHHHHhCCCCCCCCCH--HHHHHHHHccCC---C-----cCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 9999999999999974321 111111111000 0 000001112344556666665 49999998 66665
Q ss_pred H
Q 016789 351 T 351 (382)
Q Consensus 351 ~ 351 (382)
+
T Consensus 304 ~ 304 (382)
T cd05625 304 A 304 (382)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=303.04 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=201.1
Q ss_pred hCCCCCCeeeccCcccEEEEEEC------CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEe--CCee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR------DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQ--NGYQ 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 154 (382)
++|...+.||+|+||.||++.+. +..+|+|...... ...|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677789999999999999864 3589999876443 3578999999999999999999999887 5578
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999997642 25899999999999999999999987 9999999999999999999999999998
Q ss_pred ccccccccC--CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCC------------hhHHHH
Q 016789 235 LLENIEEAG--PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS------------YEALIQ 300 (382)
Q Consensus 235 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~------------~~~~~~ 300 (382)
......... ......+..|++||...+..++.++||||||+++|||++|+.|+....... ...+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 765322111 112233456999999988899999999999999999999999876432211 111111
Q ss_pred HHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 301 WVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 301 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
+.... .....+..++..+.+++.+||+.+|.+||++.+|+++|+++
T Consensus 238 ~~~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEG----------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcC----------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111 01111223446788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=311.99 Aligned_cols=240 Identities=18% Similarity=0.189 Sum_probs=186.6
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||+||++.... ..+|+|..... ....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 369999999999998765 68999987642 123577899999888 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|..++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 99998886542 5899999999999999999999987 9999999999999999999999999987432211 11
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....+++.|+|||.+.+..++.++|||||||++|||++|+.||............++.......... ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~p~~ 225 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-------RIPRF 225 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-------CCCCC
Confidence 22345678899999999999999999999999999999999999643322211111111111100000 11222
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKME 347 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~ 347 (382)
.+..+.+++.+||+.||.+||++.
T Consensus 226 ~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 226 LSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCC
Confidence 335677899999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=319.23 Aligned_cols=247 Identities=18% Similarity=0.224 Sum_probs=190.1
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+|...+.||+|+||+||++.... ..+|+|.+... ....+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 67888999999999999998754 68999986532 12457889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++|+|.+++...+ .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 82 FLPGGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999987543 5788888889999999999999988 999999999999999999999999998633210
Q ss_pred ccc------------C----------------------------------CCcccccccccCccccccCCCCccchhHHH
Q 016789 240 EEA------------G----------------------------------PSHGSIVNVFRDPEVEESGVFSEMSDIYSF 273 (382)
Q Consensus 240 ~~~------------~----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvws~ 273 (382)
... . .....+++.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 001246788999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCC---CCHHHHH
Q 016789 274 GVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRR---PKMEIVM 350 (382)
Q Consensus 274 G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---Ps~~~v~ 350 (382)
||++|||++|+.||..... ........... ..+. +. ........+.+++.+|++ +|.+| |++.+++
T Consensus 235 Gvil~elltG~~Pf~~~~~---~~~~~~i~~~~--~~~~---~p--~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS---HETYRKIINWR--ETLY---FP--DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred chhhhhhhcCCCCCCCCCH---HHHHHHHHccC--CccC---CC--CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 9999999999999964332 11111111100 0000 00 011123567788889997 66665 5888877
Q ss_pred HH
Q 016789 351 TE 352 (382)
Q Consensus 351 ~~ 352 (382)
+.
T Consensus 304 ~h 305 (377)
T cd05629 304 SH 305 (377)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=310.70 Aligned_cols=236 Identities=22% Similarity=0.251 Sum_probs=186.5
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||.||++.+.. ..+|+|.+... ....+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999865 68999986532 234566777777754 899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 99999886542 5788899999999999999999987 9999999999999999999999999987432111 11
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+...... +.+ +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~---~~~~~~~~~~~~-------~~~----~~~ 218 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---EDELFESIRVDT-------PHY----PRW 218 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCC-------CCC----CCC
Confidence 223456788999999999999999999999999999999999996432 222222222110 111 112
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKME-IVM 350 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~-~v~ 350 (382)
....+.+++.+||+.||++||++. ++.
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 235677899999999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=300.22 Aligned_cols=249 Identities=24% Similarity=0.307 Sum_probs=194.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
.+|+..+.||+|+||.||+|.... ..+++|...... ...+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 468889999999999999998743 689999875432 345778999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999886532 5788999999999999999999877 99999999999999999999999999986543211
Q ss_pred cCCCcccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 242 AGPSHGSIVNVFRDPEVEE---SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
......++..|+|||.+. ...++.++|||||||++|||++|+.|+....... ..... ....+..+....
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~--~~~~~-----~~~~~~~~~~~~ 233 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFLM-----SKSNFQPPKLKD 233 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh--hheee-----ecCCCCCCCCcc
Confidence 112234567799999874 4457889999999999999999999986432111 10000 001111111111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
....+..+.+++.+||+.||++||+++++++.
T Consensus 234 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 234 --KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred --ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 12234678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=318.75 Aligned_cols=253 Identities=22% Similarity=0.252 Sum_probs=195.1
Q ss_pred HHHHHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 016789 82 LEQATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGY 153 (382)
Q Consensus 82 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 153 (382)
+....++|+..+.||+|+||.||++.... ..+|+|.+... ....+.+|+.+++.++||||+++++++.....
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34445789999999999999999999875 68899986431 22357789999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.++||||+++|+|.+++... .++......++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999988653 4677888889999999999999988 999999999999999999999999999
Q ss_pred cccccccccCCCcccccccccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEESGV----FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN 309 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 309 (382)
+.+............+++.|+|||++.... ++.++|||||||++|||++|+.||..... ......+.......
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~~~ 266 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMNHKNSL 266 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCcc
Confidence 876443322233445788899999986543 78999999999999999999999974321 11111111110000
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 016789 310 NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRR--RPKMEIVMTE 352 (382)
Q Consensus 310 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~~v~~~ 352 (382)
.+ ......+..+.+++.+|++.++.+ ||++.++++.
T Consensus 267 ~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 267 TF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 01 111233456778888999844433 7788888774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=305.58 Aligned_cols=252 Identities=20% Similarity=0.265 Sum_probs=194.9
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
+|+..+.||+|+||.||++.+.. ..+++|...... ...+.+|++++++++||||+++++++..++..++|+||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 57888999999999999998865 577888765432 245788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++++|.+++...+ .+++.....++.|++.||.|||+ ++ ++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 82 DGGSLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999997642 57888999999999999999997 46 9999999999999999999999999987553221
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc---CCCcc------
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL---SSNNF------ 311 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~------ 311 (382)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||...... .......... .....
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCcccccC
Confidence 12234567799999998888999999999999999999999998643321 1111111100 00000
Q ss_pred --------------ccccc---CCCCC-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 312 --------------VDHRL---AGTFT-TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 312 --------------~d~~~---~~~~~-~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.+... ....+ ......+.+++.+||+.||++||++.++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00000 1134568899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=296.71 Aligned_cols=244 Identities=25% Similarity=0.368 Sum_probs=195.5
Q ss_pred CeeeccCcccEEEEEECC-----eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD-----TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|++|.||+|.+.. ..+|+|...... .+.+.+|+.++++++||||+++++++.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998743 268999876543 3478899999999999999999999988 889999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc-
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA- 242 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~- 242 (382)
|+|.+++..... ..+++...+.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+......
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976432 46899999999999999999999977 999999999999999999999999999876442211
Q ss_pred -CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 243 -GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 243 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ............ ... ..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~--~~~-------~~ 222 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS---GSQILKKIDKEG--ERL-------ER 222 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHhcC--CcC-------CC
Confidence 1112334567999999998899999999999999999999 999986432 222222222111 000 11
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 2234567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=299.97 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=201.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECC------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
.+|+..+.||+|+||.||+|.+.. ..+++|...... ..++.+|+.++.+++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 457788999999999999998643 258888765442 2468899999999999999999999987 67899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
|+||+++|+|.+++.... ..+++.....++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.+
T Consensus 86 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999987642 24889999999999999999999977 999999999999999999999999999876
Q ss_pred ccccccCC-CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 237 ENIEEAGP-SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 237 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
........ .....+..|+|||.+....++.++|+||||+++||+++ |+.||.... ...+.+....... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~~~~~---~--- 230 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP---AVEIPDLLEKGER---L--- 230 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHHhCCCC---C---
Confidence 53322111 12223456999999988889999999999999999999 999987543 2233333322111 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
..+..+...+.+++.+||..||.+||++.++++.|+++..+
T Consensus 231 ----~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 231 ----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 11112335678899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=306.24 Aligned_cols=257 Identities=25% Similarity=0.333 Sum_probs=197.7
Q ss_pred hCCCCCCeeeccCcccEEEEEEC------CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeC--Cee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR------DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQ 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 154 (382)
+.|+..+.||+|+||.||++.+. +..+++|...... ...+.+|+.+++.++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 35678889999999999999753 3689999876432 34688999999999999999999998875 568
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCcccc
Confidence 89999999999999986532 25899999999999999999999987 9999999999999999999999999998
Q ss_pred cccccccc--CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCC--------Chh-HHHHHHH
Q 016789 235 LLENIEEA--GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLG--------SYE-ALIQWVR 303 (382)
Q Consensus 235 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~--------~~~-~~~~~~~ 303 (382)
.+...... ......++..|+|||++.+..++.++||||||+++|||++++.|....... ... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 66433221 112233455699999998888999999999999999999988765321100 000 0000000
Q ss_pred hhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 304 SRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 304 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
. .... ...+.+...+..+.+++.+||+.||.+||++.++++.|+.+
T Consensus 238 ~-~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 V-LEEG------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred H-HHcC------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0 0000 00111223456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=301.56 Aligned_cols=249 Identities=26% Similarity=0.359 Sum_probs=193.3
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC--chHHHHHHHHHHhcC-CCCCccceeeEEEeC------Ce
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS--PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQN------GY 153 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~~ 153 (382)
+...|+..+.||+|+||.||+|...+ ..+|+|..... ....+.+|+.++.++ +||||+++++++... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 44567778889999999999998864 68899986543 345788999999998 699999999998753 45
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.+++|||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 799999999999999987632 235889999999999999999999987 999999999999999999999999999
Q ss_pred cccccccccCCCcccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEE-----SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS 308 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 308 (382)
........ ......++..|+|||++. ...++.++|||||||++|||++|+.||...... ... . ......
T Consensus 159 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~--~~~-~-~~~~~~- 232 (272)
T cd06637 159 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--RAL-F-LIPRNP- 232 (272)
T ss_pred eecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH--HHH-H-HHhcCC-
Confidence 86543221 122334567799999985 345888999999999999999999998643211 111 1 001100
Q ss_pred CcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 309 NNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 309 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+.. .....+..+.+++.+||+.||.+||++.++++
T Consensus 233 ----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 ----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0111 11123456889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=297.49 Aligned_cols=235 Identities=25% Similarity=0.397 Sum_probs=185.9
Q ss_pred CeeeccCcccEEEEEECCe------------eEEEEEccCCc--hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 93 SLIGFGSFGPVYKGLLRDT------------VVAIKRRVGSP--RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~~------------~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
+.||+|+||.||+|.+... .+++|...... ...|.+|+.+++.++||||+++++++.. ...++|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 3689999999999988653 37777655433 4678899999999999999999999988 7789999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC-------cEEEeecC
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF-------IAKVADTG 231 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~-------~~kl~DfG 231 (382)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 80 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999997643 16888999999999999999999877 99999999999999888 79999999
Q ss_pred CccccccccccCCCcccccccccCccccccC--CCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCC
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEESG--VFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSS 308 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 308 (382)
++...... ....++..|+|||.+... .++.++||||||+++|||++ |..|+...... ....+....
T Consensus 154 ~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~~~~~~~~--- 222 (259)
T cd05037 154 IPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EKERFYQDQ--- 222 (259)
T ss_pred cccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hHHHHHhcC---
Confidence 99865431 112234569999998876 78999999999999999999 46676543321 111111110
Q ss_pred CcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 309 NNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 309 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
... +......+.+++.+||+.+|.+||++.++++.|+
T Consensus 223 ~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 HRL---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCC---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0001167889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=302.53 Aligned_cols=246 Identities=19% Similarity=0.258 Sum_probs=194.3
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
|+..+.||+|+||.||++.... +.+|+|...... ...+.+|+.++++++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 6667889999999999998865 689999765321 23467899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999886532 235888999999999999999999877 9999999999999999999999999987653322
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
.. ....++..|+|||.+.+..++.++||||||+++|||++|+.||.................... ..+
T Consensus 157 ~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~----------~~~ 224 (285)
T cd05630 157 TI--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ----------EEY 224 (285)
T ss_pred cc--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh----------hhc
Confidence 11 123467789999999999999999999999999999999999975332111111111111000 011
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPK-----MEIVMT 351 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs-----~~~v~~ 351 (382)
+......+.+++.+||+.||++||+ +.++++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 2223456789999999999999999 778776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=298.47 Aligned_cols=235 Identities=24% Similarity=0.343 Sum_probs=182.5
Q ss_pred CeeeccCcccEEEEEECC--------------eeEEEEEccCCch---HHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 016789 93 SLIGFGSFGPVYKGLLRD--------------TVVAIKRRVGSPR---QEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--------------~~vavK~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 155 (382)
+.||+|+||.||+|.+.. ..+++|....... ..|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999997532 2578887654332 36788999999999999999999999998999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc-------EEEe
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI-------AKVA 228 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~-------~kl~ 228 (382)
++|||+++|+|..++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999988876532 35889999999999999999999977 999999999999987654 8999
Q ss_pred ecCCccccccccccCCCcccccccccCccccc-cCCCCccchhHHHHHHHHHHH-hCCCCCCccCCCChhHHHHHHHhhc
Q 016789 229 DTGISKLLENIEEAGPSHGSIVNVFRDPEVEE-SGVFSEMSDIYSFGVFLLELV-TGQEASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 229 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvws~G~vl~el~-tg~~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
|||++....... ...++..|+|||.+. +..++.++|||||||++|||+ +|..|+...... ..........
T Consensus 155 d~g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~~~~ 226 (262)
T cd05077 155 DPGIPITVLSRQ-----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA---EKERFYEGQC 226 (262)
T ss_pred CCCCCccccCcc-----cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh---HHHHHHhcCc
Confidence 999987553221 223456699999886 466899999999999999998 577776532211 1111111000
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 016789 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 307 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L 353 (382)
.. .......+.+++.+||+.||.+||++.++++.|
T Consensus 227 --------~~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 --------ML----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --------cC----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 111235678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=330.65 Aligned_cols=263 Identities=25% Similarity=0.399 Sum_probs=212.8
Q ss_pred HHHHHhCCCCCCeeeccCcccEEEEEEC---------CeeEEEEEccCC----chHHHHHHHHHHhcC-CCCCccceeeE
Q 016789 82 LEQATKQFSETSLIGFGSFGPVYKGLLR---------DTVVAIKRRVGS----PRQEFVAEVTYLSEI-RHRNLVTLLGY 147 (382)
Q Consensus 82 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~ 147 (382)
++...++....+.||+|.||.|++|... ...||||..... ..+.+..|+++|+.+ +||||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 4445555666679999999999999754 247999987653 245799999999999 59999999999
Q ss_pred EEeCCeeEEEEeecCCCChhhhhhhcC---------CCCCC--cCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCC
Q 016789 148 CQQNGYQMLVFEYLPNGSMCNHLYETG---------LESST--KLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTAN 216 (382)
Q Consensus 148 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~N 216 (382)
|...+..++|.||+..|+|.++|+..+ ..... .+.....+.++.|||.|++||++.+ +|||||.++|
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRN 448 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARN 448 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhh
Confidence 999999999999999999999999876 11122 3899999999999999999999877 9999999999
Q ss_pred eeecCCCcEEEeecCCccccccccccCCCcc--cccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCC
Q 016789 217 VLVDENFIAKVADTGISKLLENIEEAGPSHG--SIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLG 293 (382)
Q Consensus 217 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~--~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~ 293 (382)
||++++..+||+|||+|+...+......... ..+..|||||.+....|+.+|||||||++||||+| |..|+....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-- 526 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-- 526 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--
Confidence 9999999999999999997655544432222 24566999999999999999999999999999999 667765311
Q ss_pred ChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 016789 294 SYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358 (382)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~ 358 (382)
....+.+++..+.. ...|..+...+.++++.||+.+|++||++.++++.|+....
T Consensus 527 ~~~~l~~~l~~G~r----------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 PTEELLEFLKEGNR----------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred cHHHHHHHHhcCCC----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 13344444444322 13344556788899999999999999999999999999654
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=300.97 Aligned_cols=234 Identities=22% Similarity=0.328 Sum_probs=182.0
Q ss_pred eeeccCcccEEEEEECC--------------------------eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccce
Q 016789 94 LIGFGSFGPVYKGLLRD--------------------------TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTL 144 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~~--------------------------~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l 144 (382)
.||+|+||.||+|.+.. ..|++|...... ..+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997521 257888775433 2468889999999999999999
Q ss_pred eeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC-
Q 016789 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF- 223 (382)
Q Consensus 145 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~- 223 (382)
++++......++||||+++|+|..++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCc
Confidence 999999999999999999999998886532 35788999999999999999999877 99999999999997643
Q ss_pred ------cEEEeecCCccccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHH-hCCCCCCccCCCCh
Q 016789 224 ------IAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELV-TGQEASHIVSLGSY 295 (382)
Q Consensus 224 ------~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~-tg~~p~~~~~~~~~ 295 (382)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-- 228 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS-- 228 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH--
Confidence 4899999988643221 11234566999998865 56899999999999999995 688888643321
Q ss_pred hHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 016789 296 EALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 296 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L 353 (382)
........... . +......+.+++.+||+.+|++||++.++++.|
T Consensus 229 -~~~~~~~~~~~--------~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 229 -EKERFYEKKHR--------L----PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -HHHHHHHhccC--------C----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11222221111 1 111124688899999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=294.34 Aligned_cols=247 Identities=30% Similarity=0.499 Sum_probs=199.7
Q ss_pred CeeeccCcccEEEEEEC-----CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLR-----DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||.||+|... ...+++|...... ...+.+|++.++.++|+||+++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 36899999999999886 5689999876543 35788999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCC----CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 164 GSMCNHLYETGLE----SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 164 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
++|.+++...... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||.+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999764211 1346899999999999999999999977 999999999999999999999999999876543
Q ss_pred cc-cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 240 EE-AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 240 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.. .......++..|+|||.+....++.++||||+|+++|||++ |..||.... .....+...... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~----------~ 225 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS---NEEVLEYLRKGY----------R 225 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCC----------C
Confidence 21 11223345667999999988889999999999999999999 588886542 223333222210 1
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
...+...+..+.+++.+||+.||.+||++.++++.|+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1122333577889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=300.11 Aligned_cols=247 Identities=27% Similarity=0.462 Sum_probs=195.2
Q ss_pred CeeeccCcccEEEEEECC--------eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 93 SLIGFGSFGPVYKGLLRD--------TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--------~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+.||+|+||.||+|...+ ..+++|..... ....+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 358999999999998753 46888875432 245788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCC--CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC-----cEEEeecCCc
Q 016789 161 LPNGSMCNHLYETGLE--SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF-----IAKVADTGIS 233 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~-----~~kl~DfGla 233 (382)
+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.+. .++++|||++
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999999764321 2335788999999999999999999877 99999999999999877 8999999998
Q ss_pred cccccccccCC-CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcc
Q 016789 234 KLLENIEEAGP-SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 234 ~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (382)
........... .....+..|+|||.+.+..++.++||||||+++|||++ |+.||.... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~---~~~~~~~~~~~~----- 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN---NQEVLQHVTAGG----- 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC---HHHHHHHHhcCC-----
Confidence 76543222111 12233567999999999999999999999999999998 999986332 122222221111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
....+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 231 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 -----RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -----ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00112334577889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=303.11 Aligned_cols=243 Identities=21% Similarity=0.303 Sum_probs=201.3
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc---hH---HHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP---RQ---EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~---~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
..+|++.+.||+|.||+|-+|... ++.||||.+..+. .+ .+.+|++||+.|+||||+.++.+|.+.+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 356888889999999999999764 4899999765432 22 467899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||..+|.|++++..++ .+++....+++.||..|+.|+|.++ ++|||||.+|||+|.|+++||+|||++..+.
T Consensus 132 MEYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999998875 7999999999999999999999988 9999999999999999999999999998775
Q ss_pred cccccCCCcccccccccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFS-EMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
...... +..|.+.|.+||.+.+.+|. +.+|-||+||+||.|+.|.-||+..+ ...++..+... ...
T Consensus 205 ~~kfLq--TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lvrQIs~G----aYr---- 271 (668)
T KOG0611|consen 205 DKKFLQ--TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLVRQISRG----AYR---- 271 (668)
T ss_pred cccHHH--HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHHHHhhcc----ccc----
Confidence 543332 34566889999999999875 57999999999999999999997543 33344332221 111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.++.+....-||.|+|..||++|-|+.+|..-
T Consensus 272 ----EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 272 ----EPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ----CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 12223456678899999999999999999865
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=312.27 Aligned_cols=256 Identities=20% Similarity=0.211 Sum_probs=196.0
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC----eeEEEEEccCCchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD----TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
..+|...+.||+|+||.||++...+ ..+++|..... ....+|+++|++++||||+++++++......+++|||+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY 168 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence 3579999999999999999997643 57888877543 34568999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
. ++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 169 ~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 169 K-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred C-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 5 6888888432 36899999999999999999999987 99999999999999999999999999976543322
Q ss_pred c-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChh-HHHHHHHhhcCCCcc--------
Q 016789 242 A-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYE-ALIQWVRSRLSSNNF-------- 311 (382)
Q Consensus 242 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~-------- 311 (382)
. ......+++.|+|||++....++.++|||||||++|||++|+.||......... .+...... ......
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~-~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC-MQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH-hccCccccCCccch
Confidence 1 122345788899999999999999999999999999999999999754432211 11111111 000000
Q ss_pred --------cccccCCCCC-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 312 --------VDHRLAGTFT-------TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 312 --------~d~~~~~~~~-------~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
........+. ......+.+++.+||+.||.+||++.+++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 1123467789999999999999999999875
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=312.48 Aligned_cols=233 Identities=21% Similarity=0.229 Sum_probs=183.7
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHH-HHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVT-YLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||+||+|.... ..+|+|.+... ....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 369999999999999864 78999986532 1233455544 56789999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 99999886542 5788889999999999999999987 9999999999999999999999999987532211 11
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....+++.|+|||.+.+..++.++|||||||++|||++|+.||.... .....+..... . ..+ ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~---~----~~~----~~~ 218 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---TAEMYDNILNK---P----LRL----KPN 218 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC---HHHHHHHHHcC---C----CCC----CCC
Confidence 223356788999999999999999999999999999999999997432 12222111110 0 011 122
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKME 347 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~ 347 (382)
.+..+.+++.+||+.||.+||++.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 246678899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=306.01 Aligned_cols=257 Identities=21% Similarity=0.306 Sum_probs=192.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
++|...+.||+|+||.||+|.... ..+|+|.+... ....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 457888999999999999998764 68999986532 224578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++ ++|.+++...+ ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LD-KDLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 97 48888876542 35788889999999999999999987 9999999999999999999999999987543222
Q ss_pred ccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh---------hcCCCc
Q 016789 241 EAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS---------RLSSNN 310 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~---------~~~~~~ 310 (382)
. ......++..|+|||.+.+ ..++.++|||||||++|||+||+.||......+.......... ......
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1 1222345678999998865 4589999999999999999999999975432211111110000 000000
Q ss_pred ccccccCC-------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 311 FVDHRLAG-------TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 311 ~~d~~~~~-------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+..... ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000 001123456789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=299.73 Aligned_cols=248 Identities=28% Similarity=0.392 Sum_probs=194.8
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCCchH-----HHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQ-----EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~-----~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
|+..+.||+|+||+||++.... ..+|+|........ ....|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4556789999999999999987 57999997765432 2345899999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp TTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred cccccccccccc-----cccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccc-cc
Confidence 999999999843 26899999999999999999999987 99999999999999999999999999975411 11
Q ss_pred cCCCcccccccccCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEE-SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
.......++..|+|||.+. ...++.++||||+|+++|+|++|..|+......+........... ........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~--- 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR----PLPSSSQQ--- 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT----HHHHHTTS---
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc----cccccccc---
Confidence 2223345577899999998 788999999999999999999999999754211111211111110 00000000
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.......+.+++.+||+.||++||++.++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011268899999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=311.41 Aligned_cols=237 Identities=20% Similarity=0.206 Sum_probs=184.9
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHH-HHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEV-TYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||.||++.... ..+|+|...... ...+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 369999999999998865 679999865321 12344444 356788999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... .+.......++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 99999887543 5677888889999999999999988 9999999999999999999999999987542211 12
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||.... .....+..... .. .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~---~~--------~~~~~ 218 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNILNK---PL--------QLKPN 218 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC---HHHHHHHHHhC---Cc--------CCCCC
Confidence 223456788999999999999999999999999999999999997432 12222222111 00 11122
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+..+.+++.+||+.||.+||++.+.+.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 219 ITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 3456788999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=300.79 Aligned_cols=246 Identities=19% Similarity=0.238 Sum_probs=193.0
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
|+..+.||+|+||+||++.+.. +.+|+|...... ...+.+|++++++++|+||+++.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 5666889999999999998864 689999865321 23477899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++|+|.+++...+ ...+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998886542 235899999999999999999999977 9999999999999999999999999987553221
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
. .....++..|+|||.+.+..++.++|+||||+++|||++|..||........ ............ ..+
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~-------~~~ 224 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETE-------EVY 224 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccc-------ccc
Confidence 1 1233567789999999988999999999999999999999999974322111 111111110000 011
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPK-----MEIVMT 351 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs-----~~~v~~ 351 (382)
+...+..+.+++..||+.||++||+ +.+++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 2233456788999999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=331.84 Aligned_cols=260 Identities=18% Similarity=0.180 Sum_probs=201.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
.+|+..+.||+|+||.||+|.... +.||+|++... ..++|.+|++++++++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 368888999999999999998864 78999987542 1346899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCC------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCC
Q 016789 159 EYLPNGSMCNHLYETGL------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI 232 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGl 232 (382)
||+++|+|.+++..... ......++...+.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999999865321 11234667788999999999999999987 99999999999999999999999999
Q ss_pred ccccccccc-----------------cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCCh
Q 016789 233 SKLLENIEE-----------------AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSY 295 (382)
Q Consensus 233 a~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~ 295 (382)
++....... .......+|+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-- 237 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-- 237 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh--
Confidence 986521110 0011234788899999999999999999999999999999999999642211
Q ss_pred hHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHHh
Q 016789 296 EALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRP-KMEIVMTELERIHEK 359 (382)
Q Consensus 296 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~~v~~~L~~i~~~ 359 (382)
.... . ... .++... ....+.+..+.+++.+||+.||++|| +++++.+.|+.....
T Consensus 238 -ki~~-~-~~i-----~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 -KISY-R-DVI-----LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred -hhhh-h-hhc-----cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1110 0 000 000000 00123346688899999999999995 677788888877543
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=299.31 Aligned_cols=245 Identities=22% Similarity=0.295 Sum_probs=191.3
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
+|+..+.||+|+||.||+|.+.. ..+|+|..... ...++.+|++++.+++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 57778899999999999998754 68999986533 1246889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++|+|..+. .+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++..+....
T Consensus 82 ~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 82 DGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999986542 4677888899999999999999977 9999999999999999999999999997654321
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChh-HHHHHHHhhcCCCcccccccCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYE-ALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||......... ............. .+...
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 221 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED---PPVLP--- 221 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---CCCCC---
Confidence 12234567799999999889999999999999999999999998643321111 0111111100000 01110
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
....+..+.+++.+||+.||++||++.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11223567899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=298.31 Aligned_cols=248 Identities=22% Similarity=0.226 Sum_probs=199.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
+.|+..+.||+|.-|+||++...+ ..+|+|.+.+.. ..+...|.+||+.+.||.+.+||+.++.++..+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456667889999999999999988 689999876542 235678999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
|||+||+|...++++ .+..+++....-.+.++..||+|||..| ||.|||||+||||.++|++.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQ---p~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ---PGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhC---CCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999999988765 3567999999999999999999999988 99999999999999999999999998743210
Q ss_pred ---------------------------------c-cc---------------------cCCCcccccccccCccccccCC
Q 016789 239 ---------------------------------I-EE---------------------AGPSHGSIVNVFRDPEVEESGV 263 (382)
Q Consensus 239 ---------------------------------~-~~---------------------~~~~~~~~~~~y~aPE~~~~~~ 263 (382)
. .. .......||..|.|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 00 0001123567799999999999
Q ss_pred CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCC
Q 016789 264 FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRR 343 (382)
Q Consensus 264 ~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R 343 (382)
.+.++|+|+||+++|||+.|..||.... ..+.+.+.+.... .-.-.++.+....+||++.|.+||.+|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~--~~~Tl~NIv~~~l----------~Fp~~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSN--NKETLRNIVGQPL----------KFPEEPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCC--chhhHHHHhcCCC----------cCCCCCcchhHHHHHHHHHhccChhhh
Confidence 9999999999999999999999997543 3333333332221 111122556788899999999999999
Q ss_pred CC----HHHHHH
Q 016789 344 PK----MEIVMT 351 (382)
Q Consensus 344 Ps----~~~v~~ 351 (382)
.. +.||-+
T Consensus 380 lg~~rGA~eIK~ 391 (459)
T KOG0610|consen 380 LGSKRGAAEIKR 391 (459)
T ss_pred hccccchHHhhc
Confidence 98 666544
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=301.11 Aligned_cols=246 Identities=20% Similarity=0.285 Sum_probs=197.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC---chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS---PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
.+|+..+.||+|+||.||+|.... ..+++|..... ....+.+|+.+++.++||||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 467788899999999999998753 68999876543 2356888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999988642 4788899999999999999999987 99999999999999999999999999876543221
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
. .....+++.|+|||.+.+..++.++|||||||++|||++|+.||..... ........... . +.. ..+
T Consensus 172 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~--~~~~~~~~~~~--~-----~~~--~~~ 239 (296)
T cd06654 172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIATNG--T-----PEL--QNP 239 (296)
T ss_pred c-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH--HHhHHHHhcCC--C-----CCC--CCc
Confidence 1 1223456779999999988899999999999999999999999964322 11111111100 0 000 112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
...+..+.+++.+||..||++||++.++++.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 3345678899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=294.33 Aligned_cols=247 Identities=25% Similarity=0.333 Sum_probs=199.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
++|+..+.||+|+||.||++.... ..+++|...... .+++.+|++++++++||||+++++++......++++||+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 568888899999999999999875 688999876443 56799999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
++|.+++.... ..+++.....++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........ .
T Consensus 83 ~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 83 GSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 99999986532 36899999999999999999999987 99999999999999999999999999987644321 1
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .... .. ... .+.+ ..+..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~--~~~~-~~-~~~-----~~~~--~~~~~ 224 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR--AIFM-IP-NKP-----PPTL--SDPEK 224 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh--hhhh-hc-cCC-----CCCC--Cchhh
Confidence 222335667999999998899999999999999999999999987432211 1110 00 000 0011 11233
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
....+.+++.+||+.||.+||++.++++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 4467889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=292.34 Aligned_cols=262 Identities=21% Similarity=0.281 Sum_probs=199.9
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCC-ccceeeEEEeCC------e
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRN-LVTLLGYCQQNG------Y 153 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------~ 153 (382)
.|...+.||+|+||+||+|+... ..||+|++.-.. .....+|+.+|++++|+| |+++++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 35556679999999999998764 689999865432 234689999999999999 999999998877 7
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
+++|+||++ -+|..++....... ..++...+..+..|++.||+|||+++ |+||||||.||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccchH
Confidence 899999995 58999998764321 35667889999999999999999988 999999999999999999999999999
Q ss_pred cccccccccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCc--
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNN-- 310 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 310 (382)
+...-+.. ..+....|..|+|||++.+. .|+...||||+||++.||+++++.|.... +..++....+....+.+
T Consensus 168 ra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s--e~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 168 RAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS--EIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc--HHHHHHHHHHHcCCCCccC
Confidence 85542221 23445567789999998776 69999999999999999999998887543 34444444443222211
Q ss_pred ------ccccc--cCCC-----CCHHHH---HHHHHHHhhccCCCCCCCCCHHHHHHH--HHHH
Q 016789 311 ------FVDHR--LAGT-----FTTEGM---RDLIRLTLQCMSSPGRRRPKMEIVMTE--LERI 356 (382)
Q Consensus 311 ------~~d~~--~~~~-----~~~~~~---~~l~~l~~~cl~~dp~~RPs~~~v~~~--L~~i 356 (382)
+.+.. +... .....+ ....+++.+|++.+|.+|.|++.+++. +..+
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 11111 1111 111111 377899999999999999999999876 5444
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=292.34 Aligned_cols=265 Identities=20% Similarity=0.294 Sum_probs=211.9
Q ss_pred HHHHHHHhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEE
Q 016789 80 EELEQATKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYC 148 (382)
Q Consensus 80 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~ 148 (382)
.++...+.+++...++-+|.||.||+|.|.+ +.|.+|..+... ...++.|.-.+..+.|||+....+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3444445567778889999999999997764 245556544322 24588899999999999999999998
Q ss_pred EeC-CeeEEEEeecCCCChhhhhhhcCC---CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc
Q 016789 149 QQN-GYQMLVFEYLPNGSMCNHLYETGL---ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI 224 (382)
Q Consensus 149 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~ 224 (382)
.++ ...+.++.++..|+|..+|..++. ...+.++..+...++.|++.|++|||+++ +||.||.++|++||+...
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhhee
Confidence 765 467888999999999999985542 23446788899999999999999999988 999999999999999999
Q ss_pred EEEeecCCccccccccccCCCc-ccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHH
Q 016789 225 AKVADTGISKLLENIEEAGPSH-GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWV 302 (382)
Q Consensus 225 ~kl~DfGla~~~~~~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~ 302 (382)
+||+|-.+++.+-+.+...... ...+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++ .++..++
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP---fEm~~yl 511 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP---FEMEHYL 511 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH---HHHHHHH
Confidence 9999999999876655544322 223456999999999999999999999999999999 8888875543 3444444
Q ss_pred HhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 303 RSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 303 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.++.+. ..+-.+++++..++.-||..+|++||+++|++.-|.+...+
T Consensus 512 kdGyRl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 512 KDGYRL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred hcccee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 443322 23456778899999999999999999999999999987643
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=291.82 Aligned_cols=246 Identities=29% Similarity=0.491 Sum_probs=198.8
Q ss_pred CCCCeeeccCcccEEEEEECC------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 90 SETSLIGFGSFGPVYKGLLRD------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 90 ~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+..+.||.|+||.||++.... ..+++|...... ...+..|+..+..++|+||+++++++...+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999999875 679999876543 3478899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 82 YMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred ccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999999876431 12899999999999999999999987 999999999999999999999999999876544
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.........++..|+|||.+.+..++.++||||+|+++|||++ |.+|+... ......+........
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~---~~~~~~~~~~~~~~~---------- 223 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM---SNEEVLEYLKKGYRL---------- 223 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhcCCCC----------
Confidence 3222222335678999999988889999999999999999999 77777542 223333332221110
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L 353 (382)
..+...+..+.+++.+||+.||++||++.++++.|
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11122456788899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=294.62 Aligned_cols=246 Identities=22% Similarity=0.296 Sum_probs=196.4
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
+|+..+.||+|+||.||++.... ..+++|..... ..+.+.+|+.+++.++||||+++++.+...+..++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 36777899999999999998764 68899976422 2356788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++|+|.+++.... ...++......++.|++.||.|||+.+ ++|+||||+||++++++.++++|||++........
T Consensus 81 ~~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999886532 235788899999999999999999987 99999999999999999999999999976543222
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
. .....++..|+|||++.+..++.++|+||||+++|+|++|+.||.... ........... ... ..+
T Consensus 156 ~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~---~~~~~~~~~~~-~~~---------~~~ 221 (255)
T cd08219 156 Y-ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS---WKNLILKVCQG-SYK---------PLP 221 (255)
T ss_pred c-cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC---HHHHHHHHhcC-CCC---------CCC
Confidence 1 122345677999999998889999999999999999999999997432 12222111111 000 112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
...+..+.+++.+||+.||.+||++.+++..
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 2334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=307.55 Aligned_cols=238 Identities=21% Similarity=0.243 Sum_probs=188.8
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 158 (382)
+|...+.||+|+||.||++.... ..+|+|.+... ....+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 36677899999999999998764 68999986532 2235777888888885 578888999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++...+ .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999886543 5889999999999999999999987 99999999999999999999999999875422
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
... ......+++.|+|||++.+..++.++|||||||++|||++|+.||.... .....+...... .
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~----~------- 218 (323)
T cd05615 154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED---EDELFQSIMEHN----V------- 218 (323)
T ss_pred CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCC----C-------
Confidence 111 1223346788999999999999999999999999999999999997432 222222222110 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKME 347 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ 347 (382)
.++...+..+.+++.+||+.||.+|++..
T Consensus 219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 11222345678899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=310.04 Aligned_cols=254 Identities=19% Similarity=0.249 Sum_probs=190.6
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCC-----
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG----- 152 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 152 (382)
..++|+..+.||+|+||.||++.... ..+|+|.+... ....+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 34678999999999999999998754 68999987532 2346788999999999999999999986543
Q ss_pred -eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 153 -YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 153 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCC
Confidence 47999999964 66666532 3778888899999999999999987 9999999999999999999999999
Q ss_pred CccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHH---------
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWV--------- 302 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~--------- 302 (382)
+++...... ......+++.|+|||.+.+..++.++|||||||++|||++|+.||...+.. .......
T Consensus 169 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 169 LARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI--DQWNKVIEQLGTPSAE 244 (359)
T ss_pred CccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCcHH
Confidence 997543211 122345677899999999999999999999999999999999999743211 1110000
Q ss_pred -------------HhhcCCC-----cccccccC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 303 -------------RSRLSSN-----NFVDHRLA---GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 303 -------------~~~~~~~-----~~~d~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
....... +....... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 00000000 00011124567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=311.05 Aligned_cols=237 Identities=19% Similarity=0.206 Sum_probs=185.0
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHH-HHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVT-YLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||+||++.... ..+|+|..... ....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 369999999999998754 68999986532 1234555554 46778999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|..++.... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 152 (325)
T cd05604 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-T 152 (325)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-C
Confidence 99998886543 6889999999999999999999987 99999999999999999999999999875322111 1
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....+++.|+|||.+.+..++.++|||||||++|||++|+.||.... .....+..... .. . ..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~~~~~---~~----~----~~~~ 218 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---VAEMYDNILHK---PL----V----LRPG 218 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC---HHHHHHHHHcC---Cc----c----CCCC
Confidence 223456788999999999999999999999999999999999997432 12222211110 00 0 1112
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+..+.+++.+|++.||.+||++.+.++
T Consensus 219 ~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 219 ASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred CCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 3356778899999999999999874433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=305.77 Aligned_cols=191 Identities=17% Similarity=0.233 Sum_probs=162.7
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
...|...+.||+|+||.||+|.... ..+|+|..... ....|+.++++++||||+++++++......++|+||+ .
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~ 140 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-S 140 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-C
Confidence 4579999999999999999999875 58899874432 3456999999999999999999999999999999999 4
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 141 ~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~ 212 (357)
T PHA03209 141 SDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--A 212 (357)
T ss_pred CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccCc--c
Confidence 68888886532 36899999999999999999999987 9999999999999999999999999997533211 1
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASH 288 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~ 288 (382)
.....++..|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 123346788999999999999999999999999999999766553
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=291.95 Aligned_cols=243 Identities=29% Similarity=0.452 Sum_probs=194.1
Q ss_pred CeeeccCcccEEEEEEC-CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCChh
Q 016789 93 SLIGFGSFGPVYKGLLR-DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMC 167 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 167 (382)
+.||+|+||.||++... +..+++|...... ...+.+|++++++++||||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36899999999999886 5889999865432 347889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCC-Cc
Q 016789 168 NHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP-SH 246 (382)
Q Consensus 168 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~~ 246 (382)
+++.... ..+++.....++.+++.+|.|||+.+ ++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9986532 25788899999999999999999887 99999999999999999999999999986542211111 11
Q ss_pred ccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHH
Q 016789 247 GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGM 325 (382)
Q Consensus 247 ~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 325 (382)
...+..|+|||.+.++.++.++|+||||+++|||+| |..||..... ........... ....+...+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~---~~~~~~~~~~~----------~~~~~~~~~ 221 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN---QQTRERIESGY----------RMPAPQLCP 221 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH---HHHHHHHhcCC----------CCCCCccCC
Confidence 223456999999988889999999999999999999 7888754332 11122111110 011123345
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 326 RDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 326 ~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
..+.+++.+||+.+|.+||++.++++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 67889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=307.37 Aligned_cols=251 Identities=21% Similarity=0.217 Sum_probs=190.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|+||.||++.... ..+|+|.+.. .....+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 368888999999999999998864 6899998653 12345788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++.+.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999986532 35788889999999999999999988 99999999999999999999999999876543
Q ss_pred ccccCCCcccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccc
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEES-----GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVD 313 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (382)
..........+++.|+|||++.. ..++.++|||||||++|||++|+.||..... ...............+
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~---~~~~~~i~~~~~~~~~-- 229 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNHKEHFQF-- 229 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH---HHHHHHHHcCCCcccC--
Confidence 33222223456788999999863 4578899999999999999999999964321 1111111111000000
Q ss_pred cccCCCCCHHHHHHHHHHHhhccCCC--CCCCCCHHHHHHH
Q 016789 314 HRLAGTFTTEGMRDLIRLTLQCMSSP--GRRRPKMEIVMTE 352 (382)
Q Consensus 314 ~~~~~~~~~~~~~~l~~l~~~cl~~d--p~~RPs~~~v~~~ 352 (382)
+.. ....+..+.+++.+|+..+ +..||++.++++.
T Consensus 230 ~~~----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 PPD----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCc----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 000 1123455677777776543 3347888888776
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=306.32 Aligned_cols=246 Identities=20% Similarity=0.250 Sum_probs=205.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 156 (382)
...|...+.||.|.||.||+++.+. ..+|+|.+.... ...+.+|+.+|+++. ||||+.+.+++.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4568888999999999999999876 689999865432 357899999999998 9999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC----CcEEEeecCC
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN----FIAKVADTGI 232 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~----~~~kl~DfGl 232 (382)
|||+|.||.|.+.+... .+++.....++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999765 2899999999999999999999988 9999999999999643 5799999999
Q ss_pred ccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 233 SKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
+..... ........||+.|+|||++....|+..+||||+|+++|.|++|.+||...... ..........
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~--~~~~~i~~~~------- 254 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF--EIFLAILRGD------- 254 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh--HHHHHHHcCC-------
Confidence 998765 33445667899999999999999999999999999999999999999754321 1222111111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+..+.-......+.+++..++..||.+|+++.++++
T Consensus 255 -~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 255 -FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 12222333455678889999999999999999999998
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=308.23 Aligned_cols=233 Identities=21% Similarity=0.237 Sum_probs=183.1
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHH-HHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVT-YLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
++||+|+||.||+|.... ..+|+|.+... ....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999864 68999986532 1234555554 67889999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|...+... ..++......++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (321)
T cd05603 81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-T 152 (321)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-c
Confidence 9998888653 25788888899999999999999987 99999999999999999999999999875322111 1
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....+++.|+|||.+.+..++.++|||||||++|||++|+.||.... .....+..... . ...+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~----~-------~~~~~~ 218 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---VSQMYDNILHK----P-------LQLPGG 218 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---HHHHHHHHhcC----C-------CCCCCC
Confidence 223346788999999998899999999999999999999999996432 22222211110 0 011223
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKME 347 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~ 347 (382)
....+.+++.+||+.||.+||+..
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 345688999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=301.26 Aligned_cols=195 Identities=24% Similarity=0.359 Sum_probs=158.1
Q ss_pred CCeeeccCcccEEEEEECC----eeEEEEEccCCc-hHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEeecCCC
Q 016789 92 TSLIGFGSFGPVYKGLLRD----TVVAIKRRVGSP-RQEFVAEVTYLSEIRHRNLVTLLGYCQQ--NGYQMLVFEYLPNG 164 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~----~~vavK~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g 164 (382)
.+.||+|+||.||+|.... ..+|+|...... ...+.+|+.++++++||||+++++++.. +...++++||+. +
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 4679999999999998643 579999876443 3567899999999999999999998854 456889999985 5
Q ss_pred ChhhhhhhcCC----CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee----cCCCcEEEeecCCcccc
Q 016789 165 SMCNHLYETGL----ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV----DENFIAKVADTGISKLL 236 (382)
Q Consensus 165 sL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill----~~~~~~kl~DfGla~~~ 236 (382)
+|.+++..... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 88887754321 11235888999999999999999999987 9999999999999 46679999999999876
Q ss_pred cccccc--CCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCc
Q 016789 237 ENIEEA--GPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHI 289 (382)
Q Consensus 237 ~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~ 289 (382)
...... ......+++.|+|||++.+. .++.++||||+||++|||++|++||..
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 433211 12234567889999998764 589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=285.15 Aligned_cols=246 Identities=17% Similarity=0.228 Sum_probs=196.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEE-----EccCCchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIK-----RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK-----~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+.|+..++||+|.|+.||++.+.. +.+|+| ++.....++..+|+.+-+.|+||||+++...+.+....|||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 456667789999999999998765 445554 4445566788899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec---CCCcEEEeecCCcccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD---ENFIAKVADTGISKLL 236 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~---~~~~~kl~DfGla~~~ 236 (382)
+|.||+|+.-+-.+ ..+++...-....||.++|.|+|.++ |||||+||+|+|+. ...-+||+|||+|..+
T Consensus 91 ~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred cccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999877654 25677888889999999999999988 99999999999994 4457999999999988
Q ss_pred ccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 237 ENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 237 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
. .........|||.|||||++...+|+..+|||+.||+||-|+.|.+||...+ ...+.+.+... +..+
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~~rlye~I~~g-------~yd~ 231 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYEQIKAG-------AYDY 231 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHHhcc-------ccCC
Confidence 7 3333445678999999999999999999999999999999999999997532 22333222221 0111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+.+-+...+...+|+.+||..||.+|.|+.|.+.
T Consensus 232 ~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 232 PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11112233456778888999999999999987653
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=298.93 Aligned_cols=236 Identities=25% Similarity=0.339 Sum_probs=184.2
Q ss_pred CeeeccCcccEEEEEECC---------eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 93 SLIGFGSFGPVYKGLLRD---------TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~---------~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+.||+|+||.||+|.... ..+++|...... .+.+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998643 247777765432 24688899999999999999999999998899999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc--------EEEeecCC
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI--------AKVADTGI 232 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~--------~kl~DfGl 232 (382)
+++|+|.+++...+ ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999997643 25788999999999999999999987 999999999999987765 69999999
Q ss_pred ccccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCC-CCCCccCCCChhHHHHHHHhhcCCCc
Q 016789 233 SKLLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQ-EASHIVSLGSYEALIQWVRSRLSSNN 310 (382)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 310 (382)
+...... ....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+.... ............
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~---~~~~~~~~~~~~---- 222 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD---SQKKLQFYEDRH---- 222 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc---HHHHHHHHHccc----
Confidence 8754322 12234567999999976 45899999999999999999995 4543221 111111111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 311 FVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 311 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
..+......+.+++.+||+.||++||+++++++.|+
T Consensus 223 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 --------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111122356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=294.26 Aligned_cols=252 Identities=23% Similarity=0.312 Sum_probs=193.3
Q ss_pred HHHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 84 QATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 84 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
..++++.....||+|+||.||+|.+.. ..+++|...... .+.+.+|+.++++++|+||+++++++...+..++++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 344556566789999999999998764 578999766543 346889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC-CCcEEEeecCCccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-NFIAKVADTGISKLLE 237 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-~~~~kl~DfGla~~~~ 237 (382)
||+++++|.+++..... ....++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.++|+|||++....
T Consensus 85 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 85 EQVPGGSLSALLRSKWG--PLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred ecCCCCCHHHHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999999975421 112277888889999999999999877 999999999999986 6799999999987654
Q ss_pred cccccCCCcccccccccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGV--FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
.... ......++..|+|||.+.... ++.++||||||+++|+|++|+.|+....... ...+......
T Consensus 161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~-------- 228 (268)
T cd06624 161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK-------- 228 (268)
T ss_pred cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc--------
Confidence 3221 122234567799999986644 7899999999999999999999986432111 1111110000
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.....+......+.+++.+||+.+|.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 011123334567889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=292.63 Aligned_cols=249 Identities=20% Similarity=0.274 Sum_probs=184.3
Q ss_pred eeeccCcccEEEEEECC----eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCC
Q 016789 94 LIGFGSFGPVYKGLLRD----TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGS 165 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~~----~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 165 (382)
.||+|+||.||++.... ..+++|..... ....|.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 58999999999997533 34667765432 23578999999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc-cCC
Q 016789 166 MCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE-AGP 244 (382)
Q Consensus 166 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~ 244 (382)
|.+++.+... .....++.....++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++........ ...
T Consensus 82 L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999976432 1234677778899999999999999877 99999999999999999999999999864322111 111
Q ss_pred CcccccccccCcccccc-------CCCCccchhHHHHHHHHHHHhC-CCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 245 SHGSIVNVFRDPEVEES-------GVFSEMSDIYSFGVFLLELVTG-QEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 245 ~~~~~~~~y~aPE~~~~-------~~~~~~sDvws~G~vl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
....++..|+|||++.. ..++.++||||||+++|||+++ ..|+.... ........... ....+.++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~~~~~~~~~~--~~~~~~~~~~ 234 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--DREVLNHVIKD--QQVKLFKPQL 234 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhh--cccccCCCcc
Confidence 22345667999998743 2457899999999999999975 56765322 11112211111 1122233333
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
... ....+.+++..|| .+|++||++.+|++.|.
T Consensus 235 ~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 235 ELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 322 2355677888999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=293.49 Aligned_cols=243 Identities=26% Similarity=0.391 Sum_probs=193.3
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------------hHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 154 (382)
|.....||+|+||.||+|.... ..+++|.+.... ...+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 6677899999999999998754 689999764321 13577899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++++||+++++|.+++...+ .+++.....++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999997543 5788888999999999999999987 9999999999999999999999999998
Q ss_pred ccccccccC-----CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC
Q 016789 235 LLENIEEAG-----PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN 309 (382)
Q Consensus 235 ~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 309 (382)
......... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||..... ...... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~-~~~~---- 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--LQAIFK-IGEN---- 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--HHHHHH-Hhcc----
Confidence 765321111 1112355679999999988899999999999999999999999974321 111111 1110
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+ ..+...+..+.+++.+||+.||.+||++.++++
T Consensus 228 --~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 --ASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --CCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 011 112234567888999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=298.78 Aligned_cols=242 Identities=26% Similarity=0.334 Sum_probs=193.8
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
|+..+.||+|+||.||+|.+.. ..+|+|...... .+.+.+|++++++++||||+++++++...+..++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 4555679999999999998754 689999865332 2468899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 86 ~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 86 GGSALDLLKP------GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999988853 25788899999999999999999877 99999999999999999999999999976543221
Q ss_pred CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 243 GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ......... .......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~~~~----------~~~~~~~ 223 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVLFLIPKN----------SPPTLEG 223 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHHhhhhcC----------CCCCCCc
Confidence 111223466799999999988999999999999999999999998643211 111111111 0111223
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..+..+.+++.+||+.+|.+||++.++++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 345678899999999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=317.01 Aligned_cols=258 Identities=19% Similarity=0.249 Sum_probs=188.1
Q ss_pred HHHHHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC--chHHHHHHHHHHhcCCC------CCccceeeEEEeC
Q 016789 82 LEQATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS--PRQEFVAEVTYLSEIRH------RNLVTLLGYCQQN 151 (382)
Q Consensus 82 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~--~~~~~~~e~~~l~~l~h------~niv~l~~~~~~~ 151 (382)
+.....+|+..+.||+|+||+||+|.+.. ..||+|++... ...++..|+.+++.++| ++++++++++...
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 33445789999999999999999998754 68999987542 23355667777777654 4588898888765
Q ss_pred -CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeeecCCC------
Q 016789 152 -GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENF------ 223 (382)
Q Consensus 152 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill~~~~------ 223 (382)
...++|||++ +++|.+++.+.+ .+++..+..|+.|++.||.|||+ .+ |+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccc
Confidence 5788999988 778998887643 58899999999999999999997 47 99999999999998765
Q ss_pred ----------cEEEeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCC
Q 016789 224 ----------IAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLG 293 (382)
Q Consensus 224 ----------~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~ 293 (382)
.+||+|||.+..... ......+|+.|+|||++.+..|+.++|||||||++|||++|+.||......
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998764322 122345678899999999999999999999999999999999999754321
Q ss_pred ChhHHHHHHHhh---------------------cCCCcccccc----cCCCC---CHHHHHHHHHHHhhccCCCCCCCCC
Q 016789 294 SYEALIQWVRSR---------------------LSSNNFVDHR----LAGTF---TTEGMRDLIRLTLQCMSSPGRRRPK 345 (382)
Q Consensus 294 ~~~~~~~~~~~~---------------------~~~~~~~d~~----~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs 345 (382)
+....+...... .......++. +.... .......+.+|+.+||+.||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 111111100000 0000000000 00000 0011346789999999999999999
Q ss_pred HHHHHH
Q 016789 346 MEIVMT 351 (382)
Q Consensus 346 ~~~v~~ 351 (382)
+.|+++
T Consensus 432 a~e~L~ 437 (467)
T PTZ00284 432 ARQMTT 437 (467)
T ss_pred HHHHhc
Confidence 999986
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=307.50 Aligned_cols=256 Identities=18% Similarity=0.239 Sum_probs=191.0
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeC------
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN------ 151 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 151 (382)
..++|...+.||+|+||.||++.... ..+|+|.+... ....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 44689999999999999999998753 68999987542 124677899999999999999999988644
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
...++||||+++ ++.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999964 67666642 4788888999999999999999987 9999999999999999999999999
Q ss_pred CccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChh-HH------------
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYE-AL------------ 298 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~-~~------------ 298 (382)
+++...... ......++..|+|||.+.+..++.++|||||||++|||++|+.||......+.. ..
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 998653321 122334677899999999989999999999999999999999999643211100 00
Q ss_pred -------HHHHHhhcCCCcccccc------cC--CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 299 -------IQWVRSRLSSNNFVDHR------LA--GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 299 -------~~~~~~~~~~~~~~d~~------~~--~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..+............+. .. ..........+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000000000000 00 00111224567899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=295.12 Aligned_cols=244 Identities=25% Similarity=0.321 Sum_probs=197.0
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
+|+..+.||.|+||.||+|.... ..+++|...... ...+.+|+++++.++||||+++++++..+...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 57777889999999999998764 789999865432 346889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++++|.+++... .+++.....++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++.......
T Consensus 82 ~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 82 GGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred CCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999998653 6889999999999999999999877 99999999999999999999999999987654321
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ........... . +.+...
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~-~-----~~~~~~-- 221 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVLFLIPKNN-P-----PSLEGN-- 221 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHHHHhhhcC-C-----CCCccc--
Confidence 12223456679999999988899999999999999999999999864331 11111111110 1 111111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..+..+.+++.+||+.||++||+++++++.
T Consensus 222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 -KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 134568889999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=293.94 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=194.0
Q ss_pred CCCCCCeeeccCcccEEEEEECC-eeEEEEEccCCc---------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP---------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
+|...+.||+|+||.||+|.... ..+|+|...... ...+.+|++++++++|+||+++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 36778899999999999998744 678999765321 13578899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
+||+++++|.+++.+.. .+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999997542 5788888999999999999999977 9999999999999999999999999987543
Q ss_pred cccc-----cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 238 NIEE-----AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 238 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
.... .......++..|+|||.+.+..++.++||||||+++|||++|+.||..... .............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~~~~~----- 226 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR--LAAMFYIGAHRGL----- 226 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh--HHHHHHhhhccCC-----
Confidence 2111 111223456779999999988899999999999999999999999964321 1111111111000
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+.+ +...+..+.+++.+||+.+|.+||++.++++
T Consensus 227 ~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 MPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 2233466788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=302.73 Aligned_cols=257 Identities=17% Similarity=0.202 Sum_probs=190.4
Q ss_pred CCeeecc--CcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 92 TSLIGFG--SFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 92 ~~~lg~G--~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
.++||+| +|++||++.... ..||+|.+.... ...+.+|+++++.++||||+++++++..++..++|+||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 789999998764 689999876431 2346779999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 83 ~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 83 YGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999986532 124889999999999999999999987 999999999999999999999999875433211110
Q ss_pred ------CCCcccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc--
Q 016789 243 ------GPSHGSIVNVFRDPEVEES--GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV-- 312 (382)
Q Consensus 243 ------~~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 312 (382)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ......... ......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~--~~~~~~~~ 233 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKLNG--TVPCLLDT 233 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh--HHHHHHhcC--Cccccccc
Confidence 0111234456999999876 45899999999999999999999999743211 111111100 000000
Q ss_pred -----------------cc-----------------ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHH
Q 016789 313 -----------------DH-----------------RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE--LERI 356 (382)
Q Consensus 313 -----------------d~-----------------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~--L~~i 356 (382)
+. .............+.+++.+||+.||++|||+.++++. ++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00 00001122335678899999999999999999999873 4444
Q ss_pred H
Q 016789 357 H 357 (382)
Q Consensus 357 ~ 357 (382)
.
T Consensus 314 ~ 314 (327)
T cd08227 314 K 314 (327)
T ss_pred c
Confidence 3
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=295.69 Aligned_cols=246 Identities=19% Similarity=0.269 Sum_probs=192.9
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
|+..+.||+|+||.||++.... ..+++|...... ...+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5566789999999999999865 577888765433 34688899999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|..++.+.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 87 GAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 99988876532 35899999999999999999999987 99999999999999999999999999875433211 1
Q ss_pred CCcccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 244 PSHGSIVNVFRDPEVEE-----SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.....++..|+|||++. ...++.++|||||||++|||++|++||..... ........... ....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~~--~~~~------- 228 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--MRVLLKIAKSE--PPTL------- 228 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--HHHHHHHhhcC--CCCC-------
Confidence 22234567799999974 44578899999999999999999999864321 11222211110 0011
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..+...+..+.+++.+||+.||.+||++.++++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122234678899999999999999999988754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=319.76 Aligned_cols=265 Identities=17% Similarity=0.207 Sum_probs=189.3
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECCe---eEEE------------------EEccCC--chHHHHHHHHHHhcCCCCCc
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRDT---VVAI------------------KRRVGS--PRQEFVAEVTYLSEIRHRNL 141 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~~---~vav------------------K~~~~~--~~~~~~~e~~~l~~l~h~ni 141 (382)
...+|+..+.||+|+||+||++..+.. ..+. |..... ....+.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 456899999999999999999876431 1111 111111 12457899999999999999
Q ss_pred cceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC
Q 016789 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE 221 (382)
Q Consensus 142 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~ 221 (382)
+++++++...+..|+++|++ .++|.+++..................++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~ 302 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNC 302 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECC
Confidence 99999999999999999998 467888776543222223445667789999999999999987 999999999999999
Q ss_pred CCcEEEeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCC-CccCCCChhHHHH
Q 016789 222 NFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEAS-HIVSLGSYEALIQ 300 (382)
Q Consensus 222 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~-~~~~~~~~~~~~~ 300 (382)
++.+||+|||+++.+............++..|+|||.+.+..++.++|||||||++|||++|..++ ..........+.+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 999999999999876543333333345788899999999999999999999999999999998543 3222222222222
Q ss_pred HHHhhc-CCCccccc-----------ccC---CCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 301 WVRSRL-SSNNFVDH-----------RLA---GTFT-----TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 301 ~~~~~~-~~~~~~d~-----------~~~---~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
...... ...++.+. .+. ...+ ...+..+.+++.+||+.||.+||++.|+++.
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 222100 00001000 000 0000 0113456778889999999999999999874
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=312.40 Aligned_cols=241 Identities=20% Similarity=0.235 Sum_probs=186.7
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+|+..+.||+|+||.||++.... ..+|+|.+... ....+..|+.++..++||||+++++.+...+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 57788999999999999998864 68999987532 23457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++|+|.+++.+.+ .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 82 FLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred CCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999987543 5788899999999999999999987 999999999999999999999999998754321
Q ss_pred ccc----------------------------------CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCC
Q 016789 240 EEA----------------------------------GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQE 285 (382)
Q Consensus 240 ~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~ 285 (382)
... ......+|+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 0012346788999999999999999999999999999999999
Q ss_pred CCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 016789 286 ASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKM 346 (382)
Q Consensus 286 p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 346 (382)
||..... ......+... .....-+. . ......+.+++.+++ .||.+|++.
T Consensus 235 Pf~~~~~---~~~~~~i~~~--~~~~~~p~---~--~~~s~~~~~li~~l~-~~p~~R~~~ 284 (360)
T cd05627 235 PFCSETP---QETYRKVMNW--KETLVFPP---E--VPISEKAKDLILRFC-TDSENRIGS 284 (360)
T ss_pred CCCCCCH---HHHHHHHHcC--CCceecCC---C--CCCCHHHHHHHHHhc-cChhhcCCC
Confidence 9974332 1111111110 00010000 0 012345666777766 499999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=299.32 Aligned_cols=259 Identities=21% Similarity=0.290 Sum_probs=198.3
Q ss_pred HHHHHHHHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc--hHHHHHHHHHHhcC-CCCCccceeeEEE----
Q 016789 79 MEELEQATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP--RQEFVAEVTYLSEI-RHRNLVTLLGYCQ---- 149 (382)
Q Consensus 79 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~---- 149 (382)
++.+....++|+..+.||+|+||.||++.... ..+++|...... ...+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 34455566789999999999999999998754 688999765432 35688899999999 6999999999884
Q ss_pred -eCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEe
Q 016789 150 -QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVA 228 (382)
Q Consensus 150 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~ 228 (382)
.++..++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCCEEEc
Confidence 3456899999999999999886432 22346888999999999999999999877 9999999999999999999999
Q ss_pred ecCCccccccccccCCCcccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHH
Q 016789 229 DTGISKLLENIEEAGPSHGSIVNVFRDPEVEES-----GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVR 303 (382)
Q Consensus 229 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~ 303 (382)
|||+++.+..... ......++..|+|||.+.. ..++.++||||+||++|||++|+.|+..... ...+....
T Consensus 167 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~--~~~~~~~~- 242 (286)
T cd06638 167 DFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP--MRALFKIP- 242 (286)
T ss_pred cCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch--hHHHhhcc-
Confidence 9999886543221 1223346778999998753 4478899999999999999999999864321 11111110
Q ss_pred hhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 304 SRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 304 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
........+ +......+.+++.+||+.||++||++.++++.
T Consensus 243 -~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 243 -RNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -ccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000011111 11123568899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=294.88 Aligned_cols=243 Identities=26% Similarity=0.325 Sum_probs=197.1
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
.|+..+.||.|+||.||+|.+.. ..+|+|...... ...+.+|+.++++++||||+++++++..++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 46667889999999999998754 789999765432 346888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++|+|.+++... .+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999988642 4788888999999999999999977 99999999999999999999999999976543221
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
. .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+...... ....... ........
T Consensus 157 ~-~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~~----------~~~~~~~~ 222 (277)
T cd06640 157 K-RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---RVLFLIP----------KNNPPTLT 222 (277)
T ss_pred c-cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH---hHhhhhh----------cCCCCCCc
Confidence 1 12223456799999998888999999999999999999999998643211 1111110 01111234
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
...+..+.+++.+||+.+|.+||++.++++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 4567788999999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=297.97 Aligned_cols=254 Identities=22% Similarity=0.242 Sum_probs=188.7
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcC---CCCCccceeeEEEe-----CC
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEI---RHRNLVTLLGYCQQ-----NG 152 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~ 152 (382)
+|+..+.||+|+||.||+|.... ..+|+|...... ...+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 37778899999999999998864 689999765321 23466777777665 69999999998864 24
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCC
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI 232 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGl 232 (382)
..++++||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCc
Confidence 5799999997 58888886542 235889999999999999999999987 99999999999999999999999999
Q ss_pred ccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC-----
Q 016789 233 SKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS----- 307 (382)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----- 307 (382)
+........ .....++..|+|||.+.+..++.++||||+||++|||++|++||..... ...+.........
T Consensus 155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 155 ARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred cccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH--HHHHHHHHHHhCCCChhh
Confidence 986643221 2223456779999999988899999999999999999999999864322 1111111110000
Q ss_pred --C-----CcccccccC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 308 --S-----NNFVDHRLA---GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 308 --~-----~~~~d~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. .....+... ....++....+.+++.+||+.||++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000000000 0011233567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=291.74 Aligned_cols=259 Identities=20% Similarity=0.293 Sum_probs=194.2
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEe-----CC
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQ-----NG 152 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~ 152 (382)
....|...+.||+|+||.|+.+.... ..||+|++... ...+-.+|+.+|+.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34456667889999999999998865 68999987632 23467899999999999999999998865 35
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCC
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI 232 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGl 232 (382)
..|+|+|+| +-+|...++.. ..++......+..|+.+||.|+|+.+ |+||||||+|+|++.+..+||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccc
Confidence 789999999 56787777653 24888999999999999999999988 99999999999999999999999999
Q ss_pred cccccccc-ccCCCcccccccccCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc----
Q 016789 233 SKLLENIE-EAGPSHGSIVNVFRDPEVEE-SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL---- 306 (382)
Q Consensus 233 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---- 306 (382)
|+...+.. ....+....|.+|+|||.+. ...||.+.||||.||++.||++|++.|...+.-+.-.++.......
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 99875431 12234556688899999874 4569999999999999999999999886543222211111111000
Q ss_pred ----C---CCcccc-------cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 307 ----S---SNNFVD-------HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 307 ----~---~~~~~d-------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
. ....+. ..+...+ +......++|+.++|..||.+|+|++|.++-
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 000000 0000001 1223566788889999999999999998864
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=294.14 Aligned_cols=250 Identities=19% Similarity=0.299 Sum_probs=195.6
Q ss_pred CCCCCCeeeccCcccEEEEEECC---eeEEEEEccCC-------------chHHHHHHHHHHhc-CCCCCccceeeEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD---TVVAIKRRVGS-------------PRQEFVAEVTYLSE-IRHRNLVTLLGYCQQ 150 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~---~~vavK~~~~~-------------~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 150 (382)
+|+..+.||+|+||.||++.+.. ..+++|..... ...++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36777889999999999999865 67898875421 12346778888765 799999999999999
Q ss_pred CCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeeecCCCcEEEee
Q 016789 151 NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAKVAD 229 (382)
Q Consensus 151 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill~~~~~~kl~D 229 (382)
++..+++|||+++++|.+++.... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999885432 123468899999999999999999996 45 99999999999999999999999
Q ss_pred cCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC
Q 016789 230 TGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN 309 (382)
Q Consensus 230 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 309 (382)
||++....... ......++..|++||.+.+..++.++||||||+++|||++|+.||.... ............. .
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~---~~~~~~~~~~~~~-~ 231 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN---MLSLATKIVEAVY-E 231 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC---HHHHHHHHhhccC-C
Confidence 99998654432 2223345667999999998889999999999999999999999986432 1222221111110 0
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 310 NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 310 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
+. .....+..+.+++.+||+.||++||++.|+.++++
T Consensus 232 ----~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 ----PL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ----cC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00 01123467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=307.02 Aligned_cols=250 Identities=22% Similarity=0.209 Sum_probs=191.5
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+|...+.||+|+||.||++.... ..+|+|.+... ....+..|+.++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 67888999999999999999875 67899986431 12347889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++|+|.+++.+.. ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 y~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 82 YYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred ccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999997632 25788889999999999999999987 999999999999999999999999998765433
Q ss_pred cccCCCcccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 240 EEAGPSHGSIVNVFRDPEVEE-----SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
.........+++.|+|||++. ...++.++|||||||++|||++|+.||.... .......+.... ....-+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~--~~~~~p 230 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHK--ERFQFP 230 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC---HHHHHHHHhCCC--ccccCC
Confidence 222223345788899999986 3458899999999999999999999997432 112221111110 000000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRR--RPKMEIVMTE 352 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~~v~~~ 352 (382)
. .....+..+.+++.+|+..++.+ ||++.++++.
T Consensus 231 ~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 231 A----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred C----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 11223456777888877654444 7888888766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=297.02 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=191.6
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|+..+.||+|+||.||+|.... ..+++|..... ....+.+|+.++++++||||+++++++..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 36777899999999999998753 68999986532 224678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++ ++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 68888876532 2346899999999999999999999987 9999999999999999999999999987553321
Q ss_pred ccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC----------
Q 016789 241 EAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN---------- 309 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 309 (382)
. ......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||..... ...............
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE--IDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHhCCCChhhhhcchhh
Confidence 1 1122234677999998765 4578999999999999999999999874321 111111111100000
Q ss_pred --------cccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 --------NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 --------~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
........ ......+..+.+++.+||+.||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=288.87 Aligned_cols=249 Identities=24% Similarity=0.291 Sum_probs=198.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC---chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS---PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
++|+..+.||+|+||.||++.... ..+++|..... ..+.+.+|++++++++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 468888999999999999998754 67889876543 3457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++++|.+++.... ..++......++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999886541 35888999999999999999999987 99999999999999999999999999886543221
Q ss_pred cCCCcccccccccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESG---VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~---~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
......++..|+|||.+... .++.++|+||||+++|||++|+.|+..... ............. .+.+
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~--~~~~~~~~~~~~~-----~~~~-- 226 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP--MRALFLISKSNFP-----PPKL-- 226 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCC-----Cccc--
Confidence 11223445679999998776 789999999999999999999999864331 1111111111111 0111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
......+..+.+++.+||+.||.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112344567899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=296.09 Aligned_cols=251 Identities=21% Similarity=0.283 Sum_probs=197.7
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
++|+..+.||+|+||+||++... +..+++|..... ....+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45677788999999999999886 468888875432 235788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
+++|+|.+++...+ .+++.....++.+++.+|.|||+ .+ ++||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 85 MDCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999999886542 58899999999999999999996 35 999999999999999999999999998754322
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCC-----ChhHHHHHHHhhcCCCccccc
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLG-----SYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~d~ 314 (382)
. .....++..|+|||++.+..++.++|+|||||++|||++|+.||...... ................ .+
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 231 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---PP 231 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc---CC
Confidence 1 11234567799999998888999999999999999999999999754321 1111122221111000 01
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L 353 (382)
.+ ...+.+..+.+++.+||+.||.+||++.++++..
T Consensus 232 ~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 RL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11 1122456788999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=290.00 Aligned_cols=246 Identities=18% Similarity=0.275 Sum_probs=197.4
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|+..+.||.|+||.||.+.... ..+++|..... ...++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47788999999999998887654 67888875432 235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999987642 236889999999999999999999987 9999999999999999999999999998664433
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
. ......+++.|+|||.+.+..++.++||||||+++|||++|..||.... ........... ... ..
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---~~~~~~~~~~~-~~~---------~~ 221 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQG-NYT---------PV 221 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcC-CCC---------CC
Confidence 2 1223345678999999988889999999999999999999999986422 12222111111 000 11
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 12334668889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=297.85 Aligned_cols=246 Identities=20% Similarity=0.296 Sum_probs=196.7
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC---chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS---PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
.+|+..+.||.|+||.||++... +..+++|.+... ..+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 35788889999999999999864 378999976532 2356888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++++|.+++... .+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999988642 4789999999999999999999987 99999999999999999999999999876543322
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...... ..... .... ..+
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~--~~~~~~-~~~~~-~~~~-------~~~ 238 (296)
T cd06655 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--LRALYL-IATNG-TPEL-------QNP 238 (296)
T ss_pred c-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH-HHhcC-Cccc-------CCc
Confidence 1 1223456679999999988899999999999999999999999965332 111111 11110 0000 112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
...+..+.+++.+||+.||.+||++.++++.
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 2334568889999999999999999998853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=306.85 Aligned_cols=253 Identities=17% Similarity=0.243 Sum_probs=190.6
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeC------C
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN------G 152 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 152 (382)
.++|...+.||+|+||.||++.... ..+|+|++... ....+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4678999999999999999998754 68999987532 234678899999999999999999987543 3
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCC
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI 232 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGl 232 (382)
..++||||++ ++|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 5799999996 467776642 4778888999999999999999987 99999999999999999999999999
Q ss_pred ccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC-----
Q 016789 233 SKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS----- 307 (382)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----- 307 (382)
++...... ......++..|+|||.+.+..++.++|||||||++|||++|+.||...... ............
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLGTPCPEF 248 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHHH
Confidence 98654322 122335677899999999999999999999999999999999999643321 111111100000
Q ss_pred --------------CCcccc-------cccC----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 308 --------------SNNFVD-------HRLA----GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 308 --------------~~~~~d-------~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
...... +... ..........+.+++.+||+.||.+|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 0000 00011123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=300.45 Aligned_cols=195 Identities=24% Similarity=0.358 Sum_probs=157.7
Q ss_pred CCeeeccCcccEEEEEECC----eeEEEEEccCCc-hHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEEeecCCC
Q 016789 92 TSLIGFGSFGPVYKGLLRD----TVVAIKRRVGSP-RQEFVAEVTYLSEIRHRNLVTLLGYCQQ--NGYQMLVFEYLPNG 164 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~----~~vavK~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g 164 (382)
...||+|+||.||+|...+ ..+|+|...... ...+.+|+.++++++||||+++++++.. +...++|+||+. +
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence 3579999999999998753 578999876543 3467899999999999999999998854 457899999986 5
Q ss_pred ChhhhhhhcCC----CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee----cCCCcEEEeecCCcccc
Q 016789 165 SMCNHLYETGL----ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV----DENFIAKVADTGISKLL 236 (382)
Q Consensus 165 sL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill----~~~~~~kl~DfGla~~~ 236 (382)
+|.+++..... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 78777753221 12235888999999999999999999987 9999999999999 56789999999999866
Q ss_pred cccccc--CCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCc
Q 016789 237 ENIEEA--GPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHI 289 (382)
Q Consensus 237 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~ 289 (382)
...... ......++..|+|||.+.+ ..++.++|||||||++|||+||++||..
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 433221 1223456778999999876 4589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=292.32 Aligned_cols=253 Identities=24% Similarity=0.393 Sum_probs=195.7
Q ss_pred CCCCCeeeccCcccEEEEEEC-----CeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCC------
Q 016789 89 FSETSLIGFGSFGPVYKGLLR-----DTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNG------ 152 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 152 (382)
|...+.||+|+||.||+|.+. +..+|+|...... .+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456678999999999999864 2679999875432 346889999999999999999999886532
Q ss_pred eeEEEEeecCCCChhhhhhhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGL-ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
..++++||+.+|+|.+++..... .....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECccc
Confidence 24788999999999988764321 12235788999999999999999999877 9999999999999999999999999
Q ss_pred Ccccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCC
Q 016789 232 ISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSN 309 (382)
Q Consensus 232 la~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 309 (382)
+++........ .......++.|++||.+....++.++||||||+++|||++ |++|+.... ......+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~---~~~~~~~~~~~~~-- 233 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE---NSEIYNYLIKGNR-- 233 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC---HHHHHHHHHcCCc--
Confidence 99866432211 1122233456999999998889999999999999999999 888876432 2222222222110
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 310 NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 310 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
. ..+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 234 -~-------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 -L-------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -C-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01123346789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=294.58 Aligned_cols=248 Identities=21% Similarity=0.302 Sum_probs=194.5
Q ss_pred CCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
+|+..+.||+|+||.||++.+. +..+|+|.+.... ...+.+|++++++++||||+++++++...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5777889999999999999986 4788999765321 246889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++++|.+++.... ....+++..+..++.+++.||.|||+ .+ ++||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 82 DAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred CCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999988886531 12368999999999999999999996 46 9999999999999999999999999987653221
Q ss_pred ccCCCcccccccccCccccccC------CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 241 EAGPSHGSIVNVFRDPEVEESG------VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~------~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
.....++..|+|||.+.+. .++.++|+|||||++|||++|+.||....... ...........
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~------ 225 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIVDG------ 225 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHhhc------
Confidence 1223455679999998544 35889999999999999999999996432211 11111110000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.....+.+.+..+.+++.+||+.+|.+||++.++++.
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 226 -DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0011233456778899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=312.66 Aligned_cols=243 Identities=26% Similarity=0.365 Sum_probs=197.8
Q ss_pred eeeccCcccEEEEEECC--eeEEEEEccCCch---HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCChhh
Q 016789 94 LIGFGSFGPVYKGLLRD--TVVAIKRRVGSPR---QEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCN 168 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 168 (382)
+||+|.||+||-|++.. ..+|+|.+..... +-...|+.+-++++|.|||+++|.|.+++.+-+.||-++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999877 4678898765443 457889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec-CCCcEEEeecCCccccccccccCCCcc
Q 016789 169 HLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD-ENFIAKVADTGISKLLENIEEAGPSHG 247 (382)
Q Consensus 169 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~ 247 (382)
.|+..... -+-.+...--...||.+||.|||+++ |||||||-+|||++ -.|.+||+|||-++.+..... ...+.
T Consensus 662 LLrskWGP--lKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGP--LKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETF 736 (1226)
T ss_pred HHHhccCC--CccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCc-ccccc
Confidence 99875421 12255666677899999999999988 99999999999996 578999999999998754332 23455
Q ss_pred cccccccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHH
Q 016789 248 SIVNVFRDPEVEESGV--FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGM 325 (382)
Q Consensus 248 ~~~~~y~aPE~~~~~~--~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 325 (382)
+||..|||||++..++ |+.++|||||||++.||.||++||........ .+. ... -.....+.+.+.+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-AMF---kVG-------myKvHP~iPeels 805 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-AMF---KVG-------MYKVHPPIPEELS 805 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-hhh---hhc-------ceecCCCCcHHHH
Confidence 7888999999998765 99999999999999999999999975432111 111 000 0123346678888
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 326 RDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 326 ~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.....++.+|+..||.+||+++++++.
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhccC
Confidence 999999999999999999999998863
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=305.37 Aligned_cols=251 Identities=22% Similarity=0.249 Sum_probs=191.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|...+.||+|+||.||++.... ..+|+|.+... ....+.+|..++..++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 368888999999999999998865 68999986531 2234788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++.... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999997632 25788888999999999999999987 99999999999999999999999999986644
Q ss_pred ccccCCCcccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccc
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEES-----GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVD 313 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (382)
..........+++.|+|||++.. +.++.++|||||||++|||++|+.||..... ........... ...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~i~~~~--~~~-- 227 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNHE--ERF-- 227 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH---HHHHHHHHcCC--Ccc--
Confidence 33322233457888999999875 4688999999999999999999999974321 11111111110 000
Q ss_pred cccCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 016789 314 HRLAGTFTTEGMRDLIRLTLQCMSSPGRR--RPKMEIVMTE 352 (382)
Q Consensus 314 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~~v~~~ 352 (382)
.+. ....+.+..+.+++.+|+..++.+ |+++.++++.
T Consensus 228 -~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 -QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000 001123456778888888865544 4677777653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=297.28 Aligned_cols=245 Identities=21% Similarity=0.272 Sum_probs=196.5
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC---chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS---PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
++|...+.||+|+||.||++... +..+++|..... ..+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 56888899999999999999874 478999987542 2346788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999988643 4788899999999999999999977 99999999999999999999999999876543221
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
. .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....... .... .... .......+
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~--~~~~-~~~~--------~~~~~~~~ 238 (297)
T cd06656 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALYL-IATN--------GTPELQNP 238 (297)
T ss_pred C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch--heee-eccC--------CCCCCCCc
Confidence 1 122345677999999998889999999999999999999999996432211 1000 0000 00000112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+..+.+++.+||+.||++||++.++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 334566788999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=328.33 Aligned_cols=250 Identities=20% Similarity=0.314 Sum_probs=193.5
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQML 156 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 156 (382)
..+|.+.+.||+|+||+||++.... ..+++|.+... ....|..|+.++.+++||||+++++++... ...|+
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 4578899999999999999999865 57888876532 234688999999999999999999988543 56899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCC-----CCceecCCCCCCeeecC----------
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK-----PPLVHKNFKTANVLVDE---------- 221 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~ivHrDlk~~Nill~~---------- 221 (382)
||||+++|+|.++|..... ....+++..++.|+.||+.||.|||+.+ .+||||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999976421 2236899999999999999999999853 35999999999999964
Q ss_pred -------CCcEEEeecCCccccccccccCCCcccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCccCC
Q 016789 222 -------NFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEES--GVFSEMSDIYSFGVFLLELVTGQEASHIVSL 292 (382)
Q Consensus 222 -------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~G~vl~el~tg~~p~~~~~~ 292 (382)
...+||+|||++..+..... .....+++.|+|||++.. ..++.++|||||||+||||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~- 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN- 247 (1021)
T ss_pred cccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-
Confidence 34589999999986543221 123356788999999854 458999999999999999999999996432
Q ss_pred CChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 293 GSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
....+...+... . .+. ....+..+.+|+.+||+.+|.+||++.+++.
T Consensus 248 -~~~qli~~lk~~---p-----~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 -NFSQLISELKRG---P-----DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred -cHHHHHHHHhcC---C-----CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 222222222111 0 000 0122456889999999999999999999984
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=294.90 Aligned_cols=254 Identities=21% Similarity=0.271 Sum_probs=192.9
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|+..+.||+|+||.||+|.... ..+++|+.... ..+.+.+|+.++++++|||++++++++......++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 57788899999999999999864 78999976432 224578999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++++|..++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 82 CDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred cCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9988887766432 25899999999999999999999977 9999999999999999999999999998764432
Q ss_pred ccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC----------CC
Q 016789 241 EAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS----------SN 309 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------~~ 309 (382)
.. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ .+......... ..
T Consensus 155 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 155 DD-YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc-ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChHHhhhcccc
Confidence 11 112234567999999865 458899999999999999999999986433211 11111110000 00
Q ss_pred cc----cccccCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 NF----VDHRLAGTFT-----TEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 ~~----~d~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.. ..+......+ ...+..+.+++.+||+.||++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 0000000000 122467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=290.67 Aligned_cols=245 Identities=23% Similarity=0.339 Sum_probs=189.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC--------chHHHHHHHHHHhcCCCCCccceeeEEEe--CCee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS--------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQ--NGYQ 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 154 (382)
.+|...+.||+|+||.||++.... ..+++|..... ....+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 468888999999999999998754 68899875422 12357889999999999999999998875 3577
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++++||+++++|.+++.... .+++.....++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999987543 4788888999999999999999877 9999999999999999999999999987
Q ss_pred cccccccc--CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 235 LLENIEEA--GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 235 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
.+...... ......++..|+|||.+.+..++.++|||||||++|||++|+.||.... ....... ..... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~--~~~~~~~-~~~~~-----~ 226 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE--AMAAIFK-IATQP-----T 226 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc--hHHHHHH-HhcCC-----C
Confidence 65432111 1122335667999999998889999999999999999999999986432 1111111 11000 0
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+ ..+......+.+++ +||..+|++||++++|++
T Consensus 227 ~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11 12223344556666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=298.80 Aligned_cols=254 Identities=23% Similarity=0.333 Sum_probs=192.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
++|...+.||+|+||.||+|.... ..+|+|..... ....+.+|+.++++++||||+++++++...+..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 458888999999999999998764 68999986532 234678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++ ++|.+++.... ..+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 96 68988886542 35788899999999999999999987 9999999999999999999999999987543222
Q ss_pred ccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc------------C
Q 016789 241 EAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL------------S 307 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------~ 307 (382)
. ......+++.|+|||.+.+ ..++.++||||||+++|||++|++||..... ........... .
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV---EEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCChhhchhhhc
Confidence 1 1122344677999998765 3478899999999999999999999974432 11111111100 0
Q ss_pred CCcccc---cccCCC----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 308 SNNFVD---HRLAGT----FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 308 ~~~~~d---~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...... +..... .....+..+.+++.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 000000 01123456789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=310.84 Aligned_cols=242 Identities=21% Similarity=0.374 Sum_probs=191.6
Q ss_pred CCCCeeeccCcccEEEEEECCeeEEE-----EE--ccCCc--hHHHHHHHHHHhcCCCCCccceeeEEEeCCe--eEEEE
Q 016789 90 SETSLIGFGSFGPVYKGLLRDTVVAI-----KR--RVGSP--RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGY--QMLVF 158 (382)
Q Consensus 90 ~~~~~lg~G~~g~V~~~~~~~~~vav-----K~--~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 158 (382)
+...+||+|+|-+||+|.+...-+.| |. +.... .+.|..|+.+|+.|+||||+++|.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34467999999999999886643322 22 22233 3789999999999999999999999987654 78899
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC-CCcEEEeecCCccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-NFIAKVADTGISKLLE 237 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-~~~~kl~DfGla~~~~ 237 (382)
|.+..|+|..|+.+.+ .+..+.+..++.||.+||.|||++.|||+|||||.+||+|+. -|.|||+|.|||+...
T Consensus 123 EL~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 9999999999999876 688889999999999999999999999999999999999985 5899999999999775
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
... .....|||.|||||+.. ..|++.+||||||++++||+|+..|+.... ...++...+..+..+..+ . .+.
T Consensus 198 ~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n~AQIYKKV~SGiKP~sl-~-kV~ 269 (632)
T KOG0584|consen 198 KSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--NPAQIYKKVTSGIKPAAL-S-KVK 269 (632)
T ss_pred ccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--CHHHHHHHHHcCCCHHHh-h-ccC
Confidence 432 22367899999999998 679999999999999999999999986432 222222222222221111 0 111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
-..+.++|.+|+.. .++|||+.|++.-
T Consensus 270 -------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 -------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 13577888999999 9999999998863
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=289.79 Aligned_cols=248 Identities=21% Similarity=0.311 Sum_probs=196.8
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc---------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP---------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
+|+..+.||+|+||.||++.... ..+++|...... ...+.+|+.++++++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47778899999999999998743 689998765322 2468899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC-cEEEeecCCccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF-IAKVADTGISKL 235 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~~ 235 (382)
|+||+++++|.+++.+.+ .+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999987543 5788999999999999999999987 99999999999998775 699999999876
Q ss_pred cccccccCC---CcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 236 LENIEEAGP---SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 236 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
......... ....++..|+|||.+.+..++.++||||+|+++|+|++|..||..................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------- 226 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA------- 226 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc-------
Confidence 654321111 1223566799999998888999999999999999999999998644332222221111110
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
......+......+.+++.+||+.||.+||++.++++
T Consensus 227 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 --TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111233445677889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=291.61 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=192.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
++|...+.||+|+||.||+|...+ ..+++|...... ...+.+|+.+++.++||||+++++++...+..++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 356667789999999999998754 688999865432 235778999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++++|.+++...+ .+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 89 GGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 9999999886543 5889999999999999999999987 9999999999999999999999999987553221
Q ss_pred cCCCcccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 242 AGPSHGSIVNVFRDPEVEE---SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.......++..|+|||.+. ...++.++|+|||||++|||++|+.|+...... ............ .+....
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~--~~~~~~~~~~~~-----~~~~~~ 233 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--RALFLMTKSNFQ-----PPKLKD 233 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch--hhHHhhhccCCC-----CCcccc
Confidence 1122334667899999874 455889999999999999999999998643211 111111111111 111110
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
....+..+.+++.+||+.||++||++.++++
T Consensus 234 --~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 --KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0122356788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=309.78 Aligned_cols=240 Identities=28% Similarity=0.387 Sum_probs=197.5
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
-|+..+.||.|+||.||-|+... .+||||++.-+. .++++.|+..|.+++|||++.+-|++......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 36667789999999999998754 699999876432 3578999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|| -||-.|.|.-.+ .++.+-.+..|+.+...||+|||+.+ .||||||+.|||+++.|.|||+|||.|....+
T Consensus 107 YC-lGSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HH-hccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 99 567777775443 36788889999999999999999988 99999999999999999999999999987644
Q ss_pred cccCCCcccccccccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 240 EEAGPSHGSIVNVFRDPEVE---ESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~---~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
.....|||+|||||++ ..+.|+.++||||+|+++.||.-.++|..... ....+....... .|.+
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN--AMSALYHIAQNe-------sPtL 245 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNE-------SPTL 245 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch--HHHHHHHHHhcC-------CCCC
Confidence 2334689999999997 45679999999999999999999999987432 233333332221 1122
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. ..+.+..+.+++..||++-|.+|||..++++
T Consensus 246 q---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 Q---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred C---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1 4566788999999999999999999988764
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=303.19 Aligned_cols=253 Identities=18% Similarity=0.264 Sum_probs=189.9
Q ss_pred HHHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeC-----
Q 016789 84 QATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQN----- 151 (382)
Q Consensus 84 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 151 (382)
...+.|...+.||+|+||.||+|.... ..||+|...... ...+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 345679999999999999999998754 689999875432 24577899999999999999999987543
Q ss_pred -CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeec
Q 016789 152 -GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADT 230 (382)
Q Consensus 152 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~Df 230 (382)
...++++|++ +++|.+.+.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCC
Confidence 3568999988 7888877643 25889999999999999999999987 999999999999999999999999
Q ss_pred CCccccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC
Q 016789 231 GISKLLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN 309 (382)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 309 (382)
|+++..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+...........
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~ 236 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY--IDQLKRIMEVVGTPS 236 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHhCCCC
Confidence 999865432 122346778999999876 5689999999999999999999999864321 111111111100000
Q ss_pred -cccc-----------cccCCCCC--------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 310 -NFVD-----------HRLAGTFT--------TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 310 -~~~d-----------~~~~~~~~--------~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.... ..+. ..+ ......+.+++.+||+.||.+|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhcchhhHHHHhhccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000 000 0112357789999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=282.19 Aligned_cols=248 Identities=18% Similarity=0.268 Sum_probs=198.9
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-------c----hHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-------P----RQEFVAEVTYLSEI-RHRNLVTLLGYCQQN 151 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-------~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 151 (382)
-..|...+.+|.|..+.|.++.++. ...|+|++... . .+.-.+|+.+|+++ .||+|+.+.+++..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 3567778899999999999998875 57788875421 1 13456799999999 599999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
...++|+|.|+.|.|.++|... -.++++...+|+.|+.+|++|||..+ ||||||||+|||+|++.++||+|||
T Consensus 96 sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999764 36889999999999999999999988 9999999999999999999999999
Q ss_pred CccccccccccCCCcccccccccCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhh
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEES------GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSR 305 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 305 (382)
.|+.++..+.. ....|||+|+|||.+.. ..|+...|.||+||++|.|+.|.+||.... ...+...+...
T Consensus 169 Fa~~l~~GekL--relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---QmlMLR~ImeG 243 (411)
T KOG0599|consen 169 FACQLEPGEKL--RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QMLMLRMIMEG 243 (411)
T ss_pred eeeccCCchhH--HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHHHHHHHHhc
Confidence 99988765543 34567899999998743 348889999999999999999999996211 11111111111
Q ss_pred cCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 306 LSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 306 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.- .+..+.-.+.+....+|+.+||+.||.+|.|++|+++-
T Consensus 244 --ky-----qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 244 --KY-----QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred --cc-----ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 01 11122234556788899999999999999999998863
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=296.03 Aligned_cols=255 Identities=21% Similarity=0.286 Sum_probs=195.2
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|+..+.||+|+||.||+|.+.+ ..+++|..... ....+.+|++++++++|+||+++++++...+..++++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 57788899999999999999864 68999976532 235788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++++.+..+.... ..+++.....++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 82 VERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred CCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9886665554332 24789999999999999999999977 9999999999999999999999999998765543
Q ss_pred ccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC----------C
Q 016789 241 EAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS----------N 309 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------~ 309 (382)
........++..|+|||++... .++.++||||||+++|+|++|+.||...... ..+.......... .
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhcccC
Confidence 3222233456779999999887 7899999999999999999999998643221 1111111000000 0
Q ss_pred ------cccccc----cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 ------NFVDHR----LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 ------~~~d~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+.. ....++...+..+.+++.+||+.||++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 000112223678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=291.10 Aligned_cols=254 Identities=21% Similarity=0.249 Sum_probs=196.8
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 159 (382)
+|...+.||.|++|.||++.... ..+++|..... ....+.+|++++++++||||+++++++... +..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 46777899999999999999854 78999986543 234688999999999999999999988654 46899999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++++|.+++.... .....++......++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVK-KRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 999999998876432 12346788899999999999999999977 999999999999999999999999998755322
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCC--CChhHHHHHHHhhcCCCcccccccC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSL--GSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.. ....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ........+.... ....+ ....
T Consensus 159 ~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~- 232 (287)
T cd06621 159 LA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-PNPEL-KDEP- 232 (287)
T ss_pred cc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-Cchhh-ccCC-
Confidence 11 122345679999999988999999999999999999999999975432 1222333332221 11111 1110
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
......+..+.+++.+||+.||.+||++.|+++
T Consensus 233 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 -GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 001123567889999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=297.86 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=192.8
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|+..+.||+|+||.||+|.+.+ ..+|+|..... ....+.+|+++++.++||||+++++++...+..++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 57788999999999999999864 78999976432 134678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++++|.++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 82 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 82 VDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred CCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9998887766432 24889999999999999999999977 9999999999999999999999999988654432
Q ss_pred ccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh--h--------cCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS--R--------LSSN 309 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~--~--------~~~~ 309 (382)
. ......++..|+|||++.+ ..++.++||||||+++|||++|++||..... .......... . ....
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 155 E-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD--IDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred c-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHHHhCCCchhhHHHhccc
Confidence 1 1222345677999999865 4478899999999999999999988864321 1111111100 0 0000
Q ss_pred ccc----ccccCCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 NFV----DHRLAGT-----FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 ~~~----d~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
... .+..... ..+..+..+.+++.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 0000000 01123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=294.30 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=196.3
Q ss_pred HHHHHHHHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC--chHHHHHHHHHHhcC-CCCCccceeeEEEe---
Q 016789 79 MEELEQATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS--PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQ--- 150 (382)
Q Consensus 79 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--- 150 (382)
+.++......|+..+.||+|+||.||+|.+.. ..+++|..... ...++..|+.++.++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 34445556788888999999999999999854 68999986543 234678899999998 69999999999853
Q ss_pred ---CCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEE
Q 016789 151 ---NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKV 227 (382)
Q Consensus 151 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl 227 (382)
....+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEE
Confidence 457899999999999999887543 235788888999999999999999987 999999999999999999999
Q ss_pred eecCCccccccccccCCCcccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHH
Q 016789 228 ADTGISKLLENIEEAGPSHGSIVNVFRDPEVEE-----SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWV 302 (382)
Q Consensus 228 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~ 302 (382)
+|||++........ ......++..|+|||.+. ...++.++|||||||++|||++|+.||..... ...... .
T Consensus 163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~--~~~~~~-~ 238 (282)
T cd06636 163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP--MRALFL-I 238 (282)
T ss_pred eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH--Hhhhhh-H
Confidence 99999876532211 122234567799999875 34588899999999999999999999864321 111111 0
Q ss_pred HhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 303 RSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 303 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
... . .+.. .....+..+.+++.+||+.||.+||++.++++
T Consensus 239 ~~~-~-----~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 PRN-P-----PPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hhC-C-----CCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 0 0111 11234567889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=287.67 Aligned_cols=247 Identities=25% Similarity=0.335 Sum_probs=203.2
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
+|+..+.||+|++|.||++.... ..+++|+..... ...+.+|+..+.+++||||+++++++...+..++|+||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 57788999999999999998874 789999866542 467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++++|.+++... ..++......++.|+++||.|||+ .+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 82 DGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999764 368899999999999999999998 88 9999999999999999999999999988664433
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
... ....++..|+|||.+.+..++.++|+||||+++|||++|+.|+.................... + ..
T Consensus 155 ~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~------~----~~ 223 (264)
T cd06623 155 DQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP------P----SL 223 (264)
T ss_pred Ccc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC------C----CC
Confidence 221 223456679999999998999999999999999999999999875543233333333332111 1 11
Q ss_pred CHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 321 TTE-GMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 321 ~~~-~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
+.. .+..+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 222 45788899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=290.56 Aligned_cols=249 Identities=25% Similarity=0.375 Sum_probs=193.2
Q ss_pred CCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc-------------hHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP-------------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNG 152 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-------------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 152 (382)
+|...+.||+|+||.||+|... +..+|+|...... .+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3667789999999999999865 3689999754210 135778999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCC
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI 232 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGl 232 (382)
..++|+||+++|+|.+++.+.+ .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999987642 5888889999999999999999977 99999999999999999999999999
Q ss_pred ccccccccccC-CCcccccccccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC
Q 016789 233 SKLLENIEEAG-PSHGSIVNVFRDPEVEESGV--FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN 309 (382)
Q Consensus 233 a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~--~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 309 (382)
+.......... .....++..|+|||.+.... ++.++|+||||+++||+++|..|+.... ......+.. . ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~-~-~~~~ 230 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE--AIAAMFKLG-N-KRSA 230 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc--hHHHHHHhh-c-cccC
Confidence 97654322111 12234567799999987654 8899999999999999999999985322 111111111 0 0011
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+......+.+..+.+++.+||+.||.+||++.+|++
T Consensus 231 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 231 ----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 11111122334577889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=294.29 Aligned_cols=248 Identities=21% Similarity=0.283 Sum_probs=195.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
++|+..+.||.|+||.||++.+.. ..+++|...... .+.|..|++++++++||||+++++++......++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 457788889999999999998853 789999865443 246889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++++|.+++.... ..+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 85 DGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999987642 35889999999999999999999988 99999999999999999999999999875433211
Q ss_pred cCCCcccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 242 AGPSHGSIVNVFRDPEVEE-----SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
......++..|++||.+. ...++.++|+||||+++|||++|+.||..... ....... ... .. +.+
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--~~~~~~~-~~~-~~-----~~~ 228 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--MRVLLKI-LKS-EP-----PTL 228 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--HHHHHHH-hcC-CC-----CCc
Confidence 112234567799999874 34577899999999999999999999874321 1111111 111 00 001
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..+...+..+.+++.+||+.||.+||++.++++.
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 --DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1122334567889999999999999999999765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=290.47 Aligned_cols=247 Identities=21% Similarity=0.297 Sum_probs=193.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
+.|+..+.||+|+||.||+|.... ..+++|...... ...+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 457788899999999999998865 688888876543 346888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++++|..++.+.. ..+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999988876432 35889999999999999999999977 99999999999999999999999999875432211
Q ss_pred cCCCcccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 242 AGPSHGSIVNVFRDPEVEE-----SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
......++..|+|||.+. ...++.++|||||||++|||++|+.|+..... .....+... ......
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~~--~~~~~~----- 235 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIAK--SEPPTL----- 235 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--HHHHHHHhc--CCCccC-----
Confidence 112233566799999984 34578899999999999999999999864321 111111111 000000
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+...+..+.+++.+||+.||++||++.++++
T Consensus 236 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 --SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 112233456888999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=287.19 Aligned_cols=243 Identities=25% Similarity=0.349 Sum_probs=194.5
Q ss_pred CCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC--------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS--------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
+|+..+.||+|+||.||+|... +..+++|..... ....+.+|+.+++.++||||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999886 478999975432 224688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
+||+++++|.+++.+.. .+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999987542 5788899999999999999999987 9999999999999999999999999988654
Q ss_pred cccccCCCcccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGV-FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
... ......++..|++||.+.... ++.++|+||||+++|+|++|+.||.... ......... ......
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~-~~~~~~------- 221 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--GVAAVFKIG-RSKELP------- 221 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--HHHHHHHHH-hcccCC-------
Confidence 432 122234567799999987766 8999999999999999999999986433 111111111 101110
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+......+.+++.+||+.+|.+||++.++++
T Consensus 222 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 --PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 112233467788999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=287.89 Aligned_cols=245 Identities=23% Similarity=0.306 Sum_probs=194.6
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQ-NGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 159 (382)
.|+..+.||+|++|.||++.... ..+++|..... ..+.+.+|++++++++|||++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 37778899999999999998754 67999986432 23467889999999999999999998764 446789999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++++|.+++.... ...+++..+..++.+++.|++|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999987532 235889999999999999999999987 999999999999999999999999999866433
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
.. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ........... .. ..
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~---~~~~~~~~~~~-~~---------~~ 221 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD---MNSLVYRIIEG-KL---------PP 221 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhc-CC---------CC
Confidence 22 1223345677999999999999999999999999999999999986322 12211111111 00 01
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+...+..+.+++.+||+.||++||++.++++
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 22344567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=295.65 Aligned_cols=259 Identities=23% Similarity=0.327 Sum_probs=199.1
Q ss_pred CHHHHHHHHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC--chHHHHHHHHHHhcC-CCCCccceeeEEEeC-
Q 016789 78 SMEELEQATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS--PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQN- 151 (382)
Q Consensus 78 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 151 (382)
.+.++..+.++|...+.||+|+||.||++.... ..+++|..... ....+.+|+.++.++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 344555567789999999999999999998854 68899987543 235677899999999 799999999998754
Q ss_pred ----CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEE
Q 016789 152 ----GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKV 227 (382)
Q Consensus 152 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl 227 (382)
+..++|+||+++|+|.+++.... .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEE
Confidence 35899999999999999886432 22346889999999999999999999877 999999999999999999999
Q ss_pred eecCCccccccccccCCCcccccccccCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHH
Q 016789 228 ADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESG-----VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWV 302 (382)
Q Consensus 228 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~ 302 (382)
+|||++......... .....++..|+|||.+... .++.++|||||||++|||++|+.|+..... ...+....
T Consensus 170 ~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--~~~~~~~~ 246 (291)
T cd06639 170 VDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTLFKIP 246 (291)
T ss_pred eecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--HHHHHHHh
Confidence 999998865432221 1223456679999997543 368899999999999999999999864321 12222211
Q ss_pred HhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 303 RSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 303 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.. ....+. .+.+....+.+++.+||+.||++||++.++++
T Consensus 247 ~~--~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 247 RN--PPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cC--CCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 111111 12233457889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=289.53 Aligned_cols=247 Identities=23% Similarity=0.304 Sum_probs=197.1
Q ss_pred CCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
+|+..+.||+|+||.||++.+. +..+++|.+.... ..++.+|++++++++||||+++++.+...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4666788999999999999987 4788999765432 346889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++++|.+++.... ..++......++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999987642 368889999999999999999998 77 9999999999999999999999999987654322
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
... ..++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ......+.......... + ..
T Consensus 156 ~~~---~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~---~----~~ 224 (265)
T cd06605 156 AKT---FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND-PPDGIFELLQYIVNEPP---P----RL 224 (265)
T ss_pred hhc---ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-ccccHHHHHHHHhcCCC---C----CC
Confidence 111 3455679999999988999999999999999999999999865422 11112222221111100 0 11
Q ss_pred CHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 321 TTE-GMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 321 ~~~-~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+.. .+..+.+++.+||..||++||++.+++.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 111 4567889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=293.17 Aligned_cols=250 Identities=19% Similarity=0.167 Sum_probs=195.5
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+|...+.||+|+||.||++.... ..+++|...... ...+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 57888999999999999998876 689999765432 2467789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++++|.+++...+ .+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 82 YVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999996543 5788899999999999999999977 999999999999999999999999998632110
Q ss_pred cc--------------cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhh
Q 016789 240 EE--------------AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSR 305 (382)
Q Consensus 240 ~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 305 (382)
.. .......++..|+|||.+.+..++.++|+||||+++|||++|..||.... ...+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~---~~~~~~~~~~~ 231 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT---PEELFGQVISD 231 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhc
Confidence 00 00111234567999999988889999999999999999999999986322 22222211111
Q ss_pred cCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 016789 306 LSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELER 355 (382)
Q Consensus 306 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~ 355 (382)
....+.. ....+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 232 ----~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 ----DIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ----ccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0001111 11234567899999999999999998777776655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=286.33 Aligned_cols=247 Identities=21% Similarity=0.273 Sum_probs=197.4
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQ--NGYQMLVF 158 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 158 (382)
+|+..+.||.|+||.||++.... ..+++|..... ..+.+..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 36778899999999999998754 67888876532 23468889999999999999999998764 45679999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHh-----cCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH-----SLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-----~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
||+++++|.+++.... .....+++...+.++.|++.||.||| +.+ ++|+||+|+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999987642 22346899999999999999999999 655 999999999999999999999999999
Q ss_pred cccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccc
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVD 313 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (382)
......... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.... ...+.+......
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~------- 226 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKEGK------- 226 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHHhcCC-------
Confidence 876543321 122345677999999998889999999999999999999999987433 223333222211
Q ss_pred cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 314 HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 314 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
....+...+..+.+++.+||+.+|.+||++.+|++
T Consensus 227 ---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 ---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11223344577889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=286.84 Aligned_cols=247 Identities=23% Similarity=0.304 Sum_probs=194.4
Q ss_pred CCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|...+.||+|+||.||++... +..+++|...... ...+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 3677789999999999999875 3789999865432 34688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++++|.+++.... .+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999987532 4778888999999999999999987 9999999999999999999999999988764432
Q ss_pred ccCCC---cccccccccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 241 EAGPS---HGSIVNVFRDPEVEESGV---FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 241 ~~~~~---~~~~~~~y~aPE~~~~~~---~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
..... ...++..|++||.+.... ++.++||||||+++||+++|+.||..... ......... ... .+
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~~~~~~~-~~~-----~~ 225 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVG-AGH-----KP 225 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHHHHHHHh-cCC-----CC
Confidence 22111 234566799999998766 89999999999999999999999964321 111111111 110 01
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+. ........+.+++.+||+.||.+||++.+++.
T Consensus 226 ~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111 01122466778999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=291.08 Aligned_cols=254 Identities=21% Similarity=0.271 Sum_probs=195.5
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|+..+.||+|+||.||+|.... ..+++|...... ...+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 36778899999999999998753 789999865432 35788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+ +++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987543 35899999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC---------c
Q 016789 241 EAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN---------N 310 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~ 310 (382)
........++..|+|||.+.+. .++.++||||+|+++|||++|++||..... ...+ .......... +
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQL-AIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHH-HHHHHHcCCCChHHHhhccC
Confidence 2223334567789999998654 468999999999999999999877754321 1111 1111110000 0
Q ss_pred c------cccccC----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 311 F------VDHRLA----GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 311 ~------~d~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+ ..+.-. .....+....+.+++.+||+.||.+||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 000000 0001123478899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=288.16 Aligned_cols=245 Identities=23% Similarity=0.322 Sum_probs=196.3
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|+..+.||+|+||.||++.... ..+++|..... ...++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 37778899999999999998754 68999976421 234788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++++|.+++.... ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999887532 235788899999999999999999987 9999999999999999999999999997654322
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.... ............ . ...
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---~~~~~~~~~~~~-~---------~~~ 221 (256)
T cd08218 156 EL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN---MKNLVLKIIRGS-Y---------PPV 221 (256)
T ss_pred hh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC---HHHHHHHHhcCC-C---------CCC
Confidence 11 112235667999999998889999999999999999999999986422 222221111110 0 011
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+...+..+.+++.+||+.+|.+||++.+|++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 2334567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=288.87 Aligned_cols=243 Identities=26% Similarity=0.344 Sum_probs=195.4
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
-|+..+.||+|+||.||+|.... ..+|+|...... ...+.+|+.++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 46777899999999999998753 689999765322 246888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++++|.+++... .+++.....++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEPG------PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999988642 5789999999999999999999977 99999999999999999999999999876543221
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
......++..|+|||.+.+..++.++|+|||||++|+|++|..|+..... .......... .. + ...
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~-~~-----~----~~~ 222 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFLIPKN-NP-----P----TLE 222 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHHHhcC-CC-----C----CCC
Confidence 11223456679999999888899999999999999999999999864321 1111111111 00 1 112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
...+..+.+++.+||+.+|.+||++.++++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2344668889999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=292.22 Aligned_cols=238 Identities=23% Similarity=0.278 Sum_probs=194.2
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+|+..+.||+|+||.||++.+.. ..+++|..... ....+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 57888999999999999998864 78999976532 23568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++++|.+++.... .++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 82 YVPGGELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred cCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999987642 6889999999999999999999977 999999999999999999999999999866443
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .....+..... . . .
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~---~----~----~ 216 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKILEG---K----V----R 216 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcC---C----c----c
Confidence 222345677999999988889999999999999999999999986433 12222211110 0 0 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRP-----KMEIVM 350 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~~v~ 350 (382)
.+......+.+++.+||+.||.+|| ++++++
T Consensus 217 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 217 FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 1222346788999999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=286.41 Aligned_cols=252 Identities=24% Similarity=0.288 Sum_probs=198.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
++|+..+.||.|+||+||+|.... ..+++|..... ....+.+|++.++.++|+||+++++.+...+..++++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 368888999999999999998754 68899986532 235788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++++|.+++..... ...+++.....++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976421 236889999999999999999999877 9999999999999999999999999987665432
Q ss_pred cc---CCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 241 EA---GPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 241 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
.. ......++..|++||.+... .++.++|+||||+++|||++|+.||..... .......... . .+.+
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--~~~~~~~~~~---~----~~~~ 227 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP--MKVLMLTLQN---D----PPSL 227 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh--hhhHHHHhcC---C----CCCc
Confidence 22 11222456779999998776 789999999999999999999999974322 1111121111 0 0111
Q ss_pred CCCC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 317 AGTF-TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 317 ~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.... ....+..+.+++.+||+.||++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1110 1234567889999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=287.88 Aligned_cols=245 Identities=22% Similarity=0.292 Sum_probs=191.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----c---hHHHHHHHHHHhcCCCCCccceeeEEEeC--Cee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----P---RQEFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQ 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 154 (382)
.+|+..+.||+|+||.||++.... ..+++|..... . ...+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 468888999999999999998765 68999975421 1 23577899999999999999999988763 467
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++++||+++++|.+++.... .+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999987543 4778888999999999999999987 9999999999999999999999999998
Q ss_pred cccccccc--CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 235 LLENIEEA--GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 235 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||.... ......+ . ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~-~--~~~~---- 225 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE--AMAAIFK-I--ATQP---- 225 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc--hHHHHHH-H--hcCC----
Confidence 65432111 1122345667999999988889999999999999999999999986431 1111111 1 1000
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.....+......+.+++.+||. +|.+||+++++++
T Consensus 226 ---~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 ---TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0112234455677788889984 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=285.30 Aligned_cols=244 Identities=24% Similarity=0.369 Sum_probs=194.9
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|+..+.||+|+||.||++.... ..+++|..... ....+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 47778899999999999998754 68999976532 234688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC-CcEEEeecCCccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN-FIAKVADTGISKLLENI 239 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~-~~~kl~DfGla~~~~~~ 239 (382)
+++++|.+++.... ...+++..+..++.+++.+|.|||+++ ++|+||+|+||+++++ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997642 235789999999999999999999987 9999999999999855 46899999999866432
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
.. .....++..|+|||.+....++.++||||||+++|+|++|+.||..... ........... .. .
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~-~~---------~ 220 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIMSGT-FA---------P 220 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHHHhcC-CC---------C
Confidence 21 1223456679999999988899999999999999999999999864321 12222211110 00 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+...+..+.+++.+||+.||.+||++.++++
T Consensus 221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11223467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=303.17 Aligned_cols=232 Identities=19% Similarity=0.222 Sum_probs=178.8
Q ss_pred eeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcC---CCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 95 IGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEI---RHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 95 lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
||+|+||+||+|.... ..+|+|.+... ....+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999998864 78999986532 112345566676655 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++...+ .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 99999886543 5888999999999999999999987 99999999999999999999999999875422211 1
Q ss_pred CCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 244 PSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||.... ........... ... +.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~---~~~~~~~i~~~--~~~-----~~~---~ 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---TQQMYRNIAFG--KVR-----FPK---N 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC---HHHHHHHHHcC--CCC-----CCC---c
Confidence 2234567889999998754 48999999999999999999999996432 22222211111 001 110 1
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHH
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKME 347 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~ 347 (382)
..+..+.+++.+||+.||.+||++.
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 1235677899999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=293.40 Aligned_cols=254 Identities=21% Similarity=0.278 Sum_probs=190.6
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|+..+.||+|+||.||+|.... ..+++|..... ....+.+|++++++++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 36777899999999999999864 68899976532 124577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++ ++|.+++.... ..+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 58888776432 35899999999999999999999987 9999999999999999999999999998654322
Q ss_pred ccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC---------Cc
Q 016789 241 EAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS---------NN 310 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~ 310 (382)
. ......++..|+|||.+.+. .++.++|||||||++|||+||+.|+..... .....+........ ..
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHHhhh
Confidence 1 11223446779999998664 478999999999999999999988653221 11111111110000 00
Q ss_pred cccc----ccCC-----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 311 FVDH----RLAG-----TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 311 ~~d~----~~~~-----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+. .... ......+..+.+++.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 0000 011223567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=291.58 Aligned_cols=242 Identities=19% Similarity=0.257 Sum_probs=191.8
Q ss_pred CCCeeeccCcccEEEEEEC--CeeEEEEEccC---CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCC
Q 016789 91 ETSLIGFGSFGPVYKGLLR--DTVVAIKRRVG---SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGS 165 (382)
Q Consensus 91 ~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 165 (382)
....||+|+||.||++... +..+++|.... .....+.+|+.++..++||||+++++++..++..++++||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999875 47899998643 234568899999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCC
Q 016789 166 MCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPS 245 (382)
Q Consensus 166 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 245 (382)
|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ ...
T Consensus 105 L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 105 LTDIVSQ------TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred HHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 9887754 25788999999999999999999987 99999999999999999999999999875543221 112
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHH
Q 016789 246 HGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGM 325 (382)
Q Consensus 246 ~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 325 (382)
...++..|+|||++.+..++.++||||||+++|||++|+.||..... ............ .. . ......+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~-~~-----~--~~~~~~~ 244 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSPP-PK-----L--KNAHKIS 244 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhccCC-CC-----c--cccCCCC
Confidence 23456779999999988899999999999999999999999874321 121221111100 00 0 0111223
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 326 RDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 326 ~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..+.+++.+||+.||.+||++.++++.
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 567889999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=294.74 Aligned_cols=244 Identities=18% Similarity=0.260 Sum_probs=192.2
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
|.....||+|+||.||++.... ..+++|...... .+.+.+|+..++.++||||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 3334679999999999998753 689999865432 34688999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
++|.+++... .+++.....++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++........ .
T Consensus 104 ~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 174 (292)
T cd06658 104 GALTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K 174 (292)
T ss_pred CcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence 9999887532 4788899999999999999999987 99999999999999999999999999875433221 1
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ........... .+.+.. ...
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~------~~~~~~--~~~ 243 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRRIRDNL------PPRVKD--SHK 243 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcC------CCcccc--ccc
Confidence 1223456779999999888899999999999999999999999864321 11111111111 111111 112
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.+..+.+++.+||+.||.+||++.++++.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 34567788899999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=289.62 Aligned_cols=255 Identities=23% Similarity=0.307 Sum_probs=192.4
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|+..+.||+|+||.||+|.... ..+++|...... ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 47778899999999999998854 689999765322 24688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+. ++|.+++.... ...+++.....++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 68888886532 346899999999999999999999877 9999999999999999999999999987654322
Q ss_pred ccCCCcccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc-----
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGV-FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH----- 314 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~----- 314 (382)
. ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||.... +.....+.............+
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--EIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 1 112223456799999886644 6889999999999999999999986432 222222222211111100000
Q ss_pred --------ccCC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 315 --------RLAG----TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 315 --------~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.... .........+.+++.+||+.||.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000 001112356778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=291.99 Aligned_cols=255 Identities=20% Similarity=0.281 Sum_probs=193.4
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc--------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP--------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~--------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
+|...+.||+|+||.||+|.... ..+++|...... ...+..|++++++++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 36677889999999999998754 789999875432 23467899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+ +|+|.+++.... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 899999986532 25899999999999999999999988 9999999999999999999999999998765
Q ss_pred cccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhh-----------
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSR----------- 305 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~----------- 305 (382)
..... ......+..|+|||.+.+ ..++.++|||||||++|||++|.+||..... ...+.......
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD--IDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc--HHHHHHHHHHcCCCchhhhhhc
Confidence 43211 122234567999998854 4578999999999999999999877764322 11111111100
Q ss_pred cCCCcccccccCCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 306 LSSNNFVDHRLAGTF-----TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 306 ~~~~~~~d~~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
............... ....+..+.+++.+||+.||++||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000011000000111 12235678899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=293.79 Aligned_cols=247 Identities=19% Similarity=0.207 Sum_probs=194.6
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+|+..+.||+|+||.||++.... ..+++|...... ...+..|+++++.++||||+++++.+......++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 57788899999999999998865 789999875432 2357889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+.+++|.+++.... ...+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 82 YCPGGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred ecCCCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999886432 346899999999999999999999987 999999999999999999999999998754322
Q ss_pred cccC----------------------------CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccC
Q 016789 240 EEAG----------------------------PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVS 291 (382)
Q Consensus 240 ~~~~----------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~ 291 (382)
.... .....++..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1100 011235667999999998889999999999999999999999986433
Q ss_pred CCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 016789 292 LGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPK----MEIVMT 351 (382)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs----~~~v~~ 351 (382)
. ........... .........+..+.+++.+||+.||++||+ +.+++.
T Consensus 237 ~--~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 R--DETFSNILKKE----------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred h--HHHHHHHhcCC----------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2 11111111111 000111124578899999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=288.16 Aligned_cols=243 Identities=23% Similarity=0.321 Sum_probs=192.4
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIR---HRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 158 (382)
.|+..+.||+|+||.||+|.+.. ..+++|..... ...++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 46677889999999999999754 78999976532 2356888999999996 999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++++|.+++... .+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999988542 5889999999999999999999987 99999999999999999999999999987654
Q ss_pred ccccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
... ......++..|+|||.+.++ .++.++|+||||+++|+|++|+.||..... .......... ..+.+.
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~------~~~~~~ 223 (277)
T cd06917 154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA---FRAMMLIPKS------KPPRLE 223 (277)
T ss_pred Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh---hhhhhccccC------CCCCCC
Confidence 332 12223456779999988654 478999999999999999999999864321 1111110000 011111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. ...+..+.+++.+||+.||.+||++.++++
T Consensus 224 ~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 224 D---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred c---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1 114467889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=288.29 Aligned_cols=243 Identities=21% Similarity=0.198 Sum_probs=196.5
Q ss_pred CCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+|+..+.||.|+||.||++... +..+++|..... ..+.+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677889999999999999986 478999976532 23578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+.+++|.+++... ..+++.....++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998754 26788999999999999999999987 999999999999999999999999998865433
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+............+.... ....
T Consensus 154 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------~~~~ 220 (258)
T cd05578 154 TL--TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-----------ADVL 220 (258)
T ss_pred cc--ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-----------cccc
Confidence 21 1223355679999999988899999999999999999999999976543322222221110 0112
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKM--EIVM 350 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~--~~v~ 350 (382)
.+...+..+.+++.+||+.||.+||++ +|++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 233345788899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=292.00 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=190.5
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
++|+..+.||+|++|.||+|... +..+++|...... ...+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 46788899999999999999875 3789999865322 24577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++ ++|.+++.... ..+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LD-TDLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 97 58998886542 25788999999999999999999987 9999999999999999999999999987543211
Q ss_pred ccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC-Cc--------
Q 016789 241 EAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS-NN-------- 310 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~-------- 310 (382)
.. .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||..... ....+.......... .+
T Consensus 158 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD-VEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred cc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc-HHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 11 112234667999999865 4589999999999999999999999864321 111111111100000 00
Q ss_pred --ccccccCC--CC-------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 311 --FVDHRLAG--TF-------TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 311 --~~d~~~~~--~~-------~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
........ .. .......+.+++.+||+.||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 00 0011256778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=286.66 Aligned_cols=252 Identities=24% Similarity=0.323 Sum_probs=196.1
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc--hHHHHHHHHHHhcC-CCCCccceeeEEEeCC------e
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP--RQEFVAEVTYLSEI-RHRNLVTLLGYCQQNG------Y 153 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------~ 153 (382)
..++|+..+.||+|+||.||+|.... ..+++|...... .+.+.+|+.+++++ +||||+++++++.... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 34678999999999999999999864 678998866443 35788999999999 6999999999997644 4
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.++||||+++++|.+++.... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCccc
Confidence 899999999999999886532 12346889999999999999999999987 999999999999999999999999998
Q ss_pred cccccccccCCCcccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEES-----GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS 308 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 308 (382)
........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||.... ......+.... .
T Consensus 161 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~--~- 234 (275)
T cd06608 161 AQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH--PMRALFKIPRN--P- 234 (275)
T ss_pred eecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc--hHHHHHHhhcc--C-
Confidence 76543221 1223345677999998753 347789999999999999999999986422 11222221110 0
Q ss_pred CcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 309 NNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 309 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+.+ ..+...+..+.+++.+||..||++||++.++++
T Consensus 235 ----~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 235 ----PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ----CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0011 112234567889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=289.05 Aligned_cols=258 Identities=22% Similarity=0.278 Sum_probs=191.7
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCC-CCCccceeeEEEeCCe-----e
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGY-----Q 154 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----~ 154 (382)
+|+..+.||+|+||.||+|.+.. ..+++|...... ...+.+|+.+++.++ ||||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 57888999999999999998864 789999755322 246788999999995 6999999999987665 8
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC-CCcEEEeecCCc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-NFIAKVADTGIS 233 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-~~~~kl~DfGla 233 (382)
++||||+++ +|.+++..........+++.....++.||+.||.|||+.+ ++||||+|+||+++. ++.+||+|||++
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecccc
Confidence 999999975 8988887654332346899999999999999999999977 999999999999998 899999999998
Q ss_pred cccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
........ ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||.... ....+..............
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 159 RAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS--ELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred eecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHHhCCCChhh
Confidence 75533211 1122234667999998765 457999999999999999999999986432 2222221111100000000
Q ss_pred c------------cccCC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 313 D------------HRLAG----TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 313 d------------~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. +.... ...+..+..+.+++.+||+.||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00000 001224567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=292.12 Aligned_cols=252 Identities=20% Similarity=0.274 Sum_probs=189.3
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|...+.||+|+||.||++.... ..+|+|..... ....+.+|+.++.++. ||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 34556789999999999998865 78999986542 2346888999999996 99999999999998899999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL-KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
+. +++.++...........+++.....++.+++.||+|||+. + ++||||||+||+++.++.+||+|||++..+...
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 4554433211111224689999999999999999999964 6 999999999999999999999999998765432
Q ss_pred cccCCCcccccccccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESG---VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
... ....++..|+|||.+.+. .++.++||||||+++|||++|+.||.... ...+......... .+.+
T Consensus 162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~---~~~~ 231 (288)
T cd06616 162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD---PPIL 231 (288)
T ss_pred Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC---CCcC
Confidence 211 222456679999998776 68999999999999999999999986432 1111111111000 1111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
........+..+.+++.+||+.||++||++.+|++.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112222345678899999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=288.00 Aligned_cols=248 Identities=21% Similarity=0.314 Sum_probs=198.9
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc--hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP--RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
++.|+..+.||+|+||.||++.+. +..+++|...... ...+.+|++.++.++|+|++++++++...+..++++||+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 97 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYM 97 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEecc
Confidence 355777788999999999999987 4789999876544 467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 98 DGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred CCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999998653 36899999999999999999999977 99999999999999999999999999875543221
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
......++..|++||.+.+..++.++|+||||+++|+|++|+.|+..... ...... .... ..... ...
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~--~~~~~~-~~~~-~~~~~-------~~~ 239 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP--LRALFL-ITTK-GIPPL-------KNP 239 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH--HHHHHH-HHhc-CCCCC-------cch
Confidence 11222345679999999888899999999999999999999999864321 111111 1111 11111 111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+..+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 224567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=289.40 Aligned_cols=253 Identities=22% Similarity=0.309 Sum_probs=192.8
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEe
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQMLVFE 159 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 159 (382)
|+..+.||+|+||.||+|.... ..+++|...... ...+.+|++++++++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 4566789999999999999875 789999876542 34688899999999999999999999988 88999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 997 48888876532 36889999999999999999999977 999999999999999999999999999876544
Q ss_pred cccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC-C--C---cc-
Q 016789 240 EEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS-S--N---NF- 311 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~--~---~~- 311 (382)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .. ......... . . ..
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL--EQ-LEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH--HH-HHHHHHHhCCCchhhccccc
Confidence 3222223344667999998764 45889999999999999999999998643321 11 111111000 0 0 00
Q ss_pred -------------cccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 312 -------------VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 312 -------------~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
....+...+...++..+.+++.+||+.||.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000011112567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=285.60 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=195.1
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|...+.||+|+||.||++.... ..+++|..... ..+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 36777899999999999998864 67899986432 345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC-cEEEeecCCccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF-IAKVADTGISKLLENI 239 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~~~~~~ 239 (382)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999987532 235789999999999999999999987 99999999999999885 5699999999866433
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
... .....+++.|+|||...+..++.++|+||||+++|||++|+.|+.... .......... .... .
T Consensus 156 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~-----~~~~-----~ 221 (257)
T cd08225 156 MEL-AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN---LHQLVLKICQ-----GYFA-----P 221 (257)
T ss_pred ccc-ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHhc-----ccCC-----C
Confidence 221 122345677999999988889999999999999999999999986432 1111111111 0011 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.....+..+.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11233457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=289.19 Aligned_cols=257 Identities=21% Similarity=0.258 Sum_probs=190.3
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+.+|...+.||+|+||.||+|... +..+++|...... ...+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 357888899999999999999875 4789999865332 2357889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+. +++.+.+.... ..+.+.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 995 77877765432 24677888899999999999999987 999999999999999999999999998754332
Q ss_pred cccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh-hcCC---------
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS-RLSS--------- 308 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~--------- 308 (382)
... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ...+.+.... ....
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 157 SQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-FEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-HHHHHHHHHHcCCCChhhhhhhhh
Confidence 211 1222346779999998754 4788999999999999999999999743321 1111111110 0000
Q ss_pred -CcccccccCCCC---------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 309 -NNFVDHRLAGTF---------TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 309 -~~~~d~~~~~~~---------~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
............ ....+..+.+++.+|++.||++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000 0012456778999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=293.85 Aligned_cols=260 Identities=20% Similarity=0.254 Sum_probs=192.6
Q ss_pred CCCCCeeeccCcccEEEEEECC----eeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEE
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD----TVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQML 156 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~----~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 156 (382)
|...+.||+|+||.||+|.... ..+|+|.+.... ...+.+|+.++++++||||+++++++... ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 6677889999999999999844 789999876522 35678899999999999999999999988 78999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC----CCcEEEeecCC
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE----NFIAKVADTGI 232 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~----~~~~kl~DfGl 232 (382)
||||++ ++|.+.+..........++......++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||+
T Consensus 82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 82 LFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999996 47777765443333346889999999999999999999987 999999999999999 99999999999
Q ss_pred cccccccccc--CCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCC-------hhHHHHHH
Q 016789 233 SKLLENIEEA--GPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGS-------YEALIQWV 302 (382)
Q Consensus 233 a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~-------~~~~~~~~ 302 (382)
+......... ......++..|+|||.+.+. .++.++||||||+++|||++|++||....... ...+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 9866433221 11223456779999987664 58899999999999999999999997543322 00111110
Q ss_pred Hhhc-----------CCCcccc---cccCCCCC---------H--HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 303 RSRL-----------SSNNFVD---HRLAGTFT---------T--EGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 303 ~~~~-----------~~~~~~d---~~~~~~~~---------~--~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.... ...+... ......++ . .....+.+++.+||+.||++|||+.++++
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 0000000 00000111 0 22356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=288.73 Aligned_cols=246 Identities=22% Similarity=0.314 Sum_probs=204.2
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccC-CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCC
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG-SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGS 165 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 165 (382)
|....+||+|+||.||++.+++ .++|+|+... .+.+++..|+.+|.+...|++|++||.+.....+|+|||||..|+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 4455789999999999998876 7999998765 456899999999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCC
Q 016789 166 MCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPS 245 (382)
Q Consensus 166 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 245 (382)
..+.++.+. ..+.+..+..++...++||+|||..+ -+|||||+.|||++.+|.+||+|||.+-.+..... ...
T Consensus 115 iSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KRN 187 (502)
T KOG0574|consen 115 ISDIMRARR----KPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KRN 187 (502)
T ss_pred HHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHH-hhC
Confidence 999988653 47899999999999999999999987 89999999999999999999999999987654322 234
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHH
Q 016789 246 HGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGM 325 (382)
Q Consensus 246 ~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 325 (382)
..-||+.|||||++..-.|+.++||||+|++..||.-|++|+.+.-+...--.+ .... .|.+ .-+.+.+
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI----PT~P-----PPTF--~KPE~WS 256 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI----PTKP-----PPTF--KKPEEWS 256 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec----cCCC-----CCCC--CChHhhh
Confidence 567899999999999999999999999999999999999998753221100000 0000 1111 2245667
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 326 RDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 326 ~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..+.+++++||-++|++|-|+-++++-
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 889999999999999999999988764
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=290.04 Aligned_cols=255 Identities=19% Similarity=0.241 Sum_probs=192.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 157 (382)
++|+..+.||.|+||.||+|.... ..+++|...... ...+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 457788899999999999999864 688998765322 22467899999999999999999998877 889999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
+||++ ++|.+.+.... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 58988886543 25899999999999999999999987 9999999999999999999999999988665
Q ss_pred cccccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc----------
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL---------- 306 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------- 306 (382)
.... ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||...... ...........
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI--DQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchHHHHHh
Confidence 4321 11223346679999998654 4689999999999999999999998743321 11111000000
Q ss_pred ---------CCCcccccccCCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 307 ---------SSNNFVDHRLAGTFTTE-GMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 307 ---------~~~~~~d~~~~~~~~~~-~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.........+...++.. ....+.+++.+||+.||++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000011111111211 3567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=284.07 Aligned_cols=238 Identities=19% Similarity=0.202 Sum_probs=190.4
Q ss_pred eeccCcccEEEEEEC--CeeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCCh
Q 016789 95 IGFGSFGPVYKGLLR--DTVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 95 lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 166 (382)
||.|+||.||++... +..+++|..... ..+.+.+|+.+++.++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999987 578999986532 224688999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCc
Q 016789 167 CNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH 246 (382)
Q Consensus 167 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 246 (382)
.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 99997643 4788899999999999999999977 9999999999999999999999999998765432 1122
Q ss_pred ccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHH
Q 016789 247 GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMR 326 (382)
Q Consensus 247 ~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 326 (382)
..++..|++||.+....++.++|+||||+++|||++|..|+...... ........... .....++...+.
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~---------~~~~~~~~~~~~ 221 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIYNDILKG---------NGKLEFPNYIDK 221 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHHHHHhcc---------CCCCCCCcccCH
Confidence 24566799999998888999999999999999999999999754321 12222211110 011122223356
Q ss_pred HHHHHHhhccCCCCCCCCC-----HHHHHH
Q 016789 327 DLIRLTLQCMSSPGRRRPK-----MEIVMT 351 (382)
Q Consensus 327 ~l~~l~~~cl~~dp~~RPs-----~~~v~~ 351 (382)
.+.+++.+||+.||.+||+ ++|+++
T Consensus 222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 7899999999999999999 555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=289.40 Aligned_cols=242 Identities=27% Similarity=0.366 Sum_probs=190.7
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
+.|...+.||+|+||.||+|... +..+++|...... ..++.+|+++++.++||||+++.+++...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 44778889999999999999875 4789999764321 246889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+. |++.+.+.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9996 67777765432 25889999999999999999999987 99999999999999999999999999875532
Q ss_pred ccccCCCcccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEE---SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
. ....++..|+|||.+. ...++.++||||||+++|||++|+.|+..... .......... .. +.
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~---~~~~~~~~~~-~~-----~~ 233 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQN-DS-----PT 233 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH---HHHHHHHhcC-CC-----CC
Confidence 2 1223456799999874 45688999999999999999999999864321 1111111110 00 01
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
+ .....+..+.+++.+||+.||.+||++.+++..
T Consensus 234 ~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 L---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred C---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1 122345678999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=288.31 Aligned_cols=247 Identities=21% Similarity=0.278 Sum_probs=189.2
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc----hHHHHHHHHH-HhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP----RQEFVAEVTY-LSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~----~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|+..+.||+|+||.||++.+.. ..+|+|...... ...+..|+.. ++.++||||+++++++..++..+++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 67888899999999999999864 789999865432 2345566665 5667899999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL-KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
++ |+|.+++..... ....+++..++.++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 82 MD-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hc-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 96 788888765432 234689999999999999999999985 6 999999999999999999999999998865332
Q ss_pred cccCCCcccccccccCcccccc----CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 240 EEAGPSHGSIVNVFRDPEVEES----GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.... .....+...... . .+.
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~-~------~~~ 227 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK-TPFQQLKQVVEE-P------SPQ 227 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc-cCHHHHHHHHhc-C------CCC
Confidence 1 1122335567999998864 457889999999999999999999986322 112222221111 0 011
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+. ....+..+.+++.+||+.+|.+||++.++++
T Consensus 228 ~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 LP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10 1123467889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=289.35 Aligned_cols=246 Identities=21% Similarity=0.272 Sum_probs=196.1
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC---chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS---PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
.+|...+.||+|+||.||++... +..+++|..... ..+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 46788899999999999999864 368999986532 2356888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998653 4678889999999999999999987 99999999999999999999999999875543222
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
. .....+++.|++||.+....++.++|+||||+++||+++|+.||...... ..+.... .. .......+
T Consensus 171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~--~~~~~~~-~~--------~~~~~~~~ 238 (293)
T cd06647 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIA-TN--------GTPELQNP 238 (293)
T ss_pred c-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--hheeehh-cC--------CCCCCCCc
Confidence 1 12234566799999998888999999999999999999999999643221 1111100 00 00001112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
...+..+.+++.+||+.+|.+||++.+++..
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2345678899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=286.13 Aligned_cols=238 Identities=20% Similarity=0.245 Sum_probs=183.5
Q ss_pred eeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHH---hcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 94 LIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYL---SEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
.||+|+||.||++.... ..+|+|...... ...+.+|..++ ...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999998754 789999764321 12334444333 33479999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+|+|.+++...+ .+++.....++.|++.||.|||+.+ ++||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 999999887543 5899999999999999999999987 9999999999999999999999999987553322
Q ss_pred CCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 243 GPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
.....++..|+|||.+.. ..++.++|||||||++|||++|..||............... .. .....+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~--------~~~~~~ 219 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LT--------VNVELP 219 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---hc--------CCcCCc
Confidence 122346778999999864 55899999999999999999999999754332222221111 00 011123
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRP-----KMEIVMTE 352 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RP-----s~~~v~~~ 352 (382)
...+..+.+++.+||+.||.+|| +++++++.
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 33456788999999999999999 58888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=287.26 Aligned_cols=243 Identities=19% Similarity=0.258 Sum_probs=192.9
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCC---chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS---PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
|...+.||+|++|.||++.... ..+++|..... ..+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 4455789999999999998754 68999976432 234578999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
++|.+++... .+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||.+........ .
T Consensus 101 ~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 101 GALTDIVTHT------RMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred CCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 9999988652 5788899999999999999999987 99999999999999999999999998875533221 1
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||..... .......... .. +... ....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~~~~~~~~-~~-----~~~~--~~~~ 240 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKRIRDN-LP-----PKLK--NLHK 240 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHhc-CC-----CCCc--cccc
Confidence 1223456779999999888899999999999999999999999864321 1112211111 00 0110 1112
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+..+.+++.+||+.||++||++.++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 3467889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=283.49 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=191.7
Q ss_pred CCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 89 FSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
|+..+.||.|++|.||+|... +..+++|+.... ....+.+|++++++++|||++++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 556788999999999999875 478999976532 2346889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
+ ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 4 68998886543 136899999999999999999999877 99999999999999999999999999976543221
Q ss_pred cCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC-----------
Q 016789 242 AGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN----------- 309 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 309 (382)
. .....++..|+|||.+.+. .++.++|+||||+++|||++|+.||.... ....+...........
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS--EIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 1 1222346679999987654 57899999999999999999999986432 1122222211111000
Q ss_pred cccc--cccC----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 NFVD--HRLA----GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 ~~~d--~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+... +... .......+..+.+++.+||+.||.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 0000 0011122357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=287.94 Aligned_cols=258 Identities=22% Similarity=0.257 Sum_probs=192.4
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCC-----
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG----- 152 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 152 (382)
..++|+..+.||+|+||.||+|.... ..+++|..... ....+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 45678889999999999999999864 68899986532 2245778999999999999999999987654
Q ss_pred -----eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEE
Q 016789 153 -----YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKV 227 (382)
Q Consensus 153 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl 227 (382)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEEe
Confidence 78999999975 777766543 236899999999999999999999987 999999999999999999999
Q ss_pred eecCCccccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc
Q 016789 228 ADTGISKLLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 228 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
+|||++................+..|+|||.+.+ ..++.++|||||||++|||++|++||.... ....+........
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~--~~~~~~~~~~~~~ 235 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ--ELAQLELISRLCG 235 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhC
Confidence 9999998765433222222334567999998764 457899999999999999999999987432 2222211111110
Q ss_pred CCC-----cccc--------cccC--C---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 307 SSN-----NFVD--------HRLA--G---TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 307 ~~~-----~~~d--------~~~~--~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
... .+.. .... . ......+..+.+++.+||+.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 0000 0000 0 000123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=284.14 Aligned_cols=236 Identities=21% Similarity=0.258 Sum_probs=185.7
Q ss_pred eeccCcccEEEEEEC--CeeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCCh
Q 016789 95 IGFGSFGPVYKGLLR--DTVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 95 lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 166 (382)
||+|+||+||++... +..+++|..... ....+..|+++++.++||||+++++++...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 368999876432 123567899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCc
Q 016789 167 CNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH 246 (382)
Q Consensus 167 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 246 (382)
.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 999976532 35889999999999999999999987 9999999999999999999999999987654311 1222
Q ss_pred ccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCC-hhHHHHHHHhhcCCCcccccccCCCCCHHHH
Q 016789 247 GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS-YEALIQWVRSRLSSNNFVDHRLAGTFTTEGM 325 (382)
Q Consensus 247 ~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 325 (382)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ...+.. .... .....+...+
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~-------~~~~~~~~~~ 222 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR----RTLE-------MAVEYPDKFS 222 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh----cccc-------ccccCCccCC
Confidence 344567999999988889999999999999999999999986443211 111111 1000 0011222335
Q ss_pred HHHHHHHhhccCCCCCCCCCHHH
Q 016789 326 RDLIRLTLQCMSSPGRRRPKMEI 348 (382)
Q Consensus 326 ~~l~~l~~~cl~~dp~~RPs~~~ 348 (382)
..+.+++.+||+.||.+||+..+
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCc
Confidence 67889999999999999995544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=300.31 Aligned_cols=193 Identities=26% Similarity=0.332 Sum_probs=163.8
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCch--HHHHHHHHHHhcCC-C-----CCccceeeEEEeCCeeEEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPR--QEFVAEVTYLSEIR-H-----RNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~--~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~lv 157 (382)
.|...+.||+|+||.|.+|...+ ..||||+++.... .+-..|+.+|..|+ | -|+|++++++...+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 56778899999999999998866 6899999876543 45567999999996 4 3899999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC--CCcEEEeecCCccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE--NFIAKVADTGISKL 235 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~--~~~~kl~DfGla~~ 235 (382)
+|.+ .-+|.++|..... ..++...+..|+.||+.||.+||+.+ |||+||||+||||.+ ...+||+|||.|..
T Consensus 267 fELL-~~NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ehhh-hhhHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccccc
Confidence 9998 5699999987653 34899999999999999999999988 999999999999964 34899999999986
Q ss_pred cccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIV 290 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~ 290 (382)
....-. ...-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|...
T Consensus 341 ~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 341 ESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 543221 222345699999999999999999999999999999998777543
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=289.62 Aligned_cols=258 Identities=20% Similarity=0.262 Sum_probs=190.7
Q ss_pred eeecc--CcccEEEEEEC--CeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCC
Q 016789 94 LIGFG--SFGPVYKGLLR--DTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNG 164 (382)
Q Consensus 94 ~lg~G--~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 164 (382)
.||+| +||+||++.+. ++.||+|...... .+.+.+|+.+++.++||||+++++++...+..++|+||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 89999999884 4799999865322 246788999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC-
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG- 243 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~- 243 (382)
+|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++++||+.+..........
T Consensus 85 ~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 85 SANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999887643 235888999999999999999999877 9999999999999999999999998654322111110
Q ss_pred -----CCcccccccccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC---------
Q 016789 244 -----PSHGSIVNVFRDPEVEESG--VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS--------- 307 (382)
Q Consensus 244 -----~~~~~~~~~y~aPE~~~~~--~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------- 307 (382)
......+..|+|||++.+. .++.++|||||||++|||++|+.||...... ....+.......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccc
Confidence 1112234569999998763 4789999999999999999999999653311 111111110000
Q ss_pred --------------------------CCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHH
Q 016789 308 --------------------------SNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE--LERIHE 358 (382)
Q Consensus 308 --------------------------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~--L~~i~~ 358 (382)
.....+..+.......+...+.+++.+||+.||++|||+.++++. ++.+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000111111222234466789999999999999999999999754 455544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=285.99 Aligned_cols=253 Identities=15% Similarity=0.155 Sum_probs=179.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECCe-----eEEEEEccCCch--------------HHHHHHHHHHhcCCCCCccceeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDT-----VVAIKRRVGSPR--------------QEFVAEVTYLSEIRHRNLVTLLGY 147 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~vavK~~~~~~~--------------~~~~~e~~~l~~l~h~niv~l~~~ 147 (382)
+.|...+.||+|+||+||+|...+. .+++|....... .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5688899999999999999987653 556664322111 012233345566789999999997
Q ss_pred EEeCC----eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC
Q 016789 148 CQQNG----YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF 223 (382)
Q Consensus 148 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~ 223 (382)
+.... ..++++|++. .++.+.+.... ..++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCC
Confidence 76543 3467778763 35655554321 3467778899999999999999977 99999999999999999
Q ss_pred cEEEeecCCcccccccccc------CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhH
Q 016789 224 IAKVADTGISKLLENIEEA------GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEA 297 (382)
Q Consensus 224 ~~kl~DfGla~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~ 297 (382)
.++|+|||+|+........ ......+|+.|+|||...+..++.++|||||||++|||++|+.||....... .
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~ 241 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--N 241 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--H
Confidence 9999999999865322111 1122357888999999999999999999999999999999999997543211 1
Q ss_pred HHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 016789 298 LIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 298 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L 353 (382)
......... ...+...... ....++.+.+++..|++.+|++||++.++.+.|
T Consensus 242 ~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKCDF-IKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHHHH-HHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111110000 0000001111 112246788999999999999999999999876
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=279.39 Aligned_cols=246 Identities=26% Similarity=0.372 Sum_probs=199.3
Q ss_pred CCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQMLVF 158 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 158 (382)
+|...+.||+|++|.||+|... +..+++|...... .+.+.+|++.+++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999987 4789999866543 45788999999999999999999999988 8899999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++++|.+++.... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999987643 6899999999999999999999977 99999999999999999999999999887654
Q ss_pred cccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 239 IEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 239 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.... ......++..|++||......++.++||||||+++|+|++|+.||.... ....... ... .....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~---~~~------~~~~~ 222 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALY---KIG------SSGEP 222 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHH---hcc------ccCCC
Confidence 3321 1122345567999999988889999999999999999999999987543 1111111 000 01111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+...+..+.+++.+|++.||.+||++.++++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1223344678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=276.89 Aligned_cols=245 Identities=23% Similarity=0.335 Sum_probs=197.4
Q ss_pred CCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
+|...+.||+|++|.||++... +..+++|+..... ...+.+|++.+++++|||++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999986 4789999876543 4678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+++|.+++.... ..+++..+..++.+++.+|.|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999887642 36899999999999999999999977 99999999999999999999999999987654332
Q ss_pred CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 243 GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
.....++..|++||.+....++.++||||||+++|+|++|+.|+..... ......... .......+ ..
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~-~~~~~~~~-------~~ 221 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---MKALFKIAT-NGPPGLRN-------PE 221 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHHh-cCCCCcCc-------cc
Confidence 2233456679999999888899999999999999999999999864321 111111111 11111110 11
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+..+.+++.+||+.||.+||++.++++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12467889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=285.72 Aligned_cols=251 Identities=20% Similarity=0.233 Sum_probs=195.3
Q ss_pred CCCCCeeeccCcccEEEEEEC-----CeeEEEEEccCC-------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeE
Q 016789 89 FSETSLIGFGSFGPVYKGLLR-----DTVVAIKRRVGS-------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 155 (382)
|+..+.||+|+||.||++... +..+++|..... ....+.+|+.++.++ +||||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 667788999999999998753 357899976532 124578899999999 5999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+||||+++|+|.+++.... .+++.....++.|++.+|.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 82 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 82 LILDYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999986532 5788889999999999999999877 99999999999999999999999999876
Q ss_pred cccccccCCCcccccccccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCccCCCCh-hHHHHHHHhhcCCCccc
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEESGV--FSEMSDIYSFGVFLLELVTGQEASHIVSLGSY-EALIQWVRSRLSSNNFV 312 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 312 (382)
.............++..|+|||.+.+.. .+.++||||||+++|||++|..||........ ....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~------- 227 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS------- 227 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-------
Confidence 5443222222234567799999987665 78899999999999999999999864322111 1111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
.+ ..+......+.+++.+||+.||++|||+.++.+.|+...
T Consensus 228 ~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 228 KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 01 112223456788999999999999999999988876653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=279.71 Aligned_cols=245 Identities=24% Similarity=0.318 Sum_probs=198.6
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|+..+.||+|+||.||++.... ..+++|..... ...++.+|++++++++||||+++.+++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 36777899999999999998754 67889876532 234678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++++|.+++.+.. .....+++...+.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999987643 22346899999999999999999999987 999999999999999999999999999876543
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
......++..|++||.+.+..++.++|+||||+++|||++|+.||.... ........... .....
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~----------~~~~~ 221 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS---MQDLRYKVQRG----------KYPPI 221 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcC----------CCCCC
Confidence 1222345677999999999889999999999999999999999986432 12222211110 11122
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+...+..+.+++.+||+.+|.+||++.++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 3345677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=286.34 Aligned_cols=242 Identities=26% Similarity=0.358 Sum_probs=190.6
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
.|...+.||+|+||.||++.... ..+++|...... ...+.+|++++++++|||++++++++..++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 36667889999999999998754 689999865321 2368889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|++ |+|.+.+.... ..+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 106 YCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 996 58877775432 35889999999999999999999987 999999999999999999999999998754321
Q ss_pred cccCCCcccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 240 EEAGPSHGSIVNVFRDPEVEE---SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
....++..|+|||.+. .+.++.++|||||||++|||++|+.||.... .............
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~~~---------- 241 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNES---------- 241 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHhccC----------
Confidence 1234566799999973 4568999999999999999999999986432 1111111111110
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L 353 (382)
........+..+.+++.+||+.+|.+||++.++++.+
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 242 PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0011223446788999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=279.03 Aligned_cols=247 Identities=18% Similarity=0.177 Sum_probs=187.7
Q ss_pred HHHHHHhCCCCCCee--eccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeE
Q 016789 81 ELEQATKQFSETSLI--GFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 81 ~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 155 (382)
+.....++|...+.+ |+|+||.||++.... ..+++|.......... |+.....+ +||||+++++++...+..+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 333444566666666 999999999998754 6788887654322221 22222222 6999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC-cEEEeecCCcc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF-IAKVADTGISK 234 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~ 234 (382)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .++|+|||++.
T Consensus 86 iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 9999999999999997642 6899999999999999999999987 99999999999999998 99999999987
Q ss_pred ccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 235 LLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
..... ....++..|+|||++.+..++.++||||||+++|||++|+.||....... .....+........
T Consensus 159 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~----- 227 (267)
T PHA03390 159 IIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQQKKL----- 227 (267)
T ss_pred ecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhhcccC-----
Confidence 65322 12245677999999999899999999999999999999999997433221 11122211110000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPK-MEIVMT 351 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-~~~v~~ 351 (382)
......+..+.+++.+||+.||.+||+ ++++++
T Consensus 228 ----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 ----PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111234567889999999999999996 588764
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=283.81 Aligned_cols=246 Identities=20% Similarity=0.245 Sum_probs=190.8
Q ss_pred CCCCCCeeeccCcccEEEEEE-----CCeeEEEEEccCC-------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCee
Q 016789 88 QFSETSLIGFGSFGPVYKGLL-----RDTVVAIKRRVGS-------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~-------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 154 (382)
+|+..+.||+|+||.||++.. .+..+|+|..... ..+.+.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 367778999999999999986 3468999986532 124678899999999 599999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++|+||+++++|.+++.... .+++.....++.|++.||.|||+.+ ++||||+|+|||+++++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999987542 5788888999999999999999977 9999999999999999999999999998
Q ss_pred ccccccccCCCcccccccccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCccCCC-ChhHHHHHHHhhcCCCcc
Q 016789 235 LLENIEEAGPSHGSIVNVFRDPEVEESG--VFSEMSDIYSFGVFLLELVTGQEASHIVSLG-SYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvws~G~vl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 311 (382)
..............++..|+|||.+... .++.++||||||+++|+|++|+.|+...... ......+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~----- 228 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----- 228 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-----
Confidence 6543322222233456779999998653 4788999999999999999999998643221 1112211111100
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRP-----KMEIVMT 351 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~~v~~ 351 (382)
+ .++......+.+++.+||+.||.+|| +..+++.
T Consensus 229 --~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 --P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 12223446778999999999999997 6666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=302.44 Aligned_cols=245 Identities=20% Similarity=0.320 Sum_probs=193.8
Q ss_pred CCCCCeeeccCcccEEEEEECCe--eEEEEEccC---CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVG---SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~~--~vavK~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.+...||.|+||+||+|..++. ..|-|.+.. ...++|+-|++||....||+||++++.|...+.+|++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 33445699999999999998873 345555433 3446899999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|-....+... +..+...++..+++|++.||.|||+.+ |||||||+.|||++-+|.++|+|||.+-....... .
T Consensus 114 GAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q-k 186 (1187)
T KOG0579|consen 114 GAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ-K 186 (1187)
T ss_pred chHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHh-h
Confidence 9988877654 347899999999999999999999988 99999999999999999999999999754332211 2
Q ss_pred CCcccccccccCcccc-----ccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 244 PSHGSIVNVFRDPEVE-----ESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~-----~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
....-|||+|||||+. ...+|+.++||||||++|.||..+.+|.+...+ ...++.... ..++.++.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--MRVllKiaK--SePPTLlq----- 257 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIAK--SEPPTLLQ----- 257 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--HHHHHHHhh--cCCCcccC-----
Confidence 2344679999999985 456799999999999999999999999874432 122222111 11122222
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+......+.+++++||..||..||++.++++
T Consensus 258 --PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 --PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred --cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 3445677889999999999999999999875
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=291.54 Aligned_cols=254 Identities=18% Similarity=0.247 Sum_probs=191.6
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeC------
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN------ 151 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 151 (382)
..+.|+..+.||+|+||.||++.... ..+|+|.+... ....+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 44679999999999999999998754 78999986532 224677899999999999999999988644
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
...++||||+. ++|.+.+.. .++......++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCc
Confidence 35699999995 588887743 2778888999999999999999987 9999999999999999999999999
Q ss_pred CccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHH--------
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVR-------- 303 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~-------- 303 (382)
+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.. ........
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI--DQWNKIIEQLGTPSDE 239 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhcCCCCHH
Confidence 9986543221 12234567799999999999999999999999999999999998643211 10000000
Q ss_pred --------------hhcCC-----Ccccccc----cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 304 --------------SRLSS-----NNFVDHR----LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 304 --------------~~~~~-----~~~~d~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..... ....... .........+..+.+++.+||+.||++||++.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0000000 0000012345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=284.35 Aligned_cols=256 Identities=21% Similarity=0.272 Sum_probs=189.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
++|+..+.||+|++|.||+|.... ..+++|..... ....+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 357888899999999999998764 68999986532 12468889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC-CCcEEEeecCCcccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-NFIAKVADTGISKLLEN 238 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-~~~~kl~DfGla~~~~~ 238 (382)
|++ ++|.+++.... ...+++.....++.|++.||.|||+.+ ++||||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 58888775432 224578888899999999999999977 999999999999985 56799999999976533
Q ss_pred ccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC-Ccc-----
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS-NNF----- 311 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~----- 311 (382)
... ......++..|+|||.+.+ ..++.++||||||+++|+|+||+.||..... .....+........ ...
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE--IDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChhhccccc
Confidence 211 1122334677999998865 4578999999999999999999999864321 12221111110000 000
Q ss_pred --cc-----cccCCC----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 312 --VD-----HRLAGT----FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 312 --~d-----~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+ +..... .....+..+.+++.+|++.||++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000000 01123456889999999999999999999986
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=285.64 Aligned_cols=265 Identities=16% Similarity=0.159 Sum_probs=194.3
Q ss_pred CCeeeccCcccEEEEEECCeeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCCh
Q 016789 92 TSLIGFGSFGPVYKGLLRDTVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 166 (382)
.+.+|.|+++.|+++...+..+|+|+.... ....+.+|+++++.++||||+++++++...+..+++|||+++|+|
T Consensus 7 ~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 7 GKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred hHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 344566667777777776789999986533 224688999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc----
Q 016789 167 CNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA---- 242 (382)
Q Consensus 167 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~---- 242 (382)
.+++.... ...+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.+..+......
T Consensus 87 ~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 87 EDLLKTHF---PEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99987642 235788889999999999999999987 999999999999999999999999988755322111
Q ss_pred --CCCcccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC-----------
Q 016789 243 --GPSHGSIVNVFRDPEVEES--GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS----------- 307 (382)
Q Consensus 243 --~~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------- 307 (382)
.......+..|+|||.+.. ..++.++|+|||||++|||++|+.||..... .....+.......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA--TQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCccccccCchhhh
Confidence 1122234556999999866 3588999999999999999999999975331 1122221111000
Q ss_pred ---CCc----ccccc----cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHHhhhhh
Q 016789 308 ---SNN----FVDHR----LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE--LERIHEKEMAL 363 (382)
Q Consensus 308 ---~~~----~~d~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~--L~~i~~~~~~~ 363 (382)
... ..++. ............+.+++.+||+.||++||++.++++. +..+.+...++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~~~ 308 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTSL 308 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccchhH
Confidence 000 00000 0111223345678899999999999999999999874 45554443333
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=294.61 Aligned_cols=247 Identities=19% Similarity=0.231 Sum_probs=192.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC-----chHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS-----PRQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~-----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 159 (382)
+.|++.+.||+||.+.||++...+ +.+|+|++... ..+.|.+|+..|.+|+ |.+|+++++|-..++.+|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 468888999999999999998876 67788765432 2356999999999995 9999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|- ..+|...|.+... ..+...+..+..|++.++.++|+.+ |||.||||.|+|+- .|.+||+|||.|..+..+
T Consensus 441 ~G-d~DL~kiL~k~~~----~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKS----IDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred cc-cccHHHHHHhccC----CCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 85 5689998876542 2332377889999999999999988 99999999999985 578999999999987665
Q ss_pred cccC-CCcccccccccCccccccCC-----------CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC
Q 016789 240 EEAG-PSHGSIVNVFRDPEVEESGV-----------FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS 307 (382)
Q Consensus 240 ~~~~-~~~~~~~~~y~aPE~~~~~~-----------~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 307 (382)
...- .....||..||+||.+.... .+.+|||||+||+||+|+.|+.||.... .... .
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~a------K 581 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIA------K 581 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHH------H
Confidence 4433 23457889999999985433 5678999999999999999999996321 1111 1
Q ss_pred CCcccccccCCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 308 SNNFVDHRLAGTFTTE-GMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 308 ~~~~~d~~~~~~~~~~-~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
...+.||...-+++.- ....+.++++.||+.||.+||+..++++-
T Consensus 582 l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2233444332222211 11238999999999999999999999863
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=285.86 Aligned_cols=254 Identities=21% Similarity=0.260 Sum_probs=190.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 157 (382)
++|+..+.||+|+||.||+|.... ..||+|...... ...+.+|+.++++++|+||+++++++... +..++|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 568888999999999999998864 689999865322 22466899999999999999999998755 568999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 87 ~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 87 MEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 99996 58888876532 36899999999999999999999988 9999999999999999999999999998765
Q ss_pred cccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC-C-Ccc---
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS-S-NNF--- 311 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~-~~~--- 311 (382)
.... .......+..|+|||.+.+ ..++.++||||+|+++|||++|++||...... ........... . ...
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI---EQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred CccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChhhchh
Confidence 4321 1122233567999999865 45899999999999999999999999743321 11111111000 0 000
Q ss_pred -cc------cccCC---CC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 312 -VD------HRLAG---TF----TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 312 -~d------~~~~~---~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+ ..+.. .. ....+..+.+++.+||+.||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 00000 00 0112566788999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=280.44 Aligned_cols=255 Identities=21% Similarity=0.304 Sum_probs=193.2
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
+|+..+.||.|++|.||+|+... ..+++|..... ....+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 47778899999999999999864 68999986543 2346778999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
+ |+|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 D-KDLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred C-ccHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 7 588888865431 236899999999999999999999987 99999999999999999999999999975533211
Q ss_pred cCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc-----------CCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL-----------SSN 309 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~ 309 (382)
......++..|++||.+.+. .++.++||||||+++|||++|+.||...... ........... ...
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--DQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhHHHHhcCc
Confidence 11223346679999988654 5788999999999999999999998754321 11111111000 000
Q ss_pred cccccccC-------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 NFVDHRLA-------GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 ~~~d~~~~-------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
... .... ....+..+..+.+++.+||+.||.+||++.++++
T Consensus 233 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYK-PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhc-ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 0000 0011223567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=276.60 Aligned_cols=247 Identities=22% Similarity=0.303 Sum_probs=199.7
Q ss_pred CCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|...+.||.|+||.||++... +..+++|..... ....+.+|+++++.++|||++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677789999999999999987 478999986543 335688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++++|.+++.... .....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQK-KEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhh-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997643 12347899999999999999999999987 9999999999999999999999999998664432
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
. ......+++.|+|||......++.++|+||+|+++|+|++|+.|+.... ........... .. ...
T Consensus 158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~-~~---------~~~ 223 (258)
T cd08215 158 D-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKG-QY---------PPI 223 (258)
T ss_pred c-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHHHhcC-CC---------CCC
Confidence 1 1122345677999999988889999999999999999999999986432 22222221111 00 111
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+...+..+.+++.+||+.+|++||++.++++
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=280.63 Aligned_cols=241 Identities=23% Similarity=0.231 Sum_probs=190.7
Q ss_pred eeccCcccEEEEEEC--CeeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCCh
Q 016789 95 IGFGSFGPVYKGLLR--DTVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 95 lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 166 (382)
||+|+||.||++... +..+++|...... ...+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 4789999875432 24688899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc----
Q 016789 167 CNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA---- 242 (382)
Q Consensus 167 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~---- 242 (382)
.+++.+.+ .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997643 6899999999999999999999877 999999999999999999999999998754332111
Q ss_pred ---CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 243 ---GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 243 ---~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
......++..|++||......++.++||||||+++|||++|+.||.... ............ . ...
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~-~--------~~~ 221 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET---PEEIFQNILNGK-I--------EWP 221 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCC-c--------CCC
Confidence 1122334567999999988889999999999999999999999986433 222222221100 0 000
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
.....+..+.+++.+||+.+|.+||++..+.+.|+
T Consensus 222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 01112567889999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=279.34 Aligned_cols=240 Identities=21% Similarity=0.199 Sum_probs=184.7
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCCch------HHHHHHHHH-HhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPR------QEFVAEVTY-LSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~------~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||.||+|.... +.+|+|....... ..+..|..+ ....+|||++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 468999999999998854 7899998754321 123444444 3455899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999987543 5788999999999999999999987 99999999999999999999999999875432
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....++..|++||.+.+..++.++||||||+++|||++|..||.... ............. .........
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~ 219 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET---PDAVFDNILSRRI-------NWPEEVKEF 219 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhccc-------CCCCccccc
Confidence 112234567999999988889999999999999999999999996432 1222221111100 000011123
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
.+..+.+++.+||+.||++||++.++.+.|.
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 4567889999999999999998876665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=281.19 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=193.0
Q ss_pred CCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 89 FSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
|...+.||.|++|.||++... +..+++|...... ...+..|++++++++||||+++++++...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678999999999999875 3688999865432 346788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++ +|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 64 8888886532 36899999999999999999999987 99999999999999999999999999876654331
Q ss_pred cCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC-----Ccccc--
Q 016789 242 AGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS-----NNFVD-- 313 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~d-- 313 (382)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..... .............. ..+.+
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--IDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCchHhcccchhhh
Confidence 11223355679999998776 789999999999999999999999864322 11111111100000 00000
Q ss_pred -------cccC----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 314 -------HRLA----GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 314 -------~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+... .....+.+..+.+++.+||+.||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0112234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=281.09 Aligned_cols=250 Identities=19% Similarity=0.228 Sum_probs=187.6
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc----hHHHHHHHHHHhcCC-CCCccceeeEEEeC--CeeEEEEe
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP----RQEFVAEVTYLSEIR-HRNLVTLLGYCQQN--GYQMLVFE 159 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~----~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 159 (382)
|+..+.||+|+||.||++.... ..+|+|...... .....+|+.++.++. |||++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 4566789999999999998754 789999865421 223457888999885 99999999999887 88999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|++ |+|.+.+.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||+++.+...
T Consensus 81 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 68888876532 36899999999999999999999987 999999999999999 99999999999866433
Q ss_pred cccCCCcccccccccCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc-----------C
Q 016789 240 EEAGPSHGSIVNVFRDPEVEE-SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL-----------S 307 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----------~ 307 (382)
... ....++..|+|||.+. +..++.++|||||||++|||++|..||..... ........... .
T Consensus 153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH---HHHHHHHHHHcCCCCHHHHHhhc
Confidence 221 1223466799999764 45578899999999999999999999964322 11111111100 0
Q ss_pred CCcccccccCC-------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 308 SNNFVDHRLAG-------TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 308 ~~~~~d~~~~~-------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.....+..... ......+..+.+++.+||+.||++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000 001234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=291.88 Aligned_cols=256 Identities=16% Similarity=0.242 Sum_probs=191.9
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEe----CCee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQ----NGYQ 154 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 154 (382)
..+|+..+.||+|+||.||++.... ..+++|++... ....+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3678888999999999999998764 78999986542 23457789999999999999999998753 3468
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++|+||+. |+|.+++... ..+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 6888887543 24899999999999999999999977 9999999999999999999999999997
Q ss_pred ccccccccCC---CcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhh--cCC
Q 016789 235 LLENIEEAGP---SHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSR--LSS 308 (382)
Q Consensus 235 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~ 308 (382)
.......... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ....... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~ 232 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPS 232 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCCh
Confidence 6543222111 12345667999999765 4589999999999999999999999965332111 1111110 000
Q ss_pred Cccc------------cc-ccCCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 309 NNFV------------DH-RLAGTF-----TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 309 ~~~~------------d~-~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..+. +. ...... ....+..+.+++.+||+.||.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000 00 000001 12235778999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=277.78 Aligned_cols=245 Identities=22% Similarity=0.309 Sum_probs=191.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC--------chHHHHHHHHHHhcCCCCCccceeeEEEeC--Cee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS--------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQ 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 154 (382)
.+|+..+.||+|+||.||++.... ..+++|..... ....+.+|++++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 468888999999999999998754 68999975321 123678899999999999999999998764 467
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++++||+++++|.+++.... .+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999987542 4788889999999999999999987 9999999999999999999999999998
Q ss_pred cccccccc--CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 235 LLENIEEA--GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 235 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
........ ......++..|+|||.+.+..++.++|+|||||++|||++|+.||.... ......+... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~--~~~~--- 227 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE--AMAAIFKIAT--QPTK--- 227 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC--HHHHHHHHHc--CCCC---
Confidence 65432111 1112335677999999998889999999999999999999999986431 1122221111 0011
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+......+.+++.+||+ +|..||+..+++.
T Consensus 228 -----~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 -----PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11233445678889999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=285.39 Aligned_cols=258 Identities=19% Similarity=0.303 Sum_probs=188.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCC-------
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNG------- 152 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------- 152 (382)
++|+..+.||+|+||.||+|.... ..+|+|...... ...+.+|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 468888999999999999998864 789999764321 234578999999999999999999987654
Q ss_pred -eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 153 -YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 153 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
..++||||+. ++|.+.+.... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCC
Confidence 3599999996 57877775432 35899999999999999999999987 9999999999999999999999999
Q ss_pred CccccccccccC---CCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC
Q 016789 232 ISKLLENIEEAG---PSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS 307 (382)
Q Consensus 232 la~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 307 (382)
++.......... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 997654322211 1122345679999988654 378899999999999999999999864332211111111111000
Q ss_pred CC---c-----cccc-ccCCCC---------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 308 SN---N-----FVDH-RLAGTF---------TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 308 ~~---~-----~~d~-~~~~~~---------~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.. . ..+. ...... .......+.+++.+||+.||.+||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 0 0000 000000 0001245678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=287.94 Aligned_cols=244 Identities=19% Similarity=0.247 Sum_probs=195.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
+.|+..++||+|+||.||-+.... ..+|.|++.+. ...-.++|-.+|.+++.+.||.+--.+.+.+.+++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 567888999999999999987765 56777764322 1234678999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
..|.||+|.-+|...+ ...+++....-.+.+|+.||.+||+.+ ||.|||||+|||+|+.|+++|+|.|+|..+..
T Consensus 265 tlMNGGDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EeecCCceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999998765 246899999999999999999999988 99999999999999999999999999987755
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.... ....||.+|||||++.++.|+...|+||+||++|||+.|+.||.........+ .+..+... ...
T Consensus 340 g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e---Evdrr~~~-------~~~ 407 (591)
T KOG0986|consen 340 GKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE---EVDRRTLE-------DPE 407 (591)
T ss_pred CCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH---HHHHHHhc-------chh
Confidence 4332 23378999999999999999999999999999999999999997432111110 11111100 111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKME 347 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ 347 (382)
.++...+++..++....|++||++|..-.
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 34455566677777789999999997654
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=289.88 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=190.3
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC-----chHHHHHHHHHHhcC-CCCCccceeeEEEeC--CeeE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS-----PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQN--GYQM 155 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~~ 155 (382)
.++|+..+.||+|+||.||+|.+. +..+++|++... ....+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456888889999999999999875 378999976432 234577899999999 999999999998654 3689
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+||||++ ++|.+++... .+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 9999996 5888887542 5788888999999999999999977 99999999999999999999999999986
Q ss_pred ccccccc----CCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC---
Q 016789 236 LENIEEA----GPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS--- 307 (382)
Q Consensus 236 ~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--- 307 (382)
....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~ 234 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN--QLEKIIEVIGPPSA 234 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCH
Confidence 6433221 1122345677999998754 457899999999999999999999986433211 11100000000
Q ss_pred ----------CCccccc----cc--CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 308 ----------SNNFVDH----RL--AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 308 ----------~~~~~d~----~~--~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
...+.+. .. ........+..+.+++.+||+.||.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000 00 000011135678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=271.81 Aligned_cols=243 Identities=26% Similarity=0.390 Sum_probs=196.1
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|+..+.||+|++|.||++.... ..+++|...... .+.+.+|++++++++|||++++++++...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 36778899999999999998764 689999866443 34688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998654 36899999999999999999999887 9999999999999999999999999998765433
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
.. .....++..|+|||......++.++||||+|+++|+|++|+.|+.... ......... .... + ..
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~--~~~~~~~~~--~~~~-----~----~~ 219 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN--PMAALFRIV--QDDH-----P----PL 219 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHh--ccCC-----C----CC
Confidence 21 122345667999999988888999999999999999999999986432 111111111 0000 1 11
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+...+..+.+++.+||+.+|++||++.+++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 2233467889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=291.62 Aligned_cols=259 Identities=18% Similarity=0.266 Sum_probs=191.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeC-----Cee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN-----GYQ 154 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 154 (382)
.++|+..+.||+|+||.||+|.... ..||+|..... ....+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 3578889999999999999998754 68999987532 234578899999999999999999987654 357
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++++||+. ++|.+.+.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECccccee
Confidence 99999996 578777643 25888999999999999999999987 9999999999999999999999999987
Q ss_pred ccccccccC--CCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC--
Q 016789 235 LLENIEEAG--PSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN-- 309 (382)
Q Consensus 235 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 309 (382)
......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ..............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~---~~~~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY---LHQLNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCCH
Confidence 654322111 122345677999998654 5689999999999999999999999864321 11111111100000
Q ss_pred c----cccc---------ccCCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHH
Q 016789 310 N----FVDH---------RLAGTF-----TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE--LERI 356 (382)
Q Consensus 310 ~----~~d~---------~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~--L~~i 356 (382)
+ ..+. ...... .+..+..+.+++.+||+.||++||++.++++. ++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0 0000 000000 01224568899999999999999999999886 5444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=282.68 Aligned_cols=239 Identities=19% Similarity=0.274 Sum_probs=189.6
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCC---chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCChh
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGS---PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMC 167 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 167 (382)
..||+|+||.||++.... ..+++|..... ....+.+|+.+++.++|+||+++++++...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 569999999999998854 78999986432 2346889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCcc
Q 016789 168 NHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHG 247 (382)
Q Consensus 168 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 247 (382)
+++... .+++.....++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++........ .....
T Consensus 106 ~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 106 DIVTHT------RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 877432 4788899999999999999999987 99999999999999999999999999875543221 11223
Q ss_pred cccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHH
Q 016789 248 SIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRD 327 (382)
Q Consensus 248 ~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 327 (382)
.++..|++||.+.+..++.++|+||||+++|||++|..||.... ............. +.+. .....+..
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~---~~~~~~~~~~~~~------~~~~--~~~~~~~~ 245 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLP------PKLK--NLHKVSPS 245 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhhCC------cccC--CcccCCHH
Confidence 45677999999988889999999999999999999999986432 1222222221111 1110 01123456
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHH
Q 016789 328 LIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 328 l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+.+++.+||+.||.+||++.++++
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhc
Confidence 778899999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=277.41 Aligned_cols=253 Identities=22% Similarity=0.265 Sum_probs=190.0
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcC---CCCCccceeeEEEeCCe-----
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEI---RHRNLVTLLGYCQQNGY----- 153 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 153 (382)
|+..+.||+|+||.||++.+.. ..+++|...... ...+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4567889999999999999864 789999875321 23466787777665 59999999999988776
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.+++|||+. ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999996 58988886543 235899999999999999999999977 999999999999999999999999999
Q ss_pred cccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC-----
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS----- 308 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----- 308 (382)
......... ....++..|+|||.+.+..++.++|+||||+++|||++|++||..... .+............
T Consensus 155 ~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 155 RIYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE--ADQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred eeccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh--HHHHHHHHHHcCCCChHhc
Confidence 876433221 122346679999999988999999999999999999999998864322 12222221110000
Q ss_pred --Cc-----ccccccC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 309 --NN-----FVDHRLA---GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 309 --~~-----~~d~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.. ....... .....+....+.+++.+||+.||.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 0000000 0111234567789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=281.30 Aligned_cols=253 Identities=22% Similarity=0.314 Sum_probs=190.4
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc----hHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeec
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP----RQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~----~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
|...+.||+|+||+||+|...+ ..+++|+..... .....+|+..+++++ |||++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 4567889999999999999854 689999865432 224567899999999 999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
+|+|.+++.... ...+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889999887643 246899999999999999999999987 99999999999999999999999999986543222
Q ss_pred cCCCcccccccccCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh-----------hcCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEE-SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS-----------RLSSN 309 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~ 309 (382)
. ....++..|+|||.+. ...++.++|+||||+++|||++|++||...... ......... .....
T Consensus 155 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 155 Y--TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI--DQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred c--CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH--HHHHHHHHhcCCCChhhhhhHhhhh
Confidence 1 1223456799999875 445899999999999999999999998644321 111100000 00000
Q ss_pred cccccccCC-------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 NFVDHRLAG-------TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 ~~~d~~~~~-------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+..+.. .........+.+++.+||+.||++||+++|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000 001112467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=278.22 Aligned_cols=237 Identities=19% Similarity=0.233 Sum_probs=182.8
Q ss_pred eeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHH---HHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 94 LIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVT---YLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
+||+|+||.||++.... +.+|+|...... ...+..|.. .++...||||+++.+++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999998754 689999765321 112344433 4445579999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 99999888653 25899999999999999999999977 9999999999999999999999999987553321
Q ss_pred CCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 243 GPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
.....++..|+|||.+.++ .++.++||||+|+++|||++|+.||............. .... .+. ..+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~------~~~----~~~ 219 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLT------MAV----ELP 219 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-Hhhc------cCC----CCC
Confidence 1223467789999998754 58999999999999999999999997543222222111 1100 011 112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRP-----KMEIVMT 351 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RP-----s~~~v~~ 351 (382)
...+..+.+++.+|+..||.+|| ++.++++
T Consensus 220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 22356788899999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=284.36 Aligned_cols=243 Identities=19% Similarity=0.246 Sum_probs=199.3
Q ss_pred CCCCCCeeeccCcccEEEEEE--CCeeEEEEEccCCch-----HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLL--RDTVVAIKRRVGSPR-----QEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
-|...+.||+|.|..|-+|++ .+..||||++.+... ..+.+|++.|+-++|||||++|.+......+|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 355667799999999999875 567999998776533 4577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee-cCCCcEEEeecCCccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV-DENFIAKVADTGISKLLENI 239 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill-~~~~~~kl~DfGla~~~~~~ 239 (382)
-++|+|.+++-++. ..+.+......+.||..|+.|+|+.. +|||||||+||.+ ..-|.+||.|||++..+.+.
T Consensus 99 GD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999997753 35788888999999999999999988 9999999999875 56789999999999877665
Q ss_pred cccCCCcccccccccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFS-EMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
+..... .|...|-|||.+.+..|+ +++||||+||+||.|++|++||+.... .+.+...+... -
T Consensus 173 ~kL~Ts--CGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND--SETLTmImDCK------------Y 236 (864)
T KOG4717|consen 173 KKLTTS--CGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND--SETLTMIMDCK------------Y 236 (864)
T ss_pred chhhcc--cchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc--hhhhhhhhccc------------c
Confidence 554444 455679999999988876 578999999999999999999975432 22322222111 1
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..+.-...+-.+||..||..||.+|-+.++|+..
T Consensus 237 tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 237 TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 3355566778899999999999999999988753
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=279.99 Aligned_cols=247 Identities=20% Similarity=0.306 Sum_probs=188.1
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc----hHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP----RQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 159 (382)
++|...+.||+|+||.||+|.+. +..+|+|...... ...+..|+.++.+.. ||||+++++++......+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 45777889999999999999997 5789999876432 235667777777775 9999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
|+. +++.+.+.... ..+++..+..++.|++.||.|||+ .+ ++||||+|+||++++++.+||+|||++..+..
T Consensus 95 ~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 95 LMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred ccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 984 56766654422 268899999999999999999997 46 99999999999999999999999999876543
Q ss_pred ccccCCCcccccccccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGV----FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
.... ....++..|+|||.+.... ++.++||||||+++|||++|+.||..... ....+....... ..
T Consensus 168 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~--~~----- 237 (296)
T cd06618 168 SKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-EFEVLTKILQEE--PP----- 237 (296)
T ss_pred CCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-HHHHHHHHhcCC--CC-----
Confidence 2211 1223456799999987554 88899999999999999999999864211 111111111111 00
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
... .....+..+.+++.+||+.||.+||++.++++.
T Consensus 238 ~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 SLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 011234678899999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=287.61 Aligned_cols=251 Identities=20% Similarity=0.257 Sum_probs=187.2
Q ss_pred CCCeeeccCcccEEEEEECC--eeEEEEEccCCch-----------------HHHHHHHHHHhcCCCCCccceeeEEEeC
Q 016789 91 ETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPR-----------------QEFVAEVTYLSEIRHRNLVTLLGYCQQN 151 (382)
Q Consensus 91 ~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~-----------------~~~~~e~~~l~~l~h~niv~l~~~~~~~ 151 (382)
..+.||.|+||+||+|.... ..+|+|....... ..+.+|++++++++||||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 34679999999999998754 7899997653221 1467899999999999999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
+..++||||+. |+|.+++... ..+++.....++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEECCcc
Confidence 99999999996 6898888643 25888999999999999999999977 9999999999999999999999999
Q ss_pred Ccccccccc-------------ccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhH
Q 016789 232 ISKLLENIE-------------EAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEA 297 (382)
Q Consensus 232 la~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~ 297 (382)
++....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~--~~~ 242 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE--IDQ 242 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHH
Confidence 987654111 0111122345679999998764 478999999999999999999999875432 111
Q ss_pred HHHHHHhhcCCCc--cc-----------ccccCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 298 LIQWVRSRLSSNN--FV-----------DHRLAG---TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 298 ~~~~~~~~~~~~~--~~-----------d~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+............ +. ...... ......+..+.+++.+||+.||++||++.+++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111000000 00 000000 001122467889999999999999999999985
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=280.03 Aligned_cols=240 Identities=25% Similarity=0.346 Sum_probs=187.5
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
|...+.||+|+||+||+|.... ..+++|...... ...+.+|+++++.++|||++++++++......++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 5556789999999999998754 688998865321 23578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+. |++.+.+.... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 67877775432 35889999999999999999999987 99999999999999999999999999864322
Q ss_pred ccCCCcccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 241 EAGPSHGSIVNVFRDPEVEE---SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.....++..|+|||.+. ...++.++||||||+++|||++|.+|+..... .......... .....
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~-~~~~~------ 240 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQN-DSPTL------ 240 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhc-CCCCC------
Confidence 12234566799999974 45688999999999999999999999864321 1111111111 11111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.....+..+.+++.+||+.+|.+||++.++++.
T Consensus 241 --~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 --QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112233568889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=289.38 Aligned_cols=258 Identities=18% Similarity=0.264 Sum_probs=193.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeC-----Cee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN-----GYQ 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 154 (382)
+.|...+.||+|+||.||++.... ..+++|..... ....+.+|+.+++.++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 468888999999999999998764 68999986532 234577899999999999999999988644 357
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++++||+. ++|.+++... ..+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 99999995 7888887643 25889999999999999999999987 9999999999999999999999999998
Q ss_pred ccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc-C-CC--
Q 016789 235 LLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL-S-SN-- 309 (382)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~-~~-- 309 (382)
....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|++||..... ........... . ..
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 157 TTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY---VHQLKLITELLGSPSEED 232 (337)
T ss_pred ccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCChHH
Confidence 6643321 1122345667999998765 4689999999999999999999999864321 11111110000 0 00
Q ss_pred -----------------cccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHH
Q 016789 310 -----------------NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE--LERIH 357 (382)
Q Consensus 310 -----------------~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~--L~~i~ 357 (382)
...+.... ......+..+.+++.+||+.||++||++.++++. ++.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00000000 0012345678899999999999999999999987 66554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=284.63 Aligned_cols=258 Identities=21% Similarity=0.247 Sum_probs=187.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCC-------
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG------- 152 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------- 152 (382)
++|+..+.||+|+||.||+|.... ..+++|..... ....+.+|++++++++||||+++++++....
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 578889999999999999999864 67899976432 1235778999999999999999999875433
Q ss_pred -eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 153 -YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 153 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
..++|+||+. +++...+... ...+++..+..++.|+++||.|||+.+ ++||||||+||++++++.++|+|||
T Consensus 88 ~~~~lv~~~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 88 GSVYMVTPYMD-HDLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred ceEEEEEecCC-cCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCc
Confidence 4699999996 4677766542 236899999999999999999999987 9999999999999999999999999
Q ss_pred CccccccccccCC----------CcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHH
Q 016789 232 ISKLLENIEEAGP----------SHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQ 300 (382)
Q Consensus 232 la~~~~~~~~~~~----------~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~ 300 (382)
++........... ....+++.|+|||.+.+ ..++.++||||||+++|||++|++||.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9976543221111 11234567999998765 458899999999999999999999986433221111111
Q ss_pred HHHhhcC---------CCcccccccCCCCC-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 301 WVRSRLS---------SNNFVDHRLAGTFT-------TEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 301 ~~~~~~~---------~~~~~d~~~~~~~~-------~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
....... .....+.......+ ......+.+++.+||+.||++||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000 00000000000001 112356889999999999999999998874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=281.53 Aligned_cols=243 Identities=26% Similarity=0.367 Sum_probs=189.3
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
.|...+.||+|+||.||+|.... ..+++|..... ...++.+|+++++.++|+|++++.+++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 36666789999999999999854 67889876421 12357789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+. |++.+.+.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 68887775432 25788999999999999999999877 999999999999999999999999998765332
Q ss_pred cccCCCcccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 240 EEAGPSHGSIVNVFRDPEVEE---SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
....++..|+|||.+. ...++.++|||||||++|||++|+.|+..... ........... . +..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~--~-----~~~ 234 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNE--S-----PAL 234 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH--HHHHHHHhhcC--C-----CCc
Confidence 1223566799999974 35688899999999999999999999864321 11111111111 0 010
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
.....+..+.+++.+||+.+|.+||++.++++.-.
T Consensus 235 ---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 235 ---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 11234566889999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=279.01 Aligned_cols=244 Identities=21% Similarity=0.248 Sum_probs=195.7
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC------chHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS------PRQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 157 (382)
++|...+.||+|+||.||++... +..+++|..... ....+..|.+++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36788889999999999999885 378999976542 2346788999999998 99999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++++|.+++.+.+ .+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999997643 6899999999999999999999987 9999999999999999999999999987654
Q ss_pred cccc-------------------cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHH
Q 016789 238 NIEE-------------------AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEAL 298 (382)
Q Consensus 238 ~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~ 298 (382)
.... .......++..|++||......++.++|+||||+++|++++|+.|+.... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~ 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---EYLT 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---HHHH
Confidence 3221 11112234567999999988889999999999999999999999987433 1111
Q ss_pred HHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 016789 299 IQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKM----EIVMT 351 (382)
Q Consensus 299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~----~~v~~ 351 (382)
.+.... .....+...+..+.+++.+||+.||.+||++ .++++
T Consensus 231 ~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQKILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111111 0111222335678899999999999999999 66553
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=284.45 Aligned_cols=262 Identities=18% Similarity=0.240 Sum_probs=194.3
Q ss_pred ccCHHHHHHHHhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEE
Q 016789 76 QFSMEELEQATKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYC 148 (382)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~ 148 (382)
.....++...+++|...+.||+|+||.||++... +..+|+|+..... ...+.+|+.++++++||||+++++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 3445667778899999999999999999999865 3789999875422 24577899999999999999999988
Q ss_pred EeC------CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC
Q 016789 149 QQN------GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN 222 (382)
Q Consensus 149 ~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~ 222 (382)
... ...+++++++ +++|.+.+... .+++..+..++.|++.||.|||+.+ ++||||||+||+++++
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~ 156 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED 156 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCC
Confidence 643 3467888887 78888776532 4888999999999999999999987 9999999999999999
Q ss_pred CcEEEeecCCccccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHH
Q 016789 223 FIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQW 301 (382)
Q Consensus 223 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~ 301 (382)
+.+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+...
T Consensus 157 ~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~--~~~~~~~ 230 (345)
T cd07877 157 CELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLI 230 (345)
T ss_pred CCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Confidence 99999999998764321 122345677999998866 5688999999999999999999999864321 1111111
Q ss_pred HHhhcCC-Cccc---------------ccccCCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 302 VRSRLSS-NNFV---------------DHRLAGTF---TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 302 ~~~~~~~-~~~~---------------d~~~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
....... ..+. .......+ .......+.+++.+|++.||.+||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 1110000 0000 00000000 00124567899999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=294.49 Aligned_cols=260 Identities=23% Similarity=0.321 Sum_probs=195.1
Q ss_pred CCeeeccCcccEEEEEECC--eeEEEEEccC----CchHHHHHHHHHHhcCCCCCccceeeEEEeCC------eeEEEEe
Q 016789 92 TSLIGFGSFGPVYKGLLRD--TVVAIKRRVG----SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG------YQMLVFE 159 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~--~~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e 159 (382)
.+.||+|+||.||+|+++. ..||||.+.. ...+.+.+|+++|++++|||||++++.-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 4579999999999999875 7899998664 34578999999999999999999999865543 5689999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec--C--CCcEEEeecCCccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD--E--NFIAKVADTGISKL 235 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~--~--~~~~kl~DfGla~~ 235 (382)
||++|||...|.+. ++...+++...+.+..+++.||.|||+++ |+||||||.||++- + .-.-||+|||.|+.
T Consensus 98 yC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred ecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999999999764 45567999999999999999999999988 99999999999983 2 33569999999998
Q ss_pred cccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCc----
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNN---- 310 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 310 (382)
++... ......||..|.+||+... +.|+..+|.|||||++|+.+||..||...........+.|.........
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 76544 3344568899999999984 8899999999999999999999999975443322222233222111111
Q ss_pred -------ccccccCCCC----CHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHHHHH
Q 016789 311 -------FVDHRLAGTF----TTEGMRDLIRLTLQCMSSPGRRRP--KMEIVMTELERIH 357 (382)
Q Consensus 311 -------~~d~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RP--s~~~v~~~L~~i~ 357 (382)
-++-....++ .......+-..+..+|..+|++|- ...+....+..|.
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 1111111111 223344555666677888888888 6555555555443
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=264.68 Aligned_cols=266 Identities=19% Similarity=0.288 Sum_probs=195.3
Q ss_pred CCCCeeeccCcccEEEEEECC--eeEEEEEccCCch----HHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeecC
Q 016789 90 SETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPR----QEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 90 ~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~----~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
+....||.|+.|.||++++.. ...|||....... .+++..++++..-+ .|.||+.+|||..+...++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 344568999999999999987 7899998765432 35666777766554 8999999999999999999999983
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
- .+..+|.... .++++..+-++...+..||.||... .+|+|||+||+|||+|+.|++|+||||.+-.+......
T Consensus 175 ~-C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 175 T-CAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred H-HHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 2 3334443322 3588888888999999999999863 45999999999999999999999999999776543332
Q ss_pred CCCcccccccccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 243 GPSHGSIVNVFRDPEVEESG---VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~~---~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
. ...|.+.|||||.+.-. .|+-++||||||++++||.||+.||.... .+.+.+...++. ....++..
T Consensus 249 t--rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~-tdFe~ltkvln~---ePP~L~~~---- 318 (391)
T KOG0983|consen 249 T--RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK-TDFEVLTKVLNE---EPPLLPGH---- 318 (391)
T ss_pred c--cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC-ccHHHHHHHHhc---CCCCCCcc----
Confidence 2 33456779999998644 58999999999999999999999997533 233443333331 11222211
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH-----HHHHHHh-hhhhhhhccCCccc
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE-----LERIHEK-EMALTTFMGEGTAT 373 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~-----L~~i~~~-~~~~~~~~~~~~~~ 373 (382)
...+..+.+++..||++|+.+||...++++. -+.+... ..=+.+-|+..++.
T Consensus 319 --~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV~~~~~~~ 376 (391)
T KOG0983|consen 319 --MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKDVMAKTESP 376 (391)
T ss_pred --cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHHHHhccccc
Confidence 1245778899999999999999999998864 1222211 11255666666544
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=274.47 Aligned_cols=246 Identities=18% Similarity=0.241 Sum_probs=189.6
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccC--------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG--------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
.|...+.||+|+||.||++.... ..+++|.... .....+..|+.++++++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 36778899999999999998764 2333333221 1223566789999999999999999999998899999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
+||+++++|.+.+.... .....+++...+.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999887542 22346899999999999999999999977 999999999999975 569999999987654
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.... ......+++.|+|||...+..++.++|+||||+++|+|++|..|+.... ........... . .+
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---~~~~~~~~~~~-~-----~~--- 223 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---FLSVVLRIVEG-P-----TP--- 223 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHcC-C-----CC---
Confidence 3221 1122345667999999988889999999999999999999999986321 11111111110 0 01
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+...+..+.+++.+||+.||++||++.++++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 -SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 123345567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=284.70 Aligned_cols=261 Identities=20% Similarity=0.304 Sum_probs=198.8
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG-----YQM 155 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 155 (382)
+|...+.||.|+||.||+|.... ..+++|..... ..+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 46778899999999999999764 78999976543 2356889999999999999999999988765 789
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
++|||++ ++|.+++.... .+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 58888876432 6899999999999999999999987 99999999999999999999999999987
Q ss_pred cccccc--cCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC--CC-
Q 016789 236 LENIEE--AGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS--SN- 309 (382)
Q Consensus 236 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~- 309 (382)
...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+ .......... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 229 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID---QLNLIVEVLGTPSEE 229 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHhcCCCChh
Confidence 654321 112233456779999999887 79999999999999999999999997543211 1111111000 00
Q ss_pred -----------ccccc-ccC-----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHHh
Q 016789 310 -----------NFVDH-RLA-----GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE--LERIHEK 359 (382)
Q Consensus 310 -----------~~~d~-~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~--L~~i~~~ 359 (382)
..+.. ... .......+..+.+++.+||+.||.+||++.++++. ++++...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 00000 000 00111235678899999999999999999999985 6666543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=318.25 Aligned_cols=247 Identities=21% Similarity=0.264 Sum_probs=191.8
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
+-++.....||.|.||.||-|...+ ...|+|.+.... -..+.+|+.++..++|||+|+++|+-..++..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3456667789999999999998866 467887644321 245788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
|||++|+|.+.+...+ ..++.....+-.|++.|++|||+.+ ||||||||.||+++.+|.+|++|||.|..+.+
T Consensus 1314 EyC~~GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999999999987543 3455555567789999999999988 99999999999999999999999999987765
Q ss_pred cccc---CCCcccccccccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 239 IEEA---GPSHGSIVNVFRDPEVEESGV---FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 239 ~~~~---~~~~~~~~~~y~aPE~~~~~~---~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
.... ......||+.|||||++.+.. ...+.||||+|||+.||+||++||...+. +..-+ +-...+.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-e~aIM--y~V~~gh----- 1458 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-EWAIM--YHVAAGH----- 1458 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-hhHHH--hHHhccC-----
Confidence 4211 123456899999999986543 66789999999999999999999975432 11111 1111111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
....|...+..-.+++.+|+..||++|.++.|+++
T Consensus 1459 ----~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1459 ----KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ----CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 11234445666778889999999999988775544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=291.59 Aligned_cols=238 Identities=19% Similarity=0.191 Sum_probs=192.5
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeecC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
+..|.....+|.|+|+.|.++.+.. ...++|++... ..+-.+|+.++... +||||+++.+.+....+.|+|||++.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 5667778889999999999998765 67888887665 33445677666655 69999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee-cCCCcEEEeecCCccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV-DENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill-~~~~~~kl~DfGla~~~~~~~~ 241 (382)
+|-+.+.+.... .....+..|+++|+.++.|||+++ +|||||||+|||+ ++.++++|+|||.++.++..
T Consensus 400 g~ell~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 400 GGELLRRIRSKP------EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred ccHHHHHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 999988887643 222667789999999999999977 9999999999999 58999999999999977654
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
......|..|.|||++....|+++||+||||++||+|++|+.||.....+ .++.. +... +.++
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~----~i~~---------~~~s 532 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT----RIQM---------PKFS 532 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH----hhcC---------Cccc
Confidence 22334567799999999999999999999999999999999999865543 22221 1111 1122
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+....+|+.+||+.||.+||+|.++..
T Consensus 533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 444567788888999999999999999865
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=285.07 Aligned_cols=257 Identities=18% Similarity=0.302 Sum_probs=189.2
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCC------e
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG------Y 153 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~ 153 (382)
.+|...+.||+|+||.||+|... +..+|+|..... ....+.+|+.+++.++||||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 67888899999999999999875 478999986532 1245788999999999999999999987542 4
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.++|+||+. .+|...+. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 95 ~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred EEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 689999996 46655442 25788889999999999999999987 999999999999999999999999998
Q ss_pred cccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhh-cCCCc-
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSR-LSSNN- 310 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~- 310 (382)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+....... .....
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVPGPEF 238 (342)
T ss_pred cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHHH
Confidence 754321 122344667999999866 4589999999999999999999999974321 11111111100 00000
Q ss_pred -----------ccc--cccC-CCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHHh
Q 016789 311 -----------FVD--HRLA-GTF---TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE--LERIHEK 359 (382)
Q Consensus 311 -----------~~d--~~~~-~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~--L~~i~~~ 359 (382)
... +... ... .+.....+.+++.+||+.||.+||++.++++. ++.+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 000 0000 000 01124567899999999999999999999954 7666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=282.01 Aligned_cols=256 Identities=20% Similarity=0.256 Sum_probs=190.0
Q ss_pred HHHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC-----CchHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeE
Q 016789 84 QATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG-----SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQ-NGYQM 155 (382)
Q Consensus 84 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~ 155 (382)
..+++|+..+.||.|+||.||++.... ..+++|+... .....+..|+++++.++||||+++.+++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 356789999999999999999998664 6899997543 123567889999999999999999999865 45789
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+++||+ +++|.+++... .+++.....++.|+++||.|||+.+ ++||||+|+||++++++.++|+|||++..
T Consensus 87 lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEeehh-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 999998 56888877532 4677888889999999999999987 99999999999999999999999999875
Q ss_pred cccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHH-HH--------HHhh
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALI-QW--------VRSR 305 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~-~~--------~~~~ 305 (382)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||............ +. ....
T Consensus 158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 4321 112234567999998765 56899999999999999999999998643321111100 00 0000
Q ss_pred cC--CCccc-ccccCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 306 LS--SNNFV-DHRLAGTFT-----TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 306 ~~--~~~~~-d~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.. ..++. ........+ ...+..+.+++.+||+.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00000 000000111 1234678899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=286.91 Aligned_cols=245 Identities=24% Similarity=0.263 Sum_probs=196.7
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
....|.....||+|.|++|.++++.. ..||+|.+.+.. ...+.+|+++|..++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 34578888999999999999998865 789999876542 34578999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+.+|.+.++|.+.+ .+.......++.|+.++++|||+.. |||||||++|+||+.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeec
Confidence 99999999999999876 3445777788999999999999988 9999999999999999999999999999876
Q ss_pred cccccCCCcccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVF-SEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
.... .....+++.|.|||+..+..| ++++|+||+|+++|-|+.|..||+..... .+. ++.+-..+
T Consensus 207 ~~~~--lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk---~Lr---------~rvl~gk~ 272 (596)
T KOG0586|consen 207 YGLM--LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK---ELR---------PRVLRGKY 272 (596)
T ss_pred cccc--ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc---ccc---------chheeeee
Confidence 4332 233456677999999988775 57899999999999999999999743211 110 01111111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.-+ --..-+..+++++.+-.+|.+|+++.++.+.
T Consensus 273 rIp--~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 273 RIP--FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccc--ceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111 1112344567778999999999999998875
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=281.30 Aligned_cols=252 Identities=19% Similarity=0.305 Sum_probs=189.0
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCC-----
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG----- 152 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 152 (382)
..++|...+.||+|+||.||++.... ..+|+|+.... ....+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 45678889999999999999998754 68999986432 1245788999999999999999999987653
Q ss_pred -eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 153 -YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 153 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
..++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 7788877753 25889999999999999999999987 9999999999999999999999999
Q ss_pred CccccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC-
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN- 309 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~- 309 (382)
++....... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... ...............
T Consensus 164 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 164 LARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH--LDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCH
Confidence 998654321 12244667999999876 4588999999999999999999999874321 111111111000000
Q ss_pred ------------cccc--cccC----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 ------------NFVD--HRLA----GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 ------------~~~d--~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.... +... ..........+.+++.+|++.||.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 0000 0001123456889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=272.70 Aligned_cols=252 Identities=22% Similarity=0.289 Sum_probs=191.9
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
|+..+.||+|+||.||+|.... ..+++|...... ...+..|+.++++++|+|++++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4556789999999999999874 789999866432 246788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
+ ++|.+++.... ..+++..+..++.+++.||.|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 58999987642 35889999999999999999999987 99999999999999999999999999986543221
Q ss_pred cCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC-CC--------cc
Q 016789 242 AGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS-SN--------NF 311 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~--------~~ 311 (382)
.......+..|+|||.+.+. .++.++||||||+++|||++|++||..... ............ .. .+
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE---IDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHHHhCCCcHHHHHhhccc
Confidence 11122335569999998766 789999999999999999999999864321 111111111000 00 00
Q ss_pred --cccccCC-------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 312 --VDHRLAG-------TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 312 --~d~~~~~-------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+..... ...+.....+.+++.+||+.||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 001112567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=284.46 Aligned_cols=253 Identities=19% Similarity=0.281 Sum_probs=185.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC---chHHHHHHHHHHhcCCCCCccceeeEEEeC----------
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS---PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN---------- 151 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------- 151 (382)
.+|...+.||.|+||.||+|.... ..+++|..... ....+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 568888999999999999998864 68999876543 234688899999999999999999876543
Q ss_pred ----CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec-CCCcEE
Q 016789 152 ----GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD-ENFIAK 226 (382)
Q Consensus 152 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~-~~~~~k 226 (382)
...++|+||++ ++|.+++... .+++.....++.|++.||.|||+.+ ++||||||+||+++ +++.+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEE
Confidence 35789999996 5888777532 5788999999999999999999987 99999999999997 456789
Q ss_pred EeecCCccccccccccC--CCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHH
Q 016789 227 VADTGISKLLENIEEAG--PSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVR 303 (382)
Q Consensus 227 l~DfGla~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~ 303 (382)
++|||++..+....... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||..... .........
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--~~~~~~~~~ 233 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE--LEQMQLILE 233 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHH
Confidence 99999998654322111 112234667999998654 5588899999999999999999999964321 111111111
Q ss_pred hhcCCC--------------cccccccCCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 304 SRLSSN--------------NFVDHRLAGTF-----TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 304 ~~~~~~--------------~~~d~~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. .... ........... .......+.+++.+||+.||.+||++.++++
T Consensus 234 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 234 S-VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred h-cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 0000 00000000000 1123456789999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=269.50 Aligned_cols=237 Identities=21% Similarity=0.217 Sum_probs=189.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc---hH---HHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP---RQ---EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---~~---~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|...++||+|.||+|-+++-+. +.+|+|++++.. ++ .-+.|-++|...+||.+..+--.++..+.+++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 467788999999999999998765 689999876532 22 3467889999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+.||.|.-+|.+.+ .+++....-....|..||.|||+.+ ||.||||.+|.|+|.+|++||+|||+++.--.
T Consensus 248 eyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 248 EYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999987643 5666666667889999999999987 99999999999999999999999999984221
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.........|||.|+|||++....|+.++|+|.+||++|||++|+.||...+.+..-.++- .. |-+
T Consensus 321 -~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl---~e-------d~k--- 386 (516)
T KOG0690|consen 321 -YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL---ME-------DLK--- 386 (516)
T ss_pred -ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH---hh-------hcc---
Confidence 1123445678999999999999999999999999999999999999998654433333221 10 111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCC
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPK 345 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs 345 (382)
++.........|+.-.|.+||.+|..
T Consensus 387 -FPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 387 -FPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred -CCccCCHHHHHHHHHHhhcChHhhcC
Confidence 12222344566777899999999964
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=266.00 Aligned_cols=232 Identities=24% Similarity=0.263 Sum_probs=187.7
Q ss_pred eeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCCh
Q 016789 95 IGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 95 lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 166 (382)
||.|+||.||++.... ..+++|..... ....+..|+.++++++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999864 78899876542 234688999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCc
Q 016789 167 CNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH 246 (382)
Q Consensus 167 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 246 (382)
.+++.... .+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNT 152 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccC
Confidence 99987543 5789999999999999999999977 99999999999999999999999999986544321 1222
Q ss_pred ccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHH
Q 016789 247 GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMR 326 (382)
Q Consensus 247 ~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 326 (382)
..++..|++||...+...+.++|+||||+++||+++|+.||..... ....+.... .. ...+...+.
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~----~~-------~~~~~~~~~ 218 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILK----DP-------LRFPEFLSP 218 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhc----CC-------CCCCCCCCH
Confidence 3456679999999888899999999999999999999999964322 222222211 00 112222356
Q ss_pred HHHHHHhhccCCCCCCCCCHHH
Q 016789 327 DLIRLTLQCMSSPGRRRPKMEI 348 (382)
Q Consensus 327 ~l~~l~~~cl~~dp~~RPs~~~ 348 (382)
.+.+++.+||..||++||++.+
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCccc
Confidence 7889999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=265.15 Aligned_cols=200 Identities=24% Similarity=0.353 Sum_probs=170.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC------eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEe-CCee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD------TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQ-NGYQ 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 154 (382)
..|+....||+|+||.||+|.-.+ ..+|+|++..+. .....+|+.+++.++|||++.+..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 468888999999999999996433 268999877552 2467899999999999999999999887 7789
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC----CcEEEeec
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN----FIAKVADT 230 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~----~~~kl~Df 230 (382)
+|++||.+. +|.+.++-+.......++......|+.||..|+.|||++= |+||||||.|||+..+ |.|||+||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999965 8988887665555568899999999999999999999987 9999999999999877 99999999
Q ss_pred CCcccccccccc--CCCcccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCc
Q 016789 231 GISKLLENIEEA--GPSHGSIVNVFRDPEVEESGV-FSEMSDIYSFGVFLLELVTGQEASHI 289 (382)
Q Consensus 231 Gla~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~sDvws~G~vl~el~tg~~p~~~ 289 (382)
|+++.+.+.-.. .......|..|+|||.+.+.. ||.+.||||.||++.||+|-++.|..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999988765332 233456688899999988765 99999999999999999998887753
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=277.31 Aligned_cols=253 Identities=17% Similarity=0.231 Sum_probs=185.7
Q ss_pred CCCCCCeeeccCcccEEEEEECC----eeEEEEEccCC-----chHHHHHHHHHHhcC-CCCCccceeeEEEeC----Ce
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD----TVVAIKRRVGS-----PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQN----GY 153 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~----~~vavK~~~~~-----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~ 153 (382)
+|...+.||+|+||.||++.... ..+|+|..... ....+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 36677889999999999999864 47999986532 134678899999999 599999999976433 45
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.++++||+. ++|.+.+... ..+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788899885 6888888543 36889999999999999999999987 999999999999999999999999999
Q ss_pred cccccccccC---CCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc-CC
Q 016789 234 KLLENIEEAG---PSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL-SS 308 (382)
Q Consensus 234 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~ 308 (382)
+.+....... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...... .......... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~ 229 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV---DQLNQILQVLGTP 229 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH---HHHHHHHHHhCCC
Confidence 8654322211 122345677999998765 46899999999999999999999998643311 1111000000 00
Q ss_pred ----------C---ccc-------ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 309 ----------N---NFV-------DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 309 ----------~---~~~-------d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
. ... ...+. .........+.+++.+||+.||.+||++.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000 00000 0011124578899999999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=282.20 Aligned_cols=252 Identities=19% Similarity=0.263 Sum_probs=190.2
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCe----
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGY---- 153 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 153 (382)
..++|...+.||+|+||.||+|.... ..+++|..... ....+.+|+.++++++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 34678888999999999999999864 68999986532 12457789999999999999999998866554
Q ss_pred --eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 154 --QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 154 --~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 6799888764 25899999999999999999999987 9999999999999999999999999
Q ss_pred CccccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC-
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN- 309 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~- 309 (382)
++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+...........
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--IDQLKRIMNLVGTPDE 237 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCCH
Confidence 99865432 222344667999999865 3678999999999999999999999864321 111111111000000
Q ss_pred cc------------ccc---ccCCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 NF------------VDH---RLAGTF---TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 ~~------------~d~---~~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+ +.. .-...+ ....+..+.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 000 000000 0112567889999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=305.70 Aligned_cols=254 Identities=23% Similarity=0.253 Sum_probs=205.4
Q ss_pred HHHHHHHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 016789 80 EELEQATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQN 151 (382)
Q Consensus 80 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 151 (382)
.++.-.+.+|.+.++||+|+||.|..++++. .++|.|++.+ ....-|..|-++|..-+.+=|+++.-.|++.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 4555556889999999999999999999976 6899998654 2345688999999998999999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
+++|||||||+||+|..++.+.. .+++....-++..|..||.-||+.| +|||||||+|||||.+|++||+|||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccch
Confidence 99999999999999999998753 6888888889999999999999988 9999999999999999999999999
Q ss_pred CccccccccccCCCcccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEES-----GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
.+-.+..+.....+...|||.|.+||++.. +.|+..+|+||+||++|||+.|..||+.. .++.-..+-+
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KIm 294 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKIM 294 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHHh
Confidence 998888777777788899999999999843 56899999999999999999999999853 2333222222
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 016789 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPK---MEIVMT 351 (382)
Q Consensus 307 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs---~~~v~~ 351 (382)
...+.+.. +-..+.+....+||++.+ -+|+.|.. ..++-.
T Consensus 295 ~hk~~l~F----P~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 295 NHKESLSF----PDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred chhhhcCC----CcccccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence 22111111 111234566677777766 47788877 666543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=300.72 Aligned_cols=250 Identities=19% Similarity=0.290 Sum_probs=182.3
Q ss_pred HHHhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeC------
Q 016789 84 QATKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQN------ 151 (382)
Q Consensus 84 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 151 (382)
+...+|+...+||+||||.||+++++ ++.+|||++.-.. .....+|+..|++|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44567888889999999999999875 5899999976542 23577899999999999999996543110
Q ss_pred --------------------------------------------------------------------------------
Q 016789 152 -------------------------------------------------------------------------------- 151 (382)
Q Consensus 152 -------------------------------------------------------------------------------- 151 (382)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHH
Q 016789 152 ---------------------------------GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLC 198 (382)
Q Consensus 152 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~ 198 (382)
..+|+-||||+...+.+++++..... .....++++.+|++||+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLA 711 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHH
Confidence 11367888888877777776543211 34567889999999999
Q ss_pred HHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc----cc-------------cccCCCcccccccccCcccccc
Q 016789 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE----NI-------------EEAGPSHGSIVNVFRDPEVEES 261 (382)
Q Consensus 199 ~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~----~~-------------~~~~~~~~~~~~~y~aPE~~~~ 261 (382)
|+|+.+ +|||||||.||++|++..|||+|||+|+... .. .....+...||..|+|||.+.+
T Consensus 712 YIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 712 YIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHHhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 999988 9999999999999999999999999998621 00 0111233457778999999976
Q ss_pred CC---CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCC
Q 016789 262 GV---FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSS 338 (382)
Q Consensus 262 ~~---~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~ 338 (382)
.. |+.|+|+||+|+|++||+. ||... .+....+..++.. ..+. + ..+..+....=.+++.++++.
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR~g-~iP~---~---~~f~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLRKG-SIPE---P---ADFFDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcccC-CCCC---C---cccccccchHHHHHHHHHhcC
Confidence 55 9999999999999999985 45421 1222333322211 1110 0 122233344556788899999
Q ss_pred CCCCCCCHHHHHH
Q 016789 339 PGRRRPKMEIVMT 351 (382)
Q Consensus 339 dp~~RPs~~~v~~ 351 (382)
||.+|||+.|++.
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999875
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=261.20 Aligned_cols=253 Identities=18% Similarity=0.250 Sum_probs=195.5
Q ss_pred HHhCCCCC-CeeeccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhcC-CCCCccceeeEEEeC----CeeEE
Q 016789 85 ATKQFSET-SLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSEI-RHRNLVTLLGYCQQN----GYQML 156 (382)
Q Consensus 85 ~~~~~~~~-~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~~~l 156 (382)
.+++|++. ++||-|-.|+|-.+.++. ..+|+|.+.... ...+|++.--.. .|||||.+++++.+. .-+.+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi 136 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI 136 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence 44566554 589999999999998875 578999876553 345677765544 699999999988653 45788
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC---CCcEEEeecCCc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE---NFIAKVADTGIS 233 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~---~~~~kl~DfGla 233 (382)
|||.|+||.|.+.+.+++ ...+++.....|..||+.|+.|||+.+ |.||||||+|+|.+. |..+||+|||+|
T Consensus 137 VmE~meGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeecccchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccc
Confidence 999999999999998765 346899999999999999999999988 999999999999964 567999999999
Q ss_pred cccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccc
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVD 313 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (382)
+.... .........|++|.|||++...+|+..+|+||+||++|-|+.|.+||...-.... ..-.+.+.....
T Consensus 212 K~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk~rI~~gq--- 283 (400)
T KOG0604|consen 212 KETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKRRIRTGQ--- 283 (400)
T ss_pred cccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHHhHhhccC---
Confidence 96543 2334455678999999999999999999999999999999999999975432111 111111111111
Q ss_pred cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 314 HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 314 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..+..+.-...++...++|+.+|+.+|++|.|+.+++..
T Consensus 284 y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 011111224557888999999999999999999998753
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=264.96 Aligned_cols=220 Identities=19% Similarity=0.174 Sum_probs=174.4
Q ss_pred cCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCChhhhhhhcCC
Q 016789 98 GSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGL 175 (382)
Q Consensus 98 G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~ 175 (382)
|.||.||++.... ..+|+|.+.... .+..|...+....||||+++++++...+..+++|||+++|+|.+++....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~- 80 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL- 80 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc-
Confidence 8899999998864 689999876542 34455555666679999999999999999999999999999999987642
Q ss_pred CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCcccccccccC
Q 016789 176 ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD 255 (382)
Q Consensus 176 ~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~a 255 (382)
.+++.....++.|++.||.|||+.+ ++||||||+||+++.++.++++|||.+....... .....+..|+|
T Consensus 81 ----~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~a 150 (237)
T cd05576 81 ----NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCA 150 (237)
T ss_pred ----CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccC
Confidence 4889999999999999999999977 9999999999999999999999999886554321 11233456999
Q ss_pred ccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhc
Q 016789 256 PEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQC 335 (382)
Q Consensus 256 PE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c 335 (382)
||......++.++||||+|+++|||++|+.|+...... . .. ......+...+..+.+++.+|
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~---------~~----~~~~~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I---------NT----HTTLNIPEWVSEEARSLLQQL 212 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c---------cc----ccccCCcccCCHHHHHHHHHH
Confidence 99998888999999999999999999999886532110 0 00 000011222346688899999
Q ss_pred cCCCCCCCCCHHH
Q 016789 336 MSSPGRRRPKMEI 348 (382)
Q Consensus 336 l~~dp~~RPs~~~ 348 (382)
|+.||.+||++.+
T Consensus 213 l~~dp~~R~~~~~ 225 (237)
T cd05576 213 LQFNPTERLGAGV 225 (237)
T ss_pred ccCCHHHhcCCCc
Confidence 9999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=289.38 Aligned_cols=249 Identities=24% Similarity=0.311 Sum_probs=202.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC--chHHHHHHHHHHhcC-CCCCccceeeEEEe-----CCeeE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS--PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQ-----NGYQM 155 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~~~~ 155 (382)
+..|++.+++|.|.+|.||+++... +..|+|+.... ..++...|.++|+.. +|||++.++|++.. ++.+|
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 4557788899999999999997654 78888886643 456777888999888 69999999999863 46899
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
||||||.+||..|++.... +..+.|..+..|+..++.||.|||..+ ++|||+|-.|||++.++.||++|||++..
T Consensus 98 LVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeeeeeee
Confidence 9999999999999987654 668999999999999999999999988 99999999999999999999999999987
Q ss_pred cccccccCCCcccccccccCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCc
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEESG-----VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNN 310 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 310 (382)
+.... .......||++|||||++... .|+..+|+||+|++..||--|.+|+.+.-+. ..+. ..
T Consensus 173 ldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--raLF-------~I-- 240 (953)
T KOG0587|consen 173 LDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--RALF-------LI-- 240 (953)
T ss_pred eeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--hhhc-------cC--
Confidence 75533 234456789999999998643 3788899999999999999999998754321 1111 01
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 311 FVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 311 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...|......+..-.+.+.++|..||.+|-++||++.++++
T Consensus 241 pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11222222335667889999999999999999999998875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=297.84 Aligned_cols=141 Identities=27% Similarity=0.314 Sum_probs=126.6
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|...+.||+|+||.||+|.+. +..||+|.+.... ...+..|+.++..++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 46888899999999999999987 4789999875432 256888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
||+.+++|.+++...+ .+++...+.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999987543 4788888999999999999999987 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=269.01 Aligned_cols=239 Identities=22% Similarity=0.263 Sum_probs=190.9
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 156 (382)
..+|....+||+|+||+|-++.-++ ..+|||++.... .+--+.|-++|.-- +-|.++++..+++..+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3578889999999999999998776 578998876532 12234566666655 57899999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
||||+.||+|.-++...+ .+.+....-.|.+||-||-+||+.+ |+.||||.+|||+|.+|++||+|||+++.-
T Consensus 428 VMEyvnGGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999998765 5666777888999999999999988 999999999999999999999999999842
Q ss_pred ccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 237 ENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 237 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
-- ......+..+|+.|+|||.+..++|+.++|+|||||+||||+.|++||+..+ .+++.+.+... ..
T Consensus 501 i~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD---E~elF~aI~eh---------nv 567 (683)
T KOG0696|consen 501 IF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQAIMEH---------NV 567 (683)
T ss_pred cc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHHc---------cC
Confidence 11 1223345568899999999999999999999999999999999999997543 33444433321 11
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKM 346 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 346 (382)
.++...+.+...+.+..+.+.|.+|...
T Consensus 568 --syPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 568 --SYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred --cCcccccHHHHHHHHHHhhcCCccccCC
Confidence 3455556667778888999999999643
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=263.42 Aligned_cols=250 Identities=20% Similarity=0.229 Sum_probs=183.5
Q ss_pred CCeeeccCcccEEEEEECC--eeEEEEEccCCc----hHHHHHHHHHHh-cCCCCCccceeeEEEeCCeeEEEEeecCCC
Q 016789 92 TSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP----RQEFVAEVTYLS-EIRHRNLVTLLGYCQQNGYQMLVFEYLPNG 164 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~----~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 164 (382)
...||.|+||+|++-.++. +..|||++.... ..+++.|.+... .-+.||||++||.+...+..|+.||+|+ -
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 4569999999999998876 689999876543 246778877644 4478999999999999999999999994 4
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCC
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP 244 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 244 (382)
||..+-...-.-....+++..+-.|......||.||-.. -.|||||+||+|||+|..|.+||||||.+-.+...-. .
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--k 224 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--K 224 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeecccchHhHHHHHH--h
Confidence 554433221111233678888888888899999999753 2399999999999999999999999999876644221 2
Q ss_pred CcccccccccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 245 SHGSIVNVFRDPEVEESG--VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 245 ~~~~~~~~y~aPE~~~~~--~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
+...|...|||||.+... .|+-+|||||+|++|||+.||+.|+...+. ..+++.+.+... ...+.... -..
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-vfeql~~Vv~gd---pp~l~~~~---~~~ 297 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-VFEQLCQVVIGD---PPILLFDK---ECV 297 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-HHHHHHHHHcCC---CCeecCcc---ccc
Confidence 223444569999998643 489999999999999999999999874432 222333322211 11111111 113
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
+....+..++..|+.+|-..||...++.+.
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 356789999999999999999999987653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=287.54 Aligned_cols=260 Identities=19% Similarity=0.189 Sum_probs=168.1
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC------eeEEEEEccCCchHH-HHHHHHHHhcCCCCCccceeeE------EEeC
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD------TVVAIKRRVGSPRQE-FVAEVTYLSEIRHRNLVTLLGY------CQQN 151 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~~~~-~~~e~~~l~~l~h~niv~l~~~------~~~~ 151 (382)
..++|...+.||+|+||.||+|.+.. ..+|+|+.......+ +..+ .+....+.++..+... +...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 34678999999999999999998753 589999865433222 2222 1222223333332221 2455
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCC---------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCC
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLE---------------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTAN 216 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~N 216 (382)
...++|+||+.+++|.+++...... .........+..++.|++.||.|||+.+ |+||||||+|
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLKP~N 285 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVKPQN 285 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCCHHH
Confidence 6789999999999999988753210 0011123345679999999999999977 9999999999
Q ss_pred eeecC-CCcEEEeecCCccccccccccCCCcccccccccCccccccC----------------------CCCccchhHHH
Q 016789 217 VLVDE-NFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESG----------------------VFSEMSDIYSF 273 (382)
Q Consensus 217 ill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~sDvws~ 273 (382)
||+++ ++.+||+|||+|+.+............+++.|+|||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 68999999999986654333333445567889999965322 24456799999
Q ss_pred HHHHHHHHhCCCCCCccCCCChhHHHHHHHhh-cCCC---cccccccCCC----C--CHHHHHHHHHHHhhccCCCCCCC
Q 016789 274 GVFLLELVTGQEASHIVSLGSYEALIQWVRSR-LSSN---NFVDHRLAGT----F--TTEGMRDLIRLTLQCMSSPGRRR 343 (382)
Q Consensus 274 G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~---~~~d~~~~~~----~--~~~~~~~l~~l~~~cl~~dp~~R 343 (382)
||++|||+++..+++.. .......+... .... ....+..... + .........+|+.+||+.||++|
T Consensus 366 GviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 99999999977664321 11111111100 0000 0001100000 0 00112345689999999999999
Q ss_pred CCHHHHHHH
Q 016789 344 PKMEIVMTE 352 (382)
Q Consensus 344 Ps~~~v~~~ 352 (382)
||+.++++-
T Consensus 442 ~ta~e~L~H 450 (566)
T PLN03225 442 ISAKAALAH 450 (566)
T ss_pred CCHHHHhCC
Confidence 999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=284.40 Aligned_cols=246 Identities=25% Similarity=0.347 Sum_probs=189.7
Q ss_pred CCCCCeeeccCccc-EEEEEECCeeEEEEEccCCchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeecCCCCh
Q 016789 89 FSETSLIGFGSFGP-VYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 89 ~~~~~~lg~G~~g~-V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 166 (382)
|...+++|.|+.|+ ||+|.+.++.||||++..+..+-..+|+..|+.- .||||+++++.-.++...|+..|.| ..+|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL 589 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSL 589 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhH
Confidence 45556789999876 8999999999999998877777778999999888 5999999999999999999999999 5699
Q ss_pred hhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC-----CCcEEEeecCCccccccccc
Q 016789 167 CNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-----NFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 167 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-----~~~~kl~DfGla~~~~~~~~ 241 (382)
.+++.....+.. .......+.+..|+++||+|||+.+ ||||||||.||||+. ...++|+|||+++.+.....
T Consensus 590 ~dlie~~~~d~~-~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVE-MQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchh-hcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 999976421111 1111445678899999999999998 999999999999975 35789999999998865443
Q ss_pred c--CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 242 A--GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTG-QEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 242 ~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
. ..+...||.+|+|||.+....-+.++|++|+||++|..++| .+||.+....+. +.+..... +. .+.
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~----NIl~~~~~---L~--~L~- 736 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA----NILTGNYT---LV--HLE- 736 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh----hhhcCccc---ee--eec-
Confidence 2 24567788999999999998888999999999999999997 789864321110 00111110 00 000
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...++ ...+||.+|++.||..||++.+|+.
T Consensus 737 -~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 737 -PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 01111 5678888999999999999999973
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=252.23 Aligned_cols=250 Identities=18% Similarity=0.273 Sum_probs=191.6
Q ss_pred HHHHHHHHhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC---chHHHHHHHHHHhcCC-CCCccceeeEEEeCC
Q 016789 79 MEELEQATKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS---PRQEFVAEVTYLSEIR-HRNLVTLLGYCQQNG 152 (382)
Q Consensus 79 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 152 (382)
+++.-+.+. +.||+|+|+.|--++.- +..+|||++.+. .+....+|++++.+.+ |+||++++.+|.++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 556655553 57999999999988754 468999987654 3567889999999995 999999999999999
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC---CcEEEee
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN---FIAKVAD 229 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~---~~~kl~D 229 (382)
..|||||-|.||+|..++.++. .+.+....++..+|+.||.|||..+ |.||||||+|||.... .-+||||
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeec
Confidence 9999999999999999998865 6888899999999999999999977 9999999999998654 3589999
Q ss_pred cCCcccccccccc------CCCcccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCC----
Q 016789 230 TGISKLLENIEEA------GPSHGSIVNVFRDPEVEE-----SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS---- 294 (382)
Q Consensus 230 fGla~~~~~~~~~------~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~---- 294 (382)
|.+.......... ......|...|||||+.. ...|+.++|.||+||+||-|++|.+||...-..+
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 9887543221111 112334555699999863 3459999999999999999999999997543221
Q ss_pred ---h-----hHHHHHHHhhcCCCcccccccCCCCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 295 ---Y-----EALIQWVRSRLSSNNFVDHRLAGTFTT----EGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 295 ---~-----~~~~~~~~~~~~~~~~~d~~~~~~~~~----~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. ..+.+.+... +-+++. ..+....+++...+..|+.+|.++.+++.
T Consensus 303 rGe~Cr~CQ~~LFesIQEG-----------kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEG-----------KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCccHHHHHHHHHHHhcc-----------CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1 1111111111 112222 23556677888899999999999999887
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=277.47 Aligned_cols=257 Identities=20% Similarity=0.293 Sum_probs=178.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEE------------------CCeeEEEEEccCCc---hHH--------------HHHHH
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLL------------------RDTVVAIKRRVGSP---RQE--------------FVAEV 130 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~------------------~~~~vavK~~~~~~---~~~--------------~~~e~ 130 (382)
.++|...++||+|+||.||+|.. .++.||||++.... .++ +..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999964 12479999865321 122 33466
Q ss_pred HHHhcCCCCCc-----cceeeEEEe--------CCeeEEEEeecCCCChhhhhhhcCCC-------------------CC
Q 016789 131 TYLSEIRHRNL-----VTLLGYCQQ--------NGYQMLVFEYLPNGSMCNHLYETGLE-------------------SS 178 (382)
Q Consensus 131 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~ 178 (382)
.++.+++|.|+ ++++++|.. .+..+|||||+++|+|.++++..... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 677887753 35689999999999999998753210 11
Q ss_pred CcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCcccccccccCccc
Q 016789 179 TKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV 258 (382)
Q Consensus 179 ~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~ 258 (382)
..+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++................++.|+|||.
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 24567888999999999999999877 9999999999999999999999999997654333222333445778999998
Q ss_pred cccCC--------------------C--CccchhHHHHHHHHHHHhCCC-CCCccCCCCh------hHHHHHHHhhcCCC
Q 016789 259 EESGV--------------------F--SEMSDIYSFGVFLLELVTGQE-ASHIVSLGSY------EALIQWVRSRLSSN 309 (382)
Q Consensus 259 ~~~~~--------------------~--~~~sDvws~G~vl~el~tg~~-p~~~~~~~~~------~~~~~~~~~~~~~~ 309 (382)
+.... | ..+.||||+||++|||++|.. |+........ ..+..|.... .
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~---~ 458 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK---G 458 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc---c
Confidence 75432 1 124799999999999999985 5542211110 1111111110 0
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 016789 310 NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPG---RRRPKMEIVMT 351 (382)
Q Consensus 310 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp---~~RPs~~~v~~ 351 (382)
...+.. ..........+++.++|..+| .+|+|+.|+++
T Consensus 459 ~~~~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKYDFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCCCcc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 001111 112234667888889998766 78999999875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=261.85 Aligned_cols=256 Identities=23% Similarity=0.259 Sum_probs=196.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC--chHHHHHHHHHHhcCC-C-C----CccceeeEEEeCCeeE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS--PRQEFVAEVTYLSEIR-H-R----NLVTLLGYCQQNGYQM 155 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~--~~~~~~~e~~~l~~l~-h-~----niv~l~~~~~~~~~~~ 155 (382)
++.|.....+|+|+||.|-.+.+.. ..||+|++..- -++.-.-|+++|.++. + | -++.+.+|+.-.++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 6789999999999999999998766 68999987653 3456677999999994 2 3 3777888899999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec---------------
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD--------------- 220 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~--------------- 220 (382)
+|+|.+ |-|+.++|..+. ..+++...+..|+.|++++++|||+.+ ++|-||||+|||+.
T Consensus 168 ivfell-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEecc-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCccc
Confidence 999998 569999997643 457899999999999999999999988 99999999999982
Q ss_pred -----CCCcEEEeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCCh
Q 016789 221 -----ENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSY 295 (382)
Q Consensus 221 -----~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~ 295 (382)
.+..++|+|||.|+...... +...-|.-|+|||++.+-.++..+||||+||+|.|+.||...|+.....+.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 14468999999998654322 233445669999999999999999999999999999999999876553332
Q ss_pred hHHHHHHHhhcCCC-------------cccc---------------cc----cCCCCCHHHHHHHHHHHhhccCCCCCCC
Q 016789 296 EALIQWVRSRLSSN-------------NFVD---------------HR----LAGTFTTEGMRDLIRLTLQCMSSPGRRR 343 (382)
Q Consensus 296 ~~~~~~~~~~~~~~-------------~~~d---------------~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~R 343 (382)
-.+.+.+....... .-+| +. ........+...|++|+.++|..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 22222222100000 0000 00 0001123456789999999999999999
Q ss_pred CCHHHHHH
Q 016789 344 PKMEIVMT 351 (382)
Q Consensus 344 Ps~~~v~~ 351 (382)
+|+.|+++
T Consensus 398 iTl~EAL~ 405 (415)
T KOG0671|consen 398 ITLREALS 405 (415)
T ss_pred ccHHHHhc
Confidence 99999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=249.06 Aligned_cols=234 Identities=24% Similarity=0.287 Sum_probs=189.0
Q ss_pred CcccEEEEEECC--eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCChhhhhhh
Q 016789 99 SFGPVYKGLLRD--TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYE 172 (382)
Q Consensus 99 ~~g~V~~~~~~~--~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 172 (382)
+||.||+|...+ ..+++|...... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 789999876543 46899999999999999999999999999999999999999999999875
Q ss_pred cCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCccccccc
Q 016789 173 TGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV 252 (382)
Q Consensus 173 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~ 252 (382)
.. .+++.....++.+++.++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 43 2788999999999999999999987 9999999999999999999999999998765432 1222334567
Q ss_pred ccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHH
Q 016789 253 FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLT 332 (382)
Q Consensus 253 y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~ 332 (382)
|++||......++.++||||||+++|+|++|..|+... .+.....+......... . ......+..+.+++
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~--~~~~~~~~~~~~~~~~~-----~---~~~~~~~~~~~~~i 221 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD--DQLLELFKKIGKPKPPF-----P---PPEWKISPEAKDLI 221 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHhccCCCC-----c---cccccCCHHHHHHH
Confidence 99999998888999999999999999999999998642 12233333322211100 0 00001446788999
Q ss_pred hhccCCCCCCCCCHHHHHH
Q 016789 333 LQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 333 ~~cl~~dp~~RPs~~~v~~ 351 (382)
.+||..+|.+||++.++++
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHccCCchhccCHHHHhh
Confidence 9999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=265.25 Aligned_cols=251 Identities=21% Similarity=0.280 Sum_probs=190.3
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccC--C---c-----hHHHHHHHHHHhcCCCCCccceeeEEEeC-Cee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG--S---P-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQN-GYQ 154 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~--~---~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~ 154 (382)
+|-.+++||+|||+.||+|.+-. +.||+|+-.. . . .....+|.+|-+.|.||.||++|+++.-+ +..
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 34456679999999999997643 7899997321 1 1 12356899999999999999999998754 578
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec---CCCcEEEeecC
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD---ENFIAKVADTG 231 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~---~~~~~kl~DfG 231 (382)
+-|+|||+|.+|.-+|...+ .+++.....|+.||+.||.||...++||||-||||.|||+- ..|.+||+|||
T Consensus 544 CTVLEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred eeeeeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 88999999999999997654 67889999999999999999999999999999999999994 46889999999
Q ss_pred CccccccccccC------CCcccccccccCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHH
Q 016789 232 ISKLLENIEEAG------PSHGSIVNVFRDPEVEESG----VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQW 301 (382)
Q Consensus 232 la~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~----~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~ 301 (382)
+++.++...... .+.+.||.+|++||.+.-+ +++.++||||.||++|..+.|+.||.... ....++++
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq--sQQdILqe 696 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ--SQQDILQE 696 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch--hHHHHHhh
Confidence 999886544331 2456788999999987544 48899999999999999999999996322 22223222
Q ss_pred HHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 302 VRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 302 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
-. -+...++- + +..+........+|.+||++.-++|....++..
T Consensus 697 NT-IlkAtEVq---F--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 697 NT-ILKATEVQ---F--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hc-hhcceecc---C--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11 01111110 0 111223345667888999999999987776653
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=231.61 Aligned_cols=255 Identities=21% Similarity=0.270 Sum_probs=190.9
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+|...++||+|.||+||+|+..+ ..||+|+..-.+ ....++|+-+++.++|.|||+++++...+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 35556789999999999999877 689999865432 34688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
|. -+|..+.... +..++......++.|+.+||.|+|+++ +.||||||.|.||+.+|++|++|||+++.+.-.-
T Consensus 83 cd-qdlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hh-HHHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 95 4777776553 235788888999999999999999988 9999999999999999999999999998654321
Q ss_pred ccCCCcccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC--------Ccc
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGV-FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS--------NNF 311 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~ 311 (382)
...+....|..|.+|.++.+.+ |+...|+||.||++.|+.....|..... ...+++.......... ..+
T Consensus 156 -rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~-dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred -EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC-cHHHHHHHHHHHhCCCccccCCccccC
Confidence 1123345677899999987765 8999999999999999998665543222 1223344333332221 122
Q ss_pred cccccCCCCCH---------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 312 VDHRLAGTFTT---------EGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 312 ~d~~~~~~~~~---------~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.|......++. .....=.+++...+.-+|..|.+++..++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 23222222221 12223356777888899999999987765
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=251.80 Aligned_cols=258 Identities=20% Similarity=0.342 Sum_probs=188.3
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-c----hHHHHHHHHHHhcCCCCCccceeeEEEeC--------C
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-P----RQEFVAEVTYLSEIRHRNLVTLLGYCQQN--------G 152 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~ 152 (382)
.|....++|+|.||.||+|+..+ +.||+|+..-+ + ...-++|+.+|..++|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 45566789999999999998765 56788764322 1 23567899999999999999999988532 3
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCC
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI 232 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGl 232 (382)
.+|||+.+|+. +|.-.|.+. ...++...+..+..++..||.|+|..+ |+|||+||.|+||+.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeecccc
Confidence 58999999965 777777553 246888999999999999999999988 99999999999999999999999999
Q ss_pred ccccccccc---cCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC
Q 016789 233 SKLLENIEE---AGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS 308 (382)
Q Consensus 233 a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 308 (382)
++.+...+. ....+...|..|++||.+.+. .|+++.|||+.||++.||+|+.+.+........-.++..+......
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 976643322 223445568889999998765 4999999999999999999999887643322222222222211100
Q ss_pred ---Ccc--------c--ccccCCCC--CHHHH------HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 309 ---NNF--------V--DHRLAGTF--TTEGM------RDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 309 ---~~~--------~--d~~~~~~~--~~~~~------~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
+++ + .|-..+.+ -.+.. ...++|+.+++..||.+||.+.+++.-
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 000 0 00001110 01111 256788889999999999999988753
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=264.89 Aligned_cols=228 Identities=23% Similarity=0.338 Sum_probs=178.5
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
|..++.||-|+||+|.+++-.+ ..+|.|.+.+.+ ......|.+||..-..+=||+||-.|.+.+.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 5556789999999999997665 477888765432 12466799999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc---
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE--- 237 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~--- 237 (382)
++||++..+|.+.+ .+.+....-.+.++.+|+++.|..| +|||||||+|||||.+|++||+||||++-+.
T Consensus 711 IPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred cCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccceecc
Confidence 99999999998875 5677777777889999999999988 9999999999999999999999999985331
Q ss_pred ------cccccC--------------------------------CCcccccccccCccccccCCCCccchhHHHHHHHHH
Q 016789 238 ------NIEEAG--------------------------------PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLE 279 (382)
Q Consensus 238 ------~~~~~~--------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~e 279 (382)
+..... .....||+.|+|||++....|+..+|+||.||+|||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 000000 001236788999999999999999999999999999
Q ss_pred HHhCCCCCCccCCCChh-HHHHHHHhhcCCCcccccccCCCCCHHHHHHHHH
Q 016789 280 LVTGQEASHIVSLGSYE-ALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIR 330 (382)
Q Consensus 280 l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 330 (382)
|+.|+.||......+.. .++.| ..+++-...+..+.++...+.+
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw-------~~~l~~~~~~~ls~e~~~li~k 908 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINW-------RNFLHIPYQGNLSKEALDLIQK 908 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeeh-------hhccccccccccCHHHHHHHHH
Confidence 99999999876554433 33343 2334444445556665554444
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=265.27 Aligned_cols=237 Identities=16% Similarity=0.187 Sum_probs=191.6
Q ss_pred CCCCCCeeeccCcccEEEEEECCee--EEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRDTV--VAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~~~--vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
++.....||-|+||.|=+...+... +|+|.+++. ..+....|-.+|...+.|.||++|..+.++...|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4445567999999999999887743 677765432 22457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
-|-||.|...|++++ .++.....-++..+.+|++|||+.+ ||.|||||+|+++|.+|-+||.|||+|+.+.+.
T Consensus 501 aClGGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 501 ACLGGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhcCchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999876 5666667778889999999999988 999999999999999999999999999987653
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
.. .-+..||+.|.|||.+.+...+.++|.||+|+++|||++|.+||...++..... .+.+.... ..
T Consensus 574 ~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn---~ILkGid~---------i~ 639 (732)
T KOG0614|consen 574 RK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN---LILKGIDK---------IE 639 (732)
T ss_pred Cc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH---HHHhhhhh---------hh
Confidence 32 234567899999999999999999999999999999999999998654322211 11111110 12
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCC
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPK 345 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs 345 (382)
+|....+...+++++.+..+|.+|..
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhc
Confidence 33444566778899999999999987
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=260.97 Aligned_cols=239 Identities=21% Similarity=0.261 Sum_probs=189.0
Q ss_pred CCeeeccCcccEEEEEECC--eeEEEEEccC-----CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCC
Q 016789 92 TSLIGFGSFGPVYKGLLRD--TVVAIKRRVG-----SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNG 164 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~--~~vavK~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 164 (382)
.++||+|.||+||-|.++. +.||||.+.+ ...+...+|+.||.+++||.||.+...|+..+..+.|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 3689999999999998875 7999997553 33467889999999999999999999999999999999999 56
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC---CcEEEeecCCccccccccc
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN---FIAKVADTGISKLLENIEE 241 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~---~~~kl~DfGla~~~~~~~~ 241 (382)
+..+.+.... ...+++..-.-+..||..||.|||..+ |+|+||||+|||+... ..+||||||.|+.+....
T Consensus 648 DMLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 648 DMLEMILSSE---KGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred hHHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 7766665432 236888888889999999999999877 9999999999999643 479999999999876432
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
-.....||+.|+|||++.++.|+..-|+||.||++|--++|-.||... +++-+.++. ..++-|. .--
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-----EdIndQIQN----AaFMyPp---~PW 788 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-----EDINDQIQN----AAFMYPP---NPW 788 (888)
T ss_pred -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-----cchhHHhhc----cccccCC---Cch
Confidence 234567899999999999999999999999999999999999999732 222221211 1111111 111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVM 350 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~ 350 (382)
.+......++|...|+..-++|=+...-+
T Consensus 789 ~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 789 SEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 34456677888899999999998877654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=227.08 Aligned_cols=210 Identities=20% Similarity=0.273 Sum_probs=161.0
Q ss_pred hCCCCCCeeeccCcccEEEEEE--CCeeEEEEEccCCc----hHHHHHHHHHHhc-CCCCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLL--RDTVVAIKRRVGSP----RQEFVAEVTYLSE-IRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+.......||+|++|.|-+-++ .+...|+|++.... ....++|+++..+ ..+|.+|++||........|+.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 4445567799999999876665 45789999876543 2356677776444 479999999999998899999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
.|+ -||..+-.+. ...+..+++..+-+||..+.+||.|||++ -.++|||+||+|||++.+|.+|+||||.+-.+.+.
T Consensus 126 ~M~-tSldkfy~~v-~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKV-LKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHH-HhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 995 4666654432 23445789999999999999999999985 23999999999999999999999999999876543
Q ss_pred cccCCCcccccccccCcccccc----CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHH
Q 016789 240 EEAGPSHGSIVNVFRDPEVEES----GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWV 302 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~ 302 (382)
-.. +...|...|||||.+.. ..|+-+|||||+|+++.||.+++.|++... ...+++.+.+
T Consensus 203 iAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~-tpF~qLkqvV 266 (282)
T KOG0984|consen 203 IAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG-TPFQQLKQVV 266 (282)
T ss_pred hHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC-CHHHHHHHHh
Confidence 221 22234455999998753 369999999999999999999999997543 2334444433
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=240.23 Aligned_cols=244 Identities=18% Similarity=0.204 Sum_probs=187.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----ch-HHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PR-QEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~-~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 157 (382)
++|...++||+|+|++|..+++.. +.+|+|.+++. .. +=.+.|-.+..+. +||.+|-+..+++....+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 578899999999999999998876 67888876532 11 2245677777766 699999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
.||++||+|.-+..+++ ++++....-.-..|..||.|||+.+ |+.||||.+|+|+|..|++|++|+|+++.--
T Consensus 330 ieyv~ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEecCcceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999988876654 6888888888899999999999988 9999999999999999999999999998432
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhH-HHHHHHhhcCCCccccccc
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEA-LIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~d~~~ 316 (382)
.+. ...++..+||.|.|||.+.+..|....|+|++||+++||+.|+.||+.....+.+. ..+++-......++.-
T Consensus 403 ~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri--- 478 (593)
T KOG0695|consen 403 GPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI--- 478 (593)
T ss_pred CCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc---
Confidence 211 22345578899999999999999999999999999999999999998654433221 1122211111111111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCC
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPK 345 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs 345 (382)
+...+-+...+++.-|++||.+|..
T Consensus 479 ----prslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 479 ----PRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ----cceeehhhHHHHHHhhcCCcHHhcC
Confidence 1112233445667889999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=226.52 Aligned_cols=206 Identities=33% Similarity=0.445 Sum_probs=178.9
Q ss_pred eeccCcccEEEEEEC--CeeEEEEEccCCch----HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCChhh
Q 016789 95 IGFGSFGPVYKGLLR--DTVVAIKRRVGSPR----QEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCN 168 (382)
Q Consensus 95 lg~G~~g~V~~~~~~--~~~vavK~~~~~~~----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 168 (382)
||+|++|.||++... +..+++|....... +.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999998 67899998876643 679999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC-CCcEEEeecCCccccccccccCCCcc
Q 016789 169 HLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-NFIAKVADTGISKLLENIEEAGPSHG 247 (382)
Q Consensus 169 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 247 (382)
++.... ..+++..+..++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 987542 35788999999999999999999987 999999999999999 89999999999986544321 12223
Q ss_pred cccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHH
Q 016789 248 SIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMR 326 (382)
Q Consensus 248 ~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 326 (382)
.....|++||..... .++.++|+|++|+++++| .
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------~ 188 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------P 188 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------H
Confidence 345669999999877 788999999999999999 4
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 327 DLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 327 ~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.+.+++.+|++.||.+||++.++++.
T Consensus 189 ~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 189 ELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 57789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-33 Score=238.89 Aligned_cols=257 Identities=19% Similarity=0.289 Sum_probs=188.5
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCC-----eeE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG-----YQM 155 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 155 (382)
+.+..+.||.|+||.||..++.. +.|++|++..- ....+.+|+.+|..++|.|++..++.....+ ++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 34556789999999999988764 78899987642 2356889999999999999999988776543 467
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
.++|.|. .+|...+... +.++...+.-+..||.+||.|||+.+ |.||||||.|.|++.|..+||||||+++.
T Consensus 134 V~TELmQ-SDLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHH-hhhhheeccC-----CCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccc
Confidence 8888884 4666655432 35777778889999999999999988 99999999999999999999999999998
Q ss_pred cccccccCCCcccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh----------
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEESGV-FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS---------- 304 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~---------- 304 (382)
-+..+....+....|.+|+|||.+.+.+ |+.+.||||.||++.||+..+-.|+...+-+.-+++..+..
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 7766666666667788899999998765 99999999999999999998877765443222222211110
Q ss_pred -hcCCCccc-----ccccCC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 305 -RLSSNNFV-----DHRLAG----TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 305 -~~~~~~~~-----d~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
+.....++ .+.+.- ..+......-..+..+++..||++|.+..+.+.-
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 00000011 111110 0111222344566678899999999998877654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=231.80 Aligned_cols=127 Identities=22% Similarity=0.340 Sum_probs=107.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc--hHHHHHHHHHHhcCC-----C---CCccceeeEEEe----
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP--RQEFVAEVTYLSEIR-----H---RNLVTLLGYCQQ---- 150 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~--~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~---- 150 (382)
.+|...++||.|.|++||++-+.. +.||+|+.+... .+.-+.||.+|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 467788899999999999997754 799999877543 456788999999983 3 379999999964
Q ss_pred CCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeee
Q 016789 151 NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLV 219 (382)
Q Consensus 151 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill 219 (382)
+.+++||+|++ |-+|..+|.... -.-++...+..|+.||+.||.|||. ++ |||-||||+|||+
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 45899999999 778999888754 2358889999999999999999996 45 9999999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=221.67 Aligned_cols=261 Identities=18% Similarity=0.257 Sum_probs=194.0
Q ss_pred hCCCCCCeeeccCcccEEEEEE--CCeeEEEEEccCCchHHHHHHHHHHhcCC-CCCccceeeEEEeC--CeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLL--RDTVVAIKRRVGSPRQEFVAEVTYLSEIR-HRNLVTLLGYCQQN--GYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~~ 161 (382)
++|++.+.+|+|-|+.||.|.. ++..+++|.++.-....+.+|+.+|..|. ||||+++++...+. ....||+||+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v 117 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYV 117 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhh
Confidence 4677788999999999999984 45789999998888889999999999997 99999999998765 3567999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC-CCcEEEeecCCcccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-NFIAKVADTGISKLLENIE 240 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-~~~~kl~DfGla~~~~~~~ 240 (382)
.+-+...... .++...+.....++..||.|+|+.| |+|||+||.|++||. ...++|+|+|+|....+..
T Consensus 118 ~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 118 NNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred ccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 8877655432 4677788889999999999999988 999999999999995 5679999999998776543
Q ss_pred ccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC---------Cc
Q 016789 241 EAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS---------NN 310 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~ 310 (382)
.... ...+..|-.||.+.+ ..|+..-|+|||||++..|+..+.||.... .+.++++......+.. .-
T Consensus 188 eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~-dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 188 EYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-DNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred eeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC-CCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 3322 233456889999865 448889999999999999999999986433 3344444322210000 00
Q ss_pred ccccccCC----------------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHHhh
Q 016789 311 FVDHRLAG----------------TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE--LERIHEKE 360 (382)
Q Consensus 311 ~~d~~~~~----------------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~--L~~i~~~~ 360 (382)
-+|+.+.+ +...-......+++...|..|-.+|||++|.+.- +..+.++.
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~ 332 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAE 332 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHh
Confidence 01221111 0000113567788889999999999999998753 44444443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=251.52 Aligned_cols=249 Identities=22% Similarity=0.293 Sum_probs=194.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCchH---HHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQ---EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~---~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
..+|....++|.|+||.|||+++.. ...|+|.++-...+ -.++|+-+++..+||||+.++|.+...+.+|++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 3568888999999999999998865 67888876654433 456899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
|.+|+|.+.-+-.+ .+++.++..+++...+||+|||+.+ -+|||||-.|||+++.+.+|++|||.+-.+...-
T Consensus 94 cgggslQdiy~~Tg-----plselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cCCCcccceeeecc-----cchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999998776543 7889999999999999999999987 8999999999999999999999999986553321
Q ss_pred ccCCCcccccccccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 241 EAGPSHGSIVNVFRDPEVE---ESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~---~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.......||++|||||+. ..+.|..++|+|+.|+...|+---++|.....+..... ......+-.+.++
T Consensus 167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~-------LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF-------LMTKSGFQPPTLK 238 (829)
T ss_pred -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH-------HhhccCCCCCccc
Confidence 122344678999999986 44569999999999999999998888865332111100 1111111112222
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+ ...-.+.+.++++.|+.++|.+||++..+++
T Consensus 239 D--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 D--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred C--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1 1233567889999999999999999987654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=220.82 Aligned_cols=195 Identities=29% Similarity=0.405 Sum_probs=166.5
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
|...+.||.|++|.||++...+ ..+++|..... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556789999999999999875 78999987654 35678899999999999999999999999899999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+++|.+++..... .+++.....++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999876431 1788999999999999999999987 999999999999999999999999999876543211
Q ss_pred CCCcccccccccCcccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 016789 243 GPSHGSIVNVFRDPEVE-ESGVFSEMSDIYSFGVFLLELVTGQEASHI 289 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~-~~~~~~~~sDvws~G~vl~el~tg~~p~~~ 289 (382)
......+...|++||.. ....++.++|+|+||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12223445669999998 666788899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=242.33 Aligned_cols=192 Identities=21% Similarity=0.302 Sum_probs=163.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCch-----------HHHHHHHHHHhcCC---CCCccceeeEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPR-----------QEFVAEVTYLSEIR---HRNLVTLLGYCQQ 150 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~-----------~~~~~e~~~l~~l~---h~niv~l~~~~~~ 150 (382)
.+|...+.+|+|+||.|+.|.++. ..|++|.+.++.. ...-.|+.||..++ |+||++++.+|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 457888999999999999999987 5788887654321 12456999999997 9999999999999
Q ss_pred CCeeEEEEeecC-CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEee
Q 016789 151 NGYQMLVFEYLP-NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVAD 229 (382)
Q Consensus 151 ~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~D 229 (382)
++..||+||-.. +-+|.+++.... .+++.....|+.||+.|++|||+++ |||||||-+|+.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEee
Confidence 999999999763 458888886543 6889999999999999999999988 99999999999999999999999
Q ss_pred cCCccccccccccCCCcccccccccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCC
Q 016789 230 TGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFS-EMSDIYSFGVFLLELVTGQEASH 288 (382)
Q Consensus 230 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvws~G~vl~el~tg~~p~~ 288 (382)
||.|-...+.. -....||..|.|||++.+.+|- ..-|||++|++||.++....|+.
T Consensus 714 fgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99997665422 2345678889999999998875 45799999999999999988875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=239.26 Aligned_cols=198 Identities=23% Similarity=0.231 Sum_probs=165.0
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCch--HHHHHHHHHHhcCC------CCCccceeeEEEeCCee
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPR--QEFVAEVTYLSEIR------HRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~--~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~~ 154 (382)
....|......|+|-|++|.+|.... ..||||++..... ..-+.|+++|++|+ --|+++|+..|...+++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 34567667778999999999998765 6999999876542 45678999999995 34899999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC-CcEEEeecCCc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN-FIAKVADTGIS 233 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~-~~~kl~DfGla 233 (382)
|||+|-+ .-+|.+.|.+.+..- .|....+..++.|+.-||.+|-.++ |+|.||||+|||++++ ..+||||||.|
T Consensus 510 ClVFE~L-slNLRevLKKyG~nv--GL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 510 CLVFEPL-SLNLREVLKKYGRNV--GLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred EEEehhh-hchHHHHHHHhCccc--ceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccCccc
Confidence 9999987 568999999876433 4777888899999999999999999 9999999999999875 56799999999
Q ss_pred cccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIV 290 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~ 290 (382)
......+. +.......|.|||.+.+-+|+...|+||.||+||||.||+-.|...
T Consensus 585 ~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 585 SFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred cccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 86644322 1222344699999999999999999999999999999999887643
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=220.84 Aligned_cols=247 Identities=20% Similarity=0.265 Sum_probs=182.8
Q ss_pred hCCCCCCeeeccCcccEEEEEE--CCeeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCC------e
Q 016789 87 KQFSETSLIGFGSFGPVYKGLL--RDTVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG------Y 153 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~ 153 (382)
.+|...+.+|.|.- .|..+.+ .++.|++|+.... ......+|...+..++|+||++++.+++... .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34666677888877 5555533 3478898875432 2345678999999999999999999997653 5
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.|+||||| .++|+..+.- .++-..+..|..|+++|+.|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 96 ~y~v~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhh
Confidence 69999999 5689888863 4677788899999999999999988 999999999999999999999999999
Q ss_pred cccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh---hcCC--
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS---RLSS-- 308 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~-- 308 (382)
+.-... ...+....+..|.|||++.+..|.+.+||||.||++.||++|+--|...+. +-+|..- ...+
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-----idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH-----IDQWNKIIEQLGTPDP 238 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH-----HHHHHHHHHHhcCCCH
Confidence 854332 345566677889999999998899999999999999999999977753221 1111110 0000
Q ss_pred -----------------C---------cccccccCC--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 309 -----------------N---------NFVDHRLAG--TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 309 -----------------~---------~~~d~~~~~--~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+ .+-|..+.. +.+.-......+++.++|-.||++|.+..++++
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0 011111111 111122345677888999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=215.69 Aligned_cols=249 Identities=19% Similarity=0.309 Sum_probs=179.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC--chHHHHHHHHHHhcC-CCCCccceee-EEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS--PRQEFVAEVTYLSEI-RHRNLVTLLG-YCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~-~~~~~~~~~lv~e~ 160 (382)
+.|.+.+.+|+|.||.+-++.+++ +.+++|-+... ...+|.+|...--.| .|.||+.-|+ .|+..+..++++||
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 457788899999999999999987 67888877654 346899998765556 4899998776 46677788899999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec--CCCcEEEeecCCcccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD--ENFIAKVADTGISKLLEN 238 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~--~~~~~kl~DfGla~~~~~ 238 (382)
++.|+|.+.+...+ +.+.....++.|+++||.|+|+.+ +||||||.+||||- +...+||||||+.+..+.
T Consensus 104 aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 104 APRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred CccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999998886543 666777889999999999999988 99999999999983 345899999999875432
Q ss_pred ccccCCCcccccccccCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccc
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESG-----VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVD 313 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (382)
.-. ....+..|.+||.+... ...+.+|+|.||+++|.++||+.|++... .......+|..-.......+-
T Consensus 176 tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 176 TVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred eeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhcccCccCc
Confidence 111 11223448899986432 25677999999999999999999997322 222333333333222211111
Q ss_pred cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 016789 314 HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 314 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L 353 (382)
..+ ..+ ...+.++.++-+..+|++|=...++.++-
T Consensus 251 ~~F-~~f----s~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 251 KKF-NPF----SEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred hhh-ccc----CHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 111 122 34566677789999999995555554443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=259.17 Aligned_cols=195 Identities=16% Similarity=0.191 Sum_probs=137.5
Q ss_pred cCCC-CCccceeeEE-------EeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 016789 135 EIRH-RNLVTLLGYC-------QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPP 206 (382)
Q Consensus 135 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ 206 (382)
.++| +||.+++++| ......+.++||+ +++|.++|... ...+++..++.++.||++||.|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g-- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQG-- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 3455 5888888877 2334567788987 66999999643 235899999999999999999999988
Q ss_pred ceecCCCCCCeeecCC-------------------CcEEEeecCCccccccccc---------------cCCCccccccc
Q 016789 207 LVHKNFKTANVLVDEN-------------------FIAKVADTGISKLLENIEE---------------AGPSHGSIVNV 252 (382)
Q Consensus 207 ivHrDlk~~Nill~~~-------------------~~~kl~DfGla~~~~~~~~---------------~~~~~~~~~~~ 252 (382)
|+||||||+||||+.. +.+|++|||+++....... .......+|+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 4556666666653211000 00011235778
Q ss_pred ccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHH
Q 016789 253 FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLT 332 (382)
Q Consensus 253 y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~ 332 (382)
|||||++.+..|+.++|||||||+||||++|.+|+... ........... ..+.. .........++
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~-----~~~~~~~~~~~-----~~~~~-----~~~~~~~~~~~ 245 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK-----SRTMSSLRHRV-----LPPQI-----LLNWPKEASFC 245 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH-----HHHHHHHHHhh-----cChhh-----hhcCHHHHHHH
Confidence 99999999999999999999999999999998876421 11111111111 01110 11123456788
Q ss_pred hhccCCCCCCCCCHHHHHH
Q 016789 333 LQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 333 ~~cl~~dp~~RPs~~~v~~ 351 (382)
.+||+.||.+||+|.|+++
T Consensus 246 ~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHhCCCChhhCcChHHHhh
Confidence 8999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=205.48 Aligned_cols=172 Identities=18% Similarity=0.240 Sum_probs=129.4
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++...+ ..+++..++.++.|++.||.|||+.+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeecccc---
Confidence 78999987542 35899999999999999999999865 999999999999999 99988654321
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
..+++.|+|||++.+..++.++|||||||++|||++|+.||..... ..................+ ......
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~----~~~~~~ 134 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--LSAILEILLNGMPADDPRD----RSNLES 134 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--hcHHHHHHHHHhccCCccc----cccHHH
Confidence 2456889999999999999999999999999999999999864321 1121222211111110000 011122
Q ss_pred HHH--HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 016789 324 GMR--DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEM 361 (382)
Q Consensus 324 ~~~--~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~ 361 (382)
... .+.+++.+||+.||.+||++.++++.+..+..+..
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~~ 174 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAETL 174 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHHh
Confidence 223 68999999999999999999999999988876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-29 Score=214.06 Aligned_cols=243 Identities=24% Similarity=0.352 Sum_probs=192.3
Q ss_pred CCeeeccCcccEEEEEECCeeEEEEEccC-----CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCCh
Q 016789 92 TSLIGFGSFGPVYKGLLRDTVVAIKRRVG-----SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 166 (382)
..+|.+...|+.|+|++.+..++.|++.. ....+|..|.-.|+-+.||||+.++|.|....++.++..||+.|||
T Consensus 195 ~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 34678889999999999998777776543 2235799999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEe--ecCCccccccccccCC
Q 016789 167 CNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVA--DTGISKLLENIEEAGP 244 (382)
Q Consensus 167 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~--DfGla~~~~~~~~~~~ 244 (382)
+..|+... +..++-.+..+++.++|+|++|||+..|-|.---|.+..+++|++.+.+|+ |--++. ..
T Consensus 275 ynvlhe~t---~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--------qe 343 (448)
T KOG0195|consen 275 YNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------QE 343 (448)
T ss_pred HHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--------ec
Confidence 99998752 345677889999999999999999987767777899999999999988865 322221 11
Q ss_pred CcccccccccCccccccCCCC---ccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 245 SHGSIVNVFRDPEVEESGVFS---EMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 245 ~~~~~~~~y~aPE~~~~~~~~---~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
......+.||+||.++..+-+ .++|+|||.+++|||.|...||....+.+-...+. -..+.-..+
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------------leglrv~ip 411 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------------LEGLRVHIP 411 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh------------hccccccCC
Confidence 122345679999999876633 47899999999999999999998665433222111 112222345
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
+..+..+.+++.-|++.||.+||.+..|+-.|+++.
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 566678899999999999999999999999999874
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=214.94 Aligned_cols=197 Identities=23% Similarity=0.313 Sum_probs=161.3
Q ss_pred HHHhCCCCCCeeeccCcccEEEEEECC-----eeEEEEEccCC-chHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEE
Q 016789 84 QATKQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGS-PRQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 84 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~-~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 156 (382)
...+.|...++||+|.|++||++.+.. ..||+|.+... ......+|++.|..+. +.||+++.+++..++...+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i 112 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI 112 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence 345678889999999999999997543 68999987754 4567899999999995 8999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC-CCcEEEeecCCccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-NFIAKVADTGISKL 235 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-~~~~kl~DfGla~~ 235 (382)
|+||++..+..+++.. ++...+...+..+..||+|+|.+| ||||||||+|+|.+. .+.-.|.|||+|..
T Consensus 113 vlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred EecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHH
Confidence 9999999888887753 567788888999999999999988 999999999999975 45678999999862
Q ss_pred ccccc------c-------------------------c------------CCCcccccccccCcccccc-CCCCccchhH
Q 016789 236 LENIE------E-------------------------A------------GPSHGSIVNVFRDPEVEES-GVFSEMSDIY 271 (382)
Q Consensus 236 ~~~~~------~-------------------------~------------~~~~~~~~~~y~aPE~~~~-~~~~~~sDvw 271 (382)
.+... . . ......||++|.|||++.. ..-+.++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 11000 0 0 0012247889999999855 4478899999
Q ss_pred HHHHHHHHHHhCCCCCCcc
Q 016789 272 SFGVFLLELVTGQEASHIV 290 (382)
Q Consensus 272 s~G~vl~el~tg~~p~~~~ 290 (382)
|.||+++-+++++.||...
T Consensus 263 s~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eccceeehhhccccccccC
Confidence 9999999999999998643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=208.47 Aligned_cols=161 Identities=20% Similarity=0.198 Sum_probs=122.4
Q ss_pred HHhCCCCCCeeeccCcccEEEEEEC---CeeEEEEEccCC--------chHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLR---DTVVAIKRRVGS--------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGY 153 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 153 (382)
....|...+.||+|+||+||+|.+. +..+|+|+.... ....|.+|+++|++++|+|++..+.. .+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 3467999999999999999999874 367899975422 13458899999999999999863322 245
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCC-CCCCeeecCCCcEEEeecCC
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNF-KTANVLVDENFIAKVADTGI 232 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDl-k~~Nill~~~~~~kl~DfGl 232 (382)
.++||||+++++|.. +.. .. ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||+
T Consensus 93 ~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred cEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 799999999999862 211 01 1357789999999999977 999999 99999999999999999999
Q ss_pred ccccccccccCC-------CcccccccccCccccccC
Q 016789 233 SKLLENIEEAGP-------SHGSIVNVFRDPEVEESG 262 (382)
Q Consensus 233 a~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~~ 262 (382)
|+.+........ ....+++.|+|||++...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 987654321111 223345679999988543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-23 Score=191.97 Aligned_cols=258 Identities=17% Similarity=0.198 Sum_probs=191.2
Q ss_pred CCCCCCeeeccCcccEEEEEECCe---eEEEEEccCCc---hHHHHHHHHHHhcCCC----CCccceeeEE-EeCCeeEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRDT---VVAIKRRVGSP---RQEFVAEVTYLSEIRH----RNLVTLLGYC-QQNGYQML 156 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~~---~vavK~~~~~~---~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l 156 (382)
.|...+.||+|+||.||.+..... .+|+|...... ...+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 688899999999999999997663 58888654322 1267788888888863 6888888888 47778899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC-----CcEEEeecC
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN-----FIAKVADTG 231 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~-----~~~kl~DfG 231 (382)
||+.+ |.+|.++..... ...++....+.|+.|+..+|.+||+.+ ++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 779998775543 457999999999999999999999988 9999999999999754 469999999
Q ss_pred Ccc--ccccccc-----cC--CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHH
Q 016789 232 ISK--LLENIEE-----AG--PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWV 302 (382)
Q Consensus 232 la~--~~~~~~~-----~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~ 302 (382)
+++ ....... .. .....+|..|.++....+...+.+.|+||++.++.|++.|..|+...............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 3211111 11 12334788999999999999999999999999999999999998654332221111111
Q ss_pred HhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 303 RSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 303 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
...... .. .....+ ..+.++...+-..+...+|....+...|+......
T Consensus 253 ~~~~~~----~~--~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKLLT----DR--FGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhhcc----cc--ccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 111110 10 111222 34444444555689999999999999998887765
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-22 Score=188.59 Aligned_cols=257 Identities=25% Similarity=0.319 Sum_probs=192.8
Q ss_pred CCCCCeeeccCcccEEEEEECCeeEEEEEccCC------chHHHHHHHHHHhcCCCC-CccceeeEEEeCCeeEEEEeec
Q 016789 89 FSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGS------PRQEFVAEVTYLSEIRHR-NLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~ 161 (382)
|...+.||.|+||.||++... ..+++|.+... ....+.+|+.++..+.|+ +++++.+++......+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 456678999999999999988 66777765432 245689999999999988 7999999998777789999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC-cEEEeecCCcccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF-IAKVADTGISKLLENIE 240 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~~~~~~~ 240 (382)
.++++.+.+...... ..+.......+..|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+.......
T Consensus 81 ~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 81 DGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999666543211 36788899999999999999999988 99999999999999988 79999999998554433
Q ss_pred cc-----CCCcccccccccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCccCCC-ChhHHHHHHHhhcCCCcc
Q 016789 241 EA-----GPSHGSIVNVFRDPEVEES---GVFSEMSDIYSFGVFLLELVTGQEASHIVSLG-SYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 241 ~~-----~~~~~~~~~~y~aPE~~~~---~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 311 (382)
.. ......++..|++||.+.. ..++...|+||+|++++++++|..|+...... ............... .
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 234 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--S 234 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--c
Confidence 22 2345567788999999987 57889999999999999999999996543321 112222222222111 0
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
................+.+++..|+..+|..|.++.+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00001000002223567788889999999999999987765
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.5e-24 Score=201.16 Aligned_cols=219 Identities=24% Similarity=0.386 Sum_probs=167.5
Q ss_pred HhcCCCCCccceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCC
Q 016789 133 LSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNF 212 (382)
Q Consensus 133 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDl 212 (382)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+... ...+++.....+..+++.||.|||... --.|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeee
Confidence 46789999999999999999999999999999999999763 457999999999999999999999743 2399999
Q ss_pred CCCCeeecCCCcEEEeecCCccccccc-cccCCCcccccccccCccccccCC-------CCccchhHHHHHHHHHHHhCC
Q 016789 213 KTANVLVDENFIAKVADTGISKLLENI-EEAGPSHGSIVNVFRDPEVEESGV-------FSEMSDIYSFGVFLLELVTGQ 284 (382)
Q Consensus 213 k~~Nill~~~~~~kl~DfGla~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~sDvws~G~vl~el~tg~ 284 (382)
++.|+++|....+||+|||+....... ............-|.|||.+.... .+.++|+||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998766431 101111111223499999987642 467799999999999999999
Q ss_pred CCCCccCCCCh-hHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 285 EASHIVSLGSY-EALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 285 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
.||+....... .+++..+.. ......-|.+... .+....+..++.+||..+|.+||++.+|-..++.+....
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK--GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred CccccccccCChHHHHHHHHh--cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 99986433222 344444443 1112222222211 144457889999999999999999999999998887754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=208.70 Aligned_cols=250 Identities=18% Similarity=0.223 Sum_probs=178.2
Q ss_pred CCCCeeeccCcccEEEEEECC--eeEEEEE----c-cCCchH----HHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 90 SETSLIGFGSFGPVYKGLLRD--TVVAIKR----R-VGSPRQ----EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 90 ~~~~~lg~G~~g~V~~~~~~~--~~vavK~----~-~~~~~~----~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
....++|.|++|.|+...... ...+.|. . ...... .+..|+.+-..++|||++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 356789999999777665432 2222221 1 111111 2456777788889999988887777766666669
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
|||++ +|..++... ..+....+-.++.|+..|+.|+|+.+ |.|||+|++|++++.++.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 999988654 25677778889999999999999988 99999999999999999999999999876643
Q ss_pred ccc---cCCCcccccccccCccccccCCCCcc-chhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 239 IEE---AGPSHGSIVNVFRDPEVEESGVFSEM-SDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 239 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
... .......+...|+|||.+....|.+. .||||.|+++..|.+|+.||......+... ..... ..+.-..
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----~~~~~-~~~~~~~ 547 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----KTNNY-SDQRNIF 547 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch----hhhcc-ccccccc
Confidence 332 22334456667999999999888764 799999999999999999997543322211 00000 0000000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.-........+.....++.++|+.||.+|.++++|++.
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00011123456677888899999999999999999863
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=165.99 Aligned_cols=182 Identities=16% Similarity=0.064 Sum_probs=134.0
Q ss_pred CCCeeeccCcccEEEEEECCeeEEEEEccCCch--H-----HHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeecC
Q 016789 91 ETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPR--Q-----EFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 91 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--~-----~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
....|++|+||+||.+...+..++.+.+..... . .+.+|+++|++++ |+++.+++++ +..+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 346799999999998887777888776655433 2 4789999999995 5889999886 34699999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCC-CCCCeeecCCCcEEEeecCCccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNF-KTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDl-k~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
|.+|...+.. ....++.|++.+|.++|+.+ |+|||| ||+|||++.++.++|+|||++........
T Consensus 82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 82 GAAMYQRPPR------------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred CccHHhhhhh------------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 8888654311 01346778999999999988 999999 79999999999999999999985443221
Q ss_pred c----C--------CCcccccccccCccccccC-CCC-ccchhHHHHHHHHHHHhCCCCCCcc
Q 016789 242 A----G--------PSHGSIVNVFRDPEVEESG-VFS-EMSDIYSFGVFLLELVTGQEASHIV 290 (382)
Q Consensus 242 ~----~--------~~~~~~~~~y~aPE~~~~~-~~~-~~sDvws~G~vl~el~tg~~p~~~~ 290 (382)
. . ......++.|++|+...-- ..+ ...++++-|.-+|.++|++.++...
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0 0011234556666543211 122 4579999999999999999887543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-23 Score=205.21 Aligned_cols=251 Identities=18% Similarity=0.152 Sum_probs=179.6
Q ss_pred CCCCCCeeeccCcccEEEEEECCeeEEEEEccCCc----hHHHHHHHHH--HhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP----RQEFVAEVTY--LSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
++...+.||++.|=+|.+|++++..|++|.+.... .+.|.++++- ...++|||.+++.-+-..+...|||-+|.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 45667789999999999999999889999876543 2455544433 44458999999988888888889999998
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc--ccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL--ENI 239 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~--~~~ 239 (382)
. -+|.|.|..+. -+......=|+.|+..||..+|..+ |+|||||.+||||+.-..+.|+||..-+.. ..+
T Consensus 104 k-hnLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 104 K-HNLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred h-hhhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 5 48888886543 3445555668999999999999988 999999999999999999999999875432 111
Q ss_pred cccCC----CcccccccccCccccccC----------C-CCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHH
Q 016789 240 EEAGP----SHGSIVNVFRDPEVEESG----------V-FSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVR 303 (382)
Q Consensus 240 ~~~~~----~~~~~~~~y~aPE~~~~~----------~-~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~ 303 (382)
..... .+.....+|.|||.+... . .+++.||||+||++.||++ |++||. ..++..|-.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~------LSQL~aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT------LSQLLAYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc------HHHHHhHhc
Confidence 11111 112233469999987542 1 6778999999999999999 466664 334444332
Q ss_pred hhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 304 SRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 304 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.. -.|+....+ .-+...+.+++..|++.||++|.++++.++.-+.+.-.
T Consensus 250 ~~-----~~~~e~~Le--~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP 298 (1431)
T KOG1240|consen 250 GN-----ADDPEQLLE--KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFP 298 (1431)
T ss_pred cC-----ccCHHHHHH--hCcCccHHHHHHHHHccCchhccCHHHHHHhhhccccH
Confidence 21 001100000 00113677899999999999999999999996655433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=168.42 Aligned_cols=135 Identities=18% Similarity=0.144 Sum_probs=104.0
Q ss_pred CeeeccCcccEEEEEEC-CeeEEEEEccCCc------------hHHH-----------------HHHHHHHhcCCCCCcc
Q 016789 93 SLIGFGSFGPVYKGLLR-DTVVAIKRRVGSP------------RQEF-----------------VAEVTYLSEIRHRNLV 142 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~------------~~~~-----------------~~e~~~l~~l~h~niv 142 (382)
..||+|+||.||+|... +..||+|...... ...| ..|++.+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 57999999999999885 5799999865321 0122 2488999999887775
Q ss_pred ceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHH-hcCCCCceecCCCCCCeeecC
Q 016789 143 TLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL-HSLKPPLVHKNFKTANVLVDE 221 (382)
Q Consensus 143 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~ivHrDlk~~Nill~~ 221 (382)
....+... ..++||||++++++....... ..++......++.|++.+|.|+ |+.+ |+||||||+|||++
T Consensus 83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~- 152 (190)
T cd05147 83 CPEPILLK--SHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH- 152 (190)
T ss_pred CCcEEEec--CCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-
Confidence 44333222 238999999987766543222 2578888999999999999999 6877 99999999999998
Q ss_pred CCcEEEeecCCccccc
Q 016789 222 NFIAKVADTGISKLLE 237 (382)
Q Consensus 222 ~~~~kl~DfGla~~~~ 237 (382)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.5e-22 Score=172.73 Aligned_cols=168 Identities=11% Similarity=0.083 Sum_probs=129.4
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCc--hH----------HHHHHHHHHhcCCCCCccceeeEEEeC-
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP--RQ----------EFVAEVTYLSEIRHRNLVTLLGYCQQN- 151 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~----------~~~~e~~~l~~l~h~niv~l~~~~~~~- 151 (382)
...+|+..+++|.|+||.||........+++|.+.+.. .+ .+.+|+..+.++.||+|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 45789999999999999999987766789999876432 11 157899999999999999999886533
Q ss_pred -------CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc
Q 016789 152 -------GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI 224 (382)
Q Consensus 152 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~ 224 (382)
...+++|||++|.+|.+... ++. ....+++.+|..+|+.+ ++|||++|+|++++.++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-
Confidence 35789999999999877631 222 24558899999999988 99999999999999988
Q ss_pred EEEeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHH
Q 016789 225 AKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELV 281 (382)
Q Consensus 225 ~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~ 281 (382)
++|+|||........... ..+.....|..++|+||||+++.-..
T Consensus 173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988754221110 01223344667899999999987543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=163.19 Aligned_cols=259 Identities=16% Similarity=0.183 Sum_probs=190.6
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCch-HHHHHHHHHHhcCCC-CCccceeeEEEeCCeeEEEEeec
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSPR-QEFVAEVTYLSEIRH-RNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
...|...+.||+|+||.+|.|..- +..||+|.-....+ ....-|..+.+.|+| ..|..+..+..+.+...|||+.+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL 93 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL 93 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence 357888999999999999999765 47999998655443 467789999999975 78888888889999999999998
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC---CCcEEEeecCCcccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE---NFIAKVADTGISKLLEN 238 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~---~~~~kl~DfGla~~~~~ 238 (382)
|-||.+.+.-+ +..++....+-+|-|+..-++|+|..+ ++||||||+|+|..- ...+.++|||+|+....
T Consensus 94 -GPsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 94 -GPSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred -CccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 77998887654 246888999999999999999999887 999999999999853 45688999999986543
Q ss_pred ccc------cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 239 IEE------AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 239 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
... .....-+||.+|.+-....+-.-+..-|+=|+|.+|..+--|..||+........+-.+.+.+..... .
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~--~ 244 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST--P 244 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC--C
Confidence 221 12234567777887666555556778899999999999999999998766554443333322211100 0
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
-..+...+ |.++...+.-|-..-=++-|...-+.+.++-+.
T Consensus 245 ie~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 245 IEVLCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred HHHHhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 01111122 345556666777777777787776666665554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.5e-21 Score=164.61 Aligned_cols=137 Identities=16% Similarity=0.125 Sum_probs=107.0
Q ss_pred CCeeeccCcccEEEEEEC-CeeEEEEEccCCch-----------------------------HHHHHHHHHHhcCCCCCc
Q 016789 92 TSLIGFGSFGPVYKGLLR-DTVVAIKRRVGSPR-----------------------------QEFVAEVTYLSEIRHRNL 141 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-----------------------------~~~~~e~~~l~~l~h~ni 141 (382)
...||+|+||.||+|... ++.||+|....... ..+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 357999999999999876 68999998653210 113568899999999988
Q ss_pred cceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeeec
Q 016789 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVD 220 (382)
Q Consensus 142 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill~ 220 (382)
.....+.... .++||||++++++....... ..++......++.+++.++.++|+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE
Confidence 6555444332 48999999888654432221 246777888999999999999998 77 99999999999999
Q ss_pred CCCcEEEeecCCcccccc
Q 016789 221 ENFIAKVADTGISKLLEN 238 (382)
Q Consensus 221 ~~~~~kl~DfGla~~~~~ 238 (382)
++.++|+|||++..+.+
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-20 Score=165.34 Aligned_cols=260 Identities=15% Similarity=0.183 Sum_probs=190.1
Q ss_pred hCCCCCCeeeccCcccEEEEEE--CCeeEEEEEccC-CchHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeecC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLL--RDTVVAIKRRVG-SPRQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
-+|...++||+|.||..+.|.. ++.+||||.-.. +...+...|.+..+.|. .++|...+-+-.++.+-.||+|++
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 3688999999999999999974 568999997543 33457778888888884 689999998888888889999998
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC-----CCcEEEeecCCccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-----NFIAKVADTGISKLLE 237 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-----~~~~kl~DfGla~~~~ 237 (382)
|-||.|++.-++ ..++.+..+.+|.|+..-++|+|+.. +|.|||||+|+||.. ...+.++|||+|+...
T Consensus 107 GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 779999887664 47999999999999999999999988 999999999999963 3468999999998765
Q ss_pred ccccc------CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcc
Q 016789 238 NIEEA------GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 238 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (382)
..... .-..-.||.+||+-..-.+..-+.+-|+=|+|-+++..+-|..||+......-....+.+-.......+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 44322 123346788899988877777888999999999999999999999865543333222222211111111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
..+...+ +..+..-+.-.-..+=++-|...-+...+.++.+.
T Consensus 261 --~~Lc~g~----P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 261 --EVLCEGF----PEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred --HHHHhcC----HHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 1111122 23333333333345556668777776666666544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=187.31 Aligned_cols=221 Identities=23% Similarity=0.225 Sum_probs=168.5
Q ss_pred eeeccCcccEEEEEE-----CCeeEEEEEccCC-----chHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeecC
Q 016789 94 LIGFGSFGPVYKGLL-----RDTVVAIKRRVGS-----PRQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~-----~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
++|+|+||.|++++- .+..++.|..... .+.....|..++...+ ||.++++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999997642 2345555543321 1224456778888887 9999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+|+|...+.+.. .+...........++-+++++|+.+ ++|||+|++||+++.+|++++.|||+++..-..+..
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 999988886543 4556666667788999999999988 999999999999999999999999999865443322
Q ss_pred CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 243 GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
.++..|||||++. ....++|.||||++++||+||-.||.. +....+.+ .....+.
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~-----------~~~~~p~ 208 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILK-----------AELEMPR 208 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhh-----------hccCCch
Confidence 5677799999998 567889999999999999999999874 11111111 1113345
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCH
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKM 346 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~ 346 (382)
+.......++..+...+|.+|.-.
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 555566667777888888888766
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-20 Score=167.81 Aligned_cols=230 Identities=17% Similarity=0.197 Sum_probs=145.2
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCC----------CCccceeeEEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRH----------RNLVTLLGYCQ 149 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h----------~niv~l~~~~~ 149 (382)
.+.....||.|+++.||.+++.+ ..+++|.+... ..+++.+|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34556789999999999999987 79999975422 12355555544444322 12222222211
Q ss_pred ---------eC--C------eeEEEEeecCCCChhhhhh---hcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 016789 150 ---------QN--G------YQMLVFEYLPNGSMCNHLY---ETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVH 209 (382)
Q Consensus 150 ---------~~--~------~~~lv~e~~~~gsL~~~l~---~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivH 209 (382)
.. . ..+++|+-+ .+||.+.+. ..... ...+....++.+..|+++.+++||+.+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHSYG--LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhhcc--eEe
Confidence 11 1 235677776 568877654 22211 234566677788899999999999988 999
Q ss_pred cCCCCCCeeecCCCcEEEeecCCccccccccccCCCcccccccccCccccccC--------CCCccchhHHHHHHHHHHH
Q 016789 210 KNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESG--------VFSEMSDIYSFGVFLLELV 281 (382)
Q Consensus 210 rDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~sDvws~G~vl~el~ 281 (382)
+||+|+|++++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|++|+++|.|.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999877654332221 2334568999976442 4788999999999999999
Q ss_pred hCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCC
Q 016789 282 TGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRR 343 (382)
Q Consensus 282 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R 343 (382)
+|..||........... .+. .+. +.++.+..||..+|+.||.+|
T Consensus 245 C~~lPf~~~~~~~~~~~----------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW----------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG----------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc----------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999975432211110 122 334 778899999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.5e-20 Score=187.73 Aligned_cols=252 Identities=16% Similarity=0.208 Sum_probs=179.4
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCCchHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEEEee
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSPRQEFVAEVTYLSEIR---HRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
....|.+.+.+|+|+||+||+|...+ +.+|+|.-+....-+|.--.+++.+|+ -+-|..+...+.-.+.-+||+||
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey 775 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEY 775 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeec
Confidence 34567778889999999999998765 799999877666555544455666666 23445555555556677899999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec-------CCCcEEEeecCCc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD-------ENFIAKVADTGIS 233 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~-------~~~~~kl~DfGla 233 (382)
.+.|+|.+++.. ...++|...+.+..|++.-+++||.++ |||+||||+|+||. ++..++|+|||.+
T Consensus 776 ~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 776 SPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred cccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 999999999973 347899999999999999999999988 99999999999993 3457899999999
Q ss_pred ccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 234 KLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 234 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
..+.-.... .-.....|-.+-.+|+..+.+++.+.|.|.+..+++-|+.|+..-. ... ....+
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~-~~g---------------~~~~~ 912 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV-KNG---------------SSWMV 912 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh-cCC---------------cceec
Confidence 765432222 1122334556889999999999999999999999999999985421 000 00011
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhh
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMA 362 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~ 362 (382)
+..+..-...+. +-++...+|+.|-..=|...++...|+++..+-.+
T Consensus 913 ~~~~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~ 959 (974)
T KOG1166|consen 913 KTNFPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFT 959 (974)
T ss_pred cccchhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHH
Confidence 111110001222 23444456666666667788888888777766443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.8e-20 Score=159.07 Aligned_cols=134 Identities=21% Similarity=0.277 Sum_probs=102.7
Q ss_pred CCCCCeeeccCcccEEEEEECC-eeEEEEEccCC---chHHHHHHHHHHhcC-----CCCCccceeeEEEeCC---e-eE
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS---PRQEFVAEVTYLSEI-----RHRNLVTLLGYCQQNG---Y-QM 155 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~---~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-~~ 155 (382)
+...+.||+|+||.||. +.. ...++|+.... ..+.+.+|+.+++.+ .||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34457899999999996 433 34468876543 346789999999999 5799999999998873 3 33
Q ss_pred EEEee--cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHH-HHHhcCCCCceecCCCCCCeeecC----CCcEEEe
Q 016789 156 LVFEY--LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGL-CHLHSLKPPLVHKNFKTANVLVDE----NFIAKVA 228 (382)
Q Consensus 156 lv~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~ivHrDlk~~Nill~~----~~~~kl~ 228 (382)
+|+|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||+.+ |+||||||+|||++. +..++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 5579999999642 24443 34567777777 9999988 999999999999974 3489999
Q ss_pred e-cCCcc
Q 016789 229 D-TGISK 234 (382)
Q Consensus 229 D-fGla~ 234 (382)
| ||...
T Consensus 152 Dg~G~~~ 158 (210)
T PRK10345 152 DNIGEST 158 (210)
T ss_pred ECCCCcc
Confidence 9 55433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.1e-20 Score=165.80 Aligned_cols=196 Identities=16% Similarity=0.155 Sum_probs=137.6
Q ss_pred CCCCccceeeEEEe---------------------------CCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHH
Q 016789 137 RHRNLVTLLGYCQQ---------------------------NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSI 189 (382)
Q Consensus 137 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 189 (382)
+|||||++.++|.+ ...+|+||.-.+ .+|.+++..+ ..+.....-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~------~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR------HRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC------CCchHHHHHH
Confidence 59999999987743 234688988764 5888888764 3555666778
Q ss_pred HHHHHHHHHHHhcCCCCceecCCCCCCeee--cCC--CcEEEeecCCccccccccc-----cCCCcccccccccCccccc
Q 016789 190 ALGAAKGLCHLHSLKPPLVHKNFKTANVLV--DEN--FIAKVADTGISKLLENIEE-----AGPSHGSIVNVFRDPEVEE 260 (382)
Q Consensus 190 ~~~ia~~L~~LH~~~~~ivHrDlk~~Nill--~~~--~~~kl~DfGla~~~~~~~~-----~~~~~~~~~~~y~aPE~~~ 260 (382)
+.|+.+|..|||.++ |.|||+|++|||+ |+| ..+.|+|||++---++..- .......|...-||||+..
T Consensus 347 laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 899999999999988 9999999999998 333 3578999999753322111 1112234455689999876
Q ss_pred cCC------CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhh
Q 016789 261 SGV------FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQ 334 (382)
Q Consensus 261 ~~~------~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~ 334 (382)
..+ --.++|.|+.|.+.||+++...||....... -+...+....+ ...+..++..+.+++..
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~Yqe~qL-----------Palp~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRTYQESQL-----------PALPSRVPPVARQLVFD 492 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhhhhhhhC-----------CCCcccCChHHHHHHHH
Confidence 543 1247999999999999999999998522111 11111111111 12345556778899999
Q ss_pred ccCCCCCCCCCHHHHHHHH
Q 016789 335 CMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 335 cl~~dp~~RPs~~~v~~~L 353 (382)
.|+.||++||+..-....|
T Consensus 493 lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HhcCCccccCCccHHHhHH
Confidence 9999999999988666655
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.3e-19 Score=154.44 Aligned_cols=131 Identities=19% Similarity=0.308 Sum_probs=111.9
Q ss_pred CeeeccCcccEEEEEECCeeEEEEEccCCc-----------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 93 SLIGFGSFGPVYKGLLRDTVVAIKRRVGSP-----------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
+.||+|++|.||+|.+.+..+++|...... ...+.+|++++..++|+|+.....++...+..+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 569999999999999988888998754321 134778999999999999988888877777889999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+|++|.+.+.... . .+..++.+++.+|.++|+.+ ++|||++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG--------M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999885421 1 77889999999999999977 99999999999999 78999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.6e-19 Score=152.90 Aligned_cols=127 Identities=24% Similarity=0.300 Sum_probs=106.0
Q ss_pred eeeccCcccEEEEEECCeeEEEEEccCCc-----------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 94 LIGFGSFGPVYKGLLRDTVVAIKRRVGSP-----------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
.||+|+||.||+|.+.+..+++|...... ...+.+|++++..++|+++.....++...+..+++|||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 38999999999999888889999754321 1346789999999998887666666666677799999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+++|.+.+.... . .++.+++.+|.+||+.+ ++|||++|.||+++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGN------D------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcH------H------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998875421 0 68899999999999977 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.1e-19 Score=175.42 Aligned_cols=134 Identities=24% Similarity=0.276 Sum_probs=111.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEECCeeEEEEEccCC-----------chHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGS-----------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 154 (382)
...|...+.||+|+||+||++.+.+..+++|+.... ..+.+.+|++++..++|+|++....++......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 344566789999999999999988765555542211 113578899999999999999888888777778
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++||||+++++|.+++. ....++.+++.+|.|||+.+ ++||||||+|||+ +++.++|+|||+++
T Consensus 412 ~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred EEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 99999999999998874 24568899999999999987 9999999999999 67899999999987
Q ss_pred c
Q 016789 235 L 235 (382)
Q Consensus 235 ~ 235 (382)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 4
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.6e-18 Score=150.89 Aligned_cols=141 Identities=17% Similarity=0.151 Sum_probs=105.8
Q ss_pred HhCCCCCCeeeccCcccEEEEE-E--CCeeEEEEEccCCc---------------------------hHHHHHHHHHHhc
Q 016789 86 TKQFSETSLIGFGSFGPVYKGL-L--RDTVVAIKRRVGSP---------------------------RQEFVAEVTYLSE 135 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~-~--~~~~vavK~~~~~~---------------------------~~~~~~e~~~l~~ 135 (382)
...|...+.||+|+||.||+|. . .+..||+|...... ...+..|+..+.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3457788999999999999998 3 34799999765321 0124579999999
Q ss_pred CCCCC--ccceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 016789 136 IRHRN--LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFK 213 (382)
Q Consensus 136 l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk 213 (382)
+.+.+ +.+.+++ . ..++||||+++++|....... ..........++.|++.++.+||+.+ .++|||||
T Consensus 107 L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dik 176 (237)
T smart00090 107 LYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLS 176 (237)
T ss_pred HHhcCCCCCeeeEe---c-CceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCC
Confidence 97533 3344432 2 348999999998876654222 13445566789999999999999743 39999999
Q ss_pred CCCeeecCCCcEEEeecCCccccc
Q 016789 214 TANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 214 ~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|+||+++ ++.++|+|||.+....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 8899999999987543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.8e-19 Score=166.33 Aligned_cols=173 Identities=18% Similarity=0.248 Sum_probs=129.1
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCC
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI 232 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGl 232 (382)
.+|+.|++|...+|.++|.... .....++...+.++.|++.|+.| .+ .+|||+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhh
Confidence 5789999999999999997543 34467888889999999999999 56 99999999999999999999999999
Q ss_pred cccccccc-----ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCccCCCChhHHHHHHHhhc
Q 016789 233 SKLLENIE-----EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTG-QEASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 233 a~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
........ ....+...+|..||+||.+.+..|+.++||||||++|+|+++- ..++. ..... ..
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---------r~~t~--~d 471 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---------RIATL--TD 471 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---------HHHhh--hh
Confidence 88766554 2233455788899999999999999999999999999999982 22211 00000 00
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 016789 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEI 348 (382)
Q Consensus 307 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~ 348 (382)
.....+++.+..+++.+ ..++.+++...|.+||++.+
T Consensus 472 ~r~g~ip~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 472 IRDGIIPPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hhcCCCChHHhhcCcHH-----HHHHHHhcCCCcccCchHHH
Confidence 11222233333334433 24666999999999994443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=145.28 Aligned_cols=137 Identities=16% Similarity=0.111 Sum_probs=105.0
Q ss_pred HHHhCCCCCCeeeccCcccEEEEEEC-CeeEEEEEccCCc-------------------------hHHHHHHHHHHhcCC
Q 016789 84 QATKQFSETSLIGFGSFGPVYKGLLR-DTVVAIKRRVGSP-------------------------RQEFVAEVTYLSEIR 137 (382)
Q Consensus 84 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-------------------------~~~~~~e~~~l~~l~ 137 (382)
.....|...+.||+|+||.||++... +..+|+|...... ...+..|..++..+.
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 33334777889999999999999885 5799999743211 113567888888888
Q ss_pred CCC--ccceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 016789 138 HRN--LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTA 215 (382)
Q Consensus 138 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~ 215 (382)
|++ +...++ ....++||||+++++|...... .....++.+++.++.++|+.+ ++||||||+
T Consensus 92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~ 154 (198)
T cd05144 92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEF 154 (198)
T ss_pred HcCCCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcc
Confidence 774 444443 2345899999999998664321 234568889999999999977 999999999
Q ss_pred CeeecCCCcEEEeecCCccccc
Q 016789 216 NVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 216 Nill~~~~~~kl~DfGla~~~~ 237 (382)
||++++++.++|+|||++....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.2e-18 Score=171.68 Aligned_cols=213 Identities=20% Similarity=0.189 Sum_probs=142.3
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
..+|..++.+-.|+||.||..+++. +.+|.|+-+.. .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~---lilRn--ilt~a~npfvv--------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN---LILRN--ILTFAGNPFVV--------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc---hhhhc--cccccCCccee---------------------
Confidence 3578888999999999999998875 57777542211 11111 23333344433
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc----
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI---- 239 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~---- 239 (382)
|+-...+...+ .++. +++.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+++..-..
T Consensus 136 gDc~tllk~~g-----~lPv--------dmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 GDCATLLKNIG-----PLPV--------DMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred chhhhhcccCC-----CCcc--------hhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 44444444322 2221 1267899999877 999999999999999999999999998632100
Q ss_pred ----------cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHH-HHHHhhcCC
Q 016789 240 ----------EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALI-QWVRSRLSS 308 (382)
Q Consensus 240 ----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~ 308 (382)
.........+|+.|.|||++..+.|+..+|+|++|+++||.+-|+.||....+ +++. +.+......
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp---eelfg~visd~i~w 277 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDDIEW 277 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH---HHHHhhhhhhhccc
Confidence 11122345789999999999999999999999999999999999999975432 2222 112111111
Q ss_pred CcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 309 NNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 309 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. +-....+.+..+++.+.|+.+|..|.-....++
T Consensus 278 p---------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 278 P---------EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred c---------ccCcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 1 112222355667778999999999976554433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.8e-16 Score=129.75 Aligned_cols=132 Identities=21% Similarity=0.246 Sum_probs=111.7
Q ss_pred CCeeeccCcccEEEEEECCeeEEEEEccCCc-hHHHHHHHHHHhcCCC--CCccceeeEEEeCCeeEEEEeecCCCChhh
Q 016789 92 TSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP-RQEFVAEVTYLSEIRH--RNLVTLLGYCQQNGYQMLVFEYLPNGSMCN 168 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 168 (382)
.+.+|+|.++.||++...+..+++|...... ...+..|+..+..++| +++.+++++....+..++++||++++++..
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~ 82 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDE 82 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeeccc
Confidence 4679999999999999988889999876543 3578999999999976 589999998888888999999998877644
Q ss_pred hhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 169 HLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK-PPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 169 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
. +......++.+++.+|+++|... .+++|+|++|+||++++++.++++|||.+..
T Consensus 83 ~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 83 V------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred C------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 3 44566778899999999999742 3499999999999999999999999999863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.4e-16 Score=138.42 Aligned_cols=132 Identities=14% Similarity=0.124 Sum_probs=103.1
Q ss_pred CCeee-ccCcccEEEEEECCeeEEEEEccC----------------CchHHHHHHHHHHhcCCCCCc--cceeeEEEeCC
Q 016789 92 TSLIG-FGSFGPVYKGLLRDTVVAIKRRVG----------------SPRQEFVAEVTYLSEIRHRNL--VTLLGYCQQNG 152 (382)
Q Consensus 92 ~~~lg-~G~~g~V~~~~~~~~~vavK~~~~----------------~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~~ 152 (382)
...|| .|+.|+||.....+..+++|+... .....+.+|++++.+++|+++ +..+++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 45788 899999999999888888886532 112357789999999998775 66777654332
Q ss_pred ----eeEEEEeecCC-CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEE
Q 016789 153 ----YQMLVFEYLPN-GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKV 227 (382)
Q Consensus 153 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl 227 (382)
..++|+||+++ .+|.+++... .++.. .+.+++.+|.+||+.+ |+||||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEE
Confidence 23599999997 6888877542 23333 3567899999999988 999999999999999999999
Q ss_pred eecCCccc
Q 016789 228 ADTGISKL 235 (382)
Q Consensus 228 ~DfGla~~ 235 (382)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99999874
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.5e-16 Score=133.99 Aligned_cols=133 Identities=18% Similarity=0.185 Sum_probs=93.6
Q ss_pred CCeeeccCcccEEEEEEC-CeeEEEEEccCCch-----HHH----------------------HHHHHHHhcCCCCC--c
Q 016789 92 TSLIGFGSFGPVYKGLLR-DTVVAIKRRVGSPR-----QEF----------------------VAEVTYLSEIRHRN--L 141 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-----~~~----------------------~~e~~~l~~l~h~n--i 141 (382)
.+.||+|+||.||+|... +..||+|....... ..+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 357999999999999987 58899997553211 111 24555555554332 3
Q ss_pred cceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeeec
Q 016789 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVD 220 (382)
Q Consensus 142 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill~ 220 (382)
.+.+++ ...++||||++++++........ ... .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE
Confidence 444432 23589999999865432211110 011 4567789999999999998 77 99999999999999
Q ss_pred CCCcEEEeecCCccccc
Q 016789 221 ENFIAKVADTGISKLLE 237 (382)
Q Consensus 221 ~~~~~kl~DfGla~~~~ 237 (382)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.9e-16 Score=138.01 Aligned_cols=203 Identities=22% Similarity=0.297 Sum_probs=141.4
Q ss_pred HHhcCCCCCccceeeEEEeCC-----eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 016789 132 YLSEIRHRNLVTLLGYCQQNG-----YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPP 206 (382)
Q Consensus 132 ~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ 206 (382)
-|-++-|.|||++..|+.+.. ...+++|||..|++..+|++... ....+......+++.||..||.|||++.|+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 344557999999999987543 46789999999999999987643 233567777888999999999999999999
Q ss_pred ceecCCCCCCeeecCCCcEEEeecCCccc---cccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhC
Q 016789 207 LVHKNFKTANVLVDENFIAKVADTGISKL---LENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTG 283 (382)
Q Consensus 207 ivHrDlk~~Nill~~~~~~kl~DfGla~~---~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg 283 (382)
|+|+++..+-|++..++.+|+.--.-... .........+..++.++|.+||+=.....+.++|||+||+..+||.-+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999999999764221111 111111122233456779999988777788899999999999999887
Q ss_pred CCC-CCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 284 QEA-SHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 284 ~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.-- -........+...... -.... + ..=..++..|++.+|..||+|++++.-
T Consensus 279 Eiq~tnseS~~~~ee~ia~~--i~~le---n------------~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANV--IIGLE---N------------GLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeccCCCcceeehhhhhhhh--eeecc---C------------ccccCcCcccccCCCCCCcchhhhhcC
Confidence 743 2211111111111000 00000 0 011246678999999999999987654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=9.7e-17 Score=160.06 Aligned_cols=251 Identities=19% Similarity=0.197 Sum_probs=176.7
Q ss_pred CCCCCCeeeccCcccEEEEEECC---eeEEEEEccCCc--h---HHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD---TVVAIKRRVGSP--R---QEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~---~~vavK~~~~~~--~---~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 158 (382)
.|...+.||+|+|+.|-...... ..+++|...... . .....|..+-..+. |+|++++++...+.+..++.+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 35556679999999998876543 456666554332 1 12233566666665 999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeeecCCC-cEEEeecCCcccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH-SLKPPLVHKNFKTANVLVDENF-IAKVADTGISKLL 236 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~~~ 236 (382)
+|..+|++.+.+... .....+....-..+.|+..++.|+| ..+ +.|||+||+|.+++.++ ..+++|||+|...
T Consensus 101 ~~s~g~~~f~~i~~~---~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHP---DSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred CcccccccccccccC---CccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999998887311 1113444455667889999999999 766 99999999999999999 9999999999876
Q ss_pred cc-cccc-CCCcccc-cccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 237 EN-IEEA-GPSHGSI-VNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 237 ~~-~~~~-~~~~~~~-~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
.. .... ......+ ++.|+|||...+. ......|+||.|+++.-+++|..|+....... .....|..... ..
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~~----~~ 250 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNKG----RF 250 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeeccccc----cc
Confidence 55 2211 1222334 7779999998874 45677899999999999999999987544322 11112211110 00
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
... ..........++...++..+|..|.+.+++...
T Consensus 251 ~~~----~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 251 TQL----PWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ccC----ccccCChhhhhcccccccCCchhcccccccccc
Confidence 011 112223455667778888999999999887543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.3e-13 Score=133.56 Aligned_cols=138 Identities=17% Similarity=0.159 Sum_probs=95.4
Q ss_pred CCeeeccCcccEEEEEEC-CeeEEEEEccCCchH-------------------------------------------HHH
Q 016789 92 TSLIGFGSFGPVYKGLLR-DTVVAIKRRVGSPRQ-------------------------------------------EFV 127 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~-------------------------------------------~~~ 127 (382)
.+.||.|++|.||+|++. ++.||||.......+ +|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999986 489999986543222 234
Q ss_pred HHHHHHhcC----CCCCccceeeEE-EeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHH-HHHHHh
Q 016789 128 AEVTYLSEI----RHRNLVTLLGYC-QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAK-GLCHLH 201 (382)
Q Consensus 128 ~e~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH 201 (382)
+|...+.++ +|.+-+.+-.++ ......+|||||++|++|.+....... ..+ +..++..++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CCC---HHHHHHHHHHHHHHHHH
Confidence 454444444 222223322222 223456899999999999887653210 112 3345666655 467888
Q ss_pred cCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 202 ~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
..+ ++|+|++|.||++++++.++++|||++..+..
T Consensus 275 ~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 RDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred hCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 877 99999999999999999999999999976643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.1e-13 Score=112.93 Aligned_cols=126 Identities=14% Similarity=0.063 Sum_probs=95.3
Q ss_pred CeeeccCcccEEEEEECCeeEEEEEccCCc--hHHHHHHHHHHhcCCCCCcc-ceeeEEEeCCeeEEEEeecCCCChhhh
Q 016789 93 SLIGFGSFGPVYKGLLRDTVVAIKRRVGSP--RQEFVAEVTYLSEIRHRNLV-TLLGYCQQNGYQMLVFEYLPNGSMCNH 169 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL~~~ 169 (382)
+.++.|.++.||++...+..+++|...... ...+..|+.+++.+.+.+++ +++.+.. ...++||||+++.++.+.
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE 81 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc
Confidence 468899999999999988899999865443 24567899999988665544 4444432 335899999999887543
Q ss_pred hhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCC---CCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 170 LYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK---PPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 170 l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
. . ....++.+++++|+.||+.+ ..++|+|++|.||+++ ++.++++|||.+.
T Consensus 82 --~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 82 --D--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred --c--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 0 0 01235678999999999865 1259999999999999 6689999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.6e-13 Score=131.56 Aligned_cols=248 Identities=23% Similarity=0.236 Sum_probs=172.8
Q ss_pred CCCCCCeeec--cCcccEEEEEE--CC--eeEEEEEccCC-----chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeE
Q 016789 88 QFSETSLIGF--GSFGPVYKGLL--RD--TVVAIKRRVGS-----PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 88 ~~~~~~~lg~--G~~g~V~~~~~--~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 155 (382)
.|.....+|. |.+|.||.+.. .. ..+|+|+-... ....=.+|+....++ .|+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566778999 99999999877 33 56788763221 112334566666666 4999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHH----HHHHHhcCCCCceecCCCCCCeeecCC-CcEEEeec
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAK----GLCHLHSLKPPLVHKNFKTANVLVDEN-FIAKVADT 230 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~ivHrDlk~~Nill~~~-~~~kl~Df 230 (382)
+-+|+|. .+|.++-+... ..++....+.+..+... ||.++|+.. ++|-|+||.||+...+ ..++++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCc
Confidence 9999994 67777766432 23555666666667777 999999977 9999999999999999 89999999
Q ss_pred CCccccccccccCCCc----ccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc
Q 016789 231 GISKLLENIEEAGPSH----GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 231 Gla~~~~~~~~~~~~~----~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
|+...+.......... ..+...|++||...+ .++..+|+|++|.+..+..++..+...........+.+ ..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~----~~ 342 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ----GY 342 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc----cc
Confidence 9988765543222211 133445999998875 47889999999999999999887654321111111111 00
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 307 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
+..++......++..++.++++.+|..|++.+. +..|.-|.
T Consensus 343 ---------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~-~~~l~~i~ 383 (524)
T KOG0601|consen 343 ---------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQI-LTALNVIH 383 (524)
T ss_pred ---------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHH-Hhcccccc
Confidence 111111122334555888999999999998774 44555444
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.1e-11 Score=114.85 Aligned_cols=145 Identities=22% Similarity=0.260 Sum_probs=109.4
Q ss_pred HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-
Q 016789 124 QEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS- 202 (382)
Q Consensus 124 ~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~- 202 (382)
+...+-++.|+.++||||++++..+...+..|+|+|-+. .|..++...+ .....-.+.||+.||.|||+
T Consensus 54 ~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~--------~~~v~~Gl~qIl~AL~FL~~d 123 (690)
T KOG1243|consen 54 ELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG--------KEEVCLGLFQILAALSFLNDD 123 (690)
T ss_pred HHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--------HHHHHHHHHHHHHHHHHHhcc
Confidence 445677888999999999999999999999999999974 5667776532 34455578899999999984
Q ss_pred CCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh
Q 016789 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT 282 (382)
Q Consensus 203 ~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t 282 (382)
++ ++|++|.-..|++++.|..||++|.++........ ..........|..|+.+.... -..|.|-||++++|++.
T Consensus 124 ~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~n 198 (690)
T KOG1243|consen 124 CN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFN 198 (690)
T ss_pred CC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhC
Confidence 45 99999999999999999999999988754322111 000011112366676654433 34699999999999999
Q ss_pred C
Q 016789 283 G 283 (382)
Q Consensus 283 g 283 (382)
|
T Consensus 199 g 199 (690)
T KOG1243|consen 199 G 199 (690)
T ss_pred c
Confidence 9
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.9e-11 Score=120.02 Aligned_cols=141 Identities=14% Similarity=0.120 Sum_probs=89.4
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCchH----------------------------------------
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSPRQ---------------------------------------- 124 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~---------------------------------------- 124 (382)
..|.. +.||+|++|.||+|++. ++.||||.......+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 68999999999999986 479999987543110
Q ss_pred ---HHHHHHHHHhcC----CCCCccceeeEEEe-CCeeEEEEeecCCCChhhh--hhhcCCCCCCcCCHHHHHHHHHHHH
Q 016789 125 ---EFVAEVTYLSEI----RHRNLVTLLGYCQQ-NGYQMLVFEYLPNGSMCNH--LYETGLESSTKLEFKQRVSIALGAA 194 (382)
Q Consensus 125 ---~~~~e~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~~l~~~~~~~i~~~ia 194 (382)
+|.+|+..+.++ .+.+.+.+-.++.+ ....+|||||++|+++.+. +...+. ....+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-DMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-CHHHHHHHHHHHHHHH--
Confidence 134444444444 23333433333322 3456899999999999774 222210 0011222222222222
Q ss_pred HHHHHHhcCCCCceecCCCCCCeeecCCC----cEEEeecCCcccccc
Q 016789 195 KGLCHLHSLKPPLVHKNFKTANVLVDENF----IAKVADTGISKLLEN 238 (382)
Q Consensus 195 ~~L~~LH~~~~~ivHrDlk~~Nill~~~~----~~kl~DfGla~~~~~ 238 (382)
++..+ ++|+|++|.||+++.++ .++++|||+...+..
T Consensus 276 -----if~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -----VFRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HHhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33446 99999999999999888 999999999876643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=9.1e-11 Score=100.53 Aligned_cols=133 Identities=18% Similarity=0.130 Sum_probs=93.6
Q ss_pred CeeeccCcccEEEEEECC--------eeEEEEEccC--------------C-----------chHHH----HHHHHHHhc
Q 016789 93 SLIGFGSFGPVYKGLLRD--------TVVAIKRRVG--------------S-----------PRQEF----VAEVTYLSE 135 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--------~~vavK~~~~--------------~-----------~~~~~----~~e~~~l~~ 135 (382)
..||.|--+.||.|...+ ..+|+|.... . ....+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 358899999999997542 6889985211 0 01122 278889998
Q ss_pred CC--CCCccceeeEEEeCCeeEEEEeecCCCChhh-hhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHH-hcCCCCceecC
Q 016789 136 IR--HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCN-HLYETGLESSTKLEFKQRVSIALGAAKGLCHL-HSLKPPLVHKN 211 (382)
Q Consensus 136 l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~ivHrD 211 (382)
+. .-++.+.+++ ...++||||+.++.+.. .+.+. .++......+..++..+|..+ |..+ ++|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~------~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA------KLNDEEMKNAYYQVLSMMKQLYKECN--LVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc------ccCHHHHHHHHHHHHHHHHHHHHhCC--eecCC
Confidence 85 3456666654 34589999997654422 22221 234445567788999999999 8877 99999
Q ss_pred CCCCCeeecCCCcEEEeecCCcccccc
Q 016789 212 FKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 212 lk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
|++.|||++ ++.+.|+|||.+....+
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 999999997 46799999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1e-10 Score=97.15 Aligned_cols=127 Identities=20% Similarity=0.288 Sum_probs=98.7
Q ss_pred eeeccCcccEEEEEECCeeEEEEEccCCc-----------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 94 LIGFGSFGPVYKGLLRDTVVAIKRRVGSP-----------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
.+++|+-+.+|.+.+.+..+.+|...... ...-.+|+.++.+++--.|....=+..+.+...++|||.+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 57899999999998888778888654321 1245678999998875555555555666666789999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
|-.|.+.+... ...++..+-.-+.-||..+ |+|+||.++|+++..+. +.++|||++..
T Consensus 83 G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA------------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 88888888653 2446666777788899877 99999999999998765 89999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.1e-11 Score=119.03 Aligned_cols=242 Identities=22% Similarity=0.209 Sum_probs=167.6
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC---CeeEEEEEccCCch----H-HHHHHHHHHhcC-CCCCccceeeEEEeCCeeEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR---DTVVAIKRRVGSPR----Q-EFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~----~-~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 156 (382)
..+|.....||.|.|+.|+....+ +..+++|....... + .-..|+.+...+ .|.++++++..+......|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 346777888999999999988754 25778776554321 1 123455555555 58899998888888888889
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC-CcEEEeecCCccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN-FIAKVADTGISKL 235 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~-~~~kl~DfGla~~ 235 (382)
-.|||+++++...+... ..++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||+++.
T Consensus 344 p~e~~~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred chhhhcCcchhhhhHHH-----HhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccc
Confidence 99999999887666322 24667778889999999999999877 9999999999999886 8889999999874
Q ss_pred cccccccCCCcccccccc-cCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 236 LENIEEAGPSHGSIVNVF-RDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y-~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
+.- ...........| .+|+......+..+.|++|||..+.|.+++..-.... .+|...... .-+
T Consensus 417 ~~~---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--------~~~~~i~~~----~~p 481 (524)
T KOG0601|consen 417 LAF---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG--------VQSLTIRSG----DTP 481 (524)
T ss_pred cce---ecccccccccccccchhhccccccccccccccccccccccccCcccCccc--------ccceeeecc----ccc
Confidence 321 111222223334 3666777788999999999999999999988543211 111111000 000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
.. + .....+..+.+.....++..||.+.+.....+
T Consensus 482 ~~----~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 482 NL----P-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred CC----C-chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 11 1 11245556666788999999999887765544
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.1e-10 Score=94.84 Aligned_cols=141 Identities=18% Similarity=0.205 Sum_probs=104.4
Q ss_pred CCCeeeccCcccEEEEEECCeeEEEEEccCCc-----------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 91 ETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP-----------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 91 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
...++-+|+-+.|+++.+.++...+|...... +..-.+|++.|.+++--.|.-..=++.+...-.++||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 34678999999999999999998998754321 2356789999988865455444445555555679999
Q ss_pred ecCC-CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC---cEEEeecCCccc
Q 016789 160 YLPN-GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF---IAKVADTGISKL 235 (382)
Q Consensus 160 ~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~---~~kl~DfGla~~ 235 (382)
|.++ .++.+++...... .........++..|-+.+.-||..+ |+|+||..+||++..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9976 3778888764321 2233333677888889999999988 99999999999996544 458999999875
Q ss_pred c
Q 016789 236 L 236 (382)
Q Consensus 236 ~ 236 (382)
.
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.9e-10 Score=101.48 Aligned_cols=137 Identities=20% Similarity=0.301 Sum_probs=103.4
Q ss_pred CeeeccCcccEEEEEECC-eeEEEEEccCC----chHHHHHHHHHHhcCCC--CCccceeeEEEeCC---eeEEEEeecC
Q 016789 93 SLIGFGSFGPVYKGLLRD-TVVAIKRRVGS----PRQEFVAEVTYLSEIRH--RNLVTLLGYCQQNG---YQMLVFEYLP 162 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~-~~vavK~~~~~----~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~ 162 (382)
+.++.|.++.||++...+ ..+++|..... ....+..|.+++..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 568999999999998887 78999986543 24578899999999975 45677777776542 5689999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL--------------------------------------- 203 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------------------------------------- 203 (382)
+.++.+.+.. ..++......++.++++.|.+||+.
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9887665421 1355556666777777777777742
Q ss_pred ---------------CCCceecCCCCCCeeecC--CCcEEEeecCCccc
Q 016789 204 ---------------KPPLVHKNFKTANVLVDE--NFIAKVADTGISKL 235 (382)
Q Consensus 204 ---------------~~~ivHrDlk~~Nill~~--~~~~kl~DfGla~~ 235 (382)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 67789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.5e-11 Score=124.44 Aligned_cols=242 Identities=17% Similarity=0.128 Sum_probs=157.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEc------cCCchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRR------VGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
..+.+.+-+-+|.++.++.+.-.. ...+.|.. .....+....+-.++-..+||-+++....+......+|++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 345555677788888888765432 11122211 1111122222333333345677777666666667889999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc-
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE- 237 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~- 237 (382)
+|..+++|...|+..+. .+..........+..+++|||+.. +.|+|++|.|.|...+++.+++|||......
T Consensus 884 ~~~~~~~~~Skl~~~~~-----~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGC-----LSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred HHhccCCchhhhhcCCC-----cccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCcccccccccc
Confidence 99999999999987652 222222233445667899999866 8999999999999999999999998322110
Q ss_pred ------c--------------ccc---------cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 016789 238 ------N--------------IEE---------AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASH 288 (382)
Q Consensus 238 ------~--------------~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~ 288 (382)
. ... .......+++.|.+||...+......+|+|++|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 000 00122346778999999999999999999999999999999999997
Q ss_pred ccCCCChhHHHHHHHhhcCCCcccccccCC-CCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 016789 289 IVSLGSYEALIQWVRSRLSSNNFVDHRLAG-TFTTEGMRDLIRLTLQCMSSPGRRRPKME 347 (382)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ 347 (382)
....+. ..+.+. .....+ ..+.+......+++...+..+|.+|..+.
T Consensus 1037 a~tpq~---~f~ni~---------~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQ---IFENIL---------NRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhh---hhhccc---------cCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 644322 111111 111111 12334455667777788899999998876
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.4e-09 Score=94.52 Aligned_cols=137 Identities=10% Similarity=0.046 Sum_probs=99.2
Q ss_pred CeeeccCcccEEEEEECCeeEEEEEccCCc--------------hHHHHHHHHHHhcCCCCC--ccceeeEEEe-----C
Q 016789 93 SLIGFGSFGPVYKGLLRDTVVAIKRRVGSP--------------RQEFVAEVTYLSEIRHRN--LVTLLGYCQQ-----N 151 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--------------~~~~~~e~~~l~~l~h~n--iv~l~~~~~~-----~ 151 (382)
+.+-.-....|++..+.+..+.+|+..... ...+.+|...+.++..-+ ....+++... .
T Consensus 28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 445544445577888888899999654322 114778988888884333 3344555543 2
Q ss_pred CeeEEEEeecCCC-ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC-------CC
Q 016789 152 GYQMLVFEYLPNG-SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-------NF 223 (382)
Q Consensus 152 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-------~~ 223 (382)
...++|+|++++- +|.+++.... ....+......++.+++..+.-||..+ |+|+|++++|||++. +.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCc
Confidence 3578999999876 7888875321 123455667789999999999999988 999999999999975 57
Q ss_pred cEEEeecCCcc
Q 016789 224 IAKVADTGISK 234 (382)
Q Consensus 224 ~~kl~DfGla~ 234 (382)
.+.++||+.+.
T Consensus 183 ~~~LIDl~r~~ 193 (268)
T PRK15123 183 KLSVIDLHRAQ 193 (268)
T ss_pred eEEEEECCccc
Confidence 89999999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.90 E-value=6.7e-08 Score=91.81 Aligned_cols=214 Identities=20% Similarity=0.235 Sum_probs=144.8
Q ss_pred cccEEEEEEC--CeeEEEEEccCC---chHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEEeecCC-CChhhh
Q 016789 100 FGPVYKGLLR--DTVVAIKRRVGS---PRQEFVAEVTYLSEIRHRNLVTLLGYCQQ----NGYQMLVFEYLPN-GSMCNH 169 (382)
Q Consensus 100 ~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~ 169 (382)
..+.|++... +..+.+|++... .......-++..+++.|+|+|++..++.. +..+++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4567777653 467788887332 12223345678999999999999998863 3578999999886 477775
Q ss_pred hhhcC----------CCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 170 LYETG----------LESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 170 l~~~~----------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
-.... ...+...++..+|.++.|+..||.++|+.| +.-+-|.+.+||++.+..++|+..|....+..+
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 54322 123446788999999999999999999988 888999999999999999999988887765443
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
.. |.+.. -.+-|.=.||.+++.|.||.......+ .......+.
T Consensus 447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d-~~~~s~~~~------------------ 489 (655)
T KOG3741|consen 447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTD-STQSSHLTR------------------ 489 (655)
T ss_pred CC---------------cchhH---HhhhhHHHHHHHHHHHhhccccccccc-chHHHHHHH------------------
Confidence 20 11111 235699999999999999975422111 011111111
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L 353 (382)
.....+.++.+++.-....++++ -+..+++.++
T Consensus 490 I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 490 ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 12233455666777777777776 5666666554
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=6e-10 Score=108.88 Aligned_cols=149 Identities=18% Similarity=0.171 Sum_probs=99.8
Q ss_pred HHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC-----C---CcccccccccCccccccCC
Q 016789 192 GAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG-----P---SHGSIVNVFRDPEVEESGV 263 (382)
Q Consensus 192 ~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-----~---~~~~~~~~y~aPE~~~~~~ 263 (382)
+++.||.|+|.. ..+||++|.|++|.++.++.+||+.|+.+.......... + ........|.|||++....
T Consensus 107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 455899999974 569999999999999999999999999876544311111 0 0111123499999999888
Q ss_pred CCccchhHHHHHHHHHHHhCCCC-CCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCC
Q 016789 264 FSEMSDIYSFGVFLLELVTGQEA-SHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRR 342 (382)
Q Consensus 264 ~~~~sDvws~G~vl~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~ 342 (382)
.+.++|+||+|+++|-+..|..+ +............. .. +..-...++.+.+.++.+-+.+.+..++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~---~~-------~~~~~~~~s~~~p~el~~~l~k~l~~~~~~ 255 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR---NL-------LNAGAFGYSNNLPSELRESLKKLLNGDSAV 255 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh---cc-------cccccccccccCcHHHHHHHHHHhcCCccc
Confidence 89999999999999999955544 33221111111100 00 000111233455667777788899999999
Q ss_pred CCCHHHHHH
Q 016789 343 RPKMEIVMT 351 (382)
Q Consensus 343 RPs~~~v~~ 351 (382)
||++.++..
T Consensus 256 rp~~~~l~~ 264 (700)
T KOG2137|consen 256 RPTLDLLLS 264 (700)
T ss_pred Ccchhhhhc
Confidence 997776544
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.4e-07 Score=86.08 Aligned_cols=262 Identities=15% Similarity=0.110 Sum_probs=151.8
Q ss_pred CCCeeeccCcccEEEEEECCeeEEEEEccCCchHHHHHHHHHHhcC-CCCCccceeeEE------Ee-CCeeEEEEeecC
Q 016789 91 ETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEI-RHRNLVTLLGYC------QQ-NGYQMLVFEYLP 162 (382)
Q Consensus 91 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~------~~-~~~~~lv~e~~~ 162 (382)
..+.||+|+-+.+|-.---...| -|+........-.+.+..|... .||-+..=+.|= -+ ....-++|..++
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d~V-AKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v~ 93 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRDQV-AKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKVS 93 (637)
T ss_pred CCccccCCccceeeecchhhchh-heeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccCC
Confidence 45679999999999542222222 2443332222112223334444 466443312211 11 112456666665
Q ss_pred CCC-hhhhhhh-cCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 163 NGS-MCNHLYE-TGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 163 ~gs-L~~~l~~-~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+-. ..+++.. .+..+.....|...++.+..+|.+.+-||..| .+-+|++++|+|+.+++.+.|.|-..-....+.
T Consensus 94 g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng- 170 (637)
T COG4248 94 GKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDSFQINANG- 170 (637)
T ss_pred CccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccceeeccCC-
Confidence 532 2222211 11233446789999999999999999999988 999999999999999999999985433322111
Q ss_pred ccCCCcccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhC-CCCCCccCCC-----ChhHHHHHHHhhcCC-
Q 016789 241 EAGPSHGSIVNVFRDPEVEE-----SGVFSEMSDIYSFGVFLLELVTG-QEASHIVSLG-----SYEALIQWVRSRLSS- 308 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~G~vl~el~tg-~~p~~~~~~~-----~~~~~~~~~~~~~~~- 308 (382)
....+..+...|.+||... +..-+...|-|.+|+++++++.| ++||...... ..+.-+.-..-....
T Consensus 171 -~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~ 249 (637)
T COG4248 171 -TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASD 249 (637)
T ss_pred -ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechh
Confidence 1122334556699999765 33356678999999999999987 8898653321 111111000000000
Q ss_pred --CcccccccCCCCC-HHHHHHHHHHHhhccCCC--CCCCCCHHHHHHHHHHHHHh
Q 016789 309 --NNFVDHRLAGTFT-TEGMRDLIRLTLQCMSSP--GRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 309 --~~~~d~~~~~~~~-~~~~~~l~~l~~~cl~~d--p~~RPs~~~v~~~L~~i~~~ 359 (382)
....-+.. ..+ ...+..+..+..+|+... +.-||+++-.+..|..+..+
T Consensus 250 ~~~g~~p~P~--~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 250 QRRGLKPPPR--SIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred ccCCCCCCCC--CCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 00000000 111 123455666667898643 67899999999999888755
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.3e-07 Score=81.33 Aligned_cols=134 Identities=16% Similarity=0.108 Sum_probs=101.2
Q ss_pred eeccCcccEEEEEECCeeEEEEEcc---------CCchHHHHHHHHHHhcCCC--CCccceeeEEE-eC----CeeEEEE
Q 016789 95 IGFGSFGPVYKGLLRDTVVAIKRRV---------GSPRQEFVAEVTYLSEIRH--RNLVTLLGYCQ-QN----GYQMLVF 158 (382)
Q Consensus 95 lg~G~~g~V~~~~~~~~~vavK~~~---------~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~-~~----~~~~lv~ 158 (382)
-|.||.+-|++-.+.+..+-+|+.. .-....|.+|+..+.++.. -++.+.. ++. .. ...+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 4779999999998888889999754 2234679999999999853 2344444 332 11 2468999
Q ss_pred eecCC-CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc--EEEeecCCcc
Q 016789 159 EYLPN-GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI--AKVADTGISK 234 (382)
Q Consensus 159 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~--~kl~DfGla~ 234 (382)
|-+++ -||.+++.+.. ..+.+...+..+..+++..+.-||+.+ +.|+|+.+.||+++.++. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97754 47877775432 224567777889999999999999988 999999999999986666 9999998765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=8.2e-08 Score=82.00 Aligned_cols=97 Identities=19% Similarity=0.245 Sum_probs=61.8
Q ss_pred HHHHHHHHhcCCCC--CccceeeEEEeCCeeEEEEeecC--CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHH-H
Q 016789 126 FVAEVTYLSEIRHR--NLVTLLGYCQQNGYQMLVFEYLP--NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCH-L 200 (382)
Q Consensus 126 ~~~e~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~-L 200 (382)
..+|.+.|.++..- ++.+.+.+. ...+||||++ +..+. .|.... +.......++.++...+.. +
T Consensus 55 ~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~-~l~~~~------~~~~~~~~~~~~il~~~~~~~ 123 (188)
T PF01163_consen 55 AKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLP-RLKDVD------LSPEEPKELLEEILEEIIKML 123 (188)
T ss_dssp HHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGG-CHHHCG------GGGSTHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchh-hHHhcc------ccchhHHHHHHHHHHHHHHHH
Confidence 56799999999755 456665442 2369999998 44443 343321 1122334566677775555 5
Q ss_pred hcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 201 H~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
|..+ |+|+||.+.|||++++ .+.|+|||.+...
T Consensus 124 ~~~g--ivHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 124 HKAG--IVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp HCTT--EEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred HhcC--ceecCCChhhEEeecc-eEEEEecCcceec
Confidence 7877 9999999999999988 9999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.3e-07 Score=82.61 Aligned_cols=105 Identities=20% Similarity=0.240 Sum_probs=81.6
Q ss_pred HHHHHHHHHHhcCC--CCCccceeeEEEeCC----eeEEEEeecCCC-ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHH
Q 016789 124 QEFVAEVTYLSEIR--HRNLVTLLGYCQQNG----YQMLVFEYLPNG-SMCNHLYETGLESSTKLEFKQRVSIALGAAKG 196 (382)
Q Consensus 124 ~~~~~e~~~l~~l~--h~niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~ 196 (382)
....+|...+..+. .-...+.+++..... ..++|+|++++. +|.+++.... ..+......++.+++..
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALARL 130 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHHH
Confidence 45778888777774 334556666665532 458999999875 7888886532 24556677899999999
Q ss_pred HHHHhcCCCCceecCCCCCCeeecCCC---cEEEeecCCccc
Q 016789 197 LCHLHSLKPPLVHKNFKTANVLVDENF---IAKVADTGISKL 235 (382)
Q Consensus 197 L~~LH~~~~~ivHrDlk~~Nill~~~~---~~kl~DfGla~~ 235 (382)
++-||..+ |+|+|+++.|||++.+. .+.++||+-++.
T Consensus 131 i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999988 99999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.3e-07 Score=80.92 Aligned_cols=132 Identities=18% Similarity=0.132 Sum_probs=89.9
Q ss_pred CCCCCCeeeccCcccEEEEEEC-CeeEEEEEccC-----------------C--------chHHHHHHHHHHhcCCCC--
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR-DTVVAIKRRVG-----------------S--------PRQEFVAEVTYLSEIRHR-- 139 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~-----------------~--------~~~~~~~e~~~l~~l~h~-- 139 (382)
-..+...||-|--+.||.|... +..+++|.-.. . .+....+|.+.|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3456688999999999999987 48899984110 0 012356789999998644
Q ss_pred CccceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee
Q 016789 140 NLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV 219 (382)
Q Consensus 140 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill 219 (382)
.+.+.+++- ...+||||.++-.|...- ++....-.++..|.+-+.-+-..| |||+|+.+-||++
T Consensus 172 ~VP~P~~~n----RHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAWN----RHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILV 235 (304)
T ss_pred CCCCccccc----cceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEE
Confidence 556555443 346999999886554322 112222233444444444444556 9999999999999
Q ss_pred cCCCcEEEeecCCccc
Q 016789 220 DENFIAKVADTGISKL 235 (382)
Q Consensus 220 ~~~~~~kl~DfGla~~ 235 (382)
+++|.+.++||--+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999987653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.5e-06 Score=75.50 Aligned_cols=137 Identities=12% Similarity=0.116 Sum_probs=83.9
Q ss_pred CeeeccCcccEEEEEECCeeEEEEEccCC-chHHHHHHHHHHhcCCCCC--ccceeeEEEeCCeeEEEEeecCCCC-hhh
Q 016789 93 SLIGFGSFGPVYKGLLRDTVVAIKRRVGS-PRQEFVAEVTYLSEIRHRN--LVTLLGYCQQNGYQMLVFEYLPNGS-MCN 168 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs-L~~ 168 (382)
..||+|..+.||+.. +..+++|..... ......+|.++++.+..-+ +.+.+++....+...+|||+++|.+ +..
T Consensus 7 ~~i~~G~t~~~y~~~--~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~ 84 (226)
T TIGR02172 7 TQTGEGGNGESYTHK--TGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSR 84 (226)
T ss_pred eeecCCCCcceeEec--CCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhh
Confidence 468999999999842 445677776543 3456788999998886433 4677778777777889999998863 111
Q ss_pred h---------------------hhhcCCCCCCcCCHHHHHHHHH----------HHHH-HHHHHh--cCCCCceecCCCC
Q 016789 169 H---------------------LYETGLESSTKLEFKQRVSIAL----------GAAK-GLCHLH--SLKPPLVHKNFKT 214 (382)
Q Consensus 169 ~---------------------l~~~~~~~~~~l~~~~~~~i~~----------~ia~-~L~~LH--~~~~~ivHrDlk~ 214 (382)
. ||..... ...+... ...+-. .+.. ...+|. ...+.++|+|+.|
T Consensus 85 ~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 85 IISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 1 1111000 1111100 000000 0111 122222 2234589999999
Q ss_pred CCeeecCCCcEEEeecCCcc
Q 016789 215 ANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 215 ~Nill~~~~~~kl~DfGla~ 234 (382)
.||++++++ +.|+||+.+.
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcEEEcCCC-cEEEechhcC
Confidence 999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.6e-06 Score=76.37 Aligned_cols=139 Identities=16% Similarity=0.162 Sum_probs=85.8
Q ss_pred eeccCc-ccEEEEEECCeeEEEEEccCCchHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeecCCCChhhhh--
Q 016789 95 IGFGSF-GPVYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHL-- 170 (382)
Q Consensus 95 lg~G~~-g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l-- 170 (382)
|-.|.+ ..||+....+..+.+|...........+|+++++.+. +--+.+++++....+..++|||+++|.++....
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~ 85 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEE 85 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcc
Confidence 444554 7899998777788888876544456778998888884 444667777777666789999999987766431
Q ss_pred -----------------hhcCCCCCCcCCH--HHHHHHHH--------------------HHHHHHHHHhc-----CCCC
Q 016789 171 -----------------YETGLESSTKLEF--KQRVSIAL--------------------GAAKGLCHLHS-----LKPP 206 (382)
Q Consensus 171 -----------------~~~~~~~~~~l~~--~~~~~i~~--------------------~ia~~L~~LH~-----~~~~ 206 (382)
+.... ....+.. .....-.. .+...+..|-. ..+.
T Consensus 86 ~~~~~~~~~l~~~l~~lH~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 164 (244)
T cd05150 86 LEPERLVDALAEALRRLHALPV-ADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLV 164 (244)
T ss_pred cCHHHHHHHHHHHHHHHhcCCc-ccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceE
Confidence 11100 0101110 00000000 01111222211 1245
Q ss_pred ceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 207 LVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 207 ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++|+|+.|.|||++++..+.|+||+.+.
T Consensus 165 l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 165 VTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EECCCCCCccEEEeCCcEEEEEEccccc
Confidence 9999999999999998888999998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.4e-06 Score=85.44 Aligned_cols=141 Identities=17% Similarity=0.213 Sum_probs=90.1
Q ss_pred hCCCCCCeeeccCcccEEEEEEC-CeeEEEEEccCCchH-----------------------------------------
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR-DTVVAIKRRVGSPRQ----------------------------------------- 124 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~----------------------------------------- 124 (382)
..|.. +.++.++-|.||+|++. ++.||||+....-.+
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34443 57899999999999998 589999975432211
Q ss_pred --HHHHHHHHHhcC----C-CCCccceeeEE-EeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHH
Q 016789 125 --EFVAEVTYLSEI----R-HRNLVTLLGYC-QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKG 196 (382)
Q Consensus 125 --~~~~e~~~l~~l----~-h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~ 196 (382)
++..|..-+.++ + .|++ ++=.++ .-.+...|+|||++|-.+.+...... ...+... ++..++.+
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~k~---ia~~~~~~ 276 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDRKE---LAELLVRA 276 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCHHH---HHHHHHHH
Confidence 144455555544 2 2332 222333 33456789999999988888743211 1233333 22222222
Q ss_pred -HHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 197 -LCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 197 -L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
+..+-..+ ++|.|..|.||+++.++.+.+.|||+...+..
T Consensus 277 f~~q~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 277 FLRQLLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHhcC--ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 22222235 99999999999999999999999999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=7e-08 Score=93.86 Aligned_cols=180 Identities=18% Similarity=0.130 Sum_probs=129.8
Q ss_pred eeeccCcccEEEEEECC-eeEEEEEccCCchHHHHHHHHHHhcCCCCC-ccceeeEEEeCCeeEEEEeecCCC-Chhhhh
Q 016789 94 LIGFGSFGPVYKGLLRD-TVVAIKRRVGSPRQEFVAEVTYLSEIRHRN-LVTLLGYCQQNGYQMLVFEYLPNG-SMCNHL 170 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l 170 (382)
-+++|++++++|.+-.. +....+.+... ....-++++|.+++||| .++.++-++.+...++.++|+..| +-....
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~ 326 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEM 326 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccC
Confidence 46889999999887654 22223333222 33456789999999999 778888888888899999999887 221111
Q ss_pred hhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCccccc
Q 016789 171 YETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIV 250 (382)
Q Consensus 171 ~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~ 250 (382)
...+..+...+...+...-.++++++|+.. =+|+| ||+..+ +..|..||+....+.... ......++
T Consensus 327 ----~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~ 393 (829)
T KOG0576|consen 327 ----TVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGT 393 (829)
T ss_pred ----ChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc--ccccCCCC
Confidence 112223444455566667778999999754 58998 777765 678999999988765543 33444567
Q ss_pred ccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 016789 251 NVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASH 288 (382)
Q Consensus 251 ~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~ 288 (382)
+.|+|||+.....+....|+|+.|+-..++.-|-+|-.
T Consensus 394 ~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 394 PEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 78999999999999999999999988777777776643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.37 E-value=7e-06 Score=71.11 Aligned_cols=133 Identities=14% Similarity=0.137 Sum_probs=89.3
Q ss_pred HhCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCchH------------HHHHHHHHHhcCC---CCCccceeeEEEe
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQ------------EFVAEVTYLSEIR---HRNLVTLLGYCQQ 150 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~------------~~~~e~~~l~~l~---h~niv~l~~~~~~ 150 (382)
..+|...+++-......|.+-..++....+|...+.... ...+.+..+.+++ --..+.++.+...
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 456777777877788888888888888899875543221 1233344344442 2233333333322
Q ss_pred -----CCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcE
Q 016789 151 -----NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIA 225 (382)
Q Consensus 151 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~ 225 (382)
....+|+|||++|-.|.+... ++. .++..+.+++.-||+.| +.|+|..|.|+++++++ +
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-E
Confidence 234568999999988766531 221 24556778899999988 99999999999998654 8
Q ss_pred EEeecCCcc
Q 016789 226 KVADTGISK 234 (382)
Q Consensus 226 kl~DfGla~ 234 (382)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.1e-05 Score=68.97 Aligned_cols=148 Identities=20% Similarity=0.231 Sum_probs=93.6
Q ss_pred CHHHHHHHHhCCCCCCeeec---cCcccEEEEEEC-CeeEEEEEccCCc----------------------hHH-----H
Q 016789 78 SMEELEQATKQFSETSLIGF---GSFGPVYKGLLR-DTVVAIKRRVGSP----------------------RQE-----F 126 (382)
Q Consensus 78 ~~~~~~~~~~~~~~~~~lg~---G~~g~V~~~~~~-~~~vavK~~~~~~----------------------~~~-----~ 126 (382)
+.+.+....+...+....|. |--+.||+|... +..+|+|+..... ... .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 34555555555555555554 555679998765 5789999744211 000 2
Q ss_pred HHHHHHHhcCC--CCCccceeeEEEeCCeeEEEEeecCCC-ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-
Q 016789 127 VAEVTYLSEIR--HRNLVTLLGYCQQNGYQMLVFEYLPNG-SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS- 202 (382)
Q Consensus 127 ~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~- 202 (382)
.+|..-|.++. +-.+.+-+++.. ..|||||+... .-.-.|.+ ..+.......+..++.+.+.-|-.
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHHh
Confidence 35666677663 444445554433 36999998543 11112222 122222455667777888877765
Q ss_pred CCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 203 ~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
.+ +||+||..-|||+. ++.+.|+|||.|....+
T Consensus 186 a~--LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 186 AG--LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred cC--cccccchhhheEEE-CCeEEEEECccccccCC
Confidence 56 99999999999999 88999999999875543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.1e-05 Score=71.46 Aligned_cols=141 Identities=18% Similarity=0.222 Sum_probs=83.4
Q ss_pred CeeeccCcccEEEEEECCeeEEEEEccCC-chHHHHHHHHHHhcCCCC--CccceeeEEEeC---CeeEEEEeecCCCCh
Q 016789 93 SLIGFGSFGPVYKGLLRDTVVAIKRRVGS-PRQEFVAEVTYLSEIRHR--NLVTLLGYCQQN---GYQMLVFEYLPNGSM 166 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~~gsL 166 (382)
+.++.|..+.||+....+..+++|..... .......|..+++.+... .+.+++.+.... ...+++|+++++.++
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~ 82 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPL 82 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEH
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccc
Confidence 46899999999999998889999986655 345677888888888432 356677655333 356899999998877
Q ss_pred hh----------------h---hhhcCCCCCCcCCHHH---------HHHH------------HHHHHH-HHHHHhc---
Q 016789 167 CN----------------H---LYETGLESSTKLEFKQ---------RVSI------------ALGAAK-GLCHLHS--- 202 (382)
Q Consensus 167 ~~----------------~---l~~~~~~~~~~l~~~~---------~~~i------------~~~ia~-~L~~LH~--- 202 (382)
.. . |+... .......+.. .... ...+.. .+..+++
T Consensus 83 ~~~~~~~~~~~~~~~~~~~l~~lh~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (239)
T PF01636_consen 83 DDELSPEQRPELLRQLGRALAQLHQVP-PPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLP 161 (239)
T ss_dssp HHTSTHHHHHHHHHHHHHHHHHHHHSH-TTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccchhhhhhccccc-ccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhc
Confidence 77 1 11111 0111111100 0000 111222 2333331
Q ss_pred --CCCCceecCCCCCCeeec-CCCcEEEeecCCcc
Q 016789 203 --LKPPLVHKNFKTANVLVD-ENFIAKVADTGISK 234 (382)
Q Consensus 203 --~~~~ivHrDlk~~Nill~-~~~~~kl~DfGla~ 234 (382)
....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 162 ~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 162 KPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp CCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 234599999999999999 66666899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.18 E-value=3.2e-05 Score=71.49 Aligned_cols=76 Identities=14% Similarity=0.051 Sum_probs=58.1
Q ss_pred CCCeeeccCcccEEEEEECCeeEEEEEccCC-chHHHHHHHHHHhcCCC---CCccceeeEEEe---CCeeEEEEeecCC
Q 016789 91 ETSLIGFGSFGPVYKGLLRDTVVAIKRRVGS-PRQEFVAEVTYLSEIRH---RNLVTLLGYCQQ---NGYQMLVFEYLPN 163 (382)
Q Consensus 91 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e~~~~ 163 (382)
..+.||.|..+.||+....+..+.+|..... ....|..|.+.|+.+.- ..+.+.+++|.. .+..++|||++++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eeeecCCccceeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 3457999999999999876666666765442 45688999999998852 467888888754 3568999999998
Q ss_pred CCh
Q 016789 164 GSM 166 (382)
Q Consensus 164 gsL 166 (382)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.16 E-value=3e-05 Score=81.62 Aligned_cols=75 Identities=16% Similarity=0.332 Sum_probs=55.1
Q ss_pred CCeeeccCcccEEEEEECC----eeEEEEEccCC----chHHHHHHHHHHhcCC-CCCc--cceeeEEEeC---CeeEEE
Q 016789 92 TSLIGFGSFGPVYKGLLRD----TVVAIKRRVGS----PRQEFVAEVTYLSEIR-HRNL--VTLLGYCQQN---GYQMLV 157 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~----~~vavK~~~~~----~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 157 (382)
.+.++.|.++.+|+....+ ..+++|+.... ....+.+|.++|+.+. |+++ .+.+++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 4568899999999987765 35677765432 2346889999999995 6654 7788887664 457899
Q ss_pred EeecCCCCh
Q 016789 158 FEYLPNGSM 166 (382)
Q Consensus 158 ~e~~~~gsL 166 (382)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.9e-05 Score=76.17 Aligned_cols=134 Identities=15% Similarity=0.183 Sum_probs=85.4
Q ss_pred CeeeccCcccEEEEEECC-eeEEEEEccCCchH----------------------------------------HHHHHHH
Q 016789 93 SLIGFGSFGPVYKGLLRD-TVVAIKRRVGSPRQ----------------------------------------EFVAEVT 131 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~----------------------------------------~~~~e~~ 131 (382)
+.||..+.|.||+|++++ ..||||...+.-.+ +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 578999999999999987 67999975532111 2555554
Q ss_pred HHhcC----CCCC------ccceeeEEEeCCeeEEEEeecCCCChhhh--hhhcCCCCCCcCCHHHHHHHHHHHHHHHHH
Q 016789 132 YLSEI----RHRN------LVTLLGYCQQNGYQMLVFEYLPNGSMCNH--LYETGLESSTKLEFKQRVSIALGAAKGLCH 199 (382)
Q Consensus 132 ~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~ 199 (382)
-..++ .|-+ |.+++-.+ .....|+||||+|..+.+. +.+.+ ++...+..-+.++..-+-+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g------i~~~~i~~~l~~~~~~qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG------ISPHDILNKLVEAYLEQIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC------CCHHHHHHHHHHHHHHHHH
Confidence 44333 3444 22222222 2357899999999877654 33332 3434333333332222222
Q ss_pred HhcCCCCceecCCCCCCeeecC----CCcEEEeecCCcccccc
Q 016789 200 LHSLKPPLVHKNFKTANVLVDE----NFIAKVADTGISKLLEN 238 (382)
Q Consensus 200 LH~~~~~ivHrDlk~~Nill~~----~~~~kl~DfGla~~~~~ 238 (382)
-| | ++|+|=.|.||+++. ++.+.+-|||+...+..
T Consensus 319 ~~--G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KT--G--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hc--C--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 23 5 999999999999983 67899999999876543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.08 E-value=8.5e-05 Score=64.03 Aligned_cols=131 Identities=18% Similarity=0.174 Sum_probs=86.6
Q ss_pred CCCeeeccCcccEEEEEECCeeEEEEEccCCc-------------------hHHHHHHHHHHhcCC------CCCcccee
Q 016789 91 ETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP-------------------RQEFVAEVTYLSEIR------HRNLVTLL 145 (382)
Q Consensus 91 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-------------------~~~~~~e~~~l~~l~------h~niv~l~ 145 (382)
....||+|+.-.||.--.+ ....||...... ..+..+|+.....+. +.+|.+++
T Consensus 5 ~~~~i~~G~~R~cy~HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CCcccccCCCceEEECCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 3467999999999964332 334555544333 456777776665555 88999999
Q ss_pred eEEEeCCeeEEEEeecCC--C----ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee
Q 016789 146 GYCQQNGYQMLVFEYLPN--G----SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV 219 (382)
Q Consensus 146 ~~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill 219 (382)
|+..++.-.-+|+|.+.+ | +|.+++... .++. .....+. +-..||-+.+ |+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~------~~~~-~~~~~L~---~f~~~l~~~~--Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG------GLTE-ELRQALD---EFKRYLLDHH--IVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC------CccH-HHHHHHH---HHHHHHHHcC--CeecCCCcccEEE
Confidence 999999888899988643 3 466666432 2343 2223333 3345666556 9999999999999
Q ss_pred cCC---C-cEEEee-cCCcc
Q 016789 220 DEN---F-IAKVAD-TGISK 234 (382)
Q Consensus 220 ~~~---~-~~kl~D-fGla~ 234 (382)
..+ . .+.|+| ||...
T Consensus 152 ~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred EecCCCceEEEEEeCCCCcc
Confidence 532 2 577777 56544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.6e-05 Score=63.95 Aligned_cols=126 Identities=20% Similarity=0.239 Sum_probs=85.7
Q ss_pred CCeeeccCcccEEEEEECCeeEEEEEccC-CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCChhhhh
Q 016789 92 TSLIGFGSFGPVYKGLLRDTVVAIKRRVG-SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHL 170 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 170 (382)
.+.|++|++|.||+|.+.+..+|+|.... +.+..+..|.++|..+.-.++.+=+-.+.. .++.|||+.|-+|.+.-
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~L~~~~ 103 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRPLGKLE 103 (201)
T ss_pred hhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcchhhhh
Confidence 35699999999999999999999998654 456789999999999987766654333322 23559999887876654
Q ss_pred hhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC-C-CeeecCCCcEEEeecCCccc
Q 016789 171 YETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKT-A-NVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 171 ~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~-~-Nill~~~~~~kl~DfGla~~ 235 (382)
.. .+-.+... +++.---|-..+ |-|+.|.- . ||++ ++..+.|+||..|+.
T Consensus 104 ~~--------~~rk~l~~----vlE~a~~LD~~G--I~H~El~~~~k~vlv-~~~~~~iIDFd~At~ 155 (201)
T COG2112 104 IG--------GDRKHLLR----VLEKAYKLDRLG--IEHGELSRPWKNVLV-NDRDVYIIDFDSATF 155 (201)
T ss_pred hc--------ccHHHHHH----HHHHHHHHHHhc--cchhhhcCCceeEEe-cCCcEEEEEccchhh
Confidence 31 12223333 333322333335 88888753 3 5555 445999999998873
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.05 E-value=2.4e-05 Score=67.10 Aligned_cols=104 Identities=22% Similarity=0.187 Sum_probs=80.1
Q ss_pred HHHHHHHhcCCC-CCccceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCC-
Q 016789 127 VAEVTYLSEIRH-RNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK- 204 (382)
Q Consensus 127 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~- 204 (382)
..|.-+|..+++ +++.+++|+|-. +++.||...+++...-. ....-...+|..+.+||.++.+.+.+|+...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~--~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYR--PLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccc--ccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 357778888876 699999999953 67899998776643200 0011124699999999999999999998631
Q ss_pred CCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 205 ~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
..+.-.|++++|+-+++++.+|++|.......
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 22778899999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.99 E-value=8.4e-05 Score=66.24 Aligned_cols=72 Identities=10% Similarity=0.178 Sum_probs=43.8
Q ss_pred CeeeccCcc-cEEEEEECCeeEEEEEccCC-chHHHHHHHHHHhcCCCC---CccceeeEEEeC---CeeEEEEeecCCC
Q 016789 93 SLIGFGSFG-PVYKGLLRDTVVAIKRRVGS-PRQEFVAEVTYLSEIRHR---NLVTLLGYCQQN---GYQMLVFEYLPNG 164 (382)
Q Consensus 93 ~~lg~G~~g-~V~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~~~g 164 (382)
+.++.|+.. .||+. +..+++|..... ....+.+|.+++..+... .+.+.++..... ...+++|++++|.
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~ 79 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGE 79 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCC
Confidence 457767666 58875 234566764432 345788899999887531 233444433322 2348899999887
Q ss_pred Chh
Q 016789 165 SMC 167 (382)
Q Consensus 165 sL~ 167 (382)
++.
T Consensus 80 ~l~ 82 (235)
T cd05155 80 TAT 82 (235)
T ss_pred CCC
Confidence 664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.94 E-value=2.6e-05 Score=81.22 Aligned_cols=208 Identities=19% Similarity=0.247 Sum_probs=138.8
Q ss_pred HHHHHHhcCCCCCccceeeEEEeCCee----EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC
Q 016789 128 AEVTYLSEIRHRNLVTLLGYCQQNGYQ----MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203 (382)
Q Consensus 128 ~e~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~ 203 (382)
-|.+.+.++.|+|++.+++|..+.... ....|++..-++...+...+ ..+......+..+..+||.|+|+.
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-----~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-----SIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-----ccCHHHHHHHHHHHhhhHHHHHHh
Confidence 456678888999999999998765322 23457888878877776543 567777888889999999999987
Q ss_pred CCCceecCCCCC---CeeecCCCcEEEe--ecCCccccccccccCCCcccccccccCccccccCCCCcc--chhHHHHHH
Q 016789 204 KPPLVHKNFKTA---NVLVDENFIAKVA--DTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEM--SDIYSFGVF 276 (382)
Q Consensus 204 ~~~ivHrDlk~~---Nill~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--sDvws~G~v 276 (382)
. ..|.-+..+ +--.+..+.+.++ ||+.+..+......... ..+..|.+||......+..+ .|+|.+|..
T Consensus 306 ~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~--~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 306 S--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD--LLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred c--cceeEEecccccccccCccceeecchhhhcccccCCCcccchhh--cCccccccccccccccchhhhhhHHHHHHHH
Confidence 5 666666655 5555677777777 99888765443322211 12334788888876665554 799999999
Q ss_pred HHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 277 LLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 277 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
...+..|..+..... .. ..+.+.. ....+......|+..++++|++..+++...-.-
T Consensus 382 ~~~~~~~~~i~~~~~------~~---------~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~ 438 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSA------VP---------VSLLDVL--------STSELLDALPKCLDEDSEERLSALELLTHPFLR 438 (1351)
T ss_pred HhhhhhcCccccccc------ch---------hhhhccc--------cchhhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence 999999886542110 00 0011100 011355666789999999999999998875443
Q ss_pred HHhhhhhhhhc
Q 016789 357 HEKEMALTTFM 367 (382)
Q Consensus 357 ~~~~~~~~~~~ 367 (382)
....+....++
T Consensus 439 ~~~~~~~~~~~ 449 (1351)
T KOG1035|consen 439 FPTDNESSEFA 449 (1351)
T ss_pred ccccccccccc
Confidence 33444444444
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00015 Score=67.00 Aligned_cols=143 Identities=15% Similarity=0.110 Sum_probs=86.4
Q ss_pred CCeeeccCcccEEEEEECCeeEEEEEccCCchHHHHHHHHHHhcCCCC--CccceeeE------EEeCCeeEEEEeecCC
Q 016789 92 TSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEIRHR--NLVTLLGY------CQQNGYQMLVFEYLPN 163 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e~~~~ 163 (382)
.+.+..|....+|+....+..+++|............|++++..+.+. .+.+.+.. ....+..++|++|++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G 98 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAG 98 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCC
Confidence 345677878899998887778888887654455667788888877432 24444432 1233456899999988
Q ss_pred CChhh--------------hhhhcC--CCC----CCcCCHHHHH----------HHHHHHHHHHHHHhc-----CCCCce
Q 016789 164 GSMCN--------------HLYETG--LES----STKLEFKQRV----------SIALGAAKGLCHLHS-----LKPPLV 208 (382)
Q Consensus 164 gsL~~--------------~l~~~~--~~~----~~~l~~~~~~----------~i~~~ia~~L~~LH~-----~~~~iv 208 (382)
.++.. .+|... ... .....|.... .....+...+.++.. ....++
T Consensus 99 ~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 178 (296)
T cd05153 99 EHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVI 178 (296)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCC
Confidence 76532 112111 000 0111222111 011122334444442 123499
Q ss_pred ecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 209 HKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 209 HrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
|+|+.|.|++++++..+.|+||+.+.
T Consensus 179 HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 179 HADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred ccCcCcccEEEeCCceEEEeehhhhc
Confidence 99999999999998778899998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00013 Score=65.90 Aligned_cols=134 Identities=14% Similarity=0.065 Sum_probs=77.7
Q ss_pred eeccCcccEEEEEECCeeEEEEEccCCch---HHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEeecCCCChhhh-
Q 016789 95 IGFGSFGPVYKGLLRDTVVAIKRRVGSPR---QEFVAEVTYLSEIRHRNL-VTLLGYCQQNGYQMLVFEYLPNGSMCNH- 169 (382)
Q Consensus 95 lg~G~~g~V~~~~~~~~~vavK~~~~~~~---~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~~- 169 (382)
+..|-.+.+|+....+..+++|....... -+..+|.++++.+...++ .++++... .++|+||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~ 79 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQ 79 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccccc
Confidence 45678889999987777788886443221 245788889988864333 33443332 3689999988665421
Q ss_pred ----------------hhhcCCCCCCcCCHHHH-HHHHH---------HHHHHHHHHhc------CCCCceecCCCCCCe
Q 016789 170 ----------------LYETGLESSTKLEFKQR-VSIAL---------GAAKGLCHLHS------LKPPLVHKNFKTANV 217 (382)
Q Consensus 170 ----------------l~~~~~~~~~~l~~~~~-~~i~~---------~ia~~L~~LH~------~~~~ivHrDlk~~Ni 217 (382)
||.... ....++.... ..... .+..-+..+-. ..+.++|+|+.|.||
T Consensus 80 ~~~~~~~~~la~~l~~lH~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 80 FVALDLLLELAALLHQLHSQPR-FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred ccCchhHHHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 122111 1112222211 11110 11111222211 123489999999999
Q ss_pred eecCCCcEEEeecCCcc
Q 016789 218 LVDENFIAKVADTGISK 234 (382)
Q Consensus 218 ll~~~~~~kl~DfGla~ 234 (382)
++++++ +.++||..+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999877 7899998876
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.0002 Score=61.46 Aligned_cols=122 Identities=22% Similarity=0.295 Sum_probs=87.0
Q ss_pred hCCCCCCeeeccCc-ccEEEEEECCeeEEEEEccC---------------C---------chHHHHHHHHHHhcCC---C
Q 016789 87 KQFSETSLIGFGSF-GPVYKGLLRDTVVAIKRRVG---------------S---------PRQEFVAEVTYLSEIR---H 138 (382)
Q Consensus 87 ~~~~~~~~lg~G~~-g~V~~~~~~~~~vavK~~~~---------------~---------~~~~~~~e~~~l~~l~---h 138 (382)
.+++..+.||.|.- |.||++...+..+|+|.+.. . ..+.|..|-+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67888899999999 99999999999999998211 0 0124778888877774 4
Q ss_pred CCc--cceeeEEEeCC------------------eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHH
Q 016789 139 RNL--VTLLGYCQQNG------------------YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLC 198 (382)
Q Consensus 139 ~ni--v~l~~~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~ 198 (382)
.++ ++++||..-.. ..-+|.||.+... .+... -+.+|.+-|.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~~----~~~~~~~dl~ 178 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQIR----DIPQMLRDLK 178 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccchh----HHHHHHHHHH
Confidence 566 89999874220 1245667665432 12222 3455667788
Q ss_pred HHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 199 ~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k~g--I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLG--IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHCC--eeeccCcccccc-----CCEEEecccC
Confidence 999988 999999999985 3379999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.0011 Score=61.97 Aligned_cols=157 Identities=13% Similarity=0.086 Sum_probs=84.9
Q ss_pred CHHHHHHHHhCCCC-----CCeeeccCcccEEEEEECCeeEEEEEccCCchHHHHHHHHHHhcCCC--CCccceee----
Q 016789 78 SMEELEQATKQFSE-----TSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEIRH--RNLVTLLG---- 146 (382)
Q Consensus 78 ~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~---- 146 (382)
+.+++...-..|.. .+.++.|....+|+....+..+++|............|...+..|.. -.+.+.+.
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G 87 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDG 87 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCC
Confidence 34555444455543 24466777789999987777888887653233444445556655531 12333332
Q ss_pred --EEEeCCeeEEEEeecCCCChhh--------------hhhhcCC----C--CCCcCCH-HHHHH-------------HH
Q 016789 147 --YCQQNGYQMLVFEYLPNGSMCN--------------HLYETGL----E--SSTKLEF-KQRVS-------------IA 190 (382)
Q Consensus 147 --~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~----~--~~~~l~~-~~~~~-------------i~ 190 (382)
+....+..++++||++|..+.. .+|.... . ....+.| ..... +.
T Consensus 88 ~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 167 (319)
T PRK05231 88 AALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLE 167 (319)
T ss_pred CEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHH
Confidence 1223456789999998875421 1111110 0 0011112 11110 11
Q ss_pred HHHHHHHHHHhc-----CCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 191 LGAAKGLCHLHS-----LKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 191 ~~ia~~L~~LH~-----~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
..+...+..+.. ...+++|+|+.+.||+++++...-|+||+.+.
T Consensus 168 ~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 168 AELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 111112233321 22359999999999999977666899999875
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.0006 Score=60.60 Aligned_cols=71 Identities=14% Similarity=0.149 Sum_probs=45.3
Q ss_pred CeeeccCcccEEEEEEC---CeeEEEEEccCCch--HHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEeecCCCCh
Q 016789 93 SLIGFGSFGPVYKGLLR---DTVVAIKRRVGSPR--QEFVAEVTYLSEIRHRNL-VTLLGYCQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~--~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 166 (382)
+.|..|-...+|+.... ...+++|....... .+..+|+.++..+...++ .++++.+. ..++|||++|.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 45777888899999876 35777876543321 123468888888854333 34443332 2479999988765
Q ss_pred h
Q 016789 167 C 167 (382)
Q Consensus 167 ~ 167 (382)
.
T Consensus 80 ~ 80 (235)
T cd05157 80 E 80 (235)
T ss_pred C
Confidence 3
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0019 Score=60.04 Aligned_cols=156 Identities=14% Similarity=0.060 Sum_probs=88.4
Q ss_pred HHHHHHHHhCCCC-----CCeeeccCcccEEEEEECCeeEEEEEccCC-chHHHHHHHHHHhcCCC--CCccceeeEE--
Q 016789 79 MEELEQATKQFSE-----TSLIGFGSFGPVYKGLLRDTVVAIKRRVGS-PRQEFVAEVTYLSEIRH--RNLVTLLGYC-- 148 (382)
Q Consensus 79 ~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h--~niv~l~~~~-- 148 (382)
.+++...-+.|.. .+.++.|....+|+....+..+++|..... .......|.+++..|.. -++.+.+...
T Consensus 9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g 88 (307)
T TIGR00938 9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDG 88 (307)
T ss_pred HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCC
Confidence 3445444444543 345667777899998876767788875432 23455567777777632 2244444321
Q ss_pred ----EeCCeeEEEEeecCCCChhh--------------hhhhcCC--CCC--C---cCCHHHHH------------HHHH
Q 016789 149 ----QQNGYQMLVFEYLPNGSMCN--------------HLYETGL--ESS--T---KLEFKQRV------------SIAL 191 (382)
Q Consensus 149 ----~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~--~~~--~---~l~~~~~~------------~i~~ 191 (382)
...+..++++||++|.++.. .+|.... ... . .-.|.... ....
T Consensus 89 ~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~ 168 (307)
T TIGR00938 89 RQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGA 168 (307)
T ss_pred CeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHH
Confidence 22356789999998865421 1221110 000 0 01111110 0112
Q ss_pred HHHHHHHHHhc-----CCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 192 GAAKGLCHLHS-----LKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 192 ~ia~~L~~LH~-----~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
.+...++++.. ....++|+|+.+.|+++++++.+.|+||+.+.
T Consensus 169 ~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 169 ELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 23344555542 23459999999999999998877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.015 Score=55.81 Aligned_cols=71 Identities=17% Similarity=0.134 Sum_probs=50.7
Q ss_pred CeeeccCcccEEEEEECCe--eEEEEEccC----------CchHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEE
Q 016789 93 SLIGFGSFGPVYKGLLRDT--VVAIKRRVG----------SPRQEFVAEVTYLSEIR---HRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~~--~vavK~~~~----------~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 157 (382)
+.||.|.+..||+....+. .+.||.-.. -..+.+..|.+.|..+. ..++.+++.+.. +..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 4689999999999998764 899997331 12345677888888763 345666776633 446899
Q ss_pred EeecCCCC
Q 016789 158 FEYLPNGS 165 (382)
Q Consensus 158 ~e~~~~gs 165 (382)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00029 Score=64.49 Aligned_cols=73 Identities=16% Similarity=0.215 Sum_probs=50.7
Q ss_pred CCeeeccCcccEEEEEECCeeEEEEEccCCchHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEEEeecCCC
Q 016789 92 TSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEIR---HRNLVTLLGYCQQNGYQMLVFEYLPNG 164 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 164 (382)
.+.++.|....+|+....+..+.+|.........|..|.+-|+.|. --.+.+.+++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDTDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEETTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEECCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568889999999998777899999877555677899998888883 456778888888777789999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.002 Score=59.60 Aligned_cols=70 Identities=26% Similarity=0.280 Sum_probs=44.7
Q ss_pred eeeccCcccEEEEEECC--------eeEEEEEccCCc--hHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEeecC
Q 016789 94 LIGFGSFGPVYKGLLRD--------TVVAIKRRVGSP--RQEFVAEVTYLSEIRHRNL-VTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~~--------~~vavK~~~~~~--~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~ 162 (382)
.+..|-...+|+....+ ..+++|...... ..+..+|.+++..+...++ .++++++. + .+|+||++
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i~ 80 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFIP 80 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---CchhheeC
Confidence 45567777899887653 577788754432 2345678888888753333 34555543 2 36899998
Q ss_pred CCChh
Q 016789 163 NGSMC 167 (382)
Q Consensus 163 ~gsL~ 167 (382)
|.++.
T Consensus 81 G~~l~ 85 (302)
T cd05156 81 SRTLT 85 (302)
T ss_pred CCcCC
Confidence 87664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0045 Score=53.92 Aligned_cols=76 Identities=17% Similarity=0.194 Sum_probs=59.7
Q ss_pred CCeeeccCcccEEEEEECCeeEEEEEccCCchHHHHHHHHHHhcC---CCCCccceeeEEEeCCeeEEEEeecCCCChh
Q 016789 92 TSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEI---RHRNLVTLLGYCQQNGYQMLVFEYLPNGSMC 167 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 167 (382)
.+.+--|.--..|...+...++.+|.-.......|..|+.-|+.| +--++.+.+.+-...++.|+|+||++-|.+.
T Consensus 21 r~~v~gG~inea~~v~dg~~~~FvK~n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 21 REEVSGGDINEAWRLRDGTDPFFVKCNQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ccccCCccccceeEeecCCcceEEEecchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 345666777778888887889999987666677888888766666 4466788888888889999999999987665
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.17 E-value=6.5e-05 Score=80.26 Aligned_cols=160 Identities=15% Similarity=0.058 Sum_probs=110.6
Q ss_pred HHHHHHHHhcCCCCCccceeeEEE--eCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-
Q 016789 126 FVAEVTYLSEIRHRNLVTLLGYCQ--QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS- 202 (382)
Q Consensus 126 ~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~- 202 (382)
.+.|...++...|+++.....=.. +..+.+..++|+.+|.+.+.|.+.- .....++.......-.+...+..-+|+
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~-ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGL-EESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcc-ccCCcchhchHHHHHHHHHhccchhhhc
Confidence 344555666678988876655443 2345688999999999999987643 222223322222222222455555554
Q ss_pred --CCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHH
Q 016789 203 --LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLEL 280 (382)
Q Consensus 203 --~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el 280 (382)
.+...+|++||+-|.+|..+..+|++++|+.+...+... ......+++.|+.|+....-.++.++|+|..|+-+|+.
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 245689999999999999999999999999984333221 12223445678899988888889999999999999998
Q ss_pred HhCCCCC
Q 016789 281 VTGQEAS 287 (382)
Q Consensus 281 ~tg~~p~ 287 (382)
.-|..++
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8887665
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0063 Score=55.60 Aligned_cols=31 Identities=26% Similarity=0.401 Sum_probs=25.8
Q ss_pred CCceecCCCCCCeeecCCCc-EEEeecCCccc
Q 016789 205 PPLVHKNFKTANVLVDENFI-AKVADTGISKL 235 (382)
Q Consensus 205 ~~ivHrDlk~~Nill~~~~~-~kl~DfGla~~ 235 (382)
+.++|+|+.+.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999997554 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.029 Score=52.07 Aligned_cols=64 Identities=16% Similarity=0.172 Sum_probs=40.5
Q ss_pred cEEEEEECCeeEEEEEccCCchHHHHHHHHHHhcCCCC--CccceeeE------EEeCCeeEEEEeecCCCCh
Q 016789 102 PVYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEIRHR--NLVTLLGY------CQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 102 ~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e~~~~gsL 166 (382)
.||+....+..+++|+.... ......|...+..|... .+.+++.. ...++..+.++||++|.++
T Consensus 11 ~v~~v~t~~g~~~LK~~~~~-~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSGNKCLKKINYP-PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCCCeEEEEcCCC-HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 48988877778899987532 34455566666666322 33444432 2235567899999988554
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.18 Score=47.49 Aligned_cols=69 Identities=13% Similarity=0.143 Sum_probs=43.3
Q ss_pred eeeccCcccEEEEEECC--eeEEEEEccC----------CchHHHHHHHHHHhcCC--CCC-ccceeeEEEeCCeeEEEE
Q 016789 94 LIGFGSFGPVYKGLLRD--TVVAIKRRVG----------SPRQEFVAEVTYLSEIR--HRN-LVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~~--~~vavK~~~~----------~~~~~~~~e~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv~ 158 (382)
.+|.|....||++...+ +.++||.-.. -..++..-|.+.|+... -|. +.+++.+- .....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--TEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--cccceehH
Confidence 47899999999999876 4799986221 11234455777776653 343 44444332 23346899
Q ss_pred eecCCC
Q 016789 159 EYLPNG 164 (382)
Q Consensus 159 e~~~~g 164 (382)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.02 Score=54.81 Aligned_cols=69 Identities=17% Similarity=0.215 Sum_probs=48.0
Q ss_pred CeeeccCcccEEEEEECCeeEEEEEccC------C----chHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEEEe
Q 016789 93 SLIGFGSFGPVYKGLLRDTVVAIKRRVG------S----PRQEFVAEVTYLSEIR---HRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~~~vavK~~~~------~----~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e 159 (382)
+.+|.|....||+....+..++||+-.. . ....-..|.+.|+.+. ..++.+++.++.+. .+++||
T Consensus 38 ~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlvME 115 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIGMR 115 (418)
T ss_pred EEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEEEe
Confidence 4689999999999988777788987441 1 1222334566665553 35788888888843 578899
Q ss_pred ecCC
Q 016789 160 YLPN 163 (382)
Q Consensus 160 ~~~~ 163 (382)
|+++
T Consensus 116 ~L~~ 119 (418)
T PLN02756 116 YLEP 119 (418)
T ss_pred ecCC
Confidence 9976
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.019 Score=53.45 Aligned_cols=30 Identities=20% Similarity=0.164 Sum_probs=27.2
Q ss_pred CCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 205 PPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 205 ~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
.+++|+|+.+.|+|+++++.+.++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 359999999999999999999999998776
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.027 Score=52.14 Aligned_cols=140 Identities=16% Similarity=0.211 Sum_probs=76.7
Q ss_pred ccCcccEEEEEECCeeEEEEEccC-----CchHHHHHHHHHHhcCCC--CCccceeeEEEeCC--eeEEEEeecCCCChh
Q 016789 97 FGSFGPVYKGLLRDTVVAIKRRVG-----SPRQEFVAEVTYLSEIRH--RNLVTLLGYCQQNG--YQMLVFEYLPNGSMC 167 (382)
Q Consensus 97 ~G~~g~V~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~gsL~ 167 (382)
.|..-.+|.....++..++. ... ....+..+|..+|+.+.- .-+...++.|.++. ..+.||+|++|..+.
T Consensus 35 ~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~ 113 (321)
T COG3173 35 GGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVW 113 (321)
T ss_pred CCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceecc
Confidence 34444555555556566665 221 122345567777777642 23455677777665 679999999874322
Q ss_pred hhhh------------------h---cC---C-C-------CCCcC-CHHHHHHHH--------HHHHHHHHHHhcCC--
Q 016789 168 NHLY------------------E---TG---L-E-------SSTKL-EFKQRVSIA--------LGAAKGLCHLHSLK-- 204 (382)
Q Consensus 168 ~~l~------------------~---~~---~-~-------~~~~l-~~~~~~~i~--------~~ia~~L~~LH~~~-- 204 (382)
+.+. . -. . . ...++ .|....+.+ -....-..||+...
T Consensus 114 ~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~ 193 (321)
T COG3173 114 SALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPP 193 (321)
T ss_pred CcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCC
Confidence 2111 0 00 0 0 00000 111111100 01112234554332
Q ss_pred ----CCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 205 ----PPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 205 ----~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
+.++|+|+.+.|++++.+..+=|.||+++..-.
T Consensus 194 ~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 194 WAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred cCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 359999999999999999889999999987543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.0056 Score=59.32 Aligned_cols=162 Identities=18% Similarity=0.286 Sum_probs=89.6
Q ss_pred HHHHHHHHHHhcCCCCCccceeeEEEeC-CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc
Q 016789 124 QEFVAEVTYLSEIRHRNLVTLLGYCQQN-GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202 (382)
Q Consensus 124 ~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~ 202 (382)
...+....+++.+.|+|...++.+.... ....+|+|++ +-||.+.+..+. +... +++ -|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~------l~~~----------s~~--~~- 86 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN------LKDE----------SLL--AH- 86 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc------cchh----------hhc--cc-
Confidence 4566778889999999999999888654 3467899998 668888876542 1100 011 11
Q ss_pred CCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh
Q 016789 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT 282 (382)
Q Consensus 203 ~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t 282 (382)
+ +.|-. + .+++| .++. . | | .+..+|+||||+|.++.|+.-
T Consensus 87 -~--~~~~~-----~-------~~~td-~~~t---~--------------~--~-----~~~~pKsdVwsl~~i~~el~L 126 (725)
T KOG1093|consen 87 -G--VLHLN-----I-------IYITD-HFLT---K--------------Y--P-----SPIGPKSDVWSLGFIILELYL 126 (725)
T ss_pred -c--cceeh-----h-------hhccc-cccc---c--------------C--C-----CCCCcchhhhhHHHHHHHHHH
Confidence 1 33322 2 12333 0000 0 0 0 011249999999999999999
Q ss_pred CCCCCCccCCCChhHHHHHHHhhcCCCc-ccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 016789 283 GQEASHIVSLGSYEALIQWVRSRLSSNN-FVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEI 348 (382)
Q Consensus 283 g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~ 348 (382)
|...+......+ ....+.+....+. ...-.....+.-++...++++.+.|+-..|..||...+
T Consensus 127 ~~~l~~~~~~s~---~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~ 190 (725)
T KOG1093|consen 127 GISLEAELTESE---YLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPME 190 (725)
T ss_pred hhHHHHHHHHHH---HHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhH
Confidence 886543211111 1111111111000 00000000122345677889999999999999986544
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.035 Score=52.12 Aligned_cols=137 Identities=12% Similarity=0.126 Sum_probs=74.2
Q ss_pred eeeccCcccEEEEEECC-----eeEEEEEccCCch--HHHHHHHHHHhcCCCCCcc-ceeeEEEeCCeeEEEEeecCCCC
Q 016789 94 LIGFGSFGPVYKGLLRD-----TVVAIKRRVGSPR--QEFVAEVTYLSEIRHRNLV-TLLGYCQQNGYQMLVFEYLPNGS 165 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~~--~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gs 165 (382)
.+..|=...+|+....+ ..+.+|....... -+-.+|..+++.+..-++. ++++++. .+ +|.+|+++-+
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~~ 96 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINART 96 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCCC
Confidence 45456677888886553 2677776543322 1235788888888654443 4555553 22 5899997665
Q ss_pred hhh-----------------hhhhcCCCCCCcC-CHHHHHHHHHH----------------------HHHHH---H-HHh
Q 016789 166 MCN-----------------HLYETGLESSTKL-EFKQRVSIALG----------------------AAKGL---C-HLH 201 (382)
Q Consensus 166 L~~-----------------~l~~~~~~~~~~l-~~~~~~~i~~~----------------------ia~~L---~-~LH 201 (382)
+.. .+|.......... .|........+ +..-+ . .+.
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~ 176 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD 176 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence 422 1122111111111 12222111111 11111 1 121
Q ss_pred c--CCCCceecCCCCCCeeecC-CCcEEEeecCCcc
Q 016789 202 S--LKPPLVHKNFKTANVLVDE-NFIAKVADTGISK 234 (382)
Q Consensus 202 ~--~~~~ivHrDlk~~Nill~~-~~~~kl~DfGla~ 234 (382)
. .....+|.|+.+.|||+++ ++.++++||..|-
T Consensus 177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1 1123799999999999975 5789999998775
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.096 Score=49.49 Aligned_cols=137 Identities=11% Similarity=0.098 Sum_probs=75.2
Q ss_pred eeeccCcccEEEEEECC------eeEEEEEccCCchH--HHHHHHHHHhcCCCCCcc-ceeeEEEeCCeeEEEEeecCCC
Q 016789 94 LIGFGSFGPVYKGLLRD------TVVAIKRRVGSPRQ--EFVAEVTYLSEIRHRNLV-TLLGYCQQNGYQMLVFEYLPNG 164 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~~------~~vavK~~~~~~~~--~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g 164 (382)
.+-.|-...+|+....+ ..+++|........ +-.+|..++..+..-++. ++++.+..+ .|.||+++.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 45457778899987532 46777765443211 235688888888543443 455555332 589999776
Q ss_pred Chhhh-----------------hhhcCCCCCC-cCCHHHHHHHHHH-----------------HHHHHHHH----hc--C
Q 016789 165 SMCNH-----------------LYETGLESST-KLEFKQRVSIALG-----------------AAKGLCHL----HS--L 203 (382)
Q Consensus 165 sL~~~-----------------l~~~~~~~~~-~l~~~~~~~i~~~-----------------ia~~L~~L----H~--~ 203 (382)
++... +|........ ...+........+ +...+..| .. .
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 65421 2221111111 1112222122111 11112222 11 1
Q ss_pred CCCceecCCCCCCeeecC-CCcEEEeecCCcc
Q 016789 204 KPPLVHKNFKTANVLVDE-NFIAKVADTGISK 234 (382)
Q Consensus 204 ~~~ivHrDlk~~Nill~~-~~~~kl~DfGla~ 234 (382)
...++|+|+++.|||+++ ++.+.++||..+.
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 224899999999999986 4789999998875
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.025 Score=49.18 Aligned_cols=137 Identities=15% Similarity=0.108 Sum_probs=83.9
Q ss_pred eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHH
Q 016789 111 TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQR 186 (382)
Q Consensus 111 ~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~ 186 (382)
.+..+|++... ...-|..+.+++.+++ .|+++..- +....-++.|+|..-.. ....
T Consensus 86 G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i--------------~~~N-- 145 (308)
T PF07387_consen 86 GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI--------------NFSN-- 145 (308)
T ss_pred chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc--------------chhH--
Confidence 34455554432 2235677888888875 46666521 33345578898843210 1111
Q ss_pred HHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCcccccccccCccccccCCCCc
Q 016789 187 VSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSE 266 (382)
Q Consensus 187 ~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 266 (382)
+...=..+|.-.|+..+..+|+|-.|+||+-|..|.+||.|=+.-. ++ +..|..-| ....|.
T Consensus 146 --~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~-----------~V~~vN~~---Y~~lT~ 207 (308)
T PF07387_consen 146 --FITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--EN-----------QVNMVNIE---YESLTQ 207 (308)
T ss_pred --HHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhh--hh-----------eeeEEeee---ccccCh
Confidence 1111135677889766779999999999999999999999976532 00 01133322 223567
Q ss_pred cchhHHHHHHHHHHHhCCC
Q 016789 267 MSDIYSFGVFLLELVTGQE 285 (382)
Q Consensus 267 ~sDvws~G~vl~el~tg~~ 285 (382)
++.+=+|=.-++++.....
T Consensus 208 ~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 208 EAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred HHHHHHHHHHHHHHHHHHh
Confidence 7888888888888777553
|
The function of this family is unknown. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.017 Score=53.13 Aligned_cols=131 Identities=14% Similarity=0.093 Sum_probs=83.7
Q ss_pred CCCCCCeeeccCcccEEEEEEC-CeeEEEEEcc---------CC----------------chHHHHHHHHHHhcCC-CC-
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR-DTVVAIKRRV---------GS----------------PRQEFVAEVTYLSEIR-HR- 139 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~---------~~----------------~~~~~~~e~~~l~~l~-h~- 139 (382)
-++.++.||-|--+.+|.+... +++.++|.-. .. ++-...+|...|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4566788999999999999887 4777777310 00 0112346777777774 22
Q ss_pred CccceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee
Q 016789 140 NLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV 219 (382)
Q Consensus 140 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill 219 (382)
-+.+.+++ +..++|||++.+-.|...-+- .+... +...+..-+.-|...| +||+|..-=||++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v--------~d~~~---ly~~lm~~Iv~la~~G--lIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV--------EDPPT---LYDDLMGLIVRLANHG--LIHGDFNEFNIMV 235 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec--------CChHH---HHHHHHHHHHHHHHcC--ceecccchheeEE
Confidence 23333333 345789999988777654321 11122 2222333344555556 9999999999999
Q ss_pred cCCCcEEEeecCCccc
Q 016789 220 DENFIAKVADTGISKL 235 (382)
Q Consensus 220 ~~~~~~kl~DfGla~~ 235 (382)
+++..++++||--...
T Consensus 236 ~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVS 251 (465)
T ss_pred ecCCCEEEeechHhhc
Confidence 9999999999976543
|
|
| >PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host [] | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.052 Score=32.49 Aligned_cols=30 Identities=17% Similarity=0.194 Sum_probs=12.9
Q ss_pred CCcceehhHHHHHHHHHHHHHHHHHHHHHh
Q 016789 2 SKSIAAVVGGAAGALAFMAIVLGLVWLCKS 31 (382)
Q Consensus 2 s~~~~~iv~~~~~~~~~~~~~~~~~~~~~~ 31 (382)
++++..++++++.++++++++++.+..|+|
T Consensus 2 p~s~IaIIv~V~vg~~iiii~~~~YaCcyk 31 (38)
T PF02439_consen 2 PSSTIAIIVAVVVGMAIIIICMFYYACCYK 31 (38)
T ss_pred CcchhhHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 344444444444444444444333333333
|
This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.10 E-value=2.1 Score=41.00 Aligned_cols=70 Identities=16% Similarity=0.112 Sum_probs=44.8
Q ss_pred CeeeccCcccEEEEEEC--CeeEEEEEccC---------CchHHHHHHHHHHhcCC--CCC-ccceeeEEEeCCeeEEEE
Q 016789 93 SLIGFGSFGPVYKGLLR--DTVVAIKRRVG---------SPRQEFVAEVTYLSEIR--HRN-LVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~--~~~vavK~~~~---------~~~~~~~~e~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv~ 158 (382)
+.||-|.-.-||++.+. ++.++||.-.. -..++..-|.+.|+... -|. +.+++.+-. ....+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~--e~~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS--VMNCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc--HHhhHHH
Confidence 46899999999999975 46788886221 12345556777777663 343 444543333 3346889
Q ss_pred eecCCC
Q 016789 159 EYLPNG 164 (382)
Q Consensus 159 e~~~~g 164 (382)
|+++..
T Consensus 113 EdL~~~ 118 (409)
T PRK12396 113 EDLSDH 118 (409)
T ss_pred HhCccc
Confidence 998643
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.44 Score=44.62 Aligned_cols=136 Identities=19% Similarity=0.219 Sum_probs=80.1
Q ss_pred CcccEEEEEECCeeEEEEEccCC-chHHHHHHHHHHhcCCC---CC---ccceeeE----EEeCCeeEEEEeecCCCChh
Q 016789 99 SFGPVYKGLLRDTVVAIKRRVGS-PRQEFVAEVTYLSEIRH---RN---LVTLLGY----CQQNGYQMLVFEYLPNGSMC 167 (382)
Q Consensus 99 ~~g~V~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h---~n---iv~l~~~----~~~~~~~~lv~e~~~~gsL~ 167 (382)
.-..+|+....+...++|..... ...+...|...|..+.- += +..+=|- .......+-+++|++|..+.
T Consensus 37 ~eN~~f~~~~~~g~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~ 116 (331)
T COG2334 37 EENSNFRVQTEDGRYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLE 116 (331)
T ss_pred ccCceEEEEecCCCeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcC
Confidence 45678999888877788876654 55667778888877731 11 2222221 11112567789999988777
Q ss_pred h-h--------------hhhc--CC-----CCCCcCCHHH-------------HHHHHHHHHHHHHHHhcC--------C
Q 016789 168 N-H--------------LYET--GL-----ESSTKLEFKQ-------------RVSIALGAAKGLCHLHSL--------K 204 (382)
Q Consensus 168 ~-~--------------l~~~--~~-----~~~~~l~~~~-------------~~~i~~~ia~~L~~LH~~--------~ 204 (382)
. . +|.. +. .......|.. ......++...+..+.+. +
T Consensus 117 ~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~ 196 (331)
T COG2334 117 RDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALG 196 (331)
T ss_pred CCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCccc
Confidence 2 1 1111 00 0011222320 012333444455555431 1
Q ss_pred CCceecCCCCCCeeecCCCc-EEEeecCCcc
Q 016789 205 PPLVHKNFKTANVLVDENFI-AKVADTGISK 234 (382)
Q Consensus 205 ~~ivHrDlk~~Nill~~~~~-~kl~DfGla~ 234 (382)
.-+||+|+.|.||+++.+.. +.+.||+.+.
T Consensus 197 ~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 197 DQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred ceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 12899999999999998885 8899999875
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.12 Score=49.21 Aligned_cols=59 Identities=19% Similarity=0.119 Sum_probs=39.3
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeeec
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVD 220 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill~ 220 (382)
..|+=+|+.|-++..++.... .++.....++.-.+.|+.-+-- .+ .+|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~------~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS------QPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhccc------ChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEE
Confidence 356667888888888876432 3444555566555566543321 24 99999999999984
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.12 Score=48.49 Aligned_cols=53 Identities=25% Similarity=0.276 Sum_probs=43.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 181 LEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 181 l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
-.+.+...++.+.+.-+.-+.. +-+.=|||+.-.||||+ +|++-|+||-+++.
T Consensus 318 ~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeeeec
Confidence 4677788888777665555543 45699999999999999 99999999999984
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.36 Score=46.24 Aligned_cols=69 Identities=17% Similarity=0.244 Sum_probs=41.7
Q ss_pred eeeccCcccEEEEEECCe--------eEEEEEccCCchH---HHHHHHHHHhcCCCCCccc-eeeEEEeCCeeEEEEeec
Q 016789 94 LIGFGSFGPVYKGLLRDT--------VVAIKRRVGSPRQ---EFVAEVTYLSEIRHRNLVT-LLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~~~--------~vavK~~~~~~~~---~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~ 161 (382)
.+..|-...+|++...+. .|.+.. ...... +-.+|..+++.+...++.+ +++.+. -++++||+
T Consensus 57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~-~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~efI 131 (383)
T PTZ00384 57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKK-SSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEWV 131 (383)
T ss_pred EeCCcccceEEEEEecCCCCCccccceEEEEe-ccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEEe
Confidence 455677889999876431 133332 222211 2356888999887655554 444443 25999999
Q ss_pred CCCChh
Q 016789 162 PNGSMC 167 (382)
Q Consensus 162 ~~gsL~ 167 (382)
+|-+|.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 887654
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.97 E-value=0.64 Score=43.82 Aligned_cols=134 Identities=19% Similarity=0.179 Sum_probs=81.8
Q ss_pred eeeccCcccEEEEEECC-eeEEEEEccCC-----c--------------------hHH----HHHHHHHHhcCCCCCccc
Q 016789 94 LIGFGSFGPVYKGLLRD-TVVAIKRRVGS-----P--------------------RQE----FVAEVTYLSEIRHRNLVT 143 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~~-~~vavK~~~~~-----~--------------------~~~----~~~e~~~l~~l~h~niv~ 143 (382)
.|..|--+.||.+...+ ..+|||+.+.+ . +.. ...|++-|.+++.-.|.-
T Consensus 151 CiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~ 230 (520)
T KOG2270|consen 151 CISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC 230 (520)
T ss_pred ccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 45667777899987655 56888863211 0 110 235677777776544332
Q ss_pred eeeEEEeCCeeEEEEeecCCCCh-hhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHh-cCCCCceecCCCCCCeeecC
Q 016789 144 LLGYCQQNGYQMLVFEYLPNGSM-CNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH-SLKPPLVHKNFKTANVLVDE 221 (382)
Q Consensus 144 l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~ivHrDlk~~Nill~~ 221 (382)
.--.... ...|||+|+....- .-.|. ...++......+-.+++.-|.-|. .++ +||.||.--|+|+-
T Consensus 231 PePIlLk--~hVLVM~FlGrdgw~aPkLK------d~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 231 PEPILLK--NHVLVMEFLGRDGWAAPKLK------DASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH- 299 (520)
T ss_pred CCceeee--cceEeeeeccCCCCcCcccc------cccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE-
Confidence 2222222 23689999853221 11122 234555555566666776676664 456 99999999999884
Q ss_pred CCcEEEeecCCcccccc
Q 016789 222 NFIAKVADTGISKLLEN 238 (382)
Q Consensus 222 ~~~~kl~DfGla~~~~~ 238 (382)
+|.+.|+|.+-+....+
T Consensus 300 dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred CCEEEEEEccccccCCC
Confidence 67899999988765433
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.81 E-value=5.5 Score=37.23 Aligned_cols=68 Identities=16% Similarity=0.154 Sum_probs=40.1
Q ss_pred cCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCC--CCccce---ee--EEEeCCeeEEEEeecCCCC
Q 016789 98 GSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRH--RNLVTL---LG--YCQQNGYQMLVFEYLPNGS 165 (382)
Q Consensus 98 G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h--~niv~l---~~--~~~~~~~~~lv~e~~~~gs 165 (382)
+.-..||+....+ ..+++|..... .......|.+.+..|.. -.++.. -| ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 4456799988764 56888865432 34556677777776631 112221 12 1223456778999997764
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=93.55 E-value=0.014 Score=35.52 Aligned_cols=30 Identities=10% Similarity=0.218 Sum_probs=14.0
Q ss_pred CcceehhHHHHHHHHHHHHHHHHHHHHHhc
Q 016789 3 KSIAAVVGGAAGALAFMAIVLGLVWLCKSQ 32 (382)
Q Consensus 3 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~ 32 (382)
+++++.+|+++.+.++++++++++++.+||
T Consensus 9 ~~vaIa~~VvVPV~vI~~vl~~~l~~~~rR 38 (40)
T PF08693_consen 9 NTVAIAVGVVVPVGVIIIVLGAFLFFWYRR 38 (40)
T ss_pred ceEEEEEEEEechHHHHHHHHHHhheEEec
Confidence 344555555555555544444444433333
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 382 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-44 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-39 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-29 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-29 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-28 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-26 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-12 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-10 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-04 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 292 bits (751), Expect = 7e-98
Identities = 105/312 (33%), Positives = 161/312 (51%), Gaps = 19/312 (6%)
Query: 55 NRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD-TVV 113
+ A P + + + +LE+AT F LIG G FG VYKG+LRD V
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 114 AIKRRVGSPRQ---EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHL 170
A+KRR Q EF E+ LS RH +LV+L+G+C + +L+++Y+ NG++ HL
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 171 YETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADT 230
Y + L + + ++QR+ I +GAA+GL +LH ++H++ K+ N+L+DENF+ K+ D
Sbjct: 127 YGSDL-PTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDF 183
Query: 231 GISKLLENIEEAGPSHGSIVNV-----FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQE 285
GISK E +H S V V + DPE G +E SD+YSFGV L E++ +
Sbjct: 184 GISKK---GTELDQTHLSTV-VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 286 ASHIVSLGSYEALIQWVRSRLSSNNF---VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRR 342
A L +W ++ VD LA E +R ++C++
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED 299
Query: 343 RPKMEIVMTELE 354
RP M V+ +LE
Sbjct: 300 RPSMGDVLWKLE 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 8e-84
Identities = 110/303 (36%), Positives = 165/303 (54%), Gaps = 20/303 (6%)
Query: 67 PSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSPRQ- 124
P ++FS+ EL+ A+ FS +++G G FG VYKG L D T+VA+KR Q
Sbjct: 10 PEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG 69
Query: 125 ---EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKL 181
+F EV +S HRNL+ L G+C ++LV+ Y+ NGS+ + L E ES L
Sbjct: 70 GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP-ESQPPL 128
Query: 182 EFKQRVSIALGAAKGLCHLH-SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240
++ +R IALG+A+GL +LH P ++H++ K AN+L+DE F A V D G++KL++
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-- 186
Query: 241 EAGPSHGS--IVNVF--RDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYE 296
+H + + PE +G SE +D++ +GV LLEL+TGQ A + L + +
Sbjct: 187 --KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 297 A--LIQWVRSRLSSNNF---VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351
L+ WV+ L VD L G + E + LI++ L C S RPKM V+
Sbjct: 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
Query: 352 ELE 354
LE
Sbjct: 305 MLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 245 bits (629), Expect = 1e-79
Identities = 88/312 (28%), Positives = 145/312 (46%), Gaps = 32/312 (10%)
Query: 66 QPSFGPQGARQFSMEELEQATKQFSE------TSLIGFGSFGPVYKGLLRDTVVAIKR-R 118
FS EL+ T F E + +G G FG VYKG + +T VA+K+
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLA 63
Query: 119 VGSPR------QEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYE 172
Q+F E+ +++ +H NLV LLG+ LV+ Y+PNGS+ + L
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS- 122
Query: 173 TGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI 232
L+ + L + R IA GAA G+ LH +H++ K+AN+L+DE F AK++D G+
Sbjct: 123 -CLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANILLDEAFTAKISDFGL 179
Query: 233 SKLLENIEEAGPSHGS--IVNVF--RDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASH 288
++ E+ + + IV PE G + SDIYSFGV LLE++TG A
Sbjct: 180 ARAS---EKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPA-- 233
Query: 289 IVSLGSYEALIQWVRSRLSSN----NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRP 344
+ + L+ +++D ++ + + + + QC+ +RP
Sbjct: 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 345 KMEIVMTELERI 356
++ V L+ +
Sbjct: 293 DIKKVQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-63
Identities = 68/316 (21%), Positives = 116/316 (36%), Gaps = 37/316 (11%)
Query: 75 RQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAE--VTY 132
E L + + G FG V+K L + VA+K +Q + E V
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYS 71
Query: 133 LSEIRHRNLVTLLGYCQQNGYQ----MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVS 188
L ++H N++ +G ++ L+ + GS+ + L + + + +
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL------KANVVSWNELCH 125
Query: 189 IALGAAKGLCHLHS--------LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240
IA A+GL +LH KP + H++ K+ NVL+ N A +AD G++ E +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 241 EAGPSHGSIVNVFR--DPEVEESGV-----FSEMSDIYSFGVFLLELVTGQEASHIVSLG 293
AG +HG V R PEV E + D+Y+ G+ L EL + A+
Sbjct: 186 SAGDTHG-QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 294 SYEALIQWVRSRLSSNNF---VDHRLA------GTFTTEGMRDLIRLTLQCMSSPGRRRP 344
+ + S + V H+ GM L +C R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 345 KMEIVMTELERIHEKE 360
V + ++
Sbjct: 305 SAGCVGERITQMQRLT 320
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-55
Identities = 79/293 (26%), Positives = 134/293 (45%), Gaps = 34/293 (11%)
Query: 76 QFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDTVVAIKR-----RVGSPRQEFVAEV 130
++++ + IG GSFG V++ + VA+K EF+ EV
Sbjct: 26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREV 85
Query: 131 TYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIA 190
+ +RH N+V +G Q +V EYL GS+ L+++ + +L+ ++R+S+A
Sbjct: 86 AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS--GAREQLDERRRLSMA 143
Query: 191 LGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH-GSI 249
AKG+ +LH+ PP+VH+N K+ N+LVD+ + KV D G+S+L + + S G+
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTP 203
Query: 250 VNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQE------ASHIVSLGSYEALIQWVR 303
+ PEV +E SD+YSFGV L EL T Q+ + +V + R
Sbjct: 204 --EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV----AAVGFKCKR 257
Query: 304 SRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356
+ N + +I C ++ +RP +M L +
Sbjct: 258 LEIPRN-----------LNPQVAAIIE---GCWTNEPWKRPSFATIMDLLRPL 296
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-55
Identities = 61/276 (22%), Positives = 120/276 (43%), Gaps = 33/276 (11%)
Query: 95 IGFGSFGPVYKGLLRDTVVAIKR---RVGSPR--QEFVAEVTYLSEIRHRNLVTLLGYCQ 149
+ G ++KG + + +K R S R ++F E L H N++ +LG CQ
Sbjct: 18 LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77
Query: 150 Q--NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPL 207
+ L+ ++P GS+ N L+E ++ ++ Q V AL A+G+ LH+L+P +
Sbjct: 78 SPPAPHPTLITHWMPYGSLYNVLHE---GTNFVVDQSQAVKFALDMARGMAFLHTLEPLI 134
Query: 208 VHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV---EESGVF 264
+ +V++DE+ A+++ + ++ + PE +
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPA------WVAPEALQKKPEDTN 188
Query: 265 SEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA-GTFTTE 323
+D++SF V L ELVT + L + E ++ L R +
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFA--DLSNMEIGMKVALEGL--------RPTIPPGISP 238
Query: 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359
+ L++ CM+ +RPK ++++ LE++ +K
Sbjct: 239 HVSKLMK---ICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-52
Identities = 75/283 (26%), Positives = 125/283 (44%), Gaps = 36/283 (12%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKR-RVGSPRQEFVAEVTYLSEIRHRNLVTLL 145
K+ ++G G+FG V K R VAIK+ S R+ F+ E+ LS + H N+V L
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLY 67
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
G C LV EY GS+ N L+ G E +S L ++G+ +LHS++P
Sbjct: 68 GACLNPVC--LVMEYAEGGSLYNVLH--GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 206 -PLVHKNFKTANVLVDENF-IAKVADTGISKLLENI--EEAGPSHGSIVNVFRDPEVEES 261
L+H++ K N+L+ + K+ D G + ++ G + + PEV E
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAA------WMAPEVFEG 177
Query: 262 GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWV-----RSRLSSNNFVDHRL 316
+SE D++S+G+ L E++T ++ +G I W R L N
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFD--EIGGPAFRIMWAVHNGTRPPLIKN------- 228
Query: 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359
+ + L+ +C S +RP ME ++ + +
Sbjct: 229 ----LPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 175 bits (444), Expect = 8e-52
Identities = 63/329 (19%), Positives = 112/329 (34%), Gaps = 62/329 (18%)
Query: 76 QFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAE--VTYL 133
+ + E LIG G +G VYKG L + VA+K + RQ F+ E + +
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRV 61
Query: 134 SEIRHRNLVTLLGYCQQNGYQ-----MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVS 188
+ H N+ + ++ +LV EY PNGS+ +L S ++
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL------SLHTSDWVSSCR 115
Query: 189 IALGAAKGLCHLHS-------LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241
+A +GL +LH+ KP + H++ + NVLV + ++D G+S L
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 242 AGPSHGSIVNVFR-------DPEVEESGV-------FSEMSDIYSFGVFLLELVTGQE-- 285
P + PEV E V + D+Y+ G+ E+
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 286 -------------ASHIVSLGSYEALIQWV-----RSRLSSNNFVDHRLAGTFTTEGMRD 327
+ + + ++E + V R + + +R
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS--------LAVRS 287
Query: 328 LIRLTLQCMSSPGRRRPKMEIVMTELERI 356
L C R + + +
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAEL 316
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 7e-50
Identities = 72/300 (24%), Positives = 131/300 (43%), Gaps = 29/300 (9%)
Query: 71 PQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDTVVAIKR-RVGSP----RQE 125
+ + ++ E Q + IG GSFG VYKG V A+K V +P Q
Sbjct: 8 HHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDV-AVKMLNVTAPTPQQLQA 66
Query: 126 FVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQ 185
F EV L + RH N++ +GY +V ++ S+ +HL+ + TK E K+
Sbjct: 67 FKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASE----TKFEMKK 121
Query: 186 RVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPS 245
+ IA A+G+ +LH+ ++H++ K+ N+ + E+ K+ D G++ +
Sbjct: 122 LIDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 246 HGSIVNV-FRDPEV---EESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEAL--I 299
++ + PEV ++S +S SD+Y+FG+ L EL+TGQ Y +
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP--------YSNINNR 231
Query: 300 QWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359
+ + + + + RL +C+ RP ++ E+E + +
Sbjct: 232 DQIIEMVGRGSLSPDLSKVRSNCP--KRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-49
Identities = 75/310 (24%), Positives = 126/310 (40%), Gaps = 46/310 (14%)
Query: 70 GPQGARQFSM-EELEQATKQFSETSLIGFGSFGPVYKG--LLRDTVVAIKR--------- 117
G G +F A + IG G FG V+KG + +VVAIK
Sbjct: 1 GAMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 118 -RVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLE 176
+ QEF EV +S + H N+V L G +V E++P G LY L+
Sbjct: 61 TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGD----LYHRLLD 114
Query: 177 SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-----NFIAKVADTG 231
+ +++ ++ + L A G+ ++ + PP+VH++ ++ N+ + AKVAD G
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 232 ISKLLENI--EEAGPSHGSIVNVFRDPEV--EESGVFSEMSDIYSFGVFLLELVTGQEAS 287
+S+ + G + PE E ++E +D YSF + L ++TG+
Sbjct: 175 LSQQSVHSVSGLLGNFQ------WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228
Query: 288 HIVSLGSYEALIQWVRSRLSSNNFVDHRLA-GTFTTEGMRDLIRLTLQCMSSPGRRRPKM 346
S G I +R R +R++I C S ++RP
Sbjct: 229 DEYSYGKI-KFINMIREE-------GLRPTIPEDCPPRLRNVIE---LCWSGDPKKRPHF 277
Query: 347 EIVMTELERI 356
++ EL +
Sbjct: 278 SYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-48
Identities = 65/287 (22%), Positives = 115/287 (40%), Gaps = 55/287 (19%)
Query: 95 IGFGSFGPVYKGLLRDTVVAIKRRVGSP-------RQEFVAEVTYLSEIRHRNLVTLLGY 147
IG G FG VY+ VA+K P + E + ++H N++ L G
Sbjct: 15 IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKP-P 206
C + LV E+ G + L S ++ V+ A+ A+G+ +LH P
Sbjct: 75 CLKEPNLCLVMEFARGGPLNRVL------SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 207 LVHKNFKTANVLVDE--------NFIAKVADTGISKLLENIE---EAGPSHGSIVNVFRD 255
++H++ K++N+L+ + N I K+ D G+++ AG +
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA------WMA 182
Query: 256 PEVEESGVFSEMSDIYSFGVFLLELVTGQ------EASHIVSLGSYEALIQWVRSRLSSN 309
PEV + +FS+ SD++S+GV L EL+TG+ + + Y + + + S
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA----YGVAMNKLALPIPST 238
Query: 310 NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356
E L+ C + RP ++ +L I
Sbjct: 239 -----------CPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-47
Identities = 56/292 (19%), Positives = 108/292 (36%), Gaps = 53/292 (18%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQ 149
+G G FG K R+T V+ +K + ++ F+ EV + + H N++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 150 QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVH 209
++ + EY+ G++ + ++ + QRVS A A G+ +LHS+ ++H
Sbjct: 78 KDKRLNFITEYIKGGTLRGII----KSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIH 131
Query: 210 KNFKTANVLVDENFIAKVADTGISKLL-ENIEEAGPSHGSIVNVFRD------------P 256
++ + N LV EN VAD G+++L+ + + + P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316
E+ + E D++SFG+ L E++ A
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNA----------------DPDYLPRTMD---- 231
Query: 317 AGTFTTEGMR---------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359
G + +T++C +RP + LE +
Sbjct: 232 FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-46
Identities = 65/325 (20%), Positives = 121/325 (37%), Gaps = 59/325 (18%)
Query: 78 SMEELEQAT--KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAE--VTYL 133
+ L Q T + IG G FG V++G R VA+K + + E +
Sbjct: 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQT 90
Query: 134 SEIRHRNLVTLLGYCQQNGYQ----MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSI 189
+RH N++ + ++ LV +Y +GS+ ++L + + + + +
Sbjct: 91 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKL 144
Query: 190 ALGAAKGLCHLHS------LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243
AL A GL HLH KP + H++ K+ N+LV +N +AD G++ ++
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS----A 200
Query: 244 PSHGSIVN-------------VFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIV 290
I V D + + +DIY+ G+ E+ I
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
Query: 291 ------------SLGSYEALIQWV---RSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQC 335
S S E + + V + R + + +R M ++R +C
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN----IPNRWQSCEALRVMAKIMR---EC 313
Query: 336 MSSPGRRRPKMEIVMTELERIHEKE 360
+ G R + L ++ ++E
Sbjct: 314 WYANGAARLTALRIKKTLSQLSQQE 338
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-46
Identities = 73/322 (22%), Positives = 122/322 (37%), Gaps = 59/322 (18%)
Query: 79 MEELEQAT--KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFV--AEVTYLS 134
+ L Q T KQ IG G +G V+ G R VA+K + + E+
Sbjct: 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTV 86
Query: 135 EIRHRNLVTLLGYCQQNGYQ----MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIA 190
+RH N++ + + L+ +Y NGS+ ++L ST L+ K + +A
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL------KSTTLDAKSMLKLA 140
Query: 191 LGAAKGLCHLHSL------KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP 244
+ GLCHLH+ KP + H++ K+ N+LV +N +AD G++ +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV----KFISDT 196
Query: 245 SHGSIVN-------------VFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVS 291
+ I V + M+D+YSFG+ L E+ + IV
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256
Query: 292 LG------------SYEALIQWV---RSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCM 336
SYE + + V + R S +R + M L+ +C
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPS----FPNRWSSDECLRQMGKLMT---ECW 309
Query: 337 SSPGRRRPKMEIVMTELERIHE 358
+ R V L ++ E
Sbjct: 310 AHNPASRLTALRVKKTLAKMSE 331
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-45
Identities = 59/323 (18%), Positives = 116/323 (35%), Gaps = 44/323 (13%)
Query: 53 EWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDTV 112
E N + + + + ++E + +Q LIG G FG VY G V
Sbjct: 3 EMNLSLLSARSFPRKA----SQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEV 58
Query: 113 VAIKR-RVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMC 167
AI+ + + F EV + RH N+V +G C + ++ ++
Sbjct: 59 -AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117
Query: 168 NHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKV 227
+ + + L+ + IA KG+ +LH+ ++HK+ K+ NV D + +
Sbjct: 118 SVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYDNGKV-VI 170
Query: 228 ADTGISKLLENIEEAGPS------HGS-------IVNVFRDPEVEESGVFSEMSDIYSFG 274
D G+ + ++ +G I+ E+ FS+ SD+++ G
Sbjct: 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230
Query: 275 VFLLELVTGQEA-SHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTL 333
EL + + + ++ LS + + D++
Sbjct: 231 TIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIG----------MGKEISDILL--- 277
Query: 334 QCMSSPGRRRPKMEIVMTELERI 356
C + RP +M LE++
Sbjct: 278 FCWAFEQEERPTFTKLMDMLEKL 300
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-45
Identities = 58/307 (18%), Positives = 117/307 (38%), Gaps = 49/307 (15%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAE--VTYLSEIRHRNLVT 143
+ + +G G +G V++G + VA+K + + E + +RH N++
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILG 66
Query: 144 LLGYCQQNGYQ----MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCH 199
+ + + L+ Y GS+ ++L T L+ + I L A GL H
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIASGLAH 120
Query: 200 LHSL------KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG--PSHGSIVN 251
LH KP + H++ K+ N+LV +N +AD G++ + ++ +
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 252 -------VFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIV------------SL 292
V + + + DI++FG+ L E+ ++ IV +
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 293 GSYEALIQWV---RSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIV 349
S+E + + V + R + + +R T + L++ +C R +
Sbjct: 241 PSFEDMRKVVCVDQQRPN----IPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRI 293
Query: 350 MTELERI 356
L +I
Sbjct: 294 KKTLTKI 300
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 75/284 (26%), Positives = 119/284 (41%), Gaps = 49/284 (17%)
Query: 95 IGFGSFGPVYKGLLRDTVVAIKR-RVGSPRQEFVAEVTYLSEIRHRNLVTLLGYC-QQNG 152
IG G FG V G R VA+K + + Q F+AE + ++++RH NLV LLG ++ G
Sbjct: 29 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88
Query: 153 YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNF 212
+V EY+ GS+ ++L G + L + +L + + +L VH++
Sbjct: 89 GLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDL 143
Query: 213 KTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--DPEVEESGVFSEMSDI 270
NVLV E+ +AKV+D G++K E + + V + PE FS SD+
Sbjct: 144 AARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPV-KWTAPEALREKKFSTKSDV 197
Query: 271 YSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGTFTTEGMR-- 326
+SFG+ L E I S G Y + V R+ +G +
Sbjct: 198 WSFGILLWE---------IYSFGRVPYPRI---------PLKDVVPRV-----EKGYKMD 234
Query: 327 -------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMAL 363
+ + C RP + +LE I E+ L
Sbjct: 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHELHL 278
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-36
Identities = 68/282 (24%), Positives = 124/282 (43%), Gaps = 47/282 (16%)
Query: 95 IGFGSFGPVYKGLLRDTV-VAIKR-RVGSP-RQEFVAEVTYLSEIRHRNLVTLLGYCQQN 151
+G G FG V G + VA+K + GS EF E + ++ H LV G C +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKN 211
+V EY+ NG + N+L G LE Q + + +G+ L S + +H++
Sbjct: 76 YPIYIVTEYISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRD 129
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--DPEVEESGVFSEMSD 269
N LVD + KV+D G+++ + + ++ S G+ V + PEV +S SD
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPV-KWSAPEVFHYFKYSSKSD 187
Query: 270 IYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGTFTTEGMR- 326
+++FG+ + E + SLG Y+ +N+ V ++ ++G R
Sbjct: 188 VWAFGILMWE---------VFSLGKMPYDLY---------TNSEVVLKV-----SQGHRL 224
Query: 327 --------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360
+ ++ C +RP + +++ +E + EK+
Sbjct: 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 70/320 (21%), Positives = 132/320 (41%), Gaps = 41/320 (12%)
Query: 67 PSFGPQGARQFSMEELEQATKQFSETSL-----IGFGSFGPVYKGLLR------DTVVAI 115
+ QGA + E+ + QF E L +G G+FG V VVA+
Sbjct: 18 ENLYFQGAMGSAFEDRDP--TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAV 75
Query: 116 K---RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQ--MLVFEYLPNGSMCNHL 170
K ++F E+ L ++H N+V G C G + L+ EYLP GS+ ++L
Sbjct: 76 KKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 135
Query: 171 YETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADT 230
+ +++ + + KG+ +L + + +H++ T N+LV+ K+ D
Sbjct: 136 ----QKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDF 189
Query: 231 GISKLL-ENIEEAGPSHGSIVNVF-RDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASH 288
G++K+L ++ E +F PE FS SD++SFGV L EL T E S
Sbjct: 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249
Query: 289 IVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMR---------DLIRLTLQCMSSP 339
+ + ++ + ++ R ++ + +C ++
Sbjct: 250 SPPAEFMRMIGNDKQGQMIVFHLIE------LLKNNGRLPRPDGCPDEIYMIMTECWNNN 303
Query: 340 GRRRPKMEIVMTELERIHEK 359
+RP + +++I ++
Sbjct: 304 VNQRPSFRDLALRVDQIRDQ 323
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 5e-36
Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 9/192 (4%)
Query: 95 IGFGSFGPVYKGLLR--DTVVAIK--RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQ 150
+G G +G VY+G+ + VA+K + +EF+ E + EI+H NLV LLG C +
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 151 NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHK 210
++ E++ G++ ++L E ++ + +A + + +L +H+
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN--FIHR 342
Query: 211 NFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDI 270
N N LV EN + KVAD G+S+L+ + + PE FS SD+
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 271 YSFGVFLLELVT 282
++FGV L E+ T
Sbjct: 403 WAFGVLLWEIAT 414
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-36
Identities = 78/285 (27%), Positives = 120/285 (42%), Gaps = 49/285 (17%)
Query: 95 IGFGSFGPVYKGLLR--DTVVAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYC 148
IG G+FG V+ G LR +T+VA+K R P + +F+ E L + H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 149 QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLV 208
Q +V E + G L G +L K + + AA G+ +L S +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESKC--CI 235
Query: 209 HKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--DPEVEESGVFSE 266
H++ N LV E + K++D G+S+ + A V V + PE G +S
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV-KWTAPEALNYGRYSS 294
Query: 267 MSDIYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGTFTTEG 324
SD++SFG+ L E SLG+ Y L SN + +G
Sbjct: 295 ESDVWSFGILLWE---------TFSLGASPYPNL---------SNQQTREFV-----EKG 331
Query: 325 MR---------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360
R + RL QC + +RP + EL+ I ++
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-36
Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 47/282 (16%)
Query: 95 IGFGSFGPVYKGLLRDTV-VAIKR-RVGSP-RQEFVAEVTYLSEIRHRNLVTLLGYCQQN 151
+G G FG V G R VAIK + GS EF+ E + + H LV L G C +
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKN 211
++ EY+ NG + N+L E + + +Q + + + + +L S + +H++
Sbjct: 92 RPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRD 145
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--DPEVEESGVFSEMSD 269
N LV++ + KV+D G+S+ + + +E S GS V R PEV FS SD
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSD 203
Query: 270 IYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGTFTTEGMR- 326
I++FGV + E I SLG YE +N+ + +G+R
Sbjct: 204 IWAFGVLMWE---------IYSLGKMPYERF---------TNSETAEHI-----AQGLRL 240
Query: 327 --------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360
+ + C RP +I+++ + + ++E
Sbjct: 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 66/299 (22%), Positives = 122/299 (40%), Gaps = 39/299 (13%)
Query: 88 QFSETSL-----IGFGSFGPVYKGLLR------DTVVAIK---RRVGSPRQEFVAEVTYL 133
QF E L +G G+FG V VVA+K ++F E+ L
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 134 SEIRHRNLVTLLGYCQQNGYQ--MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIAL 191
++H N+V G C G + L+ EYLP GS+ ++L + +++ + +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTS 121
Query: 192 GAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE-NIEEAGPSHGSIV 250
KG+ +L + + +H++ T N+LV+ K+ D G++K+L + E
Sbjct: 122 QICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 251 NVF-RDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN 309
+F PE FS SD++SFGV L EL T E S + + ++
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 310 NFVDHRLAGTFTTEGMR---------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359
+ ++ R ++ + +C ++ +RP + +++I +
Sbjct: 240 HLIE------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-35
Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 47/283 (16%)
Query: 95 IGFGSFGPVYKGLLRDTV-VAIKR-RVGSP-RQEFVAEVTYLSEIRHRNLVTLLGYCQQN 151
IG G FG V+ G + VAIK R G+ ++F+ E + ++ H LV L G C +
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKN 211
LV E++ +G + ++L + + + L +G+ +L ++H++
Sbjct: 76 APICLVTEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRD 129
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--DPEVEESGVFSEMSD 269
N LV EN + KV+D G+++ + + ++ S G+ V + PEV +S SD
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPV-KWASPEVFSFSRYSSKSD 187
Query: 270 IYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGTFTTEGMR- 326
++SFGV + E + S G YE SN+ V + + G R
Sbjct: 188 VWSFGVLMWE---------VFSEGKIPYENR---------SNSEVVEDI-----STGFRL 224
Query: 327 --------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEM 361
+ ++ C RP ++ +L I E +
Sbjct: 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-35
Identities = 60/191 (31%), Positives = 94/191 (49%), Gaps = 9/191 (4%)
Query: 95 IGFGSFGPVYKGLLRDTV-VAIK--RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQN 151
+G G FG V+ G T VAIK + + F+ E + ++RH LV L +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKN 211
+V EY+ GS+ + L E+ L Q V +A A G+ ++ + VH++
Sbjct: 252 PI-YIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRD 305
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIY 271
+ AN+LV EN + KVAD G+++L+E+ E + PE G F+ SD++
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 272 SFGVFLLELVT 282
SFG+ L EL T
Sbjct: 366 SFGILLTELTT 376
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 77/309 (24%), Positives = 123/309 (39%), Gaps = 49/309 (15%)
Query: 70 GPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDTVVAIKR-RVGSPRQEFVA 128
+F K+ IG G FG V G R VA+K + + Q F+A
Sbjct: 176 TVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLA 235
Query: 129 EVTYLSEIRHRNLVTLLGYC-QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRV 187
E + ++++RH NLV LLG ++ G +V EY+ GS+ ++L G + L +
Sbjct: 236 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLL 292
Query: 188 SIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHG 247
+L + + +L VH++ NVLV E+ +AKV+D G++K E +
Sbjct: 293 KFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDT 345
Query: 248 SIVNVFR--DPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVR 303
+ V + PE FS SD++SFG+ L E I S G Y +
Sbjct: 346 GKLPV-KWTAPEALREKKFSTKSDVWSFGILLWE---------IYSFGRVPYPRI----- 390
Query: 304 SRLSSNNFVDHRLAGTFTTEGMR---------DLIRLTLQCMSSPGRRRPKMEIVMTELE 354
V R+ +G + + + C RP + +LE
Sbjct: 391 ----PLKDVVPRV-----EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441
Query: 355 RIHEKEMAL 363
I E+ L
Sbjct: 442 HIRTHELHL 450
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 60/191 (31%), Positives = 94/191 (49%), Gaps = 9/191 (4%)
Query: 95 IGFGSFGPVYKGLLRDTV-VAIK--RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQN 151
+G G FG V+ G T VAIK + + F+ E + ++RH LV L +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKN 211
+V EY+ GS+ + L E+ L Q V +A A G+ ++ + VH++
Sbjct: 335 PI-YIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRD 388
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIY 271
+ AN+LV EN + KVAD G+++L+E+ E + PE G F+ SD++
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 272 SFGVFLLELVT 282
SFG+ L EL T
Sbjct: 449 SFGILLTELTT 459
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 63/281 (22%), Positives = 112/281 (39%), Gaps = 43/281 (15%)
Query: 95 IGFGSFGPVYKGLLRD--TVVAIKR-RVGSP-RQEFVAEVTYLSEIRHRNLVTLLGYCQQ 150
+G G +G VY+G+ + VA+K + + +EF+ E + EI+H NLV LLG C +
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 151 NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHK 210
++ E++ G++ ++L E ++ + +A + + +L +H+
Sbjct: 81 EPPFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN--FIHR 135
Query: 211 NFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDI 270
+ N LV EN + KVAD G+S+L+ + + PE FS SD+
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 271 YSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGTFTTEGMR-- 326
++FGV L E I + G Y + + V L + R
Sbjct: 196 WAFGVLLWE---------IATYGMSPYPGI---------DLSQVYELL-----EKDYRME 232
Query: 327 -------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360
+ L C RP + E + ++
Sbjct: 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-34
Identities = 79/299 (26%), Positives = 135/299 (45%), Gaps = 54/299 (18%)
Query: 95 IGFGSFGPVYKGLLRDTV------VAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVTL 144
IG G FG VYKG+L+ + VAIK + G R +F+ E + + H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
G + M++ EY+ NG++ L E + Q V + G A G+ +L ++
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG-PSHGSIVNVFR--DPEVEES 261
VH++ N+LV+ N + KV+D G+S++LE+ EA + G + + R PE
Sbjct: 168 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI-RWTAPEAISY 224
Query: 262 GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGT 319
F+ SD++SFG+ + E +++ G Y L SN+ V +
Sbjct: 225 RKFTSASDVWSFGIVMWE---------VMTYGERPYWEL---------SNHEVMKAI--- 263
Query: 320 FTTEGMR---------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFMGE 369
+G R + +L +QC RRPK +++ L+++ +L T
Sbjct: 264 --NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 320
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-34
Identities = 49/232 (21%), Positives = 98/232 (42%), Gaps = 9/232 (3%)
Query: 54 WNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDTV- 112
G P + + + + E + +G G FG V+
Sbjct: 155 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK 214
Query: 113 VAIK--RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHL 170
VA+K + + F+AE + ++H LV L + ++ E++ GS+ + L
Sbjct: 215 VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFL 273
Query: 171 YETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADT 230
+K + + + A+G+ + +H++ + AN+LV + + K+AD
Sbjct: 274 KSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADF 328
Query: 231 GISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT 282
G+++++E+ E + PE G F+ SD++SFG+ L+E+VT
Sbjct: 329 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 9e-34
Identities = 66/289 (22%), Positives = 115/289 (39%), Gaps = 37/289 (12%)
Query: 95 IGFGSFGPVYKGLLR------DTVVAIKR-RVGSP--RQEFVAEVTYLSEIRHRNLVTLL 145
+G G+FG V +VA+K+ + P +++F E+ L + +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 146 GYCQQNGYQ--MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
G G Q LV EYLP+G + + L +L+ + + + KG+ +L S
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLE-NIEEAGPSHGSIVNVF-RDPEVEES 261
+ VH++ N+LV+ K+AD G++KLL + + +F PE
Sbjct: 147 R--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 262 GVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320
+FS SD++SFGV L EL T + S +++R +
Sbjct: 205 NIFSRQSDVWSFGVVLYELFTYCDK--------SCSPSAEFLRMMGCERDVPALSRLLEL 256
Query: 321 TTEGMR---------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360
EG R ++ L C + + RP + +L+ +
Sbjct: 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 95 IGFGSFGPVYKGLLR------DTVVAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVTL 144
+G G FG V VA+K + S + E+ L + H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 145 LGYCQQNGYQ--MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
G C ++G L+ E+LP+GS+ +L ++ K+ KQ++ A+ KG+ +L S
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE-NIEEAGPSHGSIVNVF-RDPEVEE 260
+ VH++ NVLV+ K+ D G++K +E + E VF PE
Sbjct: 145 RQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202
Query: 261 SGVFSEMSDIYSFGVFLLELVT 282
F SD++SFGV L EL+T
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 13/193 (6%)
Query: 95 IGFGSFGPVYKGLLRDTV-VAIK--RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQN 151
+G G FG V+ G VA+K ++ F+AE + +++H+ LV L Q
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKN 211
++ EY+ NGS+ + L KL + + +A A+G+ + +H++
Sbjct: 81 PI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRD 134
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--DPEVEESGVFSEMSD 269
+ AN+LV + K+AD G+++L+E+ E + PE G F+ SD
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIKSD 192
Query: 270 IYSFGVFLLELVT 282
++SFG+ L E+VT
Sbjct: 193 VWSFGILLTEIVT 205
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 64/288 (22%), Positives = 122/288 (42%), Gaps = 56/288 (19%)
Query: 95 IGFGSFGPVYKGLLRD------TVVAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVTL 144
+G G+FG VYKGL VAIK R + +E + E ++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
LG C + L+ + +P G + +++ E + + ++ + AKG+ +L +
Sbjct: 83 LGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--DPEVEESG 262
LVH++ NVLV K+ D G++KLL E+ + G V + + E
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMALESILHR 194
Query: 263 VFSEMSDIYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGTF 320
+++ SD++S+GV + E +++ GS Y+ + + + L
Sbjct: 195 IYTHQSDVWSYGVTVWE---------LMTFGSKPYDGI---------PASEISSIL---- 232
Query: 321 TTEGMR---------DLIRLTLQC-MSSPGRRRPKMEIVMTELERIHE 358
+G R D+ + +C M RPK ++ E ++
Sbjct: 233 -EKGERLPQPPICTIDVYMIMRKCWMIDA-DSRPKFRELIIEFSKMAR 278
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 77/300 (25%), Positives = 132/300 (44%), Gaps = 53/300 (17%)
Query: 95 IGFGSFGPVYKGLL-----RDTVVAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVTLL 145
+G G FG V G L ++ VAIK +VG R++F+ E + + + H N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
G ++ M+V EY+ NGS+ + L + + Q V + G A G+ +L +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMKYLSDMG- 167
Query: 206 PLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE-AGPSHGSIVNVFR--DPEVEESG 262
VH++ N+L++ N + KV+D G+ ++LE+ E A + G + + R PE
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI-RWTSPEAIAYR 225
Query: 263 VFSEMSDIYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGTF 320
F+ SD++S+G+ L E ++S G Y + SN V +
Sbjct: 226 KFTSASDVWSYGIVLWE---------VMSYGERPYWEM---------SNQDVIKAV---- 263
Query: 321 TTEGMR---------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFMGEGT 371
EG R L +L L C RPK E +++ L+++ +L
Sbjct: 264 -DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAA 322
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-33
Identities = 67/291 (23%), Positives = 110/291 (37%), Gaps = 42/291 (14%)
Query: 95 IGFGSFGPVYKGLLRD------TVVAIK--RRVGSP--RQEFVAEVTYLSEIRHRNLVTL 144
+G G FG V +VA+K + P R + E+ L + H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 145 LGYCQQNGYQ--MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
G C+ G LV EY+P GS+ ++L + Q + A +G+ +LH+
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLL-ENIEEAGPSHGSIVNVF-RDPEVEE 260
+H++ NVL+D + + K+ D G++K + E E VF PE +
Sbjct: 153 QH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210
Query: 261 SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320
F SD++SFGV L EL+T L +
Sbjct: 211 EYKFYYASDVWSFGVTLYELLT---------HCDSSQSPPTKFLELIGIAQGQMTVLRLT 261
Query: 321 T--TEGMR---------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360
G R ++ L C + RP E ++ L+ +HEK
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 95 IGFGSFGPVYKGLLRD-------TVVAIKR-RVGS--PRQEFVAEVTYLSEIRHRNLVTL 144
+G G+FG V+ + +VA+K + + R++F E L+ ++H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHL-----------YETGLESSTKLEFKQRVSIALGA 193
G C ++VFEY+ +G + L ++ +L Q + IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 194 AKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF 253
A G+ +L S VH++ T N LV N + K+ D G+S+ + + + +++ +
Sbjct: 143 ASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI- 199
Query: 254 R--DPEVEESGVFSEMSDIYSFGVFLLELVT 282
R PE F+ SD++SFGV L E+ T
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 69/316 (21%), Positives = 127/316 (40%), Gaps = 55/316 (17%)
Query: 68 SFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKR-RVGS 121
+ P+ + + ++ +IG G FG VY G L D A+K +
Sbjct: 6 ALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 65
Query: 122 P---RQEFVAEVTYLSEIRHRNLVTLLGYC-QQNGYQMLVFEYLPNGSMCNHLYETGLES 177
+F+ E + + H N+++LLG C + G ++V Y+ +G + N +
Sbjct: 66 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNE 121
Query: 178 STKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237
+ K + L AKG+ +L S K VH++ N ++DE F KVAD G+++ +
Sbjct: 122 THNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179
Query: 238 NIE--EAGPSHGSIVNVFR--DPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLG 293
+ E G+ + V + E ++ F+ SD++SFGV L E +++ G
Sbjct: 180 DKEYYSVHNKTGAKLPV-KWMALESLQTQKFTTKSDVWSFGVLLWE---------LMTRG 229
Query: 294 S--YEALIQWVRSRLSSNNFVDHRLAGTFTTEGMR---------DLIRLTLQCMSSPGRR 342
+ Y + + + L +G R L + L+C
Sbjct: 230 APPYPDV---------NTFDITVYL-----LQGRRLLQPEYCPDPLYEVMLKCWHPKAEM 275
Query: 343 RPKMEIVMTELERIHE 358
RP +++ + I
Sbjct: 276 RPSFSELVSRISAIFS 291
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 53/294 (18%)
Query: 95 IGFGSFGPVYKGLLR-----DTVVAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVTLL 145
IG G G V G LR D VAIK + G R++F++E + + + H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
G + M+V EY+ NGS+ L + Q V + G G+ +L L
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGMLRGVGAGMRYLSDLG- 171
Query: 206 PLVHKNFKTANVLVDENFIAKVADTGISKLLE-NIEEAGPSHGSIVNVFR--DPEVEESG 262
VH++ NVLVD N + KV+D G+S++LE + + A + G + + R PE
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI-RWTAPEAIAFR 229
Query: 263 VFSEMSDIYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGTF 320
FS SD++SFGV + E +++ G Y + +N V +
Sbjct: 230 TFSSASDVWSFGVVMWE---------VLAYGERPYWNM---------TNRDVISSV---- 267
Query: 321 TTEGMR---------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTT 365
EG R L +L L C +RP+ +++ L+ + +L
Sbjct: 268 -EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRA 320
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 19/201 (9%)
Query: 95 IGFGSFGPVYKGLLRD-----TVVAIK--RRVGSP--RQEFVAEVTYLSEIRHRNLVTLL 145
IG G FG VY G D AIK R+ + F+ E + + H N++ L+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 146 GYC-QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
G G ++ Y+ +G + + K +S L A+G+ +L K
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FR--DPEVEES 261
VH++ N ++DE+F KVAD G+++ + + E + + E ++
Sbjct: 145 --FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 262 GVFSEMSDIYSFGVFLLELVT 282
F+ SD++SFGV L EL+T
Sbjct: 203 YRFTTKSDVWSFGVLLWELLT 223
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 28/211 (13%)
Query: 94 LIGFGSFGPVYKGLLRD----TVVAIKR-RVGSP---RQEFVAEVTYLSEI-RHRNLVTL 144
+IG G+FG V K ++ AIKR + + ++F E+ L ++ H N++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHL-----------YETGLESSTKLEFKQRVSIALGA 193
LG C+ GY L EY P+G++ + L + +++ L +Q + A
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 194 AKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF 253
A+G+ +L + +H++ N+LV EN++AK+AD G+S+ E + V
Sbjct: 152 ARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV- 205
Query: 254 R--DPEVEESGVFSEMSDIYSFGVFLLELVT 282
R E V++ SD++S+GV L E+V+
Sbjct: 206 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 47/206 (22%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 95 IGFGSFGPVYKGLLRD-----TVVAIK--RRVGSP---RQEFVAEVTYLSEIRHRNLVTL 144
+G G FG V +G L+ VA+K + S +EF++E + + H N++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 145 LGYCQQNGYQ-----MLVFEYLPNGSMCNHLYETGLESS-TKLEFKQRVSIALGAAKGLC 198
LG C + Q M++ ++ G + +L + LE+ + + + + A G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--DP 256
+L + +H++ N ++ ++ VAD G+SK + + + + + V +
Sbjct: 162 YLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV-KWIAI 218
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVT 282
E V++ SD+++FGV + E+ T
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 95 IGFGSFGPVYKGLLRD-------TVVAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVT 143
+G FG VYKG L VAIK + + R+EF E + ++H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHL-----------YETGLESSTKLEFKQRVSIALG 192
LLG ++ ++F Y +G + L + + LE V +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 193 AAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV 252
A G+ +L S +VHK+ T NVLV + K++D G+ + + + S++ +
Sbjct: 137 IAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 194
Query: 253 FR--DPEVEESGVFSEMSDIYSFGVFLLELVT 282
R PE G FS SDI+S+GV L E+ +
Sbjct: 195 -RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 50/286 (17%)
Query: 95 IGFGSFGPVYKGLLRD-----TVVAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVTLL 145
IG G FG V++G+ VAIK + + R++F+ E + + H ++V L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
G +N ++ E G + + L L+ + A + L +L S +
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFL----QVRKFSLDLASLILYAYQLSTALAYLESKR- 511
Query: 206 PLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFS 265
VH++ NVLV N K+ D G+S+ +E+ S G + + PE F+
Sbjct: 512 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 266 EMSDIYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGTFTTE 323
SD++ FGV + E I+ G ++ + NN V R+
Sbjct: 571 SASDVWMFGVCMWE---------ILMHGVKPFQGV---------KNNDVIGRI-----EN 607
Query: 324 GMR---------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360
G R L L +C + RRP+ + +L I E+E
Sbjct: 608 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 95 IGFGSFGPVYKGLLRD-------TVVAIKR-RVGSP--RQEFVAEVTYLSEIRHRNLVTL 144
+G G+FG V+ + +VA+K + S RQ+F E L+ ++H+++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHL----------YETGLESSTKLEFKQRVSIALGAA 194
G C + ++VFEY+ +G + L + L Q +++A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 195 KGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR 254
G+ +L L VH++ T N LV + + K+ D G+S+ + + + +++ + R
Sbjct: 169 AGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI-R 225
Query: 255 --DPEVEESGVFSEMSDIYSFGVFLLELVT 282
PE F+ SD++SFGV L E+ T
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-32
Identities = 61/288 (21%), Positives = 118/288 (40%), Gaps = 54/288 (18%)
Query: 95 IGFGSFGPVYKGLLRD-----TVVAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVTLL 145
+G G FG VY+G+ + VA+K + +++F++E + + H ++V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
G ++ ++ E P G + ++L + L+ V +L K + +L S+
Sbjct: 80 GIIEEEPT-WIIMELYPYGELGHYL----ERNKNSLKVLTLVLYSLQICKAMAYLESIN- 133
Query: 206 PLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--DPEVEESGV 263
VH++ N+LV K+ D G+S+ +E+ E+ + + + + + PE
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLSRYIED-EDYYKASVTRLPI-KWMSPESINFRR 190
Query: 264 FSEMSDIYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGTFT 321
F+ SD++ F V + E I+S G + L N V L
Sbjct: 191 FTTASDVWMFAVCMWE---------ILSFGKQPFFWL---------ENKDVIGVL----- 227
Query: 322 TEGMR---------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360
+G R L L +C RP+ ++ L +++ E
Sbjct: 228 EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-32
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 86 TKQFSETSL-----IGFGSFGPVYKGLLRD------TVVAIK--RRVGSP--RQEFVAEV 130
+ F ET L +G G FG V+KG+ V IK Q +
Sbjct: 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHM 66
Query: 131 TYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIA 190
+ + H ++V LLG C + LV +YLP GS+ +H+ + L + ++
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHV----RQHRGALGPQLLLNWG 121
Query: 191 LGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIV 250
+ AKG+ +L +VH+N NVL+ +VAD G++ LL ++ +
Sbjct: 122 VQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179
Query: 251 NV-FRDPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ + E G ++ SD++S+GV + EL+T
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-32
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 95 IGFGSFGPVYKGLLRD-------TVVAIK--RRVGSP--RQEFVAEVTYLSEIRHRNLVT 143
+G GSFG VY+G+ + T VAIK S R EF+ E + + E ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHL-----YETGLESSTKLEFKQRVSIALGAAKGLC 198
LLG Q +++ E + G + ++L + + +A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--DP 256
+L++ K VH++ N +V E+F K+ D G+++ + + ++ V R P
Sbjct: 153 YLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RWMSP 209
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVT 282
E + GVF+ SD++SFGV L E+ T
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-32
Identities = 65/308 (21%), Positives = 128/308 (41%), Gaps = 54/308 (17%)
Query: 95 IGFGSFGPVYKGLLRD------TVVAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVTL 144
+G G+FG VYKGL VAIK R + +E + E ++ + + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
LG C + L+ + +P G + +++ E + + ++ + AKG+ +L +
Sbjct: 83 LGICLTSTV-QLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPEVEESGV 263
LVH++ NVLV K+ D G++KLL E+ + G V + + E +
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 264 FSEMSDIYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGTFT 321
++ SD++S+GV + E +++ GS Y+ + + + L
Sbjct: 196 YTHQSDVWSYGVTVWE---------LMTFGSKPYDGI---------PASEISSIL----- 232
Query: 322 TEGMR---------DLIRLTLQC-MSSPGRRRPKMEIVMTELERIHEKEMALTTFMGEGT 371
+G R D+ + ++C M RPK ++ E ++ G+
Sbjct: 233 EKGERLPQPPICTIDVYMIMVKCWMIDA-DSRPKFRELIIEFSKMARDPQRYLVIQGDER 291
Query: 372 ATIALGSE 379
+ ++
Sbjct: 292 MHLPSPTD 299
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 50/286 (17%)
Query: 95 IGFGSFGPVYKGLLRD-----TVVAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVTLL 145
IG G FG V++G+ VAIK + + R++F+ E + + H ++V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
G +N ++ E G + + L L+ + A + L +L S +
Sbjct: 83 GVITENPV-WIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTALAYLESKR- 136
Query: 206 PLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFS 265
VH++ NVLV N K+ D G+S+ +E+ S G + + PE F+
Sbjct: 137 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 266 EMSDIYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGTFTTE 323
SD++ FGV + E I+ G ++ + NN V R+
Sbjct: 196 SASDVWMFGVCMWE---------ILMHGVKPFQGV---------KNNDVIGRI-----EN 232
Query: 324 GMR---------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360
G R L L +C + RRP+ + +L I E+E
Sbjct: 233 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 62/303 (20%), Positives = 118/303 (38%), Gaps = 56/303 (18%)
Query: 95 IGFGSFGPVYKGLLRD-----TVVAIKR-RVGSP----RQEFVAEVTYLSEIRHRNLVTL 144
+G G FG V + L+ VA+K + +EF+ E + E H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 145 LGYCQQNG------YQMLVFEYLPNGSMCNHL-YETGLESSTKLEFKQRVSIALGAAKGL 197
+G ++ M++ ++ +G + L E+ L + V + A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--D 255
+L S +H++ N ++ E+ VAD G+S+ + + + S + V +
Sbjct: 151 EYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV-KWLA 207
Query: 256 PEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVD 313
E +++ SD+++FGV + E I++ G Y + N +
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWE---------IMTRGQTPYAGI---------ENAEIY 249
Query: 314 HRLAGTFTTEGMR---------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALT 364
+ L G R ++ L QC S+ ++RP + ELE I L+
Sbjct: 250 NYL-----IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304
Query: 365 TFM 367
T
Sbjct: 305 TSQ 307
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 70/355 (19%), Positives = 133/355 (37%), Gaps = 54/355 (15%)
Query: 30 KSQSKNYQNKNSETGSSDPSALVEWNRGAGPSSATGQP-SFGPQGARQFSMEELEQATKQ 88
+ + S A E G ++ + P+ + + ++
Sbjct: 31 SPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLI 90
Query: 89 FSETSLIGFGSFGPVYKGLLRD-----TVVAIKR-RVGSP---RQEFVAEVTYLSEIRHR 139
+IG G FG VY G L D A+K + +F+ E + + H
Sbjct: 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 150
Query: 140 NLVTLLGYCQQNGYQ-MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLC 198
N+++LLG C ++ ++V Y+ +G + N + + K + L AKG+
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQVAKGMK 206
Query: 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FR--D 255
L S K VH++ N ++DE F KVAD G+++ + + E + + + +
Sbjct: 207 FLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 256 PEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVD 313
E ++ F+ SD++SFGV L E +++ G+ Y + + +
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWE---------LMTRGAPPYPDV---------NTFDIT 306
Query: 314 HRLAGTFTTEGMR---------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359
L +G R L + L+C RP +++ + I
Sbjct: 307 VYL-----LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 56/305 (18%), Positives = 102/305 (33%), Gaps = 80/305 (26%)
Query: 95 IGFGSFGPVYKGLLRD---------TVVAIKR-RVGSP--RQEFVAEVTYLSEIRHRNLV 142
+G G+F ++KG+ R+ T V +K + F + +S++ H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 143 TLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
G C +LV E++ GS+ +L + + ++ +A A + L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEE 131
Query: 203 LKPPLVHKNFKTANVLVD--------ENFIAKVADTGISKLLENIEE--------AGPSH 246
L+H N N+L+ K++D GIS + +
Sbjct: 132 NT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP---- 185
Query: 247 GSIVNVFRDPE-VEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVR 303
PE +E + +D +SFG L E I S G AL
Sbjct: 186 ---------PECIENPKNLNLATDKWSFGTTLWE---------ICSGGDKPLSAL----- 222
Query: 304 SRLSSNNFVDHRLAGTFTTEGMR-------DLIRLTLQCMSSPGRRRPKMEIVMTELERI 356
+ + + +L L CM RP ++ +L +
Sbjct: 223 ----DSQRKLQFY-----EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
Query: 357 HEKEM 361
++
Sbjct: 274 FTPDL 278
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 95 IGFGSFGPVYKGLLRD-------TVVAIK--RRVGSP--RQEFVAEVTYLSEI-RHRNLV 142
+G G+FG V + VA+K + R+ ++E+ LS + H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 143 TLLGYCQQNGYQMLVFEYLPNGSMCNHL-------------YETGLESSTKLEFKQRVSI 189
LLG C G +++ EY G + N L + L+ + +S
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 190 ALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSI 249
+ AKG+ L S +H++ N+L+ I K+ D G+++ ++N +
Sbjct: 151 SYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 208
Query: 250 VNVFR--DPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ V + PE + V++ SD++S+G+FL EL +
Sbjct: 209 LPV-KWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-31
Identities = 49/198 (24%), Positives = 85/198 (42%), Gaps = 17/198 (8%)
Query: 95 IGFGSFGPVYKGLLR----DTVVAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVTLLG 146
+G G+FG V +G+ R VAIK + G+ +E + E + ++ + +V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPP 206
CQ MLV E G + L + ++ + + G+ +L
Sbjct: 78 VCQAEAL-MLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLEEKN-- 130
Query: 207 LVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA-GPSHGSIVNVF-RDPEVEESGVF 264
VH++ NVL+ AK++D G+SK L + + PE F
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 265 SEMSDIYSFGVFLLELVT 282
S SD++S+GV + E ++
Sbjct: 191 SSRSDVWSYGVTMWEALS 208
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 46/211 (21%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 95 IGFGSFGPVYKGLLRD-------TVVAIKR-RVGSP---RQEFVAEVTYLSEI-RHRNLV 142
+G G+FG V + VA+K + + ++ ++E+ +S + +H N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 143 TLLGYCQQNGYQMLVFEYLPNGSMCNHL---------YETGLESSTKLEFKQRVSIALGA 193
LLG C G +++ EY G + N L +++ + + +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 194 AKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF 253
A+G+ L S +H++ NVL+ +AK+ D G+++ + N + + V
Sbjct: 174 AQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV- 230
Query: 254 R--DPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ PE V++ SD++S+G+ L E+ +
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 95 IGFGSFGPVYKGLLRD---------TVVAIKR-RVGSP---RQEFVAEVTYLSEI-RHRN 140
+G G+FG V VA+K + + + V+E+ + I +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHL-----------YETGLESSTKLEFKQRVSI 189
++ LLG C Q+G ++ EY G++ +L Y+ ++ FK VS
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 190 ALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSI 249
A+G+ +L S K +H++ NVLV EN + K+AD G+++ + NI+ +
Sbjct: 163 TYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 250 VNVFR--DPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ V + PE V++ SD++SFGV + E+ T
Sbjct: 221 LPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 27/223 (12%)
Query: 78 SMEELEQATKQFSETSL------IGFGSFGPVYKGLLR----DTVVAIKR-RVGS----P 122
++EE+ L +G G+FG V KG + VA+K + +
Sbjct: 2 ALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL 61
Query: 123 RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLE 182
+ E +AE + ++ + +V ++G C+ + MLV E G + +L + ++
Sbjct: 62 KDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNR-----HVK 115
Query: 183 FKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242
K + + + G+ +L VH++ NVL+ AK++D G+SK L E
Sbjct: 116 DKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
Query: 243 -GPSHGSIVNVFR--DPEVEESGVFSEMSDIYSFGVFLLELVT 282
V + PE FS SD++SFGV + E +
Sbjct: 174 YKAQTHGKWPV-KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-30
Identities = 48/206 (23%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 95 IGFGSFGPVYKGLLRD-------TVVAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVT 143
+G G+FG VY+G + VA+K +F+ E +S+ H+N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESS--TKLEFKQRVSIALGAAKGLCHLH 201
+G Q+ + ++ E + G + + L ET S + L + +A A G +L
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 202 SLKPPLVHKNFKTANVLVD---ENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--DP 256
+H++ N L+ +AK+ D G+++ + +++ V + P
Sbjct: 158 ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV-KWMPP 214
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVT 282
E G+F+ +D +SFGV L E+ +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 62/291 (21%), Positives = 107/291 (36%), Gaps = 53/291 (18%)
Query: 95 IGFGSFGPVYKGLLR-----DTVVAIKR-RVGSP-----RQEFVAEVTYLSEIRHRNLVT 143
+G GSFG V +G VA+K + +F+ EV + + HRNL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
L G +V E P GS+ + L + A+ A+G+ +L S
Sbjct: 86 LYGVVLTPPM-KMVTELAPLGSLLDRL----RKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE-EAGPSHGSIVNVF-RDPEVEES 261
+ +H++ N+L+ + K+ D G+ + L + V PE ++
Sbjct: 141 R--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 262 GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGT 319
FS SD + FGV L E + + G + L + + + H++
Sbjct: 199 RTFSHASDTWMFGVTLWE---------MFTYGQEPWIGL---------NGSQILHKI--- 237
Query: 320 FTTEGMR---------DLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEM 361
EG R D+ + +QC + RP + L +M
Sbjct: 238 -DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 55/270 (20%), Positives = 102/270 (37%), Gaps = 18/270 (6%)
Query: 24 GLVWLCKSQSKNYQNKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELE 83
+ NS+ + +P+ + ++ T + ++L
Sbjct: 272 AHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLF 331
Query: 84 QATKQFSETSL-IGFGSFGPVYKGLLR----DTVVAIKR-RVGSP---RQEFVAEVTYLS 134
+ +G G+FG V +G+ R VAIK + G+ +E + E +
Sbjct: 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH 391
Query: 135 EIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAA 194
++ + +V L+G CQ MLV E G + L + ++ + +
Sbjct: 392 QLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVS 446
Query: 195 KGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA-GPSHGSIVNVF 253
G+ +L VH+N NVL+ AK++D G+SK L + +
Sbjct: 447 MGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 254 -RDPEVEESGVFSEMSDIYSFGVFLLELVT 282
PE FS SD++S+GV + E ++
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 95 IGFGSFGPVYKGLLRD---------TVVAIKR-RVGSP---RQEFVAEVTYLSEI-RHRN 140
+G G FG V VA+K + + + V+E+ + I +H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHL-----------YETGLESSTKLEFKQRVSI 189
++ LLG C Q+G ++ EY G++ +L Y+ ++ FK VS
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 190 ALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSI 249
A+G+ +L S K +H++ NVLV EN + K+AD G+++ + NI+ +
Sbjct: 209 TYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266
Query: 250 VNVFR--DPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ V + PE V++ SD++SFGV + E+ T
Sbjct: 267 LPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 95 IGFGSFGPVYKGLLRD---------TVVAIK--RRVGSP--RQEFVAEVTYLSEI-RHRN 140
+G G+FG V T VA+K + + + ++E+ + I +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHL-----------YETGLESSTKLEFKQRVSI 189
++ LLG C Q+G ++ EY G++ +L Y +L K VS
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 190 ALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSI 249
A A+G+ +L S K +H++ NVLV E+ + K+AD G+++ + +I+ +
Sbjct: 197 AYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 254
Query: 250 VNVFR--DPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ V + PE +++ SD++SFGV L E+ T
Sbjct: 255 LPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 48/206 (23%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 95 IGFGSFGPVYKGLLRD-------TVVAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVT 143
+G G+FG VY+G + VA+K +F+ E +S+ H+N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESS--TKLEFKQRVSIALGAAKGLCHLH 201
+G Q+ + ++ E + G + + L ET S + L + +A A G +L
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 202 SLKPPLVHKNFKTANVLVD---ENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--DP 256
+H++ N L+ +AK+ D G+++ + +++ V + P
Sbjct: 199 ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV-KWMPP 255
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVT 282
E G+F+ +D +SFGV L E+ +
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 95 IGFGSFGPVYKGLLRD-------TVVAIKR-RVGSP---RQEFVAEVTYLSEIRHRNLVT 143
IG G+FG V++ T+VA+K + + + +F E ++E + N+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHL-------------------YETGLESSTKLEFK 184
LLG C L+FEY+ G + L L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 185 QRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP 244
+++ IA A G+ +L K VH++ T N LV EN + K+AD G+S+ + + +
Sbjct: 175 EQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 232
Query: 245 SHGSIVNVFR--DPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ + R PE ++ SD++++GV L E+ +
Sbjct: 233 DGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 95 IGFGSFGPVYKGLLRD-------TVVAIK--RRVGSP--RQEFVAEVTYLSEIRHRNLVT 143
+G G FG V K T VA+K + SP ++ ++E L ++ H +++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHL-------------------YETGLESSTKLEFK 184
L G C Q+G +L+ EY GS+ L L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 185 QRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP 244
+S A ++G+ +L +K LVH++ N+LV E K++D G+S+ + +
Sbjct: 151 DLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 208
Query: 245 SHGSIVNVFR--DPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ V + E +++ SD++SFGV L E+VT
Sbjct: 209 RSQGRIPV-KWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-29
Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 31/235 (13%)
Query: 72 QGARQFSMEELEQATKQFSETS----------LIGFGSFGPVYKGLLRDT--VVAIK--- 116
Q R +++E+ + S IG GSF VYKGL +T VA
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 117 --RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGY----CQQNGYQMLVFEYLPNGSMCNHL 170
+ S RQ F E L ++H N+V + +LV E + +G++ +L
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 171 YETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD-ENFIAKVAD 229
++ K S KGL LH+ PP++H++ K N+ + K+ D
Sbjct: 121 KRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175
Query: 230 TGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
G++ L A G+ F PE+ E E D+Y+FG+ +LE+ T +
Sbjct: 176 LGLATLKRA-SFAKAVIGTP--EFMAPEMYEEKY-DESVDVYAFGMCMLEMATSE 226
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 95 IGFGSFGPVYKGLLRD-------TVVAIKR-RVGSP---RQEFVAEVTYLSEI-RHRNLV 142
+G G+FG V VA+K + + R+ ++E+ ++++ H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 143 TLLGYCQQNGYQMLVFEYLPNGSMCNHL------------------YETGLESSTKLEFK 184
LLG C +G L+FEY G + N+L E L F+
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 185 QRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP 244
+ A AKG+ L VH++ NVLV + K+ D G+++ + +
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV 230
Query: 245 SHGSIVNVFR--DPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ + V + PE G+++ SD++S+G+ L E+ +
Sbjct: 231 RGNARLPV-KWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 49/214 (22%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 95 IGFGSFGPVYKGLLRD-------TVVAIKR-RVGSP---RQEFVAEVTYLSEI-RHRNLV 142
+G G+FG V + VA+K + G+ + ++E+ L I H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 143 TLLGYC-QQNGYQMLVFEYLPNGSMCNHL-----------YETGLESSTKLEFKQRVSIA 190
LLG C + G M++ E+ G++ +L L + + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 191 LGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIV 250
AKG+ L S K +H++ N+L+ E + K+ D G+++ + + + +
Sbjct: 155 FQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 251 NVFR--DPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ + PE V++ SD++SFGV L E+ +
Sbjct: 213 PL-KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 55/238 (23%), Positives = 86/238 (36%), Gaps = 25/238 (10%)
Query: 56 RGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VV 113
S P + P F + F S +G GS+G V+K ++ +
Sbjct: 33 FRGEASETLQSPGYDPSRPESFFQQ-------SFQRLSRLGHGSYGEVFKVRSKEDGRLY 85
Query: 114 AIKR-----RVGSPRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLPNGSMC 167
A+KR R R +AEV ++ +H V L ++ G L E S+
Sbjct: 86 AVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQ 144
Query: 168 NHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKV 227
H G L Q L HLHS LVH + K AN+ + K+
Sbjct: 145 QHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKL 198
Query: 228 ADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQE 285
D G+ L G + PE+ + + +D++S G+ +LE+ E
Sbjct: 199 GDFGLLVELGTAGAGEVQEGDP--RYMAPELLQGS-YGTAADVFSLGLTILEVACNME 253
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 59/321 (18%), Positives = 114/321 (35%), Gaps = 44/321 (13%)
Query: 61 SSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVY--KGLLRDTVVAIKR- 117
SS + F + K + +G G F V +GL A+KR
Sbjct: 3 SSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI 62
Query: 118 RVGSP--RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQM----LVFEYLPNGSMCNHLY 171
R+E E H N++ L+ YC + L+ + G++ N +
Sbjct: 63 LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI- 121
Query: 172 ETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231
E + L Q + + LG +GL +H+ H++ K N+L+ + + D G
Sbjct: 122 ERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLG 179
Query: 232 ISKLLEN----------IEEAGPSHGSIVNVFRDPEV---EESGVFSEMSDIYSFGVFLL 278
+++ +I +R PE+ + V E +D++S G L
Sbjct: 180 SMNQACIHVEGSRQALTLQDWAAQRCTI--SYRAPELFSVQSHCVIDERTDVWSLGCVLY 237
Query: 279 ELVTGQ---EASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQC 335
++ G+ + S +Q S S + + L+ +
Sbjct: 238 AMMFGEGPYDMVFQ-KGDSVALAVQNQLSIPQSPRH----------SSALWQLLNSMMT- 285
Query: 336 MSSPGRRRPKMEIVMTELERI 356
P +RP + +++++LE +
Sbjct: 286 -VDP-HQRPHIPLLLSQLEAL 304
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 50/267 (18%), Positives = 92/267 (34%), Gaps = 28/267 (10%)
Query: 31 SQSKNYQNKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFS 90
S S + +S + + + E + +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61
Query: 91 ETSLIGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEFVAEVTYLSEIRHRNLVTLLGY 147
+G GSFG V++ + T A+K+ R+ R E E+ + + +V L G
Sbjct: 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---ELVACAGLSSPRIVPLYGA 118
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
++ + + E L GS+ + + G E Q AL +GL +LH+ +
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ----AL---EGLEYLHTRR- 170
Query: 206 PLVHKNFKTANVLVDEN-FIAKVADTGISKLLENIEEAGPSHGSIVNVFR------DPEV 258
++H + K NVL+ + A + D G + L+ + PEV
Sbjct: 171 -ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG--DYIPGTETHMAPEV 227
Query: 259 -EESGVFSEMSDIYSFGVFLLELVTGQ 284
DI+S +L ++ G
Sbjct: 228 VMGKP-CDAKVDIWSSCCMMLHMLNGC 253
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 64/333 (19%), Positives = 115/333 (34%), Gaps = 62/333 (18%)
Query: 58 AGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVY--KGLLRDTVVAI 115
AGP S G + F + +E + ++ G F VY + + A+
Sbjct: 2 AGPGSLGGASG---RDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYAL 58
Query: 116 KR-RVGSP--RQEFVAEVTYLSEIR-HRNLVTLLGYC-------QQNGYQMLVFEYLPNG 164
KR + + EV ++ ++ H N+V + L+ L G
Sbjct: 59 KRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKG 118
Query: 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI 224
+ L + ES L + I + + H+H KPP++H++ K N+L+
Sbjct: 119 QLVEFLKKM--ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176
Query: 225 AKVADTGISKLLEN-------------IEEAGPSHGSIVNVFRDPEV---EESGVFSEMS 268
K+ D G + + + +EE + + ++R PE+ + E
Sbjct: 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP--MYRTPEIIDLYSNFPIGEKQ 234
Query: 269 DIYSFGVFLLELVTGQ---EASHIVSL--GSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323
DI++ G L L Q E + + G Y +
Sbjct: 235 DIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQY------------------T 276
Query: 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356
LIR LQ +P R + V+ +L+ I
Sbjct: 277 VFHSLIRAMLQ--VNP-EERLSIAEVVHQLQEI 306
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-24
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR----RVGSPRQEFVAEVTYLSEIRHR 139
+ F++ IG GSFG V+KG+ T VVAIK ++ E+T LS+
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 140 NLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCH 199
+ G ++ ++ EYL GS L E G L+ Q +I KGL +
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPG-----PLDETQIATILREILKGLDY 134
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD---- 255
LHS K +H++ K ANVL+ E+ K+AD G++ L + N F
Sbjct: 135 LHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-------QIKRNTFVGTPFW 185
Query: 256 --PEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
PEV + + +DI+S G+ +EL G+
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-24
Identities = 50/239 (20%), Positives = 89/239 (37%), Gaps = 26/239 (10%)
Query: 60 PSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR 117
P F PQ A + M F IG G F VY+ VA+K+
Sbjct: 7 GMQGPPVPQFQPQKALRPDMGY--NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKK 64
Query: 118 -RVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLY 171
++ R + + E+ L ++ H N++ ++ +V E G + +
Sbjct: 65 VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124
Query: 172 ETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231
+ + + + L H+HS + ++H++ K ANV + + K+ D G
Sbjct: 125 HFK-KQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLG 181
Query: 232 ISKLLENIEEA-----G-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
+ + + A G P + S PE ++ SDI+S G L E+ Q
Sbjct: 182 LGRFFSSKTTAAHSLVGTPYYMS-------PERIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-23
Identities = 46/232 (19%), Positives = 91/232 (39%), Gaps = 43/232 (18%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIK--RRVGSPRQEFVAEVTYLSEIRHRNL 141
F E +++G G+FG V K AIK R ++EV L+ + H+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 142 VTLLG-YCQQNGYQM------------LVFEYLPNGSMCNHLYETGLESSTKLE---FKQ 185
V + ++ + + EY NG++ + ++ L F+Q
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 186 RVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPS 245
+ L ++HS ++H++ K N+ +DE+ K+ D G++K + +
Sbjct: 125 ILE-------ALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 246 HGSIVNVFRD-------------PEV-EESGVFSEMSDIYSFGVFLLELVTG 283
+ D EV + +G ++E D+YS G+ E++
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 45/225 (20%), Positives = 82/225 (36%), Gaps = 33/225 (14%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR----RVGSPRQEFVAEVTYLSEIRHRN 140
F +G G FG V++ + AIKR R++ + EV L+++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 141 LVTLLGYC------------QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVS 188
+V Y + + ++ + + + + E +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR--CTIEERERSVCLH 122
Query: 189 IALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGS 248
I L A+ + LHS L+H++ K +N+ + + KV D G+ ++ EE
Sbjct: 123 IFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 249 IVNVFRD-----------PEVEESGVFSEMSDIYSFGVFLLELVT 282
+ R PE +S DI+S G+ L EL+
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-23
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 28/218 (12%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR----RVGSPRQEFVAEVTYLSEIRHRN 140
+ +IG G+ V VAIKR + + E + E+ +S+ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCN---HLYETGLESSTKLEFKQRVSIALGAAKGL 197
+V+ LV + L GS+ + H+ G S L+ +I +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD-- 255
+LH +H++ K N+L+ E+ ++AD G+S L N R
Sbjct: 135 EYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLAT------GGDITRNKVRKTF 186
Query: 256 --------PEV-EESGVFSEMSDIYSFGVFLLELVTGQ 284
PEV E+ + +DI+SFG+ +EL TG
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-23
Identities = 51/221 (23%), Positives = 89/221 (40%), Gaps = 36/221 (16%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTL 144
F E LIG G FG V+K R IKR V ++ EV L+++ H N+V
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR-VKYNNEKAEREVKALAKLDHVNIVHY 69
Query: 145 LGY----------------CQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVS 188
G + + E+ G++ + + KL+ +
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK---RRGEKLDKVLALE 126
Query: 189 IALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHG- 247
+ KG+ ++HS K L++++ K +N+ + + K+ D G+ L+N + S G
Sbjct: 127 LFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT 184
Query: 248 ----SIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
S PE S + + D+Y+ G+ L EL+
Sbjct: 185 LRYMS-------PEQISSQDYGKEVDLYALGLILAELLHVC 218
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-22
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKR-RVGSPR--QEFVAEVTYLSEIRHRNLVTLLGYC 148
++G G++G VY G +AIK R Q E+ ++H+N+V LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 149 QQNGYQMLVFEYLPNGSMCNHLYET------GLESSTKLEFKQRVSIALGAAKGLCHLHS 202
+NG+ + E +P GS + L + E + KQ + +GL +LH
Sbjct: 89 SENGFIKIFMEQVPGGS-LSALLRSKWGPLKDNEQTIGFYTKQIL-------EGLKYLHD 140
Query: 203 LKPPLVHKNFKTANVLVD-ENFIAKVADTGISKLLENIEEAGPS-HGSIVNVFRDPEV-- 258
+ +VH++ K NVL++ + + K++D G SK L I + G++ + PE+
Sbjct: 141 NQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL--QYMAPEIID 196
Query: 259 EESGVFSEMSDIYSFGVFLLELVTGQ 284
+ + + +DI+S G ++E+ TG+
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-22
Identities = 50/222 (22%), Positives = 96/222 (43%), Gaps = 28/222 (12%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR-RVGSP----RQEFVAEVTYLSEIRHR 139
+++ IG GSFG + IK + R+E EV L+ ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 140 NLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCH 199
N+V ++NG +V +Y G + + + + Q + + L H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINA---QKGVLFQEDQILDWFVQICLALKH 140
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG------PSHGSIVNVF 253
+H K ++H++ K+ N+ + ++ ++ D GI+++L + E P + S
Sbjct: 141 VHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLS----- 193
Query: 254 RDPEVEESGVFSEMSDIYSFGVFLLELVTGQ---EASHIVSL 292
PE+ E+ ++ SDI++ G L EL T + EA + +L
Sbjct: 194 --PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-22
Identities = 50/227 (22%), Positives = 86/227 (37%), Gaps = 29/227 (12%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIK-----RRVGSPRQEFVAEVTYLSEIRHR 139
+ + IG GS+G K + ++ K + +Q V+EV L E++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 140 NLVTLLG--YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGL 197
N+V + N +V EY G + + + G + L+ + + + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-TKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 198 CHLHSLKPPL---VHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG------PSHGS 248
H +H++ K ANV +D K+ D G++++L + P + S
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 249 IVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ---EASHIVSL 292
PE ++E SDI+S G L EL A L
Sbjct: 185 -------PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-21
Identities = 49/232 (21%), Positives = 93/232 (40%), Gaps = 38/232 (16%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR----RVGSP-RQEFVAEVTYLSEI-R 137
T +F E IG G FG V+K + R + AIKR GS Q + EV + + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 138 HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGL 197
H ++V ++ + ++ EY GS+ + + E + + + + L +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENY-RIMSYFKEAELKDLLLQVGRGL 128
Query: 198 CHLHSLKPPLVHKNFKTANVLVDEN-------------------FIAKVADTGISKLLEN 238
++HS+ LVH + K +N+ + + K+ D G + +
Sbjct: 129 RYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 239 IE-EAGPSHGSIVNVFRDPEV-EESGVFSEMSDIYSFGVFLLELVTGQEASH 288
+ E G S F EV +E+ +DI++ + ++ +
Sbjct: 187 PQVEEGDSR------FLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-21
Identities = 47/206 (22%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR---RVGSPRQEFVAEVTYLSEIRHRN 140
K+++ IG G+ G VY + T VAI++ + ++ + E+ + E ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL 200
+V L +V EYL GS+ T + + T ++ Q ++ + L L
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPEV 258
HS + ++H++ K+ N+L+ + K+ D G I ++V + PEV
Sbjct: 133 HSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEV 187
Query: 259 EESGVFSEMSDIYSFGVFLLELVTGQ 284
+ DI+S G+ +E++ G+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 3e-21
Identities = 38/234 (16%), Positives = 71/234 (30%), Gaps = 22/234 (9%)
Query: 68 SFGPQGARQFSMEELEQATKQFSETSLIGFG--SFGPVYKGLLRDT--VVAIKR-----R 118
+ M + ++IG G V + T V ++R
Sbjct: 6 HHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC 65
Query: 119 VGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESS 178
E+ H N+V + +V ++ GS L T
Sbjct: 66 SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGS-AKDLICTHFM-- 122
Query: 179 TKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238
+ I G K L ++H + VH++ K +++L+ + ++ + + +
Sbjct: 123 DGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180
Query: 239 IEEAGPSHGSIVNVFRD------PEV--EESGVFSEMSDIYSFGVFLLELVTGQ 284
+ PEV + + SDIYS G+ EL G
Sbjct: 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-21
Identities = 46/206 (22%), Positives = 91/206 (44%), Gaps = 18/206 (8%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR---RVGSPRQEFVAEVTYLSEIRHRN 140
IG GS G V + + VA+K R R+ EV + + +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL 200
+V + ++ E+L G++ T + S +L +Q ++ + L +L
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGAL------TDIVSQVRLNEEQIATVCEAVLQALAYL 157
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPEV 258
H+ ++H++ K+ ++L+ + K++D G I + P S+V + PEV
Sbjct: 158 HAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCA---QISKDVPKRKSLVGTPYWMAPEV 212
Query: 259 EESGVFSEMSDIYSFGVFLLELVTGQ 284
+++ DI+S G+ ++E+V G+
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 58/243 (23%), Positives = 110/243 (45%), Gaps = 40/243 (16%)
Query: 61 SSATGQPSFGPQGARQFSMEELEQA------TKQFSETSLIGFGSFGPVYKGLLRDT--V 112
S T Q P+ +++L++ + F +G GS+G VYK + ++T +
Sbjct: 1 SLETVQLRNPPRR----QLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQI 56
Query: 113 VAIKR-RVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLY 171
VAIK+ V S QE + E++ + + ++V G +N +V EY GS + +
Sbjct: 57 VAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS-VSDII 115
Query: 172 ETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231
+ L + +I KGL +LH ++ +H++ K N+L++ AK+AD G
Sbjct: 116 RL---RNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFG 170
Query: 232 ISKLLENIEEAGPSHGSIVNVFRD----------PEVEESGVFSEMSDIYSFGVFLLELV 281
++ L + R+ PEV + ++ ++DI+S G+ +E+
Sbjct: 171 VAGQLTDTMAK-----------RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMA 219
Query: 282 TGQ 284
G+
Sbjct: 220 EGK 222
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 37/219 (16%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR---RVGSPRQEFVAEVTYLSEIRHRN 140
+ + +G G+FG VYK ++T + A K + ++++ E+ L+ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL 200
+V LLG +G ++ E+ P G+ + + E L Q + + L L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGA-VDAIML---ELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD----- 255
HS + ++H++ K NVL+ ++AD G+S + RD
Sbjct: 134 HSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK-----------RDSFIGT 180
Query: 256 -----PEVEESGVFSEMS-----DIYSFGVFLLELVTGQ 284
PEV + DI+S G+ L+E+ +
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 4e-20
Identities = 50/284 (17%), Positives = 95/284 (33%), Gaps = 55/284 (19%)
Query: 36 YQNKNSETGS-SDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQAT---KQFSE 91
+ + + +G S + E P G + S E + + +S
Sbjct: 1 HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSI 60
Query: 92 TSLIGFGSFGPVYKGLLRDT-VVAIKR-----RVGSPRQEFVAEVTYLSEIRHRNL--VT 143
IG G V++ L + AIK + E+ YL++++ + +
Sbjct: 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLH 201
L Y + Y +V E N + + L + K +K + + +H
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE-------AVHTIH 172
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD------ 255
+VH + K AN L+ + + K+ D GI+ ++ +V +D
Sbjct: 173 QHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDT---------TSVVKDSQVGAV 220
Query: 256 ----PEV-----------EESGVFSEMSDIYSFGVFLLELVTGQ 284
PE + S SD++S G L + G+
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-20
Identities = 61/241 (25%), Positives = 95/241 (39%), Gaps = 42/241 (17%)
Query: 70 GPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIK--RRVGSPRQE 125
+ + + L F L+G G++G VYKG T + AIK G +E
Sbjct: 7 PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE 66
Query: 126 FVAEVTYLSEI-RHRNLVTLLG-YCQQNGYQM-----LVFEYLPNGSMCNHLYETGLESS 178
E+ L + HRN+ T G + ++N M LV E+ GS L +
Sbjct: 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGS-VTDLIK--NTKG 123
Query: 179 TKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238
L+ + I +GL HLH K ++H++ K NVL+ EN K+ D G+S L+
Sbjct: 124 NTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
Query: 239 IEEAGPSHGSIVNVFRD----------PEV-----EESGVFSEMSDIYSFGVFLLELVTG 283
R+ PEV + SD++S G+ +E+ G
Sbjct: 182 TVGR-----------RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
Query: 284 Q 284
Sbjct: 231 A 231
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-19
Identities = 53/296 (17%), Positives = 108/296 (36%), Gaps = 48/296 (16%)
Query: 79 MEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVAEVTY 132
M + + + ++G G+ V++G + T + AIK P + E
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 133 LSEIRHRNLVTLLGY--CQQNGYQMLVFEYLPNGSMCNHLYETGL-----ESSTKLEFKQ 185
L ++ H+N+V L +++L+ E+ P GS+ L E ES + +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 186 RVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV----DENFIAKVADTGISKLLENIEE 241
V G+ HL +VH+N K N++ D + K+ D G ++ LE+ E+
Sbjct: 121 VVG-------GMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
Query: 242 AGPSHGS-------IVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTG----------- 283
+G+ + + + + D++S GV TG
Sbjct: 172 FVSLYGTEEYLHPDMYERAVLRKDHQKK-YGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 284 ---QEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCM 336
+ I++ A+ ++ ++ + G++ L+ L +
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-19
Identities = 49/210 (23%), Positives = 81/210 (38%), Gaps = 42/210 (20%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQE--FVAEVTYLSEIRHRNLVTLL 145
+G G FG VY + + ++A+K ++ E EV S +RH N++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSL 203
GY L+ EY P G++ L + E T + + L + HS
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN-------ALSYCHSK 128
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD-------- 255
+ ++H++ K N+L+ K+AD G S + R
Sbjct: 129 R--VIHRDIKPENLLLGSAGELKIADFGWSVHAP-------------SSRRTDLCGTLDY 173
Query: 256 --PEVEESGVFSEMSDIYSFGVFLLELVTG 283
PE+ E + E D++S GV E + G
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-19
Identities = 51/241 (21%), Positives = 94/241 (39%), Gaps = 36/241 (14%)
Query: 62 SATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR-R 118
++G+ P+ F+ E+L+ + IG G++G V K + + + ++A+KR R
Sbjct: 4 ESSGKLKISPEQHWDFTAEDLK-------DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR 56
Query: 119 VGSPRQEF---VAEV-TYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETG 174
+E + ++ + +V G + G + E + + S
Sbjct: 57 STVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVY 115
Query: 175 LESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234
+ + I L K L HL ++H++ K +N+L+D + K+ D GIS
Sbjct: 116 SVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174
Query: 235 LLENIEEAGPSHGSIVNVFRD-------PEV----EESGVFSEMSDIYSFGVFLLELVTG 283
L + SI PE + SD++S G+ L EL TG
Sbjct: 175 QLVD---------SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225
Query: 284 Q 284
+
Sbjct: 226 R 226
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-19
Identities = 59/326 (18%), Positives = 114/326 (34%), Gaps = 60/326 (18%)
Query: 48 PSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGL 107
P+ G +A G P+ P + ++ +++ +G G F ++
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEIS 61
Query: 108 LRDT--VVAIK----RRVGSPRQE--FVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159
DT V A K + P Q E++ + H+++V G+ + N + +V E
Sbjct: 62 DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121
Query: 160 YLPNGSMCNHLYETG--LESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANV 217
S+ E + +Q V G +LH + ++H++ K N+
Sbjct: 122 LCRRRSLLELHKRRKALTEPEARYYLRQIVL-------GCQYLHRNR--VIHRDLKLGNL 172
Query: 218 LVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD----------PEVEESGVFSEM 267
++E+ K+ D G++ +E E + PEV S
Sbjct: 173 FLNEDLEVKIGDFGLATKVEYDGE-----------RKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 268 SDIYSFGVFLLELVTGQ---EASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEG 324
D++S G + L+ G+ E S + R+ N + +
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKET----------YLRIKKNEY---SIPKHINPVA 268
Query: 325 MRDLIRLTLQCMSSPGRRRPKMEIVM 350
LI+ LQ + P RP + ++
Sbjct: 269 -ASLIQKMLQ--TDP-TARPTINELL 290
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 7e-19
Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 34/226 (15%)
Query: 71 PQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSP----RQ 124
Q + ++ E + S +G G+ G V+K + + V+A K R
Sbjct: 24 KQKVGELKDDDFE-------KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN 76
Query: 125 EFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFK 184
+ + E+ L E +V G +G + E++ GS+ L + G ++ +
Sbjct: 77 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQ 131
Query: 185 QRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP 244
+++ KGL +L K ++H++ K +N+LV+ K+ D G+S L +
Sbjct: 132 ILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID------ 184
Query: 245 SHGSIVNVFR------DPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
S+ N F PE + +S SDI+S G+ L+E+ G+
Sbjct: 185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 32/227 (14%), Positives = 72/227 (31%), Gaps = 24/227 (10%)
Query: 80 EELEQATKQFSETSLIGFGSFGPVYKGLLRDT-------VVAIKRRVGSPRQEF---VAE 129
E + +K L+G G+F VY+ D +K + + EF
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 130 VTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSI 189
+ L + +LV E G++ N + + +S
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 190 ALGAAKGLCHLHSLKPPLVHKNFKTANVLV-----------DENFIAKVADTGISKLLEN 238
A+ + +H + ++H + K N ++ D + + D G S ++
Sbjct: 178 AMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 239 IEEAGPSHGSI-VNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
+ + F+ E+ + ++ D + + ++ G
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 48/230 (20%), Positives = 90/230 (39%), Gaps = 34/230 (14%)
Query: 79 MEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVAEVTY 132
M + + + ++G G+ V++G + T + AIK P + E
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60
Query: 133 LSEIRHRNLVTLLGYCQQNGYQM--LVFEYLPNGSMCNHLYETGL-----ESSTKLEFKQ 185
L ++ H+N+V L ++ + L+ E+ P GS+ L E ES + +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 186 RVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV----DENFIAKVADTGISKLLENIEE 241
V G+ HL +VH+N K N++ D + K+ D G ++ LE+ E+
Sbjct: 121 VVG-------GMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
Query: 242 AGPSHGS-------IVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
+G+ + + + + D++S GV TG
Sbjct: 172 FVSLYGTEEYLHPDMYERAVLRKDHQKK-YGATVDLWSIGVTFYHAATGS 220
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 45/250 (18%), Positives = 85/250 (34%), Gaps = 51/250 (20%)
Query: 66 QPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT-VVAIKR-----RV 119
S G + + + +S IG G V++ L + AIK
Sbjct: 7 HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD 66
Query: 120 GSPRQEFVAEVTYLSEIRHRNL--VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGL-- 175
+ E+ YL++++ + + L Y + Y +V E N + + L +
Sbjct: 67 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSID 125
Query: 176 ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235
K +K + + +H +VH + K AN L+ + + K+ D GI+
Sbjct: 126 PWERKSYWKNMLE-------AVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQ 175
Query: 236 LENIEEAGPSHGSIVNVFRD----------PEV-----------EESGVFSEMSDIYSFG 274
++ +V +D PE + S SD++S G
Sbjct: 176 MQPDT---------TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226
Query: 275 VFLLELVTGQ 284
L + G+
Sbjct: 227 CILYYMTYGK 236
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 55/282 (19%), Positives = 100/282 (35%), Gaps = 64/282 (22%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQE--FVAEVTYLSEIRHRNLVTLL 145
+G G F ++ DT V A K + P Q E++ + H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETG--LESSTKLEFKQRVSIALGAAKGLCHLHSL 203
G+ + N + +V E S+ E + +Q V G +LH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-------GCQYLHRN 134
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD-------- 255
+ ++H++ K N+ ++E+ K+ D G++ +E E +
Sbjct: 135 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-----------RKKVLCGTPNY 181
Query: 256 --PEVEESGVFSEMSDIYSFGVFLLELVTGQ---EASHIVSLGSYEALIQWVRSRLSSNN 310
PEV S D++S G + L+ G+ E S + Y R+ N
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET--YL--------RIKKNE 231
Query: 311 FV--DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVM 350
+ H LI+ LQ + P RP + ++
Sbjct: 232 YSIPKH------INPVAASLIQKMLQ--TDP-TARPTINELL 264
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 59/266 (22%), Positives = 101/266 (37%), Gaps = 51/266 (19%)
Query: 46 SDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQA------TKQFSETSLIGFGS 99
+ + P+ A ++ + K FS+ IG GS
Sbjct: 9 HHDYDIPTTENLYFQGAMDPMPA--GGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGS 66
Query: 100 FGPVYKGLLRDT--VVAIK------RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQN 151
FG VY VVAIK ++ Q+ + EV +L ++RH N + G +
Sbjct: 67 FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 126
Query: 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKN 211
LV EY GS + L E L+ + ++ GA +GL +LHS ++H++
Sbjct: 127 HTAWLVMEYCL-GS-ASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRD 179
Query: 212 FKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD----------PEV--- 258
K N+L+ E + K+ D G + ++ + PEV
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSASIMAP---------------ANSFVGTPYWMAPEVILA 224
Query: 259 EESGVFSEMSDIYSFGVFLLELVTGQ 284
+ G + D++S G+ +EL +
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERK 250
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-18
Identities = 44/210 (20%), Positives = 77/210 (36%), Gaps = 42/210 (20%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQE--FVAEVTYLSEIRHRNLVTLL 145
+G G FG VY + ++A+K ++ E E+ S +RH N++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSL 203
Y L+ E+ P G + L + G E + ++ L + H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD-------ALHYCHER 133
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD-------- 255
K ++H++ K N+L+ K+AD G S ++ R
Sbjct: 134 K--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-------------RRRTMCGTLDY 178
Query: 256 --PEVEESGVFSEMSDIYSFGVFLLELVTG 283
PE+ E E D++ GV E + G
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 8e-18
Identities = 43/229 (18%), Positives = 81/229 (35%), Gaps = 51/229 (22%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT-VVAIKR-----RVGSPRQEFVAEVTYLSEIRHRN 140
+ +S IG G V++ L + AIK + E+ YL++++ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 141 L--VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKG 196
+ L Y + Y +V E N + + L + K +K +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE-------A 120
Query: 197 LCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD- 255
+ +H +VH + K AN L+ + + K+ D GI+ ++ +V +D
Sbjct: 121 VHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDT---------TSVVKDS 168
Query: 256 ---------PEV-----------EESGVFSEMSDIYSFGVFLLELVTGQ 284
PE + S SD++S G L + G+
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 62/296 (20%), Positives = 116/296 (39%), Gaps = 64/296 (21%)
Query: 76 QFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEF---VAE 129
+ ++LE +G G++G V K + ++A+KR R QE + +
Sbjct: 3 EVKADDLE-------PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD 55
Query: 130 VT-YLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVS 188
+ + + VT G + G + E + + S+ Y+ ++ +
Sbjct: 56 LDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDK-FYKQVIDKGQTIPEDILGK 113
Query: 189 IALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGS 248
IA+ K L HLHS K ++H++ K +NVL++ K+ D GIS L +
Sbjct: 114 IAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD---------D 163
Query: 249 IV-NVF----------R-DPEVEESGVFSEMSDIYSFGVFLLELVTGQ----EASHIVSL 292
+ ++ R +PE+ + G +S SDI+S G+ ++EL +
Sbjct: 164 VAKDIDAGCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTP--- 219
Query: 293 GSYEALIQWVRS---RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPK 345
++ L Q V +L ++ F + D QC+ + RP
Sbjct: 220 --FQQLKQVVEEPSPQLPADKF----------SAEFVDFTS---QCLKKNSKERPT 260
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 92 TSLIGFGSFGPVYKGLLRDTV----VAIK--RRVGSPRQEFVA----EVTYLSEIRHRNL 141
+G G VY DT+ VAIK ++E + EV S++ H+N+
Sbjct: 16 VDKLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH 201
V+++ +++ LV EY+ ++ ++ G L ++ G+ H H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAH 128
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN--IEEAGPSHGSIVNVFRDPEVE 259
++ +VH++ K N+L+D N K+ D GI+K L + + G+ V F PE
Sbjct: 129 DMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGT-VQYF-SPEQA 184
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQ 284
+ E +DIYS G+ L E++ G+
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGE 209
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 44/208 (21%), Positives = 81/208 (38%), Gaps = 19/208 (9%)
Query: 88 QFSETSLIGFGSFGP-VYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEI-RHRNLVTLL 145
F ++G G+ G VY+G+ + VA+KR + EV L E H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYF 84
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
+ +Q + E + L E + + +++ GL HLHSL
Sbjct: 85 CTEKDRQFQYIAIELCA-AT----LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN- 138
Query: 206 PLVHKNFKTANVLVDE-----NFIAKVADTGISKLLENIEEAGPSHGSIVN--VFRDPEV 258
+VH++ K N+L+ A ++D G+ K L + + + PE+
Sbjct: 139 -IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 259 ---EESGVFSEMSDIYSFGVFLLELVTG 283
+ + DI+S G +++
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 31/210 (14%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVAEVTYLSEIRHRNLVTLL--- 145
+G G FG V + + +DT VAIK R+ + E+ + ++ H N+V+
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 146 ---GYCQQNGYQMLVFEYLPNGSMCNHLYETGL-----ESSTKLEFKQRVSIALGAAKGL 197
N +L EY G + +L + E + S L
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS-------AL 134
Query: 198 CHLHSLKPPLVHKNFKTANVLVD---ENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR 254
+LH + ++H++ K N+++ + I K+ D G +K L+ E G++ +
Sbjct: 135 RYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL-- 190
Query: 255 DPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
PE+ E ++ D +SFG E +TG
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 46/204 (22%), Positives = 83/204 (40%), Gaps = 28/204 (13%)
Query: 93 SLIGFGSFGPVYKGL---LRDTVVAIK--RRVGSP--RQEFVAEVTYLSEIRHRNLVTLL 145
I G G +Y L + V +K G + +AE +L+E+ H ++V +
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 146 GYCQQNGYQM-----LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL 200
+ + +V EY+ S+ + KL + ++ L L +L
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYL 198
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEE 260
HS+ LV+ + K N+++ E + K+ D G I G +G+ F+ PE+
Sbjct: 199 HSI--GLVYNDLKPENIMLTEEQL-KLIDLGAVS---RINSFGYLYGTPG--FQAPEIVR 250
Query: 261 SGVFSEMSDIYSFGVFLLELVTGQ 284
+G + +DIY+ G L L
Sbjct: 251 TGP-TVATDIYTVGRTLAALTLDL 273
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 37/338 (10%), Positives = 78/338 (23%), Gaps = 69/338 (20%)
Query: 56 RGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VV 113
A A + PQ A L Q ++ + G V+ +
Sbjct: 32 EPAAMVEAVTATVW-PQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDF 90
Query: 114 AIK------RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQ------------------ 149
A+K S + + + + +
Sbjct: 91 ALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQ 150
Query: 150 --------QNGYQMLVFEYLPNGSMCN--HLYETGLESSTKLEFKQRVSIALGAAKGLCH 199
+L+ + + + + + +
Sbjct: 151 LSPGQDDYAVANYLLLMP-AASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAAN 209
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA--GPSHGSIVNVFRDPE 257
L S LVH +F N+ + + + D + A P + E
Sbjct: 210 LQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVT------YAPRE 261
Query: 258 V--EESGVFSEMSDIYSFGVFLLELVTGQ---EASHIVSLGSYEALIQWVRSRLSSNNFV 312
+ F+ + + G+ + + GS++ V S
Sbjct: 262 FLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS 321
Query: 313 DHRLAGTFTTEGMRDLI----------RLTL-QCMSSP 339
L + ++ LI RL + M +P
Sbjct: 322 CTPL-----PDFVKTLIGRFLNFDRRRRLLPLEAMETP 354
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-15
Identities = 49/211 (23%), Positives = 83/211 (39%), Gaps = 41/211 (19%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQE--FVAEVTYLSEIRHRNLVTLL 145
L+G GSF VY+ T VAIK + + EV +++H +++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETG---LESSTKLEFKQRVSIALGAAKGLCHLHS 202
Y + + Y LV E NG M +L E+ + Q ++ G+ +LHS
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT-------GMLYLHS 130
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD------- 255
++H++ +N+L+ N K+AD G++ L+ E
Sbjct: 131 HG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-----------KHYTLCGTPN 177
Query: 256 ---PEVEESGVFSEMSDIYSFGVFLLELVTG 283
PE+ SD++S G L+ G
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIG 208
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 23/278 (8%), Positives = 70/278 (25%), Gaps = 44/278 (15%)
Query: 48 PSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGL 107
+ + + S G EL + + +++G +
Sbjct: 34 ANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEAT 93
Query: 108 LRDT--VVAIK--------------------------RRVGSPRQ-----EFVAEVTYLS 134
++T + R + + +Q F+ +
Sbjct: 94 DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153
Query: 135 EIRHRNLVTLLGYCQQNGYQMLVFEY-LPNGSMCNHLYE--TGLESSTKLEFKQRVSIAL 191
+ + + ++ + + F Y ++ + + L R+ + L
Sbjct: 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTL 213
Query: 192 GAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA--GPSHGS- 248
+ L LH LVH + ++++D+ + +
Sbjct: 214 QVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPP 271
Query: 249 ---IVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTG 283
+ + + D ++ G+ + +
Sbjct: 272 ELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 48/245 (19%), Positives = 91/245 (37%), Gaps = 38/245 (15%)
Query: 59 GPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIK 116
G S ++G+ + G + + +G G+ G V+K R T V+A+K
Sbjct: 1 GSSGSSGKQT----GYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK 56
Query: 117 R-RVGSPRQEF---VAEVTYL-SEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLY 171
+ R ++E + ++ + +V G N + E + +
Sbjct: 57 QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKR 116
Query: 172 ETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231
G + + + + K L +L ++H++ K +N+L+DE K+ D G
Sbjct: 117 MQG-----PIPERILGKMTVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFG 170
Query: 232 ISKLLENIEEAGPSHGSIV-NVF----------R-DPEVEESGVFSEMSDIYSFGVFLLE 279
IS L + + R DP + +D++S G+ L+E
Sbjct: 171 ISGRLVD---------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
Query: 280 LVTGQ 284
L TGQ
Sbjct: 222 LATGQ 226
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 8e-15
Identities = 42/209 (20%), Positives = 84/209 (40%), Gaps = 25/209 (11%)
Query: 92 TSLIGFGSFGPVYKGLLRDTV----VAIK--RRVGSPRQEFVA----EVTYLSEIRHRNL 141
++GFG V+ RD VA+K R + F E + + H +
Sbjct: 17 GEILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 142 VTLLGYCQQNGYQM----LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGL 197
V + + +V EY+ ++ + ++ G + K+ + + A + L
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQAL 129
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRD 255
H ++H++ K AN+++ KV D GI++ + + + +++ +
Sbjct: 130 NFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 256 PEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
PE SD+YS G L E++TG+
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 36/186 (19%), Positives = 67/186 (36%), Gaps = 19/186 (10%)
Query: 121 SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTK 180
SP ++ + +N V L Y + + ++ + + S
Sbjct: 103 SPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLED 160
Query: 181 LEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240
E + I + A+ + LHS L+H++ K +N+ + + KV D G+ ++ E
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218
Query: 241 EAGPSHGSIVNVFRD-----------PEVEESGVFSEMSDIYSFGVFLLELV----TGQE 285
E + PE +S DI+S G+ L EL+ T E
Sbjct: 219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278
Query: 286 ASHIVS 291
I++
Sbjct: 279 RVRIIT 284
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 57/238 (23%), Positives = 100/238 (42%), Gaps = 28/238 (11%)
Query: 59 GPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIK 116
GP S P Q S ++ ++G GSFG V + T A+K
Sbjct: 1 GPGSMMDHLHATPGMFVQHSTAIFS---DRYKGQRVLGKGSFGEVILCKDKITGQECAVK 57
Query: 117 ----RRVGSP--RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHL 170
R+V ++ + EV L ++ H N++ L + + GY LV E G + + +
Sbjct: 58 VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI 117
Query: 171 YETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV---DENFIA 225
E +Q +S G+ ++H K +VH++ K N+L+ ++
Sbjct: 118 ISRKRFSEVDAARIIRQVLS-------GITYMHKNK--IVHRDLKPENLLLESKSKDANI 168
Query: 226 KVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTG 283
++ D G+S E ++ G+ + PEV G + E D++S GV L L++G
Sbjct: 169 RIIDFGLSTHFEASKKMKDKIGTA--YYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 41/214 (19%), Positives = 83/214 (38%), Gaps = 29/214 (13%)
Query: 95 IGFGSFGPVYKGLLRDTVVAIK----------RRVGSPRQEFVA----------EVTYLS 134
+ G F + + A+K R + ++ E+ ++
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 135 EIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETG-LESSTKLEFKQRVS--IAL 191
+I++ +T G +++EY+ N S+ L+ + +V I
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 192 GAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVN 251
++H+ K + H++ K +N+L+D+N K++D G S+ + + + G S G+
Sbjct: 159 SVLNSFSYIHNEKN-ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG-SRGTY-- 214
Query: 252 VFRDPEV--EESGVFSEMSDIYSFGVFLLELVTG 283
F PE ES DI+S G+ L +
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-14
Identities = 52/244 (21%), Positives = 96/244 (39%), Gaps = 43/244 (17%)
Query: 60 PSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIK- 116
P + + Q + P R+ E+ F ++G GSF V T AIK
Sbjct: 10 PGAGSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVVLARELATSREYAIKI 62
Query: 117 ---RRVGSPRQ-EFV-AEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLY 171
R + + +V E +S + H V L Q + Y NG + ++
Sbjct: 63 LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 122
Query: 172 ETG--LESSTKL---EFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAK 226
+ G E+ T+ E + AL +LH ++H++ K N+L++E+ +
Sbjct: 123 KIGSFDETCTRFYTAE----IVSALE------YLHGKG--IIHRDLKPENILLNEDMHIQ 170
Query: 227 VADTGISKLLENIEEAGPSH---GSIVNVFRD---PEVEESGVFSEMSDIYSFGVFLLEL 280
+ D G +K+L + ++ G+ PE+ + SD+++ G + +L
Sbjct: 171 ITDFGTAKVLSPESKQARANSFVGTA-----QYVSPELLTEKSACKSSDLWALGCIIYQL 225
Query: 281 VTGQ 284
V G
Sbjct: 226 VAGL 229
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 55/241 (22%), Positives = 99/241 (41%), Gaps = 29/241 (12%)
Query: 60 PSSATGQPSFGPQGARQFSMEE-LEQATKQFSET----SLIGFGSFGPVYKGLLRDT--V 112
++G+ + QG Q + + SE +G G++G V + T
Sbjct: 5 HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64
Query: 113 VAIK----RRVGSPRQEFVA-EVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMC 167
AIK V + + EV L + H N++ L + + LV E G +
Sbjct: 65 RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF 124
Query: 168 NHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV---DEN 222
+ + E + KQ +S G+ +LH +VH++ K N+L+ +++
Sbjct: 125 DEIIHRMKFNEVDAAVIIKQVLS-------GVTYLHKHN--IVHRDLKPENLLLESKEKD 175
Query: 223 FIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT 282
+ K+ D G+S + EN ++ G+ + PEV + E D++S GV L L+
Sbjct: 176 ALIKIVDFGLSAVFENQKKMKERLGTA--YYIAPEVLR-KKYDEKCDVWSIGVILFILLA 232
Query: 283 G 283
G
Sbjct: 233 G 233
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 50/238 (21%), Positives = 104/238 (43%), Gaps = 31/238 (13%)
Query: 74 ARQFSMEELEQATKQFSETS-LIGFGSFGPV-YKGLLRDTVVAIKRRVGSPRQEFVAEVT 131
+R ++ EQ+ K + ++G+GS G V ++G + VA+KR + + E+
Sbjct: 1 SRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIK 60
Query: 132 YLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVS 188
L+E H N++ + + + E N ++ + + + E+ + +S
Sbjct: 61 LLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 189 IALGAAKGLCHLHSLKPPLVHKNFKTANVLVD-------------ENFIAKVADTGISKL 235
+ A G+ HLHSLK ++H++ K N+LV EN ++D G+ K
Sbjct: 120 LLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 236 LENIEEAGPSHGSIVN---VFRDPEVEESGVFSEMS-------DIYSFGVFLLELVTG 283
L++ + + ++ + + +R PE+ E + DI+S G +++
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 6e-14
Identities = 44/205 (21%), Positives = 77/205 (37%), Gaps = 23/205 (11%)
Query: 92 TSLIGFGSFGPVYKGLLRDTV----VAIK--RRVGSPRQEFVA----EVTYLSEIRHRNL 141
L+G G G VY+ DTV VA+K S F E ++ ++
Sbjct: 39 RRLVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH 201
V + + + +G + + + L G L + V+I L H
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAH 151
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE--NIEEAGPSHGSIVNVFRDPEVE 259
+ H++ K N+LV + A + D GI+ + + G + G++ + PE
Sbjct: 152 AAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLY--YMAPERF 207
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQ 284
+ +DIY+ L E +TG
Sbjct: 208 SESHATYRADIYALTCVLYECLTGS 232
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 9e-14
Identities = 43/185 (23%), Positives = 77/185 (41%), Gaps = 22/185 (11%)
Query: 61 SSATGQPSFGPQGARQFSMEELEQATK--QFSETSLIGFGSFGPVYKGLLRDT--VVAIK 116
G QG S+ AT ++ + +G G++G VYK + T VAIK
Sbjct: 6 HHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK 65
Query: 117 R-RVGSPRQEF----VAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLY 171
R R+ + + EV+ L E++HRN++ L N L+FEY +
Sbjct: 66 RIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY------AENDL 119
Query: 172 ETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIA-----K 226
+ ++ + + + S G+ HS + +H++ K N+L+ + + K
Sbjct: 120 KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRC--LHRDLKPQNLLLSVSDASETPVLK 177
Query: 227 VADTG 231
+ D G
Sbjct: 178 IGDFG 182
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 24/279 (8%), Positives = 69/279 (24%), Gaps = 43/279 (15%)
Query: 47 DPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKG 106
+ + + S G EL + + +++G +
Sbjct: 38 QANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEA 97
Query: 107 LLRDT--VVAIK--------------------------RRVGSPRQ--EFVAEVTYLSEI 136
++T + R + + +Q + + +
Sbjct: 98 TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157
Query: 137 RHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETG------LESSTKLEFKQRVSIA 190
+ ++ ++ + M ++L G + L R+ +
Sbjct: 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLT 217
Query: 191 LGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL--ENIEEAGPSHGS 248
L + L LH LVH + ++++D+ + + G
Sbjct: 218 LQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAP 275
Query: 249 ---IVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
+ + D ++ G+ + +
Sbjct: 276 PETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 34/169 (20%)
Query: 78 SMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQE-----FVA- 128
+ E+ +G G F VYK ++T +VAIK+ ++G + A
Sbjct: 8 RAKRYEKLDF-------LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL 60
Query: 129 -EVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLES---STKLEFK 184
E+ L E+ H N++ LL LVF+++ ET LE L
Sbjct: 61 REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM----------ETDLEVIIKDNSLVLT 110
Query: 185 QRV--SIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231
+ L +GL +LH ++H++ K N+L+DEN + K+AD G
Sbjct: 111 PSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFG 157
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 6e-13
Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 16/145 (11%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVA-----EVTYLSEIRHRNLVTLLGY 147
IG GS+G V+K RDT +VAIK+ + S + E+ L +++H NLV LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRV-SIALGAAKGLCHLHSLKPP 206
++ LVFEY C+H L+ + + V SI + + H
Sbjct: 71 FRRKRRLHLVFEY------CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN-- 122
Query: 207 LVHKNFKTANVLVDENFIAKVADTG 231
+H++ K N+L+ ++ + K+ D G
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFG 147
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 6e-13
Identities = 47/164 (28%), Positives = 79/164 (48%), Gaps = 27/164 (16%)
Query: 78 SMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVA-----EV 130
SME+ E +G GS+G V K +DT +VAIK+ + S + V E+
Sbjct: 23 SMEKYENLGL-------VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREI 75
Query: 131 TYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHL--YETGLESST-KLEFKQRV 187
L ++RH NLV LL C++ LVFE++ + ++ + L + GL+ + Q +
Sbjct: 76 KLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII 134
Query: 188 SIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231
G+ HS +H++ K N+LV ++ + K+ D G
Sbjct: 135 -------NGIGFCHSHNI--IHRDIKPENILVSQSGVVKLCDFG 169
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 7e-13
Identities = 41/168 (24%), Positives = 70/168 (41%), Gaps = 31/168 (18%)
Query: 78 SMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR-RV----GSP----RQEF 126
S + +Q K +G G++ VYKGL + T VA+K ++ G+P R
Sbjct: 3 SSSQFKQLEK-------LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR--- 52
Query: 127 VAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN---GSMCNHLYETGLESSTKLEF 183
E++ + E++H N+V L LVFE++ N M +
Sbjct: 53 --EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLV 110
Query: 184 KQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231
K +GL H K ++H++ K N+L+++ K+ D G
Sbjct: 111 K---YFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFG 153
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 1e-12
Identities = 39/146 (26%), Positives = 69/146 (47%), Gaps = 17/146 (11%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEF----VAEVTYLSEIRHRNLVTLLGY 147
IG G++G VYK + T VVA+K+ R+ + + + E++ L E+ H N+V LL
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRV--SIALGAAKGLCHLHSLKP 205
LVFE+ + + +++S + S +GL HS +
Sbjct: 71 IHTENKLYLVFEF------LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 123
Query: 206 PLVHKNFKTANVLVDENFIAKVADTG 231
++H++ K N+L++ K+AD G
Sbjct: 124 -VLHRDLKPQNLLINTEGAIKLADFG 148
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 59/269 (21%), Positives = 107/269 (39%), Gaps = 41/269 (15%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVA-EVTYLSEIRHRNLVTLLGY 147
IG G+F V T VAIK ++ + + EV + + H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETG--LESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
+ L+ EY G + ++L G E + +F+Q VS + + H +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-------AVQYCHQKR- 134
Query: 206 PLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV-EESGVF 264
+VH++ K N+L+D + K+AD G S + G+ + PE+ +
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAP--PYAAPELFQGKKYD 191
Query: 265 SEMSDIYSFGVFLLELVTGQ---EASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321
D++S GV L LV+G + ++ L R R+ + +
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKEL----------RERVLRGKYRIPF----YM 237
Query: 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVM 350
+ +L++ L +P +R +E +M
Sbjct: 238 STDCENLLKRFLV--LNP-IKRGTLEQIM 263
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 38/222 (17%)
Query: 83 EQATKQFSETSLIGFGSFGPVYKGLLRDT-VVAIKRRVGSPRQEFVAEVTYLSEIRHRNL 141
EQ ++ +IG GSFG V++ L ++ VAIK +V ++ E+ + ++H N+
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK-KVLQDKRFKNRELQIMRIVKHPNV 94
Query: 142 VTLLGYCQQNG------YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALG--- 192
V L + NG + LV EY+P +Y KL KQ + + L
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRA-SRHYAKL--KQTMPMLLIKLY 146
Query: 193 ---AAKGLCHLHSLKPPLVHKNFKTANVLVDEN-FIAKVADTGISKLLENIEEAGPSHGS 248
+ L ++HS+ + H++ K N+L+D + K+ D G +K+L E P+
Sbjct: 147 MYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE---PNVSY 201
Query: 249 IVNVF-RDPEVEESGVFSEMS-----DIYSFGVFLLELVTGQ 284
I + + R PE+ +F + DI+S G + EL+ GQ
Sbjct: 202 ICSRYYRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 28/155 (18%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEF----VAEVTYLSEIRHRNLVTLLGY 147
IG G+FG V+K R T VA+K+ + + ++ F + E+ L ++H N+V L+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 148 CQQNGYQM--------LVFEYLPNGSMCNH-LYETGLESSTKLEFKQRV--SIALGAAKG 196
C+ LVF++ C H L GL S+ ++F + G
Sbjct: 85 CRTKASPYNRCKGSIYLVFDF------CEHDL--AGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 197 LCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231
L ++H K ++H++ K ANVL+ + + K+AD G
Sbjct: 137 LYYIHRNK--ILHRDMKAANVLITRDGVLKLADFG 169
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 2e-12
Identities = 42/189 (22%), Positives = 83/189 (43%), Gaps = 39/189 (20%)
Query: 56 RGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT---V 112
S+ + + ++ ++LE+ +G G++G VYK +D+ +
Sbjct: 2 HHHHHHSSGRENLYFQGLMEKY--QKLEK----------VGEGTYGVVYKA--KDSQGRI 47
Query: 113 VAIKR-RVGSPRQEF----VAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMC 167
VA+KR R+ + + + E++ L E+ H N+V+L+ LVFE++
Sbjct: 48 VALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM------ 101
Query: 168 NHLYETGLES-----STKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN 222
E L+ T L+ Q +G+ H H + ++H++ K N+L++ +
Sbjct: 102 ----EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSD 155
Query: 223 FIAKVADTG 231
K+AD G
Sbjct: 156 GALKLADFG 164
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 2e-12
Identities = 40/149 (26%), Positives = 69/149 (46%), Gaps = 24/149 (16%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEF----VAEVTYLSEIRHRNLVTLLGY 147
IG G++G V+K R+T +VA+KR R+ + + E+ L E++H+N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETGLES---STKLEFKQRV--SIALGAAKGLCHLHS 202
+ LVFE+ + L+ S + + S KGL HS
Sbjct: 70 LHSDKKLTLVFEFC----------DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTG 231
++H++ K N+L++ N K+A+ G
Sbjct: 120 RN--VLHRDLKPQNLLINRNGELKLANFG 146
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 67/318 (21%), Positives = 112/318 (35%), Gaps = 62/318 (19%)
Query: 57 GAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVA 114
G P + P + +E E Q+ L+G G FG VY G+ VA
Sbjct: 13 GLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVA 72
Query: 115 IK--------RRVGSPRQEFVA-EVTYLSEIRHR--NLVTLLGYCQQNGYQMLVFEY-LP 162
IK P V EV L ++ ++ LL + ++ +L+ E P
Sbjct: 73 IKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 132
Query: 163 NGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD 220
+ + + E G E + F Q + + H H+ ++H++ K N+L+D
Sbjct: 133 VQDLFDFITERGALQEELARSFFWQVLE-------AVRHCHNCG--VLHRDIKDENILID 183
Query: 221 ENFI-AKVADTGISKLLENIEEAGPSH---GSIVNVFRDPEVEESGVFS-EMSDIYSFGV 275
N K+ D G + + G+ V+ PE + + ++S G+
Sbjct: 184 LNRGELKLIDFGSG----ALLKDTVYTDFDGTR--VYSPPEWIRYHRYHGRSAAVWSLGI 237
Query: 276 FLLELVTGQ---EASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLT 332
L ++V G E + G + R R+SS + LIR
Sbjct: 238 LLYDMVCGDIPFEHDEEIIRGQV-----FFRQRVSS---------------ECQHLIRWC 277
Query: 333 LQCMSSPGRRRPKMEIVM 350
L P RP E +
Sbjct: 278 LA--LRP-SDRPTFEEIQ 292
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 31/202 (15%), Positives = 56/202 (27%), Gaps = 49/202 (24%)
Query: 93 SLIGFGSFGPVYKGLLRDTV----VAIK------RRVGSPRQEFVAEVTYLSEIRHRNLV 142
G ++ DT VA+ QE ++ LS I +
Sbjct: 37 IFHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 143 TLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202
+L ++V E++ GS+ + +T + Q ++ A AA H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSL-QEVADTSPSPVGAIRAMQSLAAAADAA----HRA- 148
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESG 262
+ + V V + +A + +A P
Sbjct: 149 ---GVALSIDHPSRVRVSIDGDVVLAYPAT------MPDANPQ----------------- 182
Query: 263 VFSEMSDIYSFGVFLLELVTGQ 284
DI G L L+ +
Sbjct: 183 -----DDIRGIGASLYALLVNR 199
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 43/222 (19%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVT 143
+++T +IG GSFG VY+ L D+ +VAIK +V ++ E+ + ++ H N+V
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK-KVLQDKRFKNRELQIMRKLDHCNIVR 111
Query: 144 LLGYCQQNG------YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAK-- 195
L + +G Y LV +Y+P + + + + ++ + K
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVP----------ETVYRVARHYSRAKQTLPVIYVKLY 161
Query: 196 ------GLCHLHSLKPPLVHKNFKTANVLVDEN-FIAKVADTGISKLLENIEEAGPSHGS 248
L ++HS + H++ K N+L+D + + K+ D G +K L E P+
Sbjct: 162 MYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSY 216
Query: 249 IVNVF-RDPEVEESGVFSEMS-----DIYSFGVFLLELVTGQ 284
I + + R PE+ +F D++S G L EL+ GQ
Sbjct: 217 ICSRYYRAPEL----IFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 24/201 (11%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVA-EVTYLSEIRHRNLVTLLGY 147
+G GSFG V K R T A+K + + EV L ++ H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
+ + +V E G + + + + E KQ S G+ ++H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS-------GITYMHKHN- 141
Query: 206 PLVHKNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESG 262
+VH++ K N+L+ +++ K+ D G+S + + G+ + PEV G
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI--APEVLR-G 197
Query: 263 VFSEMSDIYSFGVFLLELVTG 283
+ E D++S GV L L++G
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 1e-11
Identities = 44/182 (24%), Positives = 68/182 (37%), Gaps = 37/182 (20%)
Query: 70 GPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEF 126
GP G+ + E + IG G++G VYK + VA+K RV +
Sbjct: 1 GPLGSM--ATSRYEPVAE-------IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGG 51
Query: 127 VA-------EVTYLSEIR---HRNLVTLLGYCQQNGYQ-----MLVFEYLPNGSMCNHLY 171
EV L + H N+V L+ C + LVFE+ +
Sbjct: 52 GGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH------VDQDL 105
Query: 172 ETGLESSTKLEFKQRV--SIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVAD 229
T L+ + + +GL LH+ +VH++ K N+LV K+AD
Sbjct: 106 RTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLAD 163
Query: 230 TG 231
G
Sbjct: 164 FG 165
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 53/222 (23%), Positives = 103/222 (46%), Gaps = 24/222 (10%)
Query: 76 QFSMEELEQATKQ-FSETSLIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEF-- 126
Q+ E + TK F + ++G G FG V +R T + A K +R+ + E
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 127 VAEVTYLSEIRHRNLVTLLGYCQQNGYQM-LVFEYLPNGSMCNHLYETGLESSTKLEFKQ 185
+ E L ++ R +V+ L Y + + LV + G + H+Y G + F +
Sbjct: 232 LNEKQILEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYHMG-----QAGFPE 285
Query: 186 RVSIALGA--AKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243
++ A GL LH + +V+++ K N+L+D++ +++D G++ ++ E
Sbjct: 286 ARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQ 340
Query: 244 PSHGSIVNV-FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
G + V + PEV ++ ++ D ++ G L E++ GQ
Sbjct: 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 45/202 (22%), Positives = 88/202 (43%), Gaps = 23/202 (11%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGY 147
+G G++G V + R T VA+K +R + E+ + H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETG--LESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
++ Q L EY G + + + E + F Q ++ G+ +LH +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLHGIG- 125
Query: 206 PLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH---GSIVNVFRDPEV-EES 261
+ H++ K N+L+DE K++D G++ + + G++ V PE+ +
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV--APELLKRR 182
Query: 262 GVFSEMSDIYSFGVFLLELVTG 283
+E D++S G+ L ++ G
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAG 204
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 31/152 (20%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR-RV----GSP----RQEFVAEVTYLSEIRHRNLVT 143
+G G++ VYKG + T +VA+K R+ G+P R EV+ L +++H N+VT
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-----EVSLLKDLKHANIVT 64
Query: 144 LLGYCQQNGYQMLVFEYLPN---GSMCNHLYETGLESST-KLEFKQRVSIALGAAKGLCH 199
L LVFEYL + + + KL Q + +GL +
Sbjct: 65 LHDIIHTEKSLTLVFEYLDKDLKQYLDDC--GNIINMHNVKLFLFQLL-------RGLAY 115
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231
H K ++H++ K N+L++E K+AD G
Sbjct: 116 CHRQK--VLHRDLKPQNLLINERGELKLADFG 145
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 48/222 (21%), Positives = 98/222 (44%), Gaps = 21/222 (9%)
Query: 76 QFSMEELEQATKQ-FSETSLIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEF-- 126
Q+ E + + F + ++G G FG V+ ++ T + A K +R+ +
Sbjct: 173 QWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 127 VAEVTYLSEIRHRNLVTLLGYCQQNGYQM-LVFEYLPNGSMCNHLYETGLESSTKLEFKQ 185
+ E L+++ R +V+L Y + + LV + G + H+Y ++ F++
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG---FQE 288
Query: 186 RVSIALGA--AKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243
+I A GL HLH +++++ K NVL+D++ +++D G++ E
Sbjct: 289 PRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQT 344
Query: 244 PSHGSIVNV-FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
+ G F PE+ + D ++ GV L E++ +
Sbjct: 345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 46/212 (21%), Positives = 84/212 (39%), Gaps = 35/212 (16%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK----------------RRVGSPRQEFVAEVTYLSEI 136
+G G++G V ++ AIK + + +E E++ L +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 137 RHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAA 194
H N++ L + Y LV E+ G + + E KQ +S
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS------ 157
Query: 195 KGLCHLHSLKPPLVHKNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVN 251
G+C+LH +VH++ K N+L+ + K+ D G+S + G+
Sbjct: 158 -GICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA-- 212
Query: 252 VFRDPEVEESGVFSEMSDIYSFGVFLLELVTG 283
+ PEV + ++E D++S GV + L+ G
Sbjct: 213 YYIAPEVLK-KKYNEKCDVWSCGVIMYILLCG 243
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 36/152 (23%), Positives = 65/152 (42%), Gaps = 18/152 (11%)
Query: 95 IGFGSFGPVYKGLLRDT----VVAIK--RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYC 148
+G G++G VYK +D A+K G E+ L E++H N+++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-MSACREIALLRELKHPNVISLQKVF 87
Query: 149 QQNGYQ--MLVFEYLPN---GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
+ + L+F+Y + + H + +L S+ G+ +LH+
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 204 KPPLVHKNFKTANVLV----DENFIAKVADTG 231
++H++ K AN+LV E K+AD G
Sbjct: 148 W--VLHRDLKPANILVMGEGPERGRVKIADMG 177
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 26/122 (21%), Positives = 53/122 (43%), Gaps = 3/122 (2%)
Query: 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE 221
+ S L + + + AKG+ L S K +H++ N+L+ E
Sbjct: 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSE 228
Query: 222 NFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPEVEESGVFSEMSDIYSFGVFLLEL 280
+ K+ D G+++ + + + + + + PE V++ SD++SFGV L E+
Sbjct: 229 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288
Query: 281 VT 282
+
Sbjct: 289 FS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 23/89 (25%), Positives = 39/89 (43%), Gaps = 13/89 (14%)
Query: 95 IGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLV 142
+G G+FG V + VA+K + ++E+ L I H N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 143 TLLGYC-QQNGYQMLVFEYLPNGSMCNHL 170
LLG C + G M++ E+ G++ +L
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 33/221 (14%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK-------RRVGSPRQEFVAEVTYLSEIRHRNLVTL 144
L+G GS+G V + L +T A+K RR+ + E+ L +RH+N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 145 LG--YCQQNGYQMLVFEYLPNGS--MCNHLYETGL-ESSTKLEFKQRVSIALGAAKGLCH 199
+ Y ++ +V EY G M + + E F Q + GL +
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID-------GLEY 124
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH---GSIVNVFRDP 256
LHS +VHK+ K N+L+ K++ G+++ L GS F+ P
Sbjct: 125 LHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS--PAFQPP 180
Query: 257 EV-EESGVFS-EMSDIYSFGVFLLELVTGQ---EASHIVSL 292
E+ FS DI+S GV L + TG E +I L
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL 221
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 3e-11
Identities = 35/150 (23%), Positives = 66/150 (44%), Gaps = 27/150 (18%)
Query: 95 IGFGSFGPVYKGLLRDT---VVAIKR-RVGSPRQEF----VAEVTYLSEIRHRNLVTLLG 146
IG G++G VYK ++ A+K+ R+ + + E++ L E++H N+V L
Sbjct: 10 IGEGTYGVVYKA--QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHLYETGLES---STKLEFKQRV--SIALGAAKGLCHLH 201
+LVFE+L + L+ + + S L G+ + H
Sbjct: 68 VIHTKKRLVLVFEHL----------DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTG 231
+ ++H++ K N+L++ K+AD G
Sbjct: 118 DRR--VLHRDLKPQNLLINREGELKIADFG 145
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 46/240 (19%), Positives = 93/240 (38%), Gaps = 41/240 (17%)
Query: 59 GPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIK 116
GP A+ +F M + + + +G G+F V + + + T A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 117 ----RRVGSPRQEFVA-EVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLY 171
+++ + + + E +++H N+V L Q+ + LVF+ + G + +
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 172 ETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV---DENFIAK 226
E+ +Q + + + HS +VH+N K N+L+ + K
Sbjct: 121 AREFYSEADASHCIQQILE-------SIAYCHSNG--IVHRNLKPENLLLASKAKGAAVK 171
Query: 227 VADTGISKLLENIEEAGPSHGSIVNVFRD---------PEVEESGVFSEMSDIYSFGVFL 277
+AD G++ + + E + PEV + +S+ DI++ GV L
Sbjct: 172 LADFGLAIEVNDSE-----------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 45/202 (22%), Positives = 88/202 (43%), Gaps = 23/202 (11%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGY 147
+G G++G V + R T VA+K +R + E+ + H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETG--LESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
++ Q L EY G + + + E + F Q ++ G+ +LH +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------GVVYLHGIG- 125
Query: 206 PLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH---GSIVNVFRDPEV-EES 261
+ H++ K N+L+DE K++D G++ + + G++ V PE+ +
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV--APELLKRR 182
Query: 262 GVFSEMSDIYSFGVFLLELVTG 283
+E D++S G+ L ++ G
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAG 204
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 59/258 (22%), Positives = 95/258 (36%), Gaps = 61/258 (23%)
Query: 59 GPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIK 116
GP S + R + +F + G G+FG V G + T VAIK
Sbjct: 1 GPGSMMSLNAAAAADERSR------KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK 54
Query: 117 RRVGSPRQEF--VAEVTYLSEIRHRNLVTLLGYCQQNG-------YQMLVFEYLPNGSMC 167
+ + PR + + L+ + H N+V L Y G Y +V EY+P
Sbjct: 55 KVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----- 109
Query: 168 NHLYETGLESSTKLEFKQRVSIALGAAK--------GLCHLHSLKPPLVHKNFKTANVLV 219
L + ++++V+ K + LH + H++ K NVLV
Sbjct: 110 -----DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV 164
Query: 220 D-ENFIAKVADTGISKLLENIEEAGPSHGSIVNV-------FRDPEVEESGVFSEMS--- 268
+ + K+ D G +K L E NV +R PE+ +F
Sbjct: 165 NEADGTLKLCDFGSAKKLSPSEP---------NVAYICSRYYRAPEL----IFGNQHYTT 211
Query: 269 --DIYSFGVFLLELVTGQ 284
DI+S G E++ G+
Sbjct: 212 AVDIWSVGCIFAEMMLGE 229
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 8e-11
Identities = 47/203 (23%), Positives = 83/203 (40%), Gaps = 40/203 (19%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK---RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYC 148
++G G+F V+ R T + A+K + E+ L +I+H N+VTL
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 149 QQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKPP 206
+ + LV + + G + + + E G+ E L +Q +S + +LH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS-------AVKYLHENG-- 126
Query: 207 LVHKNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD-------- 255
+VH++ K N+L +EN + D G+SK+ +N +
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN------------GIMSTACGTPGYV 174
Query: 256 -PEVEESGVFSEMSDIYSFGVFL 277
PEV +S+ D +S GV
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVIT 197
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.8 bits (149), Expect = 8e-11
Identities = 43/238 (18%), Positives = 72/238 (30%), Gaps = 66/238 (27%)
Query: 85 ATKQFSETSLIGFGSFGPVYKGLLRDTVVAIKR-RVGSPR----------QEFVAEVTYL 133
T++ IG G FG V++ + T VAIK + P +E + E+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 134 SEI---------RHRNLVTLLG-YCQQNGY-----------------------------Q 154
E+ R + L +C Q Y
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKT 214
+V E+ G + + SI L + H++
Sbjct: 138 FIVLEFEFGGIDLEQM------RTKLSSLATAKSILHQLTASLAVAEA-SLRFEHRDLHW 190
Query: 215 ANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPEVEESG--VFSEMS 268
NVL+ + + K+ T K PS G V++ + +E G VF ++S
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTI-----PSCGLQVSIIDYTLSRLERDGIVVFCDVS 243
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 53/252 (21%), Positives = 88/252 (34%), Gaps = 76/252 (30%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK--------RRVGSPRQEFVA--------------- 128
IG GS+G V + A+K R+ G PR+
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 129 ------EVTYLSEIRHRNLVTLLGYCQQNGYQM----------LVFEYLPNGSMCNHLYE 172
E+ L ++ H N+V L ++ +VFE + G +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL--------VEVLDDPNEDHLYMVFELVNQGPVMEVPTL 131
Query: 173 TGL-ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231
L E + F+ + G+ +LH K ++H++ K +N+LV E+ K+AD G
Sbjct: 132 KPLSEDQARFYFQDLIK-------GIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 232 ISKLLENIEE-----AGPSHGSIVNVFRDPEV---EESGVFSEMSDIYSFGVFLLELVTG 283
+S + + G F PE + D+++ GV L V G
Sbjct: 183 VSNEFKGSDALLSNTVGTPA------FMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
Query: 284 Q---EASHIVSL 292
Q I+ L
Sbjct: 237 QCPFMDERIMCL 248
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 41/204 (20%), Positives = 83/204 (40%), Gaps = 41/204 (20%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVA-EVTYLSEIRHRNLVTLLGY 147
+G G+F V + + + T A K +++ + + + E +++H N+V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
Q+ + LVF+ + G + + E+ +Q + + + HS
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------SIAYCHSNG- 125
Query: 206 PLVHKNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD------- 255
+VH+N K N+L+ + K+AD G++ + + E +
Sbjct: 126 -IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-----------AWHGFAGTPGY 173
Query: 256 --PEVEESGVFSEMSDIYSFGVFL 277
PEV + +S+ DI++ GV L
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 47/204 (23%), Positives = 85/204 (41%), Gaps = 27/204 (13%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYC 148
+G G+FG V+ R + IK R P ++ AE+ L + H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 149 QQNGYQMLVFEYLPNG----SMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHS 202
+ +V E G + + E KQ ++ L + HS
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN-------ALAYFHS 142
Query: 203 LKPPLVHKNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVE 259
+VHK+ K N+L + K+ D G+++L ++ E + + G+ + + PEV
Sbjct: 143 QH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYM--APEVF 198
Query: 260 ESGVFSEMSDIYSFGVFLLELVTG 283
+ + DI+S GV + L+TG
Sbjct: 199 K-RDVTFKCDIWSAGVVMYFLLTG 221
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 37/162 (22%), Positives = 67/162 (41%), Gaps = 28/162 (17%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK-----------RRVGSPRQEFVAEVTYLSEIRHRNL 141
+G G+ G V R T VAI+ R P E+ L ++ H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCH 199
+ + + Y +V E + G + + + E++ KL F Q + + +
Sbjct: 203 IKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-------AVQY 254
Query: 200 LHSLKPPLVHKNFKTANVLV---DENFIAKVADTGISKLLEN 238
LH ++H++ K NVL+ +E+ + K+ D G SK+L
Sbjct: 255 LHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 44/227 (19%), Positives = 85/227 (37%), Gaps = 29/227 (12%)
Query: 31 SQSKNYQNKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFS 90
+ + ++ S + L+ + + G + Q A K+F
Sbjct: 34 REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY 93
Query: 91 ET----SLIGFGSFGPVYKGLLRDT--VVAIK-----RRVGSPRQEFVAEVTYLSEIR-- 137
+ +IG G V + + R T A+K SP Q E
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 138 -----HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIA 190
H +++TL+ + + + LVF+ + G + ++L E E T+ + +
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE-- 211
Query: 191 LGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237
+ LH+ +VH++ K N+L+D+N +++D G S LE
Sbjct: 212 -----AVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 4e-10
Identities = 56/236 (23%), Positives = 94/236 (39%), Gaps = 71/236 (30%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPR-QEFVA-EVTYLSEIRHRNLVTLL 145
+G G+FG V G + T VA+K +++ S + E+ L RH +++ L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 146 GYCQQNGYQM--------LVFEYLPNGSMCNHLYETG--LESSTKLEFKQRVSIALGAAK 195
YQ+ +V EY+ G + +++ + G E + F+Q +S
Sbjct: 77 -------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS------- 122
Query: 196 GLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD 255
+ + H +VH++ K NVL+D + AK+AD G+S N+ D
Sbjct: 123 AVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLS-----------------NMMSD 163
Query: 256 ---------------PEV-EESGVFSEMSDIYSFGVFLLELVTGQ---EASHIVSL 292
PEV DI+S GV L L+ G + H+ +L
Sbjct: 164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL 219
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 57/244 (23%), Positives = 94/244 (38%), Gaps = 38/244 (15%)
Query: 63 ATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIK---- 116
G P+ ++ E ++ L+G G FG V+ G VAIK
Sbjct: 7 LQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR 66
Query: 117 ----RRVGSPRQEFVA-EVTYLSEIR----HRNLVTLLGYCQQNGYQMLVFEY-LPNGSM 166
EV L ++ H ++ LL + + MLV E LP +
Sbjct: 67 NRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL 126
Query: 167 CNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD-ENF 223
+++ E G E ++ F Q V+ + H HS +VH++ K N+L+D
Sbjct: 127 FDYITEKGPLGEGPSRCFFGQVVA-------AIQHCHSRG--VVHRDIKDENILIDLRRG 177
Query: 224 IAKVADTGISKLLENIEEAGPSH---GSIVNVFRDPEVEESGVFS-EMSDIYSFGVFLLE 279
AK+ D G LL + P G+ V+ PE + + ++S G+ L +
Sbjct: 178 CAKLIDFGSGALLHD----EPYTDFDGTR--VYSPPEWISRHQYHALPATVWSLGILLYD 231
Query: 280 LVTG 283
+V G
Sbjct: 232 MVCG 235
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 39/211 (18%), Positives = 76/211 (36%), Gaps = 47/211 (22%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK--------RRVGSPRQEFVAEVTYLSEIRHRNLVTL 144
IG G F V + + R+T A+K G ++ E + ++H ++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGL------ESSTKLEFKQRVSIALGAAKGLC 198
L +G +VFE++ +C + + E+ +Q + L
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE-------ALR 144
Query: 199 HLHSLKPPLVHKNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD 255
+ H ++H++ K VL+ + + K+ G++ L V
Sbjct: 145 YCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL----------VAGG 192
Query: 256 ---------PEVEESGVFSEMSDIYSFGVFL 277
PEV + + + D++ GV L
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 46/210 (21%), Positives = 83/210 (39%), Gaps = 36/210 (17%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVA-------EVTYLSEIRHRNL 141
+G G+FG V+ + ++ V +K +V E+ LS + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGS-MCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLC 198
+ +L + G+ LV E +G + + E F+Q VS +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS-------AVG 144
Query: 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP----SHGSIVNVFR 254
+L ++H++ K N+++ E+F K+ D G + E G G+I +
Sbjct: 145 YLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSA----AYLERGKLFYTFCGTI--EYC 196
Query: 255 DPEV-EESGVFSEMSDIYSFGVFLLELVTG 283
PEV + +++S GV L LV
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 8e-10
Identities = 47/215 (21%), Positives = 84/215 (39%), Gaps = 52/215 (24%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK------------RRVGSPRQEFVAEVTYLSEI-RHR 139
+G G V + + + T A+K V R+ + EV L ++ H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 140 NLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGL 197
N++ L + N + LVF+ + G + ++L E E T+ + + +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE-------VI 137
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD-- 255
C LH L +VH++ K N+L+D++ K+ D G S L+ E R+
Sbjct: 138 CALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-----------KLREVC 184
Query: 256 -------PEVEESGVFSEMS------DIYSFGVFL 277
PE+ E + D++S GV +
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 43/261 (16%), Positives = 95/261 (36%), Gaps = 41/261 (15%)
Query: 36 YQNKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLI 95
+ + + +G + + + + +++ + + + F S +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61
Query: 96 GFGSFGPVYKGLLRDT-----VVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQ 150
G G+ VY+ + T + +K+ V ++ E+ L + H N++ L +
Sbjct: 62 GRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEIFET 119
Query: 151 NGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLV 208
LV E + G + + + E G E KQ + + +LH +V
Sbjct: 120 PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE-------AVAYLHENG--IV 170
Query: 209 HKNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD---------P 256
H++ K N+L + K+AD G+SK++E+ + + P
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-----------LMKTVCGTPGYCAP 219
Query: 257 EVEESGVFSEMSDIYSFGVFL 277
E+ + D++S G+
Sbjct: 220 EILRGCAYGPEVDMWSVGIIT 240
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 46/204 (22%), Positives = 79/204 (38%), Gaps = 42/204 (20%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFV-AEVTYLSEIRHRNLVTLLGY 147
+G GSFG V K R T A+K + + EV L ++ H N++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
+ + +V E G + + + + E KQ S G+ ++H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS-------GITYMHKHN- 141
Query: 206 PLVHKNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD------- 255
+VH++ K N+L+ +++ K+ D G+S + +D
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-----------KMKDRIGTAYY 189
Query: 256 --PEVEESGVFSEMSDIYSFGVFL 277
PEV G + E D++S GV L
Sbjct: 190 IAPEVLR-GTYDEKCDVWSAGVIL 212
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 52/216 (24%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPR-QEFVA-EVTYLSEIRHRNLVTLL 145
+G G+FG V G T VA+K +++ S + E+ L RH +++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETG--LESSTKLEFKQRVSIALGAAKGLCHLHSL 203
+V EY+ G + +++ + G E ++ F+Q +S CH H +
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-----GVDYCHRHMV 137
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD-------- 255
VH++ K NVL+D + AK+AD G+S N+ D
Sbjct: 138 ----VHRDLKPENVLLDAHMNAKIADFGLS-----------------NMMSDGEFLRTSC 176
Query: 256 -------PEV-EESGVFSEMSDIYSFGVFLLELVTG 283
PEV DI+S GV L L+ G
Sbjct: 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCG 212
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 49/197 (24%), Positives = 88/197 (44%), Gaps = 17/197 (8%)
Query: 95 IGFGSFGPVYKGLLRDT--VVA---IKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQ 149
+G G+FG V++ R T A + S ++ E+ +S +RH LV L +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 150 QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVH 209
+ ++++E++ G L+E + K+ + V KGLCH+H VH
Sbjct: 225 DDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVH 278
Query: 210 KNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSE 266
+ K N++ N + K+ D G++ L+ + + G+ F PEV E
Sbjct: 279 LDLKPENIMFTTKRSNEL-KLIDFGLTAHLDPKQSVKVTTGTA--EFAAPEVAEGKPVGY 335
Query: 267 MSDIYSFGVFLLELVTG 283
+D++S GV L++G
Sbjct: 336 YTDMWSVGVLSYILLSG 352
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 36/204 (17%), Positives = 78/204 (38%), Gaps = 40/204 (19%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVA-EVTYLSEIRHRNLVTLLGY 147
+G G+F V + + A +++ + + + E ++H N+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
+ G+ L+F+ + G + + E+ +Q + + H H +
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE-------AVLHCHQMG- 130
Query: 206 PLVHKNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD------- 255
+VH+N K N+L+ + K+AD G++ +E ++ +
Sbjct: 131 -VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ----------AWFGFAGTPGY 179
Query: 256 --PEVEESGVFSEMSDIYSFGVFL 277
PEV + + D+++ GV L
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVIL 203
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 35/173 (20%)
Query: 78 SMEELEQATKQFSETSLIGFGSFGPVYKGL-LRDT--VVAIKR-RVGSPRQEF----VAE 129
+ ++ E + IG G++G V+K L++ VA+KR RV + + + E
Sbjct: 9 ADQQYECVAE-------IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61
Query: 130 VTYLSEIR---HRNLVTLLGYCQQNGYQ-----MLVFEYLPN--GSMCNHLYETGLESST 179
V L + H N+V L C + LVFE++ + + + E G+ + T
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121
Query: 180 -KLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231
K Q + +GL LHS + +VH++ K N+LV + K+AD G
Sbjct: 122 IKDMMFQLL-------RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFG 165
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 52/269 (19%), Positives = 101/269 (37%), Gaps = 41/269 (15%)
Query: 30 KSQSKNYQNKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQF 89
S ++ ++ ++E +A + + P F +
Sbjct: 26 NSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAV 85
Query: 90 SE------TSLIGFGSFGPVYKGLLRDT--VVA---IKRRVGSPRQEFVAEVTYLSEIRH 138
+ T ++G G FG V+K T +A IK R ++E E++ ++++ H
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 139 RNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLC 198
NL+ L + +LV EY+ G L++ ++ S L + +G+
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIR 201
Query: 199 HLHSLKPPLVHKNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD 255
H+H + ++H + K N+L D I K+ D G+++ + E +
Sbjct: 202 HMHQMY--ILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPRE-----------KLKV 247
Query: 256 ---------PEVEESGVFSEMSDIYSFGV 275
PEV S +D++S GV
Sbjct: 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGV 276
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 37/162 (22%), Positives = 67/162 (41%), Gaps = 28/162 (17%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVA-------EVTYLSEIRHRNL 141
+G G+ G V R T VAIK R+ E+ L ++ H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCH 199
+ + + Y +V E + G + + + E++ KL F Q + + +
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-------AVQY 129
Query: 200 LHSLKPPLVHKNFKTANVLV---DENFIAKVADTGISKLLEN 238
LH ++H++ K NVL+ +E+ + K+ D G SK+L
Sbjct: 130 LHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 9e-09
Identities = 47/247 (19%), Positives = 79/247 (31%), Gaps = 66/247 (26%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVA----EVTYLSEIRHRNLVTL 144
IG GS+G V + T + AIK ++ + V EV + ++ H N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALG------------ 192
+ Y LV E G + + L +S+ K +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 193 ----------------AAK-------GLCHLHSLKPPLVHKNFKTANVLV--DENFIAKV 227
+ L +LH+ + H++ K N L +++F K+
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKL 211
Query: 228 ADTGISKLLENIEEAGPSHGSIVNVFRD---------PEV--EESGVFSEMSDIYSFGVF 276
D G+SK + PEV + + D +S GV
Sbjct: 212 VDFGLSKEFYKLNNGE------YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 277 LLELVTG 283
L L+ G
Sbjct: 266 LHLLLMG 272
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 57/259 (22%), Positives = 99/259 (38%), Gaps = 34/259 (13%)
Query: 40 NSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGS 99
+ + + S A + + +M +F L+G G+
Sbjct: 108 DGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN-------EFEYLKLLGKGT 160
Query: 100 FGPVYKGLLRDT--VVAIK---RRVGSPRQEF---VAEVTYLSEIRHRNLVTLLGYCQQN 151
FG V + T A+K + V + E + E L RH L L Y Q
Sbjct: 161 FGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQT 219
Query: 152 GYQM-LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGA--AKGLCHLHSLKPPLV 208
++ V EY G + HL + F + + GA L +LHS K +V
Sbjct: 220 HDRLCFVMEYANGGELFFHLSRERV-------FSEDRARFYGAEIVSALDYLHSEKN-VV 271
Query: 209 HKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH---GSIVNVFRDPEVEESGVFS 265
+++ K N+++D++ K+ D G+ K E I++ G+ + PEV E +
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTP--EYLAPEVLEDNDYG 327
Query: 266 EMSDIYSFGVFLLELVTGQ 284
D + GV + E++ G+
Sbjct: 328 RAVDWWGLGVVMYEMMCGR 346
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 48/214 (22%), Positives = 81/214 (37%), Gaps = 32/214 (14%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQE--FVAEVTYLSEIRHRN 140
+ +IG G+FG V + T V A+K + F E ++
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL 200
+V L Q + Y +V EY+P G + N + + + V +AL +
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALD------AI 184
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF------R 254
HS+ +H++ K N+L+D++ K+AD G + +
Sbjct: 185 HSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM------KMNKEGMVRCDTAVGTPDYI 236
Query: 255 DPEV----EESGVFSEMSDIYSFGVFLLELVTGQ 284
PEV G + D +S GVFL E++ G
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 39/199 (19%), Positives = 81/199 (40%), Gaps = 21/199 (10%)
Query: 95 IGFGSFGPVYKGLLRDT--VVA---IKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQ 149
+G G+FG V++ + + T V I + E++ ++++ H L+ L +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 150 QNGYQMLVFEYLPNGSMCNHLYETGL---ESSTKLEFKQRVSIALGAAKGLCHLHSLKPP 206
+L+ E+L G + + + E+ +Q GL H+H
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE-------GLKHMHEHS-- 169
Query: 207 LVHKNFKTANVLV--DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVF 264
+VH + K N++ + K+ D G++ L E + + F PE+ +
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA--EFAAPEIVDREPV 227
Query: 265 SEMSDIYSFGVFLLELVTG 283
+D+++ GV L++G
Sbjct: 228 GFYTDMWAIGVLGYVLLSG 246
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 28/206 (13%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK---------RRVGSPRQEFVAEVTYLSEIRHRNLVT 143
+G G F V K + T A K R G R+E EV+ L ++ H N++T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLH 201
L + +L+ E + G + + L + E KQ + G+ +LH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD-------GVNYLH 132
Query: 202 SLKPPLVHKNFKTANVLV----DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPE 257
+ K + H + K N+++ K+ D G++ +E+ E G+ F PE
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP--EFVAPE 188
Query: 258 VEESGVFSEMSDIYSFGVFLLELVTG 283
+ +D++S GV L++G
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 1e-08
Identities = 42/193 (21%), Positives = 73/193 (37%), Gaps = 22/193 (11%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK---RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQ 149
IG GS+G V + + T A K + F E+ + + H N++ L +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 150 QNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPL 207
N LV E G + + + ES K +S + + H L +
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS-------AVAYCHKLN--V 127
Query: 208 VHKNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVF 264
H++ K N L + K+ D G++ + + G+ V P+V E G++
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYV--SPQVLE-GLY 184
Query: 265 SEMSDIYSFGVFL 277
D +S GV +
Sbjct: 185 GPECDEWSAGVMM 197
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 28/206 (13%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK---------RRVGSPRQEFVAEVTYLSEIRHRNLVT 143
+G G F V K + T A K R G R+E EV+ L ++ H N++T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLH 201
L + +L+ E + G + + L + E KQ + G+ +LH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD-------GVNYLH 132
Query: 202 SLKPPLVHKNFKTANVLV----DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPE 257
+ K + H + K N+++ K+ D G++ +E+ E G+ F PE
Sbjct: 133 TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP--EFVAPE 188
Query: 258 VEESGVFSEMSDIYSFGVFLLELVTG 283
+ +D++S GV L++G
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 38/225 (16%), Positives = 79/225 (35%), Gaps = 32/225 (14%)
Query: 41 SETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQAT----KQFSETSLIG 96
S ++ S GQ ++ + + ++ LIG
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62
Query: 97 FGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVA-----EVTYLSEIRHRNLVTLLGYCQ 149
GS+G V + + VVAIK+ + E+ L+ + H ++V +L
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122
Query: 150 QNGYQM-----LVFEYLPNGSMCNHLYETGL----ESSTKLEFKQRVSIALGAAKGLCHL 200
+ +V E ++ + L ++ G+ ++
Sbjct: 123 PKDVEKFDELYVVLEIA----------DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYV 172
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPS 245
HS ++H++ K AN LV+++ KV D G+++ ++ E
Sbjct: 173 HSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 52/209 (24%), Positives = 80/209 (38%), Gaps = 32/209 (15%)
Query: 93 SLIGFGSFGPVYKG--LLRDTVVAIK--RRVGSPRQEFVAEVTYLSEIRHR------NLV 142
+IG GSFG V K VA+K R ++ E+ L +R + N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 143 TLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTK---LEFKQRVSIALGAAKGLCH 199
+L + + FE L SM LYE L K A + L
Sbjct: 163 HMLENFTFRNHICMTFELL---SMN--LYE--LIKKNKFQGFSLPLVRKFAHSILQCLDA 215
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIA--KVADTGISKLLENIEEAGPSHGSIVN--VFRD 255
LH + ++H + K N+L+ + + KV D G S + + +R
Sbjct: 216 LHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ------RVYTYIQSRFYRA 267
Query: 256 PEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
PEV + D++S G L EL+TG
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 38/211 (18%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK-----RRVGSPRQEFV-AEVTYLSEIRHRNLVTLL 145
IG GSFG V DT + A+K + V V E+ + + H LV L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 146 GYCQQNGYQM-LVFEYLPNGSMCNHLYETGL--ESSTKL---EFKQRVSIALGAAKGLCH 199
Y Q+ M +V + L G + HL + E + KL E + + L +
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE------LVMA----LDY 130
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD---P 256
L + + ++H++ K N+L+DE+ + D I+ +L + G+ P
Sbjct: 131 LQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTK-----PYMAP 183
Query: 257 EV---EESGVFSEMSDIYSFGVFLLELVTGQ 284
E+ + +S D +S GV EL+ G+
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 57/267 (21%), Positives = 103/267 (38%), Gaps = 31/267 (11%)
Query: 36 YQNKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATK----QFSE 91
Y N S+ + + + + + F+
Sbjct: 286 YFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNF 345
Query: 92 TSLIGFGSFGPVYKGLLRDT--VVAIK---RRVGSPRQEF---VAEVTYLSEIRHRNLVT 143
++G GSFG V + T + A+K + V + + E L+ +T
Sbjct: 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 144 LLGYCQQNGYQM-LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGA--AKGLCHL 200
L C Q ++ V EY+ G + H+ + G FK+ ++ A A GL L
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-------FKEPHAVFYAAEIAIGLFFL 458
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH---GSIVNVFRDPE 257
S +++++ K NV++D K+AD G+ K ENI + + G+ + PE
Sbjct: 459 QSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTP--DYIAPE 512
Query: 258 VEESGVFSEMSDIYSFGVFLLELVTGQ 284
+ + + D ++FGV L E++ GQ
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 55/252 (21%), Positives = 95/252 (37%), Gaps = 37/252 (14%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK---RRVGSPRQEFVA-EVTYLSEIRHRNLVTLLGY 147
IG G+FG + T +VA+K R V E+ +RH N+V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN--VQREIINHRSLRHPNIVRFKEV 84
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETG--LESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
+ ++ EY G + + G E + F+Q +S G+ + HS++
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-------GVSYCHSMQ- 136
Query: 206 PLVHKNFKTANVLVDENFIA--KVADTGISKLLENIEEAGPSHGSIVNVFRDPEV-EESG 262
+ H++ K N L+D + K+ D G SK + + G+ + PEV
Sbjct: 137 -ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI--APEVLLRQE 193
Query: 263 VFSEMSDIYSFGVFLLELVTGQ---EASHIVSLGSYEALIQWVRSRLSSNNFVDHRL-AG 318
+++D++S GV L ++ G E Y IQ + S V + +
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILS-------VKYSIPDD 244
Query: 319 TFTTEGMRDLIR 330
+ LI
Sbjct: 245 IRISPECCHLIS 256
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 43/216 (19%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQE--FVAEVTYLSEIRHRN 140
F +G GSFG V +++ A+K ++V +Q + E L +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVS------IALGAA 194
LV L + N +V EY+ G M +HL G F + + I L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-------RFSEPHARFYAAQIVL--- 152
Query: 195 KGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR 254
+LHSL L++++ K N+L+D+ +V D G +K ++
Sbjct: 153 -TFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----------RTWTLC 199
Query: 255 D------PEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
PE+ S +++ D ++ GV + E+ G
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 6e-08
Identities = 52/215 (24%), Positives = 83/215 (38%), Gaps = 46/215 (21%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK---------RRVGSPRQEFVAEVTYLSEIRHRNLVT 143
+G G F V K + T A K R G R+E EV L EIRH N++T
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLH 201
L + +L+ E + G + + L E E KQ + G+ +LH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD-------GVHYLH 125
Query: 202 SLKPPLVHKNFKTANVLV----DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD-- 255
S + + H + K N+++ N K+ D GI+ +E F++
Sbjct: 126 SKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-----------EFKNIF 172
Query: 256 -------PEVEESGVFSEMSDIYSFGVFLLELVTG 283
PE+ +D++S GV L++G
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 61/265 (23%), Positives = 99/265 (37%), Gaps = 53/265 (20%)
Query: 44 GSSDPSALVEWNRG-AGPSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGP 102
G S P N A P + + Q + GP F +IG GSFG
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPS-------DFHFLKVIGKGSFGK 53
Query: 103 VYKGLLRDT--VVAIKRRVGSPRQEFVA---EVTY-LSE-------IRHRNLVTLLGYCQ 149
V + A+K +++ + E + +SE ++H LV L +
Sbjct: 54 VLLARHKAEEVFYAVK----VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSF 108
Query: 150 QNGYQM-LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVS------IALGAAKGLCHLHS 202
Q ++ V +Y+ G + HL F + + IA L +LHS
Sbjct: 109 QTADKLYFVLDYINGGELFYHLQRERC-------FLEPRARFYAAEIASA----LGYLHS 157
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH---GSIVNVFRDPEVE 259
L +V+++ K N+L+D + D G+ K ENIE + G+ + PEV
Sbjct: 158 LN--IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPE--YLAPEVL 211
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQ 284
+ D + G L E++ G
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 7e-08
Identities = 48/215 (22%), Positives = 85/215 (39%), Gaps = 46/215 (21%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK---------RRVGSPRQEFVAEVTYLSEIRHRNLVT 143
+G G F V K + T A K R G R++ EV+ L EI+H N++T
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLH 201
L + +L+ E + G + + L E E KQ ++ G+ +LH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN-------GVYYLH 131
Query: 202 SLKPPLVHKNFKTANVLV----DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD-- 255
SL+ + H + K N+++ K+ D G++ ++ F++
Sbjct: 132 SLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-----------EFKNIF 178
Query: 256 -------PEVEESGVFSEMSDIYSFGVFLLELVTG 283
PE+ +D++S GV L++G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 53/216 (24%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPR-QEFVA-EVTYLSEIRHRNLVTLL 145
+G GSFG V T VA+K + + V E++YL +RH +++ L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETG--LESSTKLEFKQRVSIALGAAKGLCHLHSL 203
++V EY G + +++ E E + F+Q + A CH H +
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC-----AIEYCHRHKI 129
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD-------- 255
VH++ K N+L+D+N K+AD G+S N+ D
Sbjct: 130 ----VHRDLKPENLLLDDNLNVKIADFGLS-----------------NIMTDGNFLKTSC 168
Query: 256 -------PEV-EESGVFSEMSDIYSFGVFLLELVTG 283
PEV D++S G+ L ++ G
Sbjct: 169 GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEF--VAEVTYLSEI-- 136
FS +IG G FG VY DT + A+K +R+ + E + E LS +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 137 -RHRNLVTLLGYCQQNGYQM-LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGA- 193
+V + Y ++ + + + G + HL + G F + A
Sbjct: 249 GDCPFIVC-MSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-------VFSEADMRFYAAE 300
Query: 194 -AKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV 252
GL H+H+ +V+++ K AN+L+DE+ +++D G++ H S+
Sbjct: 301 IILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTH 354
Query: 253 -FRDPEVEESGV-FSEMSDIYSFGVFLLELVTGQ 284
+ PEV + GV + +D +S G L +L+ G
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 41/203 (20%), Positives = 77/203 (37%), Gaps = 42/203 (20%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYC 148
+G GSF K + + + A+K R + ++E + + H N+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKE-ITALKLCEG--HPNIVKLHEVF 75
Query: 149 QQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKPP 206
+ LV E L G + + + E+ ++ VS + H+H +
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS-------AVSHMHDVG-- 126
Query: 207 LVHKNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD-------- 255
+VH++ K N+L ++N K+ D G ++L + +
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ----------PLKTPCFTLHYA 176
Query: 256 -PEVEESGVFSEMSDIYSFGVFL 277
PE+ + E D++S GV L
Sbjct: 177 APELLNQNGYDESCDLWSLGVIL 199
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 43/213 (20%), Positives = 81/213 (38%), Gaps = 37/213 (17%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAI----KRRVGSPRQE--FVAEVTYLSEIRHRNLVTLL 145
+IG G+FG V L++ V A+ K + + F E L + + TL
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVS------IALGAAKGLCH 199
Q + LV +Y G + L S + + ++ + + +
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLL------SKFEDRLPEEMARFYLAEMVI----AIDS 190
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVN-------- 251
+H L VH++ K N+L+D N ++AD G + +E+ V
Sbjct: 191 VHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCL--KLMEDGTVQSSVAVGTPDYISPE 246
Query: 252 VFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
+ + E + + D +S GV + E++ G+
Sbjct: 247 ILQAMEGGKGR-YGPECDWWSLGVCMYEMLYGE 278
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 8e-08
Identities = 47/216 (21%), Positives = 74/216 (34%), Gaps = 41/216 (18%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK---RRVGSPRQE---FVAEVTYLSEIRHRNLVTLL 145
+IG G+F V ++ T V A+K + R E F E L R + L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 146 GYC-QQNGYQMLVFEYLPNGSMCNHLYETGL---ESSTKLEFKQRVSIALGAAKGLCHLH 201
+ Q Y LV EY G + L + G + + V + +H
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM-------AIDSVH 179
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF------RD 255
L VH++ K N+L+D ++AD G + V
Sbjct: 180 RLG--YVHRDIKPDNILLDRCGHIRLADFGSCL------KLRADGTVRSLVAVGTPDYLS 231
Query: 256 PEVEESGVFSEMSDIY-------SFGVFLLELVTGQ 284
PE+ ++ + Y + GVF E+ GQ
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 8e-08
Identities = 44/206 (21%), Positives = 87/206 (42%), Gaps = 31/206 (15%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK---RRVGSPRQEFVAEVTYLSEIR-HRNLVTLLGY 147
++G G+ V + T A+K ++ G R EV L + + HRN++ L+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 148 CQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
++ LVFE + GS+ +H+++ E + + S L LH+
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS-------ALDFLHNKG- 131
Query: 206 PLVHKNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVNV------FRDP 256
+ H++ K N+L ++ K+ D + ++ + P + + P
Sbjct: 132 -IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 257 EV-----EESGVFSEMSDIYSFGVFL 277
EV EE+ ++ + D++S GV L
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 8e-08
Identities = 40/213 (18%), Positives = 78/213 (36%), Gaps = 44/213 (20%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK-----RRVGSPRQEFVAEVTYLSEIRHR-NLVTLLG 146
+G G F V + + + T A K RR R E + E+ L + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 147 YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLE----FKQRVSIALGAAKGLCHLHS 202
+ +L+ EY G + + E ++ + KQ + G+ +LH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE-------GVYYLHQ 149
Query: 203 LKPPLVHKNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD---- 255
+VH + K N+L+ K+ D G+S+ + + R+
Sbjct: 150 NN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-----------ELREIMGT 196
Query: 256 -----PEVEESGVFSEMSDIYSFGVFLLELVTG 283
PE+ + +D+++ G+ L+T
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 49/219 (22%), Positives = 87/219 (39%), Gaps = 39/219 (17%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVA------EVTYLSEIR 137
K++ IG G+ G V VAIK+ + P Q E+ + +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK-LSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 138 HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLY------ETGLE--SSTKLEFKQRVSI 189
H+N+++LL VF +Y + L +L+ ++ +
Sbjct: 120 HKNIISLLN----------VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 169
Query: 190 ALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSI 249
G+ HLHS ++H++ K +N++V + K+ D G+++ AG S
Sbjct: 170 LYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMT 221
Query: 250 VNV----FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
V +R PEV + E DI+S G + E+V +
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 1e-07
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 36/216 (16%)
Query: 88 QFSETSLIGFGSFGPVY---KGLLRDT--VVAIK-----RRVGSPRQEFVAEVTYLSEIR 137
QF ++G GSFG V+ K D + A+K R E L E+
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 138 HRNLVTLLGYCQQNGYQM-LVFEYLPNGSMCNHLYETGL--ESSTKL---EFKQRVSIAL 191
H +V L Y Q ++ L+ ++L G + L + + E K E +AL
Sbjct: 85 HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE------LAL 137
Query: 192 GAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH---GS 248
L HLHSL +++++ K N+L+DE K+ D G+SK E+I+ ++ G+
Sbjct: 138 A----LDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGT 189
Query: 249 IVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
+ + PEV ++ +D +SFGV + E++TG
Sbjct: 190 VE--YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 46/254 (18%), Positives = 87/254 (34%), Gaps = 67/254 (26%)
Query: 82 LEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVAEVTYLSEIRHR 139
LE ++K++S +G GSFG V + ++ A+K +V + E+ + + H
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK-KVLQDPRYKNRELDIMKVLDHV 60
Query: 140 NLVTLL------GYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFK--------- 184
N++ L+ G + Q G + K
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 185 ----QRVSIALGAAK-----------------GLCHLHSLKPPLVHKNFKTANVLVD-EN 222
+V + + + +HSL + H++ K N+LV+ ++
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKD 178
Query: 223 FIAKVADTGISKLLENIEEAGPSHGSIVNV-------FRDPEVEESGVFSEMS-----DI 270
K+ D G +K L E +V +R PE+ + D+
Sbjct: 179 NTLKLCDFGSAKKLIPSEP---------SVAYICSRFYRAPEL----MLGATEYTPSIDL 225
Query: 271 YSFGVFLLELVTGQ 284
+S G EL+ G+
Sbjct: 226 WSIGCVFGELILGK 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 49/219 (22%), Positives = 89/219 (40%), Gaps = 39/219 (17%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVA------EVTYLSEIR 137
K++ IG G+ G V VAIK+ + P Q E+ + +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKK-LSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 138 HRNLVTLLG-YCQQNGYQM-----LVFEYLPNGSMCNHLYETGLES--STKLEFKQRVSI 189
H+N++ LL + Q + +V E + + L +L+ ++ +
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM----------DANLCQVIQMELDHERMSYL 132
Query: 190 ALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSI 249
G+ HLHS ++H++ K +N++V + K+ D G+++ AG S
Sbjct: 133 LYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMT 184
Query: 250 VNV----FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
V +R PEV + E DI+S G + E++ G
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 2e-07
Identities = 49/216 (22%), Positives = 95/216 (43%), Gaps = 46/216 (21%)
Query: 94 LIGFGSFGPVY---KGLLRDT--VVAIK----RRVGSPRQEFV---AEVTYLSEIRHRNL 141
++G G +G V+ K +T + A+K + ++ AE L E++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 142 VTLLGYCQQNGYQM-LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVS------IALGAA 194
V L+ Y Q G ++ L+ EYL G + L G+ F + + I++
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGI-------FMEDTACFYLAEISMA-- 133
Query: 195 KGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH---GSIVN 251
L HLH +++++ K N++++ K+ D G+ K E+I + +H G+I
Sbjct: 134 --LGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTI-- 185
Query: 252 VFRD---PEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
+ PE+ + D +S G + +++TG
Sbjct: 186 ---EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 51/209 (24%), Positives = 80/209 (38%), Gaps = 28/209 (13%)
Query: 92 TSLIGFGSFGPVYKG--LLRDTVVAIK--RRVGSPRQEFVAEVTYLSEIRHR------NL 141
SLIG GSFG V K + VAIK + + + EV L + +
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRV--SIALGAAKGLCH 199
V L + + LVFE L S LY+ L ++ + A L
Sbjct: 119 VHLKRHFMFRNHLCLVFEML---SYN--LYDL-LRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 200 LHSLKPPLVHKNFKTANVLV--DENFIAKVADTGISKLLENIEEAGPSHGSIVN--VFRD 255
L + + ++H + K N+L+ + K+ D G S L + +R
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ------RIYQYIQSRFYRS 226
Query: 256 PEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
PEV + D++S G L+E+ TG+
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 37/199 (18%), Positives = 75/199 (37%), Gaps = 38/199 (19%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIK--RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQ 150
+G G FG V++ + + K + G+ + E++ L+ RHRN++ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 151 NGYQMLVFEYLPNGSMCNHLYETGL---ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPL 207
+++FE++ + + + E Q L LHS +
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE-------ALQFLHSHN--I 123
Query: 208 VHKNFKTANVLV--DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD---------P 256
H + + N++ + K+ + G ++ L+ + FR P
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-----------NFRLLFTAPEYYAP 172
Query: 257 EVEESGVFSEMSDIYSFGV 275
EV + V S +D++S G
Sbjct: 173 EVHQHDVVSTATDMWSLGT 191
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 5e-07
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 28/205 (13%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK---RRVGSPRQEF---VAEVTYLSEIRHRNLVTLL 145
L+G G+FG V + T A+K + V + E V E L RH L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 146 GYCQQNGYQM-LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGA--AKGLCHLHS 202
Y Q ++ V EY G + HL + F + + GA L +LHS
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSALEYLHS 123
Query: 203 LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH---GSIVNVFRDPEVE 259
+V+++ K N+++D++ K+ D G+ K E I + G+ + PEV
Sbjct: 124 RD--VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTP--EYLAPEVL 177
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQ 284
E + D + GV + E++ G+
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 55/276 (19%), Positives = 98/276 (35%), Gaps = 49/276 (17%)
Query: 38 NKNSETGSSDPSALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQAT-KQFSETSLIG 96
+ + S G + + E+ + F ++G
Sbjct: 4 HHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLG 63
Query: 97 FGSFGPVY---KGLLRDT--VVAIK---RRVGSPRQEFV----AEVTYLSEIRHRNLVTL 144
G++G V+ K DT + A+K + + + E L IR +
Sbjct: 64 TGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVT 123
Query: 145 LGYCQQNGYQM-LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVS------IALGAAKGL 197
L Y Q ++ L+ +Y+ G + HL + F + I L L
Sbjct: 124 LHYAFQTETKLHLILDYINGGELFTHLSQRER-------FTEHEVQIYVGEIVLA----L 172
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF---- 253
HLH L +++++ K N+L+D N + D G+SK E + + F
Sbjct: 173 EHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK--EFVAD----ETERAYDFCGTI 224
Query: 254 --RDPEV---EESGVFSEMSDIYSFGVFLLELVTGQ 284
P++ +SG + D +S GV + EL+TG
Sbjct: 225 EYMAPDIVRGGDSG-HDKAVDWWSLGVLMYELLTGA 259
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 6e-07
Identities = 51/246 (20%), Positives = 99/246 (40%), Gaps = 45/246 (18%)
Query: 59 GPS-SATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAI 115
GP S+ G + + ++ F ++G GSFG V +++T + A+
Sbjct: 1 GPKESSKEGNGIGVNSSNRLGID-------NFEFIRVLGKGSFGKVMLARVKETGDLYAV 53
Query: 116 KRRVGSPRQEFVA---EVTY-LSE-------IRHRNLVTLLGYCQQNGYQM-LVFEYLPN 163
K +++ + +V ++E H L L C Q ++ V E++
Sbjct: 54 K----VLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNG 108
Query: 164 GSMCNHLYETGLESSTKLEFKQRVSIALGA--AKGLCHLHSLKPPLVHKNFKTANVLVDE 221
G + H+ ++ F + + A L LH +++++ K NVL+D
Sbjct: 109 GDLMFHIQKSRR-------FDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDH 159
Query: 222 NFIAKVADTGISKLLENIEEAGPSH---GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLL 278
K+AD G+ K E I + G+ + PE+ + ++ D ++ GV L
Sbjct: 160 EGHCKLADFGMCK--EGICNGVTTATFCGTP--DYIAPEILQEMLYGPAVDWWAMGVLLY 215
Query: 279 ELVTGQ 284
E++ G
Sbjct: 216 EMLCGH 221
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 8e-07
Identities = 37/159 (23%), Positives = 68/159 (42%), Gaps = 27/159 (16%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQ-EFV-AEVTYLSEIRHRNLVTLL 145
+G GSFG V+ R A+K V +Q E E LS + H ++ +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVS------IALGAAKGLCH 199
G Q ++ +Y+ G + + L ++ F V+ + L L +
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLLRKSQR-------FPNPVAKFYAAEVCL----ALEY 121
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238
LHS +++++ K N+L+D+N K+ D G +K + +
Sbjct: 122 LHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 40/208 (19%), Positives = 77/208 (37%), Gaps = 48/208 (23%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK--RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQ 149
++G G G V + R T A+K RQE V S ++V +L +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE-VDHHWQAS--GGPHIVCILDVYE 92
Query: 150 QNGYQM----LVFEYLPNGSMCNHLYETGLESSTKLE----FKQRVSIALGAAKGLCHLH 201
+ ++ E + G + + + E G ++ T+ E + + + LH
Sbjct: 93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT-------AIQFLH 145
Query: 202 SLKPPLVHKNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD--- 255
S + H++ K N+L +++ + K+ D G +K N +
Sbjct: 146 SHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ------------NALQTPCY 191
Query: 256 ------PEVEESGVFSEMSDIYSFGVFL 277
PEV + + D++S GV +
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 43/202 (21%), Positives = 87/202 (43%), Gaps = 27/202 (13%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVAEVTYLSEIR-HRNLVTLLG--YCQ 149
+G G + V++ + V +K +++ E+ L +R N++TL
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP 103
Query: 150 QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVH 209
+ LVFE++ N LY+T + + + + K L + HS+ ++H
Sbjct: 104 VSRTPALVFEHVNNTDF-KQLYQTLTDYDIRFYMYEIL-------KALDYCHSMG--IMH 153
Query: 210 KNFKTANVLVD-ENFIAKVADTGISKLLENIEEAGPSHGSIVNV----FRDPEV-EESGV 263
++ K NV++D E+ ++ D G++ E P V V F+ PE+ + +
Sbjct: 154 RDVKPHNVMIDHEHRKLRLIDWGLA------EFYHPGQEYNVRVASRYFKGPELLVDYQM 207
Query: 264 FSEMSDIYSFGVFLLELVTGQE 285
+ D++S G L ++ +E
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKE 229
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 52/273 (19%), Positives = 93/273 (34%), Gaps = 50/273 (18%)
Query: 30 KSQSKNYQNKNSETGSSDPS-ALVEWNRGAGPSSATGQPSFGPQGARQFSMEELEQATKQ 88
+ QS P+ AL P P F + Q + K
Sbjct: 6 QGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKV 65
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIK--RRVGSPRQEFVAEVTYLSEIRHRNLVTL 144
S+ +G G G V + + T A+K + R+E V S + ++V +
Sbjct: 66 TSQV--LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE-VELHWRAS--QCPHIVRI 120
Query: 145 LGYCQ----QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLE----FKQRVSIALGAAKG 196
+ + ++V E L G + + + + G ++ T+ E K
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE-------A 173
Query: 197 LCHLHSLKPPLVHKNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVNVF 253
+ +LHS+ + H++ K N+L N I K+ D G +K + N
Sbjct: 174 IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS-----------HNSL 220
Query: 254 RD---------PEVEESGVFSEMSDIYSFGVFL 277
PEV + + D++S GV +
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 46/228 (20%), Positives = 81/228 (35%), Gaps = 56/228 (24%)
Query: 93 SLIGFGSFGPVYKG--LLRDTVVAIK--RRVGSPRQEFVAEVTYLSEIR----------- 137
+G+G F V+ ++ +T VA+K R + E+ L +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 138 HRNLVTLLG---YCQQNGYQM-LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGA 193
+++ LL + NG + +VFE L +L K + + +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL---GE--NLLAL-----IKKYEHRGIPLIYVK 134
Query: 194 A------KGLCHLHSLKPPLVHKNFKTANVLVDE------NFIAKVADTGISKLLENIEE 241
GL ++H + ++H + K NVL++ K+AD G
Sbjct: 135 QISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG---------N 184
Query: 242 AGPSHGSIVNV-----FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
A N +R PEV + +DI+S + EL+TG
Sbjct: 185 ACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 42/223 (18%), Positives = 80/223 (35%), Gaps = 46/223 (20%)
Query: 79 MEELEQATKQFSET----SLIGFGSFGPVYKGLLRDT--VVAIK---RRVGSPRQEFVAE 129
+++L + + QF++ IG GS+ + + + T A+K + P +E +
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE-IEI 68
Query: 130 VTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRV 187
+ +H N++TL Y +V E + G + + + E
Sbjct: 69 LLRYG--QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT 126
Query: 188 SIALGAAKGLCHLHSLKPPLVHKNFKTANVLV----DENFIAKVADTGISKLLENIEEAG 243
+ +LH+ +VH++ K +N+L ++ D G +K L
Sbjct: 127 K-------TVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG-- 175
Query: 244 PSHGSIVNVFRD---------PEVEESGVFSEMSDIYSFGVFL 277
+ PEV E + DI+S GV L
Sbjct: 176 --------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 47/273 (17%), Positives = 98/273 (35%), Gaps = 47/273 (17%)
Query: 35 NYQNKNSETGSSDPSALVEWNRGAGPSS-----ATGQPSFGPQGARQFSMEELEQATKQF 89
+Y + + P+ + +GA S + + ++ F
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQ-------DF 54
Query: 90 SETSLIGFGSFGPVYKGLLRDT--VVAIK----------RRVGSPRQEFVAEVTYLSEIR 137
+IG GS+ V L+ T + A++ + + E +
Sbjct: 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ----TEKHVFEQAS 110
Query: 138 HRNLVTLLGYCQQNGYQM-LVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAA 194
+ + L C Q ++ V EY+ G + H+ E + + +S+AL
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALN-- 167
Query: 195 KGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH---GSIVN 251
+LH +++++ K NVL+D K+ D G+ K E + + G+
Sbjct: 168 ----YLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTP-- 217
Query: 252 VFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
+ PE+ + D ++ GV + E++ G+
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 55/242 (22%), Positives = 96/242 (39%), Gaps = 42/242 (17%)
Query: 61 SSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIK-- 116
++ T + + F+ ++G GSFG V + T + A+K
Sbjct: 1 TTNTVSKFDNNGNRDRMKLT-------DFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL 53
Query: 117 --------RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQM-LVFEYLPNGSMC 167
V E L+ +T L C Q ++ V EY+ G +
Sbjct: 54 KKDVVIQDDDVECTM----VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM 109
Query: 168 NHLYETGLESSTKLEFKQRVSIALGA--AKGLCHLHSLKPPLVHKNFKTANVLVDENFIA 225
H+ + G FK+ ++ A A GL L S +++++ K NV++D
Sbjct: 110 YHIQQVGR-------FKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHI 160
Query: 226 KVADTGISKLLENIEEAGPSH---GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT 282
K+AD G+ K ENI + + G+ + PE+ + + D ++FGV L E++
Sbjct: 161 KIADFGMCK--ENIWDGVTTKTFCGTPD--YIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216
Query: 283 GQ 284
GQ
Sbjct: 217 GQ 218
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 48/224 (21%), Positives = 79/224 (35%), Gaps = 40/224 (17%)
Query: 93 SLIGFGSFGPVYKG--LLRDTVVAIK--RRVGSPRQEFVAEVTYLSEIRHR-----NLVT 143
+G G+FG V + A+K R + + E L +I++ N+V
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRV--SIALGAAKGLCHLH 201
G + L+FE L LYE + + F + K L +L
Sbjct: 101 YHGKFMYYDHMCLIFEPL---GPS--LYEI-ITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--F------ 253
+ L H + K N+L+D+ + K T + + + + + F
Sbjct: 155 KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212
Query: 254 -------------RDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
R PEV + + SD++SFG L EL TG
Sbjct: 213 SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 36/196 (18%), Positives = 73/196 (37%), Gaps = 30/196 (15%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSP-RQEFVA-----EVTYLSEIR 137
+ LIG GS+G VY ++T VAIK+ V E+T L+ ++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKK-VNRMFEDLIDCKRILREITILNRLK 83
Query: 138 HRNLVTLLGYCQQNGYQM-----LVFEYLPNGSMCNHLYETGLE----SSTKLEFKQRVS 188
++ L + +V E ++ L+ + L + +
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIA----------DSDLKKLFKTPIFLTEEHIKT 133
Query: 189 IALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGS 248
I G +H ++H++ K AN L++++ KV D G+++ + + ++ +
Sbjct: 134 ILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 249 IVNVFRDPEVEESGVF 264
N P +
Sbjct: 192 EENEEPGPHNKNLKKQ 207
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 53/238 (22%), Positives = 95/238 (39%), Gaps = 43/238 (18%)
Query: 71 PQGARQFSMEELEQA----TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQ 124
P F +E+ + + + +G G++G V + T VAIK+ + P Q
Sbjct: 5 PPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKK-LYRPFQ 63
Query: 125 EFVA------EVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLY------E 172
+ E+ L +RH N++ LL VF Y
Sbjct: 64 SELFAKRAYRELRLLKHMRHENVIGLLD----------VFTPDETLDDFTDFYLVMPFMG 113
Query: 173 TGLE---SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVAD 229
T L KL + + KGL ++H+ ++H++ K N+ V+E+ K+ D
Sbjct: 114 TDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILD 171
Query: 230 TGISKLLENIEEAGPSHGSIVNV--FRDPEVE-ESGVFSEMSDIYSFGVFLLELVTGQ 284
G+++ +A V +R PEV +++ DI+S G + E++TG+
Sbjct: 172 FGLAR------QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 46/224 (20%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVA-----EVTYLSEIRH 138
+ F SL+G G++G V + T +VAIK+ + + A E+ L +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK-IEPFDKPLFALRTLREIKILKHFKH 68
Query: 139 RNLVTLLGYCQQNGYQM-----LVFEYLPNGSMCNHLYETGLE---SSTKLEFKQRVSIA 190
N++T+ + + ++ ++ E + +T L S+ L
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM----------QTDLHRVISTQMLSDDHIQYFI 118
Query: 191 LGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIV 250
+ + LH ++H++ K +N+L++ N KV D G++++++
Sbjct: 119 YQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 251 NV---------FRDPEVE-ESGVFSEMSDIYSFGVFLLELVTGQ 284
+ +R PEV S +S D++S G L EL +
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 49/218 (22%), Positives = 94/218 (43%), Gaps = 38/218 (17%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVA------EVTYLSEIR 137
K + + +G G++G V + + + VAIK+ + P Q + E+ L ++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKK-LSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 138 HRNLVTLLG--YCQQNGYQM----LVFEYLPNGSMCNHLYETGLES--STKLEFKQRVSI 189
H N++ LL + LV ++ +T L+ K ++ +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFM----------QTDLQKIMGLKFSEEKIQYL 131
Query: 190 ALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSI 249
KGL ++HS +VH++ K N+ V+E+ K+ D G+++ A
Sbjct: 132 VYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR------HADAEMTGY 183
Query: 250 VNV--FRDPEVE-ESGVFSEMSDIYSFGVFLLELVTGQ 284
V +R PEV +++ DI+S G + E++TG+
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 57/234 (24%), Positives = 96/234 (41%), Gaps = 46/234 (19%)
Query: 71 PQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVA 128
P + +E F ++G GSFG V+ + T AIK + +++ V
Sbjct: 8 PSLQIKLKIE-------DFILHKMLGKGSFGKVFLAEFKKTNQFFAIK----ALKKDVVL 56
Query: 129 ---EVTY-LSE-------IRHRNLVTLLGYCQQNGYQM-LVFEYLPNGSMCNHLYETGLE 176
+V + E H L + Q + V EYL G + H+
Sbjct: 57 MDDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCH-- 113
Query: 177 SSTKLEFKQRVSIALGA--AKGLCHLHSLKPPLVHKNFKTANVLVDEN-FIAKVADTGIS 233
+F + A GL LHS +V+++ K N+L+D++ I K+AD G+
Sbjct: 114 -----KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHI-KIADFGMC 165
Query: 234 KLLENIEEAGPSH---GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
K EN+ ++ G+ + PE+ ++ D +SFGV L E++ GQ
Sbjct: 166 K--ENMLGDAKTNTFCGTPD--YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 46/224 (20%), Positives = 88/224 (39%), Gaps = 44/224 (19%)
Query: 93 SLIGFGSFGPVYKGL---LRDTVVAIK--RRVGSPRQEFVAEVTYLSEIRHR------NL 141
+G G+FG V + + VA+K + V + +E+ L +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRV--SIALGAAKGLCH 199
V +L + + +G+ +VFE L + Y+ ++ + L F+ +A K +
Sbjct: 80 VQMLEWFEHHGHICIVFELL---GLS--TYDF-IKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA-------------GPSH 246
LHS K L H + K N+L ++ + + I + + H
Sbjct: 134 LHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH 191
Query: 247 GSIVN--VFRDPEVEESGV----FSEMSDIYSFGVFLLELVTGQ 284
++V+ +R PEV + +S+ D++S G L+E G
Sbjct: 192 STLVSTRHYRAPEV----ILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 44/218 (20%), Positives = 89/218 (40%), Gaps = 33/218 (15%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVA------EVTYLSEIR 137
+++ S IG G++G V VAIK+ SP + E+ L R
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFR 83
Query: 138 HRNLVTLLGYCQQNGYQM-----LVFEYLPNGSMCNHLYETGLE---SSTKLEFKQRVSI 189
H N++ + + + +V + + ET L + L
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM----------ETDLYKLLKTQHLSNDHICYF 133
Query: 190 ALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSI 249
+GL ++HS ++H++ K +N+L++ K+ D G++++ + +
Sbjct: 134 LYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 250 VNV--FRDPEVE-ESGVFSEMSDIYSFGVFLLELVTGQ 284
V +R PE+ S +++ DI+S G L E+++ +
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 44/209 (21%), Positives = 84/209 (40%), Gaps = 35/209 (16%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFV----------AEVTYLSEIRHRNL 141
+IG GS+ V L+ T + A+K ++E V E + +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMK----VVKKELVNDDEDIDWVQTEKHVFEQASNHPF 71
Query: 142 VTLLGYCQQNGYQM-LVFEYLPNGSMCNHLYETG--LESSTKLEFKQRVSIALGAAKGLC 198
+ L C Q ++ V EY+ G + H+ E + + +S+AL
Sbjct: 72 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALN------ 124
Query: 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH---GSIVNVFRD 255
+LH +++++ K NVL+D K+ D G+ K E + + G+ +
Sbjct: 125 YLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTP--NYIA 178
Query: 256 PEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
PE+ + D ++ GV + E++ G+
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 47/225 (20%), Positives = 82/225 (36%), Gaps = 46/225 (20%)
Query: 93 SLIGFGSFGPVYKGLLRDT---VVAIK--RRVGSPRQEFVAEVTYLSEIRHR------NL 141
+G G+FG V + L VA+K R VG R+ E+ L +I+ +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYE-------TGLESSTKLEFKQRVSIALGAA 194
V + + +G+ + FE L +E L + ++ L A
Sbjct: 85 VLMSDWFNFHGHMCIAFELL---GKN--TFEFLKENNFQPY----PLPHVRHMAYQLCHA 135
Query: 195 KGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA------------ 242
L LH + L H + K N+L + + + S ++++
Sbjct: 136 --LRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191
Query: 243 -GPSHGSIVN--VFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
H +IV +R PEV +++ D++S G L E G
Sbjct: 192 DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 38/217 (17%), Positives = 84/217 (38%), Gaps = 22/217 (10%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVA-----EVTYLSEIRH 138
++ + +G G G V+ + D VAIK+ V E+ + + H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV--LTDPQSVKHALREIKIIRRLDH 67
Query: 139 RNLVTLLG-YCQQNGYQMLVFEYLPNGS---MCNHLYETGLE---SSTKLEFKQRVSIAL 191
N+V + L + + ET L L +
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY 127
Query: 192 GAAKGLCHLHSLKPPLVHKNFKTANVLVD-ENFIAKVADTGISKLLENIEEAGPSHGSIV 250
+GL ++HS ++H++ K AN+ ++ E+ + K+ D G++++++ +
Sbjct: 128 QLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 251 NV--FRDPEVE-ESGVFSEMSDIYSFGVFLLELVTGQ 284
+R P + +++ D+++ G E++TG+
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 1e-04
Identities = 52/382 (13%), Positives = 98/382 (25%), Gaps = 119/382 (31%)
Query: 25 LVW-LCKSQSKNYQ-------NKNSE-------TGSSDPSALVE---------WNRGAGP 60
L W L Q + Q N + T PS + +N
Sbjct: 67 LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYN----- 121
Query: 61 SSATGQPSFGPQG-ARQFSMEELEQATKQFSETSLI---GFGSFGPVYKGLLRDTVVAIK 116
F +R +L QA + + G G K T VA+
Sbjct: 122 ----DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---K-----TWVALD 169
Query: 117 R-RVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGS---------- 165
+ + ++ +L+ +++ N + Q + +
Sbjct: 170 VCLSYKVQCKMDFKIFWLN-LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 166 ---------MCNHLYETGL------ESSTKLE-FKQRVSIAL-----GAAKGLCHLHSLK 204
+ + YE L +++ F I L L +
Sbjct: 229 SIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTH 288
Query: 205 PPLVH--KNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIV-----------N 251
L H V + + K D L + P SI+ +
Sbjct: 289 ISLDHHSMTLTPDEVK---SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWD 345
Query: 252 VFRDPEVE------ESGV----FSEMSDIY-SFGVF---------LLELV----TGQEAS 287
++ + ES + +E ++ VF LL L+ +
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVM 405
Query: 288 HIVS-LGSYEALIQWVRSRLSS 308
+V+ L Y + + + S
Sbjct: 406 VVVNKLHKYSLVEKQPKESTIS 427
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 1e-04
Identities = 44/273 (16%), Positives = 81/273 (29%), Gaps = 66/273 (24%)
Query: 104 YKGLLRDTVVAIKRRVG------SPRQEFV-AEVTYL-----SEIRHRNLVTLLGYCQQN 151
YK +L A P+ E+ ++ + L L Q+
Sbjct: 18 YKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEE 77
Query: 152 GYQMLVFEYL-PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHK 210
Q V E L N Y+ L S K E +Q + + L++
Sbjct: 78 MVQKFVEEVLRIN-------YKF-LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV---- 125
Query: 211 NFKTANVLVDENFIAKVADTGISKLLENIEEAGPS-----HG------SI--VNVFRDPE 257
F NV + ++ KL + + E P+ G + ++V +
Sbjct: 126 -FAKYNVSRLQPYL---------KLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYK 175
Query: 258 VEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317
V+ F +F L L S L + L+ + +S + DH
Sbjct: 176 VQCK---------MDFKIFWLNL--KNCNSPETVLEMLQKLLYQIDPNWTSRS--DHSSN 222
Query: 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVM 350
++ +R L+ + +V+
Sbjct: 223 IKLRIHSIQAELRRLLK-----SKPYENCLLVL 250
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 2e-04
Identities = 29/220 (13%), Positives = 61/220 (27%), Gaps = 69/220 (31%)
Query: 80 EELEQATKQFSETSLIGFGSFGPVYK--GLLRDTVVAIKRRVGSPRQEFVAEVTYLSEIR 137
++ + + SL+ + + + + + L
Sbjct: 402 SDVMVVVNKLHKYSLVEKQPKESTISIPSIYLEL-----------KVK-LENEYAL---- 445
Query: 138 HRNLVT----LLGYCQQN-------GYQMLVFEYLPNGSMCNHLYETGLESSTK------ 180
HR++V + + Y + ++ + HL
Sbjct: 446 HRSIVDHYNIPKTFDSDDLIPPYLDQY---FYSHIGH-----HLKNIEHPERMTLFRMVF 497
Query: 181 --LEF-KQRV---SIALGAAKGLCH-LHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233
F +Q++ S A A+ + + L LK +K + N D + V I
Sbjct: 498 LDFRFLEQKIRHDSTAWNASGSILNTLQQLK---FYKPYICDN---DPKYERLVNA--IL 549
Query: 234 KLLENIEEAGPSHGSIVNVFRDPEVE--ESGVFSEMSDIY 271
L IEE N+ + + +E I+
Sbjct: 550 DFLPKIEE---------NLICSKYTDLLRIALMAEDEAIF 580
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 27/195 (13%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVA------EVTYLSEIR 137
+++ +G G++G V+K + R T VVA+K+ + Q E+ L+E+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKK-IFDAFQNSTDAQRTFREIMILTELS 66
Query: 138 -HRNLVTLLGYCQQNGYQ--MLVFEYLPNGSMCNHLYETGLE---SSTKLEFKQRVSIAL 191
H N+V LL + + + LVF+Y+ ET L + LE + +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM----------ETDLHAVIRANILEPVHKQYVVY 116
Query: 192 GAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVN 251
K + +LHS L+H++ K +N+L++ KVAD G+S+ NI + +N
Sbjct: 117 QLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 252 VFRDPEVEESGVFSE 266
+ ++ + ++
Sbjct: 175 ENTENFDDDQPILTD 189
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 46/221 (20%), Positives = 89/221 (40%), Gaps = 43/221 (19%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVA------EVTYLSEIR 137
+++ S +G G++G V T VA+K+ + P Q + E+ L ++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK-LSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 138 HRNLVTLL--------GYCQQNGYQMLVFEYLPNGSMCNHLYETGLE---SSTKLEFKQR 186
H N++ LL + Y LV + L KL
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVY--LVTHLM----------GADLNNIVKCQKLTDDHV 134
Query: 187 VSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI--EEAGP 244
+ +GL ++HS ++H++ K +N+ V+E+ K+ D G+++ +
Sbjct: 135 QFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT 192
Query: 245 SHGSIVNVFRDPEVE-ESGVFSEMSDIYSFGVFLLELVTGQ 284
+R PE+ +++ DI+S G + EL+TG+
Sbjct: 193 RW------YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 46/246 (18%), Positives = 85/246 (34%), Gaps = 46/246 (18%)
Query: 70 GPQGARQFSMEELEQAT----KQFSETSLIGFGSFGPVYKGLLRDT-VVAIKRRVGSPRQ 124
G Q + +M +L ++ I GS+G V G+ + VAIKR +
Sbjct: 1 GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSD 60
Query: 125 EFVA--------------EVTYLSEIRHRNLVTLL------GYCQQNG-YQMLVFEYLPN 163
E+ L+ H N++ L + Y LV E
Sbjct: 61 GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLY--LVTEL--- 115
Query: 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF 223
M L + + + + GL LH +VH++ N+L+ +N
Sbjct: 116 --MRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNN 171
Query: 224 IAKVADTGISKLLENIEEAGPSHGSIVNV----FRDPEVE-ESGVFSEMSDIYSFGVFLL 278
+ D +++ E V +R PE+ + F+++ D++S G +
Sbjct: 172 DITICDFNLAR------EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMA 225
Query: 279 ELVTGQ 284
E+ +
Sbjct: 226 EMFNRK 231
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 382 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.43 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.23 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.98 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.79 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.63 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.53 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.53 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.49 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.36 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.32 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.11 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.03 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.96 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.72 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.68 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.54 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.45 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.38 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.23 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.16 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.04 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.02 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.95 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 96.86 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.84 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 96.76 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 96.18 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.26 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.13 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 94.53 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 93.94 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 93.63 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 93.24 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.35 | |
| 2k1a_A | 42 | Integrin alpha-IIB; single-PASS transmembrane segm | 90.75 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 89.67 | |
| 2klu_A | 70 | T-cell surface glycoprotein CD4; cell membrane, di | 88.41 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 87.93 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.02 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 85.01 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.35 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 81.97 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 80.68 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-60 Score=436.86 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=213.5
Q ss_pred hCCCCCCeeeccCcccEEEEEEC-------CeeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR-------DTVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
++|...+.||+|+||+||+|++. +..||||++.... .++|.+|+++|++++|||||+++|+|.+.+..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56778889999999999999874 3579999987543 3579999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcC--------CCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEe
Q 016789 157 VFEYLPNGSMCNHLYETG--------LESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVA 228 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~ 228 (382)
|||||++|+|.++|+..+ ......++|..++.|+.|||.||.|||+++ |+||||||+|||+++++.+||+
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCCCcEEEC
Confidence 999999999999998653 123457999999999999999999999977 9999999999999999999999
Q ss_pred ecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhc
Q 016789 229 DTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 229 DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
|||+|+......... .....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.... ..++...+....
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~i~~~~ 247 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIECITQGR 247 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHHHHTC
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHcCC
Confidence 999998765433322 223457889999999999999999999999999999999 899997533 334444433321
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 307 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
.. ..+..++..+.+++.+||+.||++||||.+|.+.|+++.+..
T Consensus 248 ~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 248 VL----------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred CC----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 11 123344567889999999999999999999999999987653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-59 Score=437.37 Aligned_cols=258 Identities=23% Similarity=0.382 Sum_probs=207.1
Q ss_pred hCCCCCCeeeccCcccEEEEEEC-------CeeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR-------DTVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
++|...+.||+|+||+||+|++. +..||||.+.... .++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677788999999999999875 3689999987543 3579999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCC----------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEE
Q 016789 157 VFEYLPNGSMCNHLYETGLE----------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAK 226 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~k 226 (382)
|||||++|+|.++|+..... ....++|..++.|+.|||.||+|||+.+ ||||||||+||||++++.+|
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCCCcEE
Confidence 99999999999999875421 2246899999999999999999999977 99999999999999999999
Q ss_pred EeecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHh
Q 016789 227 VADTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRS 304 (382)
Q Consensus 227 l~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~ 304 (382)
|+|||+|+.+....... .....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.... ...+...+..
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~i~~ 275 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS---NTEAIDCITQ 275 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC---HHHHHHHHHH
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC---HHHHHHHHHc
Confidence 99999998765433222 234567889999999999999999999999999999999 899997533 2334443333
Q ss_pred hcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 305 RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 305 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.... ..+..++..+.+++.+||+.||++||||.||++.|+.+.+.
T Consensus 276 g~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 276 GREL----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp TCCC----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCC----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 2111 12334456788999999999999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-59 Score=434.41 Aligned_cols=254 Identities=26% Similarity=0.349 Sum_probs=211.5
Q ss_pred CCCCCCeeeccCcccEEEEEEC-------CeeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR-------DTVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
++++.+.||+|+||+||+|.+. ++.||||++... ..++|.+|+.+|++++|||||+++|+|.+.+..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4556778999999999999873 368999997643 24679999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcE
Q 016789 157 VFEYLPNGSMCNHLYETGLE-----------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIA 225 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~ 225 (382)
|||||++|+|.++|...... ....++|..++.|+.|||.||+|||+.+ ||||||||+||||++++.+
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCE
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECCCCCE
Confidence 99999999999999764321 1246899999999999999999999987 9999999999999999999
Q ss_pred EEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHH
Q 016789 226 KVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVR 303 (382)
Q Consensus 226 kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~ 303 (382)
||+|||+|+.+...... ......+|+.|||||++.++.|+.++|||||||++|||+| |+.||.... ...+.+.+.
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~---~~~~~~~i~ 261 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVVEMIR 261 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC---HHHHHHHHH
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH
Confidence 99999999877544332 2344567889999999999999999999999999999999 899997543 334444443
Q ss_pred hhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 304 SRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 304 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
.... .+.+.+++..+.+++.+||+.||++||||.||++.|+.+
T Consensus 262 ~~~~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 262 NRQV----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred cCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 3221 122345567789999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-58 Score=425.93 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=202.9
Q ss_pred HhCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
.+++...+.||+|+||+||+|++.+ .||||.+.... .+.|.+|+++|++++|||||+++|+|.+ +..+|||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 3567788899999999999999876 58999875321 3579999999999999999999999865 468999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
|++|+|.++|+... ..+++..++.|+.|||.||+|||+.+ ||||||||+||||++++.+||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 113 CEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred CCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999997642 36999999999999999999999977 9999999999999999999999999998765432
Q ss_pred cc-CCCcccccccccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 241 EA-GPSHGSIVNVFRDPEVEES---GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 241 ~~-~~~~~~~~~~y~aPE~~~~---~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
.. ......||+.|||||++.. ++|+.++|||||||++|||+||+.||.... ....+...+...... +.+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~--~~~~~~~~~~~~~~~-----p~~ 259 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN--NRDQIIFMVGRGYAS-----PDL 259 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC--CHHHHHHHHHTTCCC-----CCS
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC--hHHHHHHHHhcCCCC-----CCc
Confidence 22 2344568999999999853 469999999999999999999999997432 222333333322211 111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
. ..+.+++..+.+++.+||+.||++||||.||++.|+.+.
T Consensus 260 ~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 260 S-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp T-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred c-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1 223345677889999999999999999999999998875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=420.64 Aligned_cols=266 Identities=22% Similarity=0.362 Sum_probs=204.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCchHHHHHH--HHHHhcCCCCCccceeeEEEeCC----eeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAE--VTYLSEIRHRNLVTLLGYCQQNG----YQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e--~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~ 160 (382)
++|...+.||+|+||+||+|+++++.||||++......++..| +..+.+++|||||+++|+|.+.+ .++|||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 4567778999999999999999999999999877666655554 45556789999999999998654 57999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC------CCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL------KPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
|++|+|.++|+.. .++|..+.+++.|++.||+|||+. .++|+||||||+|||++.++.+||+|||+|+
T Consensus 83 ~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 83 HEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 9999999999764 589999999999999999999976 3459999999999999999999999999998
Q ss_pred cccccccc---CCCcccccccccCccccccC------CCCccchhHHHHHHHHHHHhCCCCCCccCCCCh--------hH
Q 016789 235 LLENIEEA---GPSHGSIVNVFRDPEVEESG------VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSY--------EA 297 (382)
Q Consensus 235 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~--------~~ 297 (382)
........ ......+|+.|||||++.+. .|+.++|||||||++|||+||++|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76543221 12234689999999998764 367899999999999999999887643221110 00
Q ss_pred HHHHHHhhcCCCcccccccCC-CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 298 LIQWVRSRLSSNNFVDHRLAG-TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 298 ~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
..+....... ....++.+.. ..+.+.+..+.+++.+||+.||++||||.||++.|+++.++
T Consensus 237 ~~~~~~~~~~-~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 237 SVEEMRKVVC-EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHT-TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHh-cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0111111110 1111222211 11346678899999999999999999999999999999765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=426.09 Aligned_cols=269 Identities=21% Similarity=0.342 Sum_probs=218.6
Q ss_pred cCHHHHHHHHhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcCCC-CCccce
Q 016789 77 FSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEIRH-RNLVTL 144 (382)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l~h-~niv~l 144 (382)
+..++++...++|+..+.||+|+||+||+|.+.+ +.||+|.+.... ..+|.+|+++|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4456677778899999999999999999998753 479999986543 3468999999999965 999999
Q ss_pred eeEEEeC-CeeEEEEeecCCCChhhhhhhcCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCC
Q 016789 145 LGYCQQN-GYQMLVFEYLPNGSMCNHLYETGL-----------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNF 212 (382)
Q Consensus 145 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDl 212 (382)
+|+|.+. +.+++|||||++|+|.++|+.... .....+++..++.++.|||.||+|||+++ ||||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDL 211 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDL 211 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCcc
Confidence 9999764 578999999999999999986431 11345899999999999999999999987 999999
Q ss_pred CCCCeeecCCCcEEEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcc
Q 016789 213 KTANVLVDENFIAKVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIV 290 (382)
Q Consensus 213 k~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~ 290 (382)
||+|||+++++.+||+|||+|+.+...... ......+|+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543322 2234567889999999999999999999999999999998 89999754
Q ss_pred CCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 291 SLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.. ...+...+...... ..+..++..+.+++.+||+.||++|||+.+|++.|+++.+.
T Consensus 292 ~~--~~~~~~~i~~g~~~----------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 292 KI--DEEFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CC--SHHHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CH--HHHHHHHHHcCCCC----------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 32 22333333332211 12233456788999999999999999999999999998764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=416.14 Aligned_cols=255 Identities=17% Similarity=0.146 Sum_probs=206.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNG 164 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 164 (382)
+.|...++||+|+||+||+|++.. ..||+|++.... ...+|+.+|++++|||||++++++.+.+..|||||||++|
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 457777889999999999999874 799999986432 2357999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC-cEEEeecCCccccccccccC
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF-IAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~~~~~~~~~~ 243 (382)
+|.++|.+.+ .+++.....++.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.+.......
T Consensus 136 ~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 136 SLGQLIKQMG-----CLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 9999998754 6899999999999999999999988 99999999999999987 69999999998775432211
Q ss_pred ----CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 244 ----PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 244 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
.....||+.|||||++.+..|+.++|||||||++|||+||++||........ ...+.... ... . .
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i~~~~--~~~--~----~ 277 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLKIASEP--PPI--R----E 277 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHHHHHSC--CGG--G----G
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHHHcCC--CCc--h----h
Confidence 1234589999999999999999999999999999999999999975443222 11121111 000 0 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEM 361 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~ 361 (382)
.+...+..+.+++.+||+.||.+|||+.|+++.|.....+.-
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 223445678899999999999999999999999988876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=402.56 Aligned_cols=242 Identities=24% Similarity=0.335 Sum_probs=194.1
Q ss_pred CCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEE
Q 016789 90 SETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQ----NGYQMLVF 158 (382)
Q Consensus 90 ~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 158 (382)
+..+.||+|+||+||+|.+.. ..||+|.+... ..+.|.+|+++|++++|||||++++++.. .+..||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 455679999999999999875 68999986532 23568999999999999999999999865 34589999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC-CCcEEEeecCCccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-NFIAKVADTGISKLLE 237 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-~~~~kl~DfGla~~~~ 237 (382)
|||++|+|.+++.+.+ .+++..+..++.||+.||+|||+++++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999998753 689999999999999999999998778999999999999984 7999999999998643
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.. ......||+.|||||++.+ .|+.++|||||||++|||+||+.||.... ....+...+..... . +.+.
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~--~~~~~~~~i~~~~~-~----~~~~ 252 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVK-P----ASFD 252 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTCC-C----GGGG
T ss_pred CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC--cHHHHHHHHHcCCC-C----CCCC
Confidence 32 2234568999999998865 69999999999999999999999996422 22333332222111 1 1111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
... +..+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~----~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 KVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112 245788999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=409.68 Aligned_cols=245 Identities=19% Similarity=0.273 Sum_probs=204.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC---CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG---SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
+.|+..+.||+|+||+||+|.+.. ..||+|++.. ...+.+.+|+++|++++|||||++++++.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 458888999999999999999874 7899998743 33467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++|+|.+++.+. .+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999998753 5899999999999999999999988 99999999999999999999999999987654322
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
......||+.|||||++.+..|+.++|||||||++|||++|++||.... .......+...... .+ ...
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~------~~--~~~ 293 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLPP------RL--KNL 293 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSSCC------CC--SCG
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCC------CC--Ccc
Confidence 2334568999999999999999999999999999999999999997432 23333333322111 11 111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+..+.+++.+||+.||++|||+.|+++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 233467889999999999999999999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=415.72 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=198.4
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
++|+..+.||+|+||+||+|++.. +.||+|.+... ..+.+.+|+++|++++|||||++++++.+.+..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 468899999999999999999864 79999987543 23568999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
||++|+|.++|...+ ...+++.....++.||+.||.|||+++ |+||||||+||||++++.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999997643 235788899999999999999999988 999999999999999999999999999976543
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
... .....||+.|||||++.+..|+.++|||||||++|||+||+.||... ....+...+.... .. .
T Consensus 179 ~~~-~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~-~~---------~ 244 (350)
T 4b9d_A 179 VEL-ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVLKIISGS-FP---------P 244 (350)
T ss_dssp HHH-HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTC-CC---------C
T ss_pred ccc-ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCC-CC---------C
Confidence 211 12345889999999999999999999999999999999999999743 2233333222211 10 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12233466889999999999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-56 Score=409.01 Aligned_cols=243 Identities=18% Similarity=0.199 Sum_probs=204.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|+||+||+|++.. +.||+|.+.. ...+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 569999999999999999999865 7899998753 33457899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
|||++|+|.+++.+.+ .+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999998754 6899999999999999999999988 99999999999999999999999999997754
Q ss_pred ccc-cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 239 IEE-AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 239 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
... .......||+.|||||++.+..|+.++||||+||++|||++|+.||... +...+.+.+.... ..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~-------~~-- 252 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEGLIFAKIIKLE-------YD-- 252 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTC-------CC--
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCC-------CC--
Confidence 332 2234457899999999999999999999999999999999999999743 2333333332211 11
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVM 350 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~ 350 (382)
++...+..+.+++.+||+.||++|||+.|++
T Consensus 253 --~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 --FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1222335678899999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-54 Score=410.66 Aligned_cols=245 Identities=19% Similarity=0.273 Sum_probs=204.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC---CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG---SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
+.|+..+.||+|+||+||+|.+.. ..||+|++.. ...+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 468889999999999999999874 7899998753 33467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++|+|.+++... .+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999998653 4899999999999999999999988 99999999999999999999999999987654322
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
......||+.|||||++.+..|+.++|||||||++|||++|++||.... .......+...... .+ ...
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~------~~--~~~ 370 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLPP------RL--KNL 370 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCC------CC--SCT
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCC------CC--ccc
Confidence 2334568999999999999999999999999999999999999997432 23333333322111 11 111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+..+.+|+.+||+.||++|||+.|+++
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 223456888999999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=390.07 Aligned_cols=241 Identities=20% Similarity=0.261 Sum_probs=189.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
.+|+..+.||+|+||+||+|.... +.||+|.+... ....+.+|+++|++++||||+++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999998764 79999987532 2346899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||| +|+|.+++.+.+ .+++.....++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 789999997653 6899999999999999999999988 99999999999999999999999999987644
Q ss_pred ccccCCCcccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVF-SEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.. ......||+.|||||++.+..| +.++||||+||++|||+||+.||... ....+.+.+.....
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~~i~~~~~---------- 229 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFKNISNGVY---------- 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCC----------
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCC----------
Confidence 32 2234568999999999998876 57999999999999999999999743 23333333322110
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 230 -~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 -TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111223456788999999999999999999876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-55 Score=400.54 Aligned_cols=238 Identities=23% Similarity=0.231 Sum_probs=191.5
Q ss_pred hCCCCCCeeeccCcccEEEEEEC-----CeeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR-----DTVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
++|+..+.||+|+||+||+|+.. ++.||+|.+... ....+.+|+++|++++|||||++++++.+.+..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56899999999999999999863 368999987542 23468899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
|||||++|+|.+++.+.+ .+++.....++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999998754 6899999999999999999999988 999999999999999999999999999865
Q ss_pred ccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 237 ENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 237 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
..... ......||+.|||||++.+..|+.++||||+||++|||+||+.||.... ...+...+.... .
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~-------~-- 243 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD---RKETMTMILKAK-------L-- 243 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCC-------C--
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC---HHHHHHHHHcCC-------C--
Confidence 43222 2234568999999999999999999999999999999999999997432 233333322211 0
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKM 346 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 346 (382)
..+...+..+.+++.+||+.||++|||+
T Consensus 244 --~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 --GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred --CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1122234567889999999999999995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=386.77 Aligned_cols=246 Identities=21% Similarity=0.289 Sum_probs=184.8
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCC--------
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNG-------- 152 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------- 152 (382)
++|+..+.||+|+||+||+|++. +..||+|++.... .+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46888999999999999999986 4789999875322 346889999999999999999999987544
Q ss_pred ----eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEe
Q 016789 153 ----YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVA 228 (382)
Q Consensus 153 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~ 228 (382)
.+|+|||||++|+|.+++..... ....++...+.++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEc
Confidence 36999999999999999986542 224567778899999999999999988 9999999999999999999999
Q ss_pred ecCCccccccccccC-----------CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhH
Q 016789 229 DTGISKLLENIEEAG-----------PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEA 297 (382)
Q Consensus 229 DfGla~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~ 297 (382)
|||+|+.+....... .....||+.|||||++.+..|+.++|||||||++|||++ ||.... +...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence 999998775432211 123358999999999999999999999999999999996 664211 1111
Q ss_pred HHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 298 LIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 298 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...... ....+ ....+....+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~-~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TLTDVR-NLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHH-TTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHh-cCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111 11100 001233455678999999999999999999876
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=382.38 Aligned_cols=255 Identities=18% Similarity=0.221 Sum_probs=196.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEe------CCe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQ------NGY 153 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 153 (382)
++|+..+.||+|+||+||+|.+.. +.||||++.... ...+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 468889999999999999999864 799999976432 2467899999999999999999998764 357
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
+|+|||||+ |+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeeccee
Confidence 899999995 7899998754 36999999999999999999999988 999999999999999999999999999
Q ss_pred ccccccc---ccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC
Q 016789 234 KLLENIE---EAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN 309 (382)
Q Consensus 234 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 309 (382)
+.+.... ........||+.|||||++.+. .|+.++||||+||++|||++|++||..... ...+...........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~--~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY--VHQLQLIMMVLGTPS 283 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--HHHHHHHHHHHCCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhcCCCC
Confidence 8764322 1223445789999999998765 579999999999999999999999975332 222222222111111
Q ss_pred ccccc------------ccC--CCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 NFVDH------------RLA--GTFT-----TEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 ~~~d~------------~~~--~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..... .+. ...+ +..+..+.+|+.+||+.||.+|||+.|+++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 10000 000 0001 112356788999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=369.44 Aligned_cols=280 Identities=34% Similarity=0.578 Sum_probs=232.7
Q ss_pred cCHHHHHHHHhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 016789 77 FSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNG 152 (382)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 152 (382)
+...++...+++|...+.||+|+||.||+|.+.+ ..||+|+..... .+.+.+|+.+++.++||||+++++++...+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 3334445566889999999999999999999864 789999876432 357899999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCC
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI 232 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGl 232 (382)
..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999987543 22346899999999999999999999987 99999999999999999999999999
Q ss_pred cccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh---hcCC
Q 016789 233 SKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS---RLSS 308 (382)
Q Consensus 233 a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~ 308 (382)
++........ ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.............|... ....
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 9865432222 12233467889999999989999999999999999999999999976555444444444332 3334
Q ss_pred CcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 309 NNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 309 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
...+++........+.+..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 556667777777889999999999999999999999999999999988753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=376.12 Aligned_cols=196 Identities=22% Similarity=0.306 Sum_probs=167.6
Q ss_pred HHhCCCCCCeeeccCcccEEEEEEC-----CeeEEEEEccCC-chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLR-----DTVVAIKRRVGS-PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 157 (382)
..+.|+..+.||+|+||+||+|+.+ +..||+|.+... ....+.+|+++|+.+ +||||+++++++.+.+..|+|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 4567999999999999999999863 368999987654 345788999999998 699999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC-CcEEEeecCCcccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN-FIAKVADTGISKLL 236 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~-~~~kl~DfGla~~~ 236 (382)
||||++|+|.+++. .+++.....++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+..
T Consensus 99 mE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 99 MPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999883 4788999999999999999999988 9999999999999877 79999999999765
Q ss_pred ccccc---------------------------cCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCC
Q 016789 237 ENIEE---------------------------AGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASH 288 (382)
Q Consensus 237 ~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~ 288 (382)
..... .......||+.|||||++.+. .|+.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 33211 011233589999999999775 48999999999999999999999996
Q ss_pred cc
Q 016789 289 IV 290 (382)
Q Consensus 289 ~~ 290 (382)
..
T Consensus 249 ~~ 250 (361)
T 4f9c_A 249 KA 250 (361)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=370.17 Aligned_cols=284 Identities=37% Similarity=0.593 Sum_probs=236.0
Q ss_pred CCCcccCHHHHHHHHhCCCCCCeeeccCcccEEEEEEC-CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceee
Q 016789 72 QGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLR-DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLG 146 (382)
Q Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~ 146 (382)
.....++..++....++|+..+.||+|+||.||+|... +..||+|++.... ...+.+|+++++.++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34567889999999999999999999999999999875 4789999876533 236899999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCCeeecCCCcE
Q 016789 147 YCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL-KPPLVHKNFKTANVLVDENFIA 225 (382)
Q Consensus 147 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~ivHrDlk~~Nill~~~~~~ 225 (382)
++...+..++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+. .++|+||||||+|||++.++.+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 9999999999999999999999998653 2334689999999999999999999997 1139999999999999999999
Q ss_pred EEeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccC--CCChhHHHHHHH
Q 016789 226 KVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVS--LGSYEALIQWVR 303 (382)
Q Consensus 226 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~--~~~~~~~~~~~~ 303 (382)
||+|||+++..............+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ........+|..
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 999999998765443333344457889999999998889999999999999999999999996321 112223344443
Q ss_pred h---hcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 304 S---RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 304 ~---~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
. ........+.......+.+.+..+.+++.+||+.||.+|||+.+|++.|++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 3 2233455666677778889999999999999999999999999999999763
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=392.19 Aligned_cols=244 Identities=20% Similarity=0.234 Sum_probs=198.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHH---HHHHhcCCCCCccceeeEEEeCCeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAE---VTYLSEIRHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~~ 155 (382)
++|+..++||+|+||+||+|+... ..+|+|.+... ......+| +.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 568889999999999999999875 79999987532 22233344 56777889999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+|||||+||+|.++|.+.+ .+++.....++.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999998764 6899999999999999999999988 99999999999999999999999999987
Q ss_pred cccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
+.... .....||+.|||||++.. ..|+.++||||+||++|||++|++||......+...+........ .
T Consensus 342 ~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~-------~ 411 (689)
T 3v5w_A 342 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-------V 411 (689)
T ss_dssp CSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC-------C
T ss_pred cCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC-------C
Confidence 65432 334578999999999964 579999999999999999999999997654444333333222210 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPK-----MEIVMT 351 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~~v~~ 351 (382)
.++...+..+.+|+.+||+.||.+|++ +.||.+
T Consensus 412 ----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 ----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 112223456788999999999999998 566654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=386.05 Aligned_cols=247 Identities=20% Similarity=0.290 Sum_probs=202.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
++|++.+.||+|+||.||+|.... ..+|+|.+.... .+.+.+|+.+|+.++||||+++++++.+.+.+|+|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 578889999999999999999865 789999876543 346889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC--CcEEEeecCCccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN--FIAKVADTGISKLLENI 239 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~--~~~kl~DfGla~~~~~~ 239 (382)
++|+|.++|.... ..+++.....++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 237 ~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 237 SGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred CCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999986432 36899999999999999999999988 9999999999999854 89999999999977543
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
.. .....||+.|||||++.+..|+.++||||+||++|||++|++||.... .......+.... ..+ .....
T Consensus 311 ~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~---~~~~~~~i~~~~--~~~-~~~~~-- 380 (573)
T 3uto_A 311 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNVKSCD--WNM-DDSAF-- 380 (573)
T ss_dssp SE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHTTC--CCC-CSGGG--
T ss_pred Cc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHhCC--CCC-Ccccc--
Confidence 22 223457899999999999999999999999999999999999997432 223332222211 011 11111
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+..+.+|+.+||+.||.+||++.|+++
T Consensus 381 --~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 --SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122356788999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=357.34 Aligned_cols=261 Identities=29% Similarity=0.422 Sum_probs=204.7
Q ss_pred HhCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
..+|+..+.||+|+||+||+|.+.+..+|+|.+.... ...+.+|++++++++||||+++++++...+..++||||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 4678888999999999999999999999999876432 24688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++|+|.+++.... ....+++..++.++.|++.||+|||+.+++|+||||||+|||++.++.+||+|||+++......
T Consensus 116 ~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 116 LSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp CTTCBHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred CCCCcHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 99999999997642 1224899999999999999999999977779999999999999999999999999998544322
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
.......+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ............... ..
T Consensus 194 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~---~~~~~~~~~~~~~~~---------~~ 260 (309)
T 3p86_A 194 -LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN---PAQVVAAVGFKCKRL---------EI 260 (309)
T ss_dssp ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC---HHHHHHHHHHSCCCC---------CC
T ss_pred -cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCC---------CC
Confidence 12233456788999999999999999999999999999999999997432 222222222111111 12
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEM 361 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~ 361 (382)
+...+..+.+++.+||+.||.+||++.++++.|+.+.+...
T Consensus 261 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 23334678899999999999999999999999999986543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=361.87 Aligned_cols=263 Identities=22% Similarity=0.252 Sum_probs=206.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCchH--HHHHHHHHHhcCCCCCccceeeEEEeCC----eeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQ--EFVAEVTYLSEIRHRNLVTLLGYCQQNG----YQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~--~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~ 160 (382)
++|+..+.||+|+||+||+|.+.+..||+|++...... .+..|+.++++++||||+++++++.... ..++||||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~ 103 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred hhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence 57888999999999999999999999999998655433 4566888899999999999999998754 46999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC----------CCCceecCCCCCCeeecCCCcEEEeec
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL----------KPPLVHKNFKTANVLVDENFIAKVADT 230 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------~~~ivHrDlk~~Nill~~~~~~kl~Df 230 (382)
+++|+|.+++... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+||
T Consensus 104 ~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 104 HEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTTCCEEECCC
T ss_pred CCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999763 489999999999999999999987 6 999999999999999999999999
Q ss_pred CCccccccccccC-CCcccccccccCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhH-------
Q 016789 231 GISKLLENIEEAG-PSHGSIVNVFRDPEVEESG-----VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEA------- 297 (382)
Q Consensus 231 Gla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-----~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~------- 297 (382)
|+++......... .....+++.|+|||.+.+. .++.++|||||||++|||+||+.||..........
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 9998765433222 2234578889999998763 46678899999999999999999997543221111
Q ss_pred ---HHHHHHhhcCCCcccccccCC-CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 298 ---LIQWVRSRLSSNNFVDHRLAG-TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 298 ---~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
......... .....+.+.. ......+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 256 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 256 HPSLEDMQEVVV--HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SCCHHHHHHHHT--TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCchhhhhhhhh--cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111111100 0000111111 01234567799999999999999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=361.11 Aligned_cols=259 Identities=26% Similarity=0.428 Sum_probs=212.0
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC---------CeeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR---------DTVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVTLLGYCQQN 151 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 151 (382)
.++|...+.||+|+||.||+|.+. +..||+|.+.... ...+.+|+.+|+++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357888899999999999999863 1479999986543 24688999999999 899999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLE-----------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD 220 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~ 220 (382)
+..++||||+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~ 237 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVT 237 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEEEC
Confidence 9999999999999999999875421 2346899999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHH
Q 016789 221 ENFIAKVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEAL 298 (382)
Q Consensus 221 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~ 298 (382)
.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... ...+
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~---~~~~ 314 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEEL 314 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGGH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHH
Confidence 9999999999999866543322 2233456778999999999999999999999999999999 999987543 2333
Q ss_pred HHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 299 IQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
......... ...+..++..+.+++.+||+.||.+||++.++++.|+++...
T Consensus 315 ~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 315 FKLLKEGHR----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp HHHHHTTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 333322211 112233456788999999999999999999999999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=352.28 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=205.1
Q ss_pred HhCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCchHHHHHHHHHHhc--CCCCCccceeeEEEeC----CeeEEEEe
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSE--IRHRNLVTLLGYCQQN----GYQMLVFE 159 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~lv~e 159 (382)
.++|+..+.||+|+||+||+|.+.+..||+|.+.......+..|.+++.. ++||||+++++++... ...++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 36788999999999999999999999999999887777777788887777 7899999999987543 45899999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHh--------cCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH--------SLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
|+++|+|.+++... .+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 87 YHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp CCTTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEECCCT
T ss_pred hccCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEEeeCC
Confidence 99999999999542 5899999999999999999999 766 9999999999999999999999999
Q ss_pred Ccccccccccc---CCCcccccccccCccccccC------CCCccchhHHHHHHHHHHHhC----------CCCCCccCC
Q 016789 232 ISKLLENIEEA---GPSHGSIVNVFRDPEVEESG------VFSEMSDIYSFGVFLLELVTG----------QEASHIVSL 292 (382)
Q Consensus 232 la~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~sDvws~G~vl~el~tg----------~~p~~~~~~ 292 (382)
+++........ ......+++.|+|||.+.+. .++.++||||||+++|||++| +.||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 99765433221 12233578889999999876 455799999999999999999 788764432
Q ss_pred CCh--hHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 293 GSY--EALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 293 ~~~--~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
... ................. ....+...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcchhhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 221 12211111111111110 0112345678899999999999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=345.70 Aligned_cols=278 Identities=30% Similarity=0.520 Sum_probs=225.5
Q ss_pred CcccCHHHHHHHHhCCCCC------CeeeccCcccEEEEEECCeeEEEEEccCC-------chHHHHHHHHHHhcCCCCC
Q 016789 74 ARQFSMEELEQATKQFSET------SLIGFGSFGPVYKGLLRDTVVAIKRRVGS-------PRQEFVAEVTYLSEIRHRN 140 (382)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~h~n 140 (382)
...|+..++..++++|... +.||+|+||.||+|...+..+|+|..... ..+.+.+|+.++++++|||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 4578899999999999877 89999999999999998899999986532 2357889999999999999
Q ss_pred ccceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec
Q 016789 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD 220 (382)
Q Consensus 141 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~ 220 (382)
|+++++++...+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~ 167 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLD 167 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEc
Confidence 9999999999999999999999999999987532 2346899999999999999999999987 99999999999999
Q ss_pred CCCcEEEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChh-HH
Q 016789 221 ENFIAKVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYE-AL 298 (382)
Q Consensus 221 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~-~~ 298 (382)
.++.+||+|||++......... ......+++.|+|||.+.+ .++.++||||||+++|||++|+.||......... ..
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 9999999999999865432221 1223456788999998865 4889999999999999999999999754433221 22
Q ss_pred HHHHHhh-cCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 299 IQWVRSR-LSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 299 ~~~~~~~-~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
.+..... ....+.+++.+ ...+...+..+.+++.+||+.||.+||++.++++.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 2211111 11112223333 2456778889999999999999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=352.25 Aligned_cols=254 Identities=21% Similarity=0.356 Sum_probs=207.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
++|...+.||+|+||+||++.+.. ..+|+|.+.... .+.|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 567888999999999999999864 789999875533 356899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 90 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 90 KGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp TTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999998642 36899999999999999999999988 99999999999999999999999999986643322
Q ss_pred cCC-------------CcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChh---HHHHHHHhh
Q 016789 242 AGP-------------SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYE---ALIQWVRSR 305 (382)
Q Consensus 242 ~~~-------------~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~---~~~~~~~~~ 305 (382)
... ....+++.|+|||.+.+..++.++||||||+++|||++|..|+......... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY 243 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc
Confidence 111 1345788899999999999999999999999999999999998643322111 111111111
Q ss_pred cCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 306 LSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 306 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
.+...+..+.+++.+||+.||++||++.++++.|+++....
T Consensus 244 --------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 244 --------------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp --------------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11223356888999999999999999999999999998653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=345.22 Aligned_cols=255 Identities=22% Similarity=0.386 Sum_probs=212.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
++|+..+.||+|+||.||+|.+.+ ..+|+|.+... ..+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 568888999999999999999854 78999987654 356799999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 90 GCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp CBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 99999997542 35899999999999999999999988 9999999999999999999999999998765544444
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
.....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.... ............. . ..+.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~---~~~~~~~~~~~~~---~-------~~~~ 230 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTGFR---L-------YKPR 230 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCC---C-------CCCT
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHHhcCcc---C-------CCCC
Confidence 444555678999999999999999999999999999999 999986432 2233332222211 1 1112
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
..+..+.+++.+||+.||.+||++.++++.|+++.+..
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~g 268 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 268 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence 23466889999999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=367.51 Aligned_cols=254 Identities=27% Similarity=0.406 Sum_probs=210.7
Q ss_pred HhCCCCCCeeeccCcccEEEEEECCeeEEEEEccCC-chHHHHHHHHHHhcCCCCCccceeeEEEeCC-eeEEEEeecCC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGS-PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG-YQMLVFEYLPN 163 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~ 163 (382)
.++|...+.||+|+||.||+|.+.+..||+|.+... ..+.|.+|+.+|++++||||+++++++.... ..++||||+++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~ 271 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence 356788889999999999999999999999987654 4568999999999999999999999987765 78999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++...+ ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 272 g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 342 (450)
T 1k9a_A 272 GSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 342 (450)
T ss_dssp CBHHHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence 99999998753 224789999999999999999999988 999999999999999999999999999854322
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
.....++..|+|||.+.+..++.++||||||+++|||+| |+.||...... .....+..... ...+.
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~~~~~----------~~~p~ 409 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKGYK----------MDAPD 409 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT---THHHHHHTTCC----------CCCCT
T ss_pred ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCC----------CCCCC
Confidence 122345677999999999999999999999999999999 99999754332 22332322211 12233
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEM 361 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~ 361 (382)
.++..+.+++.+||+.||.+||++.++++.|+.+...++
T Consensus 410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l 448 (450)
T 1k9a_A 410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448 (450)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence 445778899999999999999999999999999987654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=364.84 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=209.6
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
.++|...+.||+|+||.||+|.+. +..||+|...... ...|.+|+++|++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457888899999999999999996 4789999876542 2468899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++|+|.+++...+ ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999997642 35899999999999999999999988 999999999999999999999999999865432
Q ss_pred cccCC-CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 240 EEAGP-SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 240 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
..... ....++..|+|||.+....++.++|||||||++|||++ |..||.... .....+.......
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~---~~~~~~~~~~~~~---------- 333 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS---NQQTREFVEKGGR---------- 333 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC---HHHHHHHHHTTCC----------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC----------
Confidence 22111 22234667999999998999999999999999999998 999986432 2233333332211
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
...+..++..+.+++.+||+.||++|||+.++++.|+++..+
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 112233456788999999999999999999999999999754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=354.37 Aligned_cols=258 Identities=29% Similarity=0.454 Sum_probs=208.4
Q ss_pred hCCCCCCeeeccCcccEEEEEEC-----CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR-----DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
++|...+.||+|+||.||+|.+. +..||+|.+.... ...|.+|+.++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56788899999999999999985 2469999876532 34689999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 129 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999996542 36899999999999999999999988 9999999999999999999999999998765
Q ss_pred cccccC--CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 238 NIEEAG--PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 238 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
...... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .............
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~---~~~~~~~~~~~~~------- 272 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT---NRDVISSVEEGYR------- 272 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHHHHHHTTCC-------
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHHcCCC-------
Confidence 432221 223345667999999999999999999999999999999 999986432 2233333322211
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhh
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMAL 363 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~~ 363 (382)
...+...+..+.+++.+||+.||.+||++.++++.|+.+.....++
T Consensus 273 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 273 ---LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred ---CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 1122334567889999999999999999999999999998664443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=344.92 Aligned_cols=256 Identities=23% Similarity=0.389 Sum_probs=210.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
.++|+..+.||+|+||.||++.+.+ ..+|+|.+... ..+++.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 3578888999999999999999887 58999987754 45679999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 103 ~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 103 NGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999999997532 35899999999999999999999987 999999999999999999999999999876554444
Q ss_pred CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 243 GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+...... ..+
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~~~~~~----------~~~ 243 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETAEHIAQGLRL----------YRP 243 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHHHTTCCC----------CCC
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC---hhHHHHHHhcccCC----------CCC
Confidence 4444556778999999999999999999999999999998 999987433 22222222221110 111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
...+..+.+++.+||+.||.+||++.++++.|+++.+++
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 222357889999999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=372.30 Aligned_cols=259 Identities=22% Similarity=0.402 Sum_probs=212.6
Q ss_pred HHHHHHhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 81 ELEQATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 81 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
+++...++|...+.||+|+||+||+|.+.. ..||+|.+... ..+.|.+|+.+|++++||||+++++++. .+..++|
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 344455778889999999999999999975 78999987653 4568999999999999999999999987 5678999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp ECCCTTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EeecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999997532 225788899999999999999999987 9999999999999999999999999998765
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
...........++..|+|||.+....++.++||||||+++|||+| |+.||.... .....+.+......
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~---~~~~~~~i~~~~~~-------- 404 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRALERGYRM-------- 404 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHHHTCCC--------
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCC--------
Confidence 433333333445677999999999999999999999999999999 999996432 23333333332111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~ 358 (382)
..+..++..+.+++.+||+.||++||++.+|++.|+++..
T Consensus 405 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 405 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 1123345678899999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=359.55 Aligned_cols=257 Identities=27% Similarity=0.458 Sum_probs=200.0
Q ss_pred hCCCCCCeeeccCcccEEEEEEC-----CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR-----DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
.+|...+.||+|+||.||+|.+. +..||+|.+.... ..+|.+|+.++++++||||+++++++...+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57899999999999999999875 3579999876432 34689999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 125 ~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999997542 36899999999999999999999987 9999999999999999999999999998765
Q ss_pred cccccC--CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 238 NIEEAG--PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 238 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+.....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~---~~~~~~~i~~~~~------- 268 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS---NQDVIKAVDEGYR------- 268 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC---HHHHHHHHHTTEE-------
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC-------
Confidence 432221 122334567999999999999999999999999999998 999986432 2233333322211
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhh
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMA 362 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~ 362 (382)
...+...+..+.+++.+||+.||.+||++.+|++.|+++....-.
T Consensus 269 ---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 313 (373)
T 2qol_A 269 ---LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313 (373)
T ss_dssp ---CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGG
T ss_pred ---CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCccc
Confidence 112234456788999999999999999999999999999865433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=344.25 Aligned_cols=245 Identities=19% Similarity=0.274 Sum_probs=201.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC---CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG---SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
++|+..+.||+|+||+||+|.... ..||+|.+.. ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 578999999999999999998654 7899998643 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp TTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999764 4889999999999999999999987 99999999999999999999999999986644322
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ............ ... ..+
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~-~~~-------~~~ 239 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGT-PEL-------QNP 239 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCS-CCC-------SCG
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCC-CCC-------CCc
Confidence 22344578889999999999999999999999999999999999964321 111111111111 111 112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+..+.+++.+||+.||++||++.++++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 234567889999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=343.23 Aligned_cols=255 Identities=22% Similarity=0.396 Sum_probs=210.1
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
.++|+..+.||+|+||.||+|.+.+ ..+|+|.+... ..+++.+|++++.+++||||+++++++...+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 3568888999999999999999887 57999987643 35679999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 87 ~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 87 NGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999997642 35899999999999999999999987 999999999999999999999999999876554433
Q ss_pred CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 243 GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ............ .... +
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~---~~~~-------~ 227 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT---NSEVVLKVSQGH---RLYR-------P 227 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHHHTTC---CCCC-------C
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC---hHHHHHHHHcCC---CCCC-------C
Confidence 3334455677999999998889999999999999999999 999986432 222222222111 1111 1
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
...+..+.+++.+||+.||.+||++.++++.|+.+.++
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 12235688999999999999999999999999988754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=372.14 Aligned_cols=257 Identities=24% Similarity=0.382 Sum_probs=214.2
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
...+|...+.||+|+||.||+|.+.. ..||+|.+... ..++|.+|+.+|++++||||++++++|......++||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 34668888999999999999999874 78999998654 356899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 298 MTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred cCCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999998643 235899999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
........++..|+|||.+....++.++|||||||++|||++ |+.||..... ..+.+.+..... ..
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~----------~~ 439 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKDYR----------ME 439 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHHHTTCC----------CC
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC----------CC
Confidence 333333445677999999999999999999999999999999 9999875432 233333332211 12
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.+..++..+.+++.+||+.||.+||++.++++.|+.+..+
T Consensus 440 ~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 2334456788999999999999999999999999988644
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=346.81 Aligned_cols=267 Identities=25% Similarity=0.376 Sum_probs=209.0
Q ss_pred HHHHHhCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCchHHHHHHHHHHhcC--CCCCccceeeEEEeC----CeeE
Q 016789 82 LEQATKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEI--RHRNLVTLLGYCQQN----GYQM 155 (382)
Q Consensus 82 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~----~~~~ 155 (382)
.....++|+..+.||+|+||.||+|.+.+..||+|.+.......+..|.+++..+ +||||+++++++... ...+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 3445578999999999999999999999999999998776666777777777665 899999999999887 7899
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC------CCCceecCCCCCCeeecCCCcEEEee
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL------KPPLVHKNFKTANVLVDENFIAKVAD 229 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~ivHrDlk~~Nill~~~~~~kl~D 229 (382)
+||||+++|+|.+++... .+++..++.++.|++.||.|||+. .++|+||||||+|||++.++.+||+|
T Consensus 112 lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 999999999999999653 589999999999999999999987 12499999999999999999999999
Q ss_pred cCCccccccccccC---CCcccccccccCccccccCCCCcc------chhHHHHHHHHHHHhC----------CCCCCcc
Q 016789 230 TGISKLLENIEEAG---PSHGSIVNVFRDPEVEESGVFSEM------SDIYSFGVFLLELVTG----------QEASHIV 290 (382)
Q Consensus 230 fGla~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~------sDvws~G~vl~el~tg----------~~p~~~~ 290 (382)
||+++......... .....+++.|+|||.+.+..++.+ +|||||||++|||++| +.||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99997654332221 123457888999999988776665 9999999999999999 6666543
Q ss_pred CCCCh--hHHHHHHHhhcCCCcccccccCC-CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 291 SLGSY--EALIQWVRSRLSSNNFVDHRLAG-TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 291 ~~~~~--~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
..... .......... . ..+.... ....+++..+.+++.+||+.||.+||++.++++.|+++.+.
T Consensus 266 ~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIK-K----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp SCSSCCHHHHHHHHTTS-C----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCCCCchhhhHHHHhhh-c----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 22221 1111111111 0 0111111 11236788899999999999999999999999999999865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=341.31 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=196.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-----eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
++|+..+.||+|+||.||+|.+.. ..+|+|...... .+.+.+|+.++++++||||+++++++. ++..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 578888999999999999998753 469999876532 346889999999999999999999985 4568999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999997642 35899999999999999999999987 9999999999999999999999999998765
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
...........+++.|+|||.+....++.++||||||+++|||++ |..||..... ......+......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~---~~~~~~i~~~~~~-------- 236 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGERL-------- 236 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHTTCCC--------
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH---HHHHHHHHcCCCC--------
Confidence 544333344456678999999999999999999999999999997 9999875432 2233333221110
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
..+...+..+.+++.+||+.||++||++.++++.|+++.+++
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 237 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 122334567889999999999999999999999999998653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=341.68 Aligned_cols=259 Identities=22% Similarity=0.343 Sum_probs=204.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|+||.||+|.+.. ..+|+|.+.... ...+.+|+.++++++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 468888999999999999999764 689999864321 246889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 91 e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp ECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999997653 5899999999999999999999988 99999999999999999999999999987654
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
..........+++.|+|||.+.+..++.++||||||+++|||++|+.||..... .......... .... ....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--~~~~~~~~~~--~~~~-~~~~--- 235 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--VSIAIKHIQD--SVPN-VTTD--- 235 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--HHHHHHHHSS--CCCC-HHHH---
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHhhc--cCCC-cchh---
Confidence 433333344578889999999999999999999999999999999999964321 1111111111 1111 1111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHHhhh
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRP-KMEIVMTELERIHEKEM 361 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~~v~~~L~~i~~~~~ 361 (382)
...+.+..+.+++.+||+.||.+|| ++.++.+.|+++..+.-
T Consensus 236 -~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 236 -VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp -SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred -cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 1223346788999999999999999 99999999998865543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=351.11 Aligned_cols=262 Identities=26% Similarity=0.393 Sum_probs=211.7
Q ss_pred HHHHhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 016789 83 EQATKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQN 151 (382)
Q Consensus 83 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 151 (382)
....++|...+.||+|+||.||+|.+.+ ..||+|.+.... ...+.+|+.++++++||||+++++++...
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 3345789999999999999999999864 689999976543 34688999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCC-------------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCC
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLE-------------------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNF 212 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDl 212 (382)
+..++||||+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dl 200 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDL 200 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCC
Confidence 9999999999999999999864311 1246899999999999999999999988 999999
Q ss_pred CCCCeeecCCCcEEEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcc
Q 016789 213 KTANVLVDENFIAKVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIV 290 (382)
Q Consensus 213 k~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~ 290 (382)
||+|||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 999999999999999999999866443221 2233456778999999999999999999999999999999 99998643
Q ss_pred CCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 291 SLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
. .......+..... . ..+...+..+.+++.+||+.||.+||++.++++.|+++.+.
T Consensus 281 ~---~~~~~~~~~~~~~-~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 281 A---HEEVIYYVRDGNI-L---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp C---HHHHHHHHHTTCC-C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred C---hHHHHHHHhCCCc-C---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 2 2333333322111 0 11223346788999999999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=341.69 Aligned_cols=261 Identities=23% Similarity=0.355 Sum_probs=202.2
Q ss_pred hCCCCCCeeeccCcccEEEEEE------CCeeEEEEEccCCch---HHHHHHHHHHhcCCCCCccceeeEEEeC--CeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLL------RDTVVAIKRRVGSPR---QEFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 155 (382)
++|+..+.||+|+||+||+|++ .+..||+|++..... +.+.+|++++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5688889999999999999985 247899998875543 4688999999999999999999998653 5689
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 90 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999997642 35899999999999999999999987 99999999999999999999999999987
Q ss_pred ccccccc--CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCC---------ChhHHHHHHHh
Q 016789 236 LENIEEA--GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLG---------SYEALIQWVRS 304 (382)
Q Consensus 236 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~---------~~~~~~~~~~~ 304 (382)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543221 122334566799999999999999999999999999999999988632110 00000000000
Q ss_pred hcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 305 RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 305 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
. +........+...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 244 ~------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 244 L------LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp H------HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred H------HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0 001111122334457788999999999999999999999999999753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=347.25 Aligned_cols=253 Identities=23% Similarity=0.382 Sum_probs=203.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECC------eeEEEEEccC----CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD------TVVAIKRRVG----SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
++|+..+.||+|+||+||+|.+.. ..+|+|.+.. .....|.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 568888999999999999998753 2468887653 23467999999999999999999999998765 789
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
|+||+.+|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999998643 36899999999999999999999987 999999999999999999999999999876
Q ss_pred ccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 237 ENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 237 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
....... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+..........
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~~~------ 238 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEKGERL------ 238 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHTTCCC------
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH---HHHHHHHHcCCCC------
Confidence 4433222 223345678999999999999999999999999999999 9999975432 2233333222111
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
..+...+..+.+++.+||+.||.+||++.++++.|+++...
T Consensus 239 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 12233456788999999999999999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=340.76 Aligned_cols=261 Identities=23% Similarity=0.369 Sum_probs=215.8
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc--hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP--RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
..++|...+.||+|+||.||+|.+.. ..+|+|.+.... .+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 34678888999999999999999874 789999876543 35789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 91 MTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CTTEEHHHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred CCCCcHHHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999997643 235899999999999999999999988 9999999999999999999999999998765443
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
........+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ....+....... ..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~---~~~~~~~~~~~~----------~~ 232 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKDYR----------ME 232 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHHHTTCC----------CC
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhccCC----------CC
Confidence 333334455677999999999999999999999999999999 9999865432 233333322211 11
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhh
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMAL 363 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~~ 363 (382)
.+...+..+.+++.+||+.||.+||++.++++.|+++..+....
T Consensus 233 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~~ 276 (288)
T 3kfa_A 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 276 (288)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 22233467889999999999999999999999999998775443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=346.86 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=210.8
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC-------CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR-------DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 154 (382)
.++|...+.||+|+||.||+|... +..||+|...... ...+.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 467888899999999999999862 2689999876532 24688999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCC-------------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 016789 155 MLVFEYLPNGSMCNHLYETGLE-------------------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTA 215 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~ 215 (382)
++||||+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||||+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~ 179 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAAR 179 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccccccchh
Confidence 9999999999999999875421 1235899999999999999999999988 999999999
Q ss_pred CeeecCCCcEEEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCC
Q 016789 216 NVLVDENFIAKVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLG 293 (382)
Q Consensus 216 Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~ 293 (382)
|||++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~- 258 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP- 258 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 999999999999999999866433221 2233455678999999999899999999999999999999 9999875432
Q ss_pred ChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 294 SYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
..+......... ...+...+..+.+++.+||+.||.+||++.++++.|+++..+
T Consensus 259 --~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 --ERLFNLLKTGHR----------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp --GGHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --HHHHHHhhcCCc----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 233333322211 011223346788999999999999999999999999998754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=337.72 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=204.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 159 (382)
++|...+.||+|+||.||+|.+.+..+|+|.+.... .+.+.+|+.++++++||||+++++++... +..++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 568888999999999999999999999999876432 34689999999999999999999999877 77899999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++|+|.+++.... ...+++..++.++.|++.||.|||+.+++++||||||+|||++.++.++|+|||++.....
T Consensus 90 ~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp CCTTCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred ccCCCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999999997642 2358999999999999999999999777799999999999999999999999988764322
Q ss_pred cccCCCcccccccccCccccccCCCCc---cchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSE---MSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~---~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
....+++.|+|||.+.+..++. ++||||||+++|||++|+.||.... ..............
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~~-------- 229 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---NMEIGMKVALEGLR-------- 229 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC---HHHHHHHHHHSCCC--------
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC---hHHHHHHHHhcCCC--------
Confidence 2234578899999998765444 7999999999999999999997432 12221111111111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~ 358 (382)
...+...+..+.+++.+||+.||.+||++.++++.|+++.+
T Consensus 230 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 -PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11222334678899999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=353.55 Aligned_cols=259 Identities=26% Similarity=0.421 Sum_probs=212.3
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC---------eeEEEEEccCCch----HHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD---------TVVAIKRRVGSPR----QEFVAEVTYLSEI-RHRNLVTLLGYCQQN 151 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~vavK~~~~~~~----~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 151 (382)
.++|...+.||+|+||+||+|.+.+ ..||+|++..... ..+.+|+++++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 3678888999999999999998632 5799998765432 4688999999999 899999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLE-----------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD 220 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~ 220 (382)
+..++||||+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT 225 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceEEEc
Confidence 9999999999999999999875421 1246899999999999999999999987 99999999999999
Q ss_pred CCCcEEEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHH
Q 016789 221 ENFIAKVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEAL 298 (382)
Q Consensus 221 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~ 298 (382)
.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.... ...+
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---~~~~ 302 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VEEL 302 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHH
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHH
Confidence 9999999999999876543322 2234456778999999999999999999999999999999 999986432 3333
Q ss_pred HHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 299 IQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.+.+...... ..+...+..+.+++.+||+.||++||++.++++.|+++...
T Consensus 303 ~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 303 FKLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp HHHHHTTCCC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCC----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 3333322111 11223346788999999999999999999999999999755
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=336.16 Aligned_cols=255 Identities=22% Similarity=0.368 Sum_probs=210.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
++|...+.||+|+||.||++.+.+ ..+|+|.+... ..+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 568888999999999999999855 78999987654 356799999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..........
T Consensus 88 ~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 88 GCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 99999997642 35889999999999999999999988 9999999999999999999999999998765433333
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+...... ..+.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~i~~~~~~----------~~~~ 228 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTGFRL----------YKPR 228 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCCC----------CCCT
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC---HHHHHHHHhcCCcC----------CCCc
Confidence 334455677999999999999999999999999999999 899986432 22333322222110 1112
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
..+..+.+++.+||+.||.+||++.++++.|+++.+..
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 23466889999999999999999999999999998753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=355.75 Aligned_cols=261 Identities=22% Similarity=0.337 Sum_probs=210.6
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 154 (382)
.++|...+.||+|+||+||+|.+.+ ..||+|.+.... ...+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3568888999999999999999642 479999976432 24688999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCC--CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC---cEEEee
Q 016789 155 MLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF---IAKVAD 229 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~---~~kl~D 229 (382)
++||||+++|+|.+++..... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEECC
Confidence 999999999999999987543 22346899999999999999999999988 99999999999999554 599999
Q ss_pred cCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcC
Q 016789 230 TGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLS 307 (382)
Q Consensus 230 fGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 307 (382)
||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.... ...+...+.....
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~---~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEFVTSGGR 304 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHHTTCC
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC
Confidence 9999865433222 2233456778999999999999999999999999999998 999986432 2333333332211
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 016789 308 SNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEM 361 (382)
Q Consensus 308 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~ 361 (382)
. ..+...+..+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus 305 ~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 305 M----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred C----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 1 1122334668899999999999999999999999999976543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=344.48 Aligned_cols=266 Identities=21% Similarity=0.359 Sum_probs=213.5
Q ss_pred HHHHHHhCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCchHHHHHHHHHHhc--CCCCCccceeeEEEeCC----ee
Q 016789 81 ELEQATKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSE--IRHRNLVTLLGYCQQNG----YQ 154 (382)
Q Consensus 81 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~ 154 (382)
......++|...+.||+|+||.||+|.+.++.||+|.+.......+.+|.+++.. ++||||+++++++.... ..
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 3445567899999999999999999999999999999887777788899999887 78999999999998876 78
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHh--------cCCCCceecCCCCCCeeecCCCcEE
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH--------SLKPPLVHKNFKTANVLVDENFIAK 226 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~ivHrDlk~~Nill~~~~~~k 226 (382)
++||||+++|+|.+++... .+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+|
T Consensus 116 ~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp EEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEE
T ss_pred EEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEE
Confidence 9999999999999999753 5899999999999999999999 666 99999999999999999999
Q ss_pred EeecCCcccccccccc---CCCcccccccccCccccccCC------CCccchhHHHHHHHHHHHhC----------CCCC
Q 016789 227 VADTGISKLLENIEEA---GPSHGSIVNVFRDPEVEESGV------FSEMSDIYSFGVFLLELVTG----------QEAS 287 (382)
Q Consensus 227 l~DfGla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~sDvws~G~vl~el~tg----------~~p~ 287 (382)
|+|||++......... ......+++.|+|||.+.+.. ++.++||||||+++|||++| +.||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 9999999866443221 223445788899999987653 34689999999999999999 6777
Q ss_pred CccCCCC--hhHHHHHHHhhcCCCcccccccCCC-CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 288 HIVSLGS--YEALIQWVRSRLSSNNFVDHRLAGT-FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 288 ~~~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
....... ...+........ ..+.+... ...+.+..+.+++.+||+.||++||++.+|++.|+++.++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSC-----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccCcCcccHHHHHHHHHHHH-----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 6443222 112222111111 11111111 1346778899999999999999999999999999999865
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=352.44 Aligned_cols=270 Identities=21% Similarity=0.352 Sum_probs=214.1
Q ss_pred ccCHHHHHHHHhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCccc
Q 016789 76 QFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVT 143 (382)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~ 143 (382)
.+...+++...++|...+.||+|+||.||+|.+.+ ..||+|.+.... ...+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 34456666677899999999999999999998532 689999986542 24689999999999 7999999
Q ss_pred eeeEEEeCC-eeEEEEeecCCCChhhhhhhcCCCC---------------------------------------------
Q 016789 144 LLGYCQQNG-YQMLVFEYLPNGSMCNHLYETGLES--------------------------------------------- 177 (382)
Q Consensus 144 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------- 177 (382)
+++++...+ ..++||||+++|+|.+++.......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998765 4899999999999999997653210
Q ss_pred ----------------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 178 ----------------STKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 178 ----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 112889999999999999999999988 99999999999999999999999999986643222
Q ss_pred -cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 242 -AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 242 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .............. .
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~~~~----------~ 316 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEEFCRRLKEGTRM----------R 316 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC--SHHHHHHHHHTCCC----------C
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch--hHHHHHHHHcCCCC----------C
Confidence 12233456778999999999999999999999999999998 9999965332 22222222222111 1
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.+...+..+.+++.+||+.||.+||++.++++.|+++.+.
T Consensus 317 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 317 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 1222345688999999999999999999999999999865
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=345.24 Aligned_cols=243 Identities=22% Similarity=0.253 Sum_probs=200.3
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
.+|...+.||+|+||.||+|.+. +..||+|++... ....+.+|+++|+.++||||+++++++...+..++|||
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence 46888999999999999999984 478999987542 23467899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++|+|.+++...+ .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 95 YASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999997654 5889999999999999999999988 999999999999999999999999999865433
Q ss_pred cccCCCcccccccccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFS-EMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.. .....+++.|+|||.+.+..++ .++||||+||++|||++|+.||.... ...+.+.+.....
T Consensus 168 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~----------- 231 (328)
T 3fe3_A 168 GK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---LKELRERVLRGKY----------- 231 (328)
T ss_dssp CG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCC-----------
T ss_pred Cc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC-----------
Confidence 22 2334578889999999888765 78999999999999999999997432 2333332222110
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 232 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1112234567789999999999999999999763
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=352.39 Aligned_cols=273 Identities=12% Similarity=0.103 Sum_probs=207.9
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCch--------------HHHHHHHHHHhcCCCCCccce
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSPR--------------QEFVAEVTYLSEIRHRNLVTL 144 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~--------------~~~~~e~~~l~~l~h~niv~l 144 (382)
.++|...+.||+|+||.||+|.+.. ..||+|....... ..+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3578889999999999999998854 5799998765432 124455667778899999999
Q ss_pred eeEEEeC----CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec
Q 016789 145 LGYCQQN----GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD 220 (382)
Q Consensus 145 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~ 220 (382)
++++... ...++||||+ +|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEe
Confidence 9998765 4589999999 999999997642 36899999999999999999999987 99999999999999
Q ss_pred --CCCcEEEeecCCccccccccccCC------CcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCC
Q 016789 221 --ENFIAKVADTGISKLLENIEEAGP------SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSL 292 (382)
Q Consensus 221 --~~~~~kl~DfGla~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~ 292 (382)
.++.+||+|||+++.+........ ....+|+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 889999999999987654332211 223478899999999999999999999999999999999999975332
Q ss_pred CChhHHHHHHHh--hcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhhhhhccCC
Q 016789 293 GSYEALIQWVRS--RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFMGEG 370 (382)
Q Consensus 293 ~~~~~~~~~~~~--~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~~~~~~~~~ 370 (382)
.. ........ ......+.++.+.. ...+..+.+++.+||+.||.+||++.++++.|+++..+.-.-.+..-+|
T Consensus 267 ~~--~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 341 (364)
T 3op5_A 267 DP--KYVRDSKIRYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL 341 (364)
T ss_dssp CH--HHHHHHHHHHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred CH--HHHHHHHHHhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence 21 11111111 11122223332221 1224578889999999999999999999999999987644333333333
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=337.08 Aligned_cols=250 Identities=28% Similarity=0.431 Sum_probs=200.4
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCch----------HHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSPR----------QEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~----------~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 154 (382)
++|+..+.||+|+||+||+|.+. +..+|+|.+..... +.+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 46788899999999999999985 47899998753221 56889999999999999999999987665
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc-----EEEee
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI-----AKVAD 229 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~-----~kl~D 229 (382)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+++|+||||||+|||++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 79999999999999886542 3689999999999999999999997777999999999999988776 99999
Q ss_pred cCCccccccccccCCCcccccccccCcccc--ccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC
Q 016789 230 TGISKLLENIEEAGPSHGSIVNVFRDPEVE--ESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS 307 (382)
Q Consensus 230 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 307 (382)
||+++..... .....+++.|+|||.+ ....++.++||||||+++|||++|+.||........ ...........
T Consensus 173 fg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~ 247 (287)
T 4f0f_A 173 FGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINMIREEGL 247 (287)
T ss_dssp CTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHHHHHSCC
T ss_pred CCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHHHhccCC
Confidence 9999854332 2234567889999998 445588999999999999999999999975443222 22222222111
Q ss_pred CCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 308 SNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 308 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
....+...+..+.+++.+||+.||.+||++.++++.|+++
T Consensus 248 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 ---------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ---------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1112233456788999999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=363.91 Aligned_cols=256 Identities=28% Similarity=0.416 Sum_probs=204.7
Q ss_pred HHHhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 84 QATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 84 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
...++|...+.||+|+||.||+|.+.+ ..||+|.+... ..++|.+|+.+|++++||||+++++++.+ +..++||||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 345678888999999999999999987 67999997753 35689999999999999999999999876 678999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 260 ~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 260 MSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hcCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999997531 235889999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+..... ..
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~---~~~~~~~i~~~~~----------~~ 401 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQVERGYR----------MP 401 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHTTCC----------CC
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC----------CC
Confidence 222333445677999999999999999999999999999999 899986432 2233333322211 12
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~ 358 (382)
.+..++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 233445678899999999999999999999999998763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=343.03 Aligned_cols=260 Identities=14% Similarity=0.143 Sum_probs=210.2
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC-chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeecC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS-PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
++|...+.||+|+||+||+|... +..||+|..... ..+.+.+|+.+++++ +||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~- 87 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL- 87 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence 56888899999999999999964 479999987643 345789999999999 8999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc-----EEEeecCCccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI-----AKVADTGISKLLE 237 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~-----~kl~DfGla~~~~ 237 (382)
+|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++...
T Consensus 88 ~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 88 GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999999764 236899999999999999999999987 999999999999998887 9999999998764
Q ss_pred cccccC------CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcc
Q 016789 238 NIEEAG------PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 238 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (382)
...... .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||..............+........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~- 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP- 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-
Confidence 432211 2345678899999999999999999999999999999999999986554444333333221100000
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
...+. ...+ .+.+++.+||+.||.+||++.++.+.|+++.++.
T Consensus 241 -~~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 241 -IEVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp -HHHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -HHHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 00000 0123 7889999999999999999999999999987664
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=336.70 Aligned_cols=258 Identities=17% Similarity=0.234 Sum_probs=208.3
Q ss_pred cccCHHHHHHHHhC----------CCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC---chHHHHHHHHHHhcCCCC
Q 016789 75 RQFSMEELEQATKQ----------FSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS---PRQEFVAEVTYLSEIRHR 139 (382)
Q Consensus 75 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~ 139 (382)
..++.+++..+++. |...+.||+|+||.||+|... +..||+|.+... ..+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 35777888777764 556678999999999999986 478999986532 345788999999999999
Q ss_pred CccceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee
Q 016789 140 NLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV 219 (382)
Q Consensus 140 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill 219 (382)
||+++++++...+..++||||+++|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEE
Confidence 9999999999999999999999999999988642 5899999999999999999999987 9999999999999
Q ss_pred cCCCcEEEeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHH
Q 016789 220 DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALI 299 (382)
Q Consensus 220 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~ 299 (382)
+.++.+||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.... .....
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~---~~~~~ 250 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAM 250 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHH
T ss_pred CCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHH
Confidence 9999999999999986644222 2233457888999999999999999999999999999999999996432 22222
Q ss_pred HHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 300 QWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 300 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
........ ... ......+..+.+++.+||+.||++||++.++++.
T Consensus 251 ~~~~~~~~-~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 251 KRLRDSPP-PKL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHSSC-CCC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHhcCCC-CCc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22222111 111 0112234568899999999999999999999863
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=336.21 Aligned_cols=249 Identities=25% Similarity=0.410 Sum_probs=194.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECCeeEEEEEccCC-------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGS-------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
++|+..+.||+|+||.||+|.+.+..+|+|..... ..+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 46788899999999999999999999999986542 23568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCCeeecC--------CCcEEEeec
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKP-PLVHKNFKTANVLVDE--------NFIAKVADT 230 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~ivHrDlk~~Nill~~--------~~~~kl~Df 230 (382)
|+++|+|.+++.. ..+++..+..++.|++.||.|||+.+. +|+||||||+|||++. ++.+||+||
T Consensus 87 ~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 87 FARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp CCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred cCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999998853 268999999999999999999998763 3899999999999986 778999999
Q ss_pred CCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCc
Q 016789 231 GISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNN 310 (382)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 310 (382)
|++........ ....+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ............
T Consensus 161 g~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~---- 230 (271)
T 3dtc_A 161 GLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID---GLAVAYGVAMNK---- 230 (271)
T ss_dssp CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC---HHHHHHHHHTSC----
T ss_pred Ccccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHhhhcCC----
Confidence 99986543322 23356788999999999999999999999999999999999997432 112111111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 311 FVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 311 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
.....+...+..+.+++.+||+.||.+||++.++++.|++|
T Consensus 231 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 -----LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11112233446788999999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=344.36 Aligned_cols=244 Identities=21% Similarity=0.203 Sum_probs=201.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|+||+||+++... ..+|+|.+.. .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 568888999999999999999864 7899998643 23456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++...+ .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999997653 5889999999999999999999988 99999999999999999999999999985432
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.. .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||.... ...+.+.+.... .
T Consensus 158 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~-------~---- 222 (337)
T 1o6l_A 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEE-------I---- 222 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCC-------C----
T ss_pred CC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHHHHHHHcCC-------C----
Confidence 21 12234467889999999999999999999999999999999999997432 223322222210 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRP-----KMEIVMTE 352 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~~v~~~ 352 (382)
.++...+..+.+++.+||+.||.+|| ++.++++.
T Consensus 223 ~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11222345678899999999999999 88888753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=343.55 Aligned_cols=260 Identities=22% Similarity=0.371 Sum_probs=195.9
Q ss_pred HhCCCCCCeeeccCcccEEEEEECCe-----eEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCee-
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRDT-----VVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQ- 154 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~- 154 (382)
.++|+..+.||+|+||.||+|.+... .||+|.+... ..+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 35788899999999999999987652 7999987543 235789999999999999999999999877655
Q ss_pred -----EEEEeecCCCChhhhhhhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEe
Q 016789 155 -----MLVFEYLPNGSMCNHLYETGL-ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVA 228 (382)
Q Consensus 155 -----~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~ 228 (382)
++||||+++|+|.+++..... .....+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEEC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCCCCEEEe
Confidence 999999999999999975432 22235899999999999999999999988 9999999999999999999999
Q ss_pred ecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhc
Q 016789 229 DTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 229 DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
|||+++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||..... ...........
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~~~ 256 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN---AEIYNYLIGGN 256 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHTTC
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh---HHHHHHHhcCC
Confidence 999998764433222 223345667999999999999999999999999999999 8999875432 22222222211
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 307 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
. ...+...+..+.+++.+||+.||.+||++.++++.|+++....
T Consensus 257 ~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 257 R----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp C----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred C----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 0112234467889999999999999999999999999998664
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=334.51 Aligned_cols=262 Identities=16% Similarity=0.156 Sum_probs=212.0
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC-chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeecC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS-PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
++|...+.||+|+||.||+|... +..||+|..... ....+.+|+.++..+ +|+|++++++++......++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 88 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 88 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence 56888899999999999999964 489999987543 345788999999999 7999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc-----EEEeecCCccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI-----AKVADTGISKLLE 237 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~-----~kl~DfGla~~~~ 237 (382)
+++|.+++...+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++...
T Consensus 89 ~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 89 GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 999999997642 35899999999999999999999987 999999999999987776 9999999998765
Q ss_pred ccccc------CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcc
Q 016789 238 NIEEA------GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 238 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (382)
..... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 43221 123445788899999999999999999999999999999999999865544443333322221100000
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEM 361 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~ 361 (382)
+.. ....+..+.+++.+||+.||.+||++.+|++.|+++.++.-
T Consensus 243 --~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 243 --REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp --HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --HHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 001 11234678899999999999999999999999999986543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=341.26 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=199.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCc-hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP-RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGS 165 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 165 (382)
++|+..+.||+|+||.||++.+.+..+|+|.+.... .+.|.+|++++++++||||+++++++.+ ..++||||+++|+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~ 85 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGS 85 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCB
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCC
Confidence 467788899999999999999999999999986543 4679999999999999999999998874 4789999999999
Q ss_pred hhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCCeeecCCCc-EEEeecCCccccccccccC
Q 016789 166 MCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK-PPLVHKNFKTANVLVDENFI-AKVADTGISKLLENIEEAG 243 (382)
Q Consensus 166 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-~~ivHrDlk~~Nill~~~~~-~kl~DfGla~~~~~~~~~~ 243 (382)
|.+++.... ....+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++. +||+|||++......
T Consensus 86 L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---- 159 (307)
T 2eva_A 86 LYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159 (307)
T ss_dssp HHHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred HHHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence 999997643 2234788999999999999999999832 24999999999999998886 799999999765432
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||....... .... +........ .....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~-~~~~~~~~~---------~~~~~ 228 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-FRIM-WAVHNGTRP---------PLIKN 228 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-HHHH-HHHHTTCCC---------CCBTT
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-HHHH-HHHhcCCCC---------Ccccc
Confidence 122346788999999999999999999999999999999999997533221 1111 111111111 11122
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.+..+.+++.+||+.||.+||++.++++.|+.+.+.
T Consensus 229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 345688999999999999999999999999999754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=345.06 Aligned_cols=265 Identities=22% Similarity=0.283 Sum_probs=200.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCchHHHHHHHHHHh--cCCCCCccceeeEEEe-----CCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLS--EIRHRNLVTLLGYCQQ-----NGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~-----~~~~~lv~e 159 (382)
++|+..+.||+|+||.||+|+..+..||+|.+.......+..|.+++. .++||||+++++.+.. ....++|||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 92 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME 92 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred HHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEe
Confidence 568888999999999999999999999999987766677776666644 4799999999986643 235689999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-------CCCceecCCCCCCeeecCCCcEEEeecCC
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL-------KPPLVHKNFKTANVLVDENFIAKVADTGI 232 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------~~~ivHrDlk~~Nill~~~~~~kl~DfGl 232 (382)
|+++|+|.+++... ..++..+..++.|++.||.|||+. .++|+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 93 YYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp CCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred cCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 99999999999764 358889999999999999999987 11399999999999999999999999999
Q ss_pred ccccccccc-------cCCCcccccccccCcccccc-------CCCCccchhHHHHHHHHHHHhCCCCCCccCCCCh-h-
Q 016789 233 SKLLENIEE-------AGPSHGSIVNVFRDPEVEES-------GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSY-E- 296 (382)
Q Consensus 233 a~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~-~- 296 (382)
++.+..... .......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.|+........ .
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 987643221 11223357888999999876 4567789999999999999999877643222110 0
Q ss_pred ------------HHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 297 ------------ALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 297 ------------~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
...............+.... ......+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 00011111111011011111 11235677899999999999999999999999999999854
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=336.24 Aligned_cols=256 Identities=21% Similarity=0.337 Sum_probs=204.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-----eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
++|...+.||+|+||.||+|.+.. ..||+|..... ..+.+.+|+.++++++||||+++++++.+. ..++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEE
Confidence 568888999999999999998643 35999987654 235688999999999999999999998754 56899
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 91 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 91 MELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 99999999999997643 35889999999999999999999988 9999999999999999999999999998765
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
...........+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ............
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~~~~~~~-------- 233 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVLEKGDRL-------- 233 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHHHHTCCC--------
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHHhcCCCC--------
Confidence 543333344455678999999999999999999999999999998 99999754322 222222222111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhh
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMA 362 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~ 362 (382)
..+...+..+.+++.+||+.||.+||++.++++.|+++...+-.
T Consensus 234 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 277 (281)
T 3cc6_A 234 --PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277 (281)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence 11122346688999999999999999999999999999765433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=336.10 Aligned_cols=265 Identities=19% Similarity=0.267 Sum_probs=209.5
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccC----CchHHHHHHHHHHhcCCCCCccceeeEEEeCC--eeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVG----SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG--YQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 158 (382)
++|...+.||+|+||+||+|.+. +..||+|.+.. ...+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46888899999999999999987 47899998764 23467889999999999999999999998765 779999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee----cCCCcEEEeecCCcc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV----DENFIAKVADTGISK 234 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill----~~~~~~kl~DfGla~ 234 (382)
||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 9999999999997643 1224899999999999999999999988 9999999999999 888899999999998
Q ss_pred ccccccccCCCcccccccccCccccc--------cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCC-hhHHHHHHHhh
Q 016789 235 LLENIEEAGPSHGSIVNVFRDPEVEE--------SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS-YEALIQWVRSR 305 (382)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~-~~~~~~~~~~~ 305 (382)
....... .....+++.|+|||.+. +..++.++|||||||++|||++|+.||....... ...........
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 7654332 22345678899999986 5678999999999999999999999997433222 12222222222
Q ss_pred cCCCcc----------c----ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 306 LSSNNF----------V----DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 306 ~~~~~~----------~----d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
...... . +.......+......+.+++.+||+.||++||++.|+++...+-.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111100 0 001112345778889999999999999999999999999877544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=346.39 Aligned_cols=245 Identities=21% Similarity=0.269 Sum_probs=202.4
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|...+.||+|+||.||++.... ..+|+|.+.. .....+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 568889999999999999999875 6899998643 23457889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+.+|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 95 e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999997643 5899999999999999999999988 99999999999999999999999999987643
Q ss_pred ccccCCCcccccccccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEES---GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
.. ......+|+.|+|||++.. ..++.++|||||||++|||++|+.||....................
T Consensus 168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-------- 237 (384)
T 4fr4_A 168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV-------- 237 (384)
T ss_dssp TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC--------
T ss_pred CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc--------
Confidence 22 2234467888999999864 4589999999999999999999999976554444444443332211
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPK-MEIVMT 351 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-~~~v~~ 351 (382)
.++...+..+.+++.+||+.||.+||+ +.++.+
T Consensus 238 ---~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ---TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 122233467889999999999999999 555543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=343.46 Aligned_cols=247 Identities=18% Similarity=0.213 Sum_probs=201.0
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC---------chHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS---------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 154 (382)
.+.|...+.||+|+||.||+|.... ..+|+|.+... ..+.+.+|+.+|++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 3568889999999999999999874 78999986532 235789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC----cEEEeec
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF----IAKVADT 230 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~----~~kl~Df 230 (382)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999653 26899999999999999999999988 99999999999998877 7999999
Q ss_pred CCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCc
Q 016789 231 GISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNN 310 (382)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 310 (382)
|++....... ......+++.|+|||.+.+..++.++|||||||++|||++|..||.... .......+.... ..
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~--~~ 236 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANITAVS--YD 236 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHTTC--CC
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcC--CC
Confidence 9998765432 2233457889999999999999999999999999999999999997432 222222222110 00
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 311 FVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 311 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.++... ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 237 -~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 -FDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -CCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011111 112456889999999999999999999885
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=341.85 Aligned_cols=261 Identities=28% Similarity=0.483 Sum_probs=205.4
Q ss_pred hCCCCCCeeeccCcccEEEEEECC------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
++|...+.||+|+||.||+|.+.. ..||+|.+.... ...+.+|+.++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456667899999999999998753 359999876532 2468899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999997642 36899999999999999999999987 999999999999999999999999999876
Q ss_pred cccccc--CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccc
Q 016789 237 ENIEEA--GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVD 313 (382)
Q Consensus 237 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (382)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ...+...+......
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~~~~~~~~~~~~~----- 269 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHEVMKAINDGFRL----- 269 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCCC-----
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHHCCCcC-----
Confidence 543221 1222344677999999999999999999999999999999 999986432 22333333222111
Q ss_pred cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhhhhh
Q 016789 314 HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTF 366 (382)
Q Consensus 314 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~~~~~ 366 (382)
..+...+..+.+++.+||+.||.+||++.++++.|+++........+.
T Consensus 270 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~~~ 317 (333)
T 1mqb_A 270 -----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 317 (333)
T ss_dssp -----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGSB
T ss_pred -----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhhh
Confidence 112234567889999999999999999999999999998776555443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=334.57 Aligned_cols=254 Identities=28% Similarity=0.419 Sum_probs=202.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECCeeEEEEEccCC-chHHHHHHHHHHhcCCCCCccceeeEEEeC-CeeEEEEeecCCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGS-PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN-GYQMLVFEYLPNG 164 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~g 164 (382)
++|+..+.||+|+||.||++.+.+..+|+|..... ..+.+.+|+.++++++||||+++++++... +..++||||+++|
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~ 100 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred hhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence 57888899999999999999999999999998754 346789999999999999999999997654 4789999999999
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCC
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP 244 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 244 (382)
+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 171 (278)
T 1byg_A 101 SLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 171 (278)
T ss_dssp EHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeeccccccccccc----
Confidence 9999997642 123788999999999999999999987 9999999999999999999999999988654321
Q ss_pred CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 245 SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 245 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ........... ....+..
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~~----------~~~~~~~ 238 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGY----------KMDAPDG 238 (278)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHTTTC----------CCCCCTT
T ss_pred cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCC----------CCCCccc
Confidence 22345677999999999999999999999999999998 9999865432 22222222111 1112233
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhh
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMA 362 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~ 362 (382)
.+..+.+++.+||+.||.+||++.++++.|+++...++.
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~~ 277 (278)
T 1byg_A 239 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHELH 277 (278)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC-
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhhcc
Confidence 456788999999999999999999999999999877653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=339.61 Aligned_cols=261 Identities=22% Similarity=0.378 Sum_probs=210.6
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC-------CeeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCccceeeEEEeCCe
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR-------DTVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGY 153 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 153 (382)
.++|...+.||+|+||.||+|.+. +..||+|...... .+.+.+|+.+++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 457888899999999999999862 2689999876543 35688999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCC-------------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec
Q 016789 154 QMLVFEYLPNGSMCNHLYETGL-------------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD 220 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~ 220 (382)
.++||||+++|+|.+++..... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT 179 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEc
Confidence 9999999999999999986532 11235899999999999999999999987 99999999999999
Q ss_pred CCCcEEEeecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHH
Q 016789 221 ENFIAKVADTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEAL 298 (382)
Q Consensus 221 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~ 298 (382)
.++.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~ 257 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--DSKF 257 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS--SHHH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc--hhHH
Confidence 99999999999998765433221 223345677999999999999999999999999999999 9999865432 1222
Q ss_pred HHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 299 IQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
.......... ..+...+..+.+++.+||+.||.+||++.++++.|+++..+.
T Consensus 258 ~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 258 YKMIKEGFRM----------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHHTCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHhccCCCC----------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 2222222111 112233467889999999999999999999999999988653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=343.99 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=201.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--e----eEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--T----VVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~----~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
++|+..+.||+|+||+||+|.+.. . .+++|..... ....+.+|+.++++++||||+++++++.. +..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEE
Confidence 467888899999999999999754 2 3788876432 23467889999999999999999999864 56899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
|+||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999753 236888899999999999999999988 999999999999999999999999999876
Q ss_pred ccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 237 ENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 237 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ............ .
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~---~--- 236 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL---AEVPDLLEKGER---L--- 236 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT---THHHHHHHTTCB---C---
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH---HHHHHHHHcCCC---C---
Confidence 5433222 233445668999999999999999999999999999999 9999975432 222222222111 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
..+...+..+.+++.+||+.||.+||++.++++.|+++....
T Consensus 237 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 237 ----AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp ----CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred ----CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 111122345778999999999999999999999999997654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=337.43 Aligned_cols=255 Identities=25% Similarity=0.431 Sum_probs=208.8
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
.++|...+.||+|+||.||+|...+ ..+|+|.+... ..+.+.+|++++++++||||+++++++.. +..++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence 4678888999999999999999876 68999987653 45679999999999999999999999874 45899999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.........
T Consensus 91 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 91 NGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 999999986431 225889999999999999999999988 999999999999999999999999999876544333
Q ss_pred CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 243 GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .....+........ ..+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~~~~~~~----------~~~ 232 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---NPEVIQNLERGYRM----------VRP 232 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHTTCCC----------CCC
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC---HHHHHHHHhcccCC----------CCc
Confidence 3333445677999999998889999999999999999999 899986432 22333333222110 112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
...+..+.+++.+||+.||++||++.++++.|+++...
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 23346788999999999999999999999999998765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=335.06 Aligned_cols=256 Identities=28% Similarity=0.436 Sum_probs=195.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
++|+..+.||+|+||+||+|.+.+ .+|+|.+.... .+.|.+|+.++++++||||+++++++ .....++||||+
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~ 101 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWC 101 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred cceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEec
Confidence 568888999999999999998766 48888865432 24688999999999999999999965 445689999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 102 EGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred CCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999998653 246899999999999999999999988 99999999999999999999999999986543221
Q ss_pred -cCCCcccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 242 -AGPSHGSIVNVFRDPEVEE---SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 242 -~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.......+++.|+|||.+. ...++.++||||||+++|||++|+.||.... ......+........... .
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~--~--- 248 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIEMVGRGSLSPDL--S--- 248 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC--CHHHHHHHHHHTSCCCCT--T---
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc--hHHHHHHHhcccccCcch--h---
Confidence 1223345678899999986 6678999999999999999999999997432 333333333332211111 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~ 358 (382)
......+..+.+++.+||+.||.+||++.++++.|+++.+
T Consensus 249 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 249 -KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1122345678899999999999999999999999998864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=343.13 Aligned_cols=249 Identities=18% Similarity=0.212 Sum_probs=201.6
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
..++|...+.||+|+||.||+|.... ..+|+|.+.... .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45679999999999999999999864 789999875432 24688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC---CcEEEeecCCcc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN---FIAKVADTGISK 234 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~---~~~kl~DfGla~ 234 (382)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999986542 5899999999999999999999988 9999999999999865 459999999998
Q ss_pred ccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 235 LLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
...... ......+++.|+|||.+.+..++.++|||||||++|||++|+.||.... ...+...+..... .+..+
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~~i~~~~~--~~~~~ 252 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAY--DYPSP 252 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCC--CCCTT
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCC--CCCcc
Confidence 765332 2233457888999999999999999999999999999999999996432 2233332222111 00000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.....+..+.+++.+||+.||.+||++.++++.
T Consensus 253 -----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 253 -----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011234668899999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=337.75 Aligned_cols=248 Identities=17% Similarity=0.232 Sum_probs=201.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc--hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP--RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
++|...+.||+|+||.||+|.... ..+|+|.+.... ...+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 578888999999999999999864 789999876543 3468899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC--CCcEEEeecCCcccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE--NFIAKVADTGISKLLENIE 240 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~--~~~~kl~DfGla~~~~~~~ 240 (382)
+|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 85 g~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 85 GLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999653 236899999999999999999999987 999999999999987 7899999999998764432
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
. .....+++.|+|||.+.+..++.++|||||||++|||++|..||.... .......+...... + +....
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~--~-~~~~~--- 227 (321)
T 1tki_A 159 N--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEYT--F-DEEAF--- 227 (321)
T ss_dssp E--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCC--C-CHHHH---
T ss_pred c--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC---HHHHHHHHHcCCCC--C-Chhhh---
Confidence 2 123456788999999998889999999999999999999999997432 22222222221100 0 00000
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 228 -~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 228 -KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1224678899999999999999999999873
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=336.84 Aligned_cols=246 Identities=20% Similarity=0.235 Sum_probs=200.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC---------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS---------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 155 (382)
+.|...+.||+|+||.||+|.... ..+|+|.+... ..+.+.+|+.++++++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 568889999999999999999864 78999976432 2457899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC----cEEEeecC
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF----IAKVADTG 231 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~----~~kl~DfG 231 (382)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999653 36899999999999999999999988 99999999999999887 89999999
Q ss_pred CccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcc
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (382)
+++....... .....+++.|+|||.+.+..++.++|||||||++|||++|+.||.... ............ ..+
T Consensus 164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~~~--~~~ 236 (326)
T 2y0a_A 164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSAVN--YEF 236 (326)
T ss_dssp TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHTC--CCC
T ss_pred CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHHhcC--CCc
Confidence 9987643222 233457888999999999999999999999999999999999996432 222222222110 000
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+ ... ...+..+.+++.+||+.||.+|||+.++++
T Consensus 237 ~~-~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 237 ED-EYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CH-HHH----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred Cc-ccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 000 112456789999999999999999999987
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=342.00 Aligned_cols=248 Identities=17% Similarity=0.251 Sum_probs=199.4
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
++|+..+.||+|+||+||+|.+. +..||+|.+.... .+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 56888999999999999999886 3789999865332 35688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 87 CSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999998653 25899999999999999999999988 9999999999999999999999999998664322
Q ss_pred c-cCCCcccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 241 E-AGPSHGSIVNVFRDPEVEESGVF-SEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 241 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
. .......+++.|+|||.+.+..+ +.++|||||||++|||++|+.||....... .....+....... .+
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~----~~---- 230 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYL----NP---- 230 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHHTTCTTS----TT----
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhcccccC----Cc----
Confidence 2 22234567888999999987765 778999999999999999999997543221 2222222111110 00
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
....+..+.+++.+||+.||.+|||+.|+++.
T Consensus 231 --~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 --WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 12234567889999999999999999998763
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=347.59 Aligned_cols=249 Identities=17% Similarity=0.196 Sum_probs=201.0
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
..++|+..+.||+|+||.||+|.... ..+|+|.+.... .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 35679999999999999999998754 789999865432 34688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec---CCCcEEEeecCCcc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD---ENFIAKVADTGISK 234 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~---~~~~~kl~DfGla~ 234 (382)
|||+++|+|.+.+.... .+++.....++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999998653 5899999999999999999999988 99999999999998 56889999999998
Q ss_pred ccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 235 LLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
....... ......+++.|+|||.+.+..++.++||||+||++|+|++|.+||.... ...+.+.+..... .+..+
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~--~~~~~ 235 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAY--DFPSP 235 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCC--CCCTT
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhCCC--CCCcc
Confidence 7654322 2233467889999999999999999999999999999999999996432 2333333222110 11111
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.....+..+.+++.+||+.||.+||++.|+++
T Consensus 236 -----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 236 -----EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11123456889999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=346.48 Aligned_cols=249 Identities=18% Similarity=0.212 Sum_probs=188.3
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
..+.|...+.||+|+||.||+|.+.. ..||+|.+... ..+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 34678889999999999999999875 68999987654 3456888999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC---CCcEEEeecCCcccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE---NFIAKVADTGISKLLEN 238 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~---~~~~kl~DfGla~~~~~ 238 (382)
++|+|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 131 ~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 131 TGGELFDRIVEKG-----YYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CSCBHHHHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 9999999987542 5899999999999999999999987 999999999999975 89999999999986643
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
... .....+++.|+|||.+.+..++.++|||||||++|||++|+.||..... .......+.... .....
T Consensus 204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~i~~~~--~~~~~----- 272 (349)
T 2w4o_A 204 QVL--MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG--DQFMFRRILNCE--YYFIS----- 272 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--HHHHHHHHHTTC--CCCCT-----
T ss_pred ccc--cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--cHHHHHHHHhCC--CccCC-----
Confidence 221 2234567889999999999999999999999999999999999964322 222222222111 01111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
....+.+..+.+++.+||+.||++||++.++++
T Consensus 273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111233467889999999999999999999886
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=341.90 Aligned_cols=251 Identities=17% Similarity=0.202 Sum_probs=200.7
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC--------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG--------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 155 (382)
.+.|+..+.||+|+||.||+|.... ..+|+|.+.. ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3568999999999999999999864 7899998642 13567899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc---EEEeecCC
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI---AKVADTGI 232 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~---~kl~DfGl 232 (382)
+||||+++|+|.+.+.... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998886542 12235889999999999999999999988 999999999999986654 99999999
Q ss_pred ccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 233 SKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
+........ ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||... ...+......... . .
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~i~~~~~--~-~ 251 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGIIKGKY--K-M 251 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----HHHHHHHHHHTCC--C-C
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----HHHHHHHHHcCCC--C-C
Confidence 987654322 123345788999999999999999999999999999999999999742 2222222222110 0 0
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+... ...+..+.+++.+||+.||++||++.++++
T Consensus 252 ~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 252 NPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Ccccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 112467889999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=335.12 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=203.3
Q ss_pred hCCCCCCeeeccCcccEEEEEE------CCeeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeC--Cee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLL------RDTVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQ 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 154 (382)
+.|+..+.||+|+||.||+|.+ .+..||+|.+... ....+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999985 3478999987643 236789999999999999999999999876 668
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECcccccc
Confidence 99999999999999996543 35899999999999999999999987 9999999999999999999999999998
Q ss_pred ccccccc--cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccC---------CCChhHHHHHHH
Q 016789 235 LLENIEE--AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVS---------LGSYEALIQWVR 303 (382)
Q Consensus 235 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~---------~~~~~~~~~~~~ 303 (382)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.... ............
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 7654332 12233456677999999999999999999999999999999998864211 000111111111
Q ss_pred hhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 304 SRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 304 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
... .......+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 255 ~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLK-------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHH-------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHh-------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 100 00111223344567889999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=344.04 Aligned_cols=261 Identities=21% Similarity=0.358 Sum_probs=207.9
Q ss_pred HHhCCCCCCeeeccCcccEEEEEEC-------CeeEEEEEccCC----chHHHHHHHHHHhcC-CCCCccceeeEEEeCC
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLR-------DTVVAIKRRVGS----PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNG 152 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 152 (382)
..++|...+.||+|+||.||+|.+. +..||+|.+... ....+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4467888999999999999999972 257999987643 235789999999999 8999999999999999
Q ss_pred eeEEEEeecCCCChhhhhhhcCCC------------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGLE------------------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKT 214 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~ 214 (382)
..++||||+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp 200 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAA 200 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSG
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCh
Confidence 999999999999999999765321 1134799999999999999999999987 99999999
Q ss_pred CCeeecCCCcEEEeecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCC
Q 016789 215 ANVLVDENFIAKVADTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSL 292 (382)
Q Consensus 215 ~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~ 292 (382)
+|||++.++.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||+| |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 99999999999999999998765432211 223345677999999999999999999999999999998 9999975432
Q ss_pred CChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 293 GSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
............. ...+...+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 281 --~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 281 --DANFYKLIQNGFK----------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp --SHHHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred --HHHHHHHHhcCCC----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 2222222222211 111223346788999999999999999999999999988754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=339.07 Aligned_cols=253 Identities=23% Similarity=0.380 Sum_probs=199.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--e----eEEEEEccC----CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--T----VVAIKRRVG----SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~----~vavK~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
++|+..+.||+|+||.||+|.+.. . .+++|.... .....+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 568888999999999999999753 2 467887643 23567999999999999999999999998765 789
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
|+||+.+|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998643 35889999999999999999999988 999999999999999999999999999876
Q ss_pred cccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 237 ENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 237 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .............
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~~~~~------ 238 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEKGERL------ 238 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHTTCCC------
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCCC------
Confidence 443222 2223345677999999999999999999999999999999 9999975433 2333333222111
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
..+...+..+.+++.+||+.||.+||++.++++.|+++...
T Consensus 239 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 239 ----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11223345788999999999999999999999999999754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=335.62 Aligned_cols=244 Identities=23% Similarity=0.245 Sum_probs=192.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----------------------------hHHHHHHHHHHhc
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----------------------------RQEFVAEVTYLSE 135 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----------------------------~~~~~~e~~~l~~ 135 (382)
++|...+.||+|+||.||+|.... ..||+|.+.... .+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 568888999999999999998754 789999865321 2468899999999
Q ss_pred CCCCCccceeeEEEe--CCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 016789 136 IRHRNLVTLLGYCQQ--NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFK 213 (382)
Q Consensus 136 l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk 213 (382)
++||||+++++++.. ....++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+|||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlk 164 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIK 164 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCC
Confidence 999999999999986 5688999999999999876532 36899999999999999999999988 9999999
Q ss_pred CCCeeecCCCcEEEeecCCccccccccccCCCcccccccccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCcc
Q 016789 214 TANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGV---FSEMSDIYSFGVFLLELVTGQEASHIV 290 (382)
Q Consensus 214 ~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDvws~G~vl~el~tg~~p~~~~ 290 (382)
|+|||++.++.+||+|||+++....... ......+++.|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999986643221 122345788899999997765 478899999999999999999999643
Q ss_pred CCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 291 SLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. ...+......... .. ......+..+.+++.+||+.||++||++.|+++
T Consensus 244 ~---~~~~~~~~~~~~~--~~-------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 R---IMCLHSKIKSQAL--EF-------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp S---HHHHHHHHHHCCC--CC-------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c---HHHHHHHHhcccC--CC-------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 2 2222222222110 00 001123456889999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=342.25 Aligned_cols=277 Identities=25% Similarity=0.377 Sum_probs=218.7
Q ss_pred HHHHHHhCCCCCCeeeccCcccEEEEEEC-------CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEE
Q 016789 81 ELEQATKQFSETSLIGFGSFGPVYKGLLR-------DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQ 149 (382)
Q Consensus 81 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~ 149 (382)
+++...++|...+.||+|+||.||+|.+. +..+|+|...... ...+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34445678999999999999999999865 3679999876542 235889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhhhhhhcCC-----CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc
Q 016789 150 QNGYQMLVFEYLPNGSMCNHLYETGL-----ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI 224 (382)
Q Consensus 150 ~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~ 224 (382)
..+..++||||+++|+|.+++..... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCCCe
Confidence 99999999999999999999975321 11235789999999999999999999987 999999999999999999
Q ss_pred EEEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHH
Q 016789 225 AKVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWV 302 (382)
Q Consensus 225 ~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~ 302 (382)
+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ........
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~ 253 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQVLRFV 253 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHHHHHHH
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC---HHHHHHHH
Confidence 999999999866443221 1223345678999999999999999999999999999999 888886432 23333332
Q ss_pred HhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhhhhhccCCcc
Q 016789 303 RSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFMGEGTA 372 (382)
Q Consensus 303 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~~~~~~~~~~~ 372 (382)
...... ..+...+..+.+++.+||+.||.+||++.++++.|+++........++.-.++.
T Consensus 254 ~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~~~~~~ 313 (322)
T 1p4o_A 254 MEGGLL----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEEN 313 (322)
T ss_dssp HTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTTSTTC
T ss_pred HcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccccccccc
Confidence 221110 112233467889999999999999999999999999987766655554444443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=366.63 Aligned_cols=256 Identities=28% Similarity=0.416 Sum_probs=210.2
Q ss_pred HHHhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 84 QATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 84 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
...++|...+.||+|+||.||+|.+.+ ..||+|.+... ..++|.+|+++|++++||||+++++++.+ +..++||||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 345678888999999999999999987 67999987653 34689999999999999999999999876 678999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++|+|.++|.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 343 ~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 343 MSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CTTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hcCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999997531 225889999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
........++..|+|||.+....++.++|||||||++|||++ |+.||.... ...+.+.+..... ..
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~---~~~~~~~i~~~~~----------~~ 484 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQVERGYR----------MP 484 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC---HHHHHHHHHTTCC----------CC
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC----------CC
Confidence 323333445677999999999999999999999999999999 899986432 2233333332211 11
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~ 358 (382)
.+..++..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 223445678899999999999999999999999998753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=345.20 Aligned_cols=241 Identities=19% Similarity=0.212 Sum_probs=195.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 157 (382)
++|+..++||+|+||+||+++... ..+|+|.+... ....+..|..++.++ +||||+++++++.+.+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 578889999999999999999875 68999986532 123578899999887 899999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 132 ~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEcCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999998653 6899999999999999999999988 9999999999999999999999999998532
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCC------hhHHHHHHHhhcCCCcc
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS------YEALIQWVRSRLSSNNF 311 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~ 311 (382)
... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||......+ ...+.+......
T Consensus 205 ~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 278 (396)
T 4dc2_A 205 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 278 (396)
T ss_dssp CTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-----
T ss_pred cCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-----
Confidence 221 12334567889999999999999999999999999999999999996432211 111222221110
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKM 346 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 346 (382)
. .++...+..+.+++.+||+.||.+||++
T Consensus 279 --~----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 --I----RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --C----CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --c----CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0 1122334567899999999999999996
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=350.91 Aligned_cols=251 Identities=21% Similarity=0.243 Sum_probs=202.1
Q ss_pred HHHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 016789 84 QATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 84 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 155 (382)
...++|...+.||+|+||+||+|++.. ..+|+|.+.. .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 334689999999999999999999875 6899998653 22345889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+||||+++|+|.+++... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 146 lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp EEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 999999999999998753 4788999999999999999999988 99999999999999999999999999987
Q ss_pred cccccccCCCcccccccccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcc
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEESGV----FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (382)
.............+|+.|+|||++.+.. ++.++|||||||++|||++|+.||.... .......+........
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~~~- 293 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIMNHKNSLT- 293 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTHHHHCC-
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC---hhhHHHHHHhcccccc-
Confidence 6544333334556889999999998765 7899999999999999999999997433 2222222211100000
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRR--RPKMEIVMTE 352 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~~v~~~ 352 (382)
+ ......+..+.+++.+||+.+|.+ ||++.|+++-
T Consensus 294 ----~--p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 294 ----F--PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ----C--CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ----C--CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0 001122356788999999999998 9999998864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=341.85 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=205.1
Q ss_pred CCCCCCeeeccCcccEEEEEEC------CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeC--CeeE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR------DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQN--GYQM 155 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 155 (382)
.|+..+.||+|+||+||++.+. +..||+|.+.... ...+.+|++++++++||||+++++++... ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3488899999999999998763 4689999987543 34688999999999999999999999874 6789
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+||||+++|+|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 112 lv~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 999999999999999754 4889999999999999999999988 99999999999999999999999999987
Q ss_pred cccccc--cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCC---------ChhHHHHHHHh
Q 016789 236 LENIEE--AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLG---------SYEALIQWVRS 304 (382)
Q Consensus 236 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~---------~~~~~~~~~~~ 304 (382)
...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 262 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE- 262 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH-
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH-
Confidence 654322 1123344667799999999989999999999999999999999998642210 0000000000
Q ss_pred hcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 305 RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 305 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
.++.......+...+..+.+++.+||+.||.+||++.++++.|+++.++-
T Consensus 263 ------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 263 ------LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp ------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 11111112223344577899999999999999999999999999998664
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=352.38 Aligned_cols=255 Identities=21% Similarity=0.224 Sum_probs=204.8
Q ss_pred HHHHHHHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 016789 80 EELEQATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQN 151 (382)
Q Consensus 80 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 151 (382)
.++....++|+..++||+|+||+||+|++.. ..+|+|.+.. .....+.+|..++..++||||+++++++.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 3344445789999999999999999999875 7899998753 2223488999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
+..++|||||++|+|.+++... ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999763 236899999999999999999999988 9999999999999999999999999
Q ss_pred CccccccccccCCCcccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh--
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEE-----SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS-- 304 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-- 304 (382)
+++..............+|+.|+|||++. ...++.++|||||||++|||++|+.||.... .......+..
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~ 297 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHK 297 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTHH
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC---hhHHHHhhhhcc
Confidence 99866544333334456789999999987 5568999999999999999999999997533 2222222211
Q ss_pred -hcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 016789 305 -RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRR--RPKMEIVMTE 352 (382)
Q Consensus 305 -~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~~v~~~ 352 (382)
..... ... ...+..+.+++.+||+.+|++ ||++.|+++-
T Consensus 298 ~~~~~p-----~~~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 298 ERFQFP-----TQV----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHCCCC-----SSC----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccccCC-----ccc----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11111 110 112356788999999998888 9999998763
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=329.04 Aligned_cols=273 Identities=15% Similarity=0.186 Sum_probs=209.4
Q ss_pred HHhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC-chHHHHHHHHHHhcCCCCCccceeeEE-EeCCeeEEEEee
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS-PRQEFVAEVTYLSEIRHRNLVTLLGYC-QQNGYQMLVFEY 160 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~ 160 (382)
..++|+..+.||+|+||.||+|.+. +..||+|..... ....+.+|+.+++.++|+|++..++.+ ...+..++||||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 3467999999999999999999964 478999975443 345788999999999988877777665 667788999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee---cCCCcEEEeecCCccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV---DENFIAKVADTGISKLLE 237 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill---~~~~~~kl~DfGla~~~~ 237 (382)
+ +|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 87 ~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 87 L-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp C-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred c-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9 999999987532 35899999999999999999999988 9999999999999 789999999999998765
Q ss_pred ccccc------CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh-hcCCCc
Q 016789 238 NIEEA------GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS-RLSSNN 310 (382)
Q Consensus 238 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 310 (382)
..... ......+++.|+|||.+.+..++.++|||||||++|||++|+.||................. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch-
Confidence 43321 12344678889999999999999999999999999999999999976544333222222111 11100
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhhhhhccCCc
Q 016789 311 FVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTFMGEGT 371 (382)
Q Consensus 311 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~~~~~~~~~~ 371 (382)
.+... ...+..+.+++.+||+.||++||++.++++.|+++..+.-.-.+..-+|+
T Consensus 239 --~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 4hgt_A 239 --IEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp --HHHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred --hhhhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence 00000 11246788999999999999999999999999999876543333334444
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=334.95 Aligned_cols=240 Identities=20% Similarity=0.229 Sum_probs=199.3
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|+||+||+++.. +..+|+|.+.. ...+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888899999999999999986 47899998653 23456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++.... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999997643 5889999999999999999999987 99999999999999999999999999986543
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
. .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||.... .......+.... .
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~-------~---- 220 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYEKILNAE-------L---- 220 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHCC-------C----
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCC-------C----
Confidence 2 223457888999999999999999999999999999999999997432 222222222110 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRP-----KMEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~~v~~ 351 (382)
.++...+..+.+++.+||+.||.+|| ++.++++
T Consensus 221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11222345688899999999999999 8888874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=336.40 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=196.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
++|+..+.||+|+||+||+|.+.. ..+|+|++.... ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 578889999999999999999854 789999875432 24688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++ |+|.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 101 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 101 ME-KDLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CS-EEHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CC-CCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 97 58888886542 35899999999999999999999987 9999999999999999999999999998664322
Q ss_pred ccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC--ccc-----
Q 016789 241 EAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN--NFV----- 312 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~----- 312 (382)
. ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+. +........... ...
T Consensus 174 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 174 R-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp C----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHHHHCCCCTTTSGGGTTS
T ss_pred c-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHHCCCChHHhhhhhcc
Confidence 1 2233456788999999876 5689999999999999999999999975443322 222111111110 000
Q ss_pred ----cccc--CCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 313 ----DHRL--AGTF-----TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 313 ----d~~~--~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+... .... .+..+..+.+++.+||+.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 0000 1122456789999999999999999999886
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=364.37 Aligned_cols=246 Identities=24% Similarity=0.342 Sum_probs=199.1
Q ss_pred eeeccCcccEEEEEEC----CeeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCC
Q 016789 94 LIGFGSFGPVYKGLLR----DTVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGS 165 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~----~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 165 (382)
.||+|+||.||+|.+. +..||+|.+... ..++|.+|+++|++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999874 257999987653 34679999999999999999999999976 56899999999999
Q ss_pred hhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC--
Q 016789 166 MCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG-- 243 (382)
Q Consensus 166 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-- 243 (382)
|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.......
T Consensus 422 L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99999653 236899999999999999999999988 9999999999999999999999999998765432221
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.+.+..... ...+.
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~----------~~~p~ 562 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKR----------MECPP 562 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS---HHHHHHHHTTCC----------CCCCT
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCC----------CCCCC
Confidence 123344577999999999999999999999999999998 9999975432 233333332211 12233
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.++..+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 4557788999999999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=344.07 Aligned_cols=244 Identities=19% Similarity=0.233 Sum_probs=196.7
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 156 (382)
.++|+..+.||+|+||+||+|+... ..+|+|.+... ....+.+|..++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 3678999999999999999999864 68999987532 234578899999988 69999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
||||+++|+|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999998753 6899999999999999999999988 999999999999999999999999999854
Q ss_pred ccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 237 ENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 237 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
.... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+.+.....
T Consensus 175 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~~~~--------- 241 (353)
T 3txo_A 175 ICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDEV--------- 241 (353)
T ss_dssp CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCC---------
T ss_pred ccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCC---------
Confidence 3221 12233457889999999998889999999999999999999999997432 2233332222110
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKM------EIVMT 351 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~------~~v~~ 351 (382)
.++...+..+.+++.+||+.||.+||++ .++++
T Consensus 242 --~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 --VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1122234567889999999999999998 56654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=340.15 Aligned_cols=242 Identities=18% Similarity=0.238 Sum_probs=198.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
.+|...+.||+|+||.||+|.+.. ..||+|.+.. .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 468888999999999999999854 7899998643 22356889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+ +|+|.+++...+ .+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 89 E~~-~g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 789999987653 6899999999999999999999988 99999999999999999999999999987654
Q ss_pred ccccCCCcccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVF-SEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
... .....+++.|+|||.+.+..+ +.++|||||||++|||++|+.||......... ..+.. ..
T Consensus 161 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------------~~i~~--~~ 224 (336)
T 3h4j_B 161 GNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------------KKVNS--CV 224 (336)
T ss_dssp SBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB------------CCCCS--SC
T ss_pred Ccc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH------------HHHHc--CC
Confidence 322 233457888999999988776 78999999999999999999999743221100 00000 00
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
...+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11223344668899999999999999999999763
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=341.56 Aligned_cols=256 Identities=13% Similarity=0.138 Sum_probs=209.1
Q ss_pred HhCCCCCCeeeccCcccEEEEEE-------CCeeEEEEEccCCchHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLL-------RDTVVAIKRRVGSPRQEFVAEVTYLSEIR---HRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~ 155 (382)
.++|...+.||+|+||+||+|.+ .+..||+|........++..|++++..++ |+||+++++++...+..+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~ 143 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV 143 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence 45688888999999999999942 34689999998888888999999999987 999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC-----------CCc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-----------NFI 224 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-----------~~~ 224 (382)
+||||+++|+|.+++..........+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.
T Consensus 144 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC------CTT
T ss_pred EEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCccccccccCC
Confidence 9999999999999998654434557999999999999999999999987 999999999999998 899
Q ss_pred EEEeecCCcccccccc-ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHH
Q 016789 225 AKVADTGISKLLENIE-EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVR 303 (382)
Q Consensus 225 ~kl~DfGla~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~ 303 (382)
+||+|||+++.+.... ........+|+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------- 293 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-------- 293 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--------
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--------
Confidence 9999999997654221 1122334578899999999999999999999999999999999999864322110
Q ss_pred hhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHHHHHHHhhh
Q 016789 304 SRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRR-PKMEIVMTELERIHEKEM 361 (382)
Q Consensus 304 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R-Ps~~~v~~~L~~i~~~~~ 361 (382)
.....+.... ..+.+.+++..|++.+|.+| |++.++.+.|+++.+...
T Consensus 294 -------~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 294 -------KPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp -------EECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -------eechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 0111111111 13456778889999999998 678889999998887643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=331.88 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=204.5
Q ss_pred hCCCCCC-eeeccCcccEEEEEEC----CeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETS-LIGFGSFGPVYKGLLR----DTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~-~lg~G~~g~V~~~~~~----~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
++|...+ .||+|+||.||+|.+. +..+|+|...... .+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 5677766 8999999999999653 2689999876432 35788999999999999999999999 5567899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
||||+++|+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 95 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 999999999999997643 5889999999999999999999987 999999999999999999999999999876
Q ss_pred cccccc--CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccc
Q 016789 237 ENIEEA--GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVD 313 (382)
Q Consensus 237 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (382)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~~------ 238 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAMLEKGER------ 238 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHTTCC------
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCC------
Confidence 443221 1223345677999999998889999999999999999999 999987532 2333333322111
Q ss_pred cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhh
Q 016789 314 HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMA 362 (382)
Q Consensus 314 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~ 362 (382)
...+...+..+.+++.+||+.||.+||++.++++.|+++......
T Consensus 239 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 239 ----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 112233456788999999999999999999999999999866544
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=339.61 Aligned_cols=260 Identities=26% Similarity=0.431 Sum_probs=210.3
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC---------CeeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR---------DTVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVTLLGYCQQN 151 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 151 (382)
.++|...+.||+|+||.||+|.+. +..||+|...... ...+.+|+.+++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 367888999999999999999874 2579999876543 24688999999999 899999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLE-----------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD 220 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~ 220 (382)
+..++||||+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVT 191 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceEEEc
Confidence 9999999999999999999865321 1235899999999999999999999987 99999999999999
Q ss_pred CCCcEEEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHH
Q 016789 221 ENFIAKVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEAL 298 (382)
Q Consensus 221 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~ 298 (382)
.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ...+
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~ 268 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEEL 268 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHH
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC---HHHH
Confidence 9999999999999866543221 2233455678999999998889999999999999999999 999986432 2333
Q ss_pred HHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 299 IQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
.......... ..+...+..+.+++.+||+.||.+||++.++++.|+++....
T Consensus 269 ~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 269 FKLLKEGHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 3333322111 112233467889999999999999999999999999997653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=343.80 Aligned_cols=259 Identities=15% Similarity=0.133 Sum_probs=196.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-----eeEEEEEccCCc--------------hHHHHHHHHHHhcCCCCCccceeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGSP--------------RQEFVAEVTYLSEIRHRNLVTLLGY 147 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~~~ 147 (382)
++|...+.||+|+||.||+|.+.. ..+|+|...... ...+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 568888999999999999999853 689999866432 1236678889999999999999999
Q ss_pred EEe----CCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC
Q 016789 148 CQQ----NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF 223 (382)
Q Consensus 148 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~ 223 (382)
+.. ....++||||+ +++|.+++...+ .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCC
Confidence 988 67899999999 999999987643 6899999999999999999999987 99999999999999887
Q ss_pred --cEEEeecCCccccccccccC------CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCCh
Q 016789 224 --IAKVADTGISKLLENIEEAG------PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSY 295 (382)
Q Consensus 224 --~~kl~DfGla~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~ 295 (382)
.+||+|||+++.+....... .....+++.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP- 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence 99999999998765432211 123457788999999999999999999999999999999999996432211
Q ss_pred hHHHHHHHh-hcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 296 EALIQWVRS-RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 296 ~~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
......... ............. ....+..+.+++.+||+.||.+||++.+|++.|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 VAVQTAKTNLLDELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHHHTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHHHhhcccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111111111 1111111111100 0123457889999999999999999999999998764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=340.07 Aligned_cols=245 Identities=20% Similarity=0.267 Sum_probs=180.4
Q ss_pred CCeeeccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeecCCCChhh
Q 016789 92 TSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCN 168 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 168 (382)
.+.||+|+||.||+|.+.. ..+|+|.+.......+.+|+.++..+. ||||+++++++.+....++||||+++|+|.+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE 95 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence 4789999999999999874 789999987777778899999999997 9999999999999999999999999999999
Q ss_pred hhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC---cEEEeecCCccccccccccCCC
Q 016789 169 HLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF---IAKVADTGISKLLENIEEAGPS 245 (382)
Q Consensus 169 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~---~~kl~DfGla~~~~~~~~~~~~ 245 (382)
++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++....... ...
T Consensus 96 ~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~ 167 (325)
T 3kn6_A 96 RIKKKK-----HFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLK 167 (325)
T ss_dssp HHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccc
Confidence 998643 6899999999999999999999987 99999999999997665 899999999986543222 223
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCC----ChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 246 HGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLG----SYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 246 ~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
...+++.|+|||.+.+..++.++||||||+++|||++|+.||...... ........+... .. .+.....
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~----~~---~~~~~~~ 240 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG----DF---SFEGEAW 240 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT----CC---CCCSHHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC----CC---CCCcccc
Confidence 345678899999999999999999999999999999999999754321 111222211111 00 0000001
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+..+.+++.+||+.||.+||++.++++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 123567889999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=336.25 Aligned_cols=247 Identities=21% Similarity=0.298 Sum_probs=194.7
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCC-------
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG------- 152 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------- 152 (382)
.++|+..+.||+|+||.||+|++. +..||+|++... ..+.+.+|+.+|++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888999999999999999986 478999987532 2457899999999999999999999986643
Q ss_pred --------------------------------------------------eeEEEEeecCCCChhhhhhhcCCCCCCcCC
Q 016789 153 --------------------------------------------------YQMLVFEYLPNGSMCNHLYETGLESSTKLE 182 (382)
Q Consensus 153 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~ 182 (382)
..++||||+++|+|.+++.... ......
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~ 162 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDRE 162 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGSC
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--Cccchh
Confidence 3799999999999999998654 233567
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc-----------cCCCcccccc
Q 016789 183 FKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE-----------AGPSHGSIVN 251 (382)
Q Consensus 183 ~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~~~~ 251 (382)
+..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+++
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 7788999999999999999988 99999999999999999999999999987654321 1122345788
Q ss_pred cccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHH
Q 016789 252 VFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRL 331 (382)
Q Consensus 252 ~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l 331 (382)
.|+|||.+.+..++.++||||||+++|||++|..|+.. ........... ... .........+.++
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~-~~~---------~~~~~~~~~~~~l 305 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNL-KFP---------LLFTQKYPQEHMM 305 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTT-CCC---------HHHHHHCHHHHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhcc-CCC---------cccccCChhHHHH
Confidence 89999999999999999999999999999999876431 11111111111 000 0112344667899
Q ss_pred HhhccCCCCCCCCCHHHHHH
Q 016789 332 TLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 332 ~~~cl~~dp~~RPs~~~v~~ 351 (382)
+.+||+.||.+||++.++++
T Consensus 306 i~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHccCCCCcCCCHHHHhh
Confidence 99999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=330.03 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=202.4
Q ss_pred CCCCCeeeccCcccEEEEEECC-----eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCee-EEEE
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQ-MLVF 158 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv~ 158 (382)
|...+.||+|+||+||+|.+.+ ..+|+|...... .+.+.+|+.++++++||||+++++++...+.. ++|+
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 4456789999999999998643 269999876432 24688999999999999999999999876654 9999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+.+|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 103 e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 103 PYMCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred ecccCCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999753 236789999999999999999999988 99999999999999999999999999986644
Q ss_pred cccc---CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 239 IEEA---GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 239 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
.... ......+++.|+|||.+.+..++.++||||||+++|||++|..|+.... ...............
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~------- 247 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI--DPFDLTHFLAQGRRL------- 247 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CGGGHHHHHHTTCCC-------
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC--CHHHHHHHhhcCCCC-------
Confidence 3221 2233456778999999999999999999999999999999666654222 223333333322111
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
..+...+..+.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus 248 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 248 ---PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11222346788999999999999999999999999999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=340.10 Aligned_cols=244 Identities=23% Similarity=0.276 Sum_probs=199.7
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeE
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 155 (382)
..++|...+.||+|+||.||+|++.. +.+|+|.+.. .....+..|..++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 34678899999999999999999864 7899998753 2345678899999876 8999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+||||+++|+|.+++...+ .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 95 lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999998653 5889999999999999999999988 99999999999999999999999999985
Q ss_pred cccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
..... .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||.... ...+.+.+.... +.
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~-------~~ 236 (345)
T 1xjd_A 168 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMDN-------PF 236 (345)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCC-------CC
T ss_pred cccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHhCC-------CC
Confidence 43221 12234457889999999999999999999999999999999999997432 233333222211 11
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKME-IVM 350 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~-~v~ 350 (382)
++...+..+.+++.+||+.||.+||++. +++
T Consensus 237 ----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 237 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1122345678899999999999999997 554
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=342.47 Aligned_cols=261 Identities=20% Similarity=0.356 Sum_probs=209.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCccceeeEEEeCCe
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGY 153 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 153 (382)
.++|...+.||+|+||.||+|.+.. ..+|+|...... ...+.+|+.+++++ +||||+++++++...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4678889999999999999999754 369999876542 34688999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCC---------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGL---------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI 224 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~ 224 (382)
.++||||+++|+|.+++..... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEEGGGE
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEECCCCe
Confidence 9999999999999999975421 01235799999999999999999999987 999999999999999999
Q ss_pred EEEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHH
Q 016789 225 AKVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWV 302 (382)
Q Consensus 225 ~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~ 302 (382)
+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||+| |..||...... .......
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~~ 280 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--SKFYKLV 280 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--HHHHHHH
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--HHHHHHH
Confidence 999999999866443221 1223345678999999999999999999999999999999 88998653321 2222222
Q ss_pred HhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 303 RSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 303 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
...... ..+...+..+.+++.+||+.||.+||++.++++.|+++..+.
T Consensus 281 ~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 281 KDGYQM----------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hcCCCC----------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 222111 111222467889999999999999999999999999987653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=330.48 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=205.2
Q ss_pred hCCCCCC-eeeccCcccEEEEEEC----CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETS-LIGFGSFGPVYKGLLR----DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~-~lg~G~~g~V~~~~~~----~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
++|.... .||+|+||.||+|.+. +..||+|.+.... .+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 8999999999999864 4679999876532 34688999999999999999999999 45668999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999998643 236899999999999999999999988 9999999999999999999999999998764
Q ss_pred ccccc--CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 238 NIEEA--GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 238 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i~~~~~------- 231 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKR------- 231 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCC-------
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHhcCCc-------
Confidence 33221 1223345678999999998889999999999999999999 9999975432 233333322211
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
...+...+..+.+++.+||+.||.+||++.++++.|+++....
T Consensus 232 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 232 ---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1122334567889999999999999999999999999997653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=338.29 Aligned_cols=240 Identities=22% Similarity=0.230 Sum_probs=200.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|...+.||+|+||.||++.... ..+|+|.+.. .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 468888999999999999999864 7899998643 23456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999998753 5889999999999999999999988 99999999999999999999999999986643
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
. .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||.... .....+.+.... .
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~-------~---- 255 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEKIVSGK-------V---- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCC-------C----
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC---HHHHHHHHHcCC-------C----
Confidence 2 223457888999999999999999999999999999999999997432 222222222211 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPK-----MEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~~v~~ 351 (382)
.++...+..+.+++.+||+.||.+||+ +.++++
T Consensus 256 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 112223466889999999999999998 777765
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=329.16 Aligned_cols=255 Identities=20% Similarity=0.257 Sum_probs=196.4
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
++|+..+.||+|+||+||+|.+.. ..+|+|.+.... ...+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 467888999999999999999864 789999875322 2568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++ ++.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9974 6666665432 36899999999999999999999988 999999999999999999999999999866432
Q ss_pred cccCCCcccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh-hcCCCc-----cc
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGV-FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS-RLSSNN-----FV 312 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~-----~~ 312 (382)
.. ......+++.|+|||.+.+.. ++.++|||||||++|||++|+.|+.... ........+.. ...... ..
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhhhhc
Confidence 21 223345678899999997765 8999999999999999999998865322 22222222221 111100 00
Q ss_pred ---c---------cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 313 ---D---------HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 313 ---d---------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+ ...........+..+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00000112234567889999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=344.68 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=192.3
Q ss_pred CCCCCCeeeccCcccEEEEEECC-----eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQ-NGYQMLV 157 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv 157 (382)
.|...+.||+|+||+||+|.+.. ..+|+|..... ....|.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 35566789999999999998632 36899987542 23578999999999999999999999764 4578999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999997532 35788999999999999999999988 9999999999999999999999999998664
Q ss_pred cccccC---CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccc
Q 016789 238 NIEEAG---PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVD 313 (382)
Q Consensus 238 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (382)
...... .....+++.|+|||.+.+..++.++||||||+++|||++ |.+||......+ .......... .
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~~~~~~---~-- 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQGRR---L-- 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHHHTTCC---C--
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHHHcCCC---C--
Confidence 332211 123345677999999999999999999999999999999 667775443222 2222222111 1
Q ss_pred cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 314 HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 314 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
..+...+..+.+++.+||+.||++||++.++++.|+++...
T Consensus 316 -----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 316 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11223346788999999999999999999999999999754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=344.65 Aligned_cols=268 Identities=19% Similarity=0.265 Sum_probs=211.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCC--eeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG--YQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 158 (382)
+.|...+.||+|+||+||+|.+.. ..||+|.+... ..+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 468888999999999999999874 78999987642 3467889999999999999999999998765 779999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee----cCCCcEEEeecCCcc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV----DENFIAKVADTGISK 234 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill----~~~~~~kl~DfGla~ 234 (382)
||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 89 e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CCCTTEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred ecCCCCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 9999999999997643 1224899999999999999999999988 9999999999999 788889999999998
Q ss_pred ccccccccCCCcccccccccCcccccc--------CCCCccchhHHHHHHHHHHHhCCCCCCccCCCC-hhHHHHHHHhh
Q 016789 235 LLENIEEAGPSHGSIVNVFRDPEVEES--------GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS-YEALIQWVRSR 305 (382)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~-~~~~~~~~~~~ 305 (382)
........ ....+++.|+|||.+.. ..++.++|||||||++|||++|+.||....... ...........
T Consensus 165 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCCGGGS--SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccCCCcc--ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 76543322 23456788999999865 557889999999999999999999997543222 22222222221
Q ss_pred cCCCcc----------c----ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 306 LSSNNF----------V----DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 306 ~~~~~~----------~----d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
...... + +.......+......+.+++.+||+.||++||++.++++.++++....
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 111100 0 001112345778889999999999999999999999999999987653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=331.47 Aligned_cols=255 Identities=16% Similarity=0.173 Sum_probs=197.2
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|...+.||+|+||.||++.+. +..||+|.+.... .+.+.+|+.++++++||||+++++++...+..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 67899999999999999999976 4789999876431 256889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 114 e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 114 RLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp ECCCCEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999998653 5899999999999999999999988 99999999999999999999999999987654
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
..........+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ............... ..
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~----~~--- 256 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ---LSVMGAHINQAIPRP----ST--- 256 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH---HHHHHHHHHSCCCCG----GG---
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch---HHHHHHHhccCCCCc----cc---
Confidence 33333334456788999999999999999999999999999999999997432 112222222111110 01
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHHh
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRP-KMEIVMTELERIHEK 359 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~~v~~~L~~i~~~ 359 (382)
.+...+..+.+++.+||+.||++|| ++.++++.|+++...
T Consensus 257 -~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 257 -VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp -TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred -cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 1223345688899999999999999 999999999987654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=336.54 Aligned_cols=241 Identities=20% Similarity=0.212 Sum_probs=195.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 157 (382)
++|...+.||+|+||.||++++.. ..+|+|.+.... ...+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 468888999999999999999874 789999875421 23577899999988 899999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999997653 5899999999999999999999988 9999999999999999999999999998543
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCC------ChhHHHHHHHhhcCCCcc
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLG------SYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~ 311 (382)
... .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...... ....+.+......
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 235 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 235 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-----
T ss_pred CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-----
Confidence 221 1223446788999999999999999999999999999999999999643221 1111222221110
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKM 346 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 346 (382)
. .++...+..+.+++.+||+.||.+||++
T Consensus 236 --~----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 --I----RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --C----CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --C----CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 0 1122334568889999999999999996
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=337.55 Aligned_cols=248 Identities=19% Similarity=0.209 Sum_probs=191.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
++|...+.||+|+||+||++.... ..||+|.+... ....+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 468889999999999999999864 78999987643 34678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc--EEEeecCCcccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI--AKVADTGISKLLENIE 240 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~--~kl~DfGla~~~~~~~ 240 (382)
+|+|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++......
T Consensus 100 ~~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 100 GGELYERICNAG-----RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 999999997653 5899999999999999999999988 999999999999987765 9999999997433221
Q ss_pred ccCCCcccccccccCccccccCCCCcc-chhHHHHHHHHHHHhCCCCCCccCCC-ChhHHHHHHHhhcCCCcccccccCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEM-SDIYSFGVFLLELVTGQEASHIVSLG-SYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvws~G~vl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
......+++.|+|||.+.+..++.+ +|||||||++|||++|+.||...... ......+...... ..+
T Consensus 173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~--~~~------- 241 (361)
T 3uc3_A 173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK--YSI------- 241 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC--CCC-------
T ss_pred --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC--CCC-------
Confidence 1233457888999999988887665 89999999999999999999754322 1122222221110 000
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
......+..+.+++.+||+.||.+|||+.++++.
T Consensus 242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0011123567899999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=340.00 Aligned_cols=264 Identities=17% Similarity=0.142 Sum_probs=208.6
Q ss_pred hCCCCCCeeeccCcccEEEEEEC----------CeeEEEEEccCCchHHHHHHHHHHhcCCCCCccc-------------
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR----------DTVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVT------------- 143 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~----------~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~------------- 143 (382)
++|...+.||+|+||.||+|... +..+|+|..... ..+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 119 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI 119 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence 56888899999999999999885 468999987644 56889999999999999988
Q ss_pred --eeeEEEe-CCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec
Q 016789 144 --LLGYCQQ-NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD 220 (382)
Q Consensus 144 --l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~ 220 (382)
+++++.. ....++||||+ +|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 120 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 120 PTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVD 193 (352)
T ss_dssp CCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEEEE
T ss_pred cchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEc
Confidence 6777776 67899999999 999999998641 246899999999999999999999987 99999999999999
Q ss_pred CCC--cEEEeecCCccccccccccC------CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCC
Q 016789 221 ENF--IAKVADTGISKLLENIEEAG------PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSL 292 (382)
Q Consensus 221 ~~~--~~kl~DfGla~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~ 292 (382)
.++ .+||+|||+++.+....... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 998 99999999998765433211 1233577889999999999999999999999999999999999975432
Q ss_pred CChhHHHHHHHh-hcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhh
Q 016789 293 GSYEALIQWVRS-RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMA 362 (382)
Q Consensus 293 ~~~~~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~ 362 (382)
. .......... ......+.+..... ...+..+.+++.+||+.||.+||++.++++.|+++.+..-.
T Consensus 274 ~-~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 274 N-TEDIMKQKQKFVDKPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp C-HHHHHHHHHHHHHSCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred C-HHHHHHHHHhccCChhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 2 2222222221 12222222221110 11236688899999999999999999999999999876443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=333.54 Aligned_cols=259 Identities=20% Similarity=0.284 Sum_probs=186.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
++|+..+.||+|+||.||+|.... ..||+|.+... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 568889999999999999998764 78999986532 235788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 161 LPNGSMCNHLYETGL-ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
++ |+|.+++..... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 97 699998876432 22235899999999999999999999987 999999999999999999999999999866432
Q ss_pred cccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc------
Q 016789 240 EEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV------ 312 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 312 (382)
.. ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+..............
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 162 VN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND--EEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp CC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred cc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCChhHhhhhhh
Confidence 21 2223456788999999876 4689999999999999999999999975332 112211111111110000
Q ss_pred ----ccccCC------------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 313 ----DHRLAG------------TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 313 ----d~~~~~------------~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+.+.. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000 000122457889999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=330.68 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=199.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-----eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEE-eCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQ-QNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~l 156 (382)
..|...+.||+|+||+||+|.+.. ..+|+|...... .+.+.+|+.++++++||||+++++++. ..+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 357778899999999999998653 258899876432 246889999999999999999999865 4567899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999997532 35789999999999999999999988 999999999999999999999999999876
Q ss_pred ccccccC---CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 237 ENIEEAG---PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTG-QEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 237 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
....... .....+++.|+|||.+.+..++.++||||||+++|||++| .+|+..... ............ .
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~~~~~~~~~~---~- 251 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYLLQGRR---L- 251 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT---TTHHHHHHTTCC---C-
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH---HHHHHHHhcCCC---C-
Confidence 5433221 2233456779999999999999999999999999999995 455543322 222222221110 0
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
..+...+..+.+++.+||+.||.+||++.++++.|+++...
T Consensus 252 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 252 ------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11122345788999999999999999999999999999764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=349.38 Aligned_cols=253 Identities=21% Similarity=0.206 Sum_probs=201.5
Q ss_pred HHHHHHHhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 016789 80 EELEQATKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN 151 (382)
Q Consensus 80 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 151 (382)
.+.....++|+..+.||+|+||+||+++.. ++.+|+|.+... ....+.+|..++..++||||+++++++.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 334444578999999999999999999986 478999987532 223588999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
+..|+||||+++|+|.+++.+.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999998643 26889999999999999999999988 9999999999999999999999999
Q ss_pred CccccccccccCCCcccccccccCccccc-------cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEE-------SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS 304 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 304 (382)
+++..............+|+.|+|||++. ...++.++|||||||++|||++|+.||..... ......+..
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~ 284 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST---AETYGKIVH 284 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHT
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH---HHHHHHHHh
Confidence 99876543332233456789999999987 35689999999999999999999999975332 222221111
Q ss_pred ---hcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCC---CCHHHHHH
Q 016789 305 ---RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRR---PKMEIVMT 351 (382)
Q Consensus 305 ---~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---Ps~~~v~~ 351 (382)
.... +.. ....+..+.+++.+||+ +|.+| |++.|+++
T Consensus 285 ~~~~~~~-----p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 285 YKEHLSL-----PLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHCCC-----C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cccCcCC-----Ccc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1111 111 12234678889999999 99998 57888765
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=331.94 Aligned_cols=260 Identities=20% Similarity=0.355 Sum_probs=198.4
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC-----eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCC--
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNG-- 152 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-- 152 (382)
..++|...+.||+|+||.||+|.+.. ..+|+|.+.... .+.+.+|+.++++++||||+++++++....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 34678888999999999999997643 479999876431 246889999999999999999999998765
Q ss_pred ---eeEEEEeecCCCChhhhhhhcCC-CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEe
Q 016789 153 ---YQMLVFEYLPNGSMCNHLYETGL-ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVA 228 (382)
Q Consensus 153 ---~~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~ 228 (382)
..++||||+++|+|.+++..... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTTSCEEEC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEEe
Confidence 34999999999999999865432 23346899999999999999999999987 9999999999999999999999
Q ss_pred ecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhc
Q 016789 229 DTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 229 DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ...........
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~ 266 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN---HEMYDYLLHGH 266 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHHHTTC
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHHHHcCC
Confidence 999998764432221 223345677999999999999999999999999999999 8888864332 22232222211
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 307 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.. ..+...+..+.+++.+||+.||.+||++.++++.|+++.+.
T Consensus 267 ~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 267 RL----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp CC----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11 11223346788999999999999999999999999999754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=335.84 Aligned_cols=258 Identities=21% Similarity=0.218 Sum_probs=198.9
Q ss_pred HHHHHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC--------CchHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 016789 82 LEQATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG--------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQN 151 (382)
Q Consensus 82 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 151 (382)
+....++|...+.||+|+||.||+|.... ..+|+|.+.. ...+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 45566789999999999999999999865 6899997642 2346789999999999999999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCC-----------------------------------CCCcCCHHHHHHHHHHHHHH
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLE-----------------------------------SSTKLEFKQRVSIALGAAKG 196 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~~ 196 (382)
+..++||||+++|+|.+++...... ....+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988531100 01234567788899999999
Q ss_pred HHHHhcCCCCceecCCCCCCeeecCCC--cEEEeecCCcccccccccc---CCCcccccccccCcccccc--CCCCccch
Q 016789 197 LCHLHSLKPPLVHKNFKTANVLVDENF--IAKVADTGISKLLENIEEA---GPSHGSIVNVFRDPEVEES--GVFSEMSD 269 (382)
Q Consensus 197 L~~LH~~~~~ivHrDlk~~Nill~~~~--~~kl~DfGla~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~sD 269 (382)
|.|||+.+ |+||||||+|||++.++ .+||+|||+++.+...... ......+++.|+|||.+.. ..++.++|
T Consensus 181 l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 181 LHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 99999988 99999999999998776 8999999999865432221 2234557888999999865 67899999
Q ss_pred hHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 016789 270 IYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIV 349 (382)
Q Consensus 270 vws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v 349 (382)
|||||+++|||++|+.||.... ......+......... .+. ....+..+.+++.+||+.||.+||++.++
T Consensus 259 iwslG~il~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~---~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVN--DADTISQVLNKKLCFE---NPN-----YNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCTT---SGG-----GGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCC--hHHHHHHHHhcccccC---Ccc-----cccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 9999999999999999996432 1222222222111111 111 11234678899999999999999999999
Q ss_pred HH
Q 016789 350 MT 351 (382)
Q Consensus 350 ~~ 351 (382)
++
T Consensus 329 l~ 330 (345)
T 3hko_A 329 LQ 330 (345)
T ss_dssp HH
T ss_pred hc
Confidence 86
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=364.79 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=198.2
Q ss_pred CeeeccCcccEEEEEEC----CeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLR----DTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||.||+|.+. +..||||++.... .+++.+|+++|++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 36999999999999763 2689999876432 3579999999999999999999999965 457899999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc-
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA- 242 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~- 242 (382)
|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999997643 6899999999999999999999988 999999999999999999999999999876543321
Q ss_pred -CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 243 -GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 243 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
......++..|+|||++.+..++.++|||||||++|||++ |+.||.... ...+.+.+..... ...
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~---~~~~~~~i~~~~~----------~~~ 593 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAMLEKGER----------MGC 593 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHTTCC----------CCC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC----------CCC
Confidence 2233445678999999999999999999999999999998 999997432 2333333332211 112
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
+..++..+.+++.+||+.||++||++.+|++.|+++...
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 334457788999999999999999999999999988654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=329.43 Aligned_cols=255 Identities=23% Similarity=0.299 Sum_probs=194.5
Q ss_pred hCCCCCCeeeccCcccEEEEEEC-CeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR-DTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
++|+..+.||+|+||+||+|... +..+|+|++.... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 35788899999999999999986 4789999875432 25688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++ ++|.+++.... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LD-QDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CS-EEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 97 48998887542 35889999999999999999999987 9999999999999999999999999997654321
Q ss_pred ccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC--c-------
Q 016789 241 EAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN--N------- 310 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~------- 310 (382)
. ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.... ....+........... .
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHHCCCChhhchhhhcc
Confidence 1 12233567889999998764 58999999999999999999999997432 2222222222111100 0
Q ss_pred -ccccccC-------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 311 -FVDHRLA-------GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 311 -~~d~~~~-------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..++.+. .......+..+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0011110 0011223467789999999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=340.09 Aligned_cols=251 Identities=20% Similarity=0.265 Sum_probs=201.4
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeec
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
..++|...+.||+|+||.||+|.... ..+|+|.+.... ....+|++++.++ +||||+++++++.+.+..++||||+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 98 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence 34678999999999999999999864 789999876543 3456788888888 7999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC----CcEEEeecCCccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN----FIAKVADTGISKLLE 237 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~----~~~kl~DfGla~~~~ 237 (382)
++|+|.+++...+ .+++.....++.|++.||.|||+.+ |+||||||+|||+.++ +.+||+|||+++...
T Consensus 99 ~gg~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 99 KGGELLDKILRQK-----FFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CSCBHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999997643 5899999999999999999999988 9999999999998433 359999999998664
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.... ......+++.|+|||.+.+..++.++|||||||++|||++|+.||..........+...+..... .+.
T Consensus 172 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~-------~~~ 243 (342)
T 2qr7_A 172 AENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF-------SLS 243 (342)
T ss_dssp CTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC-------CCC
T ss_pred CCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc-------ccC
Confidence 4322 22234567889999999888899999999999999999999999975443444444444332211 011
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.......+..+.+++.+||+.||++||++.++++
T Consensus 244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1112233467889999999999999999999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=331.13 Aligned_cols=249 Identities=22% Similarity=0.317 Sum_probs=199.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC---------eeEEEEEccCC---chHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD---------TVVAIKRRVGS---PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 154 (382)
++|...+.||+|+||+||+|.+.. ..+|+|..... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 568888999999999999998764 46999987543 345789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc--------EE
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI--------AK 226 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~--------~k 226 (382)
++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999997642 34899999999999999999999988 999999999999998887 99
Q ss_pred EeecCCccccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhh
Q 016789 227 VADTGISKLLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSR 305 (382)
Q Consensus 227 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 305 (382)
|+|||++....... ...+++.|+|||.+.+ ..++.++||||||+++|||++|..|+.... ............
T Consensus 162 l~Dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~--~~~~~~~~~~~~ 234 (289)
T 4fvq_A 162 LSDPGISITVLPKD-----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL--DSQRKLQFYEDR 234 (289)
T ss_dssp ECCCCSCTTTSCHH-----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHHHHHHTT
T ss_pred eccCcccccccCcc-----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc--chHHHHHHhhcc
Confidence 99999997553321 2235677999999987 679999999999999999999665544221 222222222221
Q ss_pred cCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 306 LSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 306 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
.... ...+..+.+++.+||+.||.+||++.++++.|+++....
T Consensus 235 ~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 235 HQLP------------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp CCCC------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred CCCC------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1111 111245778999999999999999999999999987543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=340.42 Aligned_cols=248 Identities=17% Similarity=0.242 Sum_probs=201.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
+.|...+.||+|+||.||+|.... ..+|+|...... ...+.+|+.+|++++||||+++++++.+....++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 578889999999999999999864 689999876542 346889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC--CCcEEEeecCCccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE--NFIAKVADTGISKLLENI 239 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~--~~~~kl~DfGla~~~~~~ 239 (382)
++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 131 ~gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 131 SGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999988643 236899999999999999999999988 999999999999974 578999999999876442
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
.. .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... . .++.
T Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i~~~~~--~-~~~~---- 272 (387)
T 1kob_A 205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDW--E-FDED---- 272 (387)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCC--C-CCSS----
T ss_pred cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC--C-CCcc----
Confidence 21 223356888999999999999999999999999999999999997432 2222222222110 0 1111
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.....+..+.+++.+||+.||.+||++.++++.
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 112234668899999999999999999999873
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=342.12 Aligned_cols=262 Identities=19% Similarity=0.199 Sum_probs=201.8
Q ss_pred cCHHHHHHHHhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc--hHHHHHHHHHHhcCC-----CCCccceeeE
Q 016789 77 FSMEELEQATKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP--RQEFVAEVTYLSEIR-----HRNLVTLLGY 147 (382)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~e~~~l~~l~-----h~niv~l~~~ 147 (382)
+++.+.....++|...+.||+|+||+||+|.+. +..||+|.+.... ...+..|+++++.++ ||||++++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 333334444578999999999999999999985 4789999886433 346778999999996 9999999999
Q ss_pred EEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC------
Q 016789 148 CQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE------ 221 (382)
Q Consensus 148 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~------ 221 (382)
+...+..++||||+ +++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEcccccccc
Confidence 99999999999999 999999998653 235899999999999999999999988 999999999999975
Q ss_pred -------------------CCcEEEeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh
Q 016789 222 -------------------NFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT 282 (382)
Q Consensus 222 -------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t 282 (382)
++.+||+|||+++..... .....+++.|+|||.+.+..++.++|||||||++|||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 789999999999864332 223456788999999999999999999999999999999
Q ss_pred CCCCCCccCCCChhHHHHHHHhh-cCCC-------------ccccc-----ccCCC-CCH---------------HHHHH
Q 016789 283 GQEASHIVSLGSYEALIQWVRSR-LSSN-------------NFVDH-----RLAGT-FTT---------------EGMRD 327 (382)
Q Consensus 283 g~~p~~~~~~~~~~~~~~~~~~~-~~~~-------------~~~d~-----~~~~~-~~~---------------~~~~~ 327 (382)
|+.||...... .....+... .... ...+. ..... ... .....
T Consensus 255 g~~pf~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 255 GSLLFRTHEHM---EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp SSCSCCCSSHH---HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred CCCCCCCCcHH---HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 99999753321 111111111 0000 00000 00000 000 01256
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHH
Q 016789 328 LIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 328 l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+.+++.+||+.||.+|||+.|+++
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhcCChhhCCCHHHHhc
Confidence 789999999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=335.32 Aligned_cols=239 Identities=21% Similarity=0.236 Sum_probs=197.1
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 156 (382)
.++|...+.||+|+||+||+|.... ..+|+|.+.. .....+..|..++..+ +||||+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 3578889999999999999999976 6899998653 2345678899999988 79999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
||||+++|+|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 99 v~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999998653 5899999999999999999999987 999999999999999999999999999854
Q ss_pred ccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 237 ENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 237 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
.... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+.+.... .
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~~~-------~-- 238 (353)
T 2i0e_A 172 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIMEHN-------V-- 238 (353)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCC-------C--
T ss_pred ccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---HHHHHHHHHhCC-------C--
Confidence 3221 12234457889999999999999999999999999999999999997432 233333222211 0
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKM 346 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 346 (382)
.++...+..+.+++.+||+.||.+||+.
T Consensus 239 --~~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 239 --AYPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1122334678899999999999999964
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=325.86 Aligned_cols=262 Identities=16% Similarity=0.200 Sum_probs=207.1
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC-chHHHHHHHHHHhcCCCCCccceeeEE-EeCCeeEEEEeecC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS-PRQEFVAEVTYLSEIRHRNLVTLLGYC-QQNGYQMLVFEYLP 162 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~ 162 (382)
++|...+.||+|+||.||+|.+. +..||+|..... ..+.+.+|+.+++.++|+|++..+.++ ...+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence 57888999999999999999964 489999986543 345789999999999988877766665 5667889999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee---cCCCcEEEeecCCccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV---DENFIAKVADTGISKLLENI 239 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill---~~~~~~kl~DfGla~~~~~~ 239 (382)
+++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++......
T Consensus 88 ~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 88 GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 999999997532 36899999999999999999999988 9999999999999 48899999999999876543
Q ss_pred ccc------CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh-hcCCCccc
Q 016789 240 EEA------GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS-RLSSNNFV 312 (382)
Q Consensus 240 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 312 (382)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||................. .....
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence 321 12344578889999999999999999999999999999999999986443332222222211 11100
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhh
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMA 362 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~ 362 (382)
.+.+. ...+..+.+++.+||+.||.+||++.++++.|+++..+.-.
T Consensus 239 ~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 239 IEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hHHHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 00011 12236688999999999999999999999999999876443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=333.70 Aligned_cols=243 Identities=18% Similarity=0.205 Sum_probs=190.4
Q ss_pred hCCCCCCeeeccCcccEEEEEEC-----CeeEEEEEccCC-------chHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR-----DTVVAIKRRVGS-------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 154 (382)
++|...+.||+|+||.||++... +..+|+|.+... ....+.+|+.++++++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 57888999999999999999873 478999987643 224578899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++||||+++|+|.+++...+ .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEeCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999997653 5788999999999999999999987 9999999999999999999999999997
Q ss_pred ccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 235 LLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
....... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.... .....+.+.... .
T Consensus 170 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~-------~ 238 (327)
T 3a62_A 170 ESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RKKTIDKILKCK-------L 238 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTC-------C
T ss_pred ccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCC-------C
Confidence 5433221 1223456788999999999999999999999999999999999997432 222222222211 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRP-----KMEIVMT 351 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~~v~~ 351 (382)
..+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 239 ----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11222346788999999999999999 5666654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=338.50 Aligned_cols=247 Identities=20% Similarity=0.256 Sum_probs=193.8
Q ss_pred CCeeeccCcccEEEEEECC--eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCCCCh
Q 016789 92 TSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 166 (382)
.+.||+|+||.||+|.... ..||+|.+.... .+.+.+|+++|++++||||+++++++...+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 5679999999999998864 789999876543 45789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee--cCCCcEEEeecCCccccccccccCC
Q 016789 167 CNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV--DENFIAKVADTGISKLLENIEEAGP 244 (382)
Q Consensus 167 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill--~~~~~~kl~DfGla~~~~~~~~~~~ 244 (382)
.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 174 FDRIIDES----YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp HHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 99887532 35899999999999999999999988 9999999999999 6778999999999987654322 2
Q ss_pred CcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHH
Q 016789 245 SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEG 324 (382)
Q Consensus 245 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 324 (382)
....+++.|+|||.+.+..++.++|||||||++|||++|+.||.... ....+........... ... . ...
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~~~---~~~-~----~~~ 315 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--DAETLNNILACRWDLE---DEE-F----QDI 315 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTCCCSC---SGG-G----TTS
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccCCCC---hhh-h----ccC
Confidence 23357888999999998899999999999999999999999996432 1222222222211111 111 1 122
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHH
Q 016789 325 MRDLIRLTLQCMSSPGRRRPKMEIVMT--ELERI 356 (382)
Q Consensus 325 ~~~l~~l~~~cl~~dp~~RPs~~~v~~--~L~~i 356 (382)
+..+.+++.+||+.||.+||++.++++ .+.+.
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 456889999999999999999999987 44443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=335.61 Aligned_cols=259 Identities=26% Similarity=0.448 Sum_probs=206.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--e--eEEEEEccCC----chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--T--VVAIKRRVGS----PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~--~vavK~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 157 (382)
++|...+.||+|+||.||+|.+.. . .+++|..... ....+.+|+++++++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 568888999999999999998754 3 4588876542 235688999999999 899999999999999999999
Q ss_pred EeecCCCChhhhhhhcCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEE
Q 016789 158 FEYLPNGSMCNHLYETGL-----------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAK 226 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~k 226 (382)
|||+++|+|.+++..... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCCCeEE
Confidence 999999999999976431 22346899999999999999999999987 99999999999999999999
Q ss_pred EeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhh
Q 016789 227 VADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSR 305 (382)
Q Consensus 227 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 305 (382)
|+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .....+.....
T Consensus 183 L~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~~~~~~~~~~ 257 (327)
T 1fvr_A 183 IADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKLPQG 257 (327)
T ss_dssp ECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHGGGT
T ss_pred EcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc---HHHHHHHhhcC
Confidence 99999987543221 2223345677999999998889999999999999999998 999986432 22222222111
Q ss_pred cCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhh
Q 016789 306 LSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMA 362 (382)
Q Consensus 306 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~ 362 (382)
. ....+...+..+.+++.+||+.||.+||++.++++.|+++.++..+
T Consensus 258 ~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 258 Y----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp C----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred C----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 1 1112223346788999999999999999999999999999877543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=333.33 Aligned_cols=260 Identities=19% Similarity=0.275 Sum_probs=197.4
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
.+|...+.||+|+||.||+|... +..+|+|.+... ....+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 56888999999999999999975 478999987532 2346889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhc-ccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999987532 12235889999999999999999999987 99999999999999999999999999986543
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ....+........ ....
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~------- 258 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCD-YPPL------- 258 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHHTTC-SCCC-------
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhhccc-CCCC-------
Confidence 222 12233467789999999999999999999999999999999999864322 2222222222111 1100
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
.....+..+.+++.+||+.||.+||++.++++.|+++....
T Consensus 259 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 259 -PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp -CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 01223456889999999999999999999999999998653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=334.34 Aligned_cols=269 Identities=22% Similarity=0.341 Sum_probs=212.2
Q ss_pred CHHHHHHHHhCCCCCCeeeccCcccEEEEEEC-------CeeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCcccee
Q 016789 78 SMEELEQATKQFSETSLIGFGSFGPVYKGLLR-------DTVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVTLL 145 (382)
Q Consensus 78 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~ 145 (382)
....+....++|...+.||+|+||.||+|.+. +..||+|.+.... ...+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 34455555678999999999999999999852 2689999876542 24688999999999 799999999
Q ss_pred eEEEeCC-eeEEEEeecCCCChhhhhhhcCCCC-----------CCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 016789 146 GYCQQNG-YQMLVFEYLPNGSMCNHLYETGLES-----------STKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFK 213 (382)
Q Consensus 146 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk 213 (382)
+++...+ ..++||||+++|+|.+++....... ...+++..+..++.|++.||.|||+.+ |+|||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dik 175 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLA 175 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCc
Confidence 9988754 5899999999999999998653210 123789999999999999999999987 9999999
Q ss_pred CCCeeecCCCcEEEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccC
Q 016789 214 TANVLVDENFIAKVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVS 291 (382)
Q Consensus 214 ~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~ 291 (382)
|+||+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 99999999999999999999866433221 1223445678999999999999999999999999999998 999986433
Q ss_pred CCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 292 LGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
. .............. ..+...+..+.+++.+||+.||.+||++.++++.|+++.+..
T Consensus 256 ~--~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 256 I--DEEFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp C--SHHHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred h--hHHHHHHhccCccC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 2 22222222222110 111223456889999999999999999999999999998653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=339.40 Aligned_cols=248 Identities=19% Similarity=0.227 Sum_probs=200.0
Q ss_pred hCCCCCCeeeccCcccEEEEEE-----CCeeEEEEEccC-------CchHHHHHHHHHHhcC-CCCCccceeeEEEeCCe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLL-----RDTVVAIKRRVG-------SPRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGY 153 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~-------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 153 (382)
++|...+.||+|+||.||++.. .+..||+|.+.. .....+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788899999999999999988 347899998653 2235677899999999 69999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999998653 5889999999999999999999987 999999999999999999999999999
Q ss_pred cccccccccCCCcccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCccCCCCh-hHHHHHHHhhcCCCc
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEES--GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSY-EALIQWVRSRLSSNN 310 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 310 (382)
+..............+++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ ..+........
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---- 282 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE---- 282 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC----
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC----
Confidence 8665443333344567889999999985 3478999999999999999999999975433222 22222221110
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 016789 311 FVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRP-----KMEIVMTE 352 (382)
Q Consensus 311 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~~v~~~ 352 (382)
..++.+.+..+.+++.+||+.||.+|| ++.++++.
T Consensus 283 -------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 -------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 112233446688999999999999999 88888764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=340.37 Aligned_cols=259 Identities=24% Similarity=0.329 Sum_probs=205.2
Q ss_pred hCCCCCCeeeccCcccEEEEEE------CCeeEEEEEccCCch---HHHHHHHHHHhcCCCCCccceeeEEE--eCCeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLL------RDTVVAIKRRVGSPR---QEFVAEVTYLSEIRHRNLVTLLGYCQ--QNGYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~ 155 (382)
++|+..+.||+|+||.||++.+ .+..||+|.+..... +.+.+|++++++++||||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5688889999999999999985 236899998765533 45889999999999999999999987 456789
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999997642 25899999999999999999999987 99999999999999999999999999987
Q ss_pred ccccccc--CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCC------------hhHHHHH
Q 016789 236 LENIEEA--GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS------------YEALIQW 301 (382)
Q Consensus 236 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~------------~~~~~~~ 301 (382)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....... .....+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 2233456777999999999999999999999999999999999986322100 0011111
Q ss_pred HHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 016789 302 VRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEM 361 (382)
Q Consensus 302 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~ 361 (382)
.. .......+...+..+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus 257 ~~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 257 LE----------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HH----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hh----------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11 111112234445778899999999999999999999999999876543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=326.60 Aligned_cols=242 Identities=23% Similarity=0.328 Sum_probs=197.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|+||.||+|.+.. ..+|+|.+... ....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 568888999999999999999876 57999986432 2456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 89 e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred ecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999997653 5899999999999999999999987 99999999999999999999999999865433
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.. .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ............ .
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~-----------~ 224 (279)
T 3fdn_A 162 SR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRISRVE-----------F 224 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTC-----------C
T ss_pred cc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc---HHHHHHHHHhCC-----------C
Confidence 22 223456788999999999999999999999999999999999997432 222222222111 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..+...+..+.+++.+||+.||.+||++.++++.
T Consensus 225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1122234567889999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=339.57 Aligned_cols=242 Identities=20% Similarity=0.204 Sum_probs=189.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHH-HhcCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTY-LSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
++|+..+.||+|+||+||+++... ..+|+|.+... ....+..|..+ ++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 578899999999999999999875 68999986532 12345667666 5778999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++...+ .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999997653 5788899999999999999999988 9999999999999999999999999998543
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+.+.... .
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~~~-------~--- 256 (373)
T 2r5t_A 191 EHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNILNKP-------L--- 256 (373)
T ss_dssp CCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB---HHHHHHHHHHSC-------C---
T ss_pred cCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcc-------c---
Confidence 221 12334467889999999999999999999999999999999999997432 222222222210 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVM 350 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~ 350 (382)
.++...+..+.+++.+||+.||.+||++.+.+
T Consensus 257 -~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 257 -QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp -CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred -CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 11122345678899999999999999986443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=325.72 Aligned_cols=249 Identities=21% Similarity=0.297 Sum_probs=203.3
Q ss_pred HHhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCchHHHHHHHHHHhcCCCCCccceeeEEEe------------
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQ------------ 150 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------------ 150 (382)
...+|+..+.||+|+||.||+|.+. +..+|+|...... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 3467889999999999999999986 4789999876543 567899999999999999999998864
Q ss_pred ----CCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEE
Q 016789 151 ----NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAK 226 (382)
Q Consensus 151 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~k 226 (382)
....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEE
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCCEE
Confidence 345799999999999999997642 236899999999999999999999987 99999999999999999999
Q ss_pred EeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc
Q 016789 227 VADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 227 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
|+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++|..|+... ..........
T Consensus 163 l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~~~~~~- 234 (284)
T 2a19_B 163 IGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFTDLRDG- 234 (284)
T ss_dssp ECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHHHHHTT-
T ss_pred ECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHHHhhcc-
Confidence 999999987654322 22345678899999999999999999999999999999999887421 1111111111
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 307 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.+. ...+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 235 --------~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 235 --------IIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp --------CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred --------ccc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 111 12235578899999999999999999999999988643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=340.45 Aligned_cols=259 Identities=16% Similarity=0.191 Sum_probs=198.6
Q ss_pred hCCCCCCeeecc--CcccEEEEEEC--CeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFG--SFGPVYKGLLR--DTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G--~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
.+|+..+.||+| +||+||+|.+. +..||+|++.... ...+.+|+.+++.++||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 568889999999 99999999987 4789999875332 24678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
||||++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||.+....
T Consensus 105 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EECCTTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEccCCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999997642 235899999999999999999999988 9999999999999999999999999986543
Q ss_pred cccc------cCCCcccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC--
Q 016789 238 NIEE------AGPSHGSIVNVFRDPEVEES--GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS-- 307 (382)
Q Consensus 238 ~~~~------~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-- 307 (382)
.... .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~ 257 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCL 257 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC--------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCcc
Confidence 2211 11222356778999999987 5799999999999999999999999975432221 1111100000
Q ss_pred -------CCc-------------ccc------c------ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 308 -------SNN-------------FVD------H------RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 308 -------~~~-------------~~d------~------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
... ..+ + ..........+..+.+++.+||+.||.+|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000 000 0 00001122335678899999999999999999999854
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=335.84 Aligned_cols=239 Identities=21% Similarity=0.282 Sum_probs=197.8
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----------chHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN 151 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 151 (382)
..++|...+.||+|+||.||+|.+.. ..||+|.+... ....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 34679999999999999999998754 78999986543 223577899999999999999999999999
Q ss_pred CeeEEEEeecCCC-ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeec
Q 016789 152 GYQMLVFEYLPNG-SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADT 230 (382)
Q Consensus 152 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~Df 230 (382)
+..++||||+.+| +|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 9999987643 5899999999999999999999987 999999999999999999999999
Q ss_pred CCccccccccccCCCcccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC
Q 016789 231 GISKLLENIEEAGPSHGSIVNVFRDPEVEESGVF-SEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN 309 (382)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 309 (382)
|++........ .....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||......
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 99987654322 223456788999999988876 88999999999999999999999642110
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 310 NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 310 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..... ..+...+..+.+++.+||+.||.+||++.++++.
T Consensus 237 --~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 --VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0011124568899999999999999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=327.80 Aligned_cols=247 Identities=19% Similarity=0.215 Sum_probs=200.7
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC---------chHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS---------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 154 (382)
.+.|...+.||+|+||.||+|.... ..+|+|.+... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3568899999999999999999864 68999976432 245789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC----cEEEeec
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF----IAKVADT 230 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~----~~kl~Df 230 (382)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999753 26889999999999999999999987 99999999999999888 7999999
Q ss_pred CCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCc
Q 016789 231 GISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNN 310 (382)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 310 (382)
|++........ .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ............ .
T Consensus 164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~---~ 235 (321)
T 2a2a_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANITSVS---Y 235 (321)
T ss_dssp TTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHTTC---C
T ss_pred ccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhcc---c
Confidence 99986654322 233456788999999999999999999999999999999999996432 222222222110 0
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 311 FVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 311 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..++... ...+..+.+++.+||+.||.+||++.++++
T Consensus 236 ~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 DFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0011111 112356889999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=331.45 Aligned_cols=256 Identities=21% Similarity=0.231 Sum_probs=195.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC--------chHHHHHHHHHHhcCC---CCCccceeeEEEeCC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS--------PRQEFVAEVTYLSEIR---HRNLVTLLGYCQQNG 152 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--------~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~ 152 (382)
.++|+..+.||+|+||+||+|.+. +..||+|.+... ....+.+|+.++++++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 468999999999999999999964 478999986521 1246778888877774 999999999998765
Q ss_pred -----eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEE
Q 016789 153 -----YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKV 227 (382)
Q Consensus 153 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl 227 (382)
..++||||+. |+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEE
Confidence 5799999996 69999997643 234899999999999999999999988 999999999999999999999
Q ss_pred eecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC
Q 016789 228 ADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS 307 (382)
Q Consensus 228 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 307 (382)
+|||+++...... ......+++.|+|||.+.+..++.++|||||||++|||++|++||..... ...+.........
T Consensus 162 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~ 237 (308)
T 3g33_A 162 ADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGKIFDLIGL 237 (308)
T ss_dssp CSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH--HHHHHHHHHHHCC
T ss_pred eeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCC
Confidence 9999998664322 22334568889999999999999999999999999999999999974332 2222222221111
Q ss_pred CC-ccc-------ccccCC--CC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 308 SN-NFV-------DHRLAG--TF-----TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 308 ~~-~~~-------d~~~~~--~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.. ... ...+.. .. ..+.+..+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00 000 000000 00 1123467889999999999999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=332.33 Aligned_cols=255 Identities=20% Similarity=0.271 Sum_probs=192.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCe----e
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGY----Q 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~ 154 (382)
++|+..+.||+|+||.||++.+.. +.||+|.+.... ...+.+|+.++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 568888999999999999999754 799999876432 1368899999999999999999999876543 4
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++||||+++|+|.+++...+ .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred EEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 99999999999999997653 5899999999999999999999988 9999999999999999999999999998
Q ss_pred cccccccc--CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 235 LLENIEEA--GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 235 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
........ ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... .....+........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~---- 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQHVREDPIP---- 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHCCCCC----
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHhcCCCCC----
Confidence 76543221 12233468889999999999999999999999999999999999964321 11111211111100
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH-HHHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVM-TELERIHE 358 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~-~~L~~i~~ 358 (382)
.... ....+..+.+++.+||+.||.+||+..+++ ..|.++..
T Consensus 239 ~~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 239 PSAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred cccc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 0000 111346688999999999999999766544 55655543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=350.29 Aligned_cols=243 Identities=20% Similarity=0.193 Sum_probs=192.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|+||.||+|.... ..||+|.+... ....+.+|+.+++.++||||+++++++...+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 568889999999999999999864 68999986532 2346788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 228 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 228 EYANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp CCCSSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred eeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999997653 68999999999999999999997 77 9999999999999999999999999998643
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+.....
T Consensus 301 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~---------- 366 (446)
T 4ejn_A 301 KDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEI---------- 366 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCC----------
T ss_pred CCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCC----------
Confidence 3221 2234567889999999999999999999999999999999999996432 2333332222110
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRP-----KMEIVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~~v~~ 351 (382)
.++...+..+.+++.+||+.||.+|| ++.++++
T Consensus 367 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 -RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11222346688999999999999999 9999886
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=331.92 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=204.1
Q ss_pred hCCCCCCeeeccCcccEEEEEE------CCeeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCC--eeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLL------RDTVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNG--YQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~ 155 (382)
++|+..+.||+|+||.||++.+ .+..||+|.+.... ...+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 5688889999999999999985 24789999876543 346889999999999999999999987654 689
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 121 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999997643 35899999999999999999999987 99999999999999999999999999987
Q ss_pred ccccccc--CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCC---------CChhHHHHHHHh
Q 016789 236 LENIEEA--GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSL---------GSYEALIQWVRS 304 (382)
Q Consensus 236 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~---------~~~~~~~~~~~~ 304 (382)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..|+..... ............
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6543221 12233456679999999988899999999999999999999998753210 000000000000
Q ss_pred hcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 305 RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 305 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
. +........+...+..+.+++.+||+.||.+||++.++++.|+++.++
T Consensus 275 ~------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 275 L------LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp H------HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H------hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0 000011112233456788999999999999999999999999999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=319.65 Aligned_cols=242 Identities=17% Similarity=0.224 Sum_probs=199.6
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC---CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG---SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
.++|+..+.||+|+||.||+|.... ..+|+|.+.. ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4578899999999999999999876 5789987653 3456899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee---cCCCcEEEeecCCccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV---DENFIAKVADTGISKLLE 237 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill---~~~~~~kl~DfGla~~~~ 237 (382)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHKR-----VFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999987653 5899999999999999999999988 9999999999999 788999999999998665
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.... .....+++.|+|||.+.+. ++.++||||||+++|||++|+.||.... .............
T Consensus 161 ~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~---------- 224 (277)
T 3f3z_A 161 PGKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVMLKIREGTF---------- 224 (277)
T ss_dssp TTSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCC----------
T ss_pred Cccc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCC----------
Confidence 4322 2334567889999998754 8999999999999999999999996432 2222222222110
Q ss_pred CCCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 318 GTFTT----EGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 318 ~~~~~----~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+. ..+..+.+++.+||+.||.+||++.++++
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 -TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111 12467889999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=335.09 Aligned_cols=242 Identities=27% Similarity=0.388 Sum_probs=195.3
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
+.|...+.||+|+||+||+|... +..||+|++.... .+.+.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45888899999999999999974 4789999875321 246889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+. |+|.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9996 78888886542 36899999999999999999999987 99999999999999999999999999986543
Q ss_pred ccccCCCcccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEE---SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
. ....+++.|+|||.+. ...++.++|||||||++|||++|+.||.... ....+.. ..... ...
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--~~~~~~~-~~~~~-~~~----- 272 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYH-IAQNE-SPA----- 272 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHH-HHHSC-CCC-----
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHH-HHhcC-CCC-----
Confidence 2 2345678899999984 5678999999999999999999999986432 1112211 11111 111
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.. +...+..+.+++.+||+.||.+||++.++++.
T Consensus 273 ~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 273 LQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 10 11224567889999999999999999998853
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=360.67 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=204.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-----eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
.++|...+.||+|+||.||+|.+.. ..+|+|...... .+.|.+|+.++++++||||+++++++.+ +..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence 4678888999999999999998753 469999876432 2568899999999999999999999854 56899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 468 v~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999997642 35889999999999999999999987 999999999999999999999999999877
Q ss_pred ccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 237 ENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 237 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
............+++.|+|||.+.+..++.++||||||+++|||++ |..||.... .......+......
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~---~~~~~~~i~~~~~~------- 611 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NNDVIGRIENGERL------- 611 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHHTCCC-------
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHcCCCC-------
Confidence 5544333344556678999999999999999999999999999997 999987432 22333333322111
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
..+...+..+.+++.+||+.||.+||++.++++.|+++.++
T Consensus 612 ---~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 612 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 12233456788999999999999999999999999999765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=335.89 Aligned_cols=254 Identities=19% Similarity=0.276 Sum_probs=186.4
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc---hHHHHHHHHHHhcCC-CCCccceeeEEE--------eCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP---RQEFVAEVTYLSEIR-HRNLVTLLGYCQ--------QNG 152 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~~~ 152 (382)
.+|+..+.||+|+||.||+|.+. +..||+|.+.... ...+.+|+.++.++. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 57888999999999999999984 4789999875433 346889999999996 999999999994 334
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCC
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI 232 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGl 232 (382)
..++||||+. |+|.+++.... ....+++..++.++.|++.||.|||+.+++|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred eEEEEEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 5799999995 89999887532 12368999999999999999999998777799999999999999999999999999
Q ss_pred ccccccccccC-----------CCcccccccccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHH
Q 016789 233 SKLLENIEEAG-----------PSHGSIVNVFRDPEVE---ESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEAL 298 (382)
Q Consensus 233 a~~~~~~~~~~-----------~~~~~~~~~y~aPE~~---~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~ 298 (382)
++......... .....+++.|+|||.+ .+..++.++||||||+++|||++|+.||......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----- 259 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----- 259 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----
Confidence 98765432211 1123467789999998 5667899999999999999999999998642211
Q ss_pred HHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 299 IQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
........ .......+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 260 -~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 260 -RIVNGKYS----------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -------CC----------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HhhcCccc----------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11111110 011111224477899999999999999999999999999865
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=351.97 Aligned_cols=247 Identities=19% Similarity=0.253 Sum_probs=201.9
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|...+.||+|+||.||+|... +..+|+|.+.. .....+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888899999999999999986 47899998643 23456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++...+ ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 264 Ey~~gg~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp CCCCSCBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EcCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999997643 235899999999999999999999988 99999999999999999999999999987643
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCC-hhHHHHHHHhhcCCCcccccccC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS-YEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+.+..... .
T Consensus 339 ~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-~---------- 405 (576)
T 2acx_A 339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-P---------- 405 (576)
T ss_dssp TCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-C----------
T ss_pred Ccc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-c----------
Confidence 221 223467889999999999899999999999999999999999997644322 22222222211 1
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRP-----KMEIVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~~v~~ 351 (382)
..++...+..+.+++.+||+.||.+|| ++.|+++
T Consensus 406 ~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 011223346788999999999999999 6777764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=329.35 Aligned_cols=258 Identities=22% Similarity=0.281 Sum_probs=194.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
++|+..+.||+|+||+||+|.+.. ..+|+|++.... ...+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 468888999999999999999874 789999875432 2457889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999988876532 5899999999999999999999988 999999999999999999999999999866432
Q ss_pred cccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhh-------------
Q 016789 240 EEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSR------------- 305 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~------------- 305 (382)
... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+...........
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 SDY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred ccc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 221 223456788999999876 66899999999999999999999999754322111111110000
Q ss_pred -cCCCcccccccCCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 306 -LSSNNFVDHRLAGTF---TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 306 -~~~~~~~d~~~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.......++...... ....+..+.+++.+||+.||.+|||+.++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000011000000 01234568899999999999999999999863
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=319.95 Aligned_cols=256 Identities=20% Similarity=0.243 Sum_probs=203.3
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC---------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS---------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 155 (382)
++|...+.||+|+||.||++... +..+|+|.+... ..+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999987 478999975432 2467899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC----cEEEeecC
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF----IAKVADTG 231 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~----~~kl~DfG 231 (382)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999997643 6899999999999999999999987 99999999999998877 89999999
Q ss_pred CccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcc
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (382)
++........ .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ............ ..
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~--~~- 229 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET---KQETLTNISAVN--YD- 229 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTC--CC-
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc---hHHHHHHhHhcc--cC-
Confidence 9986643222 223346788999999999999999999999999999999999997432 222222221110 00
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHHHHhhh
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT--ELERIHEKEM 361 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~--~L~~i~~~~~ 361 (382)
...... ...+..+.+++.+||+.||.+||++.++++ .++.+..+..
T Consensus 230 ~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 230 FDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp CCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC
T ss_pred Ccchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhh
Confidence 000110 112456889999999999999999999997 4677665543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=340.10 Aligned_cols=250 Identities=18% Similarity=0.248 Sum_probs=189.8
Q ss_pred hCCCCC-CeeeccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHh-cCCCCCccceeeEEEe----CCeeEEEE
Q 016789 87 KQFSET-SLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLS-EIRHRNLVTLLGYCQQ----NGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~-~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~~~~lv~ 158 (382)
++|... +.||+|+||+||++.+.. ..||+|.+... ..+.+|++++. ..+||||+++++++.. ....++||
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~ 138 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEE
Confidence 345444 689999999999999864 68999988643 46778888874 4589999999999875 56789999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC---CCcEEEeecCCccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE---NFIAKVADTGISKL 235 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~---~~~~kl~DfGla~~ 235 (382)
|||++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 139 E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 139 ECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp ECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EeCCCCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 9999999999997642 235899999999999999999999988 999999999999997 78999999999986
Q ss_pred cccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCCh-hHHHHHHHhhcCCCccccc
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSY-EALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~d~ 314 (382)
..... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+.... ..+..
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~--~~~~~- 288 (400)
T 1nxk_A 214 TTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--YEFPN- 288 (400)
T ss_dssp CC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC--CCCCT-
T ss_pred cCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc--ccCCC-
Confidence 54322 12334568889999999999999999999999999999999999975433221 11222222111 00000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
......+..+.+++.+||+.||++|||+.++++.
T Consensus 289 ----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 289 ----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0112234668899999999999999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=337.26 Aligned_cols=246 Identities=20% Similarity=0.265 Sum_probs=190.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCCc-----hHHHHHHHHHHhcCCC--CCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP-----RQEFVAEVTYLSEIRH--RNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~-----~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~ 158 (382)
+.|+..+.||+|+||.||++.... ..||+|.+.... .+.+.+|+.+|.+++| |||+++++++...+..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 468888999999999999998865 689999865332 2568899999999976 99999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
| +.+|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||+++....
T Consensus 89 e-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp C-CCSEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred e-CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9 56889999998643 6889999999999999999999987 99999999999997 67899999999987654
Q ss_pred cccc-CCCcccccccccCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc
Q 016789 239 IEEA-GPSHGSIVNVFRDPEVEES-----------GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 239 ~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
.... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ....+....
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~~~~---- 234 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAII---- 234 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-HHHHHHHHH----
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-HHHHHHHHh----
Confidence 3322 1234457889999999865 6789999999999999999999999964321 111111111
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 307 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
++......+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 235 ------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 ------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111111222223567899999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=332.15 Aligned_cols=261 Identities=22% Similarity=0.342 Sum_probs=205.6
Q ss_pred hCCCCCCeeeccCcccEEEEEEC-------CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR-------DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 155 (382)
++|...+.||+|+||.||+|.+. +..||+|.+.... ...+.+|+.++++++||||+++++++......+
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 57888999999999999999853 2479999975432 346889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCC--CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC---CCcEEEeec
Q 016789 156 LVFEYLPNGSMCNHLYETGLE--SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE---NFIAKVADT 230 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~---~~~~kl~Df 230 (382)
+||||+++|+|.+++...... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++. +..+||+||
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEECcc
Confidence 999999999999999875422 2245899999999999999999999987 999999999999984 456999999
Q ss_pred CCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCC
Q 016789 231 GISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSS 308 (382)
Q Consensus 231 Gla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 308 (382)
|++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||... ...............
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~---~~~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLEFVTSGGRM 264 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHHHHHTTCCC
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc---CHHHHHHHHhcCCCC
Confidence 998755432221 1223445778999999999999999999999999999998 88998643 223333333322111
Q ss_pred CcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhh
Q 016789 309 NNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMA 362 (382)
Q Consensus 309 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~ 362 (382)
..+...+..+.+++.+||+.||.+||++.++++.|+.+......
T Consensus 265 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 308 (327)
T 2yfx_A 265 ----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308 (327)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence 11223346788999999999999999999999999998766443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=320.46 Aligned_cols=248 Identities=21% Similarity=0.257 Sum_probs=193.4
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+.|...+.||+|+||.||++.... ..+|+|..... ..+.+.+|++++++++||||+++++++......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 468889999999999999999864 68899986432 346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee---cCCCcEEEeecCCccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV---DENFIAKVADTGISKLLE 237 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill---~~~~~~kl~DfGla~~~~ 237 (382)
+++|+|.+++.... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQ-ARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhh-hcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999986532 11236899999999999999999999987 9999999999999 456889999999998665
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.... .....+++.|+|||.+. ..++.++||||||+++|||++|+.||.... ................. ..
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~~~----~~ 248 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS---LEEVQQKATYKEPNYAV----EC 248 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCC------
T ss_pred Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC---HHHHHhhhccCCccccc----cc
Confidence 4322 22345678899999886 568999999999999999999999997432 22222222211111000 00
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.. .+..+.+++.+||+.||++||++.|+++
T Consensus 249 ~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 249 RP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred Cc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01 2356778999999999999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=318.92 Aligned_cols=246 Identities=18% Similarity=0.216 Sum_probs=199.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
++|+..+.||+|+||.||+|.+.. ..+|+|...... ...+.+|+.++++++||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 578888999999999999998864 689999865322 2467899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc---EEEeecCCcccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI---AKVADTGISKLL 236 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~---~kl~DfGla~~~ 236 (382)
|+++|+|.+.+.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 86 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 86 LVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred cCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999999887653 5899999999999999999999988 999999999999986655 999999999766
Q ss_pred ccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 237 ENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 237 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
..... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ............. ....+
T Consensus 159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~--~~~~~-- 229 (284)
T 3kk8_A 159 NDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAY--DYPSP-- 229 (284)
T ss_dssp CSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCC--CCCTT--
T ss_pred ccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHHHHhccc--cCCch--
Confidence 44322 223456788999999999999999999999999999999999996432 2222222222111 00000
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.....+..+.+++.+||+.||++||++.++++
T Consensus 230 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 230 ---EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ---TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11123456889999999999999999999987
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=332.82 Aligned_cols=240 Identities=23% Similarity=0.289 Sum_probs=188.6
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc-----hHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP-----RQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|+||+||+|.+. +..||+|+..... ...+..|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999986 4799999865421 22455566555555 8999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+ +|+|.+++...+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 779999887653 36899999999999999999999987 99999999999999999999999999986643
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
... .....+|+.|+|||.+.+ .++.++|||||||++|||++|..|+... .. ...+... ...+.+.
T Consensus 210 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~-~~~~~~~-----~~~~~~~- 274 (311)
T 3p1a_A 210 AGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EG-WQQLRQG-----YLPPEFT- 274 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HH-HHHHTTT-----CCCHHHH-
T ss_pred CCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cH-HHHHhcc-----CCCcccc-
Confidence 222 223457888999999876 7999999999999999999998776421 11 1111110 0011111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+..+.+++.+||+.||++||++.++++
T Consensus 275 ---~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 ---AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 122467889999999999999999999885
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=341.79 Aligned_cols=242 Identities=21% Similarity=0.276 Sum_probs=199.8
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
.+|...+.||+|+||.||+|.+. +..||+|.+... ....+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46888899999999999999986 478999987532 2356889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 96 E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999998653 36899999999999999999999987 99999999999999999999999999987654
Q ss_pred ccccCCCcccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVF-SEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
... .....+++.|+|||.+.+..+ +.++|||||||++|||++|+.||.... ...+...+.....
T Consensus 169 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~---------- 233 (476)
T 2y94_A 169 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH---VPTLFKKICDGIF---------- 233 (476)
T ss_dssp TCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS---SHHHHHHHHTTCC----------
T ss_pred ccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCc----------
Confidence 322 233457888999999988765 689999999999999999999997432 2222222222110
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+...+..+.+++.+||+.||.+|||+.++++
T Consensus 234 -~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 -YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 011122356788999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=337.40 Aligned_cols=257 Identities=23% Similarity=0.312 Sum_probs=187.1
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCC-CCCccceeeEEEeCC--ee
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIR-HRNLVTLLGYCQQNG--YQ 154 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~ 154 (382)
..++|+..+.||+|+||.||+|.+.. ..||+|++... ....+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 45789999999999999999998864 78999987532 2345788999999997 999999999997554 68
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++|||||+ |+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999997 6899888753 5888999999999999999999988 9999999999999999999999999998
Q ss_pred cccccc--------------------ccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCC
Q 016789 235 LLENIE--------------------EAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLG 293 (382)
Q Consensus 235 ~~~~~~--------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~ 293 (382)
...... ........+|+.|+|||.+.+ ..++.++|||||||++|||++|++||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~- 236 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST- 236 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 653311 111223457888999999876 6799999999999999999999999975332
Q ss_pred ChhHHHHHHHhhcCCCc-cc----------------------ccccCCCC------------CHHHHHHHHHHHhhccCC
Q 016789 294 SYEALIQWVRSRLSSNN-FV----------------------DHRLAGTF------------TTEGMRDLIRLTLQCMSS 338 (382)
Q Consensus 294 ~~~~~~~~~~~~~~~~~-~~----------------------d~~~~~~~------------~~~~~~~l~~l~~~cl~~ 338 (382)
...+............ .+ .......+ ....+..+.+++.+||+.
T Consensus 237 -~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 237 -MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp -HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred -HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 1121111111110000 00 00000000 002235688999999999
Q ss_pred CCCCCCCHHHHHHH
Q 016789 339 PGRRRPKMEIVMTE 352 (382)
Q Consensus 339 dp~~RPs~~~v~~~ 352 (382)
||.+|||+.|+++-
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999998864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=321.55 Aligned_cols=241 Identities=21% Similarity=0.280 Sum_probs=199.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|...+.||+|+||.||+|.... ..+|+|.... .....+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 568888999999999999999864 6899998643 23457889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG-----RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999997653 5889999999999999999999987 99999999999999999999999999875543
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.. .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ........... +.
T Consensus 167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~-------~~---- 229 (284)
T 2vgo_A 167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS---HTETHRRIVNV-------DL---- 229 (284)
T ss_dssp SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTT-------CC----
T ss_pred cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC---HhHHHHHHhcc-------cc----
Confidence 22 223456788999999999999999999999999999999999997432 12222111111 01
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+...+..+.+++.+||+.||.+||++.++++
T Consensus 230 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 112223466889999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=340.39 Aligned_cols=246 Identities=19% Similarity=0.254 Sum_probs=191.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCCc-----hHHHHHHHHHHhcCC--CCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP-----RQEFVAEVTYLSEIR--HRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~-----~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 158 (382)
+.|...+.||+|+||.||++.... ..||+|.+.... ...+.+|+.+|.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999998764 789999875332 256889999999996 599999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
| +.+|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 136 E-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 56889999998643 6788899999999999999999987 99999999999996 58999999999987654
Q ss_pred cccc-CCCcccccccccCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc
Q 016789 239 IEEA-GPSHGSIVNVFRDPEVEES-----------GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 239 ~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
.... ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--~~~~~~~~~~~-- 282 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHAIID-- 282 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC--CHHHHHHHHHC--
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh--HHHHHHHHHhC--
Confidence 3322 1234467889999999865 468999999999999999999999996432 11111111111
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 307 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
+......+...+..+.+++.+||+.||.+||++.++++.
T Consensus 283 -------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 283 -------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111111111123568899999999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=324.32 Aligned_cols=251 Identities=19% Similarity=0.246 Sum_probs=192.2
Q ss_pred hCCCCC-CeeeccCcccEEEEEEC--CeeEEEEEccCC---chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSET-SLIGFGSFGPVYKGLLR--DTVVAIKRRVGS---PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~-~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 159 (382)
+.|... +.||+|+||.||+|... +..||+|.+... ....+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456663 68999999999999875 478999987543 346789999999985 79999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc---EEEeecCCcccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI---AKVADTGISKLL 236 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~---~kl~DfGla~~~ 236 (382)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 92 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR-----HFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999998653 5889999999999999999999987 999999999999998776 999999998765
Q ss_pred ccccc------cCCCcccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCccCCCC-----------
Q 016789 237 ENIEE------AGPSHGSIVNVFRDPEVEES-----GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS----------- 294 (382)
Q Consensus 237 ~~~~~------~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~----------- 294 (382)
..... .......+++.|+|||.+.. ..++.++|||||||++|||++|+.||......+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 11123347888999999875 458899999999999999999999997543221
Q ss_pred -hhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 295 -YEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 295 -~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+.+...... ..+.... . ...+..+.+++.+||+.||.+||++.|+++
T Consensus 245 ~~~~~~~~i~~~~--~~~~~~~-~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEGK--YEFPDKD-W----AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHCC--CCCCHHH-H----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccC--cccCchh-c----ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 111222222110 0000000 0 012457889999999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=346.71 Aligned_cols=246 Identities=19% Similarity=0.252 Sum_probs=199.9
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|...+.||+|+||.||+|+.. +..+|+|.+.. .....+.+|+.++++++||||+++++++......++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56777889999999999999986 47899998753 23356889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++.... .....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999987643 22346899999999999999999999988 99999999999999999999999999987644
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCC-ChhHHHHHHHhhcCCCcccccccC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLG-SYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+.+......
T Consensus 342 ~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~----------- 409 (543)
T 3c4z_A 342 GQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA----------- 409 (543)
T ss_dssp TCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-----------
T ss_pred CCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-----------
Confidence 3221 22346788999999999999999999999999999999999999754322 1223332222111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKME 347 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ 347 (382)
..++...+..+.+++.+||+.||.+||++.
T Consensus 410 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 410 VTYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred cCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 012223346788899999999999999763
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=319.16 Aligned_cols=244 Identities=23% Similarity=0.335 Sum_probs=193.0
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEE
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQ----NGYQML 156 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l 156 (382)
.|...+.||+|+||.||+|.+.. ..+|+|.+... ..+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 36667789999999999999865 57888876532 23468899999999999999999999875 356899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec-CCCcEEEeecCCccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD-ENFIAKVADTGISKL 235 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~-~~~~~kl~DfGla~~ 235 (382)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+++|+||||||+|||++ .++.+||+|||++..
T Consensus 107 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEecCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999997643 58899999999999999999998776799999999999998 789999999999975
Q ss_pred cccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
..... .....+++.|+|||.+. +.++.++||||||+++|||++|+.||.... .............. . ..
T Consensus 182 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~-~----~~ 250 (290)
T 1t4h_A 182 KRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVK-P----AS 250 (290)
T ss_dssp CCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTCC-C----GG
T ss_pred ccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC--cHHHHHHHHhccCC-c----cc
Confidence 43321 22334678899999887 458999999999999999999999996432 22222222221111 1 11
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.. ...+..+.+++.+||+.||.+||++.++++
T Consensus 251 ~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 FD----KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cC----CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 111246889999999999999999999885
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=320.67 Aligned_cols=248 Identities=17% Similarity=0.256 Sum_probs=199.7
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
.++|+..+.||+|+||.||+|... +..+|+|..... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357888999999999999999986 478999986432 23578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999988643 36899999999999999999999988 999999999999999999999999999865432
Q ss_pred cc-cCCCcccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 240 EE-AGPSHGSIVNVFRDPEVEESGVF-SEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 240 ~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.. .......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .....+..... ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~----~~~---- 229 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKT----YLN---- 229 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHTTCT----TST----
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhhccc----ccC----
Confidence 21 12233456788999999987665 788999999999999999999997543221 12222221111 000
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.....+..+.+++.+||+.||.+||++.++++
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 --PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01123456788999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=330.29 Aligned_cols=255 Identities=20% Similarity=0.261 Sum_probs=191.0
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
.++|...+.||+|+||+||+|.... ..||+|.+.... ...+.+|+.++++++||||+++++++...+..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 3578999999999999999998764 799999876432 235779999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee-----cCCCcEEEeecCCc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV-----DENFIAKVADTGIS 233 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill-----~~~~~~kl~DfGla 233 (382)
||++ |+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 113 e~~~-~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp ECCS-EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred ecCC-CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9997 59999997653 5899999999999999999999988 9999999999999 45566999999999
Q ss_pred cccccccccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
+....... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.... ....+..............
T Consensus 185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS--EIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCTTT
T ss_pred cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC--HHHHHHHHHHHhCCCchhh
Confidence 86543221 12233457889999999774 48999999999999999999999997432 2222222222211110000
Q ss_pred -------------ccccCCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 313 -------------DHRLAGTF-----TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 313 -------------d~~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000000 0112467889999999999999999999875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=322.15 Aligned_cols=244 Identities=22% Similarity=0.284 Sum_probs=179.6
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|...+.||+|+||.||+|... +..+|+|.+... ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 56888899999999999999974 478999987532 2357889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999987532 36899999999999999999999987 99999999999999999999999999986643
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||........ . .. .... +.
T Consensus 165 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~~-~~~~---~~---- 229 (278)
T 3cok_A 165 PHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---L---NK-VVLA---DY---- 229 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSS---CC----
T ss_pred CCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---H---HH-Hhhc---cc----
Confidence 2211 1233567889999999998999999999999999999999999975332111 0 00 0000 11
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+...+..+.+++.+||+.||.+||++.++++
T Consensus 230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 112223457889999999999999999999876
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=331.02 Aligned_cols=258 Identities=21% Similarity=0.293 Sum_probs=199.4
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQ----NGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv 157 (382)
++|...+.||+|+||.||++... +..||+|.+.... .+.+.+|+++++.++||||+++++++.. ....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 57888999999999999999974 4789999865432 3568899999999999999999999873 3478999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
|||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLK-DKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 99999999999997642 12346899999999999999999999987 9999999999999999999999999987653
Q ss_pred cccccC--------CCcccccccccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc
Q 016789 238 NIEEAG--------PSHGSIVNVFRDPEVEESGV---FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 238 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~---~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
...... .....+++.|+|||.+.... ++.++||||||+++|||++|+.||....... ...........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~ 264 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVALAVQNQL 264 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHHHHHCC-
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhHHhhccC
Confidence 211110 11223577899999987554 7899999999999999999999986321111 11111111111
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 016789 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358 (382)
Q Consensus 307 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~ 358 (382)
. .......+..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 265 ~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 265 S----------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred C----------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 01112334678899999999999999999999999998853
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=324.57 Aligned_cols=252 Identities=16% Similarity=0.225 Sum_probs=198.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhcCC-CCCccceeeEEEe--CCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSEIR-HRNLVTLLGYCQQ--NGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~~ 161 (382)
++|+..+.||+|+||+||+|.+.. ..||+|.+.......+.+|+.++++++ ||||+++++++.. ....++||||+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 568888999999999999998754 799999998888889999999999997 9999999999987 56789999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC-cEEEeecCCcccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF-IAKVADTGISKLLENIE 240 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~~~~~~~ 240 (382)
++++|.+++. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++......
T Consensus 116 ~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 116 NNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp CCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred CchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 9999998874 3788899999999999999999988 99999999999999776 89999999998665433
Q ss_pred ccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHH------------HHHHhhc-
Q 016789 241 EAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALI------------QWVRSRL- 306 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~------------~~~~~~~- 306 (382)
. .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ....+. ++.....
T Consensus 186 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 186 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS-HHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred c--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc-hHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 2 223456778999999877 6699999999999999999999999954322 111111 1111100
Q ss_pred CCC------------cccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 307 SSN------------NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 307 ~~~------------~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
... ...............+..+.+++.+||+.||.+|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 000011111111224567889999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=325.79 Aligned_cols=256 Identities=24% Similarity=0.347 Sum_probs=196.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-----eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 155 (382)
++|+..+.||+|+||+||+|.+.. ..||+|..... ..+.+.+|+.++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 568888999999999999998632 26899986532 2357889999999999999999999998765 88
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+|+||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 97 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEcccccccc
Confidence 9999999999999997642 35889999999999999999999987 99999999999999999999999999987
Q ss_pred ccccccc--CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 236 LENIEEA--GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 236 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..............
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~---- 243 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKIDKEGER---- 243 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTSCCC----
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC---HHHHHHHHHccCCC----
Confidence 6433221 1223345667999999998889999999999999999999 999986432 22333322221110
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhh
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEM 361 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~ 361 (382)
...+...+..+.+++.+||+.||.+||++.++++.|+++...++
T Consensus 244 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 244 -----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred -----CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 01122345678899999999999999999999999999876543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=327.42 Aligned_cols=244 Identities=17% Similarity=0.243 Sum_probs=200.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|...+.||+|+||.||++.+.. ..+|+|..... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 578889999999999999999875 68999986532 2356889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 121 e~~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 121 ELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CCCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999887643 6899999999999999999999987 99999999999999999999999999986643
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ............ ..
T Consensus 194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~-------~~--- 259 (335)
T 2owb_A 194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNE-------YS--- 259 (335)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTC-------CC---
T ss_pred Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHhcCC-------CC---
Confidence 221 1233456788999999999999999999999999999999999996432 122221111110 01
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.+......+.+++.+||+.||.+||++.++++.
T Consensus 260 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 260 -IPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112223567889999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=345.68 Aligned_cols=247 Identities=11% Similarity=0.090 Sum_probs=187.8
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccC------CchHHHHHHH---HHHhcCCCCCcccee-------eEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVG------SPRQEFVAEV---TYLSEIRHRNLVTLL-------GYC 148 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~e~---~~l~~l~h~niv~l~-------~~~ 148 (382)
++|...+.||+|+||+||+|.+. +..||+|.+.. ...+.+.+|+ .++++++||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 45777889999999999999965 47999998652 1235788999 555566899999998 666
Q ss_pred EeCC-----------------eeEEEEeecCCCChhhhhhhcCC--CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 016789 149 QQNG-----------------YQMLVFEYLPNGSMCNHLYETGL--ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVH 209 (382)
Q Consensus 149 ~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivH 209 (382)
...+ ..++||||+ +|+|.+++...+. .....+++..++.++.|++.||+|||+.+ |+|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH 229 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVH 229 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 5543 278999999 6899999986431 11234557888899999999999999988 999
Q ss_pred cCCCCCCeeecCCCcEEEeecCCccccccccccCCCcccccccccCccccccC-----------CCCccchhHHHHHHHH
Q 016789 210 KNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESG-----------VFSEMSDIYSFGVFLL 278 (382)
Q Consensus 210 rDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~sDvws~G~vl~ 278 (382)
|||||+|||++.++.+||+|||+++..... .....+ +.|+|||.+.+. .++.++|||||||++|
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAR----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTCE----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCCc----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 999999999999999999999999854331 122234 779999999887 8999999999999999
Q ss_pred HHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHH
Q 016789 279 ELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT--ELERI 356 (382)
Q Consensus 279 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~--~L~~i 356 (382)
||++|+.||......... .... .. ....+..+.+++.+||+.||++||++.++++ .++++
T Consensus 305 elltg~~Pf~~~~~~~~~------------~~~~-~~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 305 WIWCADLPITKDAALGGS------------EWIF-RS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHSSCCC------CCS------------GGGG-SS-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHCCCCCcccccccch------------hhhh-hh-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 999999999643211100 0000 00 0122356888999999999999999999986 45655
Q ss_pred HHh
Q 016789 357 HEK 359 (382)
Q Consensus 357 ~~~ 359 (382)
.+.
T Consensus 367 ~~~ 369 (377)
T 3byv_A 367 RTE 369 (377)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=323.07 Aligned_cols=244 Identities=26% Similarity=0.336 Sum_probs=200.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+.|...+.||+|+||.||+|.... ..+|+|..... ....+.+|+.++++++||||+++++++......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 458888999999999999998764 78999986532 346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEP------GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999864 25899999999999999999999988 9999999999999999999999999998664432
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ............ . +.+.
T Consensus 174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~-~-----~~~~--- 240 (303)
T 3a7i_A 174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH---PMKVLFLIPKNN-P-----PTLE--- 240 (303)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSC-C-----CCCC---
T ss_pred c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC---HHHHHHHhhcCC-C-----CCCc---
Confidence 1 2233456788999999999999999999999999999999999986432 222222222211 1 1111
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
...+..+.+++.+||+.||.+||++.++++.
T Consensus 241 -~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 -GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1223568899999999999999999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=331.67 Aligned_cols=256 Identities=21% Similarity=0.331 Sum_probs=194.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
++|+..+.||+|+||.||+|.... ..||+|.+.... ...+.+|+.++++++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 568888999999999999999874 789999865432 2357789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 105 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999998888765432 5899999999999999999999988 999999999999999999999999999865432
Q ss_pred cccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC-----------
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS----------- 307 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------- 307 (382)
.. ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||..... ...+.........
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD--IDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCChhhhhHhhh
Confidence 22 12234567889999998775 689999999999999999999999975332 1222111111000
Q ss_pred ---CCcccccccCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 308 ---SNNFVDHRLAGTFT-----TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 308 ---~~~~~d~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
......+......+ +..+..+.+++.+||+.||.+||++.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00111111111111 1235678999999999999999999998863
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=320.42 Aligned_cols=244 Identities=17% Similarity=0.245 Sum_probs=199.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|...+.||+|+||.||++.... ..+|+|..... ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 568888999999999999999874 68999986432 2356889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 95 ELCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp ECCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999887643 6899999999999999999999987 99999999999999999999999999986643
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ............ .
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~-------~---- 232 (294)
T 2rku_A 168 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNE-------Y---- 232 (294)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTC-------C----
T ss_pred Ccc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhhcc-------C----
Confidence 221 1223456788999999999889999999999999999999999996432 112111111110 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..+...+..+.+++.+||+.||++||++.++++.
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1112233567889999999999999999999873
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=338.54 Aligned_cols=247 Identities=19% Similarity=0.259 Sum_probs=199.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEcc-----CCchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRV-----GSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
.++|...+.||+|+||+||+|... +..||+|.+. ......+.+|++++++++||||+++++++......++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457999999999999999999986 4789999864 234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec---CCCcEEEeecCCccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD---ENFIAKVADTGISKL 235 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~---~~~~~kl~DfGla~~ 235 (382)
||+++|+|.+.+.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999987653 6899999999999999999999988 99999999999995 456899999999986
Q ss_pred cccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
...... .....+++.|+|||.+.+ .++.++||||+||++|+|++|+.||.... .......+........ .+.
T Consensus 174 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~--~~~ 245 (486)
T 3mwu_A 174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAFD--LPQ 245 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCSC--SGG
T ss_pred CCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC--Ccc
Confidence 644322 233457888999999875 59999999999999999999999996432 2233332222111000 000
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
....+..+.+++.+||+.||.+|||+.++++.
T Consensus 246 -----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 246 -----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11234568899999999999999999999873
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=318.35 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=193.9
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCC---chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS---PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
|.....||+|+||.||+|.+.. ..||+|..... ..+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 4555689999999999999854 68999986543 245788999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC-CCcEEEeecCCcccccccccc
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-NFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-~~~~kl~DfGla~~~~~~~~~ 242 (382)
++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||++........
T Consensus 104 ~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 104 GSLSALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEHHHHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCHHHHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 99999997643 2235678889999999999999999987 999999999999987 89999999999986643221
Q ss_pred CCCcccccccccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 243 GPSHGSIVNVFRDPEVEESGV--FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~~~--~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
......+++.|+|||.+.+.. ++.++||||||+++|||++|+.||...... ........... . .+ ..
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~-~----~~----~~ 247 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP--QAAMFKVGMFK-V----HP----EI 247 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH--HHHHHHHHHHC-C----CC----CC
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch--hHHHHhhcccc-c----cc----cc
Confidence 122345678899999987654 889999999999999999999999643221 11111111111 0 01 12
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+...+..+.+++.+||+.||++||++.++++
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2233467889999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=333.99 Aligned_cols=266 Identities=20% Similarity=0.259 Sum_probs=202.8
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
++|+..+.||+|+||.||++.+. +..+|+|...... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 46888899999999999999997 4789999876432 34688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL-KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
+++|+|.+++...+ .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999998753 588999999999999999999984 7 999999999999999999999999999755332
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc---------C---
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL---------S--- 307 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------~--- 307 (382)
. .....+++.|+|||.+.+..++.++||||||+++|||++|+.||................... .
T Consensus 186 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp C-------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred c---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 1 223456788999999999999999999999999999999999997533211111000000000 0
Q ss_pred -----------CC---ccc----ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHHhhhh
Q 016789 308 -----------SN---NFV----DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE--LERIHEKEMA 362 (382)
Q Consensus 308 -----------~~---~~~----d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~--L~~i~~~~~~ 362 (382)
.. +.. ............+..+.+++.+||+.||++|||+.++++- +.+...++..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~ 337 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 337 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCCC
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhhh
Confidence 00 000 0000000011234568899999999999999999999874 4554444443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=340.55 Aligned_cols=247 Identities=20% Similarity=0.297 Sum_probs=196.3
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
.+.|...+.||+|+||+||+|.... ..+|+|.+... ....+.+|+.+++.++||||+++++++......++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4568899999999999999999864 68999986532 3467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC---CCcEEEeecCCccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE---NFIAKVADTGISKL 235 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~---~~~~kl~DfGla~~ 235 (382)
|||++|+|.+.+.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999887653 5889999999999999999999988 999999999999976 45599999999987
Q ss_pred cccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
...... .....+++.|+|||++. ..++.++||||+||++|+|++|+.||.... ...+...+..... .+..+.
T Consensus 189 ~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~--~~~~~~ 260 (494)
T 3lij_A 189 FENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT---DQEILRKVEKGKY--TFDSPE 260 (494)
T ss_dssp CBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCC--CCCSGG
T ss_pred CCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC--CCCchh
Confidence 654322 23345788899999986 569999999999999999999999997432 2333333322111 111111
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
. ...+..+.+++.+||+.||.+|||+.++++.
T Consensus 261 ~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 261 W-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp G-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred c-----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1 1223568899999999999999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=326.75 Aligned_cols=251 Identities=20% Similarity=0.292 Sum_probs=201.0
Q ss_pred HHHHHhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc-----------hHHHHHHHHHHhcC-CCCCccceeeE
Q 016789 82 LEQATKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP-----------RQEFVAEVTYLSEI-RHRNLVTLLGY 147 (382)
Q Consensus 82 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----------~~~~~~e~~~l~~l-~h~niv~l~~~ 147 (382)
......+|...+.||+|+||.||+|.+. +..||||.+.... .+.+.+|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3444567999999999999999999986 4799999865432 24578899999999 79999999999
Q ss_pred EEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEE
Q 016789 148 CQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKV 227 (382)
Q Consensus 148 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl 227 (382)
+......++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999997643 6899999999999999999999987 999999999999999999999
Q ss_pred eecCCccccccccccCCCcccccccccCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHH
Q 016789 228 ADTGISKLLENIEEAGPSHGSIVNVFRDPEVEES------GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQW 301 (382)
Q Consensus 228 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~ 301 (382)
+|||++..+..... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......
T Consensus 242 ~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~ 316 (365)
T 2y7j_A 242 SDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRM 316 (365)
T ss_dssp CCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH
T ss_pred EecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHHHH
Confidence 99999987654322 233456888999999863 358899999999999999999999996432 2222222
Q ss_pred HHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 302 VRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 302 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+..... ....+.. ...+..+.+++.+||+.||++||++.++++
T Consensus 317 i~~~~~--~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 IMEGQY--QFSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHTCC--CCCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhCCC--CCCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 222110 0000000 012356889999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=320.10 Aligned_cols=246 Identities=22% Similarity=0.276 Sum_probs=200.1
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC---chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS---PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
.++|...+.||+|+||.||++... +..+|+|.+... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467888999999999999999986 478999987643 235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee---cCCCcEEEeecCCccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV---DENFIAKVADTGISKLLE 237 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill---~~~~~~kl~DfGla~~~~ 237 (382)
+++|+|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILERG-----VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999987653 5889999999999999999999987 9999999999999 788999999999997543
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ...+.+.+..... .. .
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~--~~-----~ 227 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ESKLFEKIKEGYY--EF-----E 227 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHCCC--CC-----C
T ss_pred CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCC--CC-----C
Confidence 32 1223346788999999999999999999999999999999999996432 2233332222111 00 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.......+..+.+++.+||+.||.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111233467889999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=331.84 Aligned_cols=254 Identities=22% Similarity=0.327 Sum_probs=191.7
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCch----HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSPR----QEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
++|...+.||+|+||+||+|... +..||+|.+..... ..+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 36788899999999999999986 37899998764322 2456799999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
++ |+|.+++...+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 69999887643 35889999999999999999999988 9999999999999999999999999998654322
Q ss_pred ccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh-hcCCC-c----ccc
Q 016789 241 EAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS-RLSSN-N----FVD 313 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~-~----~~d 313 (382)
. ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+.. ..... . ...
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV---EEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHhchhhhc
Confidence 1 2223356788999999876 5689999999999999999999999975332 222222221 11110 0 000
Q ss_pred c---------ccCCC----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 314 H---------RLAGT----FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 314 ~---------~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. ..... .....+..+.+++.+||+.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 00000 01122456789999999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=342.64 Aligned_cols=252 Identities=18% Similarity=0.232 Sum_probs=189.7
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeC------C
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN------G 152 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 152 (382)
.++|+..+.||+|+||+||+|.+.. ..||+|++... ....+.+|+.+|+.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 3578889999999999999998764 78999987643 234688999999999999999999999654 3
Q ss_pred eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCC
Q 016789 153 YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI 232 (382)
Q Consensus 153 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGl 232 (382)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 57999999965 56666632 4889999999999999999999988 99999999999999999999999999
Q ss_pred ccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC----
Q 016789 233 SKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS---- 308 (382)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---- 308 (382)
++...... ......+|+.|+|||.+.+..|+.++|||||||++|||++|+.||...+. ...+..........
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~--~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp C-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCSCCHHH
T ss_pred eeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHHH
Confidence 98664322 22334678889999999999999999999999999999999999975331 11111111111100
Q ss_pred ------------------Ccc-----cccccCCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 309 ------------------NNF-----VDHRLAGTF---TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 309 ------------------~~~-----~d~~~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
... ....+.... .......+.+|+.+||+.||.+|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000000000 1122567899999999999999999999886
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=325.41 Aligned_cols=258 Identities=22% Similarity=0.275 Sum_probs=185.1
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
.++|...+.||+|+||.||+|... +..||+|.+... ..+++.+|+.++++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 467888999999999999999874 478999987542 23568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcC---CCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 160 YLPNGSMCNHLYETG---LESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
|+++|+|.+++.... ......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 999999999986421 112346899999999999999999999987 999999999999999999999999998765
Q ss_pred cccccc----CCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC--CC
Q 016789 237 ENIEEA----GPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS--SN 309 (382)
Q Consensus 237 ~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~ 309 (382)
...... ......+++.|+|||.+.. ..++.++||||||+++|||++|+.||...... ............ ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--KVLMLTLQNDPPSLET 249 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHHHHHTSSCCCTTC
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--hHHHHHhccCCCcccc
Confidence 432211 1123356788999999875 56899999999999999999999999754322 111111111100 00
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...++.... ..+..+.+++.+||+.||.+||++.++++
T Consensus 250 ~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 250 GVQDKEMLK----KYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -----CCCC----CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccchhhh----hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111111111 23356889999999999999999999987
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=341.54 Aligned_cols=189 Identities=23% Similarity=0.362 Sum_probs=151.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeC-----Cee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN-----GYQ 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 154 (382)
++|...+.||+|+||+||+|.+.. ..||+|++... ....+.+|+.+|++++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 578999999999999999998764 78999987542 124688999999999999999999998543 568
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
|+||||+ +|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 133 ~lv~e~~-~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEecc-ccchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccch
Confidence 9999998 57999988653 36899999999999999999999988 9999999999999999999999999998
Q ss_pred cccccccc--------------------------CCCcccccccccCcccc-ccCCCCccchhHHHHHHHHHHHhC
Q 016789 235 LLENIEEA--------------------------GPSHGSIVNVFRDPEVE-ESGVFSEMSDIYSFGVFLLELVTG 283 (382)
Q Consensus 235 ~~~~~~~~--------------------------~~~~~~~~~~y~aPE~~-~~~~~~~~sDvws~G~vl~el~tg 283 (382)
........ ......+|+.|+|||++ ....|+.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 76432211 11233568889999986 566799999999999999999994
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=336.82 Aligned_cols=260 Identities=17% Similarity=0.202 Sum_probs=207.8
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC-chHHHHHHHHHHhcCCC-CCccceeeEEEeCCeeEEEEeecC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS-PRQEFVAEVTYLSEIRH-RNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
++|...+.||+|+||.||+|.+. +..||||..... ....+..|+++++.++| +++..+..++...+..++||||+
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~- 85 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence 57889999999999999999976 478999986543 34578999999999987 56666666777888999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee---cCCCcEEEeecCCccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV---DENFIAKVADTGISKLLENI 239 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill---~~~~~~kl~DfGla~~~~~~ 239 (382)
+++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 86 g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 86 GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 999999997542 36899999999999999999999988 9999999999999 68899999999999876543
Q ss_pred ccc------CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccc
Q 016789 240 EEA------GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVD 313 (382)
Q Consensus 240 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (382)
... ......+++.|+|||.+.+..++.++|||||||++|||++|+.||..............+....... .+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-~~~ 238 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT-SIE 238 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS-CHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc-cHH
Confidence 321 1224567888999999999999999999999999999999999998765544444333322211000 000
Q ss_pred cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 314 HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 314 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.+. ...+..+.+++.+||+.||++||++.+|++.|+++...
T Consensus 239 -~l~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 239 -ALC----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp -HHH----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -HHh----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 000 11246788999999999999999999999999999764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=334.70 Aligned_cols=249 Identities=18% Similarity=0.226 Sum_probs=190.3
Q ss_pred HHHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----------hHHHHHHHHHHhcCCCCCccceeeEEEe
Q 016789 84 QATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----------RQEFVAEVTYLSEIRHRNLVTLLGYCQQ 150 (382)
Q Consensus 84 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~~~~~~ 150 (382)
...++|...+.||+|+||+||+|.... ..||+|.+.... ...+.+|+.+|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 456789999999999999999999875 689999864321 1258899999999999999999999754
Q ss_pred CCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC---CcEEE
Q 016789 151 NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN---FIAKV 227 (382)
Q Consensus 151 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~---~~~kl 227 (382)
+..++||||+++|+|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.+ ..+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEE
Confidence 5579999999999999988653 36899999999999999999999987 9999999999999754 45999
Q ss_pred eecCCccccccccccCCCcccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh
Q 016789 228 ADTGISKLLENIEEAGPSHGSIVNVFRDPEVEE---SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS 304 (382)
Q Consensus 228 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 304 (382)
+|||+++...... ......+++.|+|||.+. ...++.++|||||||++|||++|+.||...... ..+......
T Consensus 284 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~i~~ 359 (419)
T 3i6u_A 284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQITS 359 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHHHHHT
T ss_pred eecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHHHHhc
Confidence 9999998765422 122345688899999985 366889999999999999999999999753321 122222221
Q ss_pred hcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 305 RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 305 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
... .. .+... ...+..+.+++.+||+.||.+||++.++++
T Consensus 360 ~~~--~~-~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 GKY--NF-IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TCC--CC-CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC--CC-Cchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 110 00 00000 112467889999999999999999999886
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=336.09 Aligned_cols=260 Identities=21% Similarity=0.265 Sum_probs=193.8
Q ss_pred HHHHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhcCCCCCccceeeEEEeC---------
Q 016789 83 EQATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQN--------- 151 (382)
Q Consensus 83 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------- 151 (382)
+...++|...+.||+|+||.||+|.+.. ..||+|++.... ....+|+++|+.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 3445689999999999999999998854 789999875442 3345799999999999999999998543
Q ss_pred -----------------------------CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc
Q 016789 152 -----------------------------GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS 202 (382)
Q Consensus 152 -----------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~ 202 (382)
...++||||++ |+|.+.+.... .....+++..+..++.|++.||.|||+
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI-RSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ----------------------------CCEEEEEECCCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34889999997 68888776431 123468999999999999999999999
Q ss_pred CCCCceecCCCCCCeeec-CCCcEEEeecCCccccccccccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHH
Q 016789 203 LKPPLVHKNFKTANVLVD-ENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLEL 280 (382)
Q Consensus 203 ~~~~ivHrDlk~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el 280 (382)
.+ |+||||||+|||++ .++.+||+|||+++.+..... .....+++.|+|||.+.+. .++.++||||+||++|||
T Consensus 160 ~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 235 (383)
T 3eb0_A 160 LG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235 (383)
T ss_dssp TT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred Cc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence 88 99999999999998 689999999999986644332 2233557789999998765 489999999999999999
Q ss_pred HhCCCCCCccCCCChhHHHHHHHhhcCC------------CcccccccC-----CCCCHHHHHHHHHHHhhccCCCCCCC
Q 016789 281 VTGQEASHIVSLGSYEALIQWVRSRLSS------------NNFVDHRLA-----GTFTTEGMRDLIRLTLQCMSSPGRRR 343 (382)
Q Consensus 281 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~d~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~R 343 (382)
++|+.||.... ....+.......... ....-+... ...+...+..+.+++.+||+.||.+|
T Consensus 236 l~g~~pf~~~~--~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 236 ILGKPLFSGET--SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHSSCSSCCSS--HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999997532 222222222211110 000000100 01122345668899999999999999
Q ss_pred CCHHHHHH
Q 016789 344 PKMEIVMT 351 (382)
Q Consensus 344 Ps~~~v~~ 351 (382)
||+.|+++
T Consensus 314 ~t~~e~l~ 321 (383)
T 3eb0_A 314 INPYEAMA 321 (383)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=319.37 Aligned_cols=242 Identities=20% Similarity=0.287 Sum_probs=194.1
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC-----chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS-----PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 157 (382)
.++|+..+.||+|+||.||+|... +..+|+|.+... ....+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467889999999999999999986 479999987642 234688899999999 899999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC----------------
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE---------------- 221 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~---------------- 221 (382)
|||+++|+|.+++..... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976421 1135899999999999999999999988 999999999999984
Q ss_pred ---CCcEEEeecCCccccccccccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhH
Q 016789 222 ---NFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEA 297 (382)
Q Consensus 222 ---~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~ 297 (382)
...+||+|||++....... ...+++.|+|||.+.+. .++.++||||||+++|||++|.+++... ..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~ 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----DQ 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----HH
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----hH
Confidence 4479999999998664322 23467889999999766 5678999999999999999999876421 11
Q ss_pred HHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 298 LIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 298 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. ...... .. +. .+...+..+.+++.+||+.||++||++.++++
T Consensus 237 ~-~~~~~~-~~-----~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 W-HEIRQG-RL-----PR----IPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp H-HHHHTT-CC-----CC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-HHHHcC-CC-----CC----CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1 111111 00 11 12223466889999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=335.07 Aligned_cols=193 Identities=21% Similarity=0.327 Sum_probs=161.4
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeC-----Cee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQN-----GYQ 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 154 (382)
++|...+.||+|+||.||+|.+.. ..||+|++.... ...+.+|+.+|++++||||+++++++... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 578889999999999999999865 789999876421 24688999999999999999999999766 578
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
|+||||+. |+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 106 ~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 99999985 6999998753 36899999999999999999999988 9999999999999999999999999998
Q ss_pred cccccccc---------------------CCCcccccccccCcccc-ccCCCCccchhHHHHHHHHHHHhCCCCC
Q 016789 235 LLENIEEA---------------------GPSHGSIVNVFRDPEVE-ESGVFSEMSDIYSFGVFLLELVTGQEAS 287 (382)
Q Consensus 235 ~~~~~~~~---------------------~~~~~~~~~~y~aPE~~-~~~~~~~~sDvws~G~vl~el~tg~~p~ 287 (382)
........ ......+|+.|+|||.+ ....++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76443211 12345678889999986 5667999999999999999999865544
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=321.32 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=197.6
Q ss_pred HHhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC-chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS-PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
..+.|...+.||+|+||.||+|.+. +..||+|.+... ....+.+|+.++.+++||||+++++++...+..++||||+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 3467888999999999999999987 478999987643 3567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 107 ~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 107 GAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp TTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999987432 36899999999999999999999988 99999999999999999999999999976543221
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... .......... ....+. .+
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~-~~~~~~-------~~ 248 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---MRAIFMIPTN-PPPTFR-------KP 248 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHS-CCCCCS-------SG
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcC-CCcccC-------Cc
Confidence 22234567889999999999999999999999999999999999974321 1111111111 111111 11
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+..+.+++.+||+.||.+||++.++++
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 223467889999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=340.17 Aligned_cols=246 Identities=20% Similarity=0.283 Sum_probs=197.6
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----------------chHHHHHHHHHHhcCCCCCccceeeE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----------------PRQEFVAEVTYLSEIRHRNLVTLLGY 147 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----------------~~~~~~~e~~~l~~l~h~niv~l~~~ 147 (382)
.+.|...+.||+|+||+||+|.... ..+|+|.+... ..+.+.+|+.+|++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4679999999999999999999865 68999986532 23568899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC---c
Q 016789 148 CQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF---I 224 (382)
Q Consensus 148 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~---~ 224 (382)
+.+....++|||||++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999997653 5899999999999999999999988 99999999999998775 6
Q ss_pred EEEeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh
Q 016789 225 AKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS 304 (382)
Q Consensus 225 ~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 304 (382)
+||+|||++........ .....+++.|+|||.+. +.++.++||||+||++|+|++|+.||.... .......+..
T Consensus 188 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~ 261 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN---DQDIIKKVEK 261 (504)
T ss_dssp EEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH
T ss_pred EEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHc
Confidence 99999999987654322 23345788899999987 468999999999999999999999997432 2333333332
Q ss_pred hcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 305 RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 305 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..... +.... ...+..+.+++.+||+.||.+|||+.++++
T Consensus 262 ~~~~~---~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 262 GKYYF---DFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCCCC---CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCC---Ccccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11100 00000 112466889999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=328.29 Aligned_cols=258 Identities=21% Similarity=0.295 Sum_probs=194.8
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc--------hHHHHHHHHHHhcCCCCCccceeeEEEeCCee
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP--------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQ 154 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~--------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 154 (382)
..++|...+.||+|+||.||+|.+.. ..||+|.+.... ...+.+|+.++++++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 34679999999999999999999864 689999875321 23678999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999975 8888886532 35788889999999999999999988 9999999999999999999999999998
Q ss_pred ccccccccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC--cc
Q 016789 235 LLENIEEAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN--NF 311 (382)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 311 (382)
....... ......+++.|+|||.+.+. .++.++|||||||++|||++|.+||.... ....+........... ..
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~--~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCTTTS
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHHHcCCCChhhh
Confidence 7643322 22334568889999998654 58999999999999999999999986432 2222222222211110 00
Q ss_pred c------cc---ccCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 312 V------DH---RLAGTFT-----TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 312 ~------d~---~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
. +. ......+ ...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00 0000111 2234678899999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=331.00 Aligned_cols=249 Identities=19% Similarity=0.286 Sum_probs=189.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCC------e
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNG------Y 153 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~ 153 (382)
+.|...+.||+|+||.||+|.+.. ..||+|++.... ...+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 568888999999999999999864 789999875421 246789999999999999999999997653 4
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.++||||+ +++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 59999999 88999988753 5889999999999999999999988 999999999999999999999999999
Q ss_pred cccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCc--
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNN-- 310 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 310 (382)
+..... .....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+............
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--LDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHH
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCCHHH
Confidence 865432 233456788999999877 6799999999999999999999999974332 1111111111111100
Q ss_pred ------------------ccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 311 ------------------FVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 311 ------------------~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.....+. ......+..+.+++.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000 111223466889999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=326.89 Aligned_cols=258 Identities=20% Similarity=0.296 Sum_probs=194.4
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEe--------C
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQ--------N 151 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 151 (382)
++|+..+.||+|+||.||+|.+.. ..||+|++.... ...+.+|+.+++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 568889999999999999999854 789999865332 3468899999999999999999999987 4
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
+..++||||++ |+|.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccC-CCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccch
Confidence 46899999997 57877776532 35899999999999999999999988 9999999999999999999999999
Q ss_pred Cccccccccc---cCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC
Q 016789 232 ISKLLENIEE---AGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS 307 (382)
Q Consensus 232 la~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 307 (382)
+++.+..... .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9986643221 12233456888999999876 4589999999999999999999999975332111111111111111
Q ss_pred CC---ccccccc-------C-CCCC-HH------HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 308 SN---NFVDHRL-------A-GTFT-TE------GMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 308 ~~---~~~d~~~-------~-~~~~-~~------~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.. ...+... . .... .+ ....+.+++.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 10 0000000 0 0000 11 1345789999999999999999999886
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=341.29 Aligned_cols=246 Identities=19% Similarity=0.266 Sum_probs=200.0
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
.+.|...+.||+|+||.||+|.... ..+|+|.+.. .....+.+|+.++++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3568889999999999999999864 7899998643 2346789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee---cCCCcEEEeecCCcc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV---DENFIAKVADTGISK 234 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill---~~~~~~kl~DfGla~ 234 (382)
|||+.+|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999987643 6899999999999999999999988 9999999999999 567899999999998
Q ss_pred ccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 235 LLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
...... ......+++.|+|||.+.+ .++.++||||+||++|+|++|++||.... .......+........ .+
T Consensus 178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~--~~ 249 (484)
T 3nyv_A 178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKKVEKGKYTFE--LP 249 (484)
T ss_dssp HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC--SG
T ss_pred Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCCC--Cc
Confidence 654322 1223457888999999876 69999999999999999999999997432 2333333332211100 00
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.....+..+.+++.+||+.||.+|||+.++++
T Consensus 250 -----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 250 -----QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 01223467889999999999999999999886
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=325.28 Aligned_cols=259 Identities=23% Similarity=0.311 Sum_probs=196.9
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECCeeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
..++|...+.||+|+||.||+|.+.+ .+++|.+... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 34678889999999999999999876 4888876532 23467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++ ++.+||+|||++......
T Consensus 110 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp CCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred cccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 999999999996532 35888999999999999999999988 99999999999998 679999999998765322
Q ss_pred cc----cCCCcccccccccCcccccc---------CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc
Q 016789 240 EE----AGPSHGSIVNVFRDPEVEES---------GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 240 ~~----~~~~~~~~~~~y~aPE~~~~---------~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
.. .......+++.|+|||.+.. ..++.++||||||+++|||++|+.||.... ............
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~ 259 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP---AEAIIWQMGTGM 259 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC---HHHHHHHHHTTC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHhccCC
Confidence 11 11223346788999999864 457899999999999999999999996432 222222222211
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhh
Q 016789 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMAL 363 (382)
Q Consensus 307 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~~ 363 (382)
...... ...+..+.+++.+||+.||.+||++.++++.|+++.++.-..
T Consensus 260 -~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 260 -KPNLSQ--------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp -CCCCCC--------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred -CCCCCc--------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 111111 112345788999999999999999999999999998765443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=314.27 Aligned_cols=242 Identities=21% Similarity=0.291 Sum_probs=192.9
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|...+.||+|+||.||+|.+. +..+|+|.... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 46888899999999999999986 47899998643 22357889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp ECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred eccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999997653 5889999999999999999999988 99999999999999999999999999987644
Q ss_pred ccccCCCcccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVF-SEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
... .....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||... ......+.......
T Consensus 164 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~~~~~~~---------- 228 (276)
T 2h6d_A 164 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE---HVPTLFKKIRGGVF---------- 228 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCC----------
T ss_pred Ccc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHhhcCcc----------
Confidence 321 223356778999999987765 68999999999999999999998643 22233332222110
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+...+..+.+++.+||+.||.+||++.++++
T Consensus 229 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 -YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 011223456888999999999999999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=323.25 Aligned_cols=252 Identities=21% Similarity=0.265 Sum_probs=197.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQ--NGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 157 (382)
++|+..+.||+|+||.||++.... ..+|+|.+... ..+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 578888999999999999999864 78999987542 23468899999999999999999998854 5688999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCC---CCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK---PPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
|||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999976431 2235899999999999999999999855 349999999999999999999999999997
Q ss_pred ccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 235 LLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
........ .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ...+...+..... .
T Consensus 165 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~~~~~-~----- 234 (279)
T 2w5a_A 165 ILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIREGKF-R----- 234 (279)
T ss_dssp HC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCC-C-----
T ss_pred eecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHHHHHHhhccc-c-----
Confidence 65432111 112345778999999999899999999999999999999999987542 2233333322211 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L 353 (382)
..+...+..+.+++.+||+.||.+||++.++++.+
T Consensus 235 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 235 ----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 11223346788999999999999999999998865
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=327.42 Aligned_cols=258 Identities=16% Similarity=0.169 Sum_probs=200.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCc------h--------------HHHHHHHHHHhcCCCCCccceee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP------R--------------QEFVAEVTYLSEIRHRNLVTLLG 146 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~--------------~~~~~e~~~l~~l~h~niv~l~~ 146 (382)
++|...+.||+|+||.||+|...+..||+|.+.... . +.+.+|+.++++++||||+++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred CceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 578888999999999999999988999999865321 0 77999999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCChhhhhhhc---CCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeeecCC
Q 016789 147 YCQQNGYQMLVFEYLPNGSMCNHLYET---GLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDEN 222 (382)
Q Consensus 147 ~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill~~~ 222 (382)
++...+..++||||+++|+|.+++... .......+++..+..++.|++.||.|||+ .+ |+||||||+||+++.+
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKN 188 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEECTT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEEcCC
Confidence 999999999999999999999983211 01113578999999999999999999998 77 9999999999999999
Q ss_pred CcEEEeecCCccccccccccCCCcccccccccCccccccC-CCCc-cchhHHHHHHHHHHHhCCCCCCccCCCChhHHHH
Q 016789 223 FIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESG-VFSE-MSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQ 300 (382)
Q Consensus 223 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~ 300 (382)
+.+||+|||++...... ......++..|+|||.+.+. .++. ++||||||+++|||++|+.||..... .....+
T Consensus 189 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~ 263 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS--LVELFN 263 (348)
T ss_dssp SCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC--SHHHHH
T ss_pred CcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHH
Confidence 99999999999865433 22334567889999999877 6666 99999999999999999999975432 123333
Q ss_pred HHHhhc-CCCc----ccccccC---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 301 WVRSRL-SSNN----FVDHRLA---GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 301 ~~~~~~-~~~~----~~d~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+.... .... ...+... .......+..+.+++.+||+.||.+||++.++++
T Consensus 264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 222211 0000 0000000 0001234567889999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=333.29 Aligned_cols=194 Identities=23% Similarity=0.265 Sum_probs=167.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCch--HHHHHHHHHHhcC------CCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPR--QEFVAEVTYLSEI------RHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~--~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~~l 156 (382)
.+|+..+.||+|+||+||+|.... ..||+|.+..... ..+.+|+.+++.+ +|+||+++++++...+..++
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 468888999999999999998865 7899999876532 4677888888776 57899999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc--EEEeecCCcc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI--AKVADTGISK 234 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~--~kl~DfGla~ 234 (382)
||||+. |+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++.
T Consensus 177 v~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EECCCC-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEeccC-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 999995 69999987653 235899999999999999999999987 999999999999999887 9999999997
Q ss_pred ccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 016789 235 LLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIV 290 (382)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~ 290 (382)
.... ......+++.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 251 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 251 YEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp ETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 5432 222345678899999999999999999999999999999999999754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=321.50 Aligned_cols=253 Identities=16% Similarity=0.182 Sum_probs=198.0
Q ss_pred HHHHhCCCCC-CeeeccCcccEEEEEEC--CeeEEEEEccCC-----chHHHHHHHHHHhcCC-CCCccceeeEEEeCCe
Q 016789 83 EQATKQFSET-SLIGFGSFGPVYKGLLR--DTVVAIKRRVGS-----PRQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGY 153 (382)
Q Consensus 83 ~~~~~~~~~~-~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 153 (382)
+...+.|... +.||+|+||.||+|... +..+|+|.+... ....+.+|+.++..+. ||||+++++++...+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3444567766 78999999999999987 478999986542 2457889999999994 6999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC---CCcEEEeec
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE---NFIAKVADT 230 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~---~~~~kl~Df 230 (382)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EEEEEEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeC
Confidence 99999999999999998543 2346899999999999999999999988 999999999999998 789999999
Q ss_pred CCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCc
Q 016789 231 GISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNN 310 (382)
Q Consensus 231 Gla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 310 (382)
|+++....... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ............ ..
T Consensus 179 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~--~~ 251 (327)
T 3lm5_A 179 GMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETYLNISQVN--VD 251 (327)
T ss_dssp GGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTC--CC
T ss_pred ccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHHHhcc--cc
Confidence 99987643322 223456788999999999999999999999999999999999996432 122221111111 00
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 311 FVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 311 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
.........+..+.+++.+||+.||.+||++.++++.
T Consensus 252 -----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 252 -----YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -----cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0111112334668899999999999999999998763
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=335.59 Aligned_cols=255 Identities=13% Similarity=0.020 Sum_probs=179.2
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc------hHHHHHHH---HHHhcCCCCCcccee-------eEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP------RQEFVAEV---TYLSEIRHRNLVTLL-------GYC 148 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~---~~l~~l~h~niv~l~-------~~~ 148 (382)
.+|...+.||+|+||.||+|.+. +..||+|.+.... .+.+.+|+ ..|+. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 45788899999999999999976 3789999877533 23566774 55555 799988755 444
Q ss_pred EeC-----------------CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHH------HHHHHHHHHHHHHHhcCCC
Q 016789 149 QQN-----------------GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQR------VSIALGAAKGLCHLHSLKP 205 (382)
Q Consensus 149 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~ 205 (382)
... ...++||||++ |+|.+++...+. .+.+..+ ..++.|++.||+|||+.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSKG- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC-
Confidence 433 33799999998 899999986421 2344444 778899999999999988
Q ss_pred CceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCcccccccccCcccccc--CCCCccchhHHHHHHHHHHHhC
Q 016789 206 PLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEES--GVFSEMSDIYSFGVFLLELVTG 283 (382)
Q Consensus 206 ~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~G~vl~el~tg 283 (382)
|+||||||+|||++.++.+||+|||+++....... ...+++.|+|||.+.+ ..++.++|||||||++|||++|
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCCCcc----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 99999999999999999999999999986543221 2334578999999987 6799999999999999999999
Q ss_pred CCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHHHH
Q 016789 284 QEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT--ELERIHE 358 (382)
Q Consensus 284 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~--~L~~i~~ 358 (382)
+.||............ ....................+..+.+++.+||+.||++||++.++++ .++++..
T Consensus 290 ~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWK-----RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp SCSTTBCCTTCTTCCC-----BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred CCCCCCcCcccccchh-----hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 9999754322111000 00000000111111111234567889999999999999999999975 3455443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=352.31 Aligned_cols=239 Identities=21% Similarity=0.234 Sum_probs=197.9
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 156 (382)
.++|...+.||+|+||+||+|.+.. ..+|+|.+.. .....+..|..++..+ +||||+++++++.+.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 3578888899999999999999875 6799998653 2345678899999988 79999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
||||+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 420 V~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEeCcCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999998754 5899999999999999999999988 999999999999999999999999999854
Q ss_pred ccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 237 ENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 237 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
.... .......+|+.|+|||++.+..|+.++|||||||++|||++|+.||.... ...+.+.+....
T Consensus 493 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~---------- 558 (674)
T 3pfq_A 493 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIMEHN---------- 558 (674)
T ss_dssp CCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHSSC----------
T ss_pred ccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC---HHHHHHHHHhCC----------
Confidence 3222 12334567889999999999999999999999999999999999997532 233333222210
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKM 346 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 346 (382)
..++...+..+.+++.+||+.||.+||++
T Consensus 559 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 559 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred -CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 01223344678899999999999999998
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=331.74 Aligned_cols=255 Identities=19% Similarity=0.240 Sum_probs=198.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc--hHHHHHHHHHHhcCC--------CCCccceeeEEE----e
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP--RQEFVAEVTYLSEIR--------HRNLVTLLGYCQ----Q 150 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~--~~~~~~e~~~l~~l~--------h~niv~l~~~~~----~ 150 (382)
++|...+.||+|+||+||+|.... ..||+|.+.... .+.+.+|+.+++.++ ||||+++++++. .
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~ 116 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence 578889999999999999998764 789999987543 356889999999885 788999999987 4
Q ss_pred CCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCCeeecCCC------
Q 016789 151 NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL-KPPLVHKNFKTANVLVDENF------ 223 (382)
Q Consensus 151 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~ivHrDlk~~Nill~~~~------ 223 (382)
....++||||+ +|+|.+.+.... ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++
T Consensus 117 ~~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 117 GTHICMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EEEEEEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHHHH
T ss_pred CceEEEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhhhh
Confidence 56789999999 667777776542 23589999999999999999999986 7 99999999999999775
Q ss_pred -------------------------------------------cEEEeecCCccccccccccCCCcccccccccCccccc
Q 016789 224 -------------------------------------------IAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEE 260 (382)
Q Consensus 224 -------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~ 260 (382)
.+||+|||++...... .....+|+.|+|||.+.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 7999999999866432 23345688899999999
Q ss_pred cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChh---HHHHHHHh-hcCCC-----------ccccc-----c-----
Q 016789 261 SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYE---ALIQWVRS-RLSSN-----------NFVDH-----R----- 315 (382)
Q Consensus 261 ~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~---~~~~~~~~-~~~~~-----------~~~d~-----~----- 315 (382)
+..++.++|||||||++|||++|+.||......... ........ ..... .+... .
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 999999999999999999999999999754433211 11111111 11000 00000 0
Q ss_pred ---------cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 316 ---------LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 316 ---------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
-....+.+.+..+.+++.+||+.||++|||+.|+++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001235677889999999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=323.09 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=192.6
Q ss_pred HHhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccC--CchHHHHHHHHHHhcC-CCCCccceeeEEEe------CCe
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVG--SPRQEFVAEVTYLSEI-RHRNLVTLLGYCQQ------NGY 153 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~~~ 153 (382)
..++|+..+.||+|+||.||+|.+. +..||+|.... .....+.+|+.+++++ +||||+++++++.. .+.
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 4567888999999999999999984 47899998654 3456789999999999 79999999999987 467
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred EEEEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 899999999999999997642 236889999999999999999999987 999999999999999999999999999
Q ss_pred cccccccccCCCcccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEE-----SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS 308 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 308 (382)
........ ......+++.|+|||.+. ...++.++||||||+++|||++|+.||.... .......... ...
T Consensus 177 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~-~~~ 251 (326)
T 2x7f_A 177 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH---PMRALFLIPR-NPA 251 (326)
T ss_dssp C--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHH-SCC
T ss_pred eecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhc-Ccc
Confidence 86643221 122335678899999986 5668999999999999999999999986432 1111111111 111
Q ss_pred CcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 309 NNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 309 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.... ....+..+.+++.+||+.||.+||++.++++
T Consensus 252 ~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 PRLK--------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCS--------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCC--------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111 1122357889999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=313.76 Aligned_cols=246 Identities=21% Similarity=0.302 Sum_probs=198.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------------hHHHHHHHHHHhcCC-CCCccceeeEEEeC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------------RQEFVAEVTYLSEIR-HRNLVTLLGYCQQN 151 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------------~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 151 (382)
++|...+.||+|+||.||+|.+.. ..||+|.+.... .+.+.+|+.+++++. ||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 578888999999999999999864 789999875432 245789999999995 99999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CeEEEEEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999997643 6899999999999999999999988 9999999999999999999999999
Q ss_pred CccccccccccCCCcccccccccCccccc------cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhh
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEE------SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSR 305 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 305 (382)
++........ .....+++.|+|||.+. ...++.++||||||+++|||++|+.||.... ...........
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~ 244 (298)
T 1phk_A 170 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRMIMSG 244 (298)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHT
T ss_pred chhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HHHHHHHHhcC
Confidence 9986644322 22345677899999985 4568899999999999999999999986432 22222222221
Q ss_pred cCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 306 LSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 306 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.. .... ......+..+.+++.+||+.||.+||++.++++
T Consensus 245 ~~--~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NY--QFGS-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CC--CCCT-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Cc--ccCc-----ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 10 0000 111233567889999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=332.11 Aligned_cols=263 Identities=20% Similarity=0.256 Sum_probs=182.4
Q ss_pred hCCCC-CCeeeccCcccEEEEEEC----CeeEEEEEccCCc-hHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEEE
Q 016789 87 KQFSE-TSLIGFGSFGPVYKGLLR----DTVVAIKRRVGSP-RQEFVAEVTYLSEIRHRNLVTLLGYCQQ--NGYQMLVF 158 (382)
Q Consensus 87 ~~~~~-~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 158 (382)
+.|.. .++||+|+||+||+|.+. +..+|+|.+.... ...+.+|+.+|++++||||+++++++.. ....++||
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 34554 568999999999999975 3689999987543 4578899999999999999999999965 67899999
Q ss_pred eecCCCChhhhhhhcCC----CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee----cCCCcEEEeec
Q 016789 159 EYLPNGSMCNHLYETGL----ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV----DENFIAKVADT 230 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill----~~~~~~kl~Df 230 (382)
||+. |+|.+++..... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+||
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 9996 688887764321 12235899999999999999999999988 9999999999999 77899999999
Q ss_pred CCccccccccc--cCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCC-------ChhHHHH
Q 016789 231 GISKLLENIEE--AGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLG-------SYEALIQ 300 (382)
Q Consensus 231 Gla~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~-------~~~~~~~ 300 (382)
|+++....... .......+|+.|+|||++.+. .++.++|||||||++|||++|++||...... ....+..
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 99987654322 122334568889999998874 5999999999999999999999999643321 1122222
Q ss_pred HHHhhcCCCccccccc-----------------CCCCCH---------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 301 WVRSRLSSNNFVDHRL-----------------AGTFTT---------EGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 301 ~~~~~~~~~~~~d~~~-----------------~~~~~~---------~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
............-..+ ...... .....+.+|+.+||+.||.+|||+.|+++-
T Consensus 257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 2221111100000000 000000 013467899999999999999999998863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=316.28 Aligned_cols=247 Identities=19% Similarity=0.275 Sum_probs=194.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC---chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS---PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
+.|+..+.||+|+||.||+|.+.. ..+|+|..... ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 568888999999999999999874 68999986543 3467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 99 PGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp TTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred CCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 9999999887642 35899999999999999999999987 99999999999999999999999999764322111
Q ss_pred cCCCcccccccccCcccc-----ccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 242 AGPSHGSIVNVFRDPEVE-----ESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~-----~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
......+++.|+|||.+ ....++.++||||||+++|||++|+.||.... ............. ...
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~-~~~----- 242 (302)
T 2j7t_A 173 -KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN---PMRVLLKIAKSDP-PTL----- 242 (302)
T ss_dssp -C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCC-CCC-----
T ss_pred -ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC---HHHHHHHHhccCC-ccc-----
Confidence 12233567889999998 46678999999999999999999999987432 1222211111111 111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+...+..+.+++.+||+.||.+||++.++++
T Consensus 243 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 --LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111223467889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=328.85 Aligned_cols=262 Identities=18% Similarity=0.268 Sum_probs=194.1
Q ss_pred HHHHHHHHhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCCc--------------hHHHHHHHHHHhcCCCCCccc
Q 016789 79 MEELEQATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP--------------RQEFVAEVTYLSEIRHRNLVT 143 (382)
Q Consensus 79 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~--------------~~~~~~e~~~l~~l~h~niv~ 143 (382)
..++....++|...+.||+|+||.||+|.... ..||+|++.... .+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 56777888999999999999999999998765 789999864311 156899999999999999999
Q ss_pred eeeEEEeC-----CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCee
Q 016789 144 LLGYCQQN-----GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVL 218 (382)
Q Consensus 144 l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nil 218 (382)
+++++... ...++||||++ |+|.+.+... ...+++..+..++.|++.||.|||+.+ |+||||||+|||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl 166 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNIL 166 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEE
Confidence 99998543 36899999997 7888888743 236899999999999999999999988 999999999999
Q ss_pred ecCCCcEEEeecCCccccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhH
Q 016789 219 VDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEA 297 (382)
Q Consensus 219 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~ 297 (382)
++.++.+||+|||++........ .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~ 242 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF--YNQ 242 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHH
T ss_pred EcCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH--HHH
Confidence 99999999999999975433221 223456778999999876 6799999999999999999999999975321 111
Q ss_pred HHHHHHhhcCCC-------------cccccccC---C----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 298 LIQWVRSRLSSN-------------NFVDHRLA---G----TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 298 ~~~~~~~~~~~~-------------~~~d~~~~---~----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+........... +....... . ......+..+.+++.+||+.||.+|||+.++++
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 111111100000 00000000 0 001122456889999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=319.00 Aligned_cols=255 Identities=20% Similarity=0.240 Sum_probs=185.9
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCch-----HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSPR-----QEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
.++|+..+.||+|+||+||++... +..+|+|.+..... ..+.++...++.++||||+++++++...+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 357888999999999999999984 48999998765321 22344555688889999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL-KPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
||++ |+|.+++.... .....+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9996 58888776421 1234689999999999999999999986 7 9999999999999999999999999998664
Q ss_pred cccccCCCcccccccccCcccc----ccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccc
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVE----ESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVD 313 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (382)
.... .....+++.|+|||.+ ....++.++||||||+++|||++|+.||..... ....+........ ...
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~--~~~-- 234 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-PFQQLKQVVEEPS--PQL-- 234 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-HHHHHHHHHHSCC--CCC--
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-hHHHHHHHhccCC--CCc--
Confidence 4322 2223567889999996 556789999999999999999999999964321 1222222222111 110
Q ss_pred cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHHH
Q 016789 314 HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT--ELERIH 357 (382)
Q Consensus 314 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~--~L~~i~ 357 (382)
.....+..+.+++.+||+.||.+|||+.++++ .+....
T Consensus 235 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 235 ------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp ------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 01123456889999999999999999999987 444433
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=325.44 Aligned_cols=251 Identities=19% Similarity=0.255 Sum_probs=187.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCC------e
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG------Y 153 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~ 153 (382)
++|...+.||+|+||.||+|.... ..||+|++... ....+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 568888999999999999998764 78999987542 1246889999999999999999999997664 7
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.++||||++ |+|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred eEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 899999996 578888752 4788999999999999999999988 999999999999999999999999999
Q ss_pred cccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC-----
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS----- 308 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----- 308 (382)
+...... ......+++.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+......
T Consensus 175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHC-CCCCCHHH
T ss_pred ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHH
Confidence 8654322 12234567889999999999999999999999999999999999975321 1111111110000
Q ss_pred ---------------Ccc--------cccccCCC---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 309 ---------------NNF--------VDHRLAGT---FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 309 ---------------~~~--------~d~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
... ........ .....+..+.+++.+||+.||.+|||+.|+++-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000 00000000 012336788999999999999999999999873
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.97 Aligned_cols=256 Identities=22% Similarity=0.294 Sum_probs=191.1
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCchHHHHHHHHHHhcCCCCCccceeeEEEeC------CeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQN------GYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 158 (382)
..|...+.||+|+||.||+|.+. +..||+|++.... ..+.+|+++|++++||||+++++++... ...++||
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 35888899999999999999986 4789999875432 3345799999999999999999998542 2367899
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC-CcEEEeecCCccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN-FIAKVADTGISKLLE 237 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~-~~~kl~DfGla~~~~ 237 (382)
||+++ +|.+.+.... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 133 e~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp ECCCE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred hcccc-cHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99975 6666654321 12346899999999999999999999987 9999999999999965 678999999998764
Q ss_pred cccccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC--------
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS-------- 308 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 308 (382)
.... .....+++.|+|||++.+. .++.++|||||||++|||++|+.||.... ....+.+........
T Consensus 209 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~--~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 209 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp TTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHHhh
Confidence 3322 2234567889999998764 69999999999999999999999997532 222333222211100
Q ss_pred ----CcccccccCCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 309 ----NNFVDHRLAGT-----FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 309 ----~~~~d~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.++..+.+... +....+..+.+|+.+||+.||.+||++.|+++
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 01111111100 11223467889999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=312.98 Aligned_cols=247 Identities=21% Similarity=0.219 Sum_probs=193.9
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-------chHHHHHHHHHHhcCCCCCccceeeEEE--eCCee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-------PRQEFVAEVTYLSEIRHRNLVTLLGYCQ--QNGYQ 154 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~ 154 (382)
.++|...+.||+|+||.||++.... ..+|+|.+... ....+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 3679999999999999999999864 68999986532 2457899999999999999999999984 44578
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
++||||+++| |.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 777776542 346899999999999999999999987 9999999999999999999999999998
Q ss_pred cccccccc-CCCcccccccccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcc
Q 016789 235 LLENIEEA-GPSHGSIVNVFRDPEVEESGV--FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 235 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (382)
........ ......+++.|+|||.+.+.. ++.++||||||+++|||++|+.||.... .....+.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~~~~----- 229 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLFENIGKGS----- 229 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCC-----
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHHhcCC-----
Confidence 66432211 122345678899999987644 4789999999999999999999997432 222222222211
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
. ..+...+..+.+++.+||+.||.+||++.++++.
T Consensus 230 --~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 --Y----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --C----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --C----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 1122234567899999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=321.01 Aligned_cols=255 Identities=21% Similarity=0.253 Sum_probs=198.1
Q ss_pred hCCCCCCeeeccCcccEEEEEE---CCeeEEEEEccCCc--hHHHHHHHHHHhcCCCC------CccceeeEEEeCCeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLL---RDTVVAIKRRVGSP--RQEFVAEVTYLSEIRHR------NLVTLLGYCQQNGYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~--~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~~~~ 155 (382)
++|+..+.||+|+||.||+|.. .+..||+|.+.... .+.+.+|+.+++.++|+ +++++++++...+..+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 4688899999999999999987 34789999986543 35688899999888655 5999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC--------------
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-------------- 221 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-------------- 221 (382)
+||||+ +++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEcCC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCccccc
Confidence 999999 899999997653 235889999999999999999999987 999999999999987
Q ss_pred -----CCcEEEeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChh
Q 016789 222 -----NFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYE 296 (382)
Q Consensus 222 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~ 296 (382)
++.+||+|||+++..... .....+++.|+|||.+.+..++.++|||||||++|||++|+.||......+..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 668999999999864332 22345678899999999999999999999999999999999999754322111
Q ss_pred HHHHHHHhhcC--------CCccc-ccc---------------------cCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 016789 297 ALIQWVRSRLS--------SNNFV-DHR---------------------LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKM 346 (382)
Q Consensus 297 ~~~~~~~~~~~--------~~~~~-d~~---------------------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 346 (382)
........... ..... +.. -........+..+.+++.+||+.||.+|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 11111110000 00000 000 0011234557889999999999999999999
Q ss_pred HHHHH
Q 016789 347 EIVMT 351 (382)
Q Consensus 347 ~~v~~ 351 (382)
.|+++
T Consensus 324 ~ell~ 328 (339)
T 1z57_A 324 REALK 328 (339)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=318.37 Aligned_cols=248 Identities=19% Similarity=0.225 Sum_probs=193.7
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----------hHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----------RQEFVAEVTYLSEIRHRNLVTLLGYCQQN 151 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 151 (382)
..++|...+.||+|+||.||+|.+.. ..||+|.+.... ...+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 34679999999999999999999865 789999865321 23588999999999999999999998766
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc---EEEe
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI---AKVA 228 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~---~kl~ 228 (382)
+ .++||||+++|+|.+++... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 89999999999999988653 36899999999999999999999988 999999999999987654 9999
Q ss_pred ecCCccccccccccCCCcccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhh
Q 016789 229 DTGISKLLENIEEAGPSHGSIVNVFRDPEVEE---SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSR 305 (382)
Q Consensus 229 DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 305 (382)
|||++........ .....+++.|+|||.+. ...++.++||||||+++|||++|+.||...... ..+.......
T Consensus 160 Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~ 235 (322)
T 2ycf_A 160 DFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQITSG 235 (322)
T ss_dssp CCTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--SCHHHHHHHT
T ss_pred cCccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--HHHHHHHHhC
Confidence 9999986643221 11234677899999974 566899999999999999999999999754322 1222222211
Q ss_pred cCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 306 LSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 306 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. .. . .+... ...+..+.+++.+||+.||.+||++.++++
T Consensus 236 ~-~~-~-~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 K-YN-F-IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp C-CC-C-CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c-cc-c-Cchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1 00 0 00000 112467889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=322.11 Aligned_cols=265 Identities=22% Similarity=0.243 Sum_probs=187.6
Q ss_pred HHHHHHHhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCe--
Q 016789 80 EELEQATKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGY-- 153 (382)
Q Consensus 80 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-- 153 (382)
.......++|...+.||+|+||.||+|.+. +..||+|++... ....+.+++..+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 445666789999999999999999999986 478999986543 23467788888999999999999999976433
Q ss_pred -----eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHh--cCCCCceecCCCCCCeeecC-CCcE
Q 016789 154 -----QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH--SLKPPLVHKNFKTANVLVDE-NFIA 225 (382)
Q Consensus 154 -----~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~ivHrDlk~~Nill~~-~~~~ 225 (382)
.++||||+++ +|.+.+.... .....+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcE
Confidence 7899999976 5555444321 12346888999999999999999999 666 999999999999997 8999
Q ss_pred EEeecCCccccccccccCCCcccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh
Q 016789 226 KVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGV-FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS 304 (382)
Q Consensus 226 kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 304 (382)
||+|||+++....... .....+++.|+|||.+.+.. ++.++|||||||++|||++|+.||..... ...+......
T Consensus 172 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~~~~~ 247 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS--AGQLHEIVRV 247 (360)
T ss_dssp EECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHH
T ss_pred EEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh--HHHHHHHHHH
Confidence 9999999987654332 22335678899999986554 89999999999999999999999975332 2222222221
Q ss_pred hcCCC-----------cccccc---------cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 305 RLSSN-----------NFVDHR---------LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 305 ~~~~~-----------~~~d~~---------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
..... ...+.. .........+..+.+++.+||+.||.+|||+.|+++-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11100 000000 0011122246789999999999999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=326.80 Aligned_cols=251 Identities=19% Similarity=0.266 Sum_probs=177.8
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeC------Ce
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN------GY 153 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 153 (382)
++|...+.||+|+||.||+|.+.. ..||+|++... ....+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 578889999999999999998754 78999997543 134678999999999999999999999754 56
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 109 ~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC----
T ss_pred EEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 79999999 7899888754 25899999999999999999999988 999999999999999999999999999
Q ss_pred cccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCc-c
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNN-F 311 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~ 311 (382)
+..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+............ .
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCSCCHHH
T ss_pred cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHH
Confidence 865432 223456788999999876 6799999999999999999999999975332 1111111111111100 0
Q ss_pred ccc-----------ccC--CCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 312 VDH-----------RLA--GTFT-----TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 312 ~d~-----------~~~--~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
... .+. .... ...+..+.+++.+||+.||.+|||+.++++-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 000 0000 1123567899999999999999999999863
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=320.59 Aligned_cols=254 Identities=17% Similarity=0.215 Sum_probs=195.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeC-----CeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQN-----GYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 155 (382)
.+|+..+.||+|+||.||+|.... ..||+|.+.... ...+.+|++++++++||||+++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 568889999999999999998764 789999876432 24688999999999999999999999754 3689
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+||||+. |+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 9999996 6999988653 4889999999999999999999988 99999999999999999999999999987
Q ss_pred cccccccC--CCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCc-c
Q 016789 236 LENIEEAG--PSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNN-F 311 (382)
Q Consensus 236 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~ 311 (382)
........ .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+. +............ .
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILGSPSQED 255 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH--HHHHHHHHCSCCHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH--HHHHHHHhCCCCHHH
Confidence 65433222 233467888999998654 4589999999999999999999999975432221 1111111000000 0
Q ss_pred c------------cc-ccCCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 312 V------------DH-RLAGTF-----TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 312 ~------------d~-~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. .. ...... ....+..+.+++.+||+.||.+|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00 000000 0122456889999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=333.87 Aligned_cols=251 Identities=20% Similarity=0.277 Sum_probs=186.9
Q ss_pred CCCCCeeeccCcccEEEE-EECCeeEEEEEccCCchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeecCCCCh
Q 016789 89 FSETSLIGFGSFGPVYKG-LLRDTVVAIKRRVGSPRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~-~~~~~~vavK~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 166 (382)
|...+.||+|+||+||.+ ...+..||+|++.....+.+.+|+.++.++ +||||+++++++.+.+..++|||||. |+|
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 445678999999999654 445689999998766667788999999876 89999999999999999999999995 799
Q ss_pred hhhhhhcCCCCC--CcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC-------------CcEEEeecC
Q 016789 167 CNHLYETGLESS--TKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN-------------FIAKVADTG 231 (382)
Q Consensus 167 ~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~-------------~~~kl~DfG 231 (382)
.+++........ ....+..++.++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 999976542111 11133345789999999999999988 9999999999999654 589999999
Q ss_pred Ccccccccccc---CCCcccccccccCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHH
Q 016789 232 ISKLLENIEEA---GPSHGSIVNVFRDPEVEES-------GVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQ 300 (382)
Q Consensus 232 la~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~ 300 (382)
+++........ ......+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||..... ....
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----~~~~ 249 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS----RESN 249 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT----HHHH
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh----hHHH
Confidence 99876543221 1223467889999999865 668999999999999999999 8999864321 1112
Q ss_pred HHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 301 WVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 301 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
......... ..........+..+.+++.+||+.||.+||++.++++
T Consensus 250 i~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 250 IIRGIFSLD-----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHTCCCCC-----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhcCCCCcc-----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 222211111 1111224567788999999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=330.98 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=190.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCCchHHHHHHHHHHhcCCCCCccceeeEEEeCC------eeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG------YQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e 159 (382)
.+|...+.||+|+||.||+|.+.. ..+|+|+..... ....+|+++|+.++||||+++++++...+ ..++|||
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~-~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc-chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 468888999999999999999865 568888765432 22347999999999999999999996543 3789999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec-CCCcEEEeecCCcccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD-ENFIAKVADTGISKLLEN 238 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~-~~~~~kl~DfGla~~~~~ 238 (382)
|++++ +.+.+.... .....+++..+..++.|++.||+|||+.+ |+||||||+|||++ .++.+||+|||+++....
T Consensus 119 ~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 119 YVPET-VYRASRHYA-KLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp CCSEE-HHHHHHHHH-HTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ccCcc-HHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 99765 444333211 11236899999999999999999999988 99999999999999 799999999999987643
Q ss_pred ccccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC--------
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN-------- 309 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 309 (382)
... .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.... ....+...........
T Consensus 195 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 195 GEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES--GIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp TCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred CCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCCHHHHHhhC
Confidence 322 2234567889999998765 59999999999999999999999997543 2222222222111100
Q ss_pred -cccccccC--------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 310 -NFVDHRLA--------GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 310 -~~~d~~~~--------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
......+. ..+....+..+.+++.+||+.||.+|||+.++++-
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000 00112234678899999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=311.35 Aligned_cols=249 Identities=18% Similarity=0.309 Sum_probs=190.3
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc--hHHHHHHHHHHhcCCCCCccceeeEEEe-----------
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP--RQEFVAEVTYLSEIRHRNLVTLLGYCQQ----------- 150 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~----------- 150 (382)
.++|+..+.||+|+||.||+|... +..+|+|.+.... .+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 457888999999999999999975 4789999875432 3568899999999999999999998865
Q ss_pred --CCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEe
Q 016789 151 --NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVA 228 (382)
Q Consensus 151 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~ 228 (382)
....++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEEC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEe
Confidence 346799999999999999997642 35788899999999999999999987 9999999999999999999999
Q ss_pred ecCCccccccccc-------------cCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCC
Q 016789 229 DTGISKLLENIEE-------------AGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGS 294 (382)
Q Consensus 229 DfGla~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~ 294 (382)
|||++........ .......+++.|+|||.+.+. .++.++||||||+++|||++ |+... .+
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~ 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--ME 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hh
Confidence 9999986643211 111233467789999999764 68999999999999999998 44311 11
Q ss_pred hhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 295 YEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
........... . ..+....+...+..+.+++.+||+.||.+||++.++++.
T Consensus 234 ~~~~~~~~~~~---~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RVNILKKLRSV---S----IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHHST---T----CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhcccc---c----cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11222222111 1 111122333445678899999999999999999999873
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=320.33 Aligned_cols=197 Identities=26% Similarity=0.270 Sum_probs=166.8
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc--hHHHHHHHHHHhcCC-CC-----CccceeeEEEeCCeeE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP--RQEFVAEVTYLSEIR-HR-----NLVTLLGYCQQNGYQM 155 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~--~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~~~ 155 (382)
.++|...+.||+|+||+||+|.... ..||+|.+.... ...+..|+.+++.++ |+ +|+++++++...+..+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 4678889999999999999998864 789999987543 346777888888874 44 4999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec--CCCcEEEeecCCc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD--ENFIAKVADTGIS 233 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~--~~~~~kl~DfGla 233 (382)
+||||++ |+|.+++.... ...+++..+..++.|++.||.|||+...+|+||||||+|||++ .++.+||+|||++
T Consensus 133 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEECCC-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEecCC-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 9999995 59999998653 2358999999999999999999996444599999999999994 5788999999999
Q ss_pred cccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIV 290 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~ 290 (382)
+..... .....+++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 866432 22345678899999999999999999999999999999999999753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=316.99 Aligned_cols=256 Identities=21% Similarity=0.274 Sum_probs=195.8
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC---CeeEEEEEccCC-----chHHHHHHHHHHhcC---CCCCccceeeEEE-----
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR---DTVVAIKRRVGS-----PRQEFVAEVTYLSEI---RHRNLVTLLGYCQ----- 149 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~-----~~~~~~~e~~~l~~l---~h~niv~l~~~~~----- 149 (382)
.++|+..+.||+|+||.||+|.+. +..||+|.+... ....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 467889999999999999999984 378999976422 224577888777766 8999999999987
Q ss_pred eCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEee
Q 016789 150 QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVAD 229 (382)
Q Consensus 150 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~D 229 (382)
.....++||||++ |+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCceEEEEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999997 69999997653 235899999999999999999999988 99999999999999999999999
Q ss_pred cCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC
Q 016789 230 TGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN 309 (382)
Q Consensus 230 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 309 (382)
||++........ .....+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ...+...........
T Consensus 164 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 164 FGLARIYSFQMA--LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLPG 239 (326)
T ss_dssp CCSCCCCCGGGG--GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCC
T ss_pred CcccccccCCCC--ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHHcCCCC
Confidence 999987653321 2234567889999999999999999999999999999999999974332 112212111111000
Q ss_pred --c----cc--cccc-------CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 --N----FV--DHRL-------AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 --~----~~--d~~~-------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. .. ...+ ........+..+.+++.+||+.||.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00 0000 00111233467889999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=319.07 Aligned_cols=252 Identities=20% Similarity=0.266 Sum_probs=175.5
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc----hHHHHHHHH-HHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP----RQEFVAEVT-YLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
++|...+.||+|+||.||+|... +..||+|.+.... ...+..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 56888899999999999999987 5899999876532 234555655 7778899999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL-KPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
|++ |+|.+++..........+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 997 5888777642212234689999999999999999999987 7 99999999999999999999999999986643
Q ss_pred ccccCCCcccccccccCcccc----ccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 239 IEEAGPSHGSIVNVFRDPEVE----ESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
... .....+++.|+|||.+ .+..++.++||||||+++|||++|+.||...... .+....... ...+
T Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~---~~~~ 248 (327)
T 3aln_A 179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----FDQLTQVVK---GDPP 248 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCC---SCCC
T ss_pred ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----HHHHHHHhc---CCCC
Confidence 221 2223567889999998 4566899999999999999999999999643210 010100000 0001
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+........+..+.+++.+||+.||.+||++.++++
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 1111111233467889999999999999999999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=322.98 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=190.7
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCee----
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQ---- 154 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---- 154 (382)
.++|...+.||+|+||.||+|.+.. ..||+|.+.... ...+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3578888999999999999998864 799999876432 24688999999999999999999999877654
Q ss_pred --EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCC
Q 016789 155 --MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGI 232 (382)
Q Consensus 155 --~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGl 232 (382)
++||||+. |+|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999996 688777632 4899999999999999999999987 99999999999999999999999999
Q ss_pred ccccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCc-
Q 016789 233 SKLLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNN- 310 (382)
Q Consensus 233 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 310 (382)
++..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+............
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVPGTE 264 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCCHH
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCcHH
Confidence 9865432 223355788999999877 6799999999999999999999999974321 1122221111111000
Q ss_pred ccc---------------cccCCC---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 311 FVD---------------HRLAGT---FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 311 ~~d---------------~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
... ...... .....+..+.+++.+||+.||.+|||+.|+++-
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000 000000 011224678899999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=316.07 Aligned_cols=253 Identities=19% Similarity=0.313 Sum_probs=186.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEE------------
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQ------------ 149 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~------------ 149 (382)
++|...+.||+|+||.||+|.... ..||+|.+.... .+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 568888999999999999999874 789999876543 346889999999999999999999873
Q ss_pred --eCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec-CCCcEE
Q 016789 150 --QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD-ENFIAK 226 (382)
Q Consensus 150 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~-~~~~~k 226 (382)
.....++||||++ |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999997 6999988542 5888999999999999999999988 99999999999997 567999
Q ss_pred EeecCCcccccccccc--CCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHH
Q 016789 227 VADTGISKLLENIEEA--GPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVR 303 (382)
Q Consensus 227 l~DfGla~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~ 303 (382)
|+|||+++........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||..... ....+...
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE---LEQMQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHH
Confidence 9999999876432211 1233445778999998865 6799999999999999999999999975332 11111111
Q ss_pred hhcCCC-------------cccccccCC-C-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 304 SRLSSN-------------NFVDHRLAG-T-----FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 304 ~~~~~~-------------~~~d~~~~~-~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...... ......... . .....+..+.+++.+||+.||.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 111000 000000000 0 01123467889999999999999999999976
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=318.09 Aligned_cols=254 Identities=19% Similarity=0.244 Sum_probs=193.0
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeC-----CeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQN-----GYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 155 (382)
++|...+.||+|+||.||+|.+. +..||+|.+.... ...+.+|+.++++++||||+++++++... ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 56888899999999999999987 4789999876432 24678999999999999999999988754 6789
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+||||+. |+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 91 lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEECCCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEeccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 9999996 6999988753 5889999999999999999999987 99999999999999999999999999987
Q ss_pred ccccccc---------CCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhh
Q 016789 236 LENIEEA---------GPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSR 305 (382)
Q Consensus 236 ~~~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 305 (382)
....... ......+++.|+|||.+.. ..++.++|||||||++|||++|+.||...... ..+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~ 239 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR--HQLLLIFGII 239 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHh
Confidence 6432211 1122356788999998754 67999999999999999999999999754321 1111111111
Q ss_pred cCCCcccc------c-------ccC--CCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 306 LSSNNFVD------H-------RLA--GTF-----TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 306 ~~~~~~~d------~-------~~~--~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.......+ . .+. ... ....+..+.+++.+||+.||.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 10000000 0 000 000 0123467889999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=306.23 Aligned_cols=248 Identities=19% Similarity=0.257 Sum_probs=198.8
Q ss_pred HHHhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccC-----CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 84 QATKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVG-----SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 84 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
...++|...+.||+|+||.||+|... +..+|+|.+.. .....+.+|++++++++||||+++++++...+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34568999999999999999999986 47899998643 234678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCC---CcEEEeecCCc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN---FIAKVADTGIS 233 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~---~~~kl~DfGla 233 (382)
|+||+++++|.+.+.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999987653 5889999999999999999999987 9999999999999754 47999999999
Q ss_pred cccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccc
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVD 313 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (382)
........ .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.... .......+.........
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~-- 243 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAFDL-- 243 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCS--
T ss_pred eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCc--
Confidence 86543221 223346778999999875 48999999999999999999999997432 22333322221111000
Q ss_pred cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 314 HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 314 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+. ....+..+.+++.+||+.||.+||++.++++
T Consensus 244 ~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 244 PQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp GG-----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hh-----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 0122456889999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=322.95 Aligned_cols=255 Identities=18% Similarity=0.245 Sum_probs=196.7
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc--hHHHHHHHHHHhcCC-----------CCCccceeeEEEeC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP--RQEFVAEVTYLSEIR-----------HRNLVTLLGYCQQN 151 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~ 151 (382)
.+|...+.||+|+||+||+|... +..||+|.+.... ...+.+|+.++++++ ||||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 46888899999999999999975 4799999987543 356888999998886 89999999998865
Q ss_pred C----eeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCCeeec------
Q 016789 152 G----YQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL-KPPLVHKNFKTANVLVD------ 220 (382)
Q Consensus 152 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~ivHrDlk~~Nill~------ 220 (382)
+ ..++||||+ +++|.+++.... ...+++..+..++.|++.||.|||+. + |+||||||+|||++
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTT
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCCCc
Confidence 4 789999999 899999997643 23589999999999999999999996 7 99999999999994
Q ss_pred CCCcEEEeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCC----hh
Q 016789 221 ENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS----YE 296 (382)
Q Consensus 221 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~----~~ 296 (382)
..+.+||+|||++...... .....+++.|+|||.+.+..++.++|||||||++|||++|+.||....... ..
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4458999999999866432 223456788999999999999999999999999999999999997543221 11
Q ss_pred HHHHHHHhhcCCCc-----------------cccc-------------ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 016789 297 ALIQWVRSRLSSNN-----------------FVDH-------------RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKM 346 (382)
Q Consensus 297 ~~~~~~~~~~~~~~-----------------~~d~-------------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~ 346 (382)
.+.+.......... .... .-....+...+..+.+++.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 11111111111000 0000 00113456778899999999999999999999
Q ss_pred HHHHH
Q 016789 347 EIVMT 351 (382)
Q Consensus 347 ~~v~~ 351 (382)
.|+++
T Consensus 329 ~ell~ 333 (373)
T 1q8y_A 329 GGLVN 333 (373)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=317.66 Aligned_cols=262 Identities=18% Similarity=0.205 Sum_probs=200.6
Q ss_pred hCCCCCCeeeccCcccEEEEEECC---eeEEEEEccCCc--hHHHHHHHHHHhcCCCCC------ccceeeEEEeCCeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD---TVVAIKRRVGSP--RQEFVAEVTYLSEIRHRN------LVTLLGYCQQNGYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~---~~vavK~~~~~~--~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~~~ 155 (382)
++|...+.||+|+||+||+|.... ..||+|.+.... .+.+.+|+.++++++|+| ++.+++++...+..+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 578889999999999999998753 689999986543 356888999999987655 999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeee----------------
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLV---------------- 219 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill---------------- 219 (382)
+||||+ ++++.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 99 lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEecc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccccccccc
Confidence 999999 677888776542 235899999999999999999999987 9999999999999
Q ss_pred ---cCCCcEEEeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChh
Q 016789 220 ---DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYE 296 (382)
Q Consensus 220 ---~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~ 296 (382)
+.++.+||+|||+++..... .....+++.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--- 245 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR--- 245 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 56889999999999864332 22345678899999999999999999999999999999999999753321
Q ss_pred HHHHHHHh-hcCCCc----------c-cccc---------------------cCCCCCHHHHHHHHHHHhhccCCCCCCC
Q 016789 297 ALIQWVRS-RLSSNN----------F-VDHR---------------------LAGTFTTEGMRDLIRLTLQCMSSPGRRR 343 (382)
Q Consensus 297 ~~~~~~~~-~~~~~~----------~-~d~~---------------------~~~~~~~~~~~~l~~l~~~cl~~dp~~R 343 (382)
........ ...... . .... .........+..+.+++.+||+.||++|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 11111111 110000 0 0000 0001123446688999999999999999
Q ss_pred CCHHHHHH--HHHHHHHhhh
Q 016789 344 PKMEIVMT--ELERIHEKEM 361 (382)
Q Consensus 344 Ps~~~v~~--~L~~i~~~~~ 361 (382)
||+.++++ .+.++..++-
T Consensus 326 pt~~e~l~hp~f~~~~~~~~ 345 (355)
T 2eu9_A 326 ITLAEALLHPFFAGLTPEER 345 (355)
T ss_dssp CCHHHHTTSGGGGGCCHHHH
T ss_pred cCHHHHhcChhhcCCChhhc
Confidence 99999984 3444444433
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=315.92 Aligned_cols=248 Identities=19% Similarity=0.254 Sum_probs=190.6
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC-----chHHHHHHHHHHhcCC--CCCccceeeEEEeCCeeEE
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS-----PRQEFVAEVTYLSEIR--HRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~-----~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~l 156 (382)
..++|...+.||+|+||.||++.... ..+|+|.+... ..+.+.+|+.++.+++ ||||+++++++...+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 34678889999999999999998865 68999987532 1356889999999997 5999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
||| +.+++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||+++ +.+||+|||++...
T Consensus 106 v~e-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEC-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEe-cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 999 56889999998643 6889999999999999999999987 999999999999964 89999999999876
Q ss_pred ccccccC-CCcccccccccCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh
Q 016789 237 ENIEEAG-PSHGSIVNVFRDPEVEES-----------GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS 304 (382)
Q Consensus 237 ~~~~~~~-~~~~~~~~~y~aPE~~~~-----------~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~ 304 (382)
....... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ..........
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~~~~~- 254 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID- 254 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-HHHHHHHHHC-
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-HHHHHHHHHh-
Confidence 5432221 223456788999999875 4688999999999999999999999964321 1111111111
Q ss_pred hcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 305 RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 305 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
+......+...+..+.+++.+||+.||.+||++.++++.
T Consensus 255 ---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 255 ---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111112224568889999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=327.46 Aligned_cols=247 Identities=20% Similarity=0.260 Sum_probs=185.3
Q ss_pred hCCCCCCeeeccCccc-EEEEEECCeeEEEEEccCCchHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEEeecCCC
Q 016789 87 KQFSETSLIGFGSFGP-VYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVFEYLPNG 164 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~-V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 164 (382)
.+|...+.||+|+||+ ||++...++.||||++.......+.+|+.+|+++ +||||+++++++.+....++|||||. |
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g 102 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence 4577788999999999 5556666789999998776666678999999999 79999999999999999999999995 6
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC-----CCcEEEeecCCccccccc
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-----NFIAKVADTGISKLLENI 239 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-----~~~~kl~DfGla~~~~~~ 239 (382)
+|.+++..... .........++.|++.||.|||+.+ |+||||||+|||++. ...+||+|||+++.....
T Consensus 103 ~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 103 TLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp EHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred CHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 99999976532 2333345689999999999999988 999999999999943 346889999999876543
Q ss_pred cc--cCCCcccccccccCccccc---cCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccc
Q 016789 240 EE--AGPSHGSIVNVFRDPEVEE---SGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVD 313 (382)
Q Consensus 240 ~~--~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (382)
.. .......+|+.|+|||.+. ...++.++|||||||++|||++ |..||.... ............. ..
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~----~~~~~~~~~~~~~-~~-- 249 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL----QRQANILLGACSL-DC-- 249 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT----THHHHHHTTCCCC-TT--
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh----HHHHHHHhccCCc-cc--
Confidence 21 1223345788999999997 4567889999999999999999 888885322 1111111111110 00
Q ss_pred cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 314 HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 314 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. .........+.+++.+||+.||.+||++.++++
T Consensus 250 --~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 --L--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp --S--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --c--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 112234556789999999999999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=316.49 Aligned_cols=248 Identities=20% Similarity=0.271 Sum_probs=189.8
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCe------
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGY------ 153 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------ 153 (382)
++|...+.||+|+||.||+|.+. +..||+|.+.... ...+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 46888899999999999999986 4799999875432 2467899999999999999999999987654
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.++||||+. |+|.+++.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999996 688777632 4889999999999999999999988 999999999999999999999999999
Q ss_pred cccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC----
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS---- 308 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---- 308 (382)
+..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+..........
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH--HHHHHHHHHHHCBCCHHH
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHH
Confidence 865432 223356788999999876 6789999999999999999999999975332 11111111110000
Q ss_pred ----------------CcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 309 ----------------NNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 309 ----------------~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.....+.+ .......+..+.+++.+||+.||.+||++.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 0112234567889999999999999999999886
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=317.79 Aligned_cols=250 Identities=17% Similarity=0.243 Sum_probs=170.7
Q ss_pred hCCCCC-CeeeccCcccEEEEEEC--CeeEEEEEccCCchHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEEEe
Q 016789 87 KQFSET-SLIGFGSFGPVYKGLLR--DTVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQ----NGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~-~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e 159 (382)
++|... ++||+|+||+||+|.+. +..||+|.+.... ....+....++.++||||+++++++.. ....++|||
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 106 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEe
Confidence 567774 46999999999999987 4799999876542 222223344667799999999999876 445899999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC---CCcEEEeecCCcccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE---NFIAKVADTGISKLL 236 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~---~~~~kl~DfGla~~~ 236 (382)
|+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 107 ~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 107 CMEGGELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp CCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 999999999998643 246899999999999999999999987 999999999999976 456999999999865
Q ss_pred ccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 237 ENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 237 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
.... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||........... ......... ...
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~---~~~ 252 (336)
T 3fhr_A 182 TQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLGQ---YGF 252 (336)
T ss_dssp -------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------CC
T ss_pred cccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhccc---ccc
Confidence 4321 2234557889999999888899999999999999999999999964432211100 000000000 001
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
........+..+.+++.+||+.||.+||++.++++
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111233467889999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=316.57 Aligned_cols=240 Identities=24% Similarity=0.342 Sum_probs=187.7
Q ss_pred HHHHHhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc---------hHHHHHHHHHHhcC----CCCCccceee
Q 016789 82 LEQATKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP---------RQEFVAEVTYLSEI----RHRNLVTLLG 146 (382)
Q Consensus 82 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---------~~~~~~e~~~l~~l----~h~niv~l~~ 146 (382)
.....++|...+.||+|+||.||+|.+. +..||+|.+.... ...+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445578999999999999999999875 3789999875432 23456789999888 8999999999
Q ss_pred EEEeCCeeEEEEee-cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec-CCCc
Q 016789 147 YCQQNGYQMLVFEY-LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD-ENFI 224 (382)
Q Consensus 147 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~-~~~~ 224 (382)
++...+..++|+|| +.+++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++ .++.
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCe
Confidence 99999999999999 78999999998653 5899999999999999999999987 99999999999999 8899
Q ss_pred EEEeecCCccccccccccCCCcccccccccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHH
Q 016789 225 AKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFS-EMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVR 303 (382)
Q Consensus 225 ~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~ 303 (382)
+||+|||++....... .....++..|+|||.+.+..+. .++||||||+++|||++|+.||... ... ..
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~---~~ 247 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----QEI---LE 247 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHH---HH
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----HHH---hh
Confidence 9999999998765422 2234567889999998877664 5899999999999999999998632 111 11
Q ss_pred hhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 304 SRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 304 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
... ..+...+..+.+++.+||+.||++||++.++++
T Consensus 248 ~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 248 AEL------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp TCC------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hcc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 112223456889999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=319.47 Aligned_cols=239 Identities=22% Similarity=0.342 Sum_probs=194.8
Q ss_pred HHHHhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC---------chHHHHHHHHHHhcCC--CCCccceeeEEE
Q 016789 83 EQATKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS---------PRQEFVAEVTYLSEIR--HRNLVTLLGYCQ 149 (382)
Q Consensus 83 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---------~~~~~~~e~~~l~~l~--h~niv~l~~~~~ 149 (382)
....++|...+.||+|+||.||+|... +..||+|.+... ....+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344567999999999999999999875 478999986532 1245778999999996 599999999999
Q ss_pred eCCeeEEEEeecCC-CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec-CCCcEEE
Q 016789 150 QNGYQMLVFEYLPN-GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD-ENFIAKV 227 (382)
Q Consensus 150 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~-~~~~~kl 227 (382)
..+..++|+||+.+ ++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++ +++.+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999976 89999997643 6889999999999999999999988 99999999999999 7899999
Q ss_pred eecCCccccccccccCCCcccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhc
Q 016789 228 ADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVF-SEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 228 ~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
+|||++....... .....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||... ... .....
T Consensus 192 ~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-----~~~---~~~~~ 260 (320)
T 3a99_A 192 IDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EEI---IRGQV 260 (320)
T ss_dssp CCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHH---HHCCC
T ss_pred eeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh-----hhh---hcccc
Confidence 9999998765322 223456788999999987765 68899999999999999999998632 111 11110
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 307 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.. +...+..+.+++.+||+.||.+||++.++++
T Consensus 261 --------~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 --------FF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --------CC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------cc----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01 1122356889999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=303.79 Aligned_cols=246 Identities=20% Similarity=0.248 Sum_probs=174.5
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCch-----HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSPR-----QEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~-----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
++|...+.||+|+||.||+|.+. +..||+|.+..... ..+.++..+++.++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 56888899999999999999986 47999998765322 223444557888899999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-CCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL-KPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
|+ ++.+....... ...+++..+..++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++.....
T Consensus 105 ~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99 44444444332 23689999999999999999999984 7 99999999999999999999999999976543
Q ss_pred ccccCCCcccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccc
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEE-----SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVD 313 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (382)
... .....+++.|+|||.+. ...++.++||||||+++|||++|+.||.... .............. . ...
T Consensus 178 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~-~-~~~ 251 (318)
T 2dyl_A 178 DKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK--TDFEVLTKVLQEEP-P-LLP 251 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC--SHHHHHHHHHHSCC-C-CCC
T ss_pred Ccc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC--ccHHHHHHHhccCC-C-CCC
Confidence 222 22335678899999984 5568999999999999999999999997432 12222222221111 0 000
Q ss_pred cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 314 HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 314 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.....+..+.+++.+||+.||.+||++.++++
T Consensus 252 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 252 ------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01122356888999999999999999999987
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=299.42 Aligned_cols=229 Identities=13% Similarity=0.045 Sum_probs=180.1
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCch------HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSPR------QEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~------~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
.+|+..+.||+|+||.||+|.+. ++.||+|.+..... ..+.+|+.++.+++||||+++++++...+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 46888899999999999999987 48999999865421 56899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++++|.+++... ........++.|++.||.|||+.+ |+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999998532 344567889999999999999988 9999999999999999999998543
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
|++| ++.++|||||||++|||++|+.||............ .... ......+ .
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~-~~~~~~~---~ 226 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDT-AGQPIEP---A 226 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCT-TSCBCCH---H
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHh-ccCCCCh---h
Confidence 3433 688999999999999999999999754321100000 0000 0000000 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
......+..+.+++.+||+.||.+| |+.++++.|+++....
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0012234678899999999999999 9999999999987654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=334.69 Aligned_cols=239 Identities=22% Similarity=0.296 Sum_probs=192.2
Q ss_pred hCCCCCCeeeccCcccEEEEEEC---CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCe-----e
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR---DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGY-----Q 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~ 154 (382)
++|+..+.||+|+||.||+|.+. ++.||+|.+.... ...+.+|+.++.+++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67889999999999999999874 4789999876432 2467899999999999999999999987655 6
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
|+||||+++++|.+++.. .+++..++.++.|++.||.|||+.+ |+||||||+|||++.+ .+||+|||+++
T Consensus 160 ~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccch
Confidence 999999999999887643 5899999999999999999999988 9999999999999986 89999999998
Q ss_pred ccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 235 LLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
..... ....+|+.|+|||.+.+.. +.++|||||||++|||++|.+|+....... +.
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~~-- 285 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------LP-- 285 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------CC--
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------cc--
Confidence 66432 3345788899999987664 899999999999999999998875321100 00
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHHhhh
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRP-KMEIVMTELERIHEKEM 361 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~~v~~~L~~i~~~~~ 361 (382)
........+..+.+++.+||+.||.+|| ++.++.+.|..+..+..
T Consensus 286 --~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~ 331 (681)
T 2pzi_A 286 --EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVV 331 (681)
T ss_dssp --TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHHH
T ss_pred --ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHhh
Confidence 0000122346788999999999999999 56777788887765543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=331.31 Aligned_cols=262 Identities=20% Similarity=0.245 Sum_probs=199.4
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEe------CCee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQ------NGYQ 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~ 154 (382)
.+|...+.||+|+||.||+|.+.. ..||+|.+.... ...+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 579999999999999999998754 789999876432 3468899999999999999999998765 6678
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCc---EEEeecC
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFI---AKVADTG 231 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~---~kl~DfG 231 (382)
++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 99999999999999997643 2235788889999999999999999987 999999999999997664 9999999
Q ss_pred CccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh-------
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS------- 304 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~------- 304 (382)
++........ .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.... ....|...
T Consensus 170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-----~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-----QPVQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-----HHHHSSTTCC-----
T ss_pred cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-----chhhhhhhhhcccch
Confidence 9987654322 223456788999999999999999999999999999999999996421 11111100
Q ss_pred hcCCCcccc------c--ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH-----HHHHHHHHHHh
Q 016789 305 RLSSNNFVD------H--RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEI-----VMTELERIHEK 359 (382)
Q Consensus 305 ~~~~~~~~d------~--~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~-----v~~~L~~i~~~ 359 (382)
.....+... . ..........+..+.+++.+||+.||++||++.+ ..+.++.+...
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 000000000 0 0111234556788999999999999999999988 56677766654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=294.46 Aligned_cols=225 Identities=18% Similarity=0.263 Sum_probs=176.0
Q ss_pred hCCCCC-CeeeccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHH-hcCCCCCccceeeEEEe----CCeeEEEE
Q 016789 87 KQFSET-SLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYL-SEIRHRNLVTLLGYCQQ----NGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~-~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~ 158 (382)
.+|... +.||+|+||.||++.... ..||+|.+.. ...+.+|+.++ +..+||||+++++++.. ....++||
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 94 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence 345555 779999999999999854 7899998864 34677888888 56689999999999987 66789999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC---CCcEEEeecCCccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE---NFIAKVADTGISKL 235 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~---~~~~kl~DfGla~~ 235 (382)
||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++..
T Consensus 95 e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 95 ECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp CCCCSCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred eecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 9999999999998743 236899999999999999999999988 999999999999998 78999999999874
Q ss_pred cccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
.. +..++.++|||||||++|||++|+.||........ ... .........
T Consensus 170 ~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-------~~~-~~~~~~~~~ 218 (299)
T 3m2w_A 170 TT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------SPG-MKTRIRMGQ 218 (299)
T ss_dssp CT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------CC-SCCSSCTTC
T ss_pred cc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-------hHH-HHHHHhhcc
Confidence 32 13467899999999999999999999964321110 000 000000000
Q ss_pred cCCCCC----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 316 LAGTFT----TEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 316 ~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. ..+ ...+..+.+++.+||+.||.+||++.++++
T Consensus 219 ~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 219 Y--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp C--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 111 123567889999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=315.12 Aligned_cols=240 Identities=10% Similarity=0.046 Sum_probs=176.8
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC------chHHHHHHHHHHhcCCC-CCccce---------eeE-
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS------PRQEFVAEVTYLSEIRH-RNLVTL---------LGY- 147 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~l~~l~h-~niv~l---------~~~- 147 (382)
.+|...+.||+|+||.||+|.+. ++.||||.+... ..+.+.+|+.+++.++| +|.... ...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 34667788999999999999987 579999987622 23568899999999987 322111 111
Q ss_pred -----------EEe-----CCeeEEEEeecCCCChhhhhhhcC--CCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 016789 148 -----------CQQ-----NGYQMLVFEYLPNGSMCNHLYETG--LESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVH 209 (382)
Q Consensus 148 -----------~~~-----~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivH 209 (382)
+.. ....+++|+++ +++|.+++.... ......+++..++.++.|++.||+|||+.+ |+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iiH 234 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVH 234 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence 111 12356677765 689998885221 122346888899999999999999999988 999
Q ss_pred cCCCCCCeeecCCCcEEEeecCCccccccccccCCCcccccccccCcccc----------ccCCCCccchhHHHHHHHHH
Q 016789 210 KNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVE----------ESGVFSEMSDIYSFGVFLLE 279 (382)
Q Consensus 210 rDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~sDvws~G~vl~e 279 (382)
|||||+|||++.++.+||+|||+++..... .....+ +.|+|||.+ ....++.++|||||||++||
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 999999999999999999999999865443 222234 779999999 55568899999999999999
Q ss_pred HHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 280 LVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 280 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
|++|+.||........ .+..+.. ....+..+.+++.+||+.||++||++.++++.
T Consensus 310 lltg~~Pf~~~~~~~~----------------~~~~~~~--~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 310 IWCADLPNTDDAALGG----------------SEWIFRS--CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHSSCCCCTTGGGSC----------------SGGGGSS--CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHCCCCCCCcchhhh----------------HHHHHhh--cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999974332110 0011110 01123668899999999999999999888653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=307.07 Aligned_cols=238 Identities=16% Similarity=0.136 Sum_probs=181.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCc-----------hHHHHHHHHHHhcCC---------CCCccceee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP-----------RQEFVAEVTYLSEIR---------HRNLVTLLG 146 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~l~~l~---------h~niv~l~~ 146 (382)
++|+..+.||+|+||+||+|++.+..||+|.+.... .+.+.+|+.+++.++ ||||+++.+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~ 99 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS 99 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred ccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence 568889999999999999999988999999865331 267889999988885 777777776
Q ss_pred EEE-----------------e-------------CCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHH
Q 016789 147 YCQ-----------------Q-------------NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKG 196 (382)
Q Consensus 147 ~~~-----------------~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~ 196 (382)
.+. . .+..++||||+++|++.+.+.+ ..+++..+..++.|++.|
T Consensus 100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHH
T ss_pred eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHH
Confidence 543 2 6789999999999988777743 257899999999999999
Q ss_pred HHHHh-cCCCCceecCCCCCCeeecCCC--------------------cEEEeecCCccccccccccCCCcccccccccC
Q 016789 197 LCHLH-SLKPPLVHKNFKTANVLVDENF--------------------IAKVADTGISKLLENIEEAGPSHGSIVNVFRD 255 (382)
Q Consensus 197 L~~LH-~~~~~ivHrDlk~~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~a 255 (382)
|.||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...+|+.|+|
T Consensus 174 L~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 99999 888 99999999999999887 9999999999866432 2356788999
Q ss_pred ccccccCCCCccchhHHHHHH-HHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhh
Q 016789 256 PEVEESGVFSEMSDIYSFGVF-LLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQ 334 (382)
Q Consensus 256 PE~~~~~~~~~~sDvws~G~v-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~ 334 (382)
||.+.+.. +.++||||+|++ .+++++|..||.... ......+......... ...........+..+.+++.+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~--~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~dli~~ 318 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL--WLHYLTDKMLKQMTFK----TKCNTPAMKQIKRKIQEFHRT 318 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH--HHHHHHHHHHHTCCCS----SCCCSHHHHHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh--hhhHHHHhhhhhhccC----cccchhhhhhcCHHHHHHHHH
Confidence 99998776 899999998777 788999999984210 0011111111111111 011111234567889999999
Q ss_pred ccCCCCCCCCCHHHHH
Q 016789 335 CMSSPGRRRPKMEIVM 350 (382)
Q Consensus 335 cl~~dp~~RPs~~~v~ 350 (382)
||+.| |+.|++
T Consensus 319 ~L~~d-----sa~e~l 329 (336)
T 2vuw_A 319 MLNFS-----SATDLL 329 (336)
T ss_dssp GGGSS-----SHHHHH
T ss_pred HhccC-----CHHHHH
Confidence 99977 888877
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=266.06 Aligned_cols=180 Identities=16% Similarity=0.024 Sum_probs=123.8
Q ss_pred eeccCcccEEEEEE--CCeeEEEEEccCC-------------chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEEE
Q 016789 95 IGFGSFGPVYKGLL--RDTVVAIKRRVGS-------------PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 95 lg~G~~g~V~~~~~--~~~~vavK~~~~~-------------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 158 (382)
.+.|++|.+..++. -+..+++|.+... ..++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 45555555554432 3467888876432 124699999999999 6999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||++||+|.+.|...+ .++.. .|+.||+.||+|+|+++ ||||||||+|||+++++.+||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999997654 45543 48899999999999988 99999999999999999999999999987644
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEA 286 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p 286 (382)
... ......+|+.|||||.+.+. +..++|+||+|++++++.++..+
T Consensus 392 ~~~-~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS-WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc-cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 322 22334578999999999754 67789999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=252.30 Aligned_cols=181 Identities=17% Similarity=0.191 Sum_probs=144.5
Q ss_pred CCCCeeeccCcccEEEEEECCeeEEEEEccCCc-----------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 90 SETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP-----------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 90 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
...+.||+|+||.||+|...+..+++|+..... .+.+.+|++++++++||||+++..++...+..++||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 445689999999999998888889998754321 134789999999999999997777777777889999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+++|+|.+++.. +..++.|++.||.|||+.+ |+||||||+|||++. .+||+|||+++....
T Consensus 419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 99999999999864 4578999999999999988 999999999999998 999999999997755
Q ss_pred ccccC------CCcccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCC
Q 016789 239 IEEAG------PSHGSIVNVFRDPEVEES--GVFSEMSDIYSFGVFLLELVTGQEAS 287 (382)
Q Consensus 239 ~~~~~------~~~~~~~~~y~aPE~~~~--~~~~~~sDvws~G~vl~el~tg~~p~ 287 (382)
..... .....+|+.|||||++.. ..|+..+|+||..+-..+-+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 33221 123457889999999987 56888899999999999988877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=198.74 Aligned_cols=146 Identities=13% Similarity=0.034 Sum_probs=115.9
Q ss_pred HHHHhCCCCCCeeeccCcccEEEEEEC-CeeEEEEEccCC---------------------chHHHHHHHHHHhcCCCCC
Q 016789 83 EQATKQFSETSLIGFGSFGPVYKGLLR-DTVVAIKRRVGS---------------------PRQEFVAEVTYLSEIRHRN 140 (382)
Q Consensus 83 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---------------------~~~~~~~e~~~l~~l~h~n 140 (382)
......|...+.||+|+||.||+|.+. +..+|+|..... ....+.+|+.+|++++ |
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 333445666789999999999999994 479999987532 1345889999999999 5
Q ss_pred ccceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec
Q 016789 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD 220 (382)
Q Consensus 141 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~ 220 (382)
+++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||++
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~ 227 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS 227 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE
Confidence 666665544 45699999999999988 421 113468999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCccccccccccCCCcccccccccCcccccc
Q 016789 221 ENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEES 261 (382)
Q Consensus 221 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 261 (382)
++.+||+|||+++... .++|||.+..
T Consensus 228 -~~~vkl~DFG~a~~~~--------------~~~a~e~l~r 253 (282)
T 1zar_A 228 -EEGIWIIDFPQSVEVG--------------EEGWREILER 253 (282)
T ss_dssp -TTEEEECCCTTCEETT--------------STTHHHHHHH
T ss_pred -CCcEEEEECCCCeECC--------------CCCHHHHHHH
Confidence 9999999999997432 2788888753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=8.5e-21 Score=170.78 Aligned_cols=132 Identities=16% Similarity=0.105 Sum_probs=101.1
Q ss_pred CCCCCeeeccCcccEEEEEE--CCee--EEEEEccCCc---------------------------hHHHHHHHHHHhcCC
Q 016789 89 FSETSLIGFGSFGPVYKGLL--RDTV--VAIKRRVGSP---------------------------RQEFVAEVTYLSEIR 137 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~--~~~~--vavK~~~~~~---------------------------~~~~~~e~~~l~~l~ 137 (382)
|...+.||+|+||.||+|.+ .+.. +|+|...... ...+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55678899999999999998 5677 9999753221 025788999999998
Q ss_pred CCCc--cceeeEEEeCCeeEEEEeecCC-C----ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHh-cCCCCcee
Q 016789 138 HRNL--VTLLGYCQQNGYQMLVFEYLPN-G----SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH-SLKPPLVH 209 (382)
Q Consensus 138 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~ivH 209 (382)
|+|+ ...+++ +..++||||+.+ | +|.+.... .++.....++.|++.+|.||| +.+ |+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g--ivH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE--LVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC--EEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC--EEe
Confidence 8764 333332 246899999942 4 55544322 123346678999999999999 888 999
Q ss_pred cCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 210 KNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 210 rDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
|||||+|||+++ .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.4e-17 Score=156.34 Aligned_cols=135 Identities=13% Similarity=0.114 Sum_probs=96.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC-----------------chHHH--------HHHHHHHhcCCCCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS-----------------PRQEF--------VAEVTYLSEIRHRN 140 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~-----------------~~~~~--------~~e~~~l~~l~h~n 140 (382)
.-|++...||+|+||.||+|.... +.||||..... ....+ ..|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 348888999999999999998765 78999974321 01111 24556666665444
Q ss_pred ccceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec
Q 016789 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD 220 (382)
Q Consensus 141 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~ 220 (382)
+.-..-+.... .+|||||+++++|...... + ....++.|++.+|.|||+.+ ||||||||.|||++
T Consensus 175 v~vp~p~~~~~--~~LVME~i~G~~L~~l~~~---------~--~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQSR--HTIVMSLVDALPMRQVSSV---------P--DPASLYADLIALILRLAKHG--LIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEEET--TEEEEECCSCEEGGGCCCC---------S--CHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE
T ss_pred CCCCeeeeccC--ceEEEEecCCccHhhhccc---------H--HHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEe
Confidence 33222222222 3799999999887654321 1 13457889999999999988 99999999999998
Q ss_pred CCC----------cEEEeecCCcccc
Q 016789 221 ENF----------IAKVADTGISKLL 236 (382)
Q Consensus 221 ~~~----------~~kl~DfGla~~~ 236 (382)
+++ .+.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 776 4899999987644
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=5e-13 Score=119.94 Aligned_cols=142 Identities=13% Similarity=0.114 Sum_probs=112.1
Q ss_pred HHHHhCCCCCCeeeccCcccEEEEEECCeeEEEEEccC---CchHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEE
Q 016789 83 EQATKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVG---SPRQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 83 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 158 (382)
...-..|.....++.|+++.||+....+..+++|.... .....+.+|+.+++.+. |.++.++++++...+..|+||
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34445677777788888899999987778999998754 33457889999999884 678889999999988999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK---------------------------------- 204 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------- 204 (382)
||++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 90 e~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 90 SEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp ECCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 99999998765311 0112367788999999999710
Q ss_pred -----------------------CCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 205 -----------------------PPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 205 -----------------------~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 338999999999999876667799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.7e-11 Score=109.41 Aligned_cols=126 Identities=17% Similarity=0.178 Sum_probs=94.5
Q ss_pred eccCcccEEEEEECC-eeEEEEEccCCchHHHHHHHHHHhcCCCCC--ccceeeEEEeCCeeEEEEeecCCCChhhhhhh
Q 016789 96 GFGSFGPVYKGLLRD-TVVAIKRRVGSPRQEFVAEVTYLSEIRHRN--LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYE 172 (382)
Q Consensus 96 g~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 172 (382)
+.|..+.||+....+ ..+++|.........+..|+.+++.+.+.+ +.+++++....+..++||||++|.+|. ...
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~ 106 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH 106 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc
Confidence 455669999997654 578999866554456889999999886444 556888888877889999999998873 211
Q ss_pred cCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------------
Q 016789 173 TGLESSTKLEFKQRVSIALGAAKGLCHLHSLK------------------------------------------------ 204 (382)
Q Consensus 173 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------------------ 204 (382)
.. ...++.+++..|..||+..
T Consensus 107 --------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 107 --------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp --------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred --------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 11 1246677777788887642
Q ss_pred --------CCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 205 --------PPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 205 --------~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 129999999999999887677799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.23 E-value=3.3e-11 Score=113.20 Aligned_cols=137 Identities=13% Similarity=0.263 Sum_probs=105.8
Q ss_pred CCeeeccCcccEEEEEECCeeEEEEEcc--CC----chHHHHHHHHHHhcCC--CCCccceeeEEEeC---CeeEEEEee
Q 016789 92 TSLIGFGSFGPVYKGLLRDTVVAIKRRV--GS----PRQEFVAEVTYLSEIR--HRNLVTLLGYCQQN---GYQMLVFEY 160 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~~~vavK~~~--~~----~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e~ 160 (382)
.+.++.|.++.||+....+..+++|+.. .. ....+.+|..+++.+. +.++.++++++.+. +..++||||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 4568899999999999888888888765 32 2346888999999986 45688899988776 447999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL------------------------------------- 203 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------- 203 (382)
++|.++.+... ..++...+..++.+++..|+.||+.
T Consensus 123 v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99887754211 1366778888999999999999962
Q ss_pred -------------------CCCceecCCCCCCeeecCCCc--EEEeecCCccc
Q 016789 204 -------------------KPPLVHKNFKTANVLVDENFI--AKVADTGISKL 235 (382)
Q Consensus 204 -------------------~~~ivHrDlk~~Nill~~~~~--~kl~DfGla~~ 235 (382)
.+.++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 145999999999999997753 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.98 E-value=2.3e-10 Score=104.92 Aligned_cols=184 Identities=20% Similarity=0.200 Sum_probs=115.7
Q ss_pred CCeeeccCcccEEEEEECCeeEEEEEccCC-chHHHHHHHHHHhcCC-CCC--ccceeeEEEeCC---eeEEEEeecCCC
Q 016789 92 TSLIGFGSFGPVYKGLLRDTVVAIKRRVGS-PRQEFVAEVTYLSEIR-HRN--LVTLLGYCQQNG---YQMLVFEYLPNG 164 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~~~g 164 (382)
.+.++.|.+..||+.. ..+++|..... ....+.+|.++|+.+. +.. +.+.+......+ ..|+|||+++|.
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~ 101 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV 101 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence 4568999999999864 46778775433 2356889999998873 332 344444433332 348899999998
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL----------------------------------------- 203 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------------------------------------- 203 (382)
++.+.... .++...+..++.+++..|+.||+.
T Consensus 102 ~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 102 PLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp ECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred ECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 88654321 345555666666777777666641
Q ss_pred ---------------CCCceecCCCCCCeeecC--CCcEEEeecCCccccccccccCCCccc---cc--------ccc--
Q 016789 204 ---------------KPPLVHKNFKTANVLVDE--NFIAKVADTGISKLLENIEEAGPSHGS---IV--------NVF-- 253 (382)
Q Consensus 204 ---------------~~~ivHrDlk~~Nill~~--~~~~kl~DfGla~~~~~~~~~~~~~~~---~~--------~~y-- 253 (382)
.+.++|+|++|.||++++ +..+.|+||+.+..-............ .. ..|
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 134899999999999998 566789999988643221111000000 00 001
Q ss_pred cC-ccccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 016789 254 RD-PEVEESGVFSEMSDIYSFGVFLLELVTGQEAS 287 (382)
Q Consensus 254 ~a-PE~~~~~~~~~~sDvws~G~vl~el~tg~~p~ 287 (382)
.. |+.... .....+.|+++.++|.+.+|..++
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 221111 112268999999999999999765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=1.8e-07 Score=83.86 Aligned_cols=132 Identities=20% Similarity=0.225 Sum_probs=93.1
Q ss_pred eeeccCcc-cEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEeecCCCChhhh
Q 016789 94 LIGFGSFG-PVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNH 169 (382)
Q Consensus 94 ~lg~G~~g-~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 169 (382)
.+..|..+ .||+..... ..+.+|........++.+|...|+.+. +--+.++++++...+..++|||++++.++.+.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence 45556665 589876543 578889876666677889999998884 44477889999999999999999998877664
Q ss_pred hhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 016789 170 LYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL---------------------------------------------- 203 (382)
Q Consensus 170 l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------------------- 203 (382)
..... .....++.+++..|..||+.
T Consensus 111 ~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 111 LEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 42210 11123344444444445431
Q ss_pred ----------CCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 204 ----------KPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 204 ----------~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
.+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137999999999999988777899999876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=8.7e-07 Score=81.05 Aligned_cols=133 Identities=14% Similarity=0.125 Sum_probs=86.1
Q ss_pred CeeeccCcccEEEEEECCeeEEEEEccCC-chHHHHHHHHHHhcCCCC---CccceeeEEE-eCCeeEEEEeecCCCChh
Q 016789 93 SLIGFGSFGPVYKGLLRDTVVAIKRRVGS-PRQEFVAEVTYLSEIRHR---NLVTLLGYCQ-QNGYQMLVFEYLPNGSMC 167 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~gsL~ 167 (382)
+.++.|....||+. +..+++|.-... ....+..|.++|+.+.+. .+.+.+.++. ..+..++||||++|.++.
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~ 101 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILG 101 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECH
T ss_pred eecCCCcceeEEEE---CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECc
Confidence 45788888899987 566777764322 235688999999998642 3556666664 345678999999988876
Q ss_pred hhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 016789 168 NHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS--------------------------------------------- 202 (382)
Q Consensus 168 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~--------------------------------------------- 202 (382)
+.... .++......++.+++..|+.||+
T Consensus 102 ~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 102 EDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp HHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred hhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 53211 11222222333333333333332
Q ss_pred -------------CCCCceecCCCCCCeeecC---CCc-EEEeecCCccc
Q 016789 203 -------------LKPPLVHKNFKTANVLVDE---NFI-AKVADTGISKL 235 (382)
Q Consensus 203 -------------~~~~ivHrDlk~~Nill~~---~~~-~kl~DfGla~~ 235 (382)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234799999999999987 355 58999998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=1.4e-06 Score=81.25 Aligned_cols=75 Identities=7% Similarity=-0.013 Sum_probs=54.2
Q ss_pred Cee-eccCcccEEEEEEC--------CeeEEEEEccCCc------hHHHHHHHHHHhcCC-C--CCccceeeEEEeC---
Q 016789 93 SLI-GFGSFGPVYKGLLR--------DTVVAIKRRVGSP------RQEFVAEVTYLSEIR-H--RNLVTLLGYCQQN--- 151 (382)
Q Consensus 93 ~~l-g~G~~g~V~~~~~~--------~~~vavK~~~~~~------~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~--- 151 (382)
+.| +.|....+|+.... +..+++|...... ...+.+|..+++.+. + ..+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999998765 5678888754322 246788998888884 2 3567788887655
Q ss_pred CeeEEEEeecCCCChh
Q 016789 152 GYQMLVFEYLPNGSMC 167 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~ 167 (382)
+..++||||++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999887654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.32 E-value=5.1e-06 Score=76.71 Aligned_cols=140 Identities=14% Similarity=0.186 Sum_probs=80.6
Q ss_pred eeeccCcccEEEEEECCeeEEEEEccCCchHHHHHHHHHHhcCC-----CCCcccee-e--EEEeCCeeEEEEeecCCCC
Q 016789 94 LIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEIR-----HRNLVTLL-G--YCQQNGYQMLVFEYLPNGS 165 (382)
Q Consensus 94 ~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e~~~~gs 165 (382)
.++.|..+.||+....+..+++|..... ......|..+++.+. .|.++... | +....+..++++||++|.+
T Consensus 39 ~l~gG~~n~~~~v~~~~~~~vlk~~~~~-~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G~~ 117 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSGAVCLKRIHRP-EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEGRP 117 (346)
T ss_dssp ECC----CEEEEEEETTEEEEEEEECSC-HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCCBC
T ss_pred eccccccCcEEEEEeCCCCEEEEecCCC-HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecCcc
Confidence 4555778999999888877899987653 344445555555542 24444311 1 2234667899999999865
Q ss_pred hh--------------hhhhhcCC----CCC-----CcCCHHHH-------------------------------HHHHH
Q 016789 166 MC--------------NHLYETGL----ESS-----TKLEFKQR-------------------------------VSIAL 191 (382)
Q Consensus 166 L~--------------~~l~~~~~----~~~-----~~l~~~~~-------------------------------~~i~~ 191 (382)
+. ..+|.... ... ..-.|... ..+..
T Consensus 118 ~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (346)
T 2q83_A 118 FELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGFIE 197 (346)
T ss_dssp CCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHH
Confidence 42 12222111 000 01123211 01111
Q ss_pred HHHHHHHHHhc-----------CCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 192 GAAKGLCHLHS-----------LKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 192 ~ia~~L~~LH~-----------~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
.+..++.+|+. ..+.++|+|+++.|||++.++.+.|+||+.+.
T Consensus 198 ~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 198 DGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 23345666652 23459999999999999888899999999765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.11 E-value=3.7e-05 Score=70.27 Aligned_cols=139 Identities=18% Similarity=0.147 Sum_probs=94.4
Q ss_pred CCeeeccCcccEEEEEECCeeEEEEEccCCchHHHHHHHHHHhcCC---CCCccceeeEEEeCCeeEEEEeecCCCChhh
Q 016789 92 TSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAEVTYLSEIR---HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCN 168 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 168 (382)
.+.++.|....+|+....+..+++|.........+..|.+.|+.+. ...+.+.++++...+..++||||+++.++..
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~ 120 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQ 120 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCT
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCc
Confidence 3468899999999998877888899876555667889998888883 3678889998888888999999999876521
Q ss_pred -----------hhhhcCCCC-----------------CCcCCHHHHH---HHHH----------------HHHHH-HHHH
Q 016789 169 -----------HLYETGLES-----------------STKLEFKQRV---SIAL----------------GAAKG-LCHL 200 (382)
Q Consensus 169 -----------~l~~~~~~~-----------------~~~l~~~~~~---~i~~----------------~ia~~-L~~L 200 (382)
.||...... ...-+|.... ++.. .+... ...|
T Consensus 121 ~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L 200 (312)
T 3jr1_A 121 SSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTL 200 (312)
T ss_dssp THHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHh
Confidence 234322100 0012443221 1111 11111 1234
Q ss_pred --hcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 201 --HSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 201 --H~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
|...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 201 ~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 201 SKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp TTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred ccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23346699999999999999887 8899974
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1.9e-05 Score=74.71 Aligned_cols=71 Identities=18% Similarity=0.128 Sum_probs=47.2
Q ss_pred CCeeeccCcccEEEEEEC--CeeEEEEEccCC----------chHHHHHHHHHHhcCCC--CC-ccceeeEEEeCCeeEE
Q 016789 92 TSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS----------PRQEFVAEVTYLSEIRH--RN-LVTLLGYCQQNGYQML 156 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----------~~~~~~~e~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 156 (382)
.+.+|.|.++.||++... +..+++|..... ..+.+..|.++|+.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 346899999999999653 467889864321 12456788888887732 33 3455543 3345689
Q ss_pred EEeecCCC
Q 016789 157 VFEYLPNG 164 (382)
Q Consensus 157 v~e~~~~g 164 (382)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.96 E-value=1.4e-05 Score=76.30 Aligned_cols=79 Identities=16% Similarity=0.112 Sum_probs=47.6
Q ss_pred CCceecCCCCCCeeecCCCcEEEeecCCccccccccccCCCcccccccccCccccccC---CCCccchhHHHHHHHHHHH
Q 016789 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESG---VFSEMSDIYSFGVFLLELV 281 (382)
Q Consensus 205 ~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDvws~G~vl~el~ 281 (382)
+.++|+|+++.|||++.++ ++++||+.+..-................|.+|+..... .-....++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4599999999999998876 99999998874322111111000111235555544311 1122345567888888887
Q ss_pred hCC
Q 016789 282 TGQ 284 (382)
Q Consensus 282 tg~ 284 (382)
++.
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00058 Score=62.33 Aligned_cols=158 Identities=10% Similarity=0.044 Sum_probs=88.4
Q ss_pred cCHHHHHHHHhCCCCC-----CeeeccCcccEEEEEECCeeEEEEEccCC-chHHHHHHHHHHhcCCCCC--ccceeeE-
Q 016789 77 FSMEELEQATKQFSET-----SLIGFGSFGPVYKGLLRDTVVAIKRRVGS-PRQEFVAEVTYLSEIRHRN--LVTLLGY- 147 (382)
Q Consensus 77 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~n--iv~l~~~- 147 (382)
++.+++...-..|... +.++.|....+|+....+..+++|..... ....+..|..++..+...+ +.+++..
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~ 86 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK 86 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC
Confidence 4556666666666552 23556778899999887777888876652 3445667777777663111 2333321
Q ss_pred -----EEeCCeeEEEEeecCCCChhh--------------hhhhcCC--CCC--Cc---CCHHHHHH------------H
Q 016789 148 -----CQQNGYQMLVFEYLPNGSMCN--------------HLYETGL--ESS--TK---LEFKQRVS------------I 189 (382)
Q Consensus 148 -----~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~--~~~--~~---l~~~~~~~------------i 189 (382)
....+..+++++|++|..+.. .+|.... ... .. ..|..... +
T Consensus 87 ~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l 166 (322)
T 2ppq_A 87 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 166 (322)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhh
Confidence 223456789999998765421 1232110 000 00 11222110 0
Q ss_pred HHHHHHHHHHHhc-----CCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 190 ALGAAKGLCHLHS-----LKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 190 ~~~ia~~L~~LH~-----~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
...+...+.++.. ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 167 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 1113344555542 12349999999999999987666899998775
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00019 Score=66.09 Aligned_cols=140 Identities=11% Similarity=0.041 Sum_probs=71.8
Q ss_pred eeeccCccc-EEEEEEC-CeeEEEEEccCCchHHHHHHHHHHhcCC--CCCccceeeEEEeCCeeEEEEeecCCCChhhh
Q 016789 94 LIGFGSFGP-VYKGLLR-DTVVAIKRRVGSPRQEFVAEVTYLSEIR--HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNH 169 (382)
Q Consensus 94 ~lg~G~~g~-V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 169 (382)
.|+.|+... +|+.... +..+++|........++..|+.+++.+. .-.+.+++.+....+ +++||++.+.++.+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~~~ 102 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFTEV 102 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHHHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchHHH
Confidence 455554443 6677664 5566777654432244556777776663 233556776644333 789999976665443
Q ss_pred hhh---------------------cCCCCCCcCCHHHHH--------------------HHHHHHHHHHHHH----hcCC
Q 016789 170 LYE---------------------TGLESSTKLEFKQRV--------------------SIALGAAKGLCHL----HSLK 204 (382)
Q Consensus 170 l~~---------------------~~~~~~~~l~~~~~~--------------------~i~~~ia~~L~~L----H~~~ 204 (382)
+.. .....-..++..... .....+...+..+ ....
T Consensus 103 l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~~ 182 (333)
T 3csv_A 103 INNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEGD 182 (333)
T ss_dssp HHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCSC
T ss_pred hcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccCC
Confidence 321 100000111111000 0001111122222 1223
Q ss_pred CCceecCCCCCCeeecCC----CcEEEeecCCccc
Q 016789 205 PPLVHKNFKTANVLVDEN----FIAKVADTGISKL 235 (382)
Q Consensus 205 ~~ivHrDlk~~Nill~~~----~~~kl~DfGla~~ 235 (382)
+.++|+|+.+.||+++.+ ..+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 459999999999999874 6889999998763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00034 Score=63.34 Aligned_cols=69 Identities=12% Similarity=0.035 Sum_probs=42.4
Q ss_pred CCeeeccCcccEEEEEECCeeEEEEEccCCch--HHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEeec-CCCCh
Q 016789 92 TSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPR--QEFVAEVTYLSEIRHRNL-VTLLGYCQQNGYQMLVFEYL-PNGSM 166 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gsL 166 (382)
.+.|+.|....+|+. ..+++|....... .+..+|..+++.+...++ .++++++ .+.-++++||+ ++-++
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 467888999999998 5577776543211 133567777777642222 3555443 33357899999 55444
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00028 Score=63.53 Aligned_cols=74 Identities=18% Similarity=0.157 Sum_probs=51.7
Q ss_pred CCCCCeeeccCcccEEEEEECC-eeEEEEEccCCc---hHHHHHHHHHHhcCCC---CCccceeeEEEeCCeeEEEEeec
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP---RQEFVAEVTYLSEIRH---RNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~---~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
....+.+|.|..+.||+....+ +.+.+|+..... ...|..|...|+.+.- -.+.+.+++. ..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 3345678999999999999876 789999855332 3467889998888742 2344455432 247899999
Q ss_pred CCCCh
Q 016789 162 PNGSM 166 (382)
Q Consensus 162 ~~gsL 166 (382)
+++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00038 Score=66.51 Aligned_cols=70 Identities=21% Similarity=0.251 Sum_probs=47.6
Q ss_pred CeeeccCcccEEEEEEC---------CeeEEEEEccCCch-HHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEeec
Q 016789 93 SLIGFGSFGPVYKGLLR---------DTVVAIKRRVGSPR-QEFVAEVTYLSEIRHRNL-VTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~-~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~ 161 (382)
+.|+.|....+|+.... +..+++|+...... ..+..|..+++.+...++ .++++.+.+ .+|+||+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l 154 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 154 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEe
Confidence 45778888999999875 35678877644223 567789998888853333 566665532 3899999
Q ss_pred CCCCh
Q 016789 162 PNGSM 166 (382)
Q Consensus 162 ~~gsL 166 (382)
+|-++
T Consensus 155 ~G~~l 159 (429)
T 1nw1_A 155 PSRPL 159 (429)
T ss_dssp CEEEC
T ss_pred CCccc
Confidence 76444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.011 Score=53.79 Aligned_cols=155 Identities=10% Similarity=0.105 Sum_probs=85.5
Q ss_pred cCHHHHHHHHhCCCC-----CCeeeccCcccEEEEEECC-eeEEEEEccC--CchHHHHHHHHHHhcCCC--CCccceee
Q 016789 77 FSMEELEQATKQFSE-----TSLIGFGSFGPVYKGLLRD-TVVAIKRRVG--SPRQEFVAEVTYLSEIRH--RNLVTLLG 146 (382)
Q Consensus 77 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~-~~vavK~~~~--~~~~~~~~e~~~l~~l~h--~niv~l~~ 146 (382)
.+.+.+...-..|.. ...++ |....||+....+ ..+++|.... .....+..|..++..+.. -.+.+++.
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~ 89 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVA 89 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceee
Confidence 445555544444432 23466 7888999887654 4788998753 234567778888777632 12344443
Q ss_pred E-----EEeCCeeEEEEeecCCCChhh--------------hhhhcCC----CCCCcCCHHHH-----------------
Q 016789 147 Y-----CQQNGYQMLVFEYLPNGSMCN--------------HLYETGL----ESSTKLEFKQR----------------- 186 (382)
Q Consensus 147 ~-----~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~----~~~~~l~~~~~----------------- 186 (382)
. ....+..+++++|++|.++.. .+|.... ......++...
T Consensus 90 ~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 169 (328)
T 1zyl_A 90 FNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSG 169 (328)
T ss_dssp BTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTT
T ss_pred cCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHH
Confidence 2 223456688999998754321 1221110 00111222111
Q ss_pred -----HHHHHHHHHHHHHHhc--CCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 187 -----VSIALGAAKGLCHLHS--LKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 187 -----~~i~~~ia~~L~~LH~--~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
...+..+...+.-+.. ....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 170 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 170 LKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp THHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 0111122222222211 233489999999999999 4 89999998875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0019 Score=54.94 Aligned_cols=103 Identities=13% Similarity=0.028 Sum_probs=66.7
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCC
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP 244 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 244 (382)
||.+.|...+ .++++.+.|.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARRRQP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhcccC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 7888887654 5799999999999999998776211111 1223446888999999987764 1111
Q ss_pred CcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 016789 245 SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEAS 287 (382)
Q Consensus 245 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~ 287 (382)
.....+.+||... ...+.+.=|||+|+++|.-+--..|-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 0012267888764 34567889999999999988766553
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0024 Score=59.74 Aligned_cols=138 Identities=13% Similarity=0.105 Sum_probs=78.7
Q ss_pred CeeeccCcccEEEEEECC---------eeEEEEEccCC--chHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEee
Q 016789 93 SLIGFGSFGPVYKGLLRD---------TVVAIKRRVGS--PRQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~---------~~vavK~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+.+..|-...+|+....+ ..+.+|+-... ......+|..+++.+. +.-..++++++.+ .+|+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 457678889999998742 56788764321 3456678998888874 2223566666543 289999
Q ss_pred cCCCChhhh-----------------hhhcCCCCCCcCC--HHHHHHHHHHHH-------------------HHHHHH--
Q 016789 161 LPNGSMCNH-----------------LYETGLESSTKLE--FKQRVSIALGAA-------------------KGLCHL-- 200 (382)
Q Consensus 161 ~~~gsL~~~-----------------l~~~~~~~~~~l~--~~~~~~i~~~ia-------------------~~L~~L-- 200 (382)
++|.+|... ||........... |..+.++..++. ..+..|
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 987655321 1221111111222 333443333321 122333
Q ss_pred --hc--CCCCceecCCCCCCeeecCC----CcEEEeecCCcc
Q 016789 201 --HS--LKPPLVHKNFKTANVLVDEN----FIAKVADTGISK 234 (382)
Q Consensus 201 --H~--~~~~ivHrDlk~~Nill~~~----~~~kl~DfGla~ 234 (382)
.. ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22 12349999999999999876 789999998875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.002 Score=61.99 Aligned_cols=70 Identities=10% Similarity=0.016 Sum_probs=45.1
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccCCchH--HHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEeecCCCCh
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQ--EFVAEVTYLSEIRHRNL-VTLLGYCQQNGYQMLVFEYLPNGSM 166 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~--~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 166 (382)
+.|+.|-...+|+....+ ..+++|........ +-..|..++..+...++ .++++.+. + .+|+||++|-+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 356778889999999877 77888865332111 22578888888865444 46676662 2 259999987554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.002 Score=60.11 Aligned_cols=70 Identities=16% Similarity=0.114 Sum_probs=42.0
Q ss_pred CeeeccCcccEEEEEECC----------eeEEEEEccCCchH--HHHHHHHHHhcCCCCC-ccceeeEEEeCCeeEEEEe
Q 016789 93 SLIGFGSFGPVYKGLLRD----------TVVAIKRRVGSPRQ--EFVAEVTYLSEIRHRN-LVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~----------~~vavK~~~~~~~~--~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 159 (382)
+.++.|....+|+....+ ..+++|........ +...|..+++.+...+ ..++++.. . -++|+|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 356778888999998764 57778765432221 2357888888774333 34666543 2 368999
Q ss_pred ecCCCCh
Q 016789 160 YLPNGSM 166 (382)
Q Consensus 160 ~~~~gsL 166 (382)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0015 Score=39.97 Aligned_cols=32 Identities=16% Similarity=0.159 Sum_probs=16.9
Q ss_pred CcceehhHHHHHHHHHHHHHHHHHHHHHhccc
Q 016789 3 KSIAAVVGGAAGALAFMAIVLGLVWLCKSQSK 34 (382)
Q Consensus 3 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (382)
+.+..|++++++++++++++++++|++.||++
T Consensus 7 s~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 7 ARTPLIAAGVIGGLFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCcceEEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence 34555677776655554444444444444443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0043 Score=57.18 Aligned_cols=31 Identities=26% Similarity=0.237 Sum_probs=27.3
Q ss_pred CCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 205 PPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 205 ~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3599999999999999888899999987764
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0022 Score=39.37 Aligned_cols=31 Identities=23% Similarity=0.304 Sum_probs=15.5
Q ss_pred cceehhHHHHHHHHHHHHHHHHHHHHHhccc
Q 016789 4 SIAAVVGGAAGALAFMAIVLGLVWLCKSQSK 34 (382)
Q Consensus 4 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (382)
.+..|++++++++++++++++++|++.||++
T Consensus 9 ~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 9 KIPSIATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp CSSSSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred CcceEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 3445666666655544444444444444443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=96.18 E-value=0.0057 Score=37.32 Aligned_cols=28 Identities=14% Similarity=0.293 Sum_probs=14.2
Q ss_pred ceehhHHHHHHHHHHHHHHHHHHHHHhc
Q 016789 5 IAAVVGGAAGALAFMAIVLGLVWLCKSQ 32 (382)
Q Consensus 5 ~~~iv~~~~~~~~~~~~~~~~~~~~~~~ 32 (382)
+..|+++++|+++++++.++++++.+||
T Consensus 11 ~~~Ia~~vVGvll~vi~~l~~~~~~RRR 38 (44)
T 2jwa_A 11 LTSIISAVVGILLVVVLGVVFGILIKRR 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHHHHHHHHHhheehh
Confidence 4456677777555444444433333333
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.26 E-value=0.043 Score=52.05 Aligned_cols=70 Identities=6% Similarity=-0.017 Sum_probs=44.8
Q ss_pred CeeeccCcccEEEEEEC---------CeeEEEEEccCCch--HHHHHHHHHHhcCC-CCCccceeeEEEeCCeeEEEEee
Q 016789 93 SLIGFGSFGPVYKGLLR---------DTVVAIKRRVGSPR--QEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~--~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
+.+..|-...+|+.... +..+++++...... -+..+|..+++.+. +.-..++++.+ . -++|+||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence 45667888899999886 46678876433221 13457888887774 22234555433 2 3789999
Q ss_pred cCCCCh
Q 016789 161 LPNGSM 166 (382)
Q Consensus 161 ~~~gsL 166 (382)
++|.+|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998654
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.53 E-value=0.055 Score=34.48 Aligned_cols=33 Identities=9% Similarity=0.190 Sum_probs=23.8
Q ss_pred cceehhHHHHHHHHHHHHHHHHHHHHHhccccc
Q 016789 4 SIAAVVGGAAGALAFMAIVLGLVWLCKSQSKNY 36 (382)
Q Consensus 4 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~ 36 (382)
.+++|+++++++++++++++++.|.|.--+|++
T Consensus 8 p~WiIi~svl~GLLLL~Lii~~LwK~GFFKR~~ 40 (54)
T 2l8s_A 8 PLWVILLSAFAGLLLLMLLILALWKIGFFKRPL 40 (54)
T ss_dssp CTHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCC
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHcCcccCCC
Confidence 467778888888888887778888776555443
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.94 E-value=0.035 Score=33.61 Aligned_cols=28 Identities=21% Similarity=0.459 Sum_probs=13.7
Q ss_pred ceehhHHHHHHHHHHHHHHHHHHHHHhc
Q 016789 5 IAAVVGGAAGALAFMAIVLGLVWLCKSQ 32 (382)
Q Consensus 5 ~~~iv~~~~~~~~~~~~~~~~~~~~~~~ 32 (382)
++.+++++++++++++++++++|+++||
T Consensus 12 ~~~I~~~vv~Gv~ll~~iv~~~~~~~rR 39 (41)
T 2k9y_A 12 NLAVIGGVAVGVVLLLVLAGVGFFIHRR 39 (41)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred eEEEEeehhHHHHHHHHHHHHheeEeee
Confidence 4455565555555554233344444443
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.63 E-value=0.15 Score=32.62 Aligned_cols=33 Identities=24% Similarity=0.344 Sum_probs=23.6
Q ss_pred cceehhHHHHHHHHHHHHHHHHHHHHHhccccc
Q 016789 4 SIAAVVGGAAGALAFMAIVLGLVWLCKSQSKNY 36 (382)
Q Consensus 4 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~ 36 (382)
.+++|+++++++++++++++++.|.|.--+|++
T Consensus 11 p~wiIi~svl~GLllL~li~~~LwK~GFFkR~~ 43 (54)
T 2knc_A 11 PIWWVLVGVLGGLLLLTILVLAMWKVGFFKRNR 43 (54)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTTC
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHcCcccCCC
Confidence 456778888888888877778888776555433
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=93.24 E-value=0.099 Score=30.90 Aligned_cols=27 Identities=22% Similarity=0.300 Sum_probs=14.4
Q ss_pred eehhHHHHHHHHHHHHHHHHHHHHHhc
Q 016789 6 AAVVGGAAGALAFMAIVLGLVWLCKSQ 32 (382)
Q Consensus 6 ~~iv~~~~~~~~~~~~~~~~~~~~~~~ 32 (382)
..|+|+++++++.+++++++.|++.||
T Consensus 11 GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 11 GEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CceeeeehHHHHHHHHHHHHHHHHeec
Confidence 346666666665555444444444443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.35 E-value=1.1 Score=37.75 Aligned_cols=116 Identities=6% Similarity=0.082 Sum_probs=77.7
Q ss_pred CCCCccceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCC
Q 016789 137 RHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTAN 216 (382)
Q Consensus 137 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~N 216 (382)
.||+.+.. ..-.+.+...+.++.-+.+-=...+ ...+...+++++..|+.-..+++. -+|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i--------k~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI--------KSFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG--------GGSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH--------HhcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecce
Confidence 68888876 4555556655555554322211222 257788899999998887766653 5788899999
Q ss_pred eeecCCCcEEEeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 016789 217 VLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASH 288 (382)
Q Consensus 217 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~ 288 (382)
++++.++.+++.-.|+-..+ +|. .++...=.-.+=+++..+++++..|.
T Consensus 110 L~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999888764322 221 11222233457788899999998875
|
| >2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A | Back alignment and structure |
|---|
Probab=90.75 E-value=0.23 Score=29.98 Aligned_cols=31 Identities=23% Similarity=0.344 Sum_probs=22.4
Q ss_pred cceehhHHHHHHHHHHHHHHHHHHHHHhccc
Q 016789 4 SIAAVVGGAAGALAFMAIVLGLVWLCKSQSK 34 (382)
Q Consensus 4 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (382)
.+++|+++++++++++++++++.|.|.--+|
T Consensus 9 p~wiIi~s~l~GLllL~li~~~LwK~GFFkR 39 (42)
T 2k1a_A 9 PIWWVLVGVLGGLLLLTILVLAMWKVGFFKR 39 (42)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHTTTTCC
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHcCcccC
Confidence 3567778888888877777778887765444
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=89.67 E-value=0.051 Score=31.25 Aligned_cols=26 Identities=23% Similarity=0.396 Sum_probs=12.6
Q ss_pred ehhHHHHHHHHHHHHHHHHHHHHHhc
Q 016789 7 AVVGGAAGALAFMAIVLGLVWLCKSQ 32 (382)
Q Consensus 7 ~iv~~~~~~~~~~~~~~~~~~~~~~~ 32 (382)
.|+++++|+++++++.+.+.++.+||
T Consensus 9 sIaagVvglll~vii~l~~~~~iRRr 34 (35)
T 1iij_A 9 FIIATVVGVLLFLILVVVVGILIKRR 34 (35)
T ss_dssp HHHHHHHHHHHHHHHTTTTTHHHHHC
T ss_pred EeHHHHHHHHHHHHHHHHhheEEeec
Confidence 35555566554444444444444443
|
| >2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.41 E-value=0.47 Score=31.26 Aligned_cols=28 Identities=25% Similarity=0.456 Sum_probs=13.5
Q ss_pred ehhHHHHHHHHHHHHHHHHHHHHHhccc
Q 016789 7 AVVGGAAGALAFMAIVLGLVWLCKSQSK 34 (382)
Q Consensus 7 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~ 34 (382)
+++|++++.+++..+.++....|++|++
T Consensus 12 ivlGg~~~lll~~glcI~ccvkcrhRrr 39 (70)
T 2klu_A 12 IVLGGVAGLLLFIGLGIFFSVRSRHRRR 39 (70)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHSSCCSS
T ss_pred HHHhHHHHHHHHHHHHHHHhhHHHHHHH
Confidence 4556665555555544443333444443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.93 E-value=0.59 Score=28.51 Aligned_cols=30 Identities=17% Similarity=0.209 Sum_probs=18.9
Q ss_pred ceehhHHHHHHHHHHHHHHHHHHHHHhcccc
Q 016789 5 IAAVVGGAAGALAFMAIVLGLVWLCKSQSKN 35 (382)
Q Consensus 5 ~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (382)
.+.+|++++++++++ +++.+++..++++++
T Consensus 14 A~gVVgGv~~~~ii~-~~~~~~~RRr~~~~k 43 (44)
T 2ks1_B 14 ATGMVGALLLLLVVA-LGIGLFMRRRHIVRK 43 (44)
T ss_dssp THHHHHHHHHHHHHH-HHHHHHHHTTTCCSC
T ss_pred EeehhHHHHHHHHHH-HHHHHHhhhhHhhcc
Confidence 344566565555444 666778888887764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.02 E-value=2.3 Score=36.05 Aligned_cols=115 Identities=10% Similarity=0.025 Sum_probs=74.7
Q ss_pred CCCCccceeeEEEeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHH-HHhcCCCCceecCCCCC
Q 016789 137 RHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLC-HLHSLKPPLVHKNFKTA 215 (382)
Q Consensus 137 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~ivHrDlk~~ 215 (382)
.||+. --..-.+.+.+.+.++.-+++.=...+. .++...+++++..++.-.. +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCc
Confidence 67777 3333355666666666554443233332 4678888998888877666 5543 678889999
Q ss_pred CeeecCCCcEEEeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 016789 216 NVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASH 288 (382)
Q Consensus 216 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~ 288 (382)
|+++|.++.+++.-.|+-.. ++|.-. +..-=.-.+=|++..++.++..|.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~------------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES------------------LPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTT------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCccc------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999988886432 233211 111123357788888888887664
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.01 E-value=0.8 Score=27.86 Aligned_cols=29 Identities=24% Similarity=0.204 Sum_probs=18.4
Q ss_pred eehhHHHHHHHHHHHHHHHHHHHHHhcccc
Q 016789 6 AAVVGGAAGALAFMAIVLGLVWLCKSQSKN 35 (382)
Q Consensus 6 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~ 35 (382)
+.+||+++++++++ ++..+++..++++++
T Consensus 14 ~gVVgGv~~v~ii~-~~~~~~~RRRr~~~k 42 (44)
T 2l2t_A 14 AGVIGGLFILVIVG-LTFAVYVRRKSIKKK 42 (44)
T ss_dssp HHHHHHHHHHHHHH-HHHHHHHHTTCSSCC
T ss_pred EeehHHHHHHHHHH-HHHHHHhhhhhhhhc
Confidence 34566565555444 666777888887764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.35 E-value=0.24 Score=47.44 Aligned_cols=56 Identities=7% Similarity=0.024 Sum_probs=17.4
Q ss_pred CCeeeccCcccEEEEEECC--eeEEE------EEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEe
Q 016789 92 TSLIGFGSFGPVYKGLLRD--TVVAI------KRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQ 150 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~--~~vav------K~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 150 (382)
.+.+| ||.||+|.+.. .+||+ |..... ....|.+|..+++.++|||+++.+++...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 45565 99999999875 46777 654331 22468889999999999999999887754
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.97 E-value=1.2 Score=31.08 Aligned_cols=24 Identities=25% Similarity=0.495 Sum_probs=14.7
Q ss_pred ceehhHHHHHHHHHHHHHHHHHHH
Q 016789 5 IAAVVGGAAGALAFMAIVLGLVWL 28 (382)
Q Consensus 5 ~~~iv~~~~~~~~~~~~~~~~~~~ 28 (382)
++.|+++++++++++.++++++|.
T Consensus 10 ~~~Iv~gvi~gilliGllllliwk 33 (79)
T 2knc_B 10 ILVVLLSVMGAILLIGLAALLIWK 33 (79)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHHHHHHHHH
Confidence 445666666666666666666664
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=80.68 E-value=2 Score=24.35 Aligned_cols=25 Identities=16% Similarity=0.284 Sum_probs=14.6
Q ss_pred ceehhHHHHHHHHHHHHHHHHHHHH
Q 016789 5 IAAVVGGAAGALAFMAIVLGLVWLC 29 (382)
Q Consensus 5 ~~~iv~~~~~~~~~~~~~~~~~~~~ 29 (382)
...++|++++.++..+++.+++|++
T Consensus 6 ~gaIaGIVvgdi~~t~~i~~~vy~~ 30 (33)
T 2l34_A 6 PGVLAGIVVGDLVLTVLIALAVYFL 30 (33)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cceEEeEeHHHHHHHHHHHHHHhhe
Confidence 3456677777666655555555543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 382 | ||||
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-52 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-41 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-40 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-34 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-31 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-31 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-29 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-29 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-11 |
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 3e-52
Identities = 68/279 (24%), Positives = 123/279 (44%), Gaps = 27/279 (9%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKR-RVGSPRQEFVAEVTYLSEIRHRNLVTLL 145
K+ IG G FG V G R VA+K + + Q F+AE + ++++RH NLV LL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLL 66
Query: 146 GYC-QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
G ++ G +V EY+ GS+ ++L G + L + +L + + +L
Sbjct: 67 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG-- 121
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVF 264
VH++ NVLV E+ +AKV+D G++K + + G + + PE F
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKF 177
Query: 265 SEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS--RLSSNNFVDHRLAGTFTT 322
S SD++SFG+ L E+ + + + ++ V ++ + +
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPY--PRIPLKDVVPRVEKGYKMDAPDGCP--------- 226
Query: 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEM 361
+ ++++ C RP + +LE I E+
Sbjct: 227 PAVYEVMK---NCWHLDAAMRPSFLQLREQLEHIKTHEL 262
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-51
Identities = 70/288 (24%), Positives = 128/288 (44%), Gaps = 25/288 (8%)
Query: 80 EELEQATKQFSETSLIGFGSFGPVYKGLLRDTVVAIK-----RRVGSPRQEFVAEVTYLS 134
++ E Q + IG GSFG VYKG V A+K Q F EV L
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 135 EIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAA 194
+ RH N++ +GY +V ++ S+ +HL+ TK E + + IA A
Sbjct: 60 KTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTA 114
Query: 195 KGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-F 253
+G+ +LH ++H++ K+ N+ + E+ K+ D G++ + + ++ +
Sbjct: 115 QGMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 254 RDPEV---EESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNN 310
PEV ++ +S SD+Y+FG+ L EL+TGQ ++ + + +I V S +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS--NINNRDQIIFMVGRGYLSPD 230
Query: 311 FVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358
R + + M+ L+ +C+ RP ++ +E +
Sbjct: 231 LSKVR---SNCPKAMKRLMA---ECLKKKRDERPLFPQILASIELLAR 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (432), Expect = 5e-51
Identities = 70/309 (22%), Positives = 138/309 (44%), Gaps = 40/309 (12%)
Query: 77 FSMEELEQATKQFSET---------SLIGFGSFGPVYKGLLRDT-----VVAIKR----R 118
F+ E+ +A ++F++ +IG G FG V G L+ VAIK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 119 VGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESS 178
R++F++E + + + H N++ L G ++ M++ E++ NGS+ + L ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR----QND 122
Query: 179 TKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238
+ Q V + G A G+ +L VH++ N+LV+ N + KV+D G+S+ LE+
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 239 IEEAGPSHGSIVNV----FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGS 294
++ + PE + F+ SD++S+G+ + E+++ E + +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY--WDMT 238
Query: 295 YEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354
+ +I + D+RL + L +L L C RPK ++ L+
Sbjct: 239 NQDVINAIEQ--------DYRL--PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 355 RIHEKEMAL 363
++ +L
Sbjct: 289 KMIRNPNSL 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-49
Identities = 67/281 (23%), Positives = 120/281 (42%), Gaps = 21/281 (7%)
Query: 80 EELEQATKQFSETSLIGFGSFGPVYKGLLRD-TVVAIK--RRVGSPRQEFVAEVTYLSEI 136
+E E + +G G FG V+ G T VA+K ++ F+AE + ++
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL 65
Query: 137 RHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKG 196
+H+ LV L Q ++ EY+ NGS+ + L S KL + + +A A+G
Sbjct: 66 QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKT---PSGIKLTINKLLDMAAQIAEG 121
Query: 197 LCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDP 256
+ + +H++ + AN+LV + K+AD G+++L+E+ E + P
Sbjct: 122 MAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316
E G F+ SD++SFG+ L E+VT + + +IQ + +R+
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPY--PGMTNPEVIQNLER--------GYRM 229
Query: 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357
+L +L C RP + + + LE
Sbjct: 230 --VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 5e-48
Identities = 61/275 (22%), Positives = 116/275 (42%), Gaps = 21/275 (7%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT-VVAIK--RRVGSPRQEFVAEVTYLSEIRHRNLVT 143
+ + IG G FG V+ G + VAIK R ++F+ E + ++ H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
L G C + LVFE++ +G L + + + + L +G+ +L
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-- 118
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGV 263
+ ++H++ N LV EN + KV+D G+++ + + + + + PEV
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 264 FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323
+S SD++SFGV + E+ + + + S +++ + + RLA T
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPY--ENRSNSEVVEDISTGF---RLYKPRLAST---- 229
Query: 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358
+ ++ C RP ++ +L I E
Sbjct: 230 ---HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (408), Expect = 1e-47
Identities = 59/289 (20%), Positives = 114/289 (39%), Gaps = 21/289 (7%)
Query: 75 RQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIK--RRVGSPRQEFVAEV 130
+ ++ E + +G G +G VY+G+ + VA+K + +EF+ E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 64
Query: 131 TYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIA 190
+ EI+H NLV LLG C + ++ E++ G++ ++L E ++ + +A
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMA 121
Query: 191 LGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIV 250
+ + +L +H++ N LV EN + KVAD G+S+L+ +
Sbjct: 122 TQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 251 NVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNN 310
+ PE FS SD+++FGV L E+ T + + + +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY--PGIDLSQVYEL--------- 228
Query: 311 FVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359
++ + L C RP + E + ++
Sbjct: 229 -LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-47
Identities = 73/291 (25%), Positives = 127/291 (43%), Gaps = 30/291 (10%)
Query: 88 QFSETSLIGFGSFGPVYKGLLRDT------VVAIKR----RVGSPRQEFVAEVTYLSEIR 137
+ +IG G FG VYKG+L+ + VAIK R +F+ E + +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 138 HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGL 197
H N++ L G + M++ EY+ NG++ L E + Q V + G A G+
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLR----EKDGEFSVLQLVGMLRGIAAGM 123
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--D 255
+L + VH++ N+LV+ N + KV+D G+S++LE+ EA + R
Sbjct: 124 KYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 256 PEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315
PE F+ SD++SFG+ + E++T E + W S ++
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPY------------WELSNHEVMKAINDG 229
Query: 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTTF 366
+ + +L +QC RRPK +++ L+++ +L T
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 280
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 6e-47
Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 82 LEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR----RVGSPRQEFVAEVTYLSE 135
+E F + S +G G+ G V+K + + V+A K + R + + E+ L E
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 136 IRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAK 195
+V G +G + E++ GS+ L + G ++ + +++ K
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIK 115
Query: 196 GLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRD 255
GL +L K ++H++ K +N+LV+ K+ D G+S L + A G+ +
Sbjct: 116 GLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTR--SYMS 171
Query: 256 PEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
PE + +S SDI+S G+ L+E+ G+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-46
Identities = 60/275 (21%), Positives = 112/275 (40%), Gaps = 25/275 (9%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT-VVAIK--RRVGSPRQEFVAEVTYLSEIRHRNLVT 143
K + +G G FG V G R VAIK + EF+ E + + H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
L G C + ++ EY+ NG + N+L E + + +Q + + + + +L
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLRE----MRHRFQTQQLLEMCKDVCEAMEYLE-- 117
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGV 263
+H++ N LV++ + KV+D G+S+ + + E + PEV
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 264 FSEMSDIYSFGVFLLELVTGQEA--SHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321
FS SDI++FGV + E+ + + + + E + Q +R
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL-----------A 226
Query: 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356
+E + ++ C RP +I+++ + +
Sbjct: 227 SEKVYTIM---YSCWHEKADERPTFKILLSNILDV 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 7e-46
Identities = 58/295 (19%), Positives = 115/295 (38%), Gaps = 35/295 (11%)
Query: 95 IGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFV--AEVTYLSEIRHRNLVTLLGYCQQNG 152
IG G FG V++G R VA+K + + AE+ +RH N++ + ++
Sbjct: 11 IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN 70
Query: 153 YQ----MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL----- 203
LV +Y +GS+ ++L + + + +AL A GL HLH
Sbjct: 71 GTWTQLWLVSDYHEHGSLFDYLNRYTVTV------EGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 204 -KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE---------AGPSHGSIVNVF 253
KP + H++ K+ N+LV +N +AD G++ ++ + G V
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 254 RDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSY--------EALIQWVRSR 305
D + + +DIY+ G+ E+ I + ++ +R
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 306 LSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360
+ + + E +R + ++ +C + G R + L ++ ++E
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 9e-46
Identities = 69/307 (22%), Positives = 127/307 (41%), Gaps = 39/307 (12%)
Query: 76 QFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT-----VVAIKR--RVGSP--RQEF 126
Q + F+E +IG G FG VY G L D A+K R+ +F
Sbjct: 18 QHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75
Query: 127 VAEVTYLSEIRHRNLVTLLGYC-QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQ 185
+ E + + H N+++LLG C + G ++V Y+ +G + N + K
Sbjct: 76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKD 131
Query: 186 RVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPS 245
+ L AKG+ L VH++ N ++DE F KVAD G+++ + + E
Sbjct: 132 LIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189
Query: 246 HGSIVNV---FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWV 302
+ + + + E ++ F+ SD++SFGV L EL+T + + + ++
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--PDVNTFDITVYL 247
Query: 303 RSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMA 362
L + + + +++ L+C RP +++ + I
Sbjct: 248 LQG-------RRLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAI------ 291
Query: 363 LTTFMGE 369
+TF+GE
Sbjct: 292 FSTFIGE 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-45
Identities = 72/283 (25%), Positives = 113/283 (39%), Gaps = 21/283 (7%)
Query: 77 FSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT-VVAIK--RRVGSPRQEFVAEVTYL 133
+ + E + +G G FG V+ G T VAIK + + F+ E +
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVM 66
Query: 134 SEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGA 193
++RH LV L + +V EY+ GS+ + L E+ L Q V +A
Sbjct: 67 KKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKG---ETGKYLRLPQLVDMAAQI 122
Query: 194 AKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF 253
A G+ ++ + VH++ + AN+LV EN + KVAD G+++L+E+ E +
Sbjct: 123 ASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180
Query: 254 RDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVD 313
PE G F+ SD++SFG+ L EL T + ++ V
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY--PGMVNREVLDQVERGYRM----- 233
Query: 314 HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356
E L L QC RP E + LE
Sbjct: 234 -----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 8e-45
Identities = 69/312 (22%), Positives = 119/312 (38%), Gaps = 45/312 (14%)
Query: 78 SMEELEQATKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKR----RVGSPRQEF 126
+ LE IG G+FG V++ T+VA+K + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 127 VAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLES--------- 177
E ++E + N+V LLG C L+FEY+ G + L +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 178 ----------STKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKV 227
L +++ IA A G+ +L VH++ T N LV EN + K+
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKI 181
Query: 228 ADTGISKLLENIEEAGPSHGSIVNV-FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEA 286
AD G+S+ + + + + + + PE ++ SD++++GV L E+ +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL- 240
Query: 287 SHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKM 346
++E +I +VR + LA +L L C S RP
Sbjct: 241 -QPYYGMAHEEVIYYVRD--------GNILA--CPENCPLELYNLMRLCWSKLPADRPSF 289
Query: 347 EIVMTELERIHE 358
+ L+R+ E
Sbjct: 290 CSIHRILQRMCE 301
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 9e-44
Identities = 73/296 (24%), Positives = 125/296 (42%), Gaps = 40/296 (13%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT----VVAIKR----RVGSPRQEFVAEVTYLSEI-R 137
+IG G+FG V K ++ AIKR ++F E+ L ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 138 HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHL-----------YETGLESSTKLEFKQR 186
H N++ LLG C+ GY L EY P+G++ + L + +++ L +Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 187 VSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH 246
+ A A+G+ +L +H++ N+LV EN++AK+AD G+S+ E +
Sbjct: 130 LHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 247 GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEA--SHIVSLGSYEALIQWVRS 304
+ + E V++ SD++S+GV L E+V+ + YE L Q R
Sbjct: 188 LPV--RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 245
Query: 305 RLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360
N + + DL+R QC RP ++ L R+ E+
Sbjct: 246 EKPLN-----------CDDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLEER 287
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (384), Expect = 1e-43
Identities = 68/292 (23%), Positives = 123/292 (42%), Gaps = 40/292 (13%)
Query: 71 PQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR------RVGSP 122
P A F ++ E K FS+ IG GSFG VY VVAIK+ +
Sbjct: 2 PDVAELFFKDDPE---KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 58
Query: 123 RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLE 182
Q+ + EV +L ++RH N + G + LV EY + L+
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQ 113
Query: 183 FKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242
+ ++ GA +GL +LHS ++H++ K N+L+ E + K+ D G + + + A
Sbjct: 114 EVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI---MAPA 168
Query: 243 GPSHGSIVNVFRDPEV---EESGVFSEMSDIYSFGVFLLELVTGQEA-SHIVSLGSYEAL 298
G+ + PEV + G + D++S G+ +EL + ++ ++ + +
Sbjct: 169 NSFVGTP--YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
Query: 299 IQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVM 350
Q L S ++ +E R+ + C+ + RP E+++
Sbjct: 227 AQNESPALQSGHW----------SEYFRNFVD---SCLQKIPQDRPTSEVLL 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 1e-42
Identities = 65/284 (22%), Positives = 112/284 (39%), Gaps = 39/284 (13%)
Query: 75 RQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR------RVGSPRQEF 126
RQ+++E+ F +G G FG VY + + ++A+K +
Sbjct: 1 RQWALED-------FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 127 VAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQR 186
EV S +RH N++ L GY L+ EY P G++ L + K + ++
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRT 108
Query: 187 VSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSH 246
+ A L + HS + ++H++ K N+L+ K+AD G S +
Sbjct: 109 ATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLC 165
Query: 247 GSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRL 306
G++ + PE+ E + E D++S GV E + G+ + I V
Sbjct: 166 GTL--DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 223
Query: 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVM 350
F TEG RDLI + + +RP + V+
Sbjct: 224 PD-----------FVTEGARDLIS---RLLKHNPSQRPMLREVL 253
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 8e-42
Identities = 64/280 (22%), Positives = 110/280 (39%), Gaps = 32/280 (11%)
Query: 94 LIGFGSFGPVYKGLLRDT-----VVAIKR----RVGSPRQEFVAEVTYLSEIRHRNLVTL 144
IG G FG V++G+ VAIK S R++F+ E + + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
+G +N ++ E G + + L L+ + A + L +L S
Sbjct: 74 IGVITENPV-WIIMELCTLGELRSFLQV----RKYSLDLASLILYAYQLSTALAYLES-- 126
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVF 264
VH++ NVLV N K+ D G+S+ +E+ S G + + PE F
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 265 SEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS--RLSSNNFVDHRLAGTFTT 322
+ SD++ FGV + E++ +I + + RL
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENGERLPMPPNCP--------- 235
Query: 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMA 362
+ L+ +C + RRP+ + +L I E+E A
Sbjct: 236 PTLYSLMT---KCWAYDPSRRPRFTELKAQLSTILEEEKA 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 6e-41
Identities = 58/275 (21%), Positives = 103/275 (37%), Gaps = 35/275 (12%)
Query: 95 IGFGSFGPVYKGLLRDT----VVAIKR-----RVGSPRQEFVAEVTYLSEIRHRNLVTLL 145
+G G+FG V KG + VA+K + + E +AE + ++ + +V ++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
G C+ + MLV E G + +L + ++ K + + + G+ +L +
Sbjct: 75 GICEAESW-MLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE--ES 126
Query: 206 PLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--DPEVEESGV 263
VH++ NVL+ AK++D G+SK L E + + PE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 264 FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS--RLSSNNFVDHRLAGTFT 321
FS SD++SFGV + E + + + + R+
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQ--KPYRGMKGSEVTAMLEKGERMGCPAGCP-------- 236
Query: 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356
M DL+ C + RP V L
Sbjct: 237 -REMYDLMN---LCWTYDVENRPGFAAVELRLRNY 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 7e-41
Identities = 55/293 (18%), Positives = 105/293 (35%), Gaps = 34/293 (11%)
Query: 80 EELEQATKQFSETSL-IGFGSFGPVYKGLLRDT----VVAIKR----RVGSPRQEFVAEV 130
++L + +G G+FG V +G+ R VAIK + +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 131 TYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIA 190
+ ++ + +V L+G CQ MLV E G + L ++ +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELL 115
Query: 191 LGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIV 250
+ G+ +L + VH++ NVL+ AK++D G+SK L + + +
Sbjct: 116 HQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 251 NVFR--DPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS--RL 306
+ PE FS SD++S+GV + E ++ + ++ ++ R+
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ--KPYKKMKGPEVMAFIEQGKRM 231
Query: 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359
+ L+ C RP V + +
Sbjct: 232 ECPPECP---------PELYALMS---DCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-40
Identities = 59/289 (20%), Positives = 119/289 (41%), Gaps = 39/289 (13%)
Query: 94 LIGFGSFGPVYKGLLRD-------TVVAIKR----RVGSPRQEFVAEVTYLSEI-RHRNL 141
+G G+FG V + VA+K + R+ ++E+ LS + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETG-------------LESSTKLEFKQRVS 188
V LLG C G +++ EY G + N L + L+ + +S
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 189 IALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGS 248
+ AKG+ L S +H++ N+L+ I K+ D G+++ ++N +
Sbjct: 150 FSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 249 IVNV-FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS 307
+ V + PE + V++ SD++S+G+FL EL + + + + + ++
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-GMPVDSKFYKMIKEGF- 265
Query: 308 SNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356
L+ M D+++ C + +RP + ++ +E+
Sbjct: 266 ------RMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-40
Identities = 51/263 (19%), Positives = 101/263 (38%), Gaps = 28/263 (10%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR---RVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQ 149
+G G+FG VYK ++T + A K + ++++ E+ L+ H N+V LL
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 150 QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVH 209
++ E+ G++ + E L Q + L +LH K ++H
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNK--IIH 133
Query: 210 KNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV-----EESGVF 264
++ K N+L + K+AD G+S + S + PEV + +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP-YWMAPEVVMCETSKDRPY 192
Query: 265 SEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEG 324
+D++S G+ L+E+ + H L L++ +S + +
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHH--ELNPMRVLLKIAKSEPPTLAQPSR------WSSN 244
Query: 325 MRDLIRLTLQCMSSPGRRRPKME 347
+D ++ +C+ R
Sbjct: 245 FKDFLK---KCLEKNVDARWTTS 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-40
Identities = 53/277 (19%), Positives = 106/277 (38%), Gaps = 33/277 (11%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIKR-----RVGSPRQEFVAEVTYLSEIRHRNL 141
+ IG GS+G K + ++ K + +Q V+EV L E++H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 142 VTLLGYC--QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCH 199
V + N +V EY G + + + + G + L+ + + + L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK-GTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 200 LHSL---KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDP 256
H ++H++ K ANV +D K+ D G++++L + + + + P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYYMSP 183
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVTGQ---EASHIVSLGSYEALIQWVRSRLSSNNFVD 313
E ++E SDI+S G L EL A L + + R+
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--AGKIREGKFRRIPYR---- 237
Query: 314 HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVM 350
++ + ++I + ++ RP +E ++
Sbjct: 238 -------YSDELNEIIT---RMLNLKDYHRPSVEEIL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-40
Identities = 63/268 (23%), Positives = 109/268 (40%), Gaps = 32/268 (11%)
Query: 95 IGFGSFGPVYKGLLRDT--VVAIKR-----RVGSPRQEFVAEVTYLSEIRHRNLVTLLGY 147
IG GSF VYKGL +T VA S RQ F E L ++H N+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 148 CQ----QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
+ +LV E + +G++ +L ++ K S KGL LH+
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTR 131
Query: 204 KPPLVHKNFKTANVLV-DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESG 262
PP++H++ K N+ + K+ D G++ L A G+ F PE+ E
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTP--EFMAPEMYE-E 187
Query: 263 VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322
+ E D+Y+FG+ +LE+ T + + + + V S + +F
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYS--ECQNAAQIYRRVTSGVKPASFDKV------AI 239
Query: 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVM 350
++++I C+ R ++ ++
Sbjct: 240 PEVKEIIE---GCIRQNKDERYSIKDLL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 5e-40
Identities = 47/272 (17%), Positives = 98/272 (36%), Gaps = 26/272 (9%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR----RVGSPRQEFVAEVTYLSEIRHRN 140
+ + +G G++G V + R T VA+K R + E+ + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL 200
+V G+ ++ Q L EY G + + + + G+ +L
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYL 119
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPEVE 259
H + + H++ K N+L+DE K++D G++ + + + + PE+
Sbjct: 120 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 260 ESGVF-SEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318
+ F +E D++S G+ L ++ G+ S S + W + N +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKEKKTYLNPWKK----- 231
Query: 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVM 350
L+ + + R + +
Sbjct: 232 --IDSAPLALLH---KILVENPSARITIPDIK 258
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-40
Identities = 64/280 (22%), Positives = 119/280 (42%), Gaps = 30/280 (10%)
Query: 88 QFSETSLIGFGSFGPVYKGLLRDT------VVAIK--RRVGSP--RQEFVAEVTYLSEIR 137
+F + ++G G+FG VYKGL VAIK R SP +E + E ++ +
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 138 HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGL 197
+ ++ LLG C + L+ + +P G + +++ E + + ++ + AKG+
Sbjct: 70 NPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGS----QYLLNWCVQIAKGM 124
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDP 256
+L LVH++ NVLV K+ D G++KLL E+ + G V + +
Sbjct: 125 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316
E +++ SD++S+GV + EL+T + + RL
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS--KPYDGIPASEISSILEK--------GERL 232
Query: 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356
D+ + ++C RPK ++ E ++
Sbjct: 233 --PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-40
Identities = 60/292 (20%), Positives = 117/292 (40%), Gaps = 44/292 (15%)
Query: 94 LIGFGSFGPVYKGLLRDT-------VVAIKR----RVGSPRQEFVAEVTYLSEI-RHRNL 141
++G G+FG V VA+K S R+ ++E+ ++++ H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETG------------------LESSTKLEF 183
V LLG C +G L+FEY G + N+L E L F
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 184 KQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243
+ + A AKG+ L VH++ NVLV + K+ D G+++ + +
Sbjct: 164 EDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 221
Query: 244 PSHGSIVNV-FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWV 302
+ + V + PE G+++ SD++S+G+ L E+ + + + + +
Sbjct: 222 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY-PGIPVDANFYKLI 280
Query: 303 RSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354
++ + + TE + +++ C + R+RP + + L
Sbjct: 281 QNGFKMD-------QPFYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLG 322
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-39
Identities = 69/304 (22%), Positives = 133/304 (43%), Gaps = 31/304 (10%)
Query: 80 EELEQATKQFSETSLIGFGSFGPVYKGLLRDTV-------VAIKR----RVGSPRQEFVA 128
+E E A ++ + + +G GSFG VY+G+ + V VAIK R EF+
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 72
Query: 129 EVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETG-----LESSTKLEF 183
E + + E ++V LLG Q +++ E + G + ++L
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 184 KQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243
+ + +A A G+ +L++ VH++ N +V E+F K+ D G+++ + +
Sbjct: 133 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 244 PSHGSIVNV-FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWV 302
++ V + PE + GVF+ SD++SFGV L E+ T E + S E ++++V
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQVLRFV 248
Query: 303 RSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMA 362
+ D+ + + +L+R C + RP +++ ++ E
Sbjct: 249 MEG-GLLDKPDN------CPDMLFELMR---MCWQYNPKMRPSFLEIISSIKEEMEPGFR 298
Query: 363 LTTF 366
+F
Sbjct: 299 EVSF 302
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 4e-39
Identities = 69/298 (23%), Positives = 130/298 (43%), Gaps = 44/298 (14%)
Query: 94 LIGFGSFGPVYKGLLRDT---------VVAIKR----RVGSPRQEFVAEVTYLSEI-RHR 139
+G G+FG V VA+K + ++E+ + I +H+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 140 NLVTLLGYCQQNGYQMLVFEYLPNGSMCNHL-----------YETGLESSTKLEFKQRVS 188
N++ LLG C Q+G ++ EY G++ +L Y +L K VS
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 189 IALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGS 248
A A+G+ +L S +H++ NVLV E+ + K+AD G+++ + +I+ +
Sbjct: 140 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 249 IVNV-FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS 307
+ V + PE +++ SD++SFGV L E+ T + + E L + ++
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFKLLKE--- 252
Query: 308 SNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALTT 365
HR+ + +L + C + +RP + ++ +L+RI +ALT+
Sbjct: 253 -----GHRM--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI----VALTS 299
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 139 bits (351), Expect = 1e-38
Identities = 53/261 (20%), Positives = 103/261 (39%), Gaps = 25/261 (9%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKR---RVGSPRQEFVAEVTYLSEIRHRNLVTLLGYC 148
+G G+FG V++ R T A K S ++ E+ +S +RH LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 149 QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLV 208
+ + ++++E++ G + + + K+ + V KGLCH+H V
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN--YV 146
Query: 209 HKNFKTANVLV--DENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSE 266
H + K N++ + K+ D G++ L+ + + G+ F PEV E
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA--EFAAPEVAEGKPVGY 204
Query: 267 MSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMR 326
+D++S GV L++G + ++ + + F +E +
Sbjct: 205 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG-------ISEDGK 257
Query: 327 DLIRLTLQCMSSPGRRRPKME 347
D IR + + + R +
Sbjct: 258 DFIR---KLLLADPNTRMTIH 275
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 1e-38
Identities = 53/283 (18%), Positives = 112/283 (39%), Gaps = 31/283 (10%)
Query: 79 MEELEQA------TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR---RVGSPRQEFV 127
+E+L K+++ IG G+ G VY + T VAI++ + ++ +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 128 AEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRV 187
E+ + E ++ N+V L +V EYL GS+ + + ET ++ Q
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE------GQIA 119
Query: 188 SIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHG 247
++ + L LHS + ++H++ K+ N+L+ + K+ D G + + +
Sbjct: 120 AVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 248 SIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS 307
+ PEV + DI+S G+ +E++ G+ + AL +
Sbjct: 178 GTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTP 234
Query: 308 SNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVM 350
+ + RD + +C+ +R + ++
Sbjct: 235 ELQNPEK------LSAIFRDFLN---RCLDMDVEKRGSAKELL 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-38
Identities = 64/284 (22%), Positives = 103/284 (36%), Gaps = 33/284 (11%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT-----VVAIKR----RVGSP--RQEFVAEVTYLSE 135
K +G GSFG V +G VA+K + P +F+ EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 136 IRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAK 195
+ HRNL+ L G +V E P GS L + + A+ A+
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGS----LLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 196 GLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR- 254
G+ +L S +H++ N+L+ + K+ D G+ + L ++ F
Sbjct: 123 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 255 -DPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFV 312
PE ++ FS SD + FGV L E+ T GQE ++ I RL
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356
+D+ + +QC + RP + L
Sbjct: 241 P------------QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 130 bits (328), Expect = 4e-36
Identities = 54/282 (19%), Positives = 110/282 (39%), Gaps = 36/282 (12%)
Query: 88 QFSETSLIGFGSFGPVYKGLLRDT--VVAIK------------RRVGSPRQEFVAEVTYL 133
+ ++G G V + + + T A+K V R+ + EV L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 134 SEIR-HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALG 192
++ H N++ L + N + LVF+ + G + ++L E L K+ I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRA 118
Query: 193 AAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVN- 251
+ +C LH L +VH++ K N+L+D++ K+ D G S L+ E+ G+
Sbjct: 119 LLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 176
Query: 252 ---VFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS 308
+ + + + D++S GV + L+ G +I + S
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236
Query: 309 NNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVM 350
+ D+ ++ ++DL+ + + ++R E +
Sbjct: 237 PEWDDY-------SDTVKDLVS---RFLVVQPQKRYTAEEAL 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 6e-36
Identities = 38/197 (19%), Positives = 85/197 (43%), Gaps = 14/197 (7%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK--RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQ 149
+G G FG V++ + + K + G+ + E++ L+ RHRN++ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 150 QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVH 209
+++FE++ + + + +L ++ VS + L LHS + H
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHSHN--IGH 125
Query: 210 KNFKTANVLVD--ENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEM 267
+ + N++ + K+ + G ++ L+ + + + PEV + V S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP--EYYAPEVHQHDVVSTA 183
Query: 268 SDIYSFGVFLLELVTGQ 284
+D++S G + L++G
Sbjct: 184 TDMWSLGTLVYVLLSGI 200
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 131 bits (330), Expect = 1e-35
Identities = 46/264 (17%), Positives = 105/264 (39%), Gaps = 25/264 (9%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK---RRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYC 148
+G G+FG V++ + + T V K + E++ ++++ H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 149 QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLV 208
+ +L+ E+L G + + + K+ + ++ A +GL H+H +V
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS--IV 149
Query: 209 HKNFKTANVLVD--ENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSE 266
H + K N++ + + K+ D G++ L E + + F PE+ +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA--EFAAPEIVDREPVGF 207
Query: 267 MSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMR 326
+D+++ GV L++G + +Q V+ ++ A + + +
Sbjct: 208 YTDMWAIGVLGYVLLSGL---SPFAGEDDLETLQNVK----RCDWEFDEDAFSSVSPEAK 260
Query: 327 DLIRLTLQCMSSPGRRRPKMEIVM 350
D I+ + R+R + +
Sbjct: 261 DFIK---NLLQKEPRKRLTVHDAL 281
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 6e-35
Identities = 40/200 (20%), Positives = 76/200 (38%), Gaps = 16/200 (8%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK----RRVGSP--RQEFVAEVTYLSEIRHRNLVTLL 145
++G GSF V T AIK R + E +S + H V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 146 GYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKP 205
Q + Y NG + ++ + G + L +LH
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHG--K 127
Query: 206 PLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDPEVEESGVF 264
++H++ K N+L++E+ ++ D G +K+L + ++ + + PE+
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 265 SEMSDIYSFGVFLLELVTGQ 284
+ SD+++ G + +LV G
Sbjct: 188 CKSSDLWALGCIIYQLVAGL 207
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (318), Expect = 3e-34
Identities = 55/277 (19%), Positives = 105/277 (37%), Gaps = 28/277 (10%)
Query: 80 EELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQEFVAEVTYL 133
++ E + ++G G+F V + T +VAIK + + E+ L
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 134 SEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGA 193
+I+H N+V L + G+ L+ + + G + + + E G + +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQV 116
Query: 194 AKGLCHLHSLKPPLVHKNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIV 250
+ +LH +VH++ K N+L DE+ ++D G+SK+ + + G+
Sbjct: 117 LDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTP- 173
Query: 251 NVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNN 310
+ PEV +S+ D +S GV L+ G + + I S
Sbjct: 174 -GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY 232
Query: 311 FVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKME 347
+ D ++ +D IR M +R E
Sbjct: 233 WDD-------ISDSAKDFIR---HLMEKDPEKRFTCE 259
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 125 bits (314), Expect = 5e-34
Identities = 52/278 (18%), Positives = 102/278 (36%), Gaps = 30/278 (10%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKR------RVGSPRQEFVAEVTYLSEIRHRNLVTLL 145
++GFG V+ VA+K R S F E + + H +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 146 GYCQ----QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH 201
+ +V EY+ ++ + ++ G + K+ + + A + L H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSH 128
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIV--NVFRDPEVE 259
++H++ K AN+++ KV D GI++ + + + +++ + PE
Sbjct: 129 QNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319
SD+YS G L E++TG+ S Q VR + L
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--PVSVAYQHVREDPIPPSARHEGL--- 241
Query: 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357
+ + ++ L +P R + +L R+H
Sbjct: 242 --SADLDAVVLKALA--KNPENRYQTAAEMRADLVRVH 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-32
Identities = 57/286 (19%), Positives = 107/286 (37%), Gaps = 37/286 (12%)
Query: 77 FSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR---------RVGSPRQE 125
F E ++ + +G G F V K + T A K R G R++
Sbjct: 3 FRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 126 FVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQ 185
EV+ L EI+H N++TL + +L+ E + G + + L E L ++
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEE 114
Query: 186 RVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDEN----FIAKVADTGISKLLENIEE 241
G+ +LHS + H + K N+++ + K+ D G++ ++ E
Sbjct: 115 ATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQW 301
G+ F PE+ +D++S GV L++G + A +
Sbjct: 173 FKNIFGT--PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230
Query: 302 VRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKME 347
V F + T+ +D IR + + ++R ++
Sbjct: 231 VNYEFEDEYFSN-------TSALAKDFIR---RLLVKDPKKRMTIQ 266
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 122 bits (308), Expect = 2e-32
Identities = 51/267 (19%), Positives = 100/267 (37%), Gaps = 31/267 (11%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIKR----RVGSPRQE-----FVAEVTYLSEIR 137
FS +IG G FG VY DT + A+K R+ + E ++ +S
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 138 HRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGL 197
+V + + + + G + HL + G+ S A GL
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-----ADMRFYAAEIILGL 120
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPE 257
H+H+ +V+++ K AN+L+DE+ +++D G++ ++ S G+
Sbjct: 121 EHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGY-MAPEV 176
Query: 258 VEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317
+++ + +D +S G L +L+ G + + + L
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-------AVELP 229
Query: 318 GTFTTEGMRDLIRLTLQCMSSPGRRRP 344
+F+ E +R L+ + RR
Sbjct: 230 DSFSPE-LRSLLE---GLLQRDVNRRL 252
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 5e-32
Identities = 55/234 (23%), Positives = 100/234 (42%), Gaps = 25/234 (10%)
Query: 60 PSSATGQPSFGPQGARQFSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR 117
++ P GP ++ S +++T +IG GSFG VY+ L D+ +VAIK
Sbjct: 3 VTTVVATPGQGPDRPQEVS----------YTDTKVIGNGSFGVVYQAKLCDSGELVAIK- 51
Query: 118 RVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNG------YQMLVFEYLPNGSMCNHLY 171
+V ++ E+ + ++ H N+V L + +G Y LV +Y+P +
Sbjct: 52 KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET--VYRVA 109
Query: 172 ETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD-ENFIAKVADT 230
+ L + L ++HS + H++ K N+L+D + + K+ D
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDF 167
Query: 231 GISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
G +K L E S+ + + ++ D++S G L EL+ GQ
Sbjct: 168 GSAKQLVR-GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-31
Identities = 45/208 (21%), Positives = 90/208 (43%), Gaps = 13/208 (6%)
Query: 86 TKQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR----RVGSPRQEFVAEVTYLSEIRHR 139
+++ S IG G++G V VAIK+ + Q + E+ L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 140 NLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCH 199
N++ + + + + YL M LY+ L + L +GL +
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK--LLKTQHLSNDHICYFLYQILRGLKY 124
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV--FRDPE 257
+HS ++H++ K +N+L++ K+ D G++++ + + V +R PE
Sbjct: 125 IHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 258 V-EESGVFSEMSDIYSFGVFLLELVTGQ 284
+ S +++ DI+S G L E+++ +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 4e-31
Identities = 61/296 (20%), Positives = 116/296 (39%), Gaps = 38/296 (12%)
Query: 88 QFSETSLIGFGSFGPVYKGLLRDT-------VVAIKR----RVGSPRQEFVAEVTYLSEI 136
+ +G G+FG V + VA+K S + ++E+ L I
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 137 RHR-NLVTLLGYCQQ-NGYQMLVFEYLPNGSMCNHLYETGLE-----------SSTKLEF 183
H N+V LLG C + G M++ E+ G++ +L E L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 184 KQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243
+ + + AKG+ L S K +H++ N+L+ E + K+ D G+++ + +
Sbjct: 134 EHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 244 PSHGSIVNV-FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWV 302
+ + + + PE V++ SD++SFGV L E+ + + + + +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEF 246
Query: 303 RSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358
RL + A +TT M + L C +RP ++ L + +
Sbjct: 247 CRRLKEGTRMR---APDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (292), Expect = 1e-30
Identities = 44/280 (15%), Positives = 87/280 (31%), Gaps = 26/280 (9%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEFVAEVTYLSEIRHRNLVTLLGYC-Q 149
IG GSFG +Y G VAIK V + + E ++ + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 73
Query: 150 QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVH 209
+ Y ++V E L + + K K + +A + ++HS +H
Sbjct: 74 EGDYNVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSKN--FIH 126
Query: 210 KNFKTANVLV---DENFIAKVADTGISKLLENIEEAGPSHGSIVNV------FRDPEVEE 260
++ K N L+ + + + D G++K + +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 261 SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320
S D+ S G L+ G L + ++ R + L +
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGS--LPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360
+E + C S +P + + ++
Sbjct: 245 PSE-FATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 4e-30
Identities = 48/203 (23%), Positives = 81/203 (39%), Gaps = 13/203 (6%)
Query: 89 FSETSLIGFGSFGPVYKGLLRDT--VVAIKR-----RVGSPRQEFVAEVTYLSEIRHRNL 141
F + IG G++G VYK + T VVA+K+ + E++ L E+ H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH 201
V LL LVFE+L + + T + S +GL H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEES 261
S ++H++ K N+L++ K+AD G+++ + +
Sbjct: 120 S--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 262 GVFSEMSDIYSFGVFLLELVTGQ 284
+S DI+S G E+VT +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 6e-30
Identities = 45/264 (17%), Positives = 100/264 (37%), Gaps = 25/264 (9%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVAEV-TYLSEIRHRNLVTLLGYCQ- 149
++G G G V + + T A+K + + EV + + ++V ++ +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKARREVELHWRASQCPHIVRIVDVYEN 76
Query: 150 ---QNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPP 206
++V E L G + + + + G ++ I + + +LHS+
Sbjct: 77 LYAGRKCLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN-- 131
Query: 207 LVHKNFKTANVLVD---ENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGV 263
+ H++ K N+L N I K+ D G +K + + + PEV
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY--YVAPEVLGPEK 189
Query: 264 FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323
+ + D++S GV + L+ G A+ +++R+ + + +E
Sbjct: 190 YDKSCDMWSLGVIMYILLCGY---PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246
Query: 324 GMRDLIRLTLQCMSSPGRRRPKME 347
++ LIR + + +R +
Sbjct: 247 EVKMLIR---NLLKTEPTQRMTIT 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 9e-30
Identities = 51/201 (25%), Positives = 82/201 (40%), Gaps = 19/201 (9%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKR------RVGSPRQEFVAEVTYLS-EIRHRNLVTL 144
++G GSFG V+ + T AIK + + + E LS H L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 145 LGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK 204
Q V EYL G + H+ K + + A GL LHS
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG 123
Query: 205 PPLVHKNFKTANVLVDENFIAKVADTGISKLLE-NIEEAGPSHGSIVNVFRDPEVEESGV 263
+V+++ K N+L+D++ K+AD G+ K + G+ + PE+
Sbjct: 124 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT--PDYIAPEILLGQK 179
Query: 264 FSEMSDIYSFGVFLLELVTGQ 284
++ D +SFGV L E++ GQ
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 2e-29
Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 17/201 (8%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKR--------RVGSPRQEFVAEVTYLSEIRHRNLVT 143
+G G F VYK ++T +VAIK+ + + E+ L E+ H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 144 LLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL 203
LL LVF++ M L ++S L + L +GL +LH
Sbjct: 65 LLDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 204 KPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGV 263
++H++ K N+L+DEN + K+AD G++K + A + + +
Sbjct: 119 -HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 264 FSEMSDIYSFGVFLLELVTGQ 284
+ D+++ G L EL+
Sbjct: 178 YGVGVDMWAVGCILAELLLRV 198
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 2e-29
Identities = 57/307 (18%), Positives = 107/307 (34%), Gaps = 40/307 (13%)
Query: 85 ATKQFSETSLIGFGSFGPVYKGLLRDT---VVAIKR--------RVGSPRQEFVAEVTYL 133
A +Q+ + IG G++G V+K VA+KR + VA + +L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 134 SEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCN-HLYETGLESSTKLEFKQRVSIALG 192
H N+V L C + L + + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 193 AAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV 252
+GL LHS + +VH++ K N+LV + K+AD G++++ ++
Sbjct: 125 LLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW-- 180
Query: 253 FRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ----------EASHIVSLGSYEALIQWV 302
+R PEV ++ D++S G E+ + + I+ + W
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 303 RSRLSSNNFVDHRLAGTFTT------EGMRDLIRLTLQCMSSPGRRRPKMEIVMT----- 351
R + A E +DL+ +C++ +R ++
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSALSHPYFQ 297
Query: 352 ELERIHE 358
+LER E
Sbjct: 298 DLERCKE 304
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 112 bits (280), Expect = 3e-29
Identities = 45/203 (22%), Positives = 77/203 (37%), Gaps = 13/203 (6%)
Query: 88 QFSETSLIGFGSFGPVYKGLLRDT-VVAIK-----RRVGSPRQEFVAEVTYLSEIRHRNL 141
++ IG G++G VYK A+K + + E++ L E++H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 142 VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLH 201
V L +LVFE+L G LE S L G+ + H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCH 117
Query: 202 SLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEES 261
++H++ K N+L++ K+AD G+++ + + S
Sbjct: 118 D--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 262 GVFSEMSDIYSFGVFLLELVTGQ 284
+S DI+S G E+V G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (281), Expect = 6e-29
Identities = 52/285 (18%), Positives = 112/285 (39%), Gaps = 39/285 (13%)
Query: 77 FSMEELEQATKQFSETSLIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQ--EFVA 128
+S+++ F +G GSFG V+ R A+K V +Q
Sbjct: 1 YSLQD-------FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53
Query: 129 EVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVS 188
E LS + H ++ + G Q ++ +Y+ G + + L + S +
Sbjct: 54 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKF 108
Query: 189 IALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGS 248
A L +LHS +++++ K N+L+D+N K+ D G +K + ++
Sbjct: 109 YAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPD 166
Query: 249 IVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS 308
+ PEV + +++ D +SFG+ + E++ G + + + + + + L
Sbjct: 167 ----YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY--TPFYDSNTMKTYEKILNAELRF 220
Query: 309 NNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTEL 353
F + E ++DL+ + +R ++ ++
Sbjct: 221 PPFFN---------EDVKDLLSRLIT--RDLSQRLGNLQNGTEDV 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 110 bits (275), Expect = 2e-28
Identities = 41/281 (14%), Positives = 79/281 (28%), Gaps = 26/281 (9%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKR-RVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQ 150
IG GSFG +++G VAIK S + E + + + Y Q
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71
Query: 151 NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHK 210
G ++ L S+ + L G K K A + +H LV++
Sbjct: 72 EGLHNVLVIDLLGPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS--LVYR 125
Query: 211 NFKTANVLVDENFI-----AKVADTGISKLLENIEEAGPSHGSIVNV------FRDPEVE 259
+ K N L+ V D G+ K + +
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319
S D+ + G + + G + + + + + + S +
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC---A 242
Query: 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360
E + + P + + ++ E+
Sbjct: 243 GFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 9e-27
Identities = 42/211 (19%), Positives = 84/211 (39%), Gaps = 16/211 (7%)
Query: 88 QFSETSLIGFGSFGPVYKGLLRDT--VVAIKR-----RVGSPRQEFVAEVTYLSEIRHRN 140
++ + + IG G+FG V+K R T VA+K+ + E+ L ++H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 141 LVTLLGYCQQNGYQMLVFE---YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGL 197
+V L+ C+ + YL + L K + + GL
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130
Query: 198 CHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFR--- 254
++H ++H++ K ANVL+ + + K+AD G+++ + + P+ + V
Sbjct: 131 YYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 255 -DPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
+ + D++ G + E+ T
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 6e-26
Identities = 45/205 (21%), Positives = 85/205 (41%), Gaps = 14/205 (6%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR-----RVGSPRQEFVAEVTYLSEIRHR 139
+++ + IG G++G V+K R+T +VA+KR + E+ L E++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 140 NLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCH 199
N+V L + LVFE+ G L+ + S KGL
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGF 116
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVE 259
HS ++H++ K N+L++ N K+A+ G+++ + + +
Sbjct: 117 CHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQ 284
+ ++S D++S G EL
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAG 199
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 1e-25
Identities = 53/272 (19%), Positives = 96/272 (35%), Gaps = 44/272 (16%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKR---------RVGSPRQEFVAEVTYLSEIR--HRN 140
L+G G FG VY G+ VAIK EV L ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL 200
++ LL + ++ +L+ E + L+ + S + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDF----ITERGALQEELARSFFWQVLEAVRHC 126
Query: 201 HSLKPPLVHKNFKTANVLVDEN-FIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV- 258
H+ ++H++ K N+L+D N K+ D G LL++ G+ V+ PE
Sbjct: 127 HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTR--VYSPPEWI 181
Query: 259 EESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318
+ ++S G+ L ++V G +E + +R ++ V
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIP--------FEHDEEIIRGQVFFRQRVS----- 228
Query: 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVM 350
+ LIR C++ RP E +
Sbjct: 229 ----SECQHLIR---WCLALRPSDRPTFEEIQ 253
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 1e-24
Identities = 46/207 (22%), Positives = 75/207 (36%), Gaps = 18/207 (8%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR------RVGSPRQEFVAEVTYLSEIRH 138
F L+G G+FG V + T A+K V E L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 139 RNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLC 198
L L Q + V EY G + HL ++ L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALE 119
Query: 199 HLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE-AGPSHGSIVNVFRDPE 257
+LHS +V+++ K N+++D++ K+ D G+ K + G+ + PE
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP--EYLAPE 175
Query: 258 VEESGVFSEMSDIYSFGVFLLELVTGQ 284
V E + D + GV + E++ G+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 2e-24
Identities = 42/221 (19%), Positives = 87/221 (39%), Gaps = 21/221 (9%)
Query: 77 FSMEELEQATKQFSE----TSLIGFGSFGPVYKGLLRDT--VVAIKR-----RVGSPRQE 125
F +E+ + + +G G++G V + T VAIK+ + +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 126 FVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQ 185
E+ L +RH N++ LL + ++ L KL +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK-LMKHEKLGEDR 122
Query: 186 RVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPS 245
+ KGL ++H+ H++ K N+ V+E+ K+ D G+++ ++
Sbjct: 123 IQFLVYQMLKGLRYIHAAGII--HRDLKPGNLAVNEDCELKILDFGLARQADS-----EM 175
Query: 246 HGSIVNVFR--DPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
G +V + + +++ DI+S G + E++TG+
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 96.8 bits (240), Expect = 3e-23
Identities = 38/198 (19%), Positives = 80/198 (40%), Gaps = 19/198 (9%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIKRRVGSPRQEFVAEVTYLSEIR-HRNLVTLLGYCQQ 150
+G G + V++ + V +K +++ E+ L +R N++TL +
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD 101
Query: 151 --NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLV 208
+ LVFE++ N L K L + HS+ ++
Sbjct: 102 PVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMG--IM 151
Query: 209 HKNFKTANVLVD-ENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEV-EESGVFSE 266
H++ K NV++D E+ ++ D G+++ +E S F+ PE+ + ++
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR--YFKGPELLVDYQMYDY 209
Query: 267 MSDIYSFGVFLLELVTGQ 284
D++S G L ++ +
Sbjct: 210 SLDMWSLGCMLASMIFRK 227
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 96.0 bits (238), Expect = 8e-23
Identities = 48/205 (23%), Positives = 83/205 (40%), Gaps = 19/205 (9%)
Query: 88 QFSETSLIGFGSFGPVYKGLLRDT--VVAIK----RRVGSPRQ--EFVAEVTYLSEIRHR 139
QF +G GSFG V +++ A+K ++V +Q + E L +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 140 NLVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCH 199
LV L + N +V EY+ G M +HL G + A +
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEY 156
Query: 200 LHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVE 259
LHSL L++++ K N+L+D+ +V D G +K ++ PE+
Sbjct: 157 LHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE----ALAPEII 210
Query: 260 ESGVFSEMSDIYSFGVFLLELVTGQ 284
S +++ D ++ GV + E+ G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.0 bits (222), Expect = 9e-21
Identities = 44/225 (19%), Positives = 96/225 (42%), Gaps = 27/225 (12%)
Query: 76 QFSMEELEQATKQFSE----TSLIGFGSFGPVYKGLLRDT--VVAIKR-----RVGSPRQ 124
F +EL + + E S +G G++G V T VA+K+ + +
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 125 EFVAEVTYLSEIRHRNLVTLLGYCQ-----QNGYQMLVFEYLPNGSMCNHLYETGLESST 179
E+ L ++H N++ LL + + + +L G+ N++ +
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQ----- 116
Query: 180 KLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239
KL + +GL ++HS ++H++ K +N+ V+E+ K+ D G+++ +
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR---HT 171
Query: 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
++ + + + +++ DI+S G + EL+TG+
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 2e-20
Identities = 45/206 (21%), Positives = 77/206 (37%), Gaps = 22/206 (10%)
Query: 94 LIGFGSFGPVYKGLLR-----DTVVAIKR-------RVGSPRQEFVAEVTYLSEIRHR-N 140
++G G++G V+ + A+K + + E L IR
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 141 LVTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHL 200
LVTL Q L+ +Y+ G + HL + + + L HL
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHL 145
Query: 201 HSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEE 260
H L +++++ K N+L+D N + D G+SK E + P++
Sbjct: 146 HKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 261 SGV--FSEMSDIYSFGVFLLELVTGQ 284
G + D +S GV + EL+TG
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.7 bits (216), Expect = 7e-20
Identities = 44/211 (20%), Positives = 83/211 (39%), Gaps = 25/211 (11%)
Query: 87 KQFSETSLIGFGSFGPVYKGLLRDT--VVAIKR-----RVGSPRQEFVAEVTYLSEIRHR 139
K++ IG G+ G V VAIK+ + + + E+ + + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 140 NLVTLLGYC------QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGA 193
N+++LL ++ LV E + E E + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE--------RMSYLLYQM 128
Query: 194 AKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNVF 253
G+ HLHS ++H++ K +N++V + K+ D G+++ P + +
Sbjct: 129 LCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR--YY 184
Query: 254 RDPEVEESGVFSEMSDIYSFGVFLLELVTGQ 284
R PEV + E DI+S G + E+V +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 81.6 bits (200), Expect = 9e-18
Identities = 39/208 (18%), Positives = 70/208 (33%), Gaps = 18/208 (8%)
Query: 94 LIGFGSFGPVYKGLLRDT--VVAIK--RRVGSPRQEFVAEVTYLSEIRHRNL-------- 141
+G+G F V+ VA+K R + E+ L + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 142 ---VTLLGYCQQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLC 198
+ LL + G + + N L + I+ GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 199 HLHSLKPPLVHKNFKTANVLVD-ENFIAKVADTGISKLLENIEEAGPSHGSIVNV-FRDP 256
++H + ++H + K NVL++ + + I+ L SI +R P
Sbjct: 140 YMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP 198
Query: 257 EVEESGVFSEMSDIYSFGVFLLELVTGQ 284
EV + +DI+S + EL+TG
Sbjct: 199 EVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 60.6 bits (146), Expect = 2e-11
Identities = 32/208 (15%), Positives = 55/208 (26%), Gaps = 43/208 (20%)
Query: 93 SLIGFGSFGPVYKGLLRD-TVVAIK---------RRVGSPRQ----EFVAEVTYLSEIRH 138
L+G G V+ +K ++V R F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 139 RNLVTLLGYCQQNGY----QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAA 194
R L L G Y ++ E + + E E +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDE------------VLDMIL 113
Query: 195 KGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGPSHGSIVNV-- 252
+ + + +VH + NVLV E I + D S + + N+
Sbjct: 114 EEVAKFYH--RGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIIT 170
Query: 253 -FRDPEVEESGVFSEMSDIYSFGVFLLE 279
F + DI S +L+
Sbjct: 171 YFSRT-------YRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 382 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.58 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.19 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.74 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.48 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.19 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.0 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-57 Score=407.25 Aligned_cols=255 Identities=22% Similarity=0.371 Sum_probs=201.4
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
++|+..+.||+|+||+||+|.+.+ ..||||++... ..++|.+|++++++++||||++++|+|...+..++|||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 467788899999999999999875 68999987643 456899999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... ..+++..++.++.|+|.||.|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 85 g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 85 GCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999987542 36889999999999999999999987 9999999999999999999999999998776544444
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....+|+.|+|||.+.+..|+.++|||||||++|||+|+..|+... .....+.+.+...... ..+..
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~--~~~~~~~~~i~~~~~~----------~~p~~ 226 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--RSNSEVVEDISTGFRL----------YKPRL 226 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS--CCHHHHHHHHHHTCCC----------CCCTT
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC--CCHHHHHHHHHhcCCC----------CCccc
Confidence 44456788899999999999999999999999999999965554322 2333444444332211 11223
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
++..+.+++.+||+.||++||||++|++.|++|.+.
T Consensus 227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 346788999999999999999999999999999753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-57 Score=409.50 Aligned_cols=257 Identities=27% Similarity=0.415 Sum_probs=203.6
Q ss_pred HhCCCCCCeeeccCcccEEEEEECCeeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
.++|+..+.||+|+||+||+|++++ .||||.+... ..+.|.+|+++|++++||||++++|++.+ +..++||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 4678899999999999999998766 5899987532 23578999999999999999999999865 468999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
|++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ||||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 85 CEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred CCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999997543 36899999999999999999999977 9999999999999999999999999998765433
Q ss_pred cc-CCCcccccccccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 241 EA-GPSHGSIVNVFRDPEVEES---GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 241 ~~-~~~~~~~~~~y~aPE~~~~---~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
.. ......+|+.|||||++.+ ..|+.++|||||||++|||+||+.||.... ....+..............
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~--~~~~~~~~~~~~~~~p~~~---- 232 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSPDLS---- 232 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC--CHHHHHHHHHHTSCCCCGG----
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC--hHHHHHHHHhcCCCCCcch----
Confidence 22 2334567899999999864 358999999999999999999999997433 2233333333322221111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~ 358 (382)
..+..+++.+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 233 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 233 --KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp --GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1123345678899999999999999999999999998864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-57 Score=413.17 Aligned_cols=258 Identities=22% Similarity=0.347 Sum_probs=215.0
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
..++|+..+.||+|+||+||+|.+.. ..||+|++... ..++|.+|+++|++++||||++++|+|.+.+..++||||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 34678888999999999999999864 78999987643 356799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
|++|+|.+++.... ...+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 95 ~~~g~l~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 95 MTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ccCcchHHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999997643 346899999999999999999999987 9999999999999999999999999999775544
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
........+++.|+|||++.+..|+.++|||||||++|||++|+.|+... .+...+.+.+..... ...
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~--~~~~~~~~~i~~~~~----------~~~ 237 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--IDLSQVYELLEKDYR----------MER 237 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT--CCHHHHHHHHHTTCC----------CCC
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc--chHHHHHHHHhcCCC----------CCC
Confidence 33334455678899999999999999999999999999999987776532 233334343333211 122
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
+...+..+.+++.+||+.||++|||+.+|++.|+.+.++
T Consensus 238 ~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 333456788999999999999999999999999988644
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-56 Score=408.94 Aligned_cols=258 Identities=25% Similarity=0.433 Sum_probs=201.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-----eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
++|+..++||+|+||+||+|.+.. ..||+|.+.... .++|.+|+++|++++|||||+++|+|...+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 345566799999999999999853 368999875432 34699999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
||||++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 106 ~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999999887542 36899999999999999999999987 9999999999999999999999999998775
Q ss_pred cccccCC----CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 238 NIEEAGP----SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 238 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
....... ....+|+.|||||.+.++.++.++|||||||++|||+| |+.||.... ...+...+.....
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~---~~~~~~~i~~~~~----- 251 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT---NQDVINAIEQDYR----- 251 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCC-----
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC-----
Confidence 4332221 22346788999999999999999999999999999998 899986432 2344444433221
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhh
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMAL 363 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~~ 363 (382)
...+.+.+..+.+++.+||+.||++||||.+|++.|+++.+...++
T Consensus 252 -----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~sl 297 (299)
T d1jpaa_ 252 -----LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSL 297 (299)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred -----CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhhC
Confidence 1223345577889999999999999999999999999988665444
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-57 Score=407.43 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=210.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
.++|+..+.||+|+||+||+|.+++ +.||||++... ..+.|.+|+++|++++|||||+++|++.+ +..++|||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 4678888999999999999999976 78999987643 45679999999999999999999998865 56799999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA 242 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~ 242 (382)
+|+|.+++.... ...+++..++.|+.||++||.|||+++ |+||||||+|||+++++.+||+|||+|+.+......
T Consensus 91 ~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 91 NGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999876432 235899999999999999999999977 999999999999999999999999999987655444
Q ss_pred CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 243 GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 243 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
......+++.|+|||.+.++.++.++|||||||++|||+||..|+... .......+.+...... ..+.
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~--~~~~~~~~~i~~~~~~----------~~p~ 233 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEVIQNLERGYRM----------VRPD 233 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCC----------CCCT
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCC----------CCcc
Confidence 445566788899999999999999999999999999999976665432 2333444444332111 1122
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~ 358 (382)
..+..+.+++.+||+.||++||||.+|++.|+++..
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 344678899999999999999999999999998753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-55 Score=399.61 Aligned_cols=260 Identities=28% Similarity=0.457 Sum_probs=206.5
Q ss_pred hCCCCCCeeeccCcccEEEEEECC------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
++|+..++||+|+||+||+|.+.. ..||||++.... ..+|.+|+.+|++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 457788899999999999998754 369999876432 2468999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
|||||.+|++.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999999887542 36899999999999999999999987 999999999999999999999999999876
Q ss_pred ccccccC--CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 237 ENIEEAG--PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 237 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
....... .....+|+.|+|||.+.++.++.++|||||||++|||++|..|+.... ....+.+.+.....
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~------- 231 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAINDGFR------- 231 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCC-------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHHHHHHHHhccCC-------
Confidence 5433222 223456788999999999999999999999999999999776654322 23344444433221
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhhhh
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMALT 364 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~~~ 364 (382)
...+.+.+..+.+++.+||+.||++||+|.+|++.|+++.+...+++
T Consensus 232 ---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~l~ 278 (283)
T d1mqba_ 232 ---LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278 (283)
T ss_dssp ---CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGG
T ss_pred ---CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCccccc
Confidence 12233455778999999999999999999999999999987655554
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-55 Score=393.80 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=211.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccC--CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVG--SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
++|+..+.||+|+||+||+|++++ ..||||.+.. ...++|.+|+.++++++||||++++|+|.+.+..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 578899999999999999999976 6899998764 3457899999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 84 g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 84 GCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999876542 36889999999999999999999977 9999999999999999999999999998776554444
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTT 322 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 322 (382)
.....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..++...+..... . ..+.
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~---~~~~~~~i~~~~~---~-------~~p~ 224 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETAEHIAQGLR---L-------YRPH 224 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHHHHHHTTCC---C-------CCCT
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC---HHHHHHHHHhCCC---C-------CCcc
Confidence 445567888999999999999999999999999999998 788986443 2333333332211 1 1122
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 016789 323 EGMRDLIRLTLQCMSSPGRRRPKMEIVMTELER 355 (382)
Q Consensus 323 ~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~ 355 (382)
..+..+.+++.+||+.||++|||+.++++.|.+
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 334678899999999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-55 Score=395.47 Aligned_cols=247 Identities=24% Similarity=0.345 Sum_probs=200.2
Q ss_pred CeeeccCcccEEEEEECC----eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 93 SLIGFGSFGPVYKGLLRD----TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~----~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
+.||+|+||+||+|.+.. +.||+|.+.... .++|.+|+++|++++||||++++|+|.. +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998743 579999875422 3579999999999999999999999965 457899999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccccc-
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEA- 242 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~- 242 (382)
|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999997643 6899999999999999999999987 999999999999999999999999999876543222
Q ss_pred -CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCC
Q 016789 243 -GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTF 320 (382)
Q Consensus 243 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 320 (382)
......+|+.|||||.+.+..++.++|||||||++|||+| |+.||.... ...+...+..... ...
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~---~~~~~~~i~~~~~----------~~~ 231 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAMLEKGER----------MGC 231 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHTTCC----------CCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC---HHHHHHHHHcCCC----------CCC
Confidence 2233457888999999999999999999999999999998 899997532 2333333332211 122
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 321 TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 321 ~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
+..++..+.+++.+||+.||++|||+.+|++.|+....+.
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 3334567889999999999999999999999998876443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=395.68 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=204.9
Q ss_pred hCCCCCCe-eeccCcccEEEEEECC----eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSL-IGFGSFGPVYKGLLRD----TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~-lg~G~~g~V~~~~~~~----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 157 (382)
++|...+. ||+|+||+||+|.+.. ..||||.+.... .++|.+|+++|++++|||||+++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555554 9999999999998753 479999876432 3569999999999999999999999865 468999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
||||++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 87 mE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhccc
Confidence 99999999999886432 36899999999999999999999987 9999999999999999999999999998775
Q ss_pred cccc--cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 238 NIEE--AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 238 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
.... .......+|+.|+|||++.++.++.++|||||||++|||+| |+.||.... ..++...+......
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~---~~~~~~~i~~~~~~------ 231 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMAFIEQGKRM------ 231 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---THHHHHHHHTTCCC------
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCC------
Confidence 4332 22234557888999999999999999999999999999998 899997543 23333333332111
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~ 358 (382)
..+...+..+.+++.+||+.||++||+|.+|++.|+.+..
T Consensus 232 ----~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 232 ----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2233445678899999999999999999999999987754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-55 Score=393.33 Aligned_cols=247 Identities=17% Similarity=0.227 Sum_probs=199.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
++|+..+.||+|+||+||+|++.. ..||+|.+... ..+.+.+|+++|++++||||+++++++.+.+..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 468889999999999999999864 78999986533 234689999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
|++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 85 ~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999998653 36899999999999999999999988 9999999999999999999999999998775433
Q ss_pred cc-CCCcccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 241 EA-GPSHGSIVNVFRDPEVEESGVF-SEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 241 ~~-~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.. ......||+.|||||++.+..+ +.++||||+||++|||++|++||........ .... ...... ..
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~-~~~~~~---~~------ 226 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSD-WKEKKT---YL------ 226 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHH-HHTTCT---TS------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHHH-HhcCCC---CC------
Confidence 22 2344568999999999988775 6789999999999999999999975432221 1111 111110 00
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001122356778999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=390.57 Aligned_cols=241 Identities=23% Similarity=0.333 Sum_probs=202.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|+||+||+|++.. ..||+|.+.. .....+.+|+++|++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 468889999999999999999864 6899998642 33457889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
|||++|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999998653 6899999999999999999999988 99999999999999999999999999986643
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.. .....||+.|||||++.+..|+.++|||||||++|||++|+.||.... .....+.+.... .
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~-------~---- 221 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRISRVE-------F---- 221 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTC-------C----
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCC-------C----
Confidence 22 234467899999999999999999999999999999999999996432 233333222210 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 112223466888999999999999999999976
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-54 Score=391.58 Aligned_cols=245 Identities=20% Similarity=0.287 Sum_probs=202.7
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccC---CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVG---SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
++|+..+.||+|+||+||+|.+. +..||+|++.. ...+.+.+|+++|++++||||+++++++.+.+..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 36899999999999999999976 47899998653 34567999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++|+|.+++.+. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999987653 5899999999999999999999988 99999999999999999999999999987654322
Q ss_pred cCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCC
Q 016789 242 AGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFT 321 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 321 (382)
......+|+.|+|||.+.+..|+.++|||||||++|||++|+.||.... ....+....... . ..+ ..+
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~~~~~~-~-~~~-------~~~ 239 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--PLRALYLIATNG-T-PEL-------QNP 239 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHHC-S-CCC-------SSG
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC--HHHHHHHHHhCC-C-CCC-------CCc
Confidence 2334467899999999999999999999999999999999999996432 112222222211 1 111 112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 322 TEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 322 ~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+..+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 233467889999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=389.76 Aligned_cols=252 Identities=27% Similarity=0.415 Sum_probs=202.4
Q ss_pred hCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCc-hHHHHHHHHHHhcCCCCCccceeeEEEe-CCeeEEEEeecCCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSP-RQEFVAEVTYLSEIRHRNLVTLLGYCQQ-NGYQMLVFEYLPNG 164 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~g 164 (382)
++|+..+.||+|+||.||+|.++++.||||++.... .+.|.+|++++++++||||++++|+|.+ .+..++||||+++|
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 467788899999999999999999999999986543 4679999999999999999999999965 45689999999999
Q ss_pred ChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccCC
Q 016789 165 SMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAGP 244 (382)
Q Consensus 165 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 244 (382)
+|.++|.+.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~---- 157 (262)
T d1byga_ 87 SLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 157 (262)
T ss_dssp EHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CHHHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecCCCC----
Confidence 9999997642 225899999999999999999999977 9999999999999999999999999998654322
Q ss_pred CcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 245 SHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 245 ~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
....++..|+|||++.++.++.++|||||||++|||+| |++|+... ...++...+.... ..+.+..
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~---~~~~~~~~i~~~~----------~~~~~~~ 224 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGY----------KMDAPDG 224 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS---CGGGHHHHHTTTC----------CCCCCTT
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC---CHHHHHHHHHcCC----------CCCCCcc
Confidence 23345677999999999999999999999999999998 67776543 3334444433221 1122333
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
.+..+.+++.+||+.||.+||||.++++.|++++..+
T Consensus 225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~ 261 (262)
T d1byga_ 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261 (262)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence 4467889999999999999999999999999997653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=392.16 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=203.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecCC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLPN 163 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 163 (382)
++|+..+.||+|+||+||+|.+++ ..||||.+... ..+.|.+|+.+|++++|||||+++|+|.+ +..++|||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 578899999999999999999977 67999997644 34679999999999999999999999854 568999999999
Q ss_pred CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccccC
Q 016789 164 GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEEAG 243 (382)
Q Consensus 164 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 243 (382)
|+|.+++.... ...++|..++.++.||+.||+|||+.+ |+||||||+|||||.++.+||+|||+++.........
T Consensus 96 g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 96 GSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred Cchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 99999887532 235899999999999999999999987 9999999999999999999999999998775544444
Q ss_pred CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCCCCHH
Q 016789 244 PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTE 323 (382)
Q Consensus 244 ~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 323 (382)
.....+++.|+|||.+.++.++.++|||||||++|||++|+.|+... ....+....+..... .+.+..
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~--~~~~~~~~~i~~~~~----------~~~~~~ 238 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVERGYR----------MPCPPE 238 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCC----------CCCCTT
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCC----------CCCCcc
Confidence 44556788999999999999999999999999999999977766532 233344444433211 122334
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 324 GMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 324 ~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
.++.+.+++.+||+.||++||+|.+|++.|++..
T Consensus 239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 4567889999999999999999999999988765
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=399.98 Aligned_cols=255 Identities=22% Similarity=0.372 Sum_probs=206.2
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCC----chHHHHHHHHHHhcC-CCCCccceeeEEEeCCe
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGS----PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGY 153 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 153 (382)
.++|+..+.||+|+||+||+|++.+ ..||+|.+... ....+.+|+.+|.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4678889999999999999998753 26899986542 235789999999998 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCC------------------CCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCC
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLE------------------SSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTA 215 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~ 215 (382)
.++|||||++|+|.++|...... ....+++..++.++.|++.||+|||+++ |+||||||+
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlKp~ 193 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAAR 193 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCchh
Confidence 99999999999999999765321 1235899999999999999999999987 999999999
Q ss_pred CeeecCCCcEEEeecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCC
Q 016789 216 NVLVDENFIAKVADTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLG 293 (382)
Q Consensus 216 Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~ 293 (382)
|||++.++.+||+|||+|+......... .....+|+.|||||.+.++.|+.++|||||||++|||+| |+.||.....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~- 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV- 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH-
Confidence 9999999999999999998765433322 233456888999999999999999999999999999998 8999874332
Q ss_pred ChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 016789 294 SYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELE 354 (382)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~ 354 (382)
...+.+.+..... .+.+...+..+.+++.+||+.||++|||++||++.|.
T Consensus 273 -~~~~~~~~~~~~~----------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 -DANFYKLIQNGFK----------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp -SHHHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHHHHHhcCCC----------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2233333332211 1223334567889999999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-54 Score=388.64 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=198.6
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-----eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
.++|+..+.||+|+||.||+|++.. ..||+|.+.... .+.|.+|+++|++++||||++++|++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 4578889999999999999998753 368888875432 3468999999999999999999999964 57899
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
||||+++|+|.+++.... ..+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||+|+.+
T Consensus 85 v~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhheec
Confidence 999999999999876542 36899999999999999999999988 999999999999999999999999999877
Q ss_pred ccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 237 ENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 237 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
............+|+.|+|||.+.+..++.++|||||||++|||+| |.+||..... ..+...+......
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~i~~~~~~------- 228 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGERL------- 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHTTCCC-------
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCC-------
Confidence 6554444555667889999999999999999999999999999998 8888875432 3333333322111
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
..+...+..+.+++.+||+.||++|||+.||++.|+++.+++
T Consensus 229 ---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 229 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 123344567889999999999999999999999999987653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-54 Score=395.91 Aligned_cols=262 Identities=26% Similarity=0.376 Sum_probs=212.7
Q ss_pred HHHHHHhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEE
Q 016789 81 ELEQATKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQ 149 (382)
Q Consensus 81 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~ 149 (382)
+++..+++|+..+.||+|+||+||+|++.+ +.||||++.... ..+|.+|+++|++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 344456789999999999999999998753 589999986543 346999999999999999999999999
Q ss_pred eCCeeEEEEeecCCCChhhhhhhcCC-------------------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceec
Q 016789 150 QNGYQMLVFEYLPNGSMCNHLYETGL-------------------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHK 210 (382)
Q Consensus 150 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHr 210 (382)
..+..+++|||+++|+|.+++..... .....+++..++.++.|++.||+|||+.+ ||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHr 164 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHR 164 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEee
Confidence 99999999999999999999975431 12335889999999999999999999987 9999
Q ss_pred CCCCCCeeecCCCcEEEeecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCC-CCCC
Q 016789 211 NFKTANVLVDENFIAKVADTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ-EASH 288 (382)
Q Consensus 211 Dlk~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~-~p~~ 288 (382)
||||+|||+|.++.+||+|||+|+.+....... .....+++.|+|||.+.+..|+.++|||||||++|||++|. +||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999998765443332 23445678899999999999999999999999999999996 4565
Q ss_pred ccCCCChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 016789 289 IVSLGSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIH 357 (382)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~ 357 (382)
.. ...++...+...... ..+...+..+.+|+.+||+.||++||||.||++.|++|.
T Consensus 245 ~~---~~~e~~~~v~~~~~~----------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GM---AHEEVIYYVRDGNIL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TS---CHHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CC---CHHHHHHHHHcCCCC----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 32 333444444332111 122334467889999999999999999999999999985
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-55 Score=392.97 Aligned_cols=250 Identities=21% Similarity=0.274 Sum_probs=191.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEe--CCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQ--NGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 157 (382)
++|+..+.||+|+||+||+|+... ..||+|.+.... .+.+.+|+++|++++||||+++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 578899999999999999999864 689999875432 2458899999999999999999999864 4568999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCC---CCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLK---PPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
||||++|+|.+++.+.. .....+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.+||+|||+|+
T Consensus 84 mEy~~~g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999987532 12346899999999999999999999753 359999999999999999999999999998
Q ss_pred ccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 235 LLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
.+...... .....+|+.|||||.+.+..|+.++|||||||++|||+||++||.... ...+...+.... ..
T Consensus 163 ~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~i~~~~-~~----- 232 (269)
T d2java1 163 ILNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIREGK-FR----- 232 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTC-CC-----
T ss_pred ecccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHHHHHcCC-CC-----
Confidence 76543222 234567889999999999999999999999999999999999997432 233333332211 11
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 233 ----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 ----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 112223456889999999999999999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=382.62 Aligned_cols=243 Identities=23% Similarity=0.342 Sum_probs=193.7
Q ss_pred CCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEe----CCeeEEE
Q 016789 89 FSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQ----NGYQMLV 157 (382)
Q Consensus 89 ~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv 157 (382)
|+..+.||+|+||+||+|.+.. ..||+|.+... ..+.|.+|+++|++++||||+++++++.. ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 3455679999999999999875 58999986532 23468899999999999999999999865 3467999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec-CCCcEEEeecCCcccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD-ENFIAKVADTGISKLL 236 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~-~~~~~kl~DfGla~~~ 236 (382)
||||++|+|.+++.+.. .+++..+..++.||+.||+|||+++++|+||||||+|||++ +++.+||+|||+|+..
T Consensus 91 mE~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999999999997653 68999999999999999999999877899999999999996 5789999999999864
Q ss_pred ccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 237 ENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 237 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
... ......||+.|||||++.+ .|+.++|||||||++|||++|+.||.... ....+.+.+...... ..+
T Consensus 166 ~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~~~~~~~i~~~~~~-----~~~ 234 (270)
T d1t4ha_ 166 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVKP-----ASF 234 (270)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTCCC-----GGG
T ss_pred cCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc--cHHHHHHHHHcCCCC-----ccc
Confidence 332 1223467899999999875 59999999999999999999999996332 233333322221111 111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
... .+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~----~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 DKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Ccc----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111 2345788999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=389.26 Aligned_cols=247 Identities=19% Similarity=0.258 Sum_probs=201.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC---chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS---PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
+.|+..+.||+|+||+||+|++.. ..||+|.+... ..+.+.+|+++|++++||||+++++++.+.+..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 457888999999999999999864 68999987543 2357899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++|+|.+++.+.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 92 ~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp TTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 9999999987542 35899999999999999999999988 99999999999999999999999999976543221
Q ss_pred cCCCcccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 242 AGPSHGSIVNVFRDPEVEE-----SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
......+|+.|+|||++. ...|+.++|||||||++|||+||+.||..... ...+.. +.... ...+
T Consensus 166 -~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--~~~~~~-i~~~~-~~~~----- 235 (288)
T d2jfla1 166 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MRVLLK-IAKSE-PPTL----- 235 (288)
T ss_dssp -HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--GGHHHH-HHHSC-CCCC-----
T ss_pred -cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--HHHHHH-HHcCC-CCCC-----
Confidence 123456788999999983 45689999999999999999999999975432 222222 22111 1111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 236 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 --AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112234567889999999999999999999876
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=395.17 Aligned_cols=268 Identities=22% Similarity=0.278 Sum_probs=206.3
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
.++|+..+.||+|+||+||+|.+.. ..||+|.+... ....+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4678899999999999999999864 78999986532 23578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||++|+|.+++.+.+ .+++..+..++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999998754 58999999999999999999997 47 99999999999999999999999999986643
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHH-HHhhcC----------
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQW-VRSRLS---------- 307 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~---------- 307 (382)
.. .....||+.|+|||++.+..|+.++||||+||++|||++|+.||.............. ......
T Consensus 158 ~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp HT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred Cc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 22 2344678999999999999999999999999999999999999975432211100000 000000
Q ss_pred ---CCcccccc---------------cCCCC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHHHHhhhhh
Q 016789 308 ---SNNFVDHR---------------LAGTF-TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT--ELERIHEKEMAL 363 (382)
Q Consensus 308 ---~~~~~d~~---------------~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~--~L~~i~~~~~~~ 363 (382)
.....+.. ..... ....+..+.+++.+||+.||.+|||+.|+++ .+++...++..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~d~ 311 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDF 311 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCCCH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcccccH
Confidence 00000000 00000 0112356788999999999999999999998 466665554443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-53 Score=387.98 Aligned_cols=267 Identities=22% Similarity=0.375 Sum_probs=204.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECCeeEEEEEccCCchHHHHHHHHH--HhcCCCCCccceeeEEEeCC----eeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGSPRQEFVAEVTY--LSEIRHRNLVTLLGYCQQNG----YQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~----~~~lv~e~ 160 (382)
++|...+.||+|+||.||+|++++..||||.+......++..|.++ +.+++||||++++++|...+ ..++||||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 4567778999999999999999999999999876666666555554 45779999999999998654 57999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC------CCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL------KPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
|++|+|.++|++. .++|..++.++.|+|.||+|||+. .++|+||||||+||||+.++.+||+|||+++
T Consensus 83 ~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 83 HEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 9999999999764 589999999999999999999974 2459999999999999999999999999998
Q ss_pred cccccccc---CCCcccccccccCccccccCC------CCccchhHHHHHHHHHHHhCCCCCCccCCCCh--------hH
Q 016789 235 LLENIEEA---GPSHGSIVNVFRDPEVEESGV------FSEMSDIYSFGVFLLELVTGQEASHIVSLGSY--------EA 297 (382)
Q Consensus 235 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~--------~~ 297 (382)
........ ......+|+.|+|||++.+.. ++.++|||||||++|||+||..|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 76443221 223456789999999987653 67789999999999999999987743221110 00
Q ss_pred HHHHHHhhcCCCcccccccCCC-CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 298 LIQWVRSRLSSNNFVDHRLAGT-FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 298 ~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
.......... ....++.+... .+.+.+..+.+++.+||+.||++|||+.||++.|+++.+++
T Consensus 237 ~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 237 SVEEMRKVVC-EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHHT-TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHh-ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 0111111110 11111221111 13356678999999999999999999999999999998663
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=387.97 Aligned_cols=244 Identities=18% Similarity=0.199 Sum_probs=200.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|+||+||+|.+.. ..||+|.+.. ...+.+.+|+++|++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 568999999999999999999864 7899998642 33457899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
|||++|+|.+++...+ .+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999988654 6899999999999999999999988 99999999999999999999999999987754
Q ss_pred cccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 239 IEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 239 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
.... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||... +...+.+.+... . .
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~-~------~--- 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKIIKL-E------Y--- 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTT-C------C---
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHHHHHHcC-C------C---
Confidence 3322 233456889999999999999999999999999999999999999743 222332222211 0 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.++...+..+.+++.+||+.||++|||++|+++
T Consensus 228 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 -DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 112223456789999999999999999999754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-53 Score=387.65 Aligned_cols=241 Identities=24% Similarity=0.344 Sum_probs=196.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
+.|+..+.||+|+||+||+|++.. ..||||.+.... .+.+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 458889999999999999999764 789999875432 235889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
|||++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 999999987666543 26899999999999999999999988 99999999999999999999999999986543
Q ss_pred ccccCCCcccccccccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEES---GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
. ....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.... ............ .....
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~---~~~~~~~i~~~~-~~~~~--- 235 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQNE-SPALQ--- 235 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSC-CCCCS---
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCC-CCCCC---
Confidence 2 23467899999999853 458999999999999999999999996432 122222111111 11111
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 236 -----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 -----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1122456888999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-52 Score=386.23 Aligned_cols=247 Identities=19% Similarity=0.252 Sum_probs=189.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
.+.|+..+.||+|+||+||+|.+.. ..||+|.+... ....+.+|+.+|++++||||+++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3568889999999999999999864 78999987543 23457899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec---CCCcEEEeecCCcccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD---ENFIAKVADTGISKLL 236 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~---~~~~~kl~DfGla~~~ 236 (382)
||++|+|.+++...+ .+++.....++.|++.||+|||+.+ |+||||||+|||++ +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999997643 6899999999999999999999988 99999999999994 5789999999999866
Q ss_pred ccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccccc
Q 016789 237 ENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRL 316 (382)
Q Consensus 237 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 316 (382)
..... .....||+.|||||++.+..|+.++|||||||++|||++|+.||.... .......+..... ..
T Consensus 161 ~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~~~-------~~ 228 (307)
T d1a06a_ 161 DPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---DAKLFEQILKAEY-------EF 228 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHTTCC-------CC
T ss_pred cCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHhccCC-------CC
Confidence 44322 233457899999999999999999999999999999999999997432 2233322222110 11
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 317 AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 317 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
........+..+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11112233467889999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=388.27 Aligned_cols=253 Identities=23% Similarity=0.382 Sum_probs=204.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC------eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD------TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 156 (382)
.+|+..++||+|+||+||+|.+.. ..||+|++... ..++|.+|+++|++++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 358889999999999999998754 26899986532 345799999999999999999999999875 4678
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
++||+.+|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 88 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceec
Confidence 899999999999887642 46899999999999999999999987 999999999999999999999999999876
Q ss_pred ccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 237 ENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 237 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
....... .....+|+.|+|||.+.++.|+.++|||||||++|||+| |++||..... ..+...+......
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~---~~~~~~i~~~~~~------ 232 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEKGERL------ 232 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG---GGHHHHHHHTCCC------
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCCC------
Confidence 5433322 233457889999999999999999999999999999999 7888864432 2333333332211
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
..+..++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 233 ----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 233 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 22334456788999999999999999999999999988654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=385.50 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=207.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC----eeEEEEEccCC----chHHHHHHHHHHhcC-CCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD----TVVAIKRRVGS----PRQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~----~~vavK~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 157 (382)
++|+..++||+|+||+||+|.+.+ ..||||++... ..++|.+|+++|+++ +||||++++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 568888999999999999998854 25788876432 345799999999999 799999999999999999999
Q ss_pred EeecCCCChhhhhhhcC-----------CCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEE
Q 016789 158 FEYLPNGSMCNHLYETG-----------LESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAK 226 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~k 226 (382)
|||+++|+|.++|+... ......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCCCceE
Confidence 99999999999997542 123457999999999999999999999987 99999999999999999999
Q ss_pred EeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCC-CCCccCCCChhHHHHHHHhh
Q 016789 227 VADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQE-ASHIVSLGSYEALIQWVRSR 305 (382)
Q Consensus 227 l~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~-p~~~~~~~~~~~~~~~~~~~ 305 (382)
|+|||+++....... .....+|..|+|||.+.++.++.++|||||||++|||++|.. ||... ....+.+.+...
T Consensus 168 l~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~~~~~i~~~ 242 (309)
T d1fvra_ 168 IADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYEKLPQG 242 (309)
T ss_dssp ECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHGGGT
T ss_pred Ecccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---CHHHHHHHHHhc
Confidence 999999986543222 223456788999999999999999999999999999999765 55432 333343333221
Q ss_pred cCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhh
Q 016789 306 LSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKE 360 (382)
Q Consensus 306 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~ 360 (382)
.. ...+...+..+.+++.+||+.||++||||.+|++.|+++.++.
T Consensus 243 ~~----------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 243 YR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp CC----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CC----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 11 1222334567889999999999999999999999999998653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=383.10 Aligned_cols=267 Identities=21% Similarity=0.319 Sum_probs=202.4
Q ss_pred HHHHHHHHhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCccceee
Q 016789 79 MEELEQATKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVTLLG 146 (382)
Q Consensus 79 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~ 146 (382)
...++...++|+..+.||+|+||.||+|.+.. +.||+|++.... ...+.+|...+.++ +|+||+.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 34454455789999999999999999998642 579999876432 24577888888776 6899999999
Q ss_pred EEEeC-CeeEEEEeecCCCChhhhhhhcCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCC
Q 016789 147 YCQQN-GYQMLVFEYLPNGSMCNHLYETGL-----------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKT 214 (382)
Q Consensus 147 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~ 214 (382)
++... ...++|||||++|+|.+++..... .....+++..+..++.||+.||.|||+++ |+||||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp 162 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 162 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCc
Confidence 98765 468999999999999999976431 11235899999999999999999999987 99999999
Q ss_pred CCeeecCCCcEEEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCC-CCCCccCC
Q 016789 215 ANVLVDENFIAKVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ-EASHIVSL 292 (382)
Q Consensus 215 ~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~-~p~~~~~~ 292 (382)
+|||+++++.+||+|||+|+........ ......+|+.|+|||.+.+..++.++|||||||++|||+||. +||....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~- 241 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK- 241 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC-
Confidence 9999999999999999999876544332 233456788999999999999999999999999999999975 5665332
Q ss_pred CChhHHHHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 293 GSYEALIQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
....+...+...... ..+...+..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 242 -~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 242 -IDEEFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp -CSHHHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHHHHhcCCCC----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 222333333332211 12223346788999999999999999999999999998754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=379.74 Aligned_cols=250 Identities=25% Similarity=0.410 Sum_probs=200.7
Q ss_pred CCeeeccCcccEEEEEECC-----eeEEEEEccCC----chHHHHHHHHHHhcCCCCCccceeeEEEeC-CeeEEEEeec
Q 016789 92 TSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGS----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQN-GYQMLVFEYL 161 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 161 (382)
.++||+|+||+||+|++.. ..||||++... ...+|.+|+++|++++||||++++|++... +..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4579999999999999754 36899987642 225699999999999999999999998764 5889999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 112 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999887542 35778889999999999999999977 99999999999999999999999999987654332
Q ss_pred cC---CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 242 AG---PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 242 ~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.. .....+|+.|+|||.+....++.++||||||+++|||+||+.|+.... .......++..... ..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~--~~~~~~~~i~~g~~---~~------ 254 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQGRR---LL------ 254 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCC---CC------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCC---CC------
Confidence 22 223456888999999999999999999999999999999888876432 12222333322211 11
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.+...+..+.+++.+||+.||++||+|.||++.|+++...
T Consensus 255 -~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 255 -QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1222346788999999999999999999999999999754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=378.54 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=196.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-----eeEEEEEccCC------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-----TVVAIKRRVGS------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 155 (382)
++|+..+.||+|+||+||+|++.. ..||+|.+... ..++|.+|+.+|++++||||++++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568888999999999999998643 36899986532 13578999999999999999999999976 4678
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+|||||++|++.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhh
Confidence 9999999999999887642 36899999999999999999999977 99999999999999999999999999997
Q ss_pred ccccccc--CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 236 LENIEEA--GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 236 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
+...... ......++..|+|||.+.+..++.++||||||+++|||+| |+.||... ........+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~---~~~~~~~~i~~~~~~---- 233 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDKEGER---- 233 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTSCCC----
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc---CHHHHHHHHHhCCCC----
Confidence 6543222 2233456778999999999999999999999999999998 89998643 333344443332111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERI 356 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i 356 (382)
.+.+...+..+.+++.+||+.||++|||+.+|.+.|++.
T Consensus 234 -----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 -----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 112233446788999999999999999999999988764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=375.39 Aligned_cols=246 Identities=19% Similarity=0.234 Sum_probs=200.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC---------chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS---------PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 155 (382)
+.|+..+.||+|+||+||+|.+.. ..||+|.+... ..+.+.+|+.+|++++||||+++++++.+.+..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 568899999999999999999864 78999986421 2457899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC----cEEEeecC
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF----IAKVADTG 231 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~----~~kl~DfG 231 (382)
+|||||++|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 iv~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999997653 6899999999999999999999988 99999999999998776 59999999
Q ss_pred CccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcc
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (382)
+|+....... .....+++.|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... .+
T Consensus 163 ~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~~~--~~ 235 (293)
T d1jksa_ 163 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSAVNY--EF 235 (293)
T ss_dssp TCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHTTCC--CC
T ss_pred hhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC---HHHHHHHHHhcCC--CC
Confidence 9987654332 233456788999999999999999999999999999999999997432 2222222221110 00
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.... ....+..+.+++.+||+.||.+|||+.|+++
T Consensus 236 -~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 236 -EDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -CHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -Cchh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 1122456789999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3e-51 Score=383.12 Aligned_cols=246 Identities=20% Similarity=0.294 Sum_probs=202.1
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
++|+..+.||+|+||+||+|.+. +..||+|++.... .+.+.+|+.+|++++||||+++++++.+.+..|+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47899999999999999999986 4799999876543 346889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec--CCCcEEEeecCCccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD--ENFIAKVADTGISKLLENI 239 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~--~~~~~kl~DfGla~~~~~~ 239 (382)
++|+|.+++.+.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 106 ~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999986432 36899999999999999999999988 99999999999995 4688999999999876543
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh-hcCCCcccccccCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS-RLSSNNFVDHRLAG 318 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~~~~ 318 (382)
.. .....+|+.|||||++.+..|+.++|||||||++|||++|+.||.... .......+.. ...... .
T Consensus 180 ~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~~~~----~--- 247 (350)
T d1koaa2 180 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNVKSCDWNMDD----S--- 247 (350)
T ss_dssp SC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCSCC----G---
T ss_pred cc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCc----c---
Confidence 22 233467889999999999999999999999999999999999996432 2233322222 111111 1
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.....+..+.+++.+||+.||++|||+.|+++
T Consensus 248 -~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 248 -AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp -GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11123456889999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=378.95 Aligned_cols=258 Identities=26% Similarity=0.425 Sum_probs=205.4
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC---------eeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD---------TVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVTLLGYCQQN 151 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 151 (382)
.++|...+.||+|+||.||+|+..+ ..||||++.... ..++.+|...+.++ +||||++++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3578888999999999999998643 379999876543 24688898888888 799999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGL-----------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD 220 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~ 220 (382)
+..++|||||++|+|.+++..... .....+++..++.++.|++.||+|||+.+ ||||||||+|||++
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT 169 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccceeec
Confidence 999999999999999999976532 12346899999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccCCCChhHH
Q 016789 221 ENFIAKVADTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVT-GQEASHIVSLGSYEAL 298 (382)
Q Consensus 221 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~t-g~~p~~~~~~~~~~~~ 298 (382)
.++.+||+|||+++......... .....+++.|+|||.+.++.|+.++|||||||++|||++ |.+||... ....+
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~---~~~~~ 246 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---PVEEL 246 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC---CHHHH
Confidence 99999999999999776544332 233456778999999999999999999999999999998 67777532 23344
Q ss_pred HHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 016789 299 IQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHE 358 (382)
Q Consensus 299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~ 358 (382)
.+.+...... ..+...+..+.+++.+||+.||++|||+.||++.|++|..
T Consensus 247 ~~~i~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 FKLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHTTCCC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCC----------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 4444332211 1122334678899999999999999999999999999863
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.8e-51 Score=381.45 Aligned_cols=247 Identities=17% Similarity=0.238 Sum_probs=202.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc---hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP---RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
++|+..+.||+|+||+||+|.... ..||+|.+.... ...+.+|+.+|++++||||+++++++.+.+..|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 468899999999999999999864 789999876543 346789999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec--CCCcEEEeecCCccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD--ENFIAKVADTGISKLLENI 239 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~--~~~~~kl~DfGla~~~~~~ 239 (382)
++|+|.+.+... ...+++.....++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 109 ~gg~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999877543 236899999999999999999999988 99999999999998 6789999999999876543
Q ss_pred cccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCCC
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAGT 319 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 319 (382)
.. .....+++.|+|||++.+..|+.++||||+||++|||+||+.||.... .......+..... .....
T Consensus 183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~-------~~~~~ 250 (352)
T d1koba_ 183 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDW-------EFDED 250 (352)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCC-------CCCSS
T ss_pred Cc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC-------CCCcc
Confidence 22 233456788999999999999999999999999999999999996432 2233332222110 01111
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11233456789999999999999999999976
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-52 Score=381.23 Aligned_cols=263 Identities=24% Similarity=0.368 Sum_probs=212.6
Q ss_pred HHhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCch----HHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 016789 85 ATKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSPR----QEFVAEVTYLSEIRHRNLVTLLGYCQQNGY 153 (382)
Q Consensus 85 ~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 153 (382)
..++|...+.||+|+||+||+|.+.+ +.||||++..... ..|.+|++++++++||||++++|+|...+.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 34678888999999999999998742 5899998865322 358999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcC-----CCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEe
Q 016789 154 QMLVFEYLPNGSMCNHLYETG-----LESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVA 228 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~ 228 (382)
.++|||||++|+|.+++.... ......+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCEEEC
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCceEEEe
Confidence 999999999999999987532 122335789999999999999999999987 9999999999999999999999
Q ss_pred ecCCccccccccccC-CCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCC-CCCCccCCCChhHHHHHHHhhc
Q 016789 229 DTGISKLLENIEEAG-PSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ-EASHIVSLGSYEALIQWVRSRL 306 (382)
Q Consensus 229 DfGla~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~ 306 (382)
|||+|+.+....... .....+++.|+|||.+.+..++.++||||||+++|||+||+ +|+... ......+.+....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRFVMEGG 252 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHHHHHHHTTC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHhCC
Confidence 999998775543322 23345788899999999999999999999999999999986 555432 2233333333211
Q ss_pred CCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHhhhh
Q 016789 307 SSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEKEMA 362 (382)
Q Consensus 307 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~~~~ 362 (382)
. ...+...+..+.+++.+||+.||++||||.+|++.|++..+..+.
T Consensus 253 ~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 253 L----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred C----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 1 112233446799999999999999999999999999888766544
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=376.68 Aligned_cols=243 Identities=21% Similarity=0.198 Sum_probs=202.3
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|+||+||+|+... ..+|+|++.. .....+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 468889999999999999999864 7999998653 23456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
|||++|+|.+++...+ .+++.....++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 9999999999998754 6888899999999999999999988 99999999999999999999999999986543
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
... ......||+.|+|||++.+..|+.++||||+||++|||++|++||.... ...+.+...... .
T Consensus 158 ~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~i~~~~-------~---- 222 (337)
T d1o6la_ 158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEE-------I---- 222 (337)
T ss_dssp TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCC-------C----
T ss_pred CCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC---HHHHHHHHhcCC-------C----
Confidence 222 2334567899999999999999999999999999999999999997533 233333322211 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRPK-----MEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~~v~~ 351 (382)
.++...+..+.+++.+||+.||.+||+ +.|+++
T Consensus 223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 112223456788999999999999995 677765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-50 Score=374.52 Aligned_cols=240 Identities=20% Similarity=0.229 Sum_probs=200.3
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|+||+||+|++. +..||+|++.. ...+.+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888999999999999999986 47899998642 33457899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
|||++|+|...+.... .+++.....++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccccc-----cccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999887653 5788888899999999999999988 99999999999999999999999999987654
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
.. ....||+.|||||++.+..|+.++||||+||++|||++|+.||.... ...+...+.... .
T Consensus 157 ~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~i~~~~-------~---- 218 (316)
T d1fota_ 157 VT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYEKILNAE-------L---- 218 (316)
T ss_dssp CB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHCC-------C----
T ss_pred cc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC---HHHHHHHHHcCC-------C----
Confidence 22 23567889999999999999999999999999999999999997432 223322222210 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRP-----KMEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~~v~~ 351 (382)
..+...+..+.+++.+||+.||.+|| +++++++
T Consensus 219 ~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11222345678899999999999996 8888875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=378.71 Aligned_cols=260 Identities=22% Similarity=0.361 Sum_probs=209.5
Q ss_pred HhCCCCCCeeeccCcccEEEEEECC-------eeEEEEEccCCc----hHHHHHHHHHHhcC-CCCCccceeeEEEeCCe
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLRD-------TVVAIKRRVGSP----RQEFVAEVTYLSEI-RHRNLVTLLGYCQQNGY 153 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 153 (382)
.++|+..+.||+|+||.||+|++.. ..||||++.... ...|.+|+.+++++ +|||||+++|+|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 4678888999999999999998632 589999976532 34688999999999 69999999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCC-------------CCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec
Q 016789 154 QMLVFEYLPNGSMCNHLYETGL-------------ESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD 220 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~ 220 (382)
.++|||||++|+|.++++.... .....+++..+..++.||+.||+|||+++ ++||||||+|||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT 179 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccccccccc
Confidence 9999999999999999986532 12336899999999999999999999987 99999999999999
Q ss_pred CCCcEEEeecCCcccccccccc-CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCC-CCCCccCCCChhHH
Q 016789 221 ENFIAKVADTGISKLLENIEEA-GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQ-EASHIVSLGSYEAL 298 (382)
Q Consensus 221 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~-~p~~~~~~~~~~~~ 298 (382)
.++.+|++|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||+|++ +|+.... ....+
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~--~~~~~ 257 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--VDSKF 257 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--SSHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC--HHHHH
Confidence 9999999999999877543322 223456788899999999999999999999999999999955 4444322 22223
Q ss_pred HHHHHhhcCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 299 IQWVRSRLSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.+.+...... ..+...+..+.+|+.+||+.||++||||.+|+++|+++..+
T Consensus 258 ~~~i~~~~~~----------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 258 YKMIKEGFRM----------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHTCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCC----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 3333332211 12223346788999999999999999999999999988765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-50 Score=367.80 Aligned_cols=254 Identities=20% Similarity=0.272 Sum_probs=198.6
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc------hHHHHHHHHHHhcCCCCCccceeeEEEeCC----ee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNG----YQ 154 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 154 (382)
++|+..+.||+|+||+||+|.+. ++.||+|.+.... ...|.+|+++|++++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 56888999999999999999976 4799999875421 236889999999999999999999987654 37
Q ss_pred EEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 155 MLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 155 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
|+|||||++|+|.+++...+ .+++.....++.|++.||+|||+.+ |+||||||+|||++.++..+|+|||.+.
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEECCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhh
Confidence 89999999999999987754 6899999999999999999999988 9999999999999999999999999987
Q ss_pred cccccccc--CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 235 LLENIEEA--GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 235 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
........ ......+|+.|+|||.+.+..++.++|||||||++|||+||++||.... ......+........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~~~~~~~~~---- 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--PVSVAYQHVREDPIP---- 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHCCCCC----
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC--HHHHHHHHHhcCCCC----
Confidence 65433222 2334467899999999999999999999999999999999999996432 111222222211111
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHH
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRP-KMEIVMTELERIH 357 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~~v~~~L~~i~ 357 (382)
.... ....+..+.+++.+||+.||.+|| |++++++.|.++.
T Consensus 234 ~~~~----~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 PSAR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GGGT----SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred Cchh----ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1111 122346788899999999999999 8999999998875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.9e-50 Score=377.66 Aligned_cols=244 Identities=20% Similarity=0.240 Sum_probs=196.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC------chHHHHHH---HHHHhcCCCCCccceeeEEEeCCeeE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS------PRQEFVAE---VTYLSEIRHRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~------~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~~ 155 (382)
++|+..+.||+|+||.||+|++.. ..||+|.+... ....+.+| +.+++.++||||+++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 468889999999999999999864 78999986432 12234444 67788889999999999999999999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccc
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKL 235 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~ 235 (382)
+|||||++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999998754 5788999999999999999999988 99999999999999999999999999987
Q ss_pred cccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccccc
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDH 314 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (382)
+... ......||+.|+|||++.. ..|+.++|||||||++|||+||+.||......+...+.. ...... .
T Consensus 157 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~---~~~~~~----~ 226 (364)
T d1omwa3 157 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLTMA----V 226 (364)
T ss_dssp CSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH---HSSSCC----C
T ss_pred cCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcccCC----C
Confidence 6543 2334567899999999864 568999999999999999999999997654433332222 111111 1
Q ss_pred ccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 016789 315 RLAGTFTTEGMRDLIRLTLQCMSSPGRRRPK-----MEIVMT 351 (382)
Q Consensus 315 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~~v~~ 351 (382)
..+...+..+.+++.+||+.||.+||| ++|+++
T Consensus 227 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 ----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111223456889999999999999999 577764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.9e-50 Score=362.75 Aligned_cols=246 Identities=21% Similarity=0.297 Sum_probs=200.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCc------------hHHHHHHHHHHhcCC-CCCccceeeEEEeC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP------------RQEFVAEVTYLSEIR-HRNLVTLLGYCQQN 151 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~------------~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 151 (382)
++|+..+.||+|+||+||+|+... +.+|+|++.... .+.+.+|+.+|++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 578889999999999999999854 899999865421 135889999999997 99999999999999
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
+..|+|||||++|+|.++|...+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999997654 6899999999999999999999988 9999999999999999999999999
Q ss_pred CccccccccccCCCcccccccccCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhh
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEES------GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSR 305 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 305 (382)
+++.+.... ......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||.... .....+.+...
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~~~~i~~~ 230 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRMIMSG 230 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHT
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHHHHHHHHhC
Confidence 998765432 2234567888999999853 347889999999999999999999997432 22222222221
Q ss_pred cCCCcccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 306 LSSNNFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 306 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.. . .........++.+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~--~-----~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 231 NY--Q-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CC--C-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CC--C-----CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 10 0 111111234467889999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.9e-50 Score=374.04 Aligned_cols=240 Identities=22% Similarity=0.228 Sum_probs=201.7
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccC------CchHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVG------SPRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 158 (382)
++|+..+.||+|+||+||+|++. +..||+|.+.. ...+.+.+|+.+|+.++||||+++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46888999999999999999986 47899998642 23456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLEN 238 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~ 238 (382)
||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999998764 6899999999999999999999988 99999999999999999999999999987654
Q ss_pred ccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccCC
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLAG 318 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 318 (382)
. .....||+.|||||++.+..|+.++|||||||++|||+||+.||... ....+...+.....
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~----------- 255 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKV----------- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCC-----------
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHHhcCCC-----------
Confidence 2 23456788999999999999999999999999999999999999643 22333332222110
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 016789 319 TFTTEGMRDLIRLTLQCMSSPGRRRP-----KMEIVMT 351 (382)
Q Consensus 319 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~~v~~ 351 (382)
..+...+..+.+++.+||+.||.+|+ ++.++++
T Consensus 256 ~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11222345678999999999999994 8899876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=373.48 Aligned_cols=243 Identities=23% Similarity=0.282 Sum_probs=199.4
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccC------CchHHHHHHHHHHh-cCCCCCccceeeEEEeCCeeEEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVG------SPRQEFVAEVTYLS-EIRHRNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 157 (382)
++|...+.||+|+||+||+|++.. +.||+|++.. .....+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 468888999999999999999864 7999998752 33445677777765 68999999999999999999999
Q ss_pred EeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccc
Q 016789 158 FEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLE 237 (382)
Q Consensus 158 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~ 237 (382)
||||++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999998754 5888999999999999999999988 9999999999999999999999999998654
Q ss_pred cccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccccC
Q 016789 238 NIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHRLA 317 (382)
Q Consensus 238 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 317 (382)
... .......+|+.|+|||++.+..|+.++|||||||++|||++|+.||.... ...+...+.... +
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~-------~--- 220 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMDN-------P--- 220 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCC-------C---
T ss_pred ccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHcCC-------C---
Confidence 332 22334567889999999999999999999999999999999999997432 233333322211 1
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 016789 318 GTFTTEGMRDLIRLTLQCMSSPGRRRPKME-IVMT 351 (382)
Q Consensus 318 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~-~v~~ 351 (382)
.++...+..+.+|+.+||+.||.+||++. ++++
T Consensus 221 -~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 -FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11222345688999999999999999996 6653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=367.46 Aligned_cols=246 Identities=16% Similarity=0.221 Sum_probs=200.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCch--HHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeecC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPR--QEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
++|+..+.||+|+||+||+|.+.. ..+|+|.+..... ..+.+|+++|+.++||||+++++++.+.+..|+|||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 568888999999999999999864 7899998775543 357899999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC--CCcEEEeecCCcccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE--NFIAKVADTGISKLLENIE 240 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~--~~~~kl~DfGla~~~~~~~ 240 (382)
+|+|.+++...+ ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. ...+||+|||+++......
T Consensus 85 gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 85 GLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 999999996542 35899999999999999999999988 999999999999985 4589999999998664322
Q ss_pred ccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh-hcCCCcccccccCCC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS-RLSSNNFVDHRLAGT 319 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~~~~~ 319 (382)
. .....+++.|+|||...+..|+.++||||+||++|||++|+.||.... .......+.. ..... ....
T Consensus 159 ~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~~----~~~~-- 227 (321)
T d1tkia_ 159 N--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEYTFD----EEAF-- 227 (321)
T ss_dssp E--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCC----HHHH--
T ss_pred c--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC----hhhc--
Confidence 2 223356788999999999999999999999999999999999997532 2222222221 11111 0000
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 320 FTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 320 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...+..+.+++.+||+.||.+|||+.|+++
T Consensus 228 --~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 228 --KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 012456789999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-50 Score=371.29 Aligned_cols=250 Identities=17% Similarity=0.245 Sum_probs=195.5
Q ss_pred hCCCCC-CeeeccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhc-CCCCCccceeeEEEe----CCeeEEEE
Q 016789 87 KQFSET-SLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSE-IRHRNLVTLLGYCQQ----NGYQMLVF 158 (382)
Q Consensus 87 ~~~~~~-~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~~lv~ 158 (382)
++|... +.||+|+||+||+|++.. ..||+|.+... ..+.+|++++.+ .+||||+++++++.+ +...|+||
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm 88 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence 467765 469999999999999864 78999987543 567789998765 489999999999875 35689999
Q ss_pred eecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC---CCcEEEeecCCccc
Q 016789 159 EYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE---NFIAKVADTGISKL 235 (382)
Q Consensus 159 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~---~~~~kl~DfGla~~ 235 (382)
|||++|+|.+++.+.+ ...+++.....++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 89 Ey~~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 89 ECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp ECCCSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ECCCCCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccceeee
Confidence 9999999999997642 346999999999999999999999988 999999999999985 56799999999987
Q ss_pred cccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccccc
Q 016789 236 LENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVDHR 315 (382)
Q Consensus 236 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (382)
...... .....+|+.|+|||++.+..|+.++|||||||++|||+||+.||........ ............ ..
T Consensus 164 ~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~---~~ 235 (335)
T d2ozaa1 164 TTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQ---YE 235 (335)
T ss_dssp CCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS---SS
T ss_pred ccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCC---CC
Confidence 654332 3345678999999999999999999999999999999999999975432211 111111111000 01
Q ss_pred cCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 316 LAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 316 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+........+..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111111344677899999999999999999999976
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=366.13 Aligned_cols=250 Identities=22% Similarity=0.277 Sum_probs=190.2
Q ss_pred CCeeeccCcccEEEEEECC--eeEEEEEccCCc--------hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEeec
Q 016789 92 TSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSP--------RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 92 ~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~--------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 161 (382)
.++||+|+||+||+|.+.. +.||+|++.... ...+.+|+.+|++++||||+++++++...+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 4689999999999999764 689999875321 235889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIEE 241 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~~ 241 (382)
.++++...... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 88876655432 236788889999999999999999988 99999999999999999999999999987654322
Q ss_pred cCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC--ccc------
Q 016789 242 AGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN--NFV------ 312 (382)
Q Consensus 242 ~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~------ 312 (382)
. .....+|+.|+|||.+... .|+.++|||||||++|||++|++||.... +.+.+........... ...
T Consensus 156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred c-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC--HHHHHHHHHHhcCCCChhhccchhccc
Confidence 2 2234578889999998654 58999999999999999999999986432 2222222221111110 000
Q ss_pred ---ccccCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 313 ---DHRLAGTFT-----TEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 313 ---d~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
........+ ...+..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000111 122467889999999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=357.05 Aligned_cols=256 Identities=23% Similarity=0.308 Sum_probs=195.7
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
++|+..+.||+|+||+||+|.+. ++.||+|++... ....+.+|+++|++++||||+++++++.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 46888899999999999999986 478999987532 24578999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
|+.+ ++.+++... ....+++..+..++.|++.||.|||+.+ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCC
Confidence 9965 455555432 1336899999999999999999999988 999999999999999999999999999866432
Q ss_pred cccCCCcccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcccc-----
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGV-FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFVD----- 313 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~d----- 313 (382)
.. ......+++.|+|||.+.... ++.++||||+||++|||++|+.||.... ....+...........+...
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--EIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC--HHHHHHHHHHhcCCCchhhcccccc
Confidence 22 233446788899999877665 5889999999999999999999997432 12222222221111111000
Q ss_pred -cccCCC------C-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 314 -HRLAGT------F-----TTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 314 -~~~~~~------~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+..... . ....+..+.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000000 0 0122357788999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=356.69 Aligned_cols=235 Identities=22% Similarity=0.332 Sum_probs=191.2
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC---------chHHHHHHHHHHhcCC--CCCccceeeEEEeCCe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS---------PRQEFVAEVTYLSEIR--HRNLVTLLGYCQQNGY 153 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~---------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~ 153 (382)
++|+..+.||+|+||+||+|+... ..||+|.+... ....+.+|+.+|++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 568889999999999999999864 78999986432 1234678999999986 8999999999999999
Q ss_pred eEEEEeecCC-CChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC-CCcEEEeecC
Q 016789 154 QMLVFEYLPN-GSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-NFIAKVADTG 231 (382)
Q Consensus 154 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-~~~~kl~DfG 231 (382)
.++||||+.+ +++.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccc
Confidence 9999999976 57777776643 6899999999999999999999988 999999999999985 4799999999
Q ss_pred CccccccccccCCCcccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCc
Q 016789 232 ISKLLENIEEAGPSHGSIVNVFRDPEVEESGVF-SEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNN 310 (382)
Q Consensus 232 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 310 (382)
+|+..... ......||+.|+|||.+.+..+ +.++||||+||++|||++|+.||... ... .....
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~i---~~~~~---- 221 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EEI---IRGQV---- 221 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHH---HHCCC----
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-----hHH---hhccc----
Confidence 99865432 2234567899999999987765 67799999999999999999999632 111 11111
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 311 FVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 311 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
.+... .+..+.+++.+||+.||++|||++|+++
T Consensus 222 ----~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 ----FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11112 2356788999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.1e-48 Score=353.14 Aligned_cols=255 Identities=23% Similarity=0.287 Sum_probs=194.1
Q ss_pred hCCCCCCeeeccCcccEEEEEECC-eeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEee
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFEY 160 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 160 (382)
++|+..+.||+|+||+||+|+++. ..||+|++.... ...+.+|+.+|++++||||+++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 468888999999999999999875 789999875432 35789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccccccc
Q 016789 161 LPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENIE 240 (382)
Q Consensus 161 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~~ 240 (382)
+.++.+..+.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9876666555432 36999999999999999999999987 9999999999999999999999999998764432
Q ss_pred ccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC--cc---c--
Q 016789 241 EAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN--NF---V-- 312 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~---~-- 312 (382)
.. .....+++.|+|||.+.+. .++.++||||+||++|||++|+.||.... ....+.+......... .. .
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 155 RK-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cc-cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC--HHHHHHHHHHhhCCCChhhccchhhh
Confidence 22 2233457789999998654 57999999999999999999999997432 2222222222111110 00 0
Q ss_pred ---ccccC-------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 313 ---DHRLA-------GTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 313 ---d~~~~-------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
+.... .......+..+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0011223457889999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=354.34 Aligned_cols=256 Identities=21% Similarity=0.250 Sum_probs=192.8
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC---CeeEEEEEccC-----CchHHHHHHHHHHhcC---CCCCccceeeEEEe----
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR---DTVVAIKRRVG-----SPRQEFVAEVTYLSEI---RHRNLVTLLGYCQQ---- 150 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~-----~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 150 (382)
.++|+..+.||+|+||+||+|++. ++.||+|++.. .....+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 367999999999999999999974 35799998642 2234577888877665 79999999999853
Q ss_pred -CCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEee
Q 016789 151 -NGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVAD 229 (382)
Q Consensus 151 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~D 229 (382)
....++++||+.+|++....... ...+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecc
Confidence 24679999999887765444322 346889999999999999999999988 99999999999999999999999
Q ss_pred cCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC
Q 016789 230 TGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN 309 (382)
Q Consensus 230 fGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 309 (382)
||+++...... ......+|+.|+|||++.+..|+.++||||+||++|||++|++||..... ...+...........
T Consensus 160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VDQLGKILDVIGLPG 235 (305)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCCC
T ss_pred hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhhCCCc
Confidence 99998654433 23345678899999999999999999999999999999999999974332 222222211111100
Q ss_pred c--------cccccc-------CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 310 N--------FVDHRL-------AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 310 ~--------~~d~~~-------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. ...... ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 000000 00111223456788999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=352.09 Aligned_cols=248 Identities=21% Similarity=0.235 Sum_probs=199.8
Q ss_pred hCCCCCCeeeccCcccEEEEEEC-----CeeEEEEEccC-------CchHHHHHHHHHHhcCCC-CCccceeeEEEeCCe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR-----DTVVAIKRRVG-------SPRQEFVAEVTYLSEIRH-RNLVTLLGYCQQNGY 153 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~-------~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 153 (382)
++|+..+.||+|+||+||+|... ++.||+|.+.. ...+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56899999999999999999862 36899998643 224568899999999966 899999999999999
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.+++|||+.+|+|.+++...+ .+.......++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999998764 5678888999999999999999988 999999999999999999999999999
Q ss_pred cccccccccCCCcccccccccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcc
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEESG--VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (382)
+.+............+++.|++||.+.+. .++.++|||||||+||||++|+.||......+....+........
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~---- 252 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE---- 252 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC----
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC----
Confidence 87765544444556678889999998654 478899999999999999999999976543332222211111111
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPK-----MEIVMT 351 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~~v~~ 351 (382)
...+...+..+.+++.+||+.||.+||| ++|+++
T Consensus 253 ------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1122334567889999999999999995 677775
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=346.50 Aligned_cols=256 Identities=20% Similarity=0.252 Sum_probs=189.7
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEe--------C
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQ--------N 151 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 151 (382)
++|+..+.||+|+||+||+|++.. +.||||++... ....+.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 578899999999999999999864 79999986432 23568899999999999999999999855 3
Q ss_pred CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecC
Q 016789 152 GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTG 231 (382)
Q Consensus 152 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 231 (382)
+..++||||+.++.+...... ...++......++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecc
Confidence 457999999987766544432 236888899999999999999999988 9999999999999999999999999
Q ss_pred Ccccccccccc---CCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcC
Q 016789 232 ISKLLENIEEA---GPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLS 307 (382)
Q Consensus 232 la~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 307 (382)
+++........ ......+|+.|+|||.+.+. .|+.++||||+||++|||++|+.||............. .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~--~~~~~ 240 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS--QLCGS 240 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HHHCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH--HhcCC
Confidence 99766533222 12234578899999998765 68999999999999999999999997433211111111 11111
Q ss_pred CCccccccc-------------CCCCCH-H------HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 308 SNNFVDHRL-------------AGTFTT-E------GMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 308 ~~~~~d~~~-------------~~~~~~-~------~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
...-..... ...... + ....+.+|+.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 110000000 000011 1 1345678999999999999999999885
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=355.21 Aligned_cols=263 Identities=22% Similarity=0.300 Sum_probs=193.0
Q ss_pred CCCCCCeeeccCcccEEEEEECC--eeEEEEEccCCchHHHHHHHHHHhcCCCCCccceeeEEEeC------CeeEEEEe
Q 016789 88 QFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGSPRQEFVAEVTYLSEIRHRNLVTLLGYCQQN------GYQMLVFE 159 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e 159 (382)
+|...++||+|+||+||+|++.. +.||+|++.... ....+|+++|++++||||+++++++... ..+++|||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 57778899999999999999864 789999876542 3345799999999999999999998543 35789999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC-cEEEeecCCcccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF-IAKVADTGISKLLEN 238 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~~~~~ 238 (382)
||++|.+....... .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+..
T Consensus 100 y~~~~~~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 100 YVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp CCSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred ccCCccHHHHHhhh--hccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 99766443333221 12346899999999999999999999988 99999999999999775 899999999987654
Q ss_pred ccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCC---------
Q 016789 239 IEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSS--------- 308 (382)
Q Consensus 239 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 308 (382)
... .....+++.|+|||.+.+ ..|+.++||||+||++|||++|++||..... ...+..........
T Consensus 176 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~--~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 176 GEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp TSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--HHHHHHHHHHHCCCCHHHHHHHC
T ss_pred Ccc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH--HHHHHHHHHHhCCChHHhhhhhc
Confidence 332 223456788999998765 5689999999999999999999999974332 22222211110000
Q ss_pred Cccccccc--------CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHHh
Q 016789 309 NNFVDHRL--------AGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE--LERIHEK 359 (382)
Q Consensus 309 ~~~~d~~~--------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~--L~~i~~~ 359 (382)
....+..+ ........+..+.+|+.+||+.||++|||+.|+++- ++++.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 00000000 001112234568889999999999999999999863 5555443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-46 Score=345.01 Aligned_cols=259 Identities=16% Similarity=0.173 Sum_probs=197.2
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCC-chHHHHHHHHHHhcCCCCCccc-eeeEEEeCCeeEEEEeecC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGS-PRQEFVAEVTYLSEIRHRNLVT-LLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~ 162 (382)
++|+..+.||+|+||+||+|.+. ++.||||..... ...++..|+++++.++|+|++. +.++..+.+..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 46888999999999999999986 479999986543 3457889999999998776555 455567778899999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeec---CCCcEEEeecCCccccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVD---ENFIAKVADTGISKLLENI 239 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~---~~~~~kl~DfGla~~~~~~ 239 (382)
+|++.+.+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+...
T Consensus 86 ~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 86 GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred CCchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 566766665432 36899999999999999999999988 99999999999875 4567999999999877543
Q ss_pred ccc------CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHH-HHHHhhcCCCccc
Q 016789 240 EEA------GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALI-QWVRSRLSSNNFV 312 (382)
Q Consensus 240 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 312 (382)
... ......+|+.|+|||.+.+..++.++|||||||++|||+||+.||............ ..........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~--- 236 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 236 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC---
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC---
Confidence 322 123346789999999999999999999999999999999999999754433222211 1111111100
Q ss_pred ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 313 DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 313 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
.+.+. ...+..+.+++.+||+.||++||++.++.+.|+.+...
T Consensus 237 ~~~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 237 IEVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhHhc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 01111 12346688999999999999999999999999987643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.1e-46 Score=340.71 Aligned_cols=260 Identities=16% Similarity=0.156 Sum_probs=207.0
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-chHHHHHHHHHHhcCCC-CCccceeeEEEeCCeeEEEEeecC
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-PRQEFVAEVTYLSEIRH-RNLVTLLGYCQQNGYQMLVFEYLP 162 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~ 162 (382)
++|++.+.||+|+||+||+|++.. +.||+|..... ....+.+|++++..++| +|++.+++++......++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 568889999999999999999764 79999986543 34568889999999975 89999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecC-----CCcEEEeecCCccccc
Q 016789 163 NGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDE-----NFIAKVADTGISKLLE 237 (382)
Q Consensus 163 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~-----~~~~kl~DfGla~~~~ 237 (382)
+|+|.+++...+ ..+++.....++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+...
T Consensus 84 ~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 789999887643 36899999999999999999999988 999999999999974 5789999999998764
Q ss_pred ccccc------CCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcc
Q 016789 238 NIEEA------GPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNF 311 (382)
Q Consensus 238 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (382)
..... ......||+.|||||.+.+..++.++|||||||++|||+||+.||.......................
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~- 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP- 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC-
Confidence 33211 12234588999999999999999999999999999999999999976554443333222221100000
Q ss_pred cccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHh
Q 016789 312 VDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTELERIHEK 359 (382)
Q Consensus 312 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~L~~i~~~ 359 (382)
-+.+.. ..++.+.+++..|++.+|.+||++..+.+.|+++.++
T Consensus 237 -~~~l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 237 -LRELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp -HHHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -hHHhcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 001111 1235688899999999999999999999999888654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.7e-46 Score=345.48 Aligned_cols=253 Identities=16% Similarity=0.208 Sum_probs=195.4
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCchHHHHHHHHHHhcCC-CCCccceeeEEEeC--CeeEEEEeec
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSPRQEFVAEVTYLSEIR-HRNLVTLLGYCQQN--GYQMLVFEYL 161 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~~ 161 (382)
++|+..+.||+|+||+||+|++. ++.||+|++.....+.+.+|+++|++++ ||||+++++++... ...++|||||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 47899999999999999999986 4799999988877888999999999995 99999999999743 5689999999
Q ss_pred CCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCC-cEEEeecCCcccccccc
Q 016789 162 PNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENF-IAKVADTGISKLLENIE 240 (382)
Q Consensus 162 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~-~~kl~DfGla~~~~~~~ 240 (382)
++|+|.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+|+......
T Consensus 115 ~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 115 NNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp CSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred CCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999987653 25889999999999999999999988 99999999999998654 69999999998765433
Q ss_pred ccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChh-----------HHHHHHHhh-cC
Q 016789 241 EAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYE-----------ALIQWVRSR-LS 307 (382)
Q Consensus 241 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~-----------~~~~~~~~~-~~ 307 (382)
. .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ....+.... ..
T Consensus 185 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 185 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred c--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 2 2334567889999998765 4799999999999999999999999754321110 001111110 00
Q ss_pred CCccc------------ccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 308 SNNFV------------DHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 308 ~~~~~------------d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..... ............+..+.+|+.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 000111111223456889999999999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=350.16 Aligned_cols=255 Identities=18% Similarity=0.223 Sum_probs=190.3
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc----hHHHHHHHHHHhcCCCCCccceeeEEEeCC----eeEE
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNG----YQML 156 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~l 156 (382)
.+|+..+.||+|+||+||+|... ++.||||++.... .+.+.+|+++|++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 45888899999999999999886 4789999876432 246889999999999999999999997643 2345
Q ss_pred EEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCcccc
Q 016789 157 VFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLL 236 (382)
Q Consensus 157 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~ 236 (382)
+++|+.+|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 56677799999999653 5899999999999999999999988 999999999999999999999999999876
Q ss_pred cccccc--CCCcccccccccCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCcc--
Q 016789 237 ENIEEA--GPSHGSIVNVFRDPEVEE-SGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNF-- 311 (382)
Q Consensus 237 ~~~~~~--~~~~~~~~~~y~aPE~~~-~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 311 (382)
...... ......+++.|+|||.+. ...++.++||||+||++|||++|+.||......+ ...............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQEDL 237 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH--HHHHHhhhccCCChhhh
Confidence 443322 223455788899999984 4567899999999999999999999997543211 111111110000000
Q ss_pred -----------c--ccccCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 312 -----------V--DHRLAGTFT-----TEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 312 -----------~--d~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
. .+.. ...+ ......+.+++.+||+.||.+|||+.|+++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000 0000 1113467899999999999999999999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-46 Score=348.16 Aligned_cols=255 Identities=19% Similarity=0.300 Sum_probs=189.1
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeCC------e
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQNG------Y 153 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~ 153 (382)
++|+..+.||+|+||+||+|.+. ++.||+|++.... .+.+.+|+++|++++||||+++++++...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 57888899999999999999986 4789999976432 246889999999999999999999997654 5
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.++||||+ +++|....... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|++|||+|
T Consensus 98 ~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccccccce
Confidence 69999999 56676665432 5899999999999999999999988 999999999999999999999999999
Q ss_pred cccccccccCCCcccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCC---
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEES-GVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSN--- 309 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 309 (382)
+..... .....+++.|+|||.+.+ ..++.++||||+||++|||++|++||..... ...+...........
T Consensus 169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--LDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHH
T ss_pred eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh--HHHHHHHHhccCCCcHHH
Confidence 866432 234567788999999876 4578999999999999999999999964321 111111111111100
Q ss_pred -----------------cccccccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHH
Q 016789 310 -----------------NFVDHRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE--LERIH 357 (382)
Q Consensus 310 -----------------~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~--L~~i~ 357 (382)
......+. .........+.+|+.+||+.||.+|||+.|+++- |+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00000000 0111223467789999999999999999999873 54443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=338.10 Aligned_cols=255 Identities=20% Similarity=0.248 Sum_probs=197.9
Q ss_pred hCCCCCCeeeccCcccEEEEEECC--eeEEEEEccCC-----chHHHHHHHHHHhcCCCCCccceeeEEEeCCeeEEEEe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLRD--TVVAIKRRVGS-----PRQEFVAEVTYLSEIRHRNLVTLLGYCQQNGYQMLVFE 159 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 159 (382)
++|+..+.||+|+||+||+|++.. +.||||++... ....+.+|+.+|+.++||||+++++++......++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 468888999999999999999864 68999986432 23578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCccccccc
Q 016789 160 YLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGISKLLENI 239 (382)
Q Consensus 160 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~~~~~~ 239 (382)
++.+++|..++...+ .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccccc-----ccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999998888776543 6788999999999999999999988 999999999999999999999999999876543
Q ss_pred cccCCCcccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHh-hcCCCc-------
Q 016789 240 EEAGPSHGSIVNVFRDPEVEESGV-FSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRS-RLSSNN------- 310 (382)
Q Consensus 240 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~------- 310 (382)
... .....+++.|+|||.+.... ++.++||||+||++|||++|+.||.... +.......+.. ......
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCCCChhhhhhhh
Confidence 322 22334567799999987665 6999999999999999999999975322 22222222221 111100
Q ss_pred -ccc---------cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 311 -FVD---------HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 311 -~~d---------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
..+ ..-...........+.+|+.+||+.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00000112233456788999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=339.59 Aligned_cols=252 Identities=19% Similarity=0.248 Sum_probs=184.8
Q ss_pred hCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEe------CCe
Q 016789 87 KQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQ------NGY 153 (382)
Q Consensus 87 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 153 (382)
++|+..++||+|+||+||+|.+. +..||||++.... ...+.+|+.+|++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 46888899999999999999986 4899999976431 2358899999999999999999999964 368
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.|+|||||.+ ++.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~-~l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccch-HHHHhhhc-------CCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhh
Confidence 8999999965 45554432 5789999999999999999999988 999999999999999999999999998
Q ss_pred cccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHH----------
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVR---------- 303 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~---------- 303 (382)
+...... ......+|+.|+|||++.+..++.++||||+||++|||++|+.||..... .........
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~--~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY--IDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCHHHH
T ss_pred hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH--HHHHHHHHHhccCCCHHHH
Confidence 8654322 22334567889999999999999999999999999999999999964321 111111111
Q ss_pred ------------hhcCCCc-----ccccccCC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 016789 304 ------------SRLSSNN-----FVDHRLAG---TFTTEGMRDLIRLTLQCMSSPGRRRPKMEIVMTE 352 (382)
Q Consensus 304 ------------~~~~~~~-----~~d~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~~ 352 (382)
....... ........ ......+..+.+|+.+||+.||++|||++|+++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 00000000 1123456788999999999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=337.14 Aligned_cols=251 Identities=18% Similarity=0.244 Sum_probs=188.2
Q ss_pred HhCCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc-----hHHHHHHHHHHhcCCCCCccceeeEEEeC-----Ce
Q 016789 86 TKQFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP-----RQEFVAEVTYLSEIRHRNLVTLLGYCQQN-----GY 153 (382)
Q Consensus 86 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 153 (382)
+++|+..+.||+|+||+||+|++. ++.||+|++.... .+.+.+|+++|++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 356889999999999999999976 4799999976432 24678999999999999999999998643 34
Q ss_pred eEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEeecCCc
Q 016789 154 QMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVADTGIS 233 (382)
Q Consensus 154 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~DfGla 233 (382)
.+++++|+.+|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchh
Confidence 46777888899999988542 5899999999999999999999988 999999999999999999999999999
Q ss_pred cccccccccCCCcccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccCCCChhHHHHHHHhhcCCCccc
Q 016789 234 KLLENIEEAGPSHGSIVNVFRDPEVEESG-VFSEMSDIYSFGVFLLELVTGQEASHIVSLGSYEALIQWVRSRLSSNNFV 312 (382)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (382)
...... .....+++.|+|||...+. .++.++||||+||++|||++|+.||...... ...............-.
T Consensus 169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~--~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVGTPGAEL 242 (348)
T ss_dssp -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCHHH
T ss_pred cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCChHH
Confidence 765432 2234567789999987665 4689999999999999999999999643211 11111111111100000
Q ss_pred -------------c--cccCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 016789 313 -------------D--HRLAGTFT-----TEGMRDLIRLTLQCMSSPGRRRPKMEIVMT 351 (382)
Q Consensus 313 -------------d--~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~~v~~ 351 (382)
. .... ... ...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMP-KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCC-CCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccchhhhhhhhhcccCC-CcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 0000 000 112356788999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-39 Score=305.75 Aligned_cols=256 Identities=18% Similarity=0.212 Sum_probs=187.2
Q ss_pred CCCCCCeeeccCcccEEEEEEC--CeeEEEEEccCCc--hHHHHHHHHHHhcCC-----------CCCccceeeEEEeC-
Q 016789 88 QFSETSLIGFGSFGPVYKGLLR--DTVVAIKRRVGSP--RQEFVAEVTYLSEIR-----------HRNLVTLLGYCQQN- 151 (382)
Q Consensus 88 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~- 151 (382)
+|+..++||+|+||+||+|+.. ++.||||++.... .+.+.+|+.+++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 4888999999999999999985 4899999987553 356788998888775 57899999988643
Q ss_pred -CeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhc-CCCCceecCCCCCCeeecCCC------
Q 016789 152 -GYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHS-LKPPLVHKNFKTANVLVDENF------ 223 (382)
Q Consensus 152 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~ivHrDlk~~Nill~~~~------ 223 (382)
...+++++++..+.......... ....+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEE
T ss_pred ccceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccccc
Confidence 56677777776655443333322 23468889999999999999999997 66 99999999999998654
Q ss_pred cEEEeecCCccccccccccCCCcccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccCCCCh----hHHH
Q 016789 224 IAKVADTGISKLLENIEEAGPSHGSIVNVFRDPEVEESGVFSEMSDIYSFGVFLLELVTGQEASHIVSLGSY----EALI 299 (382)
Q Consensus 224 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvws~G~vl~el~tg~~p~~~~~~~~~----~~~~ 299 (382)
.++++|||.+..... ......+++.|+|||.+....++.++|+||+||+++||++|+.||........ ..+.
T Consensus 170 ~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 499999999975433 22344577889999999999999999999999999999999999874432211 1111
Q ss_pred HHHHhhcCC-----------------C----cccc---------cccCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 016789 300 QWVRSRLSS-----------------N----NFVD---------HRLAGTFTTEGMRDLIRLTLQCMSSPGRRRPKMEIV 349 (382)
Q Consensus 300 ~~~~~~~~~-----------------~----~~~d---------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~~v 349 (382)
......... . .... ...........+..+.+|+.+||+.||.+|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 111110000 0 0000 001122356678899999999999999999999999
Q ss_pred HH
Q 016789 350 MT 351 (382)
Q Consensus 350 ~~ 351 (382)
++
T Consensus 326 L~ 327 (362)
T d1q8ya_ 326 VN 327 (362)
T ss_dssp HT
T ss_pred hc
Confidence 76
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1.5e-24 Score=184.44 Aligned_cols=158 Identities=13% Similarity=0.071 Sum_probs=113.8
Q ss_pred CCCeeeccCcccEEEEEECC-eeEEEEEccCCc---------------------hHHHHHHHHHHhcCCCCCccceeeEE
Q 016789 91 ETSLIGFGSFGPVYKGLLRD-TVVAIKRRVGSP---------------------RQEFVAEVTYLSEIRHRNLVTLLGYC 148 (382)
Q Consensus 91 ~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~---------------------~~~~~~e~~~l~~l~h~niv~l~~~~ 148 (382)
..+.||+|+||+||+|.+.+ ..||||...... ......|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 45789999999999998754 899999743210 01245678889999999999887653
Q ss_pred EeCCeeEEEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCeeecCCCcEEEe
Q 016789 149 QQNGYQMLVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSLKPPLVHKNFKTANVLVDENFIAKVA 228 (382)
Q Consensus 149 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ivHrDlk~~Nill~~~~~~kl~ 228 (382)
. .+++|||++++.+.+ ++......++.|++.+|.|||+++ |+||||||+|||++++ .++|+
T Consensus 84 ~----~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 84 G----NAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp T----TEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEEC
T ss_pred C----CEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEE
Confidence 2 379999998765433 222334568999999999999988 9999999999999965 58999
Q ss_pred ecCCccccccccccCCCcccccccccC------ccccccCCCCccchhHHHHHHH
Q 016789 229 DTGISKLLENIEEAGPSHGSIVNVFRD------PEVEESGVFSEMSDIYSFGVFL 277 (382)
Q Consensus 229 DfGla~~~~~~~~~~~~~~~~~~~y~a------PE~~~~~~~~~~sDvws~G~vl 277 (382)
|||+|....+..... |.. .+.+ ...|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~~---------~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWRE---------ILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHH---------HHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcHH---------HHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999997654321110 111 0111 24578899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.58 E-value=1.6e-07 Score=81.50 Aligned_cols=145 Identities=14% Similarity=0.129 Sum_probs=96.8
Q ss_pred HHHHHHHhCCCCCCeeeccCcccEEEEEECCeeEEEEEccCC---chHHHHHHHHHHhcCC-CCCccceeeEEEeCCeeE
Q 016789 80 EELEQATKQFSETSLIGFGSFGPVYKGLLRDTVVAIKRRVGS---PRQEFVAEVTYLSEIR-HRNLVTLLGYCQQNGYQM 155 (382)
Q Consensus 80 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 155 (382)
.++...-..|+..+..+.++.+.||+....+..+.+|+.... ....+.+|...+..+. +--+.+++.+...++..+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 345555566665554444445789999887777888876533 2345778888877764 444677888888888999
Q ss_pred EEEeecCCCChhhhhhhcCCCCCCcCCHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 016789 156 LVFEYLPNGSMCNHLYETGLESSTKLEFKQRVSIALGAAKGLCHLHSL-------------------------------- 203 (382)
Q Consensus 156 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------- 203 (382)
+||+++++.++.+..... .. ...++.+++..++.||+.
T Consensus 87 lv~~~l~G~~~~~~~~~~-------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE-------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHTTTC-------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEeccccccccccccc-------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 999999888775543211 01 112333344444444421
Q ss_pred -------------------------CCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 204 -------------------------KPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 204 -------------------------~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
.+.++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1127999999999999987777899999876
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.19 E-value=1.8e-06 Score=74.17 Aligned_cols=73 Identities=16% Similarity=0.226 Sum_probs=53.5
Q ss_pred eeccCc-ccEEEEEECC-eeEEEEEccCCchHHHHHHHHHHhcCC--CCCccceeeEEEeCCeeEEEEeecCCCChh
Q 016789 95 IGFGSF-GPVYKGLLRD-TVVAIKRRVGSPRQEFVAEVTYLSEIR--HRNLVTLLGYCQQNGYQMLVFEYLPNGSMC 167 (382)
Q Consensus 95 lg~G~~-g~V~~~~~~~-~~vavK~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 167 (382)
+..|.. +.||+....+ ..+.+|.........+..|...++.+. .-.+.+++++..+.+..++||+|++|-++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444543 5789988766 457888776666667888888888774 334667888888888889999999876653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.74 E-value=0.00014 Score=66.39 Aligned_cols=72 Identities=18% Similarity=0.155 Sum_probs=45.4
Q ss_pred CeeeccCcccEEEEEECC--eeEEEEEccC------C----chHHHHHHHHHHhcCC-C--CCccceeeEEEeCCeeEEE
Q 016789 93 SLIGFGSFGPVYKGLLRD--TVVAIKRRVG------S----PRQEFVAEVTYLSEIR-H--RNLVTLLGYCQQNGYQMLV 157 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~--~~vavK~~~~------~----~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 157 (382)
+.||.|....||+....+ +.+++|.-.. . ..+....|.+.|+.+. + ..+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999997654 5788885321 1 1234556887777662 2 345555544 34456789
Q ss_pred EeecCCCCh
Q 016789 158 FEYLPNGSM 166 (382)
Q Consensus 158 ~e~~~~gsL 166 (382)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.48 E-value=0.0093 Score=51.89 Aligned_cols=158 Identities=11% Similarity=0.054 Sum_probs=85.2
Q ss_pred cCHHHHHHHHhCCCCCCeee-----ccCcccEEEEEECCeeEEEEEccCC-chHHHHHHHHHHhcCCC-----CCcccee
Q 016789 77 FSMEELEQATKQFSETSLIG-----FGSFGPVYKGLLRDTVVAIKRRVGS-PRQEFVAEVTYLSEIRH-----RNLVTLL 145 (382)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~lg-----~G~~g~V~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~h-----~niv~l~ 145 (382)
++.+++....++|...++.. .|---+.|+....+..+++|+.... ...+...|+++|..+.. |..+...
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~ 82 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK 82 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceec
Confidence 46678888888898765543 4555778999888888899886543 33455567777776632 2222110
Q ss_pred -e--EEEeCCeeEEEEeecCCCChhh--------------hhhhcCC----CCCCcCCH------------------HHH
Q 016789 146 -G--YCQQNGYQMLVFEYLPNGSMCN--------------HLYETGL----ESSTKLEF------------------KQR 186 (382)
Q Consensus 146 -~--~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~----~~~~~l~~------------------~~~ 186 (382)
| +.........++.+..+..... .++.... ........ ...
T Consensus 83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (316)
T d2ppqa1 83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 162 (316)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence 1 1223345566677766543221 1111100 00000000 011
Q ss_pred HHHHHHHHHHHHHHhc--CCCCceecCCCCCCeeecCCCcEEEeecCCcc
Q 016789 187 VSIALGAAKGLCHLHS--LKPPLVHKNFKTANVLVDENFIAKVADTGISK 234 (382)
Q Consensus 187 ~~i~~~ia~~L~~LH~--~~~~ivHrDlk~~Nill~~~~~~kl~DfGla~ 234 (382)
...+......+.-.+- ...++||+|+.++|++++++...-|.||+.+.
T Consensus 163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1122222222222221 12349999999999999998877899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.19 E-value=0.006 Score=55.14 Aligned_cols=70 Identities=21% Similarity=0.272 Sum_probs=44.9
Q ss_pred CeeeccCcccEEEEEECC---------eeEEEEEccCC-chHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeeEEEEeec
Q 016789 93 SLIGFGSFGPVYKGLLRD---------TVVAIKRRVGS-PRQEFVAEVTYLSEIRHRNL-VTLLGYCQQNGYQMLVFEYL 161 (382)
Q Consensus 93 ~~lg~G~~g~V~~~~~~~---------~~vavK~~~~~-~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~ 161 (382)
+.|+.|-.-.+|+....+ ..+.++..... ...+..+|..+++.+.-.++ .++++++.+ .+|+||+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence 467778888999998753 23555543322 22345678888888753344 467776643 5899999
Q ss_pred CCCCh
Q 016789 162 PNGSM 166 (382)
Q Consensus 162 ~~gsL 166 (382)
++-++
T Consensus 124 ~g~~l 128 (395)
T d1nw1a_ 124 PSRPL 128 (395)
T ss_dssp CEEEC
T ss_pred ccccC
Confidence 87544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.00 E-value=0.025 Score=49.39 Aligned_cols=66 Identities=14% Similarity=0.147 Sum_probs=42.0
Q ss_pred cccEEEEEECC-eeEEEEEccCC--chHHHHHHHHHHhcCCCC-----Ccccee--eEEEeCCeeEEEEeecCCCC
Q 016789 100 FGPVYKGLLRD-TVVAIKRRVGS--PRQEFVAEVTYLSEIRHR-----NLVTLL--GYCQQNGYQMLVFEYLPNGS 165 (382)
Q Consensus 100 ~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~e~~~l~~l~h~-----niv~l~--~~~~~~~~~~lv~e~~~~gs 165 (382)
--.||+....+ ..+++|.-... ...++..|...+..|... ..+..- ......+..+.++++++|..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 35799998765 67889876543 456788888888776321 111111 12345567788999987643
|